PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Das, C; Lucia, MS; Hansen, KC; Tyler, JK				Das, Chandrima; Lucia, M. Scott; Hansen, Kirk C.; Tyler, Jessica K.			CBP/p300-mediated acetylation of histone H3 on lysine 56	NATURE			English	Article							IN-GEL DIGESTION; DNA-REPLICATION; S-PHASE; H3K56 ACETYLATION; CHAPERONE ASF1; CELL-CYCLE; PROTEIN; REPAIR; RTT109; ACETYLTRANSFERASE	Acetylation within the globular core domain of histone H3 on lysine 56 (H3K56) has recently been shown to have a critical role in packaging DNA into chromatin following DNA replication and repair in budding yeast(1,2). However, the function or occurrence of this specific histone mark has not been studied in multicellular eukaryotes, mainly because the Rtt109 enzyme that is known to mediate acetylation of H3K56 (H3K56ac) is fungal-specific(3,4). Here we demonstrate that the histone acetyl transferase CBP (also known as Nejire) in flies and CBP and p300 (Ep300) in humans acetylate H3K56, whereas Drosophila Sir2 and human SIRT1 and SIRT2 deacetylate H3K56ac. The histone chaperones ASF1A in humans and Asf1 in Drosophila are required for acetylation of H3K56 in vivo, whereas the histone chaperone CAF-1 (chromatin assembly factor 1) in humans and Caf1 in Drosophila are required for the incorporation of histones bearing this mark into chromatin. We show that, in response to DNA damage, histones bearing acetylated K56 are assembled into chromatin in Drosophila and human cells, forming foci that colocalize with sites of DNA repair. Furthermore, acetylation of H3K56 is increased in multiple types of cancer, correlating with increased levels of ASF1A in these tumours. Our identification of multiple proteins regulating the levels of H3K56 acetylation in metazoans will allow future studies of this critical and unique histone modification that couples chromatin assembly to DNA synthesis, cell proliferation and cancer.	[Das, Chandrima; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Lucia, M. Scott] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Hansen, Kirk C.] Univ Colorado, Sch Med, Canc Ctr Prote Core, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, POB 6511, Aurora, CO 80045 USA.	jessica.tyler@uchsc.edu	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810; Tyler, Jessica/0000-0001-9765-1659	National Institutes of Health [GM64475, CA95641]; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kadonaga for Drosophila embryos and the Sir2 antibody, A. Mazo for the CBP antisera, and E. Nigg for ASF1A/B antisera. We thank C. Wike and the UC microscope core, and the UCCC flow cytometry core for assistance. This work was supported by funding from the National Institutes of Health (grants GM64475 and CA95641) to J. K. T.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Florence B, 1998, GENETICS, V150, P1497; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Frei C, 2000, GENE DEV, V14, P81; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	41	516	533	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					113	U123		10.1038/nature07861	http://dx.doi.org/10.1038/nature07861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270680	Green Accepted			2022-12-28	WOS:000265801300040
J	Wolf, D; Goff, SP				Wolf, Daniel; Goff, Stephen P.			Embryonic stem cells use ZFP809 to silence retroviral DNAs	NATURE			English	Article							PRIMER-BINDING-SITE; MURINE LEUKEMIA-VIRUS; CARCINOMA-CELLS; TRANSFER-RNA; HTLV-I; PROTEIN; EXPRESSION; TRIM28; ASSAYS; ZINC	Embryonic stem cells (ESCs) and other primitive stem cells of mice have been known for more than 30 years to potently block retrovirus replication(1). Infection of ESCs by the murine leukaemia viruses (MLVs) results in the normal establishment of integrated proviral DNA, but this DNA is then transcriptionally silenced, preventing further viral spread. The repression is largely mediated by transacting factors that recognize a conserved sequence element termed the primer binding site, an 18-base pair sequence complementary to the 39 end of a cellular transfer RNA(2-6). A specific tRNA is annealed to the primer binding site sequence of the viral genomic RNA, and is used to prime DNA synthesis(7). This same sequence in the context of the integrated proviral DNA is targeted for silencing in ESCs. We have recently shown that a large protein complex binding to the primer binding site in ESCs contains TRIM28 (refs 8, 9), a well-characterized transcriptional co-repressor(10-12). An important question remains as to the identity of the factor that directly recognizes integrated retroviral DNAs and recruits TRIM28 to mediate their specific silencing. Here we identify the zinc finger protein ZFP809 as the recognition molecule that bridges the integrated proviral DNA and TRIM28. We show that expression of ZFP809 is sufficient to render even differentiated cells highly resistant to MLV infection. Furthermore, we demonstrate that ZFP809 is able to potently block transcription from DNA constructs of human T-cell lymphotropic virus-1 (HTLV-1), which use the same primer tRNA. These results identify ZFP809 as a DNA-binding factor that specifically recognizes a large subset of mammalian retroviruses and retroelements, targeting them for transcriptional silencing. We propose that ZFP809 evolved as a stem-cell-specific retroviral restriction factor, and therefore constitutes a new component of the intrinsic immune system of stem cells.	[Wolf, Daniel; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, HHSC 1310,701 W 168th St, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	National Cancer Institute [R37 CA 30488]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant R37 CA 30488 from the National Cancer Institute. We thank D. Derse, F. Bouamr and E. Barklis for their generosity with reagents. We are grateful to M. de los Santos, H. Nickerson and M. A. Gawinowicz (Protein Core Facility Columbia University) for technical assistance. We would also like to thank P. Adusumilli, M. Banes, M. Bilsky, J. Yamada and co-workers, without whose help this paper would never have been written. D. W. is an Associate, and S. P. G. is an Investigator of the Howard Hughes Medical Institute.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; HARADA F, 1979, J BIOL CHEM, V254, P979; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; YAMAUCHI M, 1995, J VIROL, V69, P1142, DOI 10.1128/JVI.69.2.1142-1149.1995	22	260	265	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1201	1204		10.1038/nature07844	http://dx.doi.org/10.1038/nature07844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19270682	Green Accepted			2022-12-28	WOS:000265754600053
J	Wardlaw, D; Cummings, SR; Van Meirhaeghe, J; Bastian, L; Tillman, JB; Ranstam, J; Eastell, R; Shabe, P; Talmadge, K; Boonen, S				Wardlaw, Douglas; Cummings, Steven R.; Van Meirhaeghe, Jan; Bastian, Leonard; Tillman, John B.; Ranstam, Jonas; Eastell, Richard; Shabe, Peter; Talmadge, Karen; Boonen, Steven			Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; OSTEOPOROTIC FRACTURES; IMPORTANT DIFFERENCE; BACK-PAIN; OUTCOMES; QUESTIONNAIRE; ASSOCIATION; PREVALENT; SPINE	Background Balloon kyphoplasty is a minimally invasive procedure for the treatment of painful vertebral fractures, which is intended to reduce pain and improve quality of life. We assessed the efficacy and safety of the procedure. Methods Adults with one to three acute vertebral fractures were eligible for enrolment in this randomised controlled trial at 21 sites in eight countries. We randomly assigned 300 patients by a computer-generated sequence to receive kyphoplasty treatment (n=149) or non-surgical care (n=151). The primary outcome was the difference in change from baseline to 1 month in the short-form (SF)-36 physical component summary (PCS) score (scale 0-100) between the kyphoplasty and control groups. Quality of life and other efficacy measurements and safety were assessed up to 12 months. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00211211. Findings 138 participants in the kyphoplasty group and 128 controls completed follow-up at 1 month. By use of repeated measures mixed effects modelling, all 300 randomised participants were included in the analysis. Mean SF-36 PCS score improved by 7.2 points (95% CI 5.7-8.8), from 26.0 at baseline to 33.4 at 1 month, in the kyphoplasty group, and by 2.0 points (0.4-3.6), from 25.5 to 27.4, in the non-surgical group (difference between groups 5.2 points, 2.9-7.4; p<0.0001). The frequency of adverse events did not differ between groups. There were two serious adverse events related to kyphoplasty (haematoma and urinary tract infection); other serious adverse events (such as myocardial infarction and pulmonary embolism) did not occur perioperatively and were not related to procedure. Interpretation Our findings suggest that balloon Icyphoplasty is an effective and safe procedure for patients with acute vertebral fractures and will help to inform decisions regarding its use as an early treatment option. Funding Medtronic Spine LLC.	[Wardlaw, Douglas] Woodend Gen Hosp, Dept Orthopaed, NHS Grampian, Aberdeen AB15 6ZQ, Scotland; [Cummings, Steven R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [Van Meirhaeghe, Jan] Algemeen Ziekenhuis St Jan, Dienst Orthopedie & Traumatol, Brugge, Belgium; [Bastian, Leonard] Klinikum Leverkusen, Leverkusen, Germany; [Tillman, John B.; Talmadge, Karen] Medtron Spine LLC, Sunnyvale, CA USA; [Ranstam, Jonas] Univ Lund Hosp, Swedish Natl Competence Ctr Musculoskeletal Disor, S-22185 Lund, Sweden; [Eastell, Richard] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England; [Shabe, Peter] Adv Res Associates Inc, Mountain View, CA USA; [Boonen, Steven] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium	University of Aberdeen; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Lund University; Skane University Hospital; University of Sheffield; KU Leuven	Wardlaw, D (corresponding author), Woodend Gen Hosp, Dept Orthopaed, NHS Grampian, Aberdeen AB15 6ZQ, Scotland.	d.wardlaw@nhs.net	Wardlaw, Douglas/AAF-6460-2020; Eastell, Richard/G-5851-2011; Ranstam, Jonas/A-4386-2009	Eastell, Richard/0000-0002-0323-3366; Ranstam, Jonas/0000-0002-8287-7273; Tillman, John/0000-0003-2912-2370	Medtronic Spine LLC; Fund for Scientific Research (FWO-Vlaanderen)	Medtronic Spine LLC; Fund for Scientific Research (FWO-Vlaanderen)(FWO)	This study was sponsored and funded by Medtronic Spine LLC. We thank the patients who consented to participate in the FREE trial and all participating staffat the investigational centres. We wish to acknowledge and dedicate this manuscript to the late Olof johnell, whose contributions as the original principal investigator were invaluable. We thank M Nevitt and P Lips for initial review of the data and manuscript and G Jiang for providing third readings of radiographic images. SB is senior clinical investigator of the Fund for Scientific Research (FWO-Vlaanderen). DW and SRC are co-primary authors. JR, biostatistician at the Swedish National Competence Centre for musculoskeletal disorders at Lund University Hospital, Sweden, did the independent statistical review.	Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P1781, DOI 10.1007/s00198-006-0193-z; Briggs AM, 2006, EUR SPINE J, V15, P1785, DOI 10.1007/s00586-006-0158-0; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Davidson M, 2004, SPINE, V29, P586, DOI 10.1097/01.BRS.0000103346.38557.73; EASTELL R, 1991, J BONE MINER RES, V6, P207; EuroQol Group, 1996, EQ 5D US GUID; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fribourg D, 2004, SPINE, V29, P2270, DOI 10.1097/01.brs.0000142469.41565.2a; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Garfin SR, 2006, SPINE, V31, P2213, DOI 10.1097/01.brs.0000232803.71640.ba; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Grafe IA, 2005, OSTEOPOROSIS INT, V16, P2005, DOI 10.1007/s00198-005-1982-5; Jiang G, 2004, OSTEOPOROSIS INT, V15, P887, DOI 10.1007/s00198-004-1626-1; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Komp M., 2004, J MINER STOFFWECH S1, V1, P13; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; LYRITIS G P, 1989, Clinical Rheumatology, V8, P66; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rothman K J, 1990, Epidemiology, V1, P417, DOI 10.1097/00001648-199011000-00001; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Silverman SL, 2001, ARTHRITIS RHEUM, V44, P2611, DOI 10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N; Sullivan M., 2002, SF 36 HALSOENKAT SVE; Voggenreiter G, 2005, SPINE, V30, P2806, DOI 10.1097/01.brs.0000190885.85675.a0; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; [No title captured]	30	554	607	2	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1016	1024		10.1016/S0140-6736(09)60010-6	http://dx.doi.org/10.1016/S0140-6736(09)60010-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19246088				2022-12-28	WOS:000264398200029
J	Mukherjee, D; Moliterno, DJ				Mukherjee, Debabrata; Moliterno, David J.			Effectiveness of PCI for non-acute coronary artery disease	LANCET			English	Editorial Material							MEDICAL THERAPY; RANDOMIZED-TRIALS; BYPASS SURGERY; RITA-2 TRIAL; OF-LIFE; INTERVENTION; ANGIOPLASTY; METAANALYSIS; ANGINA		[Mukherjee, Debabrata] Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA; Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Mukherjee, D (corresponding author), Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA.	Moliterno@uky.edu	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Alderman EL, 1996, NEW ENGL J MED, V335, P217; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chamberlain DA, 1997, LANCET, V350, P461; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Kapadia SR, 2004, J AM COLL CARDIOL, V44, P775, DOI 10.1016/j.jacc.2004.05.043; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; MacIver J, 2008, J HEART LUNG TRANSPL, V27, P1002, DOI 10.1016/j.healun.2008.06.002; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; Rihal CS, 2003, CIRCULATION, V108, P2439, DOI 10.1161/01.CIR.0000094405.21583.7C; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	13	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					870	872		10.1016/S0140-6736(09)60522-5	http://dx.doi.org/10.1016/S0140-6736(09)60522-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286067				2022-12-28	WOS:000264158700005
J	Patel, MR; Shen, K				Patel, Maulik R.; Shen, Kang			RSY-1 Is a Local Inhibitor of Presynaptic Assembly in C. elegans	SCIENCE			English	Article							CORNEAL EPITHELIAL-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN; SYNAPSES; GENE; DIFFERENTIATION; TRANSCRIPTION; BRUCHPILOT; MECHANISMS; COMPONENTS	As fundamental units of neuronal communication, chemical synapses are composed of presynaptic and postsynaptic specializations that form at specific locations with defined shape and size. Synaptic assembly must be tightly regulated to prevent overgrowth of the synapse size and number, but the molecular mechanisms that inhibit synapse assembly are poorly understood. We identified regulator of synaptogenesis-1 (RSY-1) as an evolutionarily conserved molecule that locally antagonized presynaptic assembly. The loss of RSY-1 in Caenorhabditis elegans led to formation of extra synapses and recruitment of excessive synaptic material to presynaptic sites. RSY-1 directly interacted with and negatively regulated SYD-2/liprin-alpha, a master assembly molecule that recruits numerous synaptic components to presynaptic sites. RSY-1 also bound and regulated SYD-1, a synaptic protein required for proper functioning of SYD-2. Thus, local inhibitory mechanisms govern synapse formation.	[Patel, Maulik R.; Shen, Kang] Stanford Univ, Neurosci Program, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Biol, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Pathol, Herrin Labs, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Neurosci Program, Herrin Labs, 385 Serra Mall,Room 144, Stanford, CA 94305 USA.	kangshen@stanford.edu			NIH [1R01NS048392, National Research Service Award predoctoral fellowship]; Human Frontier Science Foundation; Howard Hughes Medical Institute; W. M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Foundation(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the Caenorhabditis Genetics Center and the Japanese NBPR for strains; Y. Kohara (National Institute of Genetics, Japan) for Y53H1A.1 cDNAs; J. Audhya (University of California, San Diego) for C. elegans optimized mCherry cDNA; L. Luo (Stanford University) for vertebrate mCherry cDNA; T. Meyer (Stanford University) for eYFP-C3 plasmid; M. Park (Stanford University) for mCerulean-C1 plasmid; C. Gao for technical assistance; and members of the Shen lab, C. Bargmann, T. Clandinin, and L. Luo for critical comments on the manuscript. We would also like to thank B. Grill (Stanford University) for providing protocol and guidance for coimmunoprecipitation experiments. This work was funded by grants awarded to K.S. [from NIH (1R01NS048392), the Human Frontier Science Foundation, the Howard Hughes Medical Institute, and the W. M. Keck Foundation] and by a National Research Service Award predoctoral fellowship awarded to M.R.P. by NIH.	Alpatov R, 2004, MOL CELL BIOL, V24, P10223, DOI 10.1128/MCB.24.23.10223-10235.2004; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DEKEN SL, 2005, CELL, P5975; DESAI C, 1989, GENETICS, V121, P703; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FULGA TA, 2008, CAENORHABDITIS, P339; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Joo JH, 2005, MOL VIS, V11, P133; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; KO J, E KIM; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pin OY, 1999, BIOCHEM BIOPH RES CO, V263, P192, DOI 10.1006/bbrc.1999.1353; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang P, 2002, BIOCHEM BIOPH RES CO, V294, P448, DOI 10.1016/S0006-291X(02)00495-3; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zimowska G, 2003, INVEST OPHTH VIS SCI, V44, P4715, DOI 10.1167/iovs.03-0240	31	35	40	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1500	1503		10.1126/science.1169025	http://dx.doi.org/10.1126/science.1169025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286562	Green Accepted			2022-12-28	WOS:000264101700047
J	Buckley, B; Grant, AM				Buckley, Brian; Grant, Adrian M.			Uncertainties Page What is the most effective management of neurogenic bladder dysfunction?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grant, Adrian M.] Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen		bsbuckley@iol.ie	Buckley, Brian/B-4080-2010	Buckley, Brian/0000-0002-6007-9238				Broome Barbara Ann Shelton, 2003, Health Qual Life Outcomes, V1, P35, DOI 10.1186/1477-7525-1-35; Buckley B., 2007, CONTINENCE UK, V1, P76; *CONS SPIN CORD ME, 2006, BLADD MAN AD SPIN CO; Fowler CJ, 2003, J NEUROL NEUROSUR PS, V74, P27; HERBISON GP, 2003, COCHRANE DB SYST REV; Jamison J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004375.PUB2, 10.1002/14651858.CD004375.pub2]; Moore KN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006008.pub2; NABI G, 2003, COCHRANE DB SYST REV; NIELWEISE BS, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004201.PUB2; *NIH CLIN EXC ROY, 2006, UR INC MAN UR INC WO; *SOCTT INT GUID NE, 2004, MAN UR INC PRIM CAR; Stohrer M, 2003, GUIDELINES NEUROGENI; *U AB HLTH SERV RE, 2007, OUTC TRANSP INT SEGM	13	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2009	338								b659	10.1136/bmj.b659	http://dx.doi.org/10.1136/bmj.b659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FV	19282439				2022-12-28	WOS:000264205400004
J	Kuo, Y; Sharma, G; Freeman, JL; Goodwin, JS				Kuo, Yong-Fang; Sharma, Gulshan; Freeman, Jean L.; Goodwin, James S.			Growth in the Care of Older Patients by Hospitalists in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY-CARE; MEDICINE; SERVICE; PHYSICIANS; OUTCOMES; QUALITY; CANCER; ASSOCIATION; IMPACT; BREAST	Background: National and population-based information on the increase in patient care by hospitalists in the United States is lacking. Methods: Using a 5% sample of Medicare beneficiaries in 1995, 1997, 1999, and the period from 2001 through 2006, we identified 120,226 physicians in general internal medicine who were providing care to older patients in 5800 U.S. hospitals. We defined hospitalists as general internists who derived 90% or more of their Medicare claims for evaluation-and-management services from the care of hospitalized patients. We then calculated the percentage of all inpatient Medicare services provided by hospitalists and identified patient and hospital characteristics associated with the receipt of hospitalist services. Results: The percentage of physicians in general internal medicine who were identified as hospitalists increased from 5.9% in 1995 to 19.0% in 2006, and the percentage of all claims for inpatient evaluation-and-management services by general internists that were attributed to hospitalists increased from 9.1% to 37.1% during this same period. Accompanying the increase in care by hospitalists was an increase in the percentage of all hospitalized Medicare patients who were treated by general internists (both hospitalists and traditional, non-hospital-based general internists), from 46.4% in 1995 to 61.0% in 2006. In a multilevel, multivariable analysis controlling for patient and hospital characteristics, the odds of receiving care from a hospitalist increased by 29.2% per year from 1997 through 2006. In 2006, there was marked geographic variation in the rates of care provided by hospitalists, with rates of more than 70% in some hospital-referral regions. Conclusions: These analyses of data from Medicare claims showed a substantial increase in the care of hospitalized patients by hospitalist physicians from 1995 to 2006. N Engl J Med 2009;360:1102-12.	[Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kuo, Y (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	yokuo@utmb.edu			Americans Independence Center [5P30AG024832]; Center for Population Health and Health Disparities [5P50CA105631]; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE [P50CA105631, K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033134, P30AG024832] Funding Source: NIH RePORTER	Americans Independence Center; Center for Population Health and Health Disparities; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the Claude D. Pepper Older Americans Independence Center (5P30AG024832) and the Center for Population Health and Health Disparities (5P50CA105631) at the University of Texas Medical Branch.	Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Baldwin LM, 2002, MED CARE, V40, P82; Coffman J, 2005, MED CARE RES REV, V62, P379, DOI 10.1177/1077558705277379; Freed David H, 2004, Health Care Manag (Frederick), V23, P238; Freed GL, 2007, PEDIATRICS, V120, P33, DOI 10.1542/peds.2007-0304; Glasheen JJ, 2007, ARCH INTERN MED, V167, P727, DOI 10.1001/archinte.167.7.727; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Kralovec PD, 2006, J HOSP MED, V1, P75, DOI 10.1002/jhm.82; Lackan NA, 2004, MED CARE, V42, P116, DOI 10.1097/01.mlr.0000108765.86294.1b; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Saint S, 2000, Eff Clin Pract, V3, P35; *SHM, 2008, SOC HOSP MED REL RES; Snyder CF, 2008, J GEN INTERN MED, V23, P254, DOI 10.1007/s11606-007-0497-5; *SOC HOSP MED, 2007, HOSP MED SPEC SHOWS; The Dartmouth Atlas of Health Care, ZIP COD CROSSW FIL H; Vansaghi LM, 2008, AM J MED, V121, P349, DOI 10.1016/j.amjmed.2007.11.019; VASILEVSKIS EE, 2007, RISE HOSP CALIFORNIA; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008	27	180	180	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1102	1112		10.1056/NEJMsa0802381	http://dx.doi.org/10.1056/NEJMsa0802381			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279342	Bronze, Green Accepted			2022-12-28	WOS:000264051000008
J	Hyder, AA; Dawson, L; Bachani, AM; Lavery, JV				Hyder, Adrian A.; Dawson, Liza; Bachani, Abdulgafoor M.; Lavery, James V.			Moving from research ethics review to research ethics systems in low-income and middle-income countries	LANCET			English	Article							HEALTH RESEARCH		[Hyder, Adrian A.; Bachani, Abdulgafoor M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Hyder, Adrian A.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA; [Dawson, Liza] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Lavery, James V.] St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Lavery, James V.] St Michaels Hosp, Ctr Global Hlth Res, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Lavery, James V.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; [Lavery, James V.] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite E-8132, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Lavery, James/E-5254-2012; Hyder, Adnan/AAT-9503-2021	Hyder, Adnan/0000-0002-7292-577X				[Anonymous], 2006, ETH GUID BIOM RES HU; [Anonymous], 1999, DEV FREEDOM; Benatar SR, 2005, PLOS MED, V2, P587, DOI 10.1371/journal.pmed.0020143; Bhutta Z. A., 2004, BUILDING CAPACITY ET; Elsayed DEM, 2007, DEV WORLD BIOETH, V7, P143, DOI 10.1111/j.1471-8847.2006.00163.x; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Hyder AA, 2004, J MED ETHICS, V30, P68, DOI 10.1136/jme.2002.001933; Hyder AA, 2007, ACAD MED, V82, P675, DOI 10.1097/ACM.0b013e3180674484; *I MED, 2002, RESP RES SYST APPR P; Ikingura J K B, 2007, Tanzan Health Res Bull, V9, P154; Institute of Medicine and US National Research Council, 2002, INT SCI RES CREAT EN; KASS N, 2001, ETHICAL POLICY ISSUE, V3; Kass Nancy, 2003, IRB, V25, P1, DOI 10.2307/3563634; Kass NE, 2007, PLOS MED, V4, P26, DOI 10.1371/journal.pmed.0040003; LAVERY JV, 2001, WG25 WHO COMM MACR H; Luna F, 1999, BIOETHICS, V13, P262, DOI 10.1111/1467-8519.00155; *NAT CONS C BIOETH, 1997, GUID COND HLTH RES I; *OFF INSP GEN, 2008, INV REP END SPEC ACT, P1; Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815; Rivera R, 2001, IRB, V23, P9, DOI 10.2307/3564049; United Nations, 2008, MILL DEV GOALS IND O; VANBOGAERT DK, 2007, ETHICAL ISSUES INT B, P237	22	38	39	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					862	865		10.1016/S0140-6736(09)60488-8	http://dx.doi.org/10.1016/S0140-6736(09)60488-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416BT	19269523				2022-12-28	WOS:000263980900037
J	Long, YW; Hayashi, N; Saito, T; Azuma, M; Muranaka, S; Shimakawa, Y				Long, Y. W.; Hayashi, N.; Saito, T.; Azuma, M.; Muranaka, S.; Shimakawa, Y.			Temperature-induced A-B intersite charge transfer in an A-site-ordered LaCu3Fe4O12 perovskite	NATURE			English	Article							HIGH-DIELECTRIC-CONSTANT; CRYSTAL-STRUCTURE; PRESSURE; MAGNETORESISTANCE; INSULATOR; PHYSICS	Changes of valence states in transition-metal oxides often cause significant changes in their structural and physical properties(1,2). Chemical doping is the conventional way of modulating these valence states. In ABO(3) perovskite and/or perovskite-like oxides, chemical doping at the A site can introduce holes or electrons at the B site, giving rise to exotic physical properties like high-transition-temperature superconductivity and colossal magneto-resistance(3,4). When valence-variable transition metals at two different atomic sites are involved simultaneously, we expect to be able to induce charge transfer-and, hence, valence changes by using a small external stimulus rather than by introducing a doping element. Materials showing this type of charge transfer are very rare, however, and such externally induced valence changes have been observed only under extreme conditions like high pressure(5,6). Here we report unusual temperature-induced valence changes at the A and B sites in the A-site-ordered double perovskite LaCu3Fe4O12; the underlying intersite charge transfer is accompanied by considerable changes in the material's structural, magnetic and transport properties. When cooled, the compound shows a first-order, reversible transition at 393 K from LaCu32+Fe43.75+O12 with Fe3.75+ ions at the B site to LaCu33+Fe43+O12 with rare Cu3+ ions at the A site. Intersite charge transfer between the A-site Cu and B-site Fe ions leads to paramagnetism-to-antiferromagnetism and metal-to-insulator isostructural phase transitions. What is more interesting in relation to technological applications is that this above-room-temperature transition is associated with a large negative thermal expansion.	[Long, Y. W.; Saito, T.; Azuma, M.; Shimakawa, Y.] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Hayashi, N.; Muranaka, S.] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Long, YW (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	ywlong@msk.kuicr.kyoto-u.ac.jp; shimak@scl.kyoto-u.ac.jp	Azuma, Masaki/C-2945-2009; Saito, Takashi/G-9102-2011; Shimakawa, Yuichi/L-3231-2017; Long, Youwen/B-2930-2011	Azuma, Masaki/0000-0002-8378-321X; Saito, Takashi/0000-0002-2565-8795; Shimakawa, Yuichi/0000-0003-1019-2512; Long, Youwen/0000-0002-8587-7818	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [19GS0207, 18350097, 17038014, 19014010, 19340098]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Nishimura and K. Oka for help with the high-pressure synthesis and magnetic measurements, and we thank K. Jungeun for help with the SXRD experiments. Thanks are also due to M. Takano for discussions. This work was partly supported by Grants-in-Aid for Scientific Research (19GS0207, 18350097, 17038014, 19014010 and 19340098), by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' and by a grant for the Joint Project of Chemical Synthesis Core Research Institutions from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alonso JA, 2003, APPL PHYS LETT, V83, P2623, DOI 10.1063/1.1611647; Azuma M, 2007, J AM CHEM SOC, V129, P14433, DOI 10.1021/ja074880u; BLAAUW C, 1973, J PHYS C SOLID STATE, V6, P1422, DOI 10.1088/0022-3719/6/8/009; BOCQUET AE, 1992, PHYS REV B, V45, P1561, DOI 10.1103/PhysRevB.45.1561; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Goto T, 2003, ADV PHYS, V52, P67, DOI 10.1080/0001873021000057114; Homes CC, 2001, SCIENCE, V293, P673, DOI 10.1126/science.1061655; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; IMAI K, 1992, J PHYS SOC JPN, V61, P1819, DOI 10.1143/JPSJ.61.1819; Kawasaki S, 1996, J SOLID STATE CHEM, V121, P174, DOI 10.1006/jssc.1996.0025; Larson A.C., 1994, 86748 LAUR LOS AL NA; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; LI X, 1991, HYPERFINE INTERACT, V69, P851, DOI 10.1007/BF02401960; Prodi A, 2004, NAT MATER, V3, P48, DOI 10.1038/nmat1038; RIESEMEIER H, 1994, J PHYS CHEM SOLIDS, V55, P613, DOI 10.1016/0022-3697(94)90060-4; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; Sanchez-Benitez J, 2003, CHEM MATER, V15, P2193, DOI 10.1021/cm0212616; Seda T, 2004, J PHYS-CONDENS MAT, V16, P2707, DOI 10.1088/0953-8984/16/15/021; Shimakawa Y, 2008, INORG CHEM, V47, P8562, DOI 10.1021/ic800696u; Sleight AW, 1998, ANNU REV MATER SCI, V28, P29, DOI 10.1146/annurev.matsci.28.1.29; Subramanian MA, 2000, J SOLID STATE CHEM, V151, P323, DOI 10.1006/jssc.2000.8703; TAKANO M, 1977, MATER RES BULL, V12, P923, DOI 10.1016/0025-5408(77)90104-0; TAKANO M, 1981, J SOLID STATE CHEM, V39, P75, DOI 10.1016/0022-4596(81)90304-2; Takata K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024429; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Takenaka K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831715; Yamada I, 2008, ANGEW CHEM INT EDIT, V47, P7032, DOI 10.1002/anie.200801482; Zeng Z, 1999, PHYS REV LETT, V82, P3164, DOI 10.1103/PhysRevLett.82.3164	28	292	297	16	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					60	U3		10.1038/nature07816	http://dx.doi.org/10.1038/nature07816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262669				2022-12-28	WOS:000263836000032
J	Jorgensen, HF; Chen, ZF; Merkenschlager, M; Fisher, AG				Jorgensen, Helle F.; Chen, Zhou-Feng; Merkenschlager, Matthias; Fisher, Amanda G.			Is REST required for ESC pluripotency?	NATURE			English	Letter							EMBRYONIC STEM-CELLS; SELF-RENEWAL; NETWORK; GENES		[Jorgensen, Helle F.; Merkenschlager, Matthias; Fisher, Amanda G.] Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat & Dev Biol, St Louis, MO 63110 USA	Imperial College London; Washington University (WUSTL); Washington University (WUSTL)	Jorgensen, HF (corresponding author), Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	helle.jorgensen@imperial.ac.uk; amanda.fisher@csc.mrc.ac.uk		Merkenschlager, Matthias/0000-0003-2889-3288; Jorgensen, Helle/0000-0002-7909-2977	Medical Research Council [MC_U120027516] Funding Source: Medline; MRC [MC_U120027516] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Jorgensen HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r169; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780	13	48	50	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					E4	E5		10.1038/nature07783	http://dx.doi.org/10.1038/nature07783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242417				2022-12-28	WOS:000263680100053
J	Wu, HM; Harcourt, BH; Hatcher, CP; Wei, SC; Novak, RT; Wang, X; Juni, BA; Glennen, A; Boxrud, DJ; Rainbow, J; Schmink, S; Mair, RD; Theodore, MJ; Sander, MA; Miller, TK; Kruger, K; Cohn, AC; Clark, TA; Messonnier, NE; Mayer, LW; Lynfield, R				Wu, Henry M.; Harcourt, Brian H.; Hatcher, Cynthia P.; Wei, Stanley C.; Novak, Ryan T.; Wang, Xin; Juni, Billie A.; Glennen, Anita; Boxrud, David J.; Rainbow, Jean; Schmink, Susanna; Mair, Raydel D.; Theodore, M. Jordan; Sander, Molly A.; Miller, Tracy K.; Kruger, Kirby; Cohn, Amanda C.; Clark, Thomas A.; Messonnier, Nancy E.; Mayer, Leonard W.; Lynfield, Ruth			Brief Report: Emergence of Ciprofloxacin-Resistant Neisseria meningitidis in North America.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBIOTIC-RESISTANCE; MENINGOCOCCAL DISEASE; SUSCEPTIBILITY; IDENTIFICATION; INFECTIONS; MECHANISMS; COMMUNITY; RIFAMPIN; CLONES	We report on three cases of meningococcal disease caused by ciprofloxacin-resistant Neisseria meningitidis, one in North Dakota and two in Minnesota. The cases were caused by the same serogroup B strain. To assess local carriage of resistant N. meningitidis, we conducted a pharyngeal-carriage survey and isolated the resistant strain from one asymptomatic carrier. Sequencing of the gene encoding subunit A of DNA gyrase (gyrA) revealed a mutation associated with fluoroquinolone resistance and suggests that the resistance was acquired by means of horizontal gene transfer with the commensal N. lactamica. In susceptibility testing of invasive N. meningitidis isolates from the Active Bacterial Core surveillance system between January 2007 and January 2008, an additional ciprofloxacin-resistant isolate was found, in this case from California. Ciprofloxacin-resistant N. meningitidis has emerged in North America.	[Wu, Henry M.; Harcourt, Brian H.; Hatcher, Cynthia P.; Wei, Stanley C.; Novak, Ryan T.; Wang, Xin; Schmink, Susanna; Mair, Raydel D.; Theodore, M. Jordan; Cohn, Amanda C.; Clark, Thomas A.; Messonnier, Nancy E.; Mayer, Leonard W.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA; [Wu, Henry M.; Wei, Stanley C.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Juni, Billie A.; Glennen, Anita; Boxrud, David J.; Rainbow, Jean; Lynfield, Ruth] Minnesota Dept Hlth, Emerging Infect Program, St Paul, MN USA; [Sander, Molly A.; Miller, Tracy K.; Kruger, Kirby] N Dakota Dept Hlth, Bismarck, ND USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD)	Wu, HM (corresponding author), Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Coordinating Ctr Infect Dis, 1600 Clifton Rd,MS C-09, Atlanta, GA 30333 USA.	hwu@cdc.gov		Howell, Molly/0000-0003-3307-2310				Arreaza L, 2002, J ANTIMICROB CHEMOTH, V49, P545, DOI 10.1093/jac/49.3.545; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; *COUNC STAT TERR E, 2005, REV NAT SURV CAS DEF; CUEVAS LE, 1993, J ANTIMICROB CHEMOTH, V31, P79, DOI 10.1093/jac/31.suppl_B.79; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Girgis N, 1998, PEDIATR INFECT DIS J, V17, P816, DOI 10.1097/00006454-199809000-00013; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jorgensen JH, 2005, J CLIN MICROBIOL, V43, P3162, DOI 10.1128/JCM.43.7.3162-3171.2005; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Maiden MCJ, 1998, CLIN INFECT DIS, V27, pS12, DOI 10.1086/514917; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; *NEISS ORG, FETA TYP INF; *NEISS ORG, MEN TYP; PODGORE JK, 1993, J TROP MED, V2, P41; Popovic T, 2001, J CLIN MICROBIOL, V39, P75, DOI 10.1128/JCM.39.1.75-85.2001; Rainbow J., 2008, Morbidity and Mortality Weekly Report, V57, P173; Rainbow J, 2005, EMERG INFECT DIS, V11, P977; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P348, DOI 10.1128/CDLI.5.3.348-354.1998; Sacchi CT, 2000, J INFECT DIS, V182, P1169, DOI 10.1086/315833; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Strahilevitz J, 2008, EMERG INFECT DIS, V14, P1667, DOI 10.3201/eid1410.080252; Tanaka M, 2000, ANTIMICROB AGENTS CH, V44, P192, DOI 10.1128/AAC.44.1.192-195.2000; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368	33	77	81	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					886	892		10.1056/NEJMoa0806414	http://dx.doi.org/10.1056/NEJMoa0806414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246360				2022-12-28	WOS:000263624700007
J	Murray, N; Winstanley, J; Bennett, A; Francis, K				Murray, N.; Winstanley, J.; Bennett, A.; Francis, K.			Guidelines Diagnosis and treatment of advanced breast cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Murray, N.] Univ Southampton, Canc Res UK Clin Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; [Winstanley, J.] Royal Bolton Hosp, Bolton BL4 0RJ, England; [Bennett, A.; Francis, K.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, Wales	Cancer Research UK; University of Southampton; Royal Bolton Hospital	Murray, N (corresponding author), Univ Southampton, Canc Res UK Clin Ctr, Southampton Gen Hosp, Somers Canc Res Bldg, Southampton SO16 6YD, Hants, England.	nickm@soton.ac.uk						Harnett A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b438; *INF STAT DIV NHS, ONL DAT ISD CANC INF; National Institute for Health and Clinical Excellence, 2007, GUID MAN; *NIH CLIN EXC, 2002, TECHN APPR NICE; *NIH CLIN EXC, 2009, CLIN GUID NICE, V81; *NO IR CANC REG, 2008, CANC INC MORT; *OFF NAT STAT, 2005, SER MB1 ONS, V36; Rockson SG, 1998, CANCER, V83, P2882, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2882::AID-CNCR45>3.0.CO;2-0; *WELSH CANC INT SU, 2008, CANC INC WAL	9	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2009	338								b509	10.1136/bmj.b509	http://dx.doi.org/10.1136/bmj.b509			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244303	Green Published			2022-12-28	WOS:000264056200005
J	Cech, TR				Cech, Thomas R.			Crawling Out of the RNA World	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; GROUP-II INTRON; RIBOSOMAL-SUBUNIT; TELOMERASE RNA; PROTEINS; EVOLUTION; CATALYSIS; RIBONUCLEOPROTEIN; RIBOZYME; ENZYME	Comparison of phylogenetically diverse ribonucleoprotein (RNP) enzymes and information about their biochemistry have stimulated hypotheses about their evolution. Instead of the canonical view, in which catalysis proceeds from ribozyme to RNP enzyme to protein enzyme, RNP enzymes and proteins are seen to share contemporary catalysis. Furthermore, the RNA components of RNP enzymes show no evidence of fading out but instead, in some cases, have elaborated new functions.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atsumi S, 2001, EMBO J, V20, P5453, DOI 10.1093/emboj/20.19.5453; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cleaves HJ, 2008, ORIGINS LIFE EVOL B, V38, P105, DOI 10.1007/s11084-007-9120-3; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Helm M, 2005, J AM CHEM SOC, V127, P10492, DOI 10.1021/ja052886i; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; KASHIWAGI N, 2007, NUCL ACIDS S SER, V51, P387; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Miller MC, 2002, P NATL ACAD SCI USA, V99, P6585, DOI 10.1073/pnas.102024699; Noller HF, 2006, COLD SPRING HARB MON, V43, P287; Noller HF, 2004, RNA, V10, P1833, DOI 10.1261/rna.7142404; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Villa T, 2002, CELL, V109, P149, DOI 10.1016/S0092-8674(02)00726-2; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	24	78	80	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					599	602		10.1016/j.cell.2009.02.002	http://dx.doi.org/10.1016/j.cell.2009.02.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239881	Bronze, Green Published			2022-12-28	WOS:000263688200011
J	Cullen, BR				Cullen, Bryan R.			Viral RNAs: Lessons from the Enemy	CELL			English	Article							MESSENGER-RNA; NUCLEAR EXPORT; GENE-EXPRESSION; VIRUS GENOME; ENTRY SITE; HIV-1; TRANSLATION; INITIATION; MICRORNAS; CYTOPLASM	Viruses are adept at evolving or co-opting genomic elements that allow them to maximize their replication potential in the infected host. This evolutionary plasticity makes viruses an invaluable system to identify new mechanisms used not only by viruses but also by vertebrate cells to modulate gene expression. Here, I discuss the identification and characterization of viral mRNA structures and noncoding RNAs that have led to important insights into the molecular mechanisms of eukaryotic cells.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA	Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA.	bryan.cullen@duke.edu						Atanasiu D, 2007, J VIROL, V81, P7695, DOI 10.1128/JVI.00282-07; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KATES J, 1970, COLD SPRING HARB SYM, V35, P743, DOI 10.1101/SQB.1970.035.01.090; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; LeBlanc JJ, 2007, VIROLOGY, V363, P376, DOI 10.1016/j.virol.2007.01.026; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Sullivan Christopher S., 2009, P645, DOI 10.1007/978-0-387-68945-6_25; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	39	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					592	597		10.1016/j.cell.2009.01.048	http://dx.doi.org/10.1016/j.cell.2009.01.048			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239880	Green Published, Bronze			2022-12-28	WOS:000263688200010
J	Dessler, AE; Sherwood, SC				Dessler, Andrew E.; Sherwood, Steven C.			ATMOSPHERIC SCIENCE A Matter of Humidity	SCIENCE			English	Editorial Material							WATER-VAPOR FEEDBACK; RELATIVE-HUMIDITY; CLIMATE FEEDBACK; PINATUBO		[Dessler, Andrew E.] Texas A&M Univ, College Stn, TX 77843 USA; [Sherwood, Steven C.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia	Texas A&M University System; Texas A&M University College Station; University of New South Wales Sydney	Dessler, AE (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	adessler@tamu.edu; s.sherwood@unsw.edu.au	Sherwood, Steven/B-5673-2008; Dessler, Andrew E/G-8852-2012	Sherwood, Steven/0000-0001-7420-8216; Dessler, Andrew E/0000-0003-3939-4820				Dessler AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035333; Folkins I, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002185; Forster PMD, 2004, CLIM DYNAM, V23, P207, DOI 10.1007/s00382-004-0431-z; Hall A, 1999, J CLIMATE, V12, P2327, DOI 10.1175/1520-0442(1999)012<2327:TROWVF>2.0.CO;2; Hartmann DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015835; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Inamdar AK, 1998, J GEOPHYS RES-ATMOS, V103, P32177, DOI 10.1029/1998JD900007; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; Minschwaner K, 2004, J CLIMATE, V17, P1272, DOI 10.1175/1520-0442(2004)017<1272:WVFITT>2.0.CO;2; Pierrehumbert R. T., 2007, GLOBAL CIRCULATION A, P143; Sherwood SC, 2006, J CLIMATE, V19, P6278, DOI 10.1175/JCLI3979.1; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Soden BJ, 2002, SCIENCE, V296, P727, DOI 10.1126/science.296.5568.727; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1	14	113	116	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1020	1021		10.1126/science.1171264	http://dx.doi.org/10.1126/science.1171264			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229026				2022-12-28	WOS:000263478400028
J	Cho, SB; Kim, HS				Cho, Sung Bin; Kim, Hyung Su			Pediculosis of the Pubis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cho, Sung Bin; Kim, Hyung Su] Armed Forces Yangju Hosp, Yangju, South Korea		Cho, SB (corresponding author), Armed Forces Yangju Hosp, Yangju, South Korea.	sbnim@hanmail.net	Bin Cho, Sung/AAI-5899-2021	Bin Cho, Sung/0000-0001-6748-5071					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					E11	E11		10.1056/NEJMicm0707428	http://dx.doi.org/10.1056/NEJMicm0707428			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228614				2022-12-28	WOS:000263411300011
J	Britton, J				Britton, John			In defence of helping people to stop smoking	LANCET			English	Editorial Material							CESSATION		Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England	University of Nottingham	Britton, J (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England.	j.britton@virgin.net						Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Chapman S, 2009, LANCET, V373, P701, DOI 10.1016/S0140-6736(09)60416-5; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; FIORE MC, 2005, TREATING TOBACCO USE; Joossens L, 2007, PROGR TOBACCO CONTRO; LADER D, 2008, SMOKING RELATED BEHA; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; Parrott S, 2004, BMJ-BRIT MED J, V328, P947, DOI 10.1136/bmj.328.7445.947; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; The Information Centre, 2008, STAT NHS STOP SMOK S; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; World Health Organization, 2003, WHO FRAM CONV TOB CO	13	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					703	705		10.1016/S0140-6736(09)60417-7	http://dx.doi.org/10.1016/S0140-6736(09)60417-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249617				2022-12-28	WOS:000263725400009
J	Ferrara, JLM; Levine, JE; Reddy, P; Holler, E				Ferrara, James L. M.; Levine, John E.; Reddy, Pavan; Holler, Ernst			Graft-versus-host disease	LANCET			English	Review							STEM-CELL TRANSPLANTATION; UMBILICAL-CORD BLOOD; BONE-MARROW-TRANSPLANTATION; TRIAL COMPARING CYCLOSPORINE; TREATMENT-RELATED MORTALITY; TOTAL-BODY IRRADIATION; TERM-FOLLOW-UP; T-CELLS; ALLOGENEIC TRANSPLANTATION; RANDOMIZED-TRIAL	Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk haematological malignant disorders and other life-threatening haematological and genetic diseases. The main complication of HCT is graft-versus-host disease (GVHD), an immunological disorder that affects many organ systems, including the gastrointestinal tract, liver, skin, and lungs. The number of patients with this complication continues to grow, and many return home from transplant centres after HCT requiring continued treatment with immunosuppressive drugs that increases their risks for serious infections and other complications. In this Seminar, we review our understanding of the risk factors and causes of GHVD, the cellular and cytokine networks implicated in its pathophysiology, and current strategies to prevent and treat the disease. We also summarise supportive-care measures that are essential for management of this medically fragile population.	[Ferrara, James L. M.; Levine, John E.; Reddy, Pavan] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA; [Holler, Ernst] Univ Hosp, Dept Haematol Oncol, Regensburg, Germany	University of Michigan System; University of Michigan; University of Regensburg	Ferrara, JLM (corresponding author), Univ Michigan, Blood & Marrow Transplantat Program, 1500 E Med Ctr Dr,6303 CCC, Ann Arbor, MI 48109 USA.	ferrara@umich.edu		Reddy, Pavan/0000-0001-7264-8429; Levine, John/0000-0002-5611-7828; Levine, John/0000-0002-9133-0800	National Institutes of Health (Bethesda, MD, USA) [P01 CA 39542]; Jose Carreras Foundation; NATIONAL CANCER INSTITUTE [P01CA039542] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jose Carreras Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health (Bethesda, MD, USA), P01 CA 39542, and the Jose Carreras Foundation. JLMF is a Doris Duke distinguished clinical scientist and an American Cancer Society clinical research professor.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alyea EP, 2008, BIOL BLOOD MARROW TR, V14, P920, DOI 10.1016/j.bbmt.2008.05.024; ANASETTI C, 1989, BLOOD, V73, P1054; ANTIN JH, 1992, BLOOD, V80, P2964; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Arai S, 2002, BIOL BLOOD MARROW TR, V8, P155, DOI 10.1053/bbmt.2002.v8.pm11939605; Bacigalupo A, 2005, BONE MARROW TRANSPL, V35, P225, DOI 10.1038/sj.bmt.1704758; Bacigalupo A, 2006, BIOL BLOOD MARROW TR, V12, P560, DOI 10.1016/j.bbmt.2005.12.034; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Barge RMY, 2006, BONE MARROW TRANSPL, V37, P1129, DOI 10.1038/sj.bmt.1705385; Barker JN, 2003, BLOOD, V102, P1915, DOI 10.1182/blood-2002-11-3337; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; Bashoura L, 2008, BONE MARROW TRANSPL, V41, P63, DOI 10.1038/sj.bmt.1705877; Billingham R E, 1966, Harvey Lect, V62, P21; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Boeckh M, 2006, BLOOD, V107, P1800, DOI 10.1182/blood-2005-09-3624; Bolwell B, 2004, BONE MARROW TRANSPL, V34, P621, DOI 10.1038/sj.bmt.1704647; Brown GR, 2002, J IMMUNOL, V168, P3065, DOI 10.4049/jimmunol.168.6.3065; Burroughs L, 2006, TRANSPLANTATION, V81, P818, DOI 10.1097/01.tp.0000203556.06145.5b; Cahn JY, 2005, BLOOD, V106, P1495, DOI 10.1182/blood-2004-11-4557; Carlens S, 1998, BONE MARROW TRANSPL, V22, P755, DOI 10.1038/sj.bmt.1701423; Carpenter PA, 2007, BIOL BLOOD MARROW TR, V13, P683, DOI 10.1016/j.bbmt.2007.02.001; Cavet J, 1999, BLOOD, V94, P3941, DOI 10.1182/blood.V94.11.3941.423k10_3941_3946; *CDCP INF DIS SOC, 2000, BIOL BLOOD MARROW TR, V6, P1; Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Champlin RE, 2000, BLOOD, V95, P3996; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Cohen JL, 2006, CURR OPIN IMMUNOL, V18, P580, DOI 10.1016/j.coi.2006.07.007; Cornetta K, 2005, BIOL BLOOD MARROW TR, V11, P149, DOI 10.1016/j.bbmt.2004.11.020; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P37, DOI 10.1016/j.bbmt.2005.11.009; Couriel DR, 2004, BIOL BLOOD MARROW TR, V10, P178, DOI 10.1016/j.bbmt.2003.10.006; Cragg L, 2000, BIOL BLOOD MARROW TR, V6, P441, DOI 10.1016/S1083-8791(00)70036-X; Cutler C, 2005, BIOL BLOOD MARROW TR, V11, P551, DOI 10.1016/j.bbmt.2005.04.007; Cutler C, 2004, BIOL BLOOD MARROW TR, V10, P328, DOI 10.1016/j.bbmt.2003.12.305; Darabi K, 2006, TRANSFUSION, V46, P741, DOI 10.1111/j.1537-2995.2006.00792.x; Delgado J, 2006, BLOOD, V107, P1724, DOI 10.1182/blood-2005-08-3372; Dickinson AM, 2005, CURR OPIN IMMUNOL, V17, P517, DOI 10.1016/j.coi.2005.07.017; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Dustin ML, 2001, J CLIN IMMUNOL, V21, P258, DOI 10.1023/A:1010927208180; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; FERRARA JLM, 2006, HEMATOLOGY BASIC PRI; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; FOWLER DH, 1994, BLOOD, V84, P3540; Fujii N, 2001, BONE MARROW TRANSPL, V27, P1007, DOI 10.1038/sj.bmt.1702997; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Goerner M, 2003, J HEMATOTH STEM CELL, V12, P309, DOI 10.1089/152581603322023043; Goker H, 2001, EXP HEMATOL, V29, P259, DOI 10.1016/S0301-472X(00)00677-9; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Greinix HT, 2006, HAEMATOLOGICA, V91, P405; Griffith Linda M, 2008, Biol Blood Marrow Transplant, V14, P379, DOI 10.1016/j.bbmt.2008.01.005; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; Hill GR, 2000, J IMMUNOL, V164, P656, DOI 10.4049/jimmunol.164.2.656; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Ho VT, 2004, BONE MARROW TRANSPL, V34, P987, DOI 10.1038/sj.bmt.1704690; Holler E, 2006, BLOOD, V107, P4189, DOI 10.1182/blood-2005-09-3741; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; KERNAN NA, 1986, BLOOD, V68, P770; Koc S, 2002, BLOOD, V100, P48, DOI 10.1182/blood.V100.1.48; Kolb Hans-Jochem, 1997, Current Opinion in Oncology, V9, P139; KORNGOLD R, 1985, J IMMUNOL, V135, P3004; KORNGOLD R, 1982, J EXP MED, V155, P872, DOI 10.1084/jem.155.3.872; Korngold R., 1987, PROGR BONE MARROW TR, P213; Krenger W, 1996, BLOOD, V88, P1113, DOI 10.1182/blood.V88.3.1113.bloodjournal8831113; KRENSKY AM, 1990, NEW ENGL J MED, V322, P510, DOI 10.1056/NEJM199002223220805; Kroger N, 2002, BONE MARROW TRANSPL, V29, P683, DOI 10.1038/sj.bmt.1703530; Kulkarni S, 2000, BLOOD, V95, P3683; Kumar A, 2006, INT ARCH ALLERGY IMM, V140, P185, DOI 10.1159/000093204; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Levine JE, 2003, BIOL BLOOD MARROW TR, V9, P189, DOI 10.1053/bbmt.2003.50012; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; Lin M, 2003, NEW ENGL J MED, V349, P2201, DOI 10.1056/NEJMoa022060; Ljungman P, 2005, BONE MARROW TRANSPL, V35, P737, DOI 10.1038/sj.bmt.1704870; Loiseau P, 2007, BIOL BLOOD MARROW TR, V13, P965, DOI 10.1016/j.bbmt.2007.04.010; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; Machado CM, 2004, BONE MARROW TRANSPL, V34, P111, DOI 10.1038/sj.bmt.1704534; Machado CM, 2005, BONE MARROW TRANSPL, V36, P897, DOI 10.1038/sj.bmt.1705159; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P40, DOI 10.1053/bbmt.2002.v8.pm11858189; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; MARTIN PJ, 1988, BONE MARROW TRANSPL, V3, P437; MARTIN PJ, 1990, BLOOD, V76, P1464, DOI 10.1182/blood.V76.8.1464.1464; Martino R, 2006, BLOOD, V108, P836, DOI 10.1182/blood-2005-11-4503; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; Nash RA, 2000, BLOOD, V96, P2062; Nevo S, 1999, TRANSPLANTATION, V67, P681, DOI 10.1097/00007890-199903150-00007; Perez-Simon JA, 2005, BRIT J HAEMATOL, V130, P394, DOI 10.1111/j.1365-2141.2005.05614.x; Perez-Simon JA, 2002, BLOOD, V100, P3121, DOI 10.1182/blood-2002-03-0701; Petersdorf E. W., 1995, Blood, V86, p291A; PETERSDORF EW, 1995, BLOOD, V86, P1606, DOI 10.1182/blood.V86.4.1606.bloodjournal8641606; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; Platzbecker U, 2004, LEUKEMIA LYMPHOMA, V45, P447, DOI 10.1080/10428190310001615684; Ponec RJ, 1999, GASTROINTEST ENDOSC, V49, P612, DOI 10.1016/S0016-5107(99)70390-1; Qu LR, 2005, SEMIN THROMB HEMOST, V31, P691, DOI 10.1055/s-2005-925475; Ratanatharathorn V, 1998, BLOOD, V92, P2303; Reddy P, 2005, NAT MED, V11, P1244, DOI 10.1038/nm1309; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Reddy P, 2001, J EXP MED, V194, P1433, DOI 10.1084/jem.194.10.1433; Remberger M, 2001, PEDIATR TRANSPLANT, V5, P285, DOI 10.1034/j.1399-3046.2001.005004285.x; Rizzo JD, 2006, BONE MARROW TRANSPL, V37, P249, DOI 10.1038/sj.bmt.1705243; Rovira M, 2004, TRANSPLANTATION, V77, P1260, DOI 10.1097/01.TP.0000120536.20045.AA; Sano Y, 2005, ANN THORAC SURG, V79, P1051, DOI 10.1016/j.athoracsur.2003.09.111; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SNOVER DC, 1985, HUM PATHOL, V16, P387, DOI 10.1016/S0046-8177(85)80232-X; SNOVER DC, 1984, HEPATOLOGY, V4, P123, DOI 10.1002/hep.1840040122; Soiffer R., 2008, THOMAS HEMATOPOIETIC, P221; Sorror ML, 2004, BLOOD, V104, P961, DOI 10.1182/blood-2004-02-0545; STORB R, 1971, J CLIN INVEST, V50, P1272, DOI 10.1172/JCI106605; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; SULLIVAN KM, 1992, BONE MARROW TRANSPL, V10, P127; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; UrbanoIspizua A, 1997, BLOOD, V89, P3967, DOI 10.1182/blood.V89.11.3967; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; Velardi A, 2002, TRENDS IMMUNOL, V23, P438, DOI 10.1016/S1471-4906(02)02284-6; Vogelsang GB, 2003, ANNU REV MED, V54, P29, DOI 10.1146/annurev.med.54.101601.152339; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Wagner JE, 2005, LANCET, V366, P733, DOI 10.1016/S0140-6736(05)66996-6; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445; Welniak LA, 2006, BLOOD, V107, P410, DOI 10.1182/blood-2004-11-4565; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wong R, 2003, BRIT J HAEMATOL, V122, P128, DOI 10.1046/j.1365-2141.2003.04447.x; Wysocki CA, 2005, BLOOD, V105, P4191, DOI 10.1182/blood-2004-12-4726; XUN CQ, 1994, BLOOD, V83, P2360; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073	139	1589	1685	4	186	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1550	1561		10.1016/S0140-6736(09)60237-3	http://dx.doi.org/10.1016/S0140-6736(09)60237-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19282026	Green Accepted			2022-12-28	WOS:000265710300034
J	Raj, A; Saggurti, N; Balaiah, D; Silverman, JG				Raj, Anita; Saggurti, Niranjan; Balaiah, Donta; Silverman, Jay G.			Prevalence of child marriage and its effect on fertility and fertility-control outcomes of young women in India: a cross-sectional, observational study	LANCET			English	Article							HEALTH	Background Child marriage is a substantial barrier to social and economic development in India, and a primary concern for women's health. We assessed the prevalence of child marriage-ie, before 18 years of age-in young adult women in India, and the associations between child marriage and women's fertility and fertility-control outcomes. Methods Data from the National Family Health Survey-3 (2005-06) were limited to a sample of Indian women aged 20-24 years (n=22807), of whom 14813 had been or were presently married (ever-married). Prevalence of child marriage was estimated for the whole sample. We used regression models adjusted for demographics, and models adjusted for demographics and duration of marriage to estimate odds ratios (ORs) for the associations between child marriage and both fertility and fertility-control outcomes, in the ever-married subsample. Findings 44.5% of women aged 20-24 years were married before age 18 years, 22.6% were married before age 16 years, and 2.6% were married before age 13 years. Child marriage was significantly associated with no contraceptive use before first childbirth (adjusted OR 1.37 [95% CI 1.22-1.54]), high fertility (three or more births) (7.40 [6.45-8.50]), a repeat childbirth in less than 24 months (3.00 [2.74-3.29]), multiple unwanted pregnancies (2.36 [1.90-2.94]), pregnancy termination (1.48 [1.34-1.63]), and female sterilisation (6.68 [5.78-7.60]). The association between child marriage and high fertility, a repeat childbirth in less than 24 months, multiple unwanted pregnancies, pregnancy termination, and sterilisation all remained significant after controlling for duration of marriage. Interpretation Increased enforcement of existing policies is crucial for prevention of child marriage. improved family-planning education, access, and support are urgently needed for women married as children, their husbands, and their families to reduce the high fertility and poor fertility-control outcomes of this practice. Funding US National Institutes of Health and Indian Council of Medical Research.	[Raj, Anita] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Balaiah, Donta] Indian Council Med Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Silverman, Jay G.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Boston University; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Harvard University; Harvard T.H. Chan School of Public Health	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 801 Massachusetts Ave,C-O 715 Albany St, Boston, MA 02118 USA.	anitaraj@bu.edu		Saggurti, Niranjan/0000-0002-5267-8425	US National Institutes of Health; Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development [1 R03 HD055120-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD055120] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the US National Institutes of Health and the Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development to JGS (grant number 1 R03 HD055120-01).	AUDINARAYANA N, 1993, DEMOGRAPHY INDIA, V22, P169; AUDINARAYANA N, 1986, J FAM WELFARE, V31, P56; BHAGAT RB, 2002, EARLY MARRIAGES INDI; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; Chatterjee P, 2007, LANCET, V370, P1023, DOI 10.1016/S0140-6736(07)61460-3; Chatterjee P, 2006, LANCET, V368, P1483, DOI 10.1016/S0140-6736(06)69620-7; DATT G, 2846 WPS; *GOV IND MIN HUM R, 2007, SEL ED STAT; *I SOC STUD TRUST, 2007, PROGR WOM S AS; *INT CTR RES WOM, NEW INS PREV CHILD M; *INT I POP SCI MAC, 2007, NAT FAM HLTH SURV NF; KROLL L, 2008, FORBES MAGAZINE 0305; Mensch B., 2003, TRENDS TIMING 1 MARR; Ministry of Health and Family Welfare (MOHFW), NAT RUR HLTH MISS 20; PANAGARIYA A, 2008, BROOKINGS WASHI 0124; PATIL PA, 2002, J 3 WORLD STUD, V19, P195; RAO GR, 1998, DEMOGRAPHY INDIA, V27, P401; RICHARD J, 1997, DEMOGRAPHY INDIA, V24, P81; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; Saardchom N, 2005, MARRIAGE FAM REV, V37, P73, DOI 10.1300/J002v37n03_05; SIVARAM M, 1995, J BIOSOC SCI, V27, P325, DOI 10.1017/S0021932000022847; SUREENDER S, 1993, NEW TIMES BOMBAY, P5; THENMOZHI N, 1992, INDIAN J PUBL ADMIN, V38, P341; *UN, MILL DEV GOALS; *UNFPA, STAT WORLD POP 2005; UNICEF, 2001, EARL MARR CHILD SPOU; United Nations Children's Fund (UNICEF), PROGR CHILDR WORLD F; *WOLD BANK, IND COUNTR OV 2008	29	203	203	1	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1883	1889		10.1016/S0140-6736(09)60246-4	http://dx.doi.org/10.1016/S0140-6736(09)60246-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19278721	Green Accepted			2022-12-28	WOS:000266616400031
J	Lee, MR; Eckert, RD; Forberich, K; Dennler, G; Brabec, CJ; Gaudiana, RA				Lee, Michael R.; Eckert, Robert D.; Forberich, Karen; Dennler, Gilles; Brabec, Christoph J.; Gaudiana, Russell A.			Solar Power Wires Based on Organic Photovoltaic Materials	SCIENCE			English	Article							ENERGY-CONVERSION EFFICIENCY; DESIGN RULES; CELLS; POLYMER; DONORS; FILMS	Organic photovoltaics in a flexible wire format has potential advantages that are described in this paper. A wire format requires long-distance transport of current that can be achieved only with conventional metals, thus eliminating the use of transparent oxide semiconductors. A phase-separated, photovoltaic layer, comprising a conducting polymer and a fullerene derivative, is coated onto a thin metal wire. A second wire, coated with a silver film, serving as the counter electrode, is wrapped around the first wire. Both wires are encased in a transparent polymer cladding. Incident light is focused by the cladding onto to the photovoltaic layer even when it is completely shadowed by the counter electrode. Efficiency values of the wires range from 2.79% to 3.27%.	[Lee, Michael R.; Eckert, Robert D.; Forberich, Karen; Dennler, Gilles; Brabec, Christoph J.; Gaudiana, Russell A.] Konarka Technol Inc, Lowell, MA 01852 USA		Gaudiana, RA (corresponding author), Konarka Technol Inc, Lowell, MA 01852 USA.	rgaudiana@konarka.com	Brabec, Christoph J./N-1897-2013; Wu, Yi-Yi/F-4191-2011; Dennler, Gilles/C-6927-2011	Brabec, Christoph J./0000-0002-9440-0253; Dennler, Gilles/0000-0002-1564-5632	ARMY Soldier Center (Natick, MA)	ARMY Soldier Center (Natick, MA)	We would like to thank the ARMY Soldier Center (Natick, MA) for their support of this work. We acknowledge the following related patents, PCT/US2006/039364 and U.S. Patent 6,913,713.	[Anonymous], Patent, Patent No. [6913713, US 6,913,713 B2]; ARMY SOLDIER CTR, 2006, Patent No. 2006039364; Dennler G, 2008, ADV MATER, V20, P579, DOI 10.1002/adma.200702337; Fan X, 2008, ADV MATER, V20, P592, DOI 10.1002/adma.200701249; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574; Liu JW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2716864; O'Connor B, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2927533; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Ramier J, 2008, THIN SOLID FILMS, V516, P1913, DOI 10.1016/j.tsf.2007.08.057; Ramier J, 2008, RENEW ENERG, V33, P314, DOI 10.1016/j.renene.2007.05.029; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; SARICIFTCI NS, 1994, Patent No. 5454880; SARICIFTCI NS, 1992, Patent No. 5331183; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Yu G, 1997, SYNTHETIC MET, V85, P1183, DOI 10.1016/S0379-6779(97)80202-0	21	294	305	8	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					232	235		10.1126/science.1168539	http://dx.doi.org/10.1126/science.1168539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19286521				2022-12-28	WOS:000265024400041
J	Wittebolle, L; Marzorati, M; Clement, L; Balloi, A; Daffonchio, D; Heylen, K; De Vos, P; Verstraete, W; Boon, N				Wittebolle, Lieven; Marzorati, Massimo; Clement, Lieven; Balloi, Annalisa; Daffonchio, Daniele; Heylen, Kim; De Vos, Paul; Verstraete, Willy; Boon, Nico			Initial community evenness favours functionality under selective stress	NATURE			English	Article							CURRENT KNOWLEDGE; SPECIES RICHNESS; BIODIVERSITY; DIVERSITY; STABILITY; ECOLOGY; PRODUCTIVITY; REDUNDANCY; SYSTEMS	Owing to the present global biodiversity crisis, the biodiversity-stability relationship and the effect of biodiversity on ecosystem functioning have become major topics in ecology(1-3). Biodiversity is a complex term that includes taxonomic, functional, spatial and temporal aspects of organismic diversity, with species richness (the number of species) and evenness (the relative abundance of species) considered among the most important measures(4,5). With few exceptions (see, for example, ref. 6), the majority of studies of biodiversity-functioning and biodiversity-stability theory have predominantly examined richness(7-11). Here we show, using microbial microcosms, that initial community evenness is a key factor in preserving the functional stability of an ecosystem. Using experimental manipulations of both richness and initial evenness in microcosms with denitrifying bacterial communities, we found that the stability of the net ecosystem denitrification in the face of salinity stress was strongly influenced by the initial evenness of the community. Therefore, when communities are highly uneven, or there is extreme dominance by one or a few species, their functioning is less resistant to environmental stress. Further unravelling how evenness influences ecosystem processes in natural and humanized environments constitutes a major future conceptual challenge.	[Wittebolle, Lieven; Marzorati, Massimo; Verstraete, Willy; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium; [Clement, Lieven] Univ Ghent, BIOSTAT, Dept Appl Math Biometr & Proc Control, B-9000 Ghent, Belgium; [Heylen, Kim; De Vos, Paul] Univ Ghent, Microbiol Lab, Dept Biochem Physiol & Microbiol, LM UGent, B-9000 Ghent, Belgium; [Balloi, Annalisa; Daffonchio, Daniele] Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, DISTAM, I-20133 Milan, Italy	Ghent University; Ghent University; Ghent University; University of Milan	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium.	nico.boon@ugent.be	Clement, Lieven/G-5143-2012; Daffonchio, Daniele/AAF-4922-2019; Marzorati, Massimo/A-3419-2013; Boon, Nico/B-4083-2011; Heylen, Kim/G-4085-2011; De Vos, Paul/J-5392-2013	Daffonchio, Daniele/0000-0003-0947-925X; Boon, Nico/0000-0002-7734-3103; clement, lieven/0000-0002-9050-4370	Institute for the Promotion of Innovation through Science and Technology in Flanders; Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy; 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University; Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy(Belgian Federal Science Policy Office); 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University(Ghent University); Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	We are grateful to R. Amann for comments on the original manuscript and to P. Van Damme for practical assistance. This work was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders ( IWT- Vlaanderen) ( to L. W.), by an Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy ( to L. C.), by 'Program Master and Back' from Regione Sardegna ( Italy; to A. B.), by 'Programma dell'Universita' per la Ricerca, PUR 2008' (ex FIRST) of the University of Milan ( to D. D.), and by the Geconcerteerde Onderzoeksactie of Ghent University contract grant of the Ministerie van de Vlaamse Gemeenschap, Bestuur Wetenschappelijk Onderzoek ( Belgium; to K. H., P. D. V., W. V. and N. B.). Author Contributions L. W., M. M. and N. B. had the original idea for the experiment.	Balvanera P, 2005, ECOL APPL, V15, P360, DOI 10.1890/03-5192; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Griffiths BS, 2001, APPL SOIL ECOL, V16, P49, DOI 10.1016/S0929-1393(00)00081-0; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kutner M. H., 2004, APPL LINEAR REGRESSI; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MONTGOMERY H, 1961, ANALYST, V86, P414; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Symonds MRE, 2008, AM NAT, V171, P480, DOI 10.1086/528960; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang DR, 2008, SYMBIOSIS, V45, P153	30	674	702	18	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					623	626		10.1038/nature07840	http://dx.doi.org/10.1038/nature07840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19270679				2022-12-28	WOS:000264796200039
J	Anderson, RF; Ali, S; Bradtmiller, LI; Nielsen, SHH; Fleisher, MQ; Anderson, BE; Burckle, LH				Anderson, R. F.; Ali, S.; Bradtmiller, L. I.; Nielsen, S. H. H.; Fleisher, M. Q.; Anderson, B. E.; Burckle, L. H.			Wind-Driven Upwelling in the Southern Ocean and the Deglacial Rise in Atmospheric CO2	SCIENCE			English	Article							PACIFIC SECTOR; CARBON-CYCLE; PARTICLE COMPOSITION; TROPICAL ATLANTIC; NORTH-ATLANTIC; CLIMATE; VARIABILITY; CIRCULATION; TH-230; ACCUMULATION	Wind-driven upwelling in the ocean around Antarctica helps regulate the exchange of carbon dioxide (CO2) between the deep sea and the atmosphere, as well as the supply of dissolved silicon to the euphotic zone of the Southern Ocean. Diatom productivity south of the Antarctic Polar Front and the subsequent burial of biogenic opal in underlying sediments are limited by this silicon supply. We show that opal burial rates, and thus upwelling, were enhanced during the termination of the last ice age in each sector of the Southern Ocean. In the record with the greatest temporal resolution, we find evidence for two intervals of enhanced upwelling concurrent with the two intervals of rising atmospheric CO2 during deglaciation. These results directly link increased ventilation of deep water to the deglacial rise in atmospheric CO2.	[Anderson, R. F.; Ali, S.; Bradtmiller, L. I.; Fleisher, M. Q.; Anderson, B. E.; Burckle, L. H.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Anderson, R. F.; Ali, S.; Bradtmiller, L. I.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Nielsen, S. H. H.] Florida State Univ, Antarctic Marine Geol Res Facil, Tallahassee, FL 32306 USA	Columbia University; Columbia University; State University System of Florida; Florida State University	Anderson, RF (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, POB 1000, Palisades, NY 10964 USA.	boba@ldeo.columbia.edu		Anderson, Robert/0000-0002-8472-2494	National Oceanic and Atmospheric Administration; National Science Foundation; Norwegian Research Council [VISTA project 6535]; Norwegian Polar Institute [VISTA project 6535]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute	Work described in this paper was funded by a grants/cooperative agreement from the National Oceanic and Atmospheric Administration, by the National Science Foundation, and by the Norwegian Research Council and the Norwegian Polar Institute as part of VISTA project 6535. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its sub-agencies. Comments on earlier drafts of the manuscript by J. R. Toggweiler, L. K. Armand, and M.-E. Carr led to substantial improvements. W. S. Broecker brought to our attention the importance of paleo lake level records. Discussions with P. de Menocal, J. McManus, and D. Martinson helped clarify our thinking about processes discussed in this paper. Comments from two anonymous reviewers improved the manuscript. Samples from TN057 cores were provided by the repository at Lamont-Doherty Earth Observatory; samples from E27-23 were provided by the Antarctic Marine Geology Research Facility at Florida State University.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; ANDERSON RF, 1983, EARTH PLANET SC LETT, V62, P7, DOI 10.1016/0012-821X(83)90067-5; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; BENSON L, 1995, PALAEOGEOGR PALAEOCL, V117, P1, DOI 10.1016/0031-0182(94)00103-F; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bradtmiller LI, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001282; Bradtmiller LI, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001443; Brauer A, 2008, NAT GEOSCI, V1, P520, DOI 10.1038/ngeo263; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Brown ET, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031240; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; Chase Z, 2003, DEEP-SEA RES PT II, V50, P739, DOI 10.1016/S0967-0645(02)00593-3; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Chen G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031200; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Crosta X, 1998, PALEOCEANOGRAPHY, V13, P284, DOI 10.1029/98PA00339; Crosta X, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000565; Crosta X, 2004, MAR MICROPALEONTOL, V50, P209, DOI 10.1016/S0377-8398(03)00072-0; Dahl K, 2005, CLIM DYNAM, V24, P325, DOI 10.1007/s00382-004-0499-5; Fleisher MQ, 2003, DEEP-SEA RES PT II, V50, P693, DOI 10.1016/S0967-0645(02)00591-X; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Govin A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001603; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Kienast SS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026651; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Lamy F, 2007, EARTH PLANET SC LETT, V259, P400, DOI 10.1016/j.epsl.2007.04.040; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Nelson DM, 2002, DEEP-SEA RES PT II, V49, P1645, DOI 10.1016/S0967-0645(02)00005-X; NIELSEN S, 2004, THESIS U TROMSO; Nielsen SHH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001618; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Peacock S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002448; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Placzek C, 2006, GEOL SOC AM BULL, V118, P515, DOI 10.1130/B25770.1; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Rashid H, 2003, EARTH PLANET SC LETT, V205, P281, DOI 10.1016/S0012-821X(02)01047-6; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rickaby REM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000858; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SHACKLETON NJ, 1983, NATURE, V306, P319, DOI 10.1038/306319a0; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman D.M., 2007, OCEAN CIRCULATION ME, V173, P335, DOI [10.1029/173GM21, DOI 10.1029/173GM21]; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Tierney JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029508; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; Trull T, 2001, DEEP-SEA RES PT II, V48, P2439, DOI 10.1016/S0967-0645(01)00003-0; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zickfeld K, 2008, SCIENCE, V319, DOI [10.1126/science.1146886, 10.1126/science.1149077]	68	795	828	13	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1443	1448		10.1126/science.1167441	http://dx.doi.org/10.1126/science.1167441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286547				2022-12-28	WOS:000264101700031
J	Calais, E; Stein, S				Calais, Eric; Stein, Seth			Time-Variable Deformation in the New Madrid Seismic Zone	SCIENCE			English	Article							EARTHQUAKES; FAULT		[Calais, Eric] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA; [Stein, Seth] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University	Calais, E (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA.		Calais, Eric/K-8219-2012	Calais, Eric/0000-0002-5935-8117				Calais E, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004253; Calais E, 2005, NATURE, V438, pE9, DOI 10.1038/nature04428; Crone AJ, 2003, B SEISMOL SOC AM, V93, P1913, DOI 10.1785/0120000094; Holbrook J, 2006, TECTONOPHYSICS, V420, P431, DOI 10.1016/j.tecto.2006.04.002; Kenner SJ, 2000, SCIENCE, V289, P2329, DOI 10.1126/science.289.5488.2329; Li QS, 2009, B SEISMOL SOC AM, V99, P52, DOI 10.1785/0120080005	6	66	66	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1442	1442		10.1126/science.1168122	http://dx.doi.org/10.1126/science.1168122			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286546				2022-12-28	WOS:000264101700030
J	Sebag-Montefiore, D; Stephens, RJ; Steele, R; Monson, J; Grieve, R; Khanna, S; Quirke, P; Couture, J; de Metz, C; Myint, AS; Bessell, E; Griffiths, G; Thompson, LC; Parmar, M				Sebag-Montefiore, David; Stephens, Richard J.; Steele, Robert; Monson, John; Grieve, Robert; Khanna, Subhash; Quirke, Phil; Couture, Jean; de Metz, Catherine; Myint, Arthur Sun; Bessell, Eric; Griffiths, Gareth; Thompson, Lindsay C.; Parmar, Mahesh		Trial Collaborators	Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; QUALITY-OF-LIFE; SHORT-TERM RADIOTHERAPY; LOCAL RECURRENCE; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; CARCINOMA; SURGERY; THERAPY; ADENOCARCINOMA	Background Preoperative or postoperative radiotherapy reduces the risk of local recurrence in patients with operable rectal cancer. However, improvements in surgery and histopathological assessment mean that the role of radiotherapy needs to be reassessed. We compared short-course preoperative radiotherapy versus initial surgery with selective postoperative chemoradiotherapy. Methods We undertook a randomised trial in 80 centres in four countries. 1350 patients with operable adenocarcinoma of the rectum were randomly assigned, by a minimisation procedure, to short-course preoperative radiotherapy (25 Gy in five fractions; n=674) or to initial surgery with selective postoperative chemoradiotherapy (45 Gy in 25 fractions with concurrent 5-fluorouracil) restricted to patients with involvement of the circumferential resection margin (n=676). The primary outcome measure was local recurrence. Analysis was by intention to treat. This study is registered, number ISRCTN 28785842. Findings At the time of analysis, which included all participants, 330 patients had died (157 preoperative radiotherapy group vs 173 selective postoperative chemoradiotherapy), and median follow-up of surviving patients was 4 years. 99 patients had developed local recurrence (27 preoperative radiotherapy vs 72 selective postoperative chemoradiotherapy). We noted a reduction of 61% in the relative risk of local recurrence for patients receiving preoperative radiotherapy (hazard ratio [HR] 0.39, 95% CI 0.27-0.58,p<0.0001), and an absolute difference at 3 years of 6.2% (95% CI 5.3-7.1) (4.4% preoperative radiotherapy vs 10.6% selective postoperative chemoradiotherapy). We recorded a relative improvement in disease-free survival of 24% for patients receiving preoperative radiotherapy (HR 0.76, 95% CI 0.62-0.94, p=0.013), and an absolute difference at 3 years of 6.0% (95% CI 5.3-6.8) (77.5% vs 71.5%). Overall survival did not differ between the groups (HR 0.91, 95% CI 0.73-1.13, p=0.40). Interpretation Taken with results from other randomised trials, our findings provide convincing and consistent evidence that short-course preoperative radiotherapy is an effective treatment for patients with operable rectal cancer. Funding Medical Research Council (UK) and the National Cancer Institute of Canada.	[Sebag-Montefiore, David] St James Univ Hosp, St James Inst Oncol, Leeds L59 7TF, W Yorkshire, England; [Stephens, Richard J.; Griffiths, Gareth; Thompson, Lindsay C.; Parmar, Mahesh] MRC, Clin Trial Unit, London, England; [Steele, Robert] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Monson, John] Castle Hill Hosp, Kingston Upon Hull, N Humberside, England; [Grieve, Robert] Walsgrave Gen Hosp, Coventry CV2 2DY, W Midlands, England; [Khanna, Subhash] Leicester Royal Infirm, Leicester, Leics, England; [Couture, Jean; de Metz, Catherine] Natl Canc Inst, Canada Clin Trials Grp, Kingston, ON, Canada; [Myint, Arthur Sun] Clatterbridge Ctr Oncol, Wirral, Merseyside, England; [Bessell, Eric] City Hosp Nottingham, Nottingham, England	Saint James's University Hospital; Medical Research Council Clinical Trials Unit; University of Dundee; University of Hull; University of Leicester; Queens University - Canada; Canadian Cancer Trials Group; Clatterbridge Cancer Centre; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Sebag-Montefiore, D (corresponding author), St James Univ Hosp, St James Inst Oncol, Level 4 Bexley Wing, Leeds L59 7TF, W Yorkshire, England.	david.sebag-montefiore@leedsth.nhs.uk	Quirke, Philip/AAI-1362-2019; Myint, Arthur Sun/AAO-7695-2020	Myint, Arthur Sun/0000-0001-5323-5696; Steele, Robert JC/0000-0003-4248-6785; Griffiths, Gareth/0000-0002-9579-8021; Sebag-Montefiore, David/0000-0002-5978-9259; Quirke, Philip/0000-0002-3597-5444; Artioukh, Dmitri/0000-0002-8068-4128	Medical Research Council; Canada by the National Cancer Institute of Canada; MRC [MC_U122861325] Funding Source: UKRI; Medical Research Council [MC_U122861325] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canada by the National Cancer Institute of Canada; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	In the UK the trial was funded and sponsored by the Medical Research Council, and in Canada by the National Cancer Institute of Canada. The trial was run by the Medical Research Council Clinical Trials Unit. We thank all the patients who participated in this study.	ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Arnott SJ, 1996, LANCET, V348, P1610; Birgisson H, 2005, J CLIN ONCOL, V23, P6126, DOI 10.1200/JCO.2005.02.543; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Brown G, 2006, BRIT MED J, V333, P779, DOI 10.1136/bmj.38937.646400.55; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Bujko K, 2004, RADIOTHER ONCOL, V72, P15, DOI 10.1016/j.radonc.2003.12.006; BUYSE M, 1988, JAMA-J AM MED ASSOC, V259, P3571; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T; Dahlberg M, 1998, DIS COLON RECTUM, V41, P543, DOI 10.1007/BF02235256; Enker WE, 1997, ANN MED, V29, P127, DOI 10.3109/07853899709113698; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Fowler JM, 2007, RADIOLOGY, V243, P132, DOI 10.1148/radiol.2431051825; Frykholm GJ, 2001, INT J RADIAT ONCOL, V50, P427, DOI 10.1016/S0360-3016(01)01479-1; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; GOLDBERG PA, 1994, EUR J CANCER, V30A, P1602, DOI 10.1016/0959-8049(94)00312-S; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; HOLM T, 1994, BRIT J SURG, V81, P452, DOI 10.1002/bjs.1800810344; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; KOLLMORGEN CF, 1994, ANN SURG, V220, P676, DOI 10.1097/00000658-199411000-00012; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Machin D, 2007, SURVIVAL ANAL PRACTI, P40; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Marijnen CAM, 2002, J CLIN ONCOL, V20, P817, DOI 10.1200/JCO.20.3.817; MARSH PJ, 1994, DIS COLON RECTUM, V37, P1205, DOI 10.1007/BF02257783; MCLACHLAN S, 2008, P AN M AM SOC CLIN, V26, pS202; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Oates GD, 1996, LANCET, V348, P1605; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2008, INT J RADIAT ONCOL, V72, pS28, DOI 10.1016/j.ijrobp.2008.06.830; Sprangers MAG, 1999, EUR J CANCER, V35, P238, DOI 10.1016/S0959-8049(98)00357-8; THOMAS PRM, 1988, RADIOTHER ONCOL, V13, P245, DOI 10.1016/0167-8140(88)90219-8; Tveit KM, 1997, BRIT J SURG, V84, P1130, DOI 10.1046/j.1365-2168.1997.02863.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wong CS, 1998, INT J RADIAT ONCOL, V40, P427, DOI 10.1016/S0360-3016(97)00737-2; Wong RK, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002102.PUB	43	1003	1078	1	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					811	820		10.1016/S0140-6736(09)60484-0	http://dx.doi.org/10.1016/S0140-6736(09)60484-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269519	Green Accepted, Green Published			2022-12-28	WOS:000263980900031
J	Fu, DL; Uauy, C; Distelfeld, A; Blechl, A; Epstein, L; Chen, XM; Sela, HA; Fahima, T; Dubcovsky, J				Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Blechl, Ann; Epstein, Lynn; Chen, Xianming; Sela, Hanan; Fahima, Tzion; Dubcovsky, Jorge			A Kinase-START Gene Confers Temperature-Dependent Resistance to Wheat Stripe Rust	SCIENCE			English	Article								Stripe rust is a devastating fungal disease that afflicts wheat in many regions of the world. New races of Puccinia striiformis, the pathogen responsible for this disease, have overcome most of the known race-specific resistance genes. We report the map-based cloning of the gene Yr36 (WKS1), which confers resistance to a broad spectrum of stripe rust races at relatively high temperatures (25 degrees to 35 degrees C). This gene includes a kinase and a putative START lipid-binding domain. Five independent mutations and transgenic complementation confirmed that both domains are necessary to confer resistance. Yr36 is present in wild wheat but is absent in modern pasta and bread wheat varieties, and therefore it can now be used to improve resistance to stripe rust in a broad set of varieties.	[Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Distelfeld, Assaf; Sela, Hanan; Fahima, Tzion] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel; [Blechl, Ann] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Epstein, Lynn] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, USDA ARS, Pullman, WA 99164 USA	University of California System; University of California Davis; University of Haifa; United States Department of Agriculture (USDA); University of California System; University of California Davis; Washington State University; United States Department of Agriculture (USDA); Washington State University	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Dubcovsky, Jorge/A-4969-2008; Distelfeld, Assaf/D-4951-2014; Uauy, Cristobal/T-4382-2019; Uauy, Cristobal/B-3879-2011; Epstein, Lynn/F-1251-2013; Uauy, Cristobal/B-7912-2014; Dubcovsky, Jorge/T-5214-2019	Dubcovsky, Jorge/0000-0002-7571-4345; Distelfeld, Assaf/0000-0003-1777-3053; Uauy, Cristobal/0000-0002-9814-1770; Uauy, Cristobal/0000-0002-9814-1770; Sela, Hanan/0000-0002-4218-4376; Fahima, Tzion/0000-0001-5555-0040	USDA-CSREES [2005-00975, 2006-55606-16629]; U.S. and Israel BARD Fund [US-4024-07]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0628] Funding Source: researchfish	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); U.S. and Israel BARD Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by USDA-CSREES grants 2005-00975 and 2006-55606-16629 and by U.S. and Israel BARD Fund grant US-4024-07. We thank C. Li, F. Paraiso, L. Penman, K. L. Richardson, S. Bassein, M.R. Paddy, Q. Lam, and M. Jindal for technical assistance and R. Thilmony and M. Whalen for critical reading of the manuscript. Gene sequences have been deposited in GenBank with accession numbers EU835198-EU835200, FJ154103-FJ154118, and FJ155069-FJ155070.	ALPY F, 2005, PLANT PHYSIOL, V2791, P129; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Distelfeld Assaf, 2004, Functional & Integrative Genomics, V4, P59, DOI 10.1007/s10142-003-0097-3; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Ma Q, 2004, J PLANT PATHOL, V86, P19; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Shang HongSheng, 1998, Scientia Agricultura Sinica, V31, P46; Singh R.P., 2004, 4 INT CROP SCI C BRI; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142	17	463	510	6	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1357	1360		10.1126/science.1166289	http://dx.doi.org/10.1126/science.1166289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19228999	Green Accepted			2022-12-28	WOS:000263876700046
J	Levine, DK				Levine, David K.			Eyes on the Prize?	SCIENCE			English	Editorial Material							INNOVATION		Washington Univ, Dept Econ, St Louis, MO 63130 USA	Washington University (WUSTL)	Levine, DK (corresponding author), Washington Univ, Dept Econ, St Louis, MO 63130 USA.	david@dklevine.com						Boldrin M., 2008, INTELLECTUAL MONOPOL; Hopenhayn HA, 2001, RAND J ECON, V32, P152, DOI 10.2307/2696402; Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865; KREMER M, 2000, W7716 NBER; LERNER RE, 2009, AM EC ASS ANN M SAN; Meloso D, 2009, SCIENCE, V323, P1335, DOI 10.1126/science.1158624	6	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1296	1297		10.1126/science.1171406	http://dx.doi.org/10.1126/science.1171406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414PC	19265006				2022-12-28	WOS:000263876700025
J	Barroso, FA; Nogues, MA				Barroso, Fabio A.; Nogues, Martin A.			Percussion Myotonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barroso, Fabio A.; Nogues, Martin A.] Raul Carrea Inst Neurol Res, RA-1428 Buenos Aires, DF, Argentina		Barroso, FA (corresponding author), Raul Carrea Inst Neurol Res, RA-1428 Buenos Aires, DF, Argentina.	fbarroso@fleni.org.ar		Barroso, Fabio/0000-0002-3647-1803					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					E13	E13		10.1056/NEJMicm064068	http://dx.doi.org/10.1056/NEJMicm064068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264682				2022-12-28	WOS:000263824500010
J	Byberg, L; Melhus, H; Gedeborg, R; Sundstrom, J; Ahlbom, A; Zethelius, B; Berglund, LG; Wolk, A; Michaelsson, K				Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Sundstroem, Johan; Ahlbom, Anders; Zethelius, Bjoer; Berglund, Lars G.; Wolk, Alicja; Michaelsson, Karl			Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-COLLEGE; LIFE EXPECTANCY; PUBLIC-HEALTH; RISK; ASSOCIATION; PREVENTION; SMOKING; WOMEN; RECOMMENDATION; CHOLESTEROL	Objective To examine how change in level of physical activity after middle age influences mortality and to compare it with the effect of smoking cessation. Design Population based cohort study with follow-up over 35 years. Setting Municipality of Uppsala, Sweden. Participants 2205 men aged 50 in 1970-3 who were re-examined at ages 60, 70, 77, and 82 years. Main outcome measure Total (all cause) mortality. Results The absolute mortality rate was 27.1, 23.6, and 18.4 per 1000 person years in the groups with low, medium, and high physical activity, respectively. The relative rate reduction attributable to high physical activity was 32% for low and 22% for medium physical activity. Men who increased their physical activity level between the ages of 50 and 60 continued to have a higher mortality rate during the first five years of follow-up (adjusted hazard ratio 2.64, 95% confidence interval 1.32 to 5.27, compared with unchanged high physical activity). After 10 years of follow-up their increased physical activity was associated with reduced mortality to the level of men with unchanged high physical activity (1.10, 0.87 to 1.38). The reduction in mortality associated with increased physical activity (0.51, 0.26 to 0.97, compared with unchanged low physical activity) was similar to that associated with smoking cessation (0.64, 0.53 to 0.78, compared with continued smoking). Conclusions Increased physical activity in middle age is eventually followed by a reduction in mortality to the same level as seen among men with constantly high physical activity. This reduction is comparable with that associated with smoking cessation.	[Byberg, Liisa; Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, SE-75185 Uppsala, Sweden; [Byberg, Liisa; Gedeborg, Rolf; Berglund, Lars G.; Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Clin Pharmacol Sect, SE-75185 Uppsala, Sweden; [Gedeborg, Rolf] Uppsala Univ, Dept Surg Sci, Sect Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Sundstroem, Johan] Uppsala Univ, Dept Med Sci, Sect Acute & Internal Med, SE-75185 Uppsala, Sweden; [Ahlbom, Anders] Karolinska Inst, Dept Epidemiol, Inst Environm Med, SE-17177 Stockholm, Sweden; [Zethelius, Bjoer] Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, SE-75185 Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Dept Nutr Epidemiol, Inst Environm Med, Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University; Karolinska Institutet	Byberg, L (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, SE-75185 Uppsala, Sweden.	liisa.byberg@surgsci.uu.se	Berglund, Lars/AAD-3856-2019; Michaelsson, Karl/AAM-9094-2021; Berglund, Lars/AAA-3188-2019; Gedeborg, Rolf/AAV-6702-2020; Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019	Berglund, Lars/0000-0002-7437-9047; Gedeborg, Rolf/0000-0002-8850-7863; Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454; Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Research Council. The funder had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication. Competing interests: None declared.	Aires N, 2003, EUR J EPIDEMIOL, V18, P479, DOI 10.1023/A:1024682523710; Andersen LB, 2004, AM J EPIDEMIOL, V160, P189, DOI 10.1093/aje/kwh195; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Bostrom G, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034950600677287; BULL FC, 2004, COMP QUANTIFICATION, P729; Byberg L, 2001, DIABETOLOGIA, V44, P2134, DOI 10.1007/s001250100022; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; Carlsson S, 2007, AM J EPIDEMIOL, V166, P255, DOI 10.1093/aje/kwm132; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; COLLEN MF, 1969, ARCH INTERN MED, V123, P664, DOI 10.1001/archinte.123.6.664; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Farahmand BY, 2000, INT J EPIDEMIOL, V29, P308, DOI 10.1093/ije/29.2.308; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hedman A, 2002, ACTA PHYSIOL SCAND, V175, P325, DOI 10.1046/j.1365-201X.2002.01000.x; Jonker JT, 2006, DIABETES CARE, V29, P38; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; LOCHEN ML, 1992, J EPIDEMIOL COMMUN H, V46, P103, DOI 10.1136/jech.46.2.103; Michaelsson K, 2007, PLOS MED, V4, P1094, DOI 10.1371/journal.pmed.0040199; Munro JF, 2004, J EPIDEMIOL COMMUN H, V58, P1004, DOI 10.1136/jech.2003.014225; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rankinen T, 2007, AM J EPIDEMIOL, V166, P260, DOI 10.1093/aje/kwm130; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Schnohr P, 2003, AM J EPIDEMIOL, V158, P639, DOI 10.1093/aje/kwg207; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SEQUEIRA MM, 1995, AM J EPIDEMIOL, V142, P989, DOI 10.1093/oxfordjournals.aje.a117748; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; [No title captured]; [No title captured]	49	184	187	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2009	338								b688	10.1136/bmj.b688	http://dx.doi.org/10.1136/bmj.b688			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417ED	19264819	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000264058400002
J	Torchinsky, MB; Garaude, J; Martin, AP; Blander, JM				Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian			Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation	NATURE			English	Article							ESCHERICHIA-COLI ESPF; T-HELPER-CELLS; TGF-BETA; INTERLEUKIN-22; IL-17; MITOCHONDRIA; INFLAMMATION; CYTOKINE	Adaptive immune responses rely on differentiation of CD4 Thelper cells into subsets with distinct effector functions best suited for host defence against the invading pathogen. Interleukin (IL)-17 producing T helper cells (T(H)17) are a recently identified subset, separate from the T helper type 1 (T(H)1) and T helper type 2 (T(H)2) subsets(1). Synergy between the cytokines transforming growth factor-beta and IL-6 in vitro induces development of TH17 cells in mouse(1-5) and human(6) systems, whereas IL-23 supports expansion of these cells(2,4,5). However, it is not known which conditions in vivo would induce this combination of cytokines. Furthermore, it is enigmatic that a combination of pro-inflammatory and anti-inflammatory cytokines would be required to generate an effector TH17 response. Here we show that the relevant physiological stimulus triggering this combination of cytokines is the recognition and phagocytosis of infected apoptotic cells by dendritic cells. Phagocytosis of infected apoptotic cells uniquely triggers the combination of IL-6 and transforming growth factor-beta through recognition of pathogen-associated molecular patterns(7) and phosphatidylserine exposed on apoptotic cells(8), respectively. Conversely, phagocytosis of apoptotic cells in the absence of microbial signals induces differentiation of the closely related regulatory T cells, which are important for controlling autoimmunity(9). Blocking apoptosis during infection of the mouse intestinal epithelium with the rodent pathogen Citrobacter rodentium(10), which models human infections with the attaching and effacing enteropathogenic and enterohaemorrhagic Escherichia coli, impairs the characteristic TH17 response in the lamina propria. Our results demonstrate that infected apoptotic cells are a critical component of the innate immune signals instructing TH17 differentiation, and point to pathogens particularly adept at triggering apoptosis that might preferentially induce T(H)17-mediated immunity. Because TH17 cells have been correlated with autoimmune diseases(1), investigation of the pathways of innate recognition of infected apoptotic cells might lead to improved understanding of the causative defects in autoimmunity.	[Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Blander, JM (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1425 Madison Ave, New York, NY 10029 USA.	julie.blander@mssm.edu		Blander, Julie Magarian/0000-0001-9207-1700; Garaude, Johan/0000-0001-7789-7715	NIH [AI073899]; Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073899, R01AI123284, R56AI073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. Medzhitov, L. Mayer and D. Amsen for advice and critical reading of the manuscript, S. Lira for use of cryostat and microscope, B. B. Finlay and W. Deng for Citrobacter mutants, former Blander laboratory members H. Peche and B. Trinite for technical assistance and discussions, S. Mehrotra for advice with caspase inhibitors, and I. George and M. Grisotto for cell sorting. We are indebted to B. Brown, H. Xiong, G. Frankel, C. Dong, K. Schluns, M. Kamanaka, S. Yu, P. Arnaboldi, M. Bogunovic, B. M. Baker, S. L. Fishman, M. Blander and S. J. Blander for technical advice, assistance and support. J. G. is supported by the Fondation pour la Recherche Medicale, and J. M. B. is supported by NIH grant AI073899 and the Kinship Foundation Searle Scholar Award.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Betti M, 2006, ANN ONCOL, V17, P235; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Viswanathan VK, 2008, AM J PHYSIOL-GASTR L, V294, pG1165, DOI 10.1152/ajpgi.00596.2007; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zitvogel L, 2008, CURR OPIN IMMUNOL, V20, P501, DOI 10.1016/j.coi.2008.07.009	30	262	270	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					78	82		10.1038/nature07781	http://dx.doi.org/10.1038/nature07781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262671				2022-12-28	WOS:000263836000036
J	Evans, JA; Reimer, J				Evans, James A.; Reimer, Jacob			Open Access and Global Participation in Science	SCIENCE			English	Article							CITATIONS; DOWNLOADS; ARTICLES		[Evans, James A.] Univ Chicago, Sch Sociol, Chicago, IL 60637 USA; [Reimer, Jacob] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Evans, JA (corresponding author), Univ Chicago, Sch Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu	McBee, David J/F-3968-2012		NSF [0242971]	NSF(National Science Foundation (NSF))	Supported by NSF grant 0242971. We thank Thomson Reuters, Incorporated, for use of its SCI data.	Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; Maher ER, 2005, J MED GENET, V42, P97, DOI 10.1136/jmg.2004.030239; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683	8	133	138	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1025	1025		10.1126/science.1154562	http://dx.doi.org/10.1126/science.1154562			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	409AK	19229029				2022-12-28	WOS:000263478400031
J	Wahl, MC; Will, CL; Luhrmann, R				Wahl, Markus C.; Will, Cindy L.; Luehrmann, Reinhard			The Spliceosome: Design Principles of a Dynamic RNP Machine	CELL			English	Review							PRE-MESSENGER-RNA; SPLICING FACTOR PRP8; 2ND CATALYTIC STEP; SM-LIKE PROTEINS; CRYSTAL-STRUCTURE; PROTEOMIC ANALYSIS; SNRNP PROTEIN; U5 SNRNP; CONFORMATIONAL REARRANGEMENT; PRP19P-ASSOCIATED COMPLEX	Ribonucleoproteins (RNPs) mediate key cellular functions such as gene expression and its regulation. Whereas most RNP enzymes are stable in composition and harbor preformed active sites, the spliceosome, which removes noncoding introns from precursor messenger RNAs (pre-mRNAs), follows fundamentally different strategies. In order to provide both accuracy to the recognition of reactive splice sites in the pre-mRNA and flexibility to the choice of splice sites during alternative splicing, the spliceosome exhibits exceptional compositional and structural dynamics that are exploited during substrate-dependent complex assembly, catalytic activation, and active site remodeling.	[Wahl, Markus C.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wahl, Markus C.] Free Univ Berlin, Inst Chem & Biochem, Fachbereich Biol, AG Strukturbiochem, D-14195 Berlin, Germany	Max Planck Society; Free University of Berlin	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de; cwill1@gwdg.de; reinhard.luehrmann@mpi-bpc.mpg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307	Volkswagen Stiftung; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft; European Commission grant; Fonds der Chemischen Industrie; Ernst-Jung-Stiftung; Max-Planck-Society	Volkswagen Stiftung(Volkswagen); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission grant(European CommissionEuropean Commission Joint Research Centre); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Ernst-Jung-Stiftung; Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	We thank B. Kastner for help with the figures. Work in the authors' labs is supported by the Volkswagen Stiftung ( R. L. and M. C. W.), the Bundesministerium fur Bildung und Forschung ( R. L. and M. C. W.), the Deutsche Forschungsgemeinschaft ( R. L.), a European Commission grant ( EURASNET NoE) ( R. L.), the Fonds der Chemischen Industrie ( R. L.), the Ernst-Jung-Stiftung ( R. L.), and the Max-Planck-Society ( R. L. and M. C. W.).	Abelson J, 2008, NAT STRUCT MOL BIOL, V15, P1235, DOI 10.1038/nsmb1208-1235; Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burge CB, 1999, RNA WORLD, P525; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Donmez G, 2007, MOL CELL, V25, P399, DOI 10.1016/j.molcel.2006.12.019; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; Hilliker AK, 2004, RNA, V10, P921, DOI 10.1261/rna.7310704; Hoogstraten CG, 2007, BIOPOLYMERS, V87, P317, DOI [10.1002/bip.20836, 10.1002/bip.20S36]; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Ismaili N, 2001, RNA, V7, P182, DOI 10.1017/S1355838201001807; Izquierdo JM, 2006, GENE DEV, V20, P1679, DOI 10.1101/gad.1449106; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kent OA, 2002, NAT STRUCT BIOL, V9, P576, DOI 10.1038/nsb822; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mackereth CD, 2005, CHEMBIOCHEM, V6, P1578, DOI 10.1002/cbic.200500106; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Nagradova N, 2007, CURR PROTEIN PEPT SC, V8, P273, DOI 10.2174/138920307780831866; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Nissim-Rafinia M, 2005, TRENDS GENET, V21, P480, DOI 10.1016/j.tig.2005.07.005; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pena V, 2008, EMBO J, V27, P2929, DOI 10.1038/emboj.2008.209; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Reyes J, 1996, RNA, V2, P213; Rhode BM, 2006, EMBO J, V25, P2475, DOI 10.1038/sj.emboj.7601134; Ritchie DB, 2008, NAT STRUCT MOL BIOL, V15, P1199, DOI 10.1038/nsmb.1505; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROY J, 1995, RNA, V1, P375; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Simonovc M, 2008, P NATL ACAD SCI USA, V105, P500, DOI 10.1073/pnas.0711076105; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Tsai RT, 2005, GENE DEV, V19, P2991, DOI 10.1101/gad.1377405; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Umen JG, 1995, RNA, V1, P869; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; WEINER AM, 1993, CELL, V72, P161, DOI 10.1016/0092-8674(93)90654-9; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Wohlgemuth I, 2006, EMBO REP, V7, P699, DOI 10.1038/sj.embor.7400732; Xu YZ, 2007, MOL CELL, V28, P838, DOI 10.1016/j.molcel.2007.09.022; Yang K, 2008, P NATL ACAD SCI USA, V105, P13817, DOI 10.1073/pnas.0805960105; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	138	1746	1805	11	291	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					701	718		10.1016/j.cell.2009.02.009	http://dx.doi.org/10.1016/j.cell.2009.02.009			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239890	Bronze, Green Submitted			2022-12-28	WOS:000263688200020
J	Xiu, XA; Puskar, NL; Shanata, JAP; Lester, HA; Dougherty, DA				Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Lester, Henry A.; Dougherty, Dennis A.			Nicotine binding to brain receptors requires a strong cation-pi interaction	NATURE			English	Article							ACETYLCHOLINE-RECEPTORS; ION CHANNELS; M2 DOMAIN; AGONISTS; ACHBP; SITE; ACTIVATION; TOLERANCE; COMPLEXES; CHEMISTRY	Nicotine addiction begins with high-affinity binding of nicotine to acetylcholine (ACh) receptors in the brain. The end result is over 4,000,000 smoking-related deaths annually worldwide and the largest source of preventable mortality in developed countries. Stress reduction, pleasure, improved cognition and other central nervous system effects are strongly associated with smoking. However, if nicotine activated ACh receptors found in muscle as potently as it does brain ACh receptors, smoking would cause intolerable and perhaps fatal muscle contractions. Despite extensive pharmacological, functional and structural studies of ACh receptors, the basis for the differential action of nicotine on brain compared with muscle ACh receptors has not been determined. Here we show that at the alpha 4 beta 2 brain receptors thought to underlie nicotine addiction, the high affinity for nicotine is the result of a strong cation-pi interaction to a specific aromatic amino acid of the receptor, TrpB. In contrast, the low affinity for nicotine at the muscle-type ACh receptor is largely due to the fact that this key interaction is absent, even though the immediate binding site residues, including the key amino acid TrpB, are identical in the brain and muscle receptors. At the same time a hydrogen bond from nicotine to the backbone carbonyl of TrpB is enhanced in the neuronal receptor relative to the muscle type. A point mutation near TrpB that differentiates alpha 4 beta 2 and muscle-type receptors seems to influence the shape of the binding site, allowing nicotine to interact more strongly with TrpB in the neuronal receptor. ACh receptors are established therapeutic targets for Alzheimer's disease, schizophrenia, Parkinson's disease, smoking cessation, pain, attention-deficit hyperactivity disorder, epilepsy, autism and depression(1). Along with solving a chemical mystery in nicotine addiction, our results provide guidance for efforts to develop drugs that target specific types of nicotinic receptors.	[Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu		Shanata, Jai/0000-0003-3588-040X	NIH [NS 34407, NS 11756]; California Tobacco-Related Disease Research Program of the University of California [16RT-0160]; NRSA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS011756, R01NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research Program of the University of California(University of California System); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. N. Cohen for advice on single-channel recording and analysis. This work was supported by the NIH (NS 34407; NS 11756) and the California Tobacco-Related Disease Research Program of the University of California, grant number 16RT-0160. J.A.P.S. was partially supported by an NRSA training grant.	Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dougherty DA, 2008, J ORG CHEM, V73, P3667, DOI 10.1021/jo8001722; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	31	281	288	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					534	U10		10.1038/nature07768	http://dx.doi.org/10.1038/nature07768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19252481	Green Accepted			2022-12-28	WOS:000264532400050
J	Kang, B; Ceder, G				Kang, Byoungwoo; Ceder, Gerbrand			Battery materials for ultrafast charging and discharging	NATURE			English	Article							RECHARGEABLE LITHIUM BATTERIES; PHOSPHATE-GLASSES; PHOTOELECTRON-SPECTROSCOPY; ELECTROCHEMICAL PROPERTIES; NANOSTRUCTURED MATERIALS; ACTIVE MATERIALS; ENERGY-STORAGE; ION BATTERIES; LIFEPO4; TRANSPORT	The storage of electrical energy at high charge and discharge rate is an important technology in today's society, and can enable hybrid and plug-in hybrid electric vehicles and provide back-up for wind and solar energy. It is typically believed that in electrochemical systems very high power rates can only be achieved with supercapacitors, which trade high power for low energy density as they only store energy by surface adsorption reactions of charged species on an electrode material(1-3). Here we show that batteries(4,5) which obtain high energy density by storing charge in the bulk of a material can also achieve ultrahigh discharge rates, comparable to those of supercapacitors. We realize this in LiFePO4 (ref. 6), a material with high lithium bulk mobility(7,8), by creating a fast ion-conducting surface phase through controlled off-stoichiometry. A rate capability equivalent to full battery discharge in 10-20 s can be achieved.	[Kang, Byoungwoo; Ceder, Gerbrand] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ceder, G (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gceder@mit.edu	Wang, Kevin/E-7153-2011; Ceder, Gerbrand/Y-2544-2019		US National Science Foundation through the Materials Research Science and Engineering Centers programme; Batteries for Advanced Transportation Program of the US Department of Energy	US National Science Foundation through the Materials Research Science and Engineering Centers programme(National Science Foundation (NSF)); Batteries for Advanced Transportation Program of the US Department of Energy(United States Department of Energy (DOE))	B. K. thanks D. S. Yun and Y. Zhang for the help with transmission electron microscope measurements and K. Kang and Y. S. Meng for experimental help and discussions. Support from the US National Science Foundation through the Materials Research Science and Engineering Centers programme and the Batteries for Advanced Transportation Program of the US Department of Energy is gratefully acknowledged.	Amatucci GG, 2001, J ELECTROCHEM SOC, V148, pA930, DOI 10.1149/1.1383553; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Chen GY, 2006, ELECTROCHEM SOLID ST, V9, pA295, DOI 10.1149/1.2192695; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; CONWAY BE, 1991, J ELECTROCHEM SOC, V138, P1539, DOI 10.1149/1.2085829; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Dominko R, 2007, J EUR CERAM SOC, V27, P909, DOI 10.1016/j.jeurceramsoc.2006.04.133; Ellis B, 2007, FARADAY DISCUSS, V134, P119, DOI 10.1039/b602698b; Gaberscek M, 2006, SOLID STATE IONICS, V177, P3015, DOI 10.1016/j.ssi.2006.07.060; Herle PS, 2004, NAT MATER, V3, P147, DOI 10.1038/nmat1063; Islam MS, 2005, CHEM MATER, V17, P5085, DOI 10.1021/cm050999v; Kim DK, 2006, J POWER SOURCES, V159, P237, DOI 10.1016/j.jpowsour.2006.04.086; Kim DH, 2006, ELECTROCHEM SOLID ST, V9, pA439, DOI 10.1149/1.2218308; MARTIN SW, 1991, J AM CERAM SOC, V74, P1767, DOI 10.1111/j.1151-2916.1991.tb07788.x; Mogus-Milankovic A, 2003, J NON-CRYST SOLIDS, V330, P128, DOI 10.1016/j.jnoncrysol.2003.08.050; Morgan D, 2004, ELECTROCHEM SOLID ST, V7, pA30, DOI 10.1149/1.1633511; MORGAN WE, 1973, J AM CHEM SOC, V95, P751, DOI 10.1021/ja00784a018; Okubo M, 2007, J AM CHEM SOC, V129, P7444, DOI 10.1021/ja0681927; Ong SP, 2008, CHEM MATER, V20, P1798, DOI 10.1021/cm702327g; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1609, DOI 10.1149/1.1837649; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Ravet N, 2001, J POWER SOURCES, V97-8, P503, DOI 10.1016/S0378-7753(01)00727-3; Reed J, 2004, CHEM REV, V104, P4513, DOI 10.1021/cr020733x; Rho YH, 2007, J ELECTROCHEM SOC, V154, pA283, DOI 10.1149/1.2433539; SAYER M, 1972, PHYS REV B, V6, P4629, DOI 10.1103/PhysRevB.6.4629; Sobha KC, 1996, J NON-CRYST SOLIDS, V201, P52, DOI 10.1016/0022-3093(95)00547-1; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; WANG B, 1995, J NON-CRYST SOLIDS, V183, P297, DOI 10.1016/0022-3093(94)00665-2; Wang L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165435; Zhou HS, 2005, ANGEW CHEM INT EDIT, V44, P797, DOI 10.1002/anie.200460937	30	2917	3046	68	3277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					190	193		10.1038/nature07853	http://dx.doi.org/10.1038/nature07853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279634				2022-12-28	WOS:000264059700040
J	Dharan, NJ; Gubareva, LV; Meyer, JJ; Okomo-Adhiambo, M; McClinton, RC; Marshall, SA; George, KS; Epperson, S; Brammer, L; Klimov, AI; Bresee, JS; Fry, AM				Dharan, Nila J.; Gubareva, Larisa V.; Meyer, John J.; Okomo-Adhiambo, Margaret; McClinton, Reginald C.; Marshall, Steven A.; George, Kirsten St.; Epperson, Scott; Brammer, Lynnette; Klimov, Alexander I.; Bresee, Joseph S.; Fry, Alicia M.		Oseltamivir-Resistance Working Grp	Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 25, 2008	Washington, DC	Infect Dis Soc Amer			NEURAMINIDASE INHIBITORS; ADAMANTANE RESISTANCE; A VIRUSES; SURVEILLANCE; SUSCEPTIBILITY; WORLDWIDE	Context During the 2007-2008 influenza season, oseltamivir resistance among influenza A(H1N1) viruses increased significantly for the first time worldwide. Early surveillance data suggest that the prevalence of oseltamivir resistance among A( H1N1) viruses will most likely be higher during the 2008-2009 season. Objectives To describe patients infected with oseltamivir-resistant influenza A( H1N1) virus and to determine whether there were any differences between these patients and patients infected with oseltamivir-susceptible A(H1N1) virus in demographic or epidemiological characteristics, clinical symptoms, severity of illness, or clinical outcomes. Design, Setting, and Patients Influenza A(H1N1) viruses that were identified and submitted to the Centers for Disease Control and Prevention by US public health laboratories between September 30, 2007, and May 17, 2008, and between September 28, 2008, and February 19, 2009, were tested as part of ongoing surveillance. Oseltamivir resistance was determined by neuraminidase inhibition assay and pyrosequencing analysis. Information was collected using a standardized case form from patients with oseltamivir-resistant A(H1N1) infections and a comparison group of patients with oseltamivir-susceptible A(H1N1) infections during 2007-2008. Main Outcome Measures Demographic and epidemiological information as well as clinical information, including symptoms, severity of illness, and clinical outcomes. Results During the 2007-2008 season, influenza A(H1N1) accounted for an estimated 19% of circulating influenza viruses in the United States. Among 1155 influenza A(H1N1) viruses tested from 45 states, 142 (12.3%) from 24 states were resistant to oseltamivir. Data were available for 99 oseltamivir-resistant cases and 182 oseltamivir-susceptible cases from this period. Among resistant cases, median age was 19 years (range, 1 month to 62 years), 5 patients (5%) were hospitalized, and 4 patients (4%) died. None reported oseltamivir exposure before influenza diagnostic sample collection. No significant differences were found between cases of oseltamivir-resistant and oseltamivir-susceptible influenza in demographic characteristics, underlying medical illness, or clinical symptoms. Preliminary data from the 2008- 2009 influenza season identified resistance to oseltamivir among 264 of 268 influenza A(H1N1) viruses (98.5%) tested. Conclusions Oseltamivir-resistant A(H1N1) viruses circulated widely in the United States during the 2007-2008 influenza season, appeared to be unrelated to oseltamivir use, and appeared to cause illness similar to oseltamivir-susceptible A(H1N1) viruses. Circulation of oseltamivir-resistant A(H1N1) viruses will continue, with a higher prevalence of resistance, during the 2008-2009 season.	[Dharan, Nila J.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev Assigned, Influenza Div, Atlanta, GA 30333 USA; [Meyer, John J.] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [McClinton, Reginald C.] Wyoming Dept Hlth, Cheyenne, WY USA; [Marshall, Steven A.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [George, Kirsten St.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA	Centers for Disease Control & Prevention - USA; Arizona Department of Health Services; University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; Wadsworth Center	Dharan, NJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev Assigned, Influenza Div, 1600 Clifton Rd,MS A-32, Atlanta, GA 30333 USA.	nfd6@cdc.gov	Dharan, Nila/AEX-8364-2022	Dharan, Nila/0000-0003-1175-5962				Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1287; Aoki FY, 2007, ANTIVIR THER, V12, P603; Brammer L., 2008, Morbidity and Mortality Weekly Report, V57, P1329; Brammer L., 2008, Morbidity and Mortality Weekly Report, V57, P179; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CDCP, ISS INT REC US INFL; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; *FLUV, WEEKL INFL SURV REP; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; LAPIANTE J, 2008, 24 ANN CLIN VIR S AP; Loonsk John W, 2004, MMWR Suppl, V53, P53; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mungall BA, 2004, VIRUS RES, V103, P195, DOI 10.1016/j.virusres.2004.02.033; Roberts NA, 2001, PHILOS T ROY SOC B, V356, P1895, DOI 10.1098/rstb.2001.1002; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2008, INFL A H1N1 VIR RES; *WHO, 2008, INFL AH1N1 VIR RES O	30	389	431	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1034	1041		10.1001/jama.2009.294	http://dx.doi.org/10.1001/jama.2009.294			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	416OQ	19255110				2022-12-28	WOS:000264015800027
J	Phillips, OL; Aragao, LEOC; Lewis, SL; Fisher, JB; Lloyd, J; Lopez-Gonzalez, G; Malhi, Y; Monteagudo, A; Peacock, J; Quesada, CA; van der Heijden, G; Almeida, S; Amaral, I; Arroyo, L; Aymard, G; Baker, TR; Banki, O; Blanc, L; Bonal, D; Brando, P; Chave, J; de Oliveira, ACA; Cardozo, ND; Czimczik, CI; Feldpausch, TR; Freitas, MA; Gloor, E; Higuchi, N; Jimenez, E; Lloyd, G; Meir, P; Mendoza, C; Morel, A; Neill, DA; Nepstad, D; Patino, S; Penuela, MC; Prieto, A; Ramirez, F; Schwarz, M; Silva, J; Silveira, M; Thomas, AS; ter Steege, H; Stropp, J; Vasquez, R; Zelazowski, P; Davila, EA; Andelman, S; Andrade, A; Chao, KJ; Erwin, T; Di Fiore, A; Honorio, E; Keeling, H; Killeen, TJ; Laurance, WF; Cruz, AP; Pitman, NCA; Vargas, PN; Ramirez-Angulo, H; Rudas, A; Salamao, R; Silva, N; Terborgh, J; Torres-Lezama, A				Phillips, Oliver L.; Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Malhi, Yadvinder; Monteagudo, Abel; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Almeida, Samuel; Amaral, Ieda; Arroyo, Luzmila; Aymard, Gerardo; Baker, Tim R.; Banki, Olaf; Blanc, Lilian; Bonal, Damien; Brando, Paulo; Chave, Jerome; Alves de Oliveira, Atila Cristina; Cardozo, Nallaret Davila; Czimczik, Claudia I.; Feldpausch, Ted R.; Freitas, Maria Aparecida; Gloor, Emanuel; Higuchi, Niro; Jimenez, Eliana; Lloyd, Gareth; Meir, Patrick; Mendoza, Casimiro; Morel, Alexandra; Neill, David A.; Nepstad, Daniel; Patino, Sandra; Cristina Penuela, Maria; Prieto, Adriana; Ramirez, Fredy; Schwarz, Michael; Silva, Javier; Silveira, Marcos; Thomas, Anne Sota; ter Steege, Hans; Stropp, Juliana; Vasquez, Rodolfo; Zelazowski, Przemyslaw; Alvarez Davila, Esteban; Andelman, Sandy; Andrade, Ana; Chao, Kuo-Jung; Erwin, Terry; Di Fiore, Anthony; Honorio C, Euridice; Keeling, Helen; Killeen, Tim J.; Laurance, William F.; Pena Cruz, Antonio; Pitman, Nigel C. A.; Nunez Vargas, Percy; Ramirez-Angulo, Hirma; Rudas, Agustin; Salamao, Rafael; Silva, Natalino; Terborgh, John; Torres-Lezama, Armando			Drought Sensitivity of the Amazon Rainforest	SCIENCE			English	Article							TROPICAL FORESTS; CLIMATE-CHANGE; CARBON; MORTALITY; IMPACT; TREE; DYNAMICS; EXCHANGE; TRENDS; XYLEM	Amazon forests are a key but poorly understood component of the global carbon cycle. If, as anticipated, they dry this century, they might accelerate climate change through carbon losses and changed surface energy balances. We used records from multiple long-term monitoring plots across Amazonia to assess forest responses to the intense 2005 drought, a possible analog of future events. Affected forest lost biomass, reversing a large long-term carbon sink, with the greatest impacts observed where the dry season was unusually intense. Relative to pre-2005 conditions, forest subjected to a 100-millimeter increase in water deficit lost 5.3 megagrams of aboveground biomass of carbon per hectare. The drought had a total biomass carbon impact of 1.2 to 1.6 petagrams (1.2 x 10(15) to 1.6 x 10(15) grams). Amazon forests therefore appear vulnerable to increasing moisture stress, with the potential for large carbon losses to exert feedback on climate change.	[Phillips, Oliver L.; Lewis, Simon L.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Baker, Tim R.; Feldpausch, Ted R.; Gloor, Emanuel; Patino, Sandra; Schwarz, Michael; Chao, Kuo-Jung; Keeling, Helen] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Malhi, Yadvinder; Morel, Alexandra; Silva, Javier; Zelazowski, Przemyslaw] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Monteagudo, Abel; Vasquez, Rodolfo; Pena Cruz, Antonio] Jardin Bot Missouri, Oxapampa, Pasco, Peru; [Quesada, Carlos A.; Amaral, Ieda; Alves de Oliveira, Atila Cristina; Andrade, Ana; Laurance, William F.] Inst Nacl de Pesquisas da Amazonia, BR-69060011 Manaus, Amazonas, Brazil; [Almeida, Samuel; Freitas, Maria Aparecida; Salamao, Rafael] Museu Paraense Emilio Goeldi, BR-66077830 Belem, Para, Brazil; [Amaral, Ieda; Andelman, Sandy] Conservat Int, Trop Ecol Assessment & Monitoring Network, Arlington, VA 22202 USA; [Arroyo, Luzmila; Killeen, Tim J.] Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arroyo, Luzmila; Neill, David A.] Missouri Bot Garden, St Louis, MO 63166 USA; [Aymard, Gerardo] Univ Nacl Expt Los Llanos Occidentales Ezequiel Z, Herbario Univ PORTI, Programa Ciencias Agro & Mar, Mesa De Cavacas 3350, Portuguesa, Venezuela; [Banki, Olaf] Natl Herbarium Nederland, NL-3584 CS Utrecht, Netherlands; [Blanc, Lilian; Patino, Sandra] CIRAD, UMR EcoFoG, Kourou 97387, French Guiana; [Bonal, Damien] INRA, UMR EcoFoG, Kourou 97387, French Guiana; [Brando, Paulo] Inst Pesquisa Ambiental Amazonia, BR-66035 Belem, Para, Brazil; [Brando, Paulo] Univ Florida, Dept Bot, Gainesville, FL 32611 USA; [Brando, Paulo] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Chave, Jerome] Univ Toulouse 3, Lab EDB, F-31062 Toulouse, France; [Cardozo, Nallaret Davila; Ramirez, Fredy] Univ Nacl Amazonia Peruana, Iquitos, Loreto, Peru; [Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Higuchi, Niro] Inst Nacl de Pesquisas da Amazonia, Dept Silvicultura Trop, Manaus, Amazonas, Brazil; [Jimenez, Eliana; Cristina Penuela, Maria] Univ Nacl Colombia, Leticia, Amazonas, Colombia; [Lloyd, Gareth] Natl Australia Bank, UB2211, Docklands, Vic 3008, Australia; [Meir, Patrick] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mendoza, Casimiro] FOMABO Manejo Forestal Tierras Trop Bolivia, Sacta, Bolivia; [Neill, David A.] Jatun Sacha Fdn, Quito, Ecuador; [Nepstad, Daniel] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Nepstad, Daniel] Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; [Prieto, Adriana] Inst Alexander von Humboldt, Villa De Leyva, Boyaca, Colombia; [Schwarz, Michael] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res, D-95440 Bayreuth, Germany; [Silveira, Marcos] Univ Fed Acre, Dept Ciencias Nat, BR-69910900 Rio Branco, AC, Brazil; [Thomas, Anne Sota] Humboldt Univ, Fac Agr & Hort, D-10557 Berlin, Germany; [ter Steege, Hans; Stropp, Juliana] Univ Utrecht, Fac Sci, Dept Biol, Inst Environm Biol, NL-3584 CA Utrecht, Netherlands; [Alvarez Davila, Esteban] Univ Tolima, Fac Ingn Forestal, Ibague 546, Colombia; [Erwin, Terry] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20013 USA; [Di Fiore, Anthony] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Honorio C, Euridice] Inst Invest Amazonia Peruana, Loreto, Peru; [Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Pitman, Nigel C. A.] Ctr Invest & Capacitac Rio de Los Amigos, Madre De Dios, Peru; [Nunez Vargas, Percy] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Ramirez-Angulo, Hirma; Torres-Lezama, Armando] Univ Los Andes, Fac Ciencias Forestales, INDEFOR, Merida, Venezuela; [Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Silva, Natalino] Serv Florestal Brasileiro, BR-70818900 Brasilia, DF, Brazil; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA	University of Leeds; University of Oxford; Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Conservation International; Missouri Botanical Gardens; CIRAD; INRAE; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidad Nacional de la Amazonia Peruana; University of California System; University of California Irvine; Institute Nacional de Pesquisas da Amazonia; Universidad Nacional de Colombia; University of Edinburgh; Woods Hole Research Center; University of Bayreuth; Universidade Federal do Acre (UFAC); Humboldt University of Berlin; Utrecht University; Universidad del Tolima; Smithsonian Institution; Smithsonian National Museum of Natural History; New York University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de San Antonio Abad del Cusco; University of Los Andes Venezuela; Universidad Nacional de Colombia; Duke University	Phillips, OL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	o.phillips@leeds.ac.uk	Aymard, Gerardo/ABE-9203-2020; van der Heijden, Geertje/AAB-4102-2019; Alvarez-Davila, Esteban/AAP-4231-2020; Laurance, William F/B-2709-2012; aragao, luiz eoc/G-8387-2012; Meir, Patrick/J-8344-2012; Higuchi, Niro/ABC-9134-2020; Morel, Alexandra/J-4071-2019; Higuchi, Niro/J-1287-2016; Phillips, Oliver/A-1523-2011; Feldpausch, Ted/ABH-3123-2020; Feldpausch, Ted/D-3436-2009; Lloyd, Jonathan J/F-8893-2010; Steege, Hans ter/B-5866-2011; Andrade, Ana Cristina/E-8218-2013; Coronado, Eurídice Nora Honorio/K-3412-2015; Brando, Paulo/AAC-9396-2019; Pitman, Nigel C A/A-7681-2008; Silveira, Marcos/H-7906-2013; BONAL, Damien/B-2384-2009; Brando, Paulo M/C-4302-2012; Higuchi, Niro/ABC-8890-2020; Stropp, Juliana/AAF-7946-2020; Ramirez, Fredy/R-1522-2016	Aymard, Gerardo/0000-0001-9405-0508; van der Heijden, Geertje/0000-0002-2110-5173; Alvarez-Davila, Esteban/0000-0001-9032-0099; Laurance, William F/0000-0003-4430-9408; aragao, luiz eoc/0000-0002-4134-6708; Higuchi, Niro/0000-0002-1203-4502; Morel, Alexandra/0000-0002-0905-8079; Higuchi, Niro/0000-0002-1203-4502; Phillips, Oliver/0000-0002-8993-6168; Feldpausch, Ted/0000-0002-6631-7962; Feldpausch, Ted/0000-0002-6631-7962; Lloyd, Jonathan J/0000-0002-5458-9960; Steege, Hans ter/0000-0002-8738-2659; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Brando, Paulo/0000-0001-8952-7025; Pitman, Nigel C A/0000-0002-9211-2880; Silveira, Marcos/0000-0003-0485-7872; Brando, Paulo M/0000-0001-8952-7025; Stropp, Juliana/0000-0002-2831-4066; Blanc, Lilian/0000-0003-3605-4230; Jimenez, Eliana M./0000-0002-8610-1771; Neill, David Alan/0000-0002-5143-9430; Lewis, Simon/0000-0002-8066-6851; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Czimczik, Claudia/0000-0002-8251-6603; Banki, Olaf/0000-0001-6197-9951; Fisher, Joshua/0000-0003-4734-9085; Ramirez, Fredy/0000-0003-2441-9984; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Zelazowski, Przemyslaw/0000-0003-0442-2529; Silva, Jose/0000-0003-4068-2432	Leverhulme Trust; NERC [NE/B503384/1, NE/D01025X/1, NER/A/S/2003/00608/2]; WOTRO [W84-581]; Royal Society; University of Leeds; Gordon and Betty Moore Foundation; NERC [NE/D010306/1] Funding Source: UKRI; Natural Environment Research Council [NE/D01025X/1, NE/D010306/1, NE/B503384/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); WOTRO; Royal Society(Royal Society of London); University of Leeds; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a product of the RAINFOR network. Funding for the 2006 recensuses came primarily from a Natural Environment Research Council (NERC) Urgency Grant. The results summarized here also depend on contributions from numerous field assistants and rural communities in Brazil, Bolivia, Colombia, Ecuador, French Guiana, Guyana, Peru, and Venezuela, many previously acknowledged. I. Huamantupa, N. Jaramillo, N. Saavedram (Peru), V. Pena (Ecuador), J.-C. Arias, and D. Navarrete (Colombia) assisted with recent censuses. We thank CNPQ (Brazil), MCT (Brazil), Ministerio del Medio Ambiente, Vivienda y Desarrollo Territorial (Colombia), Ministerio de Ambiente (Ecuador), the Forestry Commission (Guyana), INRENA (Peru), and Ministerio del Ambiente para el Poder Popular (Venezuela) for research permissions, and the Large Scale Biosphere-Atmosphere Experiment in Amazonia (LBA) for logistical support. This paper was supported by the Leverhulme Trust (O.L.P.), NERC grants NE/B503384/1 and NE/D01025X/1 (O.L.P.), NER/A/S/2003/00608/2 (Y.M.), WOTRO (W84-581) (H.t.S., O.B.), the Royal Society (S.L.L., Y.M.), University of Leeds (T.R.B., K.-J.C., G.L.-G.), and a Gordon and Betty Moore Foundation grant to RAINFOR. Some of the data used in these analyses were collected with support from the TEAM Network of Conservation International, funded by the Gordon and Betty Moore Foundation. We thank D. Galbraith, L. Anderson, C. Michelaki, J. Ratnam, and M. Wagner for discussions; three anonymous reviewers for comments on the manuscript; M. Garcia-Hernandez for help in managing co-author contributions; and A. Manson and D. Appleyard for help in creating the figures.	Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Christensen J.H., 2007, CLIMATE CHANGE 2007; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Hasler N, 2007, J HYDROMETEOROL, V8, P380, DOI 10.1175/JHM587.1; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Ichii K, 2005, GLOBAL PLANET CHANGE, V48, P274, DOI 10.1016/j.gloplacha.2005.02.005; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; *NAT OC ATM ADM, 2008, TRENDS ATM CARB DIOX; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	32	1161	1193	26	838	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1344	1347		10.1126/science.1164033	http://dx.doi.org/10.1126/science.1164033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265020	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000263876700042
J	Fanta, CH				Fanta, Christopher H.			DRUG THERAPY Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHURG-STRAUSS-SYNDROME; AIRWAY SMOOTH-MUSCLE; LEUKOTRIENE RECEPTOR ANTAGONIST; DOSE FLUTICASONE PROPIONATE; ACTING BETA-AGONIST; INHALED CORTICOSTEROIDS; DOUBLE-BLIND; PERSISTENT ASTHMA; EOSINOPHILIC INFLAMMATION; COMBINATION THERAPY		[Fanta, Christopher H.] Harvard Univ, Sch Med, Boston, MA USA; [Fanta, Christopher H.] Brigham & Womens Hosp, Partners Asthma Ctr, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Fanta, CH (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	cfanta@partners.org						ADAMS N, 2001, COCHRANE DB SYST REV, V4; Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; Barnes Neil C, 2007, Prim Care Respir J, V16, P149, DOI 10.3132/pcrj.2007.00038; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; BEASLEY R, 2004, GLOBAL INITIATIVE AS; Berger WE, 2006, CURR MED RES OPIN, V22, P1217, DOI 10.1185/030079906X112534; Boulet LP, 2007, RESP MED, V101, P1677, DOI 10.1016/j.rmed.2007.03.001; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Bousquet J, 2007, RESP MED, V101, P1483, DOI 10.1016/j.rmed.2007.01.011; Brabson JH, 2002, AM J MED, V113, P15, DOI 10.1016/S0002-9343(02)01099-9; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Castro M, 2001, NEW ENGL J MED, V345, P1529, DOI 10.1056/NEJMoa011961; Cates CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000052.pub2; Chanez Pascal, 2004, Proc Am Thorac Soc, V1, P184, DOI 10.1513/pats.200402-006MS; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, P1373, DOI 10.1016/j.jaci.2007.09.032; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Dahlen B, 1998, AM J RESP CRIT CARE, V157, P1187, DOI 10.1164/ajrccm.157.4.9707089; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; DelGaudio JM, 2002, ARCH OTOLARYNGOL, V128, P677, DOI 10.1001/archotol.128.6.677; Derendorf H, 2006, EUR RESPIR J, V28, P1042, DOI 10.1183/09031936.00074905; Deykin A, 2007, AM J RESP CRIT CARE, V175, P228, DOI 10.1164/rccm.200601-112OC; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; DOSHAN HD, 1986, J CARDIOVASC PHARM, V8, pS105, DOI 10.1097/00005344-198608004-00023; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; *EP STAT UN, 2007, TRENDS ASTHM MORB MO; Feltis BN, 2007, THORAX, V62, P314, DOI 10.1136/thx.2006.069229; *FOOD DRUG AGM CTR, 2008, UPD SAF REV FOLL UP; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; *GINA, 2007, GLOB STRAT ASTHM MAN; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Hauser T, 2008, THORAX, V63, P677, DOI 10.1136/thx.2007.087825; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Hodges IGC, 2005, CLIN DRUG INVEST, V25, P13, DOI 10.2165/00044011-200525010-00002; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Israel E, 2001, NEW ENGL J MED, V345, P941, DOI 10.1056/NEJMoa002304; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; ISRAEL E, 1993, ANN INTERN MED, V119, P1059, DOI 10.7326/0003-4819-119-11-199312010-00001; James AL, 2007, EUR RESPIR J, V30, P134, DOI 10.1183/09031936.00146905; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Jonasson G, 2000, ALLERGY, V55, P740, DOI 10.1034/j.1398-9995.2000.00661.x; Kim SH, 2007, PHARMACOGENOMICS, V8, P1143, DOI 10.2217/14622416.8.9.1143; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; LAWFORD P, 1983, BRIT J DIS CHEST, V77, P276; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC; LIPWORTH BJ, 1989, AM REV RESPIR DIS, V140, P586, DOI 10.1164/ajrccm/140.3.586; Lotvall J, 2001, RESP MED, V95, pS7, DOI 10.1053/rmed.2001.1139; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; MACKAY AD, 1981, BRIT J DIS CHEST, V75, P273, DOI 10.1016/0007-0971(81)90005-X; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Minoguchi K, 2002, CHEST, V121, P732, DOI 10.1378/chest.121.3.732; NATHAN RA, 1992, J ASTHMA, V29, P49, DOI 10.3109/02770909209110640; Nathani N, 2008, THORAX, V63, P883, DOI 10.1136/thx.2007.093955; National Institutes of Health, 2007, NIH PUBL, V02-3659; Nelson HS, 2006, J ALLERGY CLIN IMMUN, V117, P3, DOI 10.1016/j.jaci.2005.10.013; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; Nelson JA, 1998, NEW ENGL J MED, V339, P141, DOI 10.1056/NEJM199807163390301; Newman SP, 2004, CLIN PHARMACOKINET, V43, P349, DOI 10.2165/00003088-200443060-00001; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Ostrom NK, 2005, J PEDIATR-US, V147, P213, DOI 10.1016/j.jpeds.2005.03.052; Pajaron-Fernandez M, 2006, PEDIATR PULM, V41, P222, DOI 10.1002/ppul.20377; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pauwels RA, 1998, NEW ENGL J MED, V338, P139; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; PEARLMAN DS, 1992, NEW ENGL J MED, V327, P1420, DOI 10.1056/NEJM199211123272004; Peters SP, 2007, NEW ENGL J MED, V357, P728; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Pizzichini E, 1999, EUR RESPIR J, V14, P12, DOI 10.1034/j.1399-3003.1999.14a04.x; Price DB, 2003, THORAX, V58, P211, DOI 10.1136/thorax.58.3.211; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Ramsdell JW, 1998, ANN ALLERG ASTHMA IM, V81, P593, DOI 10.1016/S1081-1206(10)62711-1; REBUCK AS, 1987, AM J MED, V82, P59, DOI 10.1016/0002-9343(87)90378-0; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; REPSHER LH, 1984, CHEST, V85, P34, DOI 10.1378/chest.85.1.34; Rodrigo GJ, 2008, THORAX, V63, P1029, DOI 10.1136/thx.2005.047803corr1; Rodrigo GJ, 2006, THORAX, V61, P274; Rodrigo GJ, 2005, THORAX, V60, P740, DOI 10.1136/thx.2005.040444; Salpeter SR, 2002, ANN INTERN MED, V137, P715, DOI 10.7326/0003-4819-137-9-200211050-00035; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Shore SA, 2004, NEW ENGL J MED, V351, P531, DOI 10.1056/NEJMp048139; Simons FER, 1997, PEDIATRICS, V99, P655, DOI 10.1542/peds.99.5.655; Simons FER, 2001, J PEDIATR-US, V138, P694, DOI 10.1067/mpd.2001.112899; Skoner DP, 2008, PEDIATRICS, V121, pE1, DOI 10.1542/peds.2006-2206; SMYTH ET, 1993, BRIT MED J, V306, P543, DOI 10.1136/bmj.306.6877.543; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Soler M, 2001, EUR RESPIR J, V18, P739; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V120, P285; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Sovijarvi ARA, 2003, THORAX, V58, P500, DOI 10.1136/thorax.58.6.500; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229, DOI 10.1080/09629359890910; Wechsler ME, 1999, DRUG SAFETY, V21, P241, DOI 10.2165/00002018-199921040-00001; Wechsler ME, 2000, CHEST, V117, P708, DOI 10.1378/chest.117.3.708; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 1999, CHEST, V116, P266, DOI 10.1378/chest.116.1.266-a; Weinberger M, 2006, NEW ENGL J MED, V355, P852, DOI 10.1056/NEJMc066282; Wilson DH, 2006, MED J AUSTRALIA, V184, P226, DOI 10.5694/j.1326-5377.2006.tb00207.x; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; STATE ASTHMA AM ASTH	122	334	354	2	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					1002	1014		10.1056/NEJMra0804579	http://dx.doi.org/10.1056/NEJMra0804579			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264689				2022-12-28	WOS:000263824500008
J	Fielding, EJ; Lundgren, PR; Burgmann, R; Funning, GJ				Fielding, Eric J.; Lundgren, Paul R.; Buergmann, Roland; Funning, Gareth J.			Shallow fault-zone dilatancy recovery after the 2003 Bam earthquake in Iran	NATURE			English	Article							DEFORMATION; PARKFIELD; VELOCITY; DAMAGE; SLIP	Earthquakes radiate from slip on discrete faults, but also commonly involve distributed deformation within a broader fault zone, especially near the surface. Variations in rock strain during an earthquake are caused by heterogeneity in the elastic stress before the earthquake, by variable material properties and geometry of the fault zones, and by dynamic processes during the rupture(1,2). Stress changes due to the earthquake slip, both dynamic and static, have long been thought to cause dilatancy in the fault zone that recovers after the earthquake(3-5). Decreases in the velocity of seismic waves passing through the fault zone due to coseismic dilatancy have been observed(6) followed by postseismic seismic velocity increases during healing(5,7,8). Dilatancy and its recovery have not previously been observed geodetically. Here we use interferometric analysis of synthetic aperture radar images to measure postseismic surface deformation after the 2003 Bam, Iran, earthquake and show reversal of coseismic dilatancy in the shallow fault zone that causes subsidence of the surface. This compaction of the fault zone is directly above the patch of greatest coseismic slip at depth. The dilatancy and compaction probably reflects distributed shear and damage to the material during the earthquake that heals afterwards. Coseismic and postseismic deformation spread through a fault zone volume may resolve the paradox of shallow slip deficits for some strike-slip fault ruptures(9).	[Fielding, Eric J.; Lundgren, Paul R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Funning, Gareth J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Berkeley; University of California System; University of California Riverside	Fielding, EJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Eric.J.Fielding@jpl.nasa.gov	Funning, Gareth J./F-6926-2011; Funning, Gareth J./CAG-5302-2022; Burgmann, Roland/AAE-5138-2022; Fielding, Eric/L-8187-2019; Fielding, Eric Jameson/A-1288-2007	Funning, Gareth J./0000-0002-8247-0545; Funning, Gareth J./0000-0002-8247-0545; Fielding, Eric/0000-0002-6648-8067; Fielding, Eric Jameson/0000-0002-6648-8067; Burgmann, Roland/0000-0002-3560-044X	AOE [668]	AOE	Envisat data are copyright 2004-07 European Space Agency and were provided under AOE project 668. We thank R. Lohman for the use of data resampling programs and discussions. We thank J. Jackson, M. Talebian, D. McKenzie, J.- P. Avouac, Z. Liu, Z. H. Li, E. Cochran, F. Horowitz, G. Peltzer, Y. Ben-Zion and E. Hearn for discussions. Part of this research was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration.	Ben-Zion Y, 2003, PURE APPL GEOPHYS, V160, P677, DOI 10.1007/PL00012554; Berardino P, 2002, IEEE T GEOSCI REMOTE, V40, P2375, DOI 10.1109/TGRS.2002.803792; Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; Burgmann R, 2008, ANNU REV EARTH PL SC, V36, P531, DOI 10.1146/annurev.earth.36.031207.124326; Chen CW, 2000, J OPT SOC AM A, V17, P401, DOI 10.1364/JOSAA.17.000401; Fialko Y, 2005, NATURE, V435, P295, DOI 10.1038/nature03425; Funning GJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003338; Hamiel Y, 2004, GEOPHYS J INT, V156, P701, DOI 10.1111/j.1365-246X.2004.02172.x; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Jackson J, 2006, GEOPHYS J INT, V166, P1270, DOI 10.1111/j.1365-246X.2006.03056.x; Johanson IA, 2006, B SEISMOL SOC AM, V96, pS269, DOI 10.1785/0120050818; Jonsson S, 2003, NATURE, V424, P179, DOI 10.1038/nature01776; Langbein J, 2006, B SEISMOL SOC AM, V96, pS304, DOI 10.1785/0120050823; Li YG, 2006, B SEISMOL SOC AM, V96, pS349, DOI 10.1785/0120050803; Lohman RB, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000841; Mai PM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000588; Motagh M, 2006, PURE APPL GEOPHYS, V163, P1, DOI 10.1007/s00024-005-0005-y; NUR A, 1971, J GEOPHYS RES, V76, P2022, DOI 10.1029/JB076i008p02022; Peltzer G, 1998, J GEOPHYS RES-SOL EA, V103, P30131, DOI 10.1029/98JB02302; Peltzer G, 1996, SCIENCE, V273, P1202, DOI 10.1126/science.273.5279.1202; Peng ZG, 2006, PURE APPL GEOPHYS, V163, P567, DOI 10.1007/s00024-005-0034-6; Peyret M, 2007, GEOPHYS J INT, V169, P849, DOI 10.1111/j.1365-246X.2007.03358.x; Rosen P.A., 2004, EOS T AM GEOPHYS UN, V85, P47, DOI DOI 10.1029/2004EO050004; Sadeghi H, 2006, TECTONOPHYSICS, V417, P269, DOI 10.1016/j.tecto.2006.01.005; Schaff DP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003011; Scholz CH, 1974, GEOLOGY, V2, P551; Talebian M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020058; Thomas A.L., 1993, THESIS STANFORD U; Vidale JE, 2003, NATURE, V421, P524, DOI 10.1038/nature01354	29	91	92	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					64	68		10.1038/nature07817	http://dx.doi.org/10.1038/nature07817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262670				2022-12-28	WOS:000263836000033
J	Haldar, P; Brightling, CE; Hargadon, B; Gupta, S; Monteiro, W; Sousa, A; Marshall, RP; Bradding, P; Green, RH; Wardlaw, AJ; Pavord, ID				Haldar, Pranabashis; Brightling, Christopher E.; Hargadon, Beverley; Gupta, Sumit; Monteiro, William; Sousa, Ana; Marshall, Richard P.; Bradding, Peter; Green, Ruth H.; Wardlaw, Andrew J.; Pavord, Ian D.			Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRWAY INFLAMMATION; COUNTS; ANTI-IL-5; COPD	Background Exacerbations of asthma are associated with substantial morbidity and mortality and with considerable use of health care resources. Preventing exacerbations remains an important goal of therapy. There is evidence that eosinophilic inflammation of the airway is associated with the risk of exacerbations. Methods We conducted a randomized, double-blind, placebo-controlled, parallel-group study of 61 subjects who had refractory eosinophilic asthma and a history of recurrent severe exacerbations. Subjects received infusions of either mepolizumab, an anti interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year. The primary outcome measure was the number of severe exacerbations per subject during the 50-week treatment phase. Secondary outcomes included a change in asthma symptoms, scores on the Asthma Quality of Life Questionnaire (AQLQ, in which scores range from 1 to 7, with lower values indicating more severe impairment and a change of 0.5 unit considered to be clinically important), forced expiratory volume in 1 second (FEV1) after use of a bronchodilator, airway hyperresponsiveness, and eosinophil counts in the blood and sputum. Results Mepolizumab was associated with significantly fewer severe exacerbations than placebo over the course of 50 weeks (2.0 vs. 3.4 mean exacerbations per subject; relative risk, 0.57; 95% confidence interval [CI], 0.32 to 0.92; P = 0.02) and with a significant improvement in the score on the AQLQ ( mean increase from baseline, 0.55 vs. 0.19; mean difference between groups, 0.35; 95% CI, 0.08 to 0.62; P = 0.02). Mepolizumab significantly lowered eosinophil counts in the blood (P<0.001) and sputum (P=0.002). There were no significant differences between the groups with respect to symptoms, FEV1 after bronchodilator use, or airway hyperresponsiveness. The only serious adverse events reported were hospitalizations for acute severe asthma. Conclusions Mepolizumab therapy reduces exacerbations and improves AQLQ scores in patients with refractory eosinophilic asthma. The results of our study suggest that eosinophils have a role as important effector cells in the pathogenesis of severe exacerbations of asthma in this patient population. (Current Controlled Trials number, ISRCTN75169762.)	[Haldar, Pranabashis; Brightling, Christopher E.; Hargadon, Beverley; Gupta, Sumit; Monteiro, William; Bradding, Peter; Green, Ruth H.; Wardlaw, Andrew J.; Pavord, Ian D.] Univ Hosp Leicester Natl Hlth Serv Trust, Glenfield Hosp, Inst Lung Hlth, Leicester LE3 9QP, Leics, England; [Sousa, Ana; Marshall, Richard P.] GlaxoSmithKline, Resp & Inflammat Ctr Excellence Drug Discovery, Stevenage, Herts, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; GlaxoSmithKline	Pavord, ID (corresponding author), Univ Hosp Leicester Natl Hlth Serv Trust, Glenfield Hosp, Inst Lung Hlth, Groby Rd, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk		Haldar, Pranabashis/0000-0002-1572-5421; brightling, chris/0000-0002-9345-4903; Gupta, Sumit/0000-0002-7123-6139; Wardlaw, Andrew/0000-0001-6583-0791; Pavord, Ian/0000-0002-4288-5973; Bradding, Peter/0000-0001-8403-0319	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by an unrestricted educational grant from GlaxoSmithKline.	Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; FitzGerald JM, 2006, THORAX, V61, P992, DOI 10.1136/thx.2005.045195; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; *GINA, 2007, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; HOUSTON JC, 1953, THORAX, V8, P207, DOI 10.1136/thx.8.3.207; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; O'Byrne PM, 2007, AM J RESP CRIT CARE, V176, P1059, DOI 10.1164/rccm.200708-1264ED; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x	24	1354	1424	0	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					973	984		10.1056/NEJMoa0808991	http://dx.doi.org/10.1056/NEJMoa0808991			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264686	Green Accepted			2022-12-28	WOS:000263824500005
J	Sabatinelli, G; Pace-Shanklin, S; Riccardo, F; Shahin, Y				Sabatinelli, Guido; Pace-Shanklin, Stefania; Riccardo, Flavia; Shahin, Yousef			Palestinian refugees outside the occupied Palestinian territory	LANCET			English	Editorial Material									[Sabatinelli, Guido; Pace-Shanklin, Stefania; Riccardo, Flavia; Shahin, Yousef] United Nations Relief & Works Agcy Palestine Refu, Amman 11814, Jordan		Riccardo, F (corresponding author), United Nations Relief & Works Agcy Palestine Refu, Amman 11814, Jordan.	flaviariccardo@hotmail.com	Riccardo, Flavia/J-6167-2012; Riccardo, Flavia/GRJ-5156-2022	Riccardo, Flavia/0000-0002-1582-6329				ABDULRAHIM HF, 2009, LANCET, V373, P967, DOI DOI 10.1016/S0140-6736(09)60108-2; ABUMOUSA HS, E MED HLTH IN PRESS; BATNIJI R, 2009, LANCET, DOI DOI 10.1016/S0140-6736(09)60110.0; GLACAMAN R, 2009, LANCET, DOI DOI 10.1016/50140-6736(09)60107-0; HUSSEINI A, 2009, LANCET, DOI DOI 10.1016/S1040-6736(09)60109-4; *ICRC, 2007, ACC HLTH CAR SERV PA, P40; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; SABATINELLI G, 2008, BABYLON, V1, P22; *UN MED GROUP LEB, 2006, MENT HLTH WOM AD PAL; *UNRWA, 2004, INF CHILD MORT PAL R, P40; *UNRWA, 2007, ANN REP DEP HLTH; 2007, IRIN MIDDLE E   0620	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1063	1065		10.1016/S0140-6736(09)60101-X	http://dx.doi.org/10.1016/S0140-6736(09)60101-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19268354				2022-12-28	WOS:000264773600009
J	Hugonnet, JE; Tremblay, LW; Boshoff, HI; Barry, CE; Blanchard, JS				Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Boshoff, Helena I.; Barry, Clifton E., III; Blanchard, John S.			Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis	SCIENCE			English	Article							BETA-LACTAM ANTIBIOTICS; PERSISTENCE; INHIBITION; ACID	beta-lactam antibiotics are ineffective against Mycobacterium tuberculosis, being rapidly hydrolyzed by the chromosomally encoded blaC gene product. The carbapenem class of beta-lactams are very poor substrates for BlaC, allowing us to determine the three-dimensional structure of the covalent BlaC-meropenem covalent complex at 1.8 angstrom resolution. When meropenem was combined with the beta-lactamase inhibitor clavulanate, potent activity against laboratory strains of M. tuberculosis was observed [minimum inhibitory concentration (MICmeropenem) less than 1 microgram per milliliter], and sterilization of aerobically grown cultures was observed within 14 days. In addition, this combination exhibited inhibitory activity against anaerobically grown cultures that mimic the "persistent" state and inhibited the growth of 13 extensively drug-resistant strains of M. tuberculosis at the same levels seen for drug-susceptible strains. Meropenem and clavulanate are Food and Drug Administration-approved drugs and could potentially be used to treat patients with currently untreatable disease.	[Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Boshoff, Helena I.; Barry, Clifton E., III] NIAID, TB Res Stn, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	blanchar@aecom.yu.edu	HUGONNET, Jean-Emmanuel/H-3581-2014; Barry, Clifton E/ABE-7992-2020; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Barry, III, Clifton/H-3839-2012	HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Barry, Clifton E/0000-0002-2927-270X; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Barry, III, Clifton/0000-0002-2927-270X	NIH [AI33696]; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783, ZIAAI000693, R01AI033696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank J. Chan and E. Russel for help in the Wayne model studies and H. Xiao for assistance in mass spectrometry. This work was supported partially by the NIH (AI33696 to J.S.B.); in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; and in part by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. A provisional U.S. patent application was filed on 27 May 2008 related to this work. Structure coordinates have been deposited as Protein Data Bank identification code 3DWZ.	Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bush K, 1998, ADV EXP MED BIOL, V456, P71; Chambers HF, 1998, CLIN INFECT DIS, V26, P874, DOI 10.1086/513945; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CYNAMON MH, 1983, ANTIMICROB AGENTS CH, V24, P429, DOI 10.1128/AAC.24.3.429; Dincer I, 2004, INT J ANTIMICROB AG, V23, P408, DOI 10.1016/j.ijantimicag.2003.09.023; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Segura C, 1998, ANTIMICROB AGENTS CH, V42, P1524, DOI 10.1128/AAC.42.6.1524; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P5312, DOI 10.1021/bi8001055; Wang F, 2006, ANTIMICROB AGENTS CH, V50, P2762, DOI 10.1128/AAC.00320-06; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	19	368	382	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1215	1218		10.1126/science.1167498	http://dx.doi.org/10.1126/science.1167498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251630	Green Accepted			2022-12-28	WOS:000263687600039
J	Hartnick, CJ; Barth, WH; Cote, CJ; Albrecht, MA; Grant, PE; Geyer, JT; Harris, NL				Hartnick, Christopher J.; Barth, William H., Jr.; Cote, Charles J.; Albrecht, Meredith A.; Grant, P. Ellen; Geyer, Julia T.; Harris, Nancy Lee			A Pregnant Woman with a Large Mass in the Fetal Oral Cavity Foregut-duplication cyst, arising from the ventral surface of the tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UTERO; TRACT		[Hartnick, Christopher J.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Barth, William H., Jr.] Massachusetts Gen Hosp, Dept Maternal & Fetal Med, Boston, MA 02114 USA; [Cote, Charles J.; Albrecht, Meredith A.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Grant, P. Ellen] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Geyer, Julia T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hartnick, Christopher J.] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Barth, William H., Jr.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Cote, Charles J.; Albrecht, Meredith A.] Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Boston, MA USA; [Grant, P. Ellen] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Geyer, Julia T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hartnick, CJ (corresponding author), Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.		Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013				Altman KW, 1999, ARCH OTOLARYNGOL, V125, P525, DOI 10.1001/archotol.125.5.525; BIEHL DR, 1983, CAN ANAESTH SOC J, V30, P581, DOI 10.1007/BF03015226; Carachi R, 2002, PEDIATR SURG INT, V18, P371, DOI 10.1007/s00383-002-0835-y; Chang AB, 2004, OBSTET ANESTHESIA PR, P15; Chang LC, 2008, ARCH GYNECOL OBSTET, V277, P83, DOI 10.1007/s00404-007-0402-9; Edwards J, 2005, ARCH OTOLARYNGOL, V131, P1112, DOI 10.1001/archotol.131.12.1112; Eschertzhuber S, 2005, ANESTH ANALG, V101, P658, DOI 10.1213/01.ANE.0000175206.91231.77; Fisk NM, 2001, ANESTHESIOLOGY, V95, P828, DOI 10.1097/00000542-200110000-00008; ILDSTAD ST, 1988, ANN SURG, V208, P184, DOI 10.1097/00000658-198808000-00009; Kim JK, 2007, J PEDIATR SURG, V42, DOI 10.1016/j.jpedsurg.2006.11.007; Kong K, 2004, INT J PEDIATR OTORHI, V68, P827, DOI 10.1016/j.ijporl.2004.01.011; Kuczkowski KM, 2004, OBSTET ANESTHESIA PR, P421; Leung MK, 2007, ARCH OTOLARYNGOL, V133, P946, DOI 10.1001/archotol.133.9.946; Luks FI, 1998, J PEDIATR SURG, V33, P1297, DOI 10.1016/S0022-3468(98)90173-7; MACPHERSON RI, 1993, RADIOGRAPHICS, V13, P1063, DOI 10.1148/radiographics.13.5.8210590; Marwan Ahmad, 2006, Semin Pediatr Surg, V15, P107, DOI 10.1053/j.sempedsurg.2006.02.008; Myers LB, 2002, PAEDIATR ANAESTH, V12, P569, DOI 10.1046/j.1460-9592.2002.00840.x; Noah MMS, 2002, AM J OBSTET GYNECOL, V186, P773, DOI 10.1067/mob.2002.112249; Qi BQ, 2001, ANAT RECORD, V264, P93, DOI 10.1002/ar.1125; SABIK JF, 1993, J PEDIATR SURG, V28, P542, DOI 10.1016/0022-3468(93)90613-P; Schwartz DA, 2001, J CLIN ANESTH, V13, P387, DOI 10.1016/S0952-8180(01)00287-2	21	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					913	921		10.1056/NEJMcpc0809061	http://dx.doi.org/10.1056/NEJMcpc0809061			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246364				2022-12-28	WOS:000263624700012
J	Varagunam, M; Yaqoob, MM; Dohler, B; Opelz, G				Varagunam, Mira; Yaqoob, Muhammad M.; Doehler, Bernd; Opelz, Gerhard			C3 Polymorphisms and Allograft Outcome in Renal Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEMENT C3; MOLECULAR ANALYSIS; REJECTION; ALLOTYPES; COMPONENT	Background: Complement activation plays a role in the development of chronic allograft nephropathy, a common cause of late allograft loss. The role of two complement component 3 (C3) allotypes, called C3F (fast) and C3S (slow) on the basis of their electrophoretic motility, in the long-term outcome of renal allografts remains controversial. Methods: We selected a random sample of 1147 donor and recipient pairs from the Collaborative Transplant Study DNA bank, and their DNA specimens were genotyped for the C3F and C3S alleles. The genotyping results were analyzed according to allograft outcome. Transplants were divided into four groups, according to the recipient and donor genotypes: SS recipient and FS or FF donor (the standard for comparison, since this combination has been reported to have the best outcome), SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor. Results: Baseline characteristics of the four transplant groups were similar. The hazard ratios for allograft survival in the SS recipient and FS or FF donor group as compared with the other three groups (SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor) were not significant: 0.90 (95% confidence interval [CI], 0.7 to 1.14; P=0.33), 0.87 (95% CI, 0.65 to 1.16; P=0.33), and 0.89 (95% CI, 0.65 to 1.23; P=0.48), respectively. The four groups had similar patient-survival rates and similar cumulative rates of acute rejection and allograft dysfunction, as assessed by means of serum creatinine levels. Conclusions: Our results suggest that transplantation of FS or FF kidneys to SS recipients is not advantageous, possibly because chronic allograft nephropathy is a multifaceted disease involving the interplay of many biologic pathways. N Engl J Med 2009;360:874-80.	[Varagunam, Mira; Yaqoob, Muhammad M.] Barts & London Queen Marys Sch Med & Dent, London, England; [Varagunam, Mira; Yaqoob, Muhammad M.] Natl Hlth Serv Trust, London, England; [Doehler, Bernd; Opelz, Gerhard] Univ Heidelberg, Dept Transplantat Immunol, Heidelberg, Germany	University of London; Queen Mary University London; Ruprecht Karls University Heidelberg	Yaqoob, MM (corresponding author), Royal London Hosp, Dept Renal Med & Transplantat, London E1 1BB, England.	m.m.yaqoob@qmul.ac.uk			Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Supported by grants from the Renal Unit, Barts and the London National Health Service Trust, and the Department of Transplantation Immunology, University of Heidelberg.; No potential conflict of interest relevant to this article was reported.	ANDREWS PA, 1995, EUR J IMMUNOL, V25, P1087, DOI 10.1002/eji.1830250434; Andrews PA, 1995, TRANSPLANTATION, V60, P1342; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; BARTOK I, 1995, J IMMUNOL, V154, P5367; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Feucht HE, 2003, AM J TRANSPLANT, V3, P646, DOI 10.1034/j.1600-6143.2003.00171.x; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Heinold A, 2008, AM J TRANSPLANT, V8, P95, DOI 10.1111/j.1600-6143.2007.02042.x; POZNANSKY MC, 1989, J IMMUNOL, V143, P3860; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Soulillou J, 2006, NEW ENGL J MED, V354, P2060, DOI 10.1056/NEJMe068066; Tang S, 1999, J IMMUNOL, V162, P4336; TEISBERG P, 1970, VOX SANG, V19, P47, DOI 10.1111/j.1423-0410.1970.tb01494.x; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yates PJ, 2006, TRANSPL IMMUNOL, V16, P148, DOI 10.1016/j.trim.2006.10.001	19	60	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					874	880		10.1056/NEJMoa0801861	http://dx.doi.org/10.1056/NEJMoa0801861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246358	Bronze			2022-12-28	WOS:000263624700005
J	Sidebotham, P; Pearson, G				Sidebotham, Peter; Pearson, Gale			Responding to and learning from childhood deaths	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNEXPECTED DEATH; SUDDEN		[Sidebotham, Peter] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Pearson, Gale] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England	University of Warwick; University of Birmingham	Sidebotham, P (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010	Sidebotham, Peter D/0000-0003-4891-6926				Axford N., 2005, CHILD DEATH SIGNIFIC; Bunting L., 2005, CHILD ABUSE REV, V14, P82, DOI DOI 10.1002/CAR.886; Dent A, 1996, ARCH DIS CHILD, V74, P522, DOI 10.1136/adc.74.6.522; *DEP ED SKILLS, 2006, WORK TOG SAF CHILDR; Durfee M, 2002, CHILD ABUSE NEGLECT, V26, P619, DOI 10.1016/S0145-2134(02)00337-X; Fleming P., 2000, SUDDEN UNEXPECTED DE; Livesey A, 2005, BRIT MED J, V330, P227, DOI 10.1136/bmj.38323.652523.F7; *OFF NAT STAT, 2007, MORT STAT CHILDH INF; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; Pearson G., 2008, WHY CHILDREN DIE PIL; Reder P, 1999, LOST INNOCENTS FOLLO; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; *ROY COLL PATH ROY, 2004, SUDD UN DEATH INF MU; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P97; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P10; Sidebotham P., 2008, PREVENTING CHILDHOOD	16	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2009	338								b531	10.1136/bmj.b531	http://dx.doi.org/10.1136/bmj.b531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DP	19237412				2022-12-28	WOS:000264056000018
J	Sotiriou, C; Pusztai, L				Sotiriou, Christos; Pusztai, Lajos			MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROGNOSTIC SIGNATURE; HISTOLOGIC GRADE; PREDICT SURVIVAL; CLINICAL UTILITY; MICROARRAY DATA; PROFILES; RECEPTOR; SUBTYPES; RECURRENCE; CARCINOMAS		[Sotiriou, Christos] Univ Libre Bruxelles, Dept Med Oncol, Translat Res Unit, Inst Jules Bordet, B-1000 Brussels, Belgium; [Pusztai, Lajos] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	Institut Jules Bordet; Universite Libre de Bruxelles; University of Texas System; UTMD Anderson Cancer Center	Sotiriou, C (corresponding author), Univ Libre Bruxelles, Dept Med Oncol, Translat Res Unit, Inst Jules Bordet, 121 Blvd Waterloo, B-1000 Brussels, Belgium.	christos.sotiriou@bordet.be	Pusztai, Lajos/AAB-2901-2019		Breast Cancer Research Foundation; Belgian National Foundation for Research	Breast Cancer Research Foundation; Belgian National Foundation for Research	Supported by grants from the Breast Cancer Research Foundation (to Drs. Sotiriou and Pusztai) and the Belgian National Foundation for Research (to Dr. Sotiriou). No potential conflict of interest relevant to this article was reported. We thank Drs. Martine Piccart-Gebhart and Gabriel N. Hortobagyi for their comments.	ALBAIN K, 2007, BREAST CANC RES TR S, V106, pS10; [Anonymous], 2007, LANCET ONCOL, V8, P1079, DOI 10.1016/S1470-2045(07)70346-7; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foekens JA, 2006, J CLIN ONCOL, V24, P1665, DOI 10.1200/JCO.2005.03.9115; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Glinsky GV, 2007, STEM CELL REV, V3, P79, DOI 10.1007/s12015-007-0011-9; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jansen MPHM, 2007, J CLIN ONCOL, V25, P662, DOI 10.1200/JCO.2006.07.3676; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Liang H, 2007, BREAST CANCER RES TR, V106, pS105; Linn SC, 2008, LANCET ONCOL, V9, P198, DOI 10.1016/S1470-2045(08)70048-2; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Melchor L, 2008, ONCOGENE, V27, P3165, DOI 10.1038/sj.onc.1210975; Melchor L, 2007, CLIN CANCER RES, V13, P7305, DOI 10.1158/1078-0432.CCR-07-0711; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mumby PB, 2007, BREAST CANCER RES TR, V106, pS73; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Potti A, 2008, NAT MED, V14, P889, DOI 10.1038/nm0808-889; Potti A, 2007, NAT MED, V13, P1388, DOI 10.1038/nm1107-1388; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Pusztai L, 2003, CLIN CANCER RES, V9, P2406; PUSZTAI L, 2008, J CLIN ONCOL, V26, pS15; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Wessels LFA, 2002, CANCER RES, V62, P7110; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	93	1039	1073	4	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					790	800		10.1056/NEJMra0801289	http://dx.doi.org/10.1056/NEJMra0801289			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228622				2022-12-28	WOS:000263411300009
J	Garcia, DA				Garcia, David A.			Review: D-dimer levels predict risk for recurrent VTE after anticoagulant therapy is stopped	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Garcia, DA (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.							Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-14	10.7326/0003-4819-150-4-200902170-02014	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238612				2022-12-28	WOS:000263562500035
J	Gill, SS				Gill, Sudeep S.			High-dose vitamin B supplements did not slow cognitive decline in mild-to-moderate Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Queens Univ, Kingston, ON, Canada	Queens University - Canada	Gill, SS (corresponding author), Queens Univ, Kingston, ON, Canada.							Balk EM, 2007, ARCH INTERN MED, V167, P21, DOI 10.1001/archinte.167.1.21; Clarke RJ, 2008, JAMA-J AM MED ASSOC, V300, P1819, DOI 10.1001/jama.300.15.1819; Malouf R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004514.pub2; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-7	10.7326/0003-4819-150-4-200902170-02007	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238605				2022-12-28	WOS:000263562500028
J	Scheid, JF; Mouquet, H; Feldhahn, N; Seaman, MS; Velinzon, K; Pietzsch, J; Ott, RG; Anthony, RM; Zebroski, H; Hurley, A; Phogat, A; Chakrabarti, B; Li, YX; Connors, M; Pereyra, F; Walker, BD; Wardemann, H; Ho, D; Wyatt, RT; Mascola, JR; Ravetch, JV; Nussenzweig, MC				Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Seaman, Michael S.; Velinzon, Klara; Pietzsch, John; Ott, Rene G.; Anthony, Robert M.; Zebroski, Henry; Hurley, Arlene; Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Connors, Mark; Pereyra, Florencia; Walker, Bruce D.; Wardemann, Hedda; Ho, David; Wyatt, Richard T.; Mascola, John R.; Ravetch, Jeffrey V.; Nussenzweig, Michel C.			Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; BINDING-SITE; TYPE-1; EPITOPE; GLYCOPROTEIN; GENERATION; GP41	Antibodies to conserved epitopes on the human immunodeficiency virus (HIV) surface protein gp140 can protect against infection in non-human primates, and some infected individuals show high titres of broadly neutralizing immunoglobulin (Ig)G antibodies in their serum. However, little is known about the specificity and activity of these antibodies(1-3). To characterize the memory antibody responses to HIV, we cloned 502 antibodies from HIV envelope-binding memory B cells from six HIV-infected patients with broadly neutralizing antibodies and low to intermediate viral loads. We show that in these patients, the B-cell memory response to gp140 is composed of up to 50 independent clones expressing high affinity neutralizing antibodies to the gp120 variable loops, the CD4-binding site, the co-receptor-binding site, and to a new neutralizing epitope that is in the same region of gp120 as the CD4-binding site. Thus, the IgG memory B-cell compartment in the selected group of patients with broad serum neutralizing activity to HIV is comprised of multiple clonal responses with neutralizing activity directed against several epitopes on gp120.	[Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Velinzon, Klara; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Ott, Rene G.; Anthony, Robert M.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Zebroski, Henry] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pietzsch, John] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Wyatt, Richard T.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Pereyra, Florencia; Walker, Bruce D.] Mass Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; [Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ho, David] Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Free University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Max Planck Society; Harvard University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Mouquet, Hugo/M-2750-2014; Mascola, John/AAI-7193-2021; Nussenzweig, Michel/AAE-7292-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Wardemann, Hedda/0000-0003-3921-5933	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation; Intramural Research Program of the Vaccine Research Center; Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Deutscher Akademischer Austauschdienst; Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005089, ZIAAI005010, Z01AI005095, ZIAAI005069, ZIAAI001090, ZIAAI005089, ZIAAI005095, Z01AI005069] Funding Source: NIH RePORTER	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Wycuff, E. Lybarger and B. Dey for supplying gp120 proteins for mapping studies, K. McKee for serum adsorption studies and N. Doria- Rose for her work with patient material from patients 4 and 6. This research was supported by the Rockefeller University, the International Aids Vaccine Initiative, the Bill and Melinda Gates Foundation, the Intramural Research Program of the Vaccine Research Center ( R. T. W., J. R. M.), and the Division of Intramural Research ( M. C.), National Institute of Allergy and Infectious Diseases, National Institutes of Health. J. F. S. was supported by the Deutscher Akademischer Austauschdienst, H. M. was supported by the Fondation Recherche Medicale. M. C. N. is a Howard Hughes Medical Institute investigator.	BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	29	685	763	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					636	640		10.1038/nature07930	http://dx.doi.org/10.1038/nature07930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19287373				2022-12-28	WOS:000264796200042
J	Chen, GY; Tang, J; Zheng, P; Liu, Y				Chen, Guo-Yun; Tang, Jie; Zheng, Pan; Liu, Yang			CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses	SCIENCE			English	Article							MOBILITY GROUP BOX-1; HEAT-STABLE ANTIGEN; T-CELL GROWTH; ISCHEMIA-REPERFUSION; PROTEIN; HMGB1; ACTIVATION; SYSTEM; AUTOIMMUNITY; INFLAMMATION	Patten recognition receptors, which recognize pathogens or components of injured cells (danger), trigger activation of the innate immune system. Whether and how the host distinguishes between danger-versus pathogen-associated molecular patterns remains unresolved. We report that CD24-deficient mice exhibit increased susceptibility to danger- but not pathogen-associated molecular patterns. CD24 associates with high mobility group box 1, heat shock protein 70, and heat shock protein 90; negatively regulates their stimulatory activity; and inhibits nuclear factor kappa B (NF-kappa B) activation. This occurs at least in part through CD24 association with Siglec-10 in humans or Siglec-G in mice. Our results reveal that the CD24-Siglec G pathway protects the host against a lethal response to pathological cell death and discriminates danger-versus pathogen-associated molecular patterns.	[Chen, Guo-Yun; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tang, Jie] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zheng, P (corresponding author), Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Chen, Guo-yun/C-2436-2011; Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	NIH [AI064350, CA58033, CA112001]; U.S. department of Defense [W81XWH-08-1-0036]; Natural Science Foundation of China [30640420558]; Ministry of Science and Technology of China [2006CB910901]; NATIONAL CANCER INSTITUTE [R01CA058033, R01CA112001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. department of Defense(United States Department of Defense); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the NIH (AI064350, CA58033, and CA112001), U.S. department of Defense (W81XWH-08-1-0036), and Natural Science Foundation of China (30640420558) and Ministry of Science and Technology of China (2006CB910901). The authors have no conflicts of interest. We dedicate this study to Dr. Charles A. Janeway Jr.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; Liu Y, 2007, TRENDS IMMUNOL, V28, P315, DOI 10.1016/j.it.2007.05.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2007, MICROW OPT TECHN LET, V49, P100, DOI 10.1002/mop.22056; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	26	524	556	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1722	1725		10.1126/science.1168988	http://dx.doi.org/10.1126/science.1168988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19264983	Green Accepted			2022-12-28	WOS:000264559800038
J	Kallmes, DF; Jarvik, JG				Kallmes, David F.; Jarvik, Jeffrey G.			Spinal augmentation research: FREE at last?	LANCET			English	Editorial Material							OSTEOPOROTIC VERTEBRAL FRACTURES; RANDOMIZED CONTROLLED-TRIAL; PERCUTANEOUS VERTEBROPLASTY; COMPRESSION FRACTURES; EFFICACY; SAFETY		[Kallmes, David F.] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Jarvik, Jeffrey G.] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA	Mayo Clinic; University of Washington; University of Washington Seattle	Kallmes, DF (corresponding author), Mayo Clin, Dept Radiol, Rochester, MN 55905 USA.	Kallmes.david@mayo.edu	Jarvik, Jeffrey/AAL-4292-2021					Alvarez L, 2006, SPINE, V31, P1113; Buchbinder R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-156; Diamond TH, 2003, AM J MED, V114, P257, DOI 10.1016/S0002-9343(02)01524-3; Gill J Brian, 2007, Pain Physician, V10, P583; Gray LA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-126; McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Taylor RS, 2006, SPINE, V31, P2747, DOI 10.1097/01.brs.0000244639.71656.7d; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; WARDLAW D, 2009, LANCET, DOI DOI 10.1016/S0140-6736(0G)600I0-6	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					982	984		10.1016/S0140-6736(09)60014-3	http://dx.doi.org/10.1016/S0140-6736(09)60014-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19246087				2022-12-28	WOS:000264398200005
J	Kotseva, K; Wood, D; De Backer, G; De Bacquer, D; Pyorala, K; Keil, U				Kotseva, Kornelia; Wood, David; De Backer, Guy; De Bacquer, Dirk; Pyorala, Kalevi; Keil, Ulrich		EUROASPIRE Study Grp	Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries	LANCET			English	Article							CORONARY-HEART-DISEASE; SECONDARY PREVENTION; MYOCARDIAL-INFARCTION; SMOKING-CESSATION; CARDIAC-REHABILITATION; SERUM-CHOLESTEROL; CLINICAL-PRACTICE; RISK-FACTORS; LIFE-STYLE; METAANALYSIS	Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular risk factors in patients with coronary heart disease. The third EUROASPIRE survey was done in 2006-07 in 22 countries to see whether preventive cardiology had improved and if the joint European Societies' recommendations on cardiovascular disease prevention are being followed in clinical practice. Methods EUROASPIRE I, II, and III were designed as cross-sectional studies and included the same selected geographical areas and hospitals in the Czech Republic, Finland, France, Germany, Hungary, Italy, the Netherlands, and Slovenia. Consecutive patients (men and women <= 70 years) were identified after coronary artery bypass graft or percutaneous coronary intervention, or a hospital admission with acute myocardial infarction or ischaemia, and were interviewed at least 6 months later. Findings 3180 patients were interviewed in the first survey, 2975 in the second, and 2392 in the third. Overall, the proportion of patients who smoke has remained nearly the same (20.3% in EUROASPIRE I, 21.2% in II, and 18.2% in III; comparison of all surveys p=0.64), but the proportion of women smokers aged less than 50 years has increased. The frequency of obesity (body-mass index >= 30 kg/m(2)) increased from 25.0% in EUROASPIRE I, to 32.6% in 11, and 38.0% in III (p=0.0006). The proportion of patients with raised blood pressure (>= 140/90 mm Hg in patients without diabetes or >= 130/80 mm Hg in patients with diabetes) was similar (58.1% in EUROASPIRE 1, 58.3% in II, and 60.9% in III; p=0.49), whereas the proportion with raised total cholesterol (>= 4.5 mmol/L) decreased, from 94.5% in EUROASPIRE I to 76.7% in II, and 46.2% in III (p<0.0001). The frequency of self-reported diabetes mellitus increased, from 17.4%, to 20.1%, and 28.0% (p=0.004). Interpretation These time trends show a compelling need for more effective lifestyle management of patients with coronary heart disease. Despite a substantial increase in anti hypertensive and lipid-lowering drugs, blood pressure management remained unchanged, and almost half of all patients remain above the recommended lipid targets. To salvage the acutely ischaemic myocardium without addressing the underlying causes of the disease is futile; we need to invest in prevention.	[Kotseva, Kornelia; Wood, David] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiovasc Med, London W6 8RF, England; [De Backer, Guy; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Pyorala, Kalevi] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Keil, Ulrich] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany	Imperial College London; Ghent University; Kuopio University Hospital; University of Eastern Finland; University of Munster	Wood, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiovasc Med, Charing Cross Campus,Fulham Palace Rd, London W6 8RF, England.	d.wood@ic.ac.uk	De Backer, Guy/AAI-4607-2021; Cífková, Renata/O-5731-2017; De Bacquer, Dirk/HGU-3191-2022	Cífková, Renata/0000-0003-2765-3821; De Bacquer, Dirk/0000-0002-3202-7238; Lehto, Seppo/0000-0003-0414-5285; Amouyel, Philippe/0000-0001-9088-234X; Kotseva, Kornelia/0000-0003-0469-9413	Merck Sharp & Dohme (EUROASPIRE I); AstraZeneca; Bristol-Myers Squibb; Merck Sharp Dohme; Pfizer (EUROASPIRE II); GlaxoSmithKline; Sanofi-Aventis; Servier; Merck/Schering-Plough; Novartis	Merck Sharp & Dohme (EUROASPIRE I)(Merck & Company); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); Pfizer (EUROASPIRE II)(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); Novartis(Novartis)	Funding European Society of Cardiology through grants from Merck Sharp & Dohme (EUROASPIRE I); AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, and Pfizer (EUROASPIRE II); and AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi-Aventis, Servier, Merck/Schering-Plough, and Novartis (EUROASPIRE III).	Allender S, 2008, EUROPEAN CARDIOVASCU; [Anonymous], 1997, Eur Heart J, V18, P1569; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Balfour D, 2000, EUR HEART J, V21, P438, DOI 10.1053/euhj.1999.1949; Brown, 2006, APPL MIXED MODELS ME; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Danchin N., 2003, Annales de Cardiologie et d'Angeiologie, V52, P1, DOI 10.1016/S0003-3928(02)00181-6; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; de Velasco JA, 2002, REV ESP CARDIOL, V55, P801, DOI 10.1016/S0300-8932(02)76708-0; deVelasco JA, 1997, REV ESP CARDIOL, V50, P406, DOI 10.1016/S0300-8932(97)73242-1; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gerin W, 2006, J HYPERTENS, V24, P67, DOI 10.1097/01.hjh.0000194117.96979.13; Giannuzzi P, 2003, EUR HEART J, V24, P1273, DOI 10.1016/S0195-668X(03)00198-2; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kotseva K, 2004, EUR HEART J SUPPL, V6, pJ17, DOI 10.1093/eurheartj/6.suppl_j.j17; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; PYORALA K, 1994, EUR HEART J, V15, P1300; Raw M, 1999, BMJ-BRIT MED J, V318, P182, DOI 10.1136/bmj.318.7177.182; Reiner Z, 2006, EUR J CARDIOV PREV R, V13, P646, DOI 10.1097/01.hjr.0000183910.59741.96; SILAGY C, 2002, COCHRANE LIB; Sundvall J, 2007, CLIN CHIM ACTA, V378, P93, DOI 10.1016/j.cca.2006.10.021; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; Wood D, 1998, EUR HEART J, V19, P1434; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300	38	742	775	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					929	940		10.1016/S0140-6736(09)60330-5	http://dx.doi.org/10.1016/S0140-6736(09)60330-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286092				2022-12-28	WOS:000264158700034
J	Lerner, BH				Lerner, Barron H.			The art of medicine Complicated lessons: Lorenzo Odone and medical miracles	LANCET			English	Editorial Material							OIL		Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA.	bhl5@columbia.edu						Jones AH, 2000, ANN INTERN MED, V133, P567, DOI 10.7326/0003-4819-133-7-200010030-00030; Lerner B.H., 2006, ILLNESS GOES PUBLIC; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; ODONE C, 2008, DAILY MAIL      0601; Rettig R. A., 2007, FALSE HOPE BONE MARR	5	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					888	889		10.1016/S0140-6736(09)60534-1	http://dx.doi.org/10.1016/S0140-6736(09)60534-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19291841				2022-12-28	WOS:000264158700014
J	Serruys, PW; Ormiston, JA; Onuma, Y; Regar, E; Gonzalo, N; Garcia-Garcia, HM; Nieman, K; Bruining, N; Dorange, C; Miquel-Hebert, K; Veldhof, S; Webster, M; Thuesen, L; Dudek, D				Serruys, Patrick W.; Ormiston, John A.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Garcia-Garcia, Hector M.; Nieman, Koen; Bruining, Nico; Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan; Webster, Mark; Thuesen, Leif; Dudek, Dariusz			A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods	LANCET			English	Article							ATHEROSCLEROTIC PLAQUE COMPOSITION; INTRAVASCULAR ULTRASOUND; ARTERY LESIONS; ANGIOPLASTY; TOMOGRAPHY; COVERAGE	Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair imaging with multislice CT. We assessed the safety of the bioabsorbable everolimus-eluting stent (BVS). Methods 30 patients with a single de-novo coronary artery lesion were followed up for 2 years clinically and with multiple imaging methods: multislice CT, angiography, intravascular ultrasound, derived morphology parameters (virtual histology, palpography, and echogenicity), and optical coherence tomography (OCT). Findings Clinical data were obtained from 29 of 30 patients. At 2 years, the device was safe with no cardiac deaths, ischaemia-driven target lesion revascularisations, or stent thromboses recorded, and only one myocardial infarction (non-Q wave). 18-month multislice CT (assessed in 25 patients) showed a mean diameter stenosis of 19% (SD 9). At 2-year angiography, the in-stent late loss of 0.48 mm (SD 0.28) and the diameter stenosis of 27% (11) did not differ from the findings at 6 months. The luminal area enlargement on OCT and intravascular ultrasound between 6 months and 2 years was due to a decrease in plaque size without change in vessel size. At 2 years, 34.5% of strut locations presented no discernible features by OCT, confirming decreases in echogenicity and in radiofrequency backscattering; the remaining apparent struts were fully apposed. Additionally, vasomotion occurred at the stented site and adjacent coronary artery in response to vasoactive agents. Interpretation At 2 years after implantation the stent was bioabsorbed, had vasomotion restored and restenosis prevented, and was clinically safe, suggesting freedom from late thrombosis. Late luminal enlargement due to plaque reduction without vessel remodelling needs confirmation.	[Serruys, Patrick W.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Nieman, Koen; Bruining, Nico] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands; [Nieman, Koen] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ormiston, John A.; Webster, Mark] Auckland City Hosp, Auckland, New Zealand; [Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan] Abbott Vasc, Diegem, Belgium; [Thuesen, Leif] Aarhus Univ Hosp, Skejby Sygehus, Skejby, Denmark; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Auckland City Hospital; Cardialysis; Aarhus University; Jagiellonian University	Serruys, PW (corresponding author), SGravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Regar, E/ABA-3301-2020; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Onuma, Yoshinobu/AHB-6273-2022; Regar, Evelyn/AAD-8201-2019; Bruining, Nico/ABG-5155-2020	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Onuma, Yoshinobu/0000-0001-7702-0649; Bruining, Nico/0000-0002-0272-5617	Abbott Vascular (Santa Clara, CA, USA)	Abbott Vascular (Santa Clara, CA, USA)(Abbott Laboratories)	This study was sponsored by Abbott Vascular (Santa Clara, CA, USA). We thank Wai-Fung Cheong, Krishnankutty Sudhir, and Robert McGreevy for their intellectual input in writing the report.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Aoki J, 2005, J AM COLL CARDIOL, V46, P1670, DOI 10.1016/j.jacc.2005.06.076; Bruining N, 1998, CATHETER CARDIO DIAG, V43, P254, DOI 10.1002/(SICI)1097-0304(199803)43:3<254::AID-CCD3>3.0.CO;2-8; Bruining N, 1999, CATHETER CARDIO INTE, V48, P133, DOI 10.1002/(SICI)1522-726X(199910)48:2<133::AID-CCD3>3.0.CO;2-H; BRUINING N, 2008, EUROINTERVENTION, V4, P1; Bruining N, 2007, CATHETER CARDIO INTE, V70, P968, DOI 10.1002/ccd.21310; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Winter SA, 2003, COMPUT CARDIOL, V30, P73, DOI 10.1109/CIC.2003.1291093; Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; FOLEY DP, 1994, PROG CARDIOVASC DIS, V36, P363, DOI 10.1016/S0033-0620(05)80027-1; Fujimoto J.G.S.J., 2007, OPTICAL COHERENCE TO, V1st, DOI [10.3109/9780203931561, DOI 10.3109/9780203931561]; Garcia-Garcia HM, 2009, EUROINTERVENTION, V4, P443, DOI 10.4244/EIJV4I4A77; HAASE J, 1995, EUR HEART J, V16, P112, DOI 10.1093/eurheartj/16.1.112; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; KURNIK PB, 1984, CATHETER CARDIO DIAG, V10, P353, DOI 10.1002/ccd.1810100408; Lind A Y, 2005, Heart, V91, P1604, DOI 10.1136/hrt.2005.064113; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair A, 2001, ULTRASOUND MED BIOL, V27, P1319, DOI 10.1016/S0301-5629(01)00436-7; Nair Anuja, 2007, EuroIntervention, V3, P113; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Sabate M, 1999, CIRCULATION, V100, P1623, DOI 10.1161/01.CIR.100.15.1623; Schaar JA, 2004, CIRCULATION, V109, P2716, DOI 10.1161/01.CIR.0000131887.65955.3B; Schaar JA, 2003, CIRCULATION, V108, P2636, DOI 10.1161/01.CIR.0000097067.96619.1F; Serruys P W, 1983, Z Kardiol, V72 Suppl 3, P116; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tamai H, 2000, CIRCULATION, V102, P399; TAMAI H, 2004, BIODEGRADABLE STENTS; Tanigawa Jun, 2007, EuroIntervention, V3, P128; Tsuchida K, 2007, AM J CARDIOL, V99, P607, DOI 10.1016/j.amjcard.2006.09.107; Van Mieghem CAG, 2006, J AM COLL CARDIOL, V47, P1134, DOI 10.1016/j.jacc.2005.09.075; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; vonBirgelen C, 1996, AM J CARDIOL, V78, P520, DOI 10.1016/S0002-9149(96)00356-6; vonBirgelen C, 1997, CIRCULATION, V96, P2944, DOI 10.1161/01.CIR.96.9.2944	41	632	681	3	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					897	910		10.1016/S0140-6736(09)60325-1	http://dx.doi.org/10.1016/S0140-6736(09)60325-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286089				2022-12-28	WOS:000264158700031
J	Pruneda-Paz, JL; Breton, G; Para, A; Kay, SA				Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.			A Functional Genomics Approach Reveals CHE as a Component of the Arabidopsis Circadian Clock	SCIENCE			English	Article							GENE-EXPRESSION; RHYTHMS; TOC1; PLANTS; REGULATOR; GROWTH	Transcriptional feedback loops constitute the molecular circuitry of the plant circadian clock. In Arabidopsis, a core loop is established between CCA1 and TOC1. Although CCA1 directly represses TOC1, the TOC1 protein has no DNA binding domains, which suggests that it cannot directly regulate CCA1. We established a functional genomic strategy that led to the identification of CHE, a TCP transcription factor that binds specifically to the CCA1 promoter. CHE is a clock component partially redundant with LHY in the repression of CCA1. The expression of CHE is regulated by CCA1, thus adding a CCA1/CHE feedback loop to the Arabidopsis circadian network. Because CHE and TOC1 interact, and CHE binds to the CCA1 promoter, a molecular linkage between TOC1 and CCA1 gene regulation is established.	[Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kay, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	skay@ucsd.edu	Kay, Steve A/F-6025-2011; Breton, Ghislain/F-7266-2016	Kay, Steve A/0000-0002-0402-2878; Breton, Ghislain/0000-0001-6400-3858	NIH [GM56006, GM67837]; Fundacion Antorchas [postdoctoral fellowships]; National Sciences and Engineering Research Council of Canada; Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067837, R01GM056006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Antorchas; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Imaizumi, E. Hamilton, E. Farre, B. Chow, D. A. Nusinow, and M. Sawa for critical reading of the manuscript; K. Yamada for providing the YM187 yeast strain; Y. Zhao for microscopy assistance; and A. Schopke, R. Sawaya, and S. Asbaghi for technical assistance. This work was supported by NIH grants GM56006 and GM67837 to S.A.K. and partially by postdoctoral fellowships from Fundacion Antorchas to J.L.P.-P., the National Sciences and Engineering Research Council of Canada to G.B., and Wenner-Gren Stiftelserna to A.P.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Baudry A, 2008, ADV BOT RES, V48, P69, DOI 10.1016/S0065-2296(08)00402-3; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603	20	328	358	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1481	1485		10.1126/science.1167206	http://dx.doi.org/10.1126/science.1167206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286557	Green Accepted			2022-12-28	WOS:000264101700042
J	Curtiss, LK				Curtiss, Linda K.			Reversing Atherosclerosis?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Curtiss, LK (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.							Fan EG, 2008, J MED FOOD, V11, P610, DOI 10.1089/jmf.2007.0091; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Witztum JL, 2005, J CLIN INVEST, V115, P2072, DOI 10.1172/JCI26130	4	38	46	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1144	1146		10.1056/NEJMcibr0810383	http://dx.doi.org/10.1056/NEJMcibr0810383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279347				2022-12-28	WOS:000264051000015
J	Treasure, T				Treasure, Tom			Commentary: The big question remains unanswered	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Clin Operat Res Unit, London WC1H 0BT, England	University of London; University College London	Treasure, T (corresponding author), UCL, Clin Operat Res Unit, London WC1H 0BT, England.	tom.treasure@gmail.com						Internullo E, 2008, J THORAC ONCOL, V3, P1257, DOI 10.1097/JTO.0b013e31818bd9da; Keshtgar M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b630; Treasure T, 2007, J THORAC CARDIOV SUR, V133, P1414, DOI 10.1016/j.jtcvs.2007.02.014; Treasure T, 2007, BMJ-BRIT MED J, V334, P831, DOI 10.1136/bmj.39161.403218.AD	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 10	2009	338								b759	10.1136/bmj.b759	http://dx.doi.org/10.1136/bmj.b759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278975				2022-12-28	WOS:000264205300006
J	Bell, G; Hey, T; Szalay, A				Bell, Gordon; Hey, Tony; Szalay, Alex			Beyond the Data Deluge	SCIENCE			English	Editorial Material									[Bell, Gordon; Hey, Tony] Microsoft Res, Redmond, WA 98052 USA; [Szalay, Alex] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Microsoft; Johns Hopkins University	Bell, G (corresponding author), Microsoft Res, 1 Microsoft Way, Redmond, WA 98052 USA.	szalay@jhu.edu		Hey, Tony/0000-0001-6782-3691				GRAHAM M, 2007, ASP C SERIES, V382; GRAY J, 2007, COMP SCI TECHN BOARD; GRAY J, 1994, COMMUNICATION   1004; GRAY J, 2003, DISTRIBUTED DATA STR, V4, P189; Hey AJG, 2003, GRID COMPUTING MAKIN, P809, DOI DOI 10.1002/0470867167.CH36; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; OZZIE R, 2008, WIRED MAGAZINE   DEC; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WOOLEY JC, 2005, CATALYZING INQUIRY I, pCH3; [No title captured]	10	291	298	4	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1297	1298		10.1126/science.1170411	http://dx.doi.org/10.1126/science.1170411			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414PC	19265007				2022-12-28	WOS:000263876700026
J	Ressl, S; van Scheltinga, ACT; Vonrhein, C; Ott, V; Ziegler, C				Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Vonrhein, Clemens; Ott, Vera; Ziegler, Christine			Molecular basis of transport and regulation in the Na+/betaine symporter BetP	NATURE			English	Article							SOLUTES GLYCINE BETAINE; RENAL MEDULLARY CELLS; CORYNEBACTERIUM-GLUTAMICUM; COMPATIBLE SOLUTES; ORGANIC OSMOLYTES; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; OSMOTIC REGULATION; CRYSTAL-STRUCTURE; VOLUME REGULATION	Osmoregulated transporters sense intracellular osmotic pressure and respond to hyperosmotic stress by accumulation of osmolytes to restore normal hydration levels. Here we report the determination of the X-ray structure of a member of the family of betaine/choline/carnitine transporters, the Na+-coupled symporter BetP from Corynebacterium glutamicum, which is a highly effective osmoregulated uptake system for glycine betaine. Glycine betaine is bound in a tryptophan box occluded from both sides of the membrane with aromatic side chains lining the transport pathway. BetP has the same overall fold as three unrelated Na+-coupled symporters. Whereas these are crystallized in either the outward-facing or the inward-facing conformation, the BetP structure reveals a unique intermediate conformation in the Na+-coupled transport cycle. The trimeric architecture of BetP and the break in three-fold symmetry by the osmosensing C-terminal helices suggest a regulatory mechanism of Na+-coupled osmolyte transport to counteract osmotic stress.	[Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Vonrhein, Clemens] Global Phasing Ltd, Sheraton House, Cambridge CB3 0AX, England; [Ott, Vera] Univ Cologne, Inst Biochem, D-50937 Cologne, Germany	Max Planck Society; Global Phasing Limited; University of Cologne	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@mpibp-frankfurt.mpg.de	Ressl, Susanne/AAT-2517-2021	Ziegler, Christine Maria/0000-0003-3439-7213	German Research Foundation; Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	German Research Foundation(German Research Foundation (DFG)); Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	The authors thank W. Kuhlbrandt and R. Kramer for support and comments on the manuscript; J. StandfuB for contributions in the early stages of the project; O. Yildiz, T. Barros and R. Wouts for computational support; S. Schulze, S. Morbach, S. Nicklisch and L. Forrest for discussions; J. Hakulinen and J. Carrera for cloning, C. Perez for the reconstitution and freeze fracture experiments; and H. Volk for help with the figures. Special thanks are due to E. Pohl and the X10SA beamline staff at the Swiss Light Source, as well as the European Synchrotron Radiation Facility. This work is supported by the German Research Foundation, Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Athawale MV, 2005, BIOPHYS J, V89, P858, DOI 10.1529/biophysj.104.056671; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blomberg A, 1997, ELECTROPHORESIS, V18, P1429, DOI 10.1002/elps.1150180818; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; da Costa M. S., 1998, V61, P117; Empadinhas N, 2006, INT MICROBIOL, V9, P199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; KINNE RKH, 1993, J EXP ZOOL, V265, P346, DOI 10.1002/jez.1402650403; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lim CH, 2007, METHOD ENZYMOL, V428, P325, DOI 10.1016/S0076-6879(07)28019-x; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peter H, 1998, J BIOL CHEM, V273, P2567, DOI 10.1074/jbc.273.5.2567; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Pfluger K, 2004, J BIOENERG BIOMEMBR, V36, P17, DOI 10.1023/B:JOBB.0000019594.43450.c5; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026	59	257	258	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					47	U1		10.1038/nature07819	http://dx.doi.org/10.1038/nature07819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262666	Green Submitted, Green Published			2022-12-28	WOS:000263836000029
J	Weismann, A; Wenderoth, M; Lounis, S; Zahn, P; Quaas, N; Ulbrich, RG; Dederichs, PH; Blugel, S				Weismann, Alexander; Wenderoth, Martin; Lounis, Samir; Zahn, Peter; Quaas, Norbert; Ulbrich, Rainer G.; Dederichs, Peter H.; Bluegel, Stefan			Seeing the Fermi Surface in Real Space by Nanoscale Electron Focusing	SCIENCE			English	Article							METAL; LAYERS	The Fermi surface that characterizes the electronic band structure of crystalline solids can be difficult to image experimentally in a way that reveals local variations. We show that Fermi surfaces can be imaged in real space with a low-temperature scanning tunneling microscope when subsurface point scatterers are present: in this case, cobalt impurities under a copper surface. Even the very simple Fermi surface of copper causes strongly anisotropic propagation characteristics of bulk electrons that are confined in beamlike paths on the nanoscale. The induced charge density oscillations on the nearby surface can be used for mapping buried defects and interfaces and some of their properties.	[Weismann, Alexander; Wenderoth, Martin; Quaas, Norbert; Ulbrich, Rainer G.] Univ Gottingen, Inst Phys 4, D-37077 Gottingen, Germany; [Weismann, Alexander] Courant Res Ctr Gottingen, D-37077 Gottingen, Germany; [Lounis, Samir; Dederichs, Peter H.; Bluegel, Stefan] Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany; [Lounis, Samir; Dederichs, Peter H.; Bluegel, Stefan] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Zahn, Peter] Univ Halle Wittenberg, Fachbereich Phys, D-06099 Halle, Germany	University of Gottingen; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Martin Luther University Halle Wittenberg	Wenderoth, M (corresponding author), Univ Gottingen, Inst Phys 4, D-37077 Gottingen, Germany.	wenderoth@ph4.physik.uni-goettingen.de	Zahn, Peter/B-2529-2010; Blügel, Stefan/J-8323-2013; Wenderoth, Martin/Q-3966-2016; Lounis, Samir/G-1875-2010	Zahn, Peter/0000-0003-4756-5239; Blügel, Stefan/0000-0001-9987-4733; Lounis, Samir/0000-0003-2573-2841; Weismann, Alexander/0000-0003-2487-3917	European Science Foundation EUROCORES Programme Self-Organized NanoStructures [ERAS-CT-2003-980409]; Deutsche Forschungsgemeinschaft Priority Programme [SPP1153]; Deutsche Forschungsgemeinschaft Collaborative Research Centre [SFB602]	European Science Foundation EUROCORES Programme Self-Organized NanoStructures(European Science Foundation (ESF)); Deutsche Forschungsgemeinschaft Priority Programme(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG))	This work was supported by the European Science Foundation EUROCORES Programme Self-Organized NanoStructures under contract N. ERAS-CT-2003-980409, the Deutsche Forschungsgemeinschaft Priority Programme SPP1153, and the Deutsche Forschungsgemeinschaft Collaborative Research Centre SFB602.	BRUNO P, 1991, PHYS REV LETT, V67, P1602, DOI 10.1103/PhysRevLett.67.1602; Campillo I, 2000, PHYS REV LETT, V85, P3241, DOI 10.1103/PhysRevLett.85.3241; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; *EUR SCI FDN EUROC, SPP1153 EUR SCI FDN; Friedel J, 1958, NUOVO CIM SUPPL, V7, P287, DOI DOI 10.1007/BF02751483; GRUNBERG P, 1986, PHYS REV LETT, V57, P2442, DOI 10.1103/PhysRevLett.57.2442; HEIL J, 1995, PHYS REV LETT, V74, P146, DOI 10.1103/PhysRevLett.74.146; Kunes J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.174415; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Moon CR, 2008, SCIENCE, V319, P782, DOI 10.1126/science.1151490; Papaconstantopoulos D. A., 1986, HDB BAND STRUCTURE E; Papanikolaou N, 2002, J PHYS-CONDENS MAT, V14, P2799, DOI 10.1088/0953-8984/14/11/304; Quaas N, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.201103; Rose MK, 2001, J CHEM PHYS, V115, P10927, DOI 10.1063/1.1420732; RUDERMAN MA, 1954, PHYS REV, V96, P99, DOI 10.1103/PhysRev.96.99; Schmid M, 1996, PHYS REV LETT, V76, P2298, DOI 10.1103/PhysRevLett.76.2298; SHARVIN YV, 1965, JETP LETT-USSR, V1, P152; SHOENBERG D, 1959, NATURE, V183, P171, DOI 10.1038/183171a0; Sprunger PT, 1997, SCIENCE, V275, P1764, DOI 10.1126/science.275.5307.1764; TSOI VS, 1974, JETP LETT+, V19, P70	20	87	87	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1190	1193		10.1126/science.1168738	http://dx.doi.org/10.1126/science.1168738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251623				2022-12-28	WOS:000263687600032
J	Sabbagh, K				Sabbagh, Karl			Personal paper Perils of criticising Israel	BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2004, BMJ; Clarfield AM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b722; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b500; Freedland J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b524; *HON REP, CAS STUD CNN; Mearsheimer J., 2006, LONDON REV BOOKS, V28.6; O'Donnell M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2094; ODONNELL M, 1981, WORLD MED, V17, P5; SABBAGH K, 1981, WORLD MED, V17, P93; Summerfield D, 2004, BRIT MED J, V329, P924, DOI 10.1136/bmj.329.7471.924	10	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2009	338								a2066	10.1136/bmj.a2066	http://dx.doi.org/10.1136/bmj.a2066			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19244219				2022-12-28	WOS:000264056100017
J	Waller, J				Waller, John			The art of medicine A forgotten plague: making sense of dancing mania	LANCET			English	Editorial Material									[Waller, John] Michigan State Univ, Dept Hist, E Lansing, MI 48825 USA	Michigan State University	Waller, J (corresponding author), Michigan State Univ, Dept Hist, E Lansing, MI 48825 USA.							Backman Louis, 1952, RELIG DANCES CHRISTI; Bourguignon Erika, 1991, POSSESSION; Midelfort Erik, 1999, HIST MADNESS 16 CENT; Waller John, 2008, TIME DANCE TIME DIE	4	9	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					624	625		10.1016/S0140-6736(09)60386-X	http://dx.doi.org/10.1016/S0140-6736(09)60386-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19238695				2022-12-28	WOS:000263563500012
J	Webster, P				Webster, Paul			Profile Affan Hamakhan Jafar: treating trauma in northern Iraq	LANCET			English	Editorial Material												pcwebster@sympatico.ca							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					623	623		10.1016/S0140-6736(09)60385-8	http://dx.doi.org/10.1016/S0140-6736(09)60385-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231619				2022-12-28	WOS:000263563500011
J	Waters, LS; Storz, G				Waters, Lauren S.; Storz, Gisela			Regulatory RNAs in Bacteria	CELL			English	Review							SMALL NONCODING RNAS; PROVIDES ACQUIRED-RESISTANCE; SOS-INDUCED TOXIN; MESSENGER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; 6S RNA; DEPENDENT REGULATION; PROTEIN-SYNTHESIS; GLMS EXPRESSION	Bacteria possess numerous and diverse means of gene regulation using RNA molecules, including mRNA leaders that affect expression in cis, small RNAs that bind to proteins or base pair with target RNAs, and CRISPR RNAs that inhibit the uptake of foreign DNA. Although examples of RNA regulators have been known for decades in bacteria, we are only now coming to a full appreciation of their importance and prevalence. Here, we review the known mechanisms and roles of regulatory RNAs, highlight emerging themes, and discuss remaining questions.	[Waters, Lauren S.; Storz, Gisela] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA.	storz@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	Intramural Research Program of NICHD; PRAT program of NIGMS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER	Intramural Research Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PRAT program of NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We appreciate the comments from many colleagues. This work was supported by the Intramural Research Program of NICHD and a fellowship from the PRAT program of NIGMS ( L. S. W.).	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gorke B, 2008, GENE DEV, V22, P2914, DOI 10.1101/gad.1717808; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hebert CG, 2008, CURR OPIN BIOTECH, V19, P500, DOI 10.1016/j.copbio.2008.08.006; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kalamorz F, 2007, MOL MICROBIOL, V65, P1518, DOI 10.1111/j.1365-2958.2007.05888.x; Kawamoto H, 2005, GENE DEV, V19, P328, DOI 10.1101/gad.1270605; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Maki K, 2008, P NATL ACAD SCI USA, V105, P10332, DOI 10.1073/pnas.0803106105; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stork M, 2007, J BACTERIOL, V189, P3479, DOI 10.1128/JB.00619-06; STOUGAARD P, 1981, P NATL ACAD SCI-BIOL, V78, P6008, DOI 10.1073/pnas.78.10.6008; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Updegrove T, 2008, BIOCHEMISTRY-US, V47, P11184, DOI 10.1021/bi800479p; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wagner EGH, 2002, ADV GENET, V46, P361; Wassarman KM, 2007, CURR OPIN MICROBIOL, V10, P164, DOI 10.1016/j.mib.2007.03.008; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	119	1112	1155	1	374	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					615	628		10.1016/j.cell.2009.01.043	http://dx.doi.org/10.1016/j.cell.2009.01.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239884	Green Accepted, Bronze			2022-12-28	WOS:000263688200014
J	He, LM; Xue, L; Xu, JH; McNeil, BD; Bai, L; Melicoff, E; Adachi, R; Wu, LG				He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Melicoff, Ernestina; Adachi, Roberto; Wu, Ling-Gang			Compound vesicle fusion increases quantal size and potentiates synaptic transmission	NATURE			English	Article							MULTIVESICULAR RELEASE; POSTTETANIC POTENTIATION; TRANSMITTER RELEASE; RAT CALYX; 2 MODES; EXOCYTOSIS; ENDOCYTOSIS; CAPACITANCE; MEMBRANE; CURRENTS	Exocytosis at synapses involves fusion between vesicles and the plasma membrane(1). Although compound fusion between vesicles(2,3) was proposed to occur at ribbon-type synapses(4,5), whether it exists, how it is mediated, and what role it plays at conventional synapses remain unclear. Here we report the existence of compound fusion, its underlying mechanism, and its role at a nerve terminal containing conventional active zones in rats and mice. We found that high potassium application and high frequency firing induced giant capacitance up-steps, reflecting exocytosis of vesicles larger than regular ones, followed by giant down-steps, reflecting bulk endocytosis. These intense stimuli also induced giant vesicle-like structures, as observed with electron microscopy, and giant miniature excitatory postsynaptic currents (mEPSCs), reflecting more transmitter release. Calcium and its sensor for vesicle fusion, synaptotagmin, were required for these giant events. After high frequency firing, calcium/synaptotagmin-dependent mEPSC size increase was paralleled by calcium/synaptotagmin-dependent post-tetanic potentiation. These results suggest a new route of exocytosis and endocytosis composed of three steps. First, calcium/synaptotagmin mediates compound fusion between vesicles. Second, exocytosis of compound vesicles increases quantal size, which increases synaptic strength and contributes to the generation of post-tetanic potentiation. Third, exocytosed compound vesicles are retrieved via bulk endocytosis. We suggest that this vesicle cycling route be included in models of synapses in which only vesicle fusion with the plasma membrane is considered(1).	[He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Wu, Ling-Gang] NINDS, Bethesda, MD 20892 USA; [Melicoff, Ernestina; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Texas System; UTMD Anderson Cancer Center	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Room 2B 1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Adachi, Roberto/0000-0002-0146-0768; McNeil, Benjamin/0000-0001-7545-3598; Melicoff, Ernestina/0000-0001-5696-7112; Xu, Jianhua/0000-0003-0084-8856	National Institute of Neurological Disorders and Stroke Intramural Research Program; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Diamond and K. Paradiso for comments on the manuscript, and S. Cheng, R. Azzam and V. Crocker for help in EM. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (L.-G. W.) and the American Heart Association (R. A.).	ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Coggins MR, 2007, J PHYSIOL-LONDON, V584, P853, DOI 10.1113/jphysiol.2007.140848; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1974, J PHYSIOL-LONDON, V239, pP106, DOI 10.1113/jphysiol.1974.sp010593; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Paillart C, 2003, J NEUROSCI, V23, P4092; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Satzler K, 2002, J NEUROSCI, V22, P10567; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	91	92	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					93	U99		10.1038/nature07860	http://dx.doi.org/10.1038/nature07860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19279571	Green Accepted			2022-12-28	WOS:000265801300036
J	Nejentsev, S; Walker, N; Riches, D; Egholm, M; Todd, JA				Nejentsev, Sergey; Walker, Neil; Riches, David; Egholm, Michael; Todd, John A.			Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; COMMON DISEASES; SUSCEPTIBILITY; LOCUS; POLYMORPHISMS; RECOGNITION; CONTRIBUTE; MUTATION; VIRUSES	Genome-wide association studies (GWASs) are regularly used to map genomic regions contributing to common human diseases, but they often do not identify the precise causative genes and sequence variants. To identify causative type 1 diabetes (T1D) variants, we resequenced exons and splice sites of 10 candidate genes in pools of DNA from 480 patients and 480 controls and tested their disease association in over 30,000 participants. We discovered four rare variants that lowered T1D risk independently of each other (odds ratio = 0.51 to 0.74; P = 1.3 x 10(-3) to 2.1 x 10(-16)) in IFIH1 (interferon induced with helicase C domain 1), a gene located in a region previously associated with T1D by GWASs. These variants are predicted to alter the expression and structure of IFIH1 [MDA5 (melanoma differentiation-associated protein 5)], a cytoplasmic helicase that mediates induction of interferon response to viral RNA. This finding firmly establishes the role of IFIH1 in T1D and demonstrates that resequencing studies can pinpoint disease-causing genes in genomic regions initially identified by GWASs.	[Nejentsev, Sergey; Walker, Neil; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Riches, David; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA	University of Cambridge; University of Cambridge	Nejentsev, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England.	sn262@cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship; Juvenile Diabetes Research Foundation; Wellcome Trust; National Institute for Health Research Biomedical Research Centre; Cambridge Institute for Medical Research [079895]; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship(Royal Society of London); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Institute for Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the patients, control participants, and family members for participating in the study. S.N. held the Diabetes Research and Wellness Foundation Non-Clinical Fellowship at the early stages of the project and now holds the Royal Society University Research Fellowship. The Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory is funded by the Juvenile Diabetes Research Foundation, the Wellcome Trust, and the National Institute for Health Research Biomedical Research Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). Full acknowledgements are in the supporting online material. Previously unseen SNPs were submitted to dbSNP database (www.ncbi.nlm.nih.gov/SNP/); their submission numbers are in table S3.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	25	710	728	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					387	389		10.1126/science.1167728	http://dx.doi.org/10.1126/science.1167728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19264985	Green Accepted			2022-12-28	WOS:000265221600042
J	Jones, S; Hruban, RH; Kamiyama, M; Borges, M; Zhang, XS; Parsons, DW; Lin, JCH; Palmisano, E; Brune, K; Jaffee, EM; Iacobuzio-Donahue, CA; Maitra, A; Parmigiani, G; Kern, SE; Velculescu, VE; Kinzler, KW; Vogelstein, B; Eshleman, JR; Goggins, M; Klein, AP				Jones, Sian; Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.			Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene	SCIENCE			English	Article							BREAST-CANCER; FUTURE		[Jones, Sian; Hruban, Ralph H.; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Goggins, Michael] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Eshleman, JR (corresponding author), Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA.	aklein1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; Iacobuzio-Donahue, Christine/ABF-1295-2020	Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Parsons, Donald/0000-0002-8775-3501; Jaffee, Elizabeth/0000-0003-3841-6549	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA62924, CA123483, RO1CA97075]; Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA057345, P50CA062924, R01CA123483, R37CA043460, R01CA121113, R01CA097075] Funding Source: NIH RePORTER	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Sol Goldman Pancreatic Cancer Research Center; the Lustgarten Foundation for Pancreatic Cancer Research; the Virginia and D. K. Ludwig Fund for Cancer Research; NIH grants CA62924, CA123483, and RO1CA97075; and the Michael Rolfe Pancreatic Cancer Foundation.	Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; *LUSTG FDN PANCR C, CA62924 NIH LUSTG FD; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; McGuire AL, 2007, SCIENCE, V317, P1687, DOI 10.1126/science.1147475; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	9	560	579	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					217	217		10.1126/science.1171202	http://dx.doi.org/10.1126/science.1171202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264984	Green Accepted			2022-12-28	WOS:000265024400036
J	Mataria, A; Khatib, R; Donaldson, C; Bossert, T; Hunter, DJ; Alsayed, F; Moatti, JP				Mataria, Awad; Khatib, Rana; Donaldson, Cam; Bossert, Thomas; Hunter, David J.; Alsayed, Fahed; Moatti, Jean-Paul			Health in the Occupied Palestinian Territory 5 The health-care system: an assessment and reform agenda	LANCET			English	Article							CONTINGENT VALUATION METHOD; QUALITY	Attempts to establish a health plan for the occupied Palestinian territory were made before the 1993 Oslo Accords. However, the first official national health plan was published in 1994 and aimed to regulate the health sector and integrate the activities of the four main health-care providers: the Palestinian Ministry of Health, Palestinian non-governmental organisations, the UN Relief and Works Agency, and a cautiously developing private sector. However, a decade and a half later, attempts to create an effective, efficient, and equitable system remain unsuccessful. This failure results from arrangements for health care established by the Israeli military government between 1967 and 1994, the nature of the Palestinian National Authority, which has little authority in practice and has been burdened by inefficiency, cronyism, corruption, and the inappropriate priorities repeatedly set to satisfy the preferences of foreign aid donors. Although similar problems exist elsewhere, in the occupied Palestinian territory they are exacerbated and perpetuated under conditions of military occupation. Developmental approaches integrated with responses to emergencies should be advanced to create a more effective, efficient, and equitable health system, but this process would be difficult under military occupation.	[Mataria, Awad; Khatib, Rana] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Mataria, Awad] Birzeit Univ, Dept Econ, Fac Commerce & Econ, Birzeit, Israel; [Donaldson, Cam] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Bossert, Thomas] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Cambridge, MA 02138 USA; [Hunter, David J.] Univ Durham, Sch Med & Hlth, Ctr Publ Policy & Hlth, Middlesbrough, England; [Moatti, Jean-Paul] Univ Mediterranean, Inst Hlth & Med Res, INSERM, Marseille, France; [Moatti, Jean-Paul] Univ Mediterranean, SE Hlth Reg Observ ORS PACA, Res Unit 912, Marseille, France; [Moatti, Jean-Paul] Univ Mediterranean, Fac Econ, Marseille, France	Birzeit University; Birzeit University; Newcastle University - UK; Harvard University; Harvard T.H. Chan School of Public Health; Durham University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Mataria, A (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel.	awad@birzeit.edu		Donaldson, Cam/0000-0003-4670-5340	ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		ABED Y, 2007, HLTH SECTOR REV SUMM; Abu-Zaineh M, 2008, SOC SCI MED, V66, P2308, DOI 10.1016/j.socscimed.2008.01.028; ABUZAINEH M, 2008, THESIS U MEDITERRANE; ADJIBOLOSOO S, 1998, INT PERSPECTIVES HUM; AILUNI S, 2003, J PALESTINE STUD, V32, P64; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 1999, DEV FREEDOM; Arhin-Tenkorang D., 2004, HLTH FINANCING POOR, P157; Barghouthi M., 1997, HLTH PALESTINE POTEN; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Carrin G, 2005, APPL HEALTH ECON HEA, V4, P15, DOI 10.2165/00148365-200504010-00004; Chalmers I, 2008, EUR J DENT EDUC, V12, P11, DOI 10.1111/j.1600-0579.2007.00475.x; DAOUD A, 2007, CAPACITY BUILDING RA; Devi S, 2007, LANCET, V369, P2147, DOI 10.1016/S0140-6736(07)60993-3; *DFID, 2006, W BANK GAZ HLTH SECT; ESHEL D, INNER STRIFE SPLITS; GARNER P, 1997, EXPENSIVE MED TECHNO; Giacaman R, 2003, HEALTH POLICY PLANN, V18, P59, DOI 10.1093/heapol/18.1.59; GIACAMAN R, 1994, UNCTADECDCSEU3; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; GOTTRET P, 2006, HLTH FINANCING REV P; *GOV JAP WORLD BAN, 2000, AID EFF W BANK GAZ; GUTTMAN N, C THREAT CUT PA AID; Habib I., 2005, WALL ITS MIDST SEPAR; Halevi I, 1998, J PALESTINE STUD, V27, P35, DOI 10.1525/jps.1998.27.3.00p0186t; Hamdan M, 2003, INT J HEALTH PLAN M, V18, P63, DOI 10.1002/hpm.691; Hanafi S., 2003, COMP STUD SOUTH ASIA, V23, P205, DOI DOI 10.1215/1089201X-23-1-2-205; Horton R, 2007, NEW YORK REV BOOKS, V54, P22; Hsiao WC, 2007, HEALTH AFFAIR, V26, P950, DOI 10.1377/hlthaff.26.4.950; HUNTER D, 2004, EFFECTIVE PURCHASING; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; *ICJ, ISR ISR SEP BARR CHA; *ICPH BZU, 2006, EV UNFPA REPR HLTH P; *IRIN, ISRAEL OPT PAL EC DE; JUBRAN J, 2005, HLTH SEGREGATION, V2; Khatib R, 2008, PHARMACOEPIDEM DR S, V17, P1123, DOI 10.1002/pds.1662; KHATIB R, PUBLIC HLTH IN PRESS; Mataria A, 2006, HEALTH POLICY, V75, P312, DOI 10.1016/j.healthpol.2005.03.014; Mataria A, 2004, J HEALTH ECON, V23, P1285, DOI 10.1016/j.jhealeco.2004.05.001; Mataria A, 2009, ANAL HLTH EQUITY W B; Mataria A, 2008, BRAIN DRAIN PALESTIN; MATARIA A, 2007, PATIENTS FLOW REFERR; MATARIA A, 2004, ASSESSMENT TRAINING; Mataria A, 2008, PUBLIC POLICIES ENHA; Mataria A, 2007, HEALTH ECON, V16, P1051, DOI 10.1002/hec.1216; McKee M, 2001, BRIT MED J, V323, P295, DOI 10.1136/bmj.323.7308.295; *MIN HLTH, 2008, NAT STRAT HLTH PLAN; *MIN PLANN, 2005, MED TERM DEV PLAN; *MOEHE MOH WA, 2001, NAT PLAN HUM RES DEV; *MOH PHIC, 2006, HLTH STAT PAL ANN RE; *MOL, ISR FOR RIGHT WING P; *NHP, 1994, NAT HLTH PLAN PAL PE; *NSHP, 1999, NAT STRAT HLTH PLAN; *OCHA, 2006, W BANK CLOS COUNT AN; *OFF COORD HUM AFF, 2007, HUM MON OCC PAL TERR; *OFF HIGH COMM HUM, 1949, GEN CONV REL PROT CI; *PAL CENTR BUR STA, 2006, HLTH CAR PROV BEN SU; *PAL CENTR BUR STA, 2007, POP HOUS EST CENS; *PAL NAT AUTH, BUILD PAL STAT PEAC; *PAL PLANN RES CTR, 2001, NAT STRAT HLTH PLAN; Palestinian Central Bureau of Statistics (PCBS), 2007, POV LIV COND PAL TER; *PARTN PEAC, LOC AID COORD COMM L; Pauly MV, 2006, HEALTH AFFAIR, V25, P369, DOI 10.1377/hlthaff.25.2.369; PAVIGNANI E, 2007, MANAGING AID PALESTI; *PCBS, 2004, HOUS HLTH EXP SURV 2; *PCBS, 2004, ACC HLTH SERV SURV 2; PCBS-Palestinian Central Bureau of Statistics, 2008, PAL FIG 2007; *PHR, PHYS HUM RIGHTS ISR; *PIC, 2008, EREK PA VERG COLL FA; *PSF, 2003, MED PHARM SIT IND W; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Roberts M. J., 2003, GETTING HLTH REFORM; Roy S, 1999, J PALESTINE STUD, V28, P64, DOI 10.1525/jps.1999.28.3.00p0031k; SAID N, PUBLIC ADM W BANK GA; SAYIGH Y, STRENGHTENING PALEST; Sayigh Y, 2007, SURVIVAL, V49, P7, DOI 10.1080/00396330701564786; Schoenbaum M., 2005, STRENGTHENING PALEST; Sen A, 1992, INEQUALITY RE EXAMIN; Townsend J, 2004, HEALTH TECHNOL ASSES, V8, P1; *UN, COMM HUM RIGHTS 60 S; *UN, QUEST PAL HIST; *UN, 2004, 2 MULT FUND FRAM; *UN OFF COORD HUM, HLTH FAC MAP 2; *UNRWA, 1995, UN REL WORKS AG PAL; WEITZ J, SOLUTION REFUGEE PRO; *WHO, HLTH ACT CRIS W BANK; *WHO, MON HLTH SECT OCC PA; *WHO, 2005, HLTH ACT CRIS W BANK; *WHO, HLTH SECT SURV IND M; WHO, 2008, ACC HLTH SERV PAL PE; WHO, 2007, EV BUS STRENGTH HLTH; *WHO, PAL HLTH STAT; *WHO EMRO, 2007, TECHN DISC MED PRIC; *WORLD BANK, 2 YEARS LOND REST PA; *WORLD BANK, INV PAL EC REF DEV R; *WORLD BANK, 1987, FIN HLTH SERV DEV CO; *WORLD BANK, 2008, W BANK GAZ EC DEV PR; *WORLD BANK BIS CT, ROL PERF PAL NGOS HL; World Health Organization, 2000, WORLD HLTH REP 2000; YAGHI M, FAYADS REFORM PLAN D; ZIARA S, 1997, HLTH PROFILE 1 GRADE; 2007, PALESTINIAN EC  0818; 2007, PALESTINIAN EC B, P10; GAZA STRIP HUMANITAR; SWANS COMMENTARY INS	105	59	60	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1207	1217		10.1016/S0140-6736(09)60111-2	http://dx.doi.org/10.1016/S0140-6736(09)60111-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19268349				2022-12-28	WOS:000264940600035
J	Wood, E; Werb, D; Marshall, BDL; Montaner, JSG; Kerr, T				Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas			The war on drugs: a devastating public-policy disaster	LANCET			English	Editorial Material							HIV		[Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Div Aids, Dept Med, Vancouver, BC, Canada; [Werb, Daniel; Marshall, Brandon D. L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Wood, E (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca	Marshall, Brandon/B-4895-2010; Montaner, Julio/K-7621-2012	Marshall, Brandon/0000-0002-0134-7052; 				[Anonymous], 2003, INT J DRUG POLICY, DOI DOI 10.1016/S0955-3959(03)00005-7; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; *EUR MON CTR DRUGS, 2008, STAT B 2008; FAZEY C, 2003, INT J DRUG POLICY, V14, P159; FELLNER J, 2008, TARGETING BLACKS DRU; HANSON S, 2008, WASHINGTON POST 1125; JELSMA M, 2003, INT J DRUG POLICY, V14, P195; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; MORRIS SK, 2003, INT J DRUG POLICY, V14, P209; *UN OFF DRUGS CRIM, 2002, 2005 WORLD DRUG REP; Werb D, 2008, J PUBLIC HEALTH POL, V29, P440, DOI 10.1057/jphp.2008.29	13	39	39	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					989	990		10.1016/S0140-6736(09)60455-4	http://dx.doi.org/10.1016/S0140-6736(09)60455-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19282025				2022-12-28	WOS:000264398200009
J	Brown, CJ; Roth, DL; Allman, RM; Sawyer, P; Ritchie, CS; Roseman, JM				Brown, Cynthia J.; Roth, David L.; Allman, Richard M.; Sawyer, Patricia; Ritchie, Christine S.; Roseman, Jeffrey M.			Trajectories of Life-Space Mobility After Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL DECLINE; OLDER-ADULTS; MULTICOMPONENT INTERVENTION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ACUTE-CARE; OUTCOMES; DELIRIUM; PREVALENCE; DISABILITY	Background: Life space is a measure of where a person goes, the frequency of going there, and the dependency in getting there. It may be a more accurate measure of mobility in older adults because it reflects participation in society as well as physical ability. Objective: To assess effects of hospitalization on life space in older adults, and to compare life-space trajectories associated with surgical and nonsurgical hospitalizations. Design: Prospective observational study. Setting: Central Alabama. Participants: 687 community-dwelling Medicare beneficiaries at least 65 years of age with surgical (n = 44), nonsurgical (n = 167), or no (n = 476) hospitalizations. Measurements: Life-Space Assessment (LSA) scores before and after hospitalization (range, 0 to 120; higher scores reflect greater mobility). Results: Mean age of participants was 74.6 years (SD, 6.3). Fifty percent were black, and 46% were male. Before hospitalization, adjusted LSA scores were similar in participants with surgical and nonsurgical admissions. Life-space assessment scores decreased in both groups immediately after hospitalization; however, participants with surgical hospitalizations had a greater decrease in scores (12.1 more points [95% CI, 3.6 to 20.7 points]; P = 0.005) than those with nonsurgical hospitalizations. However, participants with surgical hospitalizations recovered more rapidly over time (gain of 4.7 more points [CI, 2.0 to 7.4 points] per ln [week after discharge]; P < 0.001). Score recovery for participants with nonsurgical hospitalizations did not significantly differ from the null (average recovery, 0.7 points [CI,-0.6 to 1.9 points] per ln [week after discharge]). Limitation: Life space immediately before and after hospitalization was self-reported, often after hospital discharge. Conclusion: Hospitalization decreases life space in older adults. Surgical hospitalizations are associated with immediate marked life-space declines followed by rapid recovery, in contrast to nonsurgical hospitalizations, which are associated with more modest immediate declines and little evidence of recovery after several years of follow-up.	Birmingham & Atlanta Vet Affairs Geriatr Res, Birmingham, AL USA; Ctr Clin, Birmingham, AL USA; Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Brown, CJ (corresponding author), Birmingham Vet Affairs Med Ctr, 11G,700 S 19th St, Birmingham, AL 35233 USA.	cbrown@aging.uab.edu; droth@uab.edu	Allman, Richard M./O-1693-2019	Allman, Richard M./0000-0002-1850-6515; Brown, Cynthia J/0000-0002-1629-5507	National Institute on Aging [R01 AG015062]; Veterans Affairs Research Career Development Award [E4-3842VA]; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING [R01AG015062] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Research Career Development Award(US Department of Veterans Affairs); John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: National Institute on Aging.; Grant Support: By a Veterans Affairs Research Career Development Award (E4-3842VA) (Dr. Brown) and a John A. Hartford Foundation-funded Southeast Center of Excellence in Geriatric Medicine Special Fellows grant (Dr. Brown). The UAB Study of Aging is funded through a grant from the National Institute on Aging (R01 AG015062).	Ahmed A, 2007, AM J CARDIOL, V99, P549, DOI 10.1016/j.amjcard.2006.08.065; *AL RUR HLTH ASS, 1998, HLTH STAT RUR AL; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Dubois MF, 2007, J CLIN EPIDEMIOL, V60, P1040, DOI 10.1016/j.jclinepi.2006.12.011; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; *I MED, 2006, FUT DIS AM; Incalzi RA, 1996, ARCH INTERN MED, V156, P425, DOI 10.1001/archinte.156.4.425; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; JETTE AM, 2006, PHYS THER, V86, P726, DOI DOI 10.1093/PTJ/86.5.726; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LAZARUS BA, 1991, ARCH INTERN MED, V151, P2452, DOI 10.1001/archinte.151.12.2452; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; MARGITIC SE, 1993, J AM GERIATR SOC, V41, P258, DOI 10.1111/j.1532-5415.1993.tb06703.x; McAvay GJ, 2006, J AM GERIATR SOC, V54, P1245, DOI 10.1111/j.1532-5415.2006.00815.x; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; MCVEY LJ, 1989, ANN INTERN MED, V110, P79, DOI 10.7326/0003-4819-110-1-79; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Parker M, 2002, J GERONTOL NURS, V35, P35, DOI DOI 10.1300/J083V35N04_04; Peak EL, 2005, J BONE JOINT SURG AM, V87A, P247, DOI 10.2106/JBJS.C.01513; Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008; Roseman, 2006, AGING HLTH, V2, P417, DOI [10.2217/1745509x.2.3.417, DOI 10.2217/1745509X.2.3.417]; RUEL M, 2005, SABISTON SPENCER SUR, P1476; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Sager MA, 1998, CLIN GERIATR MED, V14, P669; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Singer J.D., 2003, APPL LONGITUDINAL DA; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; VAITKEVICUS VP, 2003, PRINCIPLES GERIATRIC, P361; WARSHAW GA, 1982, JAMA-J AM MED ASSOC, V248, P847, DOI 10.1001/jama.248.7.847; WHO, 2001, WHO INT CLASS FUNCT	40	131	131	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					372	W67		10.7326/0003-4819-150-6-200903170-00005	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293070	Green Accepted			2022-12-28	WOS:000264468500002
J	Deighton, C; O'Mahony, R; Tosh, J; Turner, C; Rudolf, M				Deighton, Chris; O'Mahony, Rachel; Tosh, Jonathan; Turner, Claire; Rudolf, Michael		Guideline Dev Grp	Practice Guidelines Management of rheumatoid arthritis: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Deighton, Chris] Derbyshire Royal Infirm, Dept Rheumatol, Derby DE1 2QY, England; [Tosh, Jonathan] Univ Sheffield, ScHARR, Sheffield S10 2TN, S Yorkshire, England; [Turner, Claire] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England; [Rudolf, Michael] Ealing Gen Hosp, Dept Resp Med, Ealing UB1 3HW, England	University of Sheffield; Royal College of Physicians	Deighton, C (corresponding author), Derbyshire Royal Infirm, Dept Rheumatol, Derby DE1 2QY, England.	chris.deighton@derbyhospitals.nhs.uk		Tosh, Jonathan/0000-0002-8288-4270				ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Arthritis and Musculoskeletal Alliance, 2004, STAND CAR PEOPL INFL; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Luqmani R, 2006, RHEUMATOLOGY, V45, P1167, DOI 10.1093/rheumatology/kel215a; LUQMANI R, RHEUMATOLOGY; *NAT I HLTH CLIN E, 2007, RIT TREATM RHEUM ART; *NAT I HLTH CLIN E, 2003, AN RHEUM ARTHR TECHN; National Institute for Health and Clinical Excellence, 2007, GUID MAN 2007; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD C; National Institute for Health and Clinical Excellence, 2009, MAN RHEUM ARTHR AD C; National Institute for Health and Clinical Excellence, 2007, AD ET INFL TREATM RH; National Institute for Health and Clinical Excellence, 2001, COX 2 INH TREATM OST; National Institute for Health and Clinical Excellence, 2008, AB TREATM RHEUM ARTH, V141; PREEVO MLL, 1995, ARTHRITIS RHEUM, V38, P44; *SCOTT INT GUID NE, 2000, MAN EARL RHEUM ARTHR; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793	16	83	85	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2009	338								b702	10.1136/bmj.b702	http://dx.doi.org/10.1136/bmj.b702			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NT	19289413	Green Published			2022-12-28	WOS:000264435700002
J	Colombo, A; Merlini, P				Colombo, Alessandro; Merlini, Piera			The ischaemia/bleeding balance in PCI	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; CLINICAL-OUTCOMES; INTERVENTION; PRETREATMENT; CLOPIDOGREL; IMPACT; TRIAL		[Colombo, Alessandro] Luigi Sacco Hosp, Div Cardiol, I-20157 Milan, Italy; Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Colombo, A (corresponding author), Luigi Sacco Hosp, Div Cardiol, I-20157 Milan, Italy.	colombo_alessandro@hotmail.com						Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Chintala M, 2008, J PHARMACOL SCI, V108, P433, DOI 10.1254/jphs.08R06FM; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169	11	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					872	873		10.1016/S0140-6736(09)60523-7	http://dx.doi.org/10.1016/S0140-6736(09)60523-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286068				2022-12-28	WOS:000264158700006
J	Cooter, R				Cooter, Roger			Historical keyword Crisis	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr, London, England	University of London; University College London	Cooter, R (corresponding author), UCL, Wellcome Trust Ctr, London, England.	r.cooter@ucl.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					887	887		10.1016/S0140-6736(09)60532-8	http://dx.doi.org/10.1016/S0140-6736(09)60532-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286073				2022-12-28	WOS:000264158700013
J	Krum, H; Abraham, WT				Krum, Henry; Abraham, William T.			Heart failure	LANCET			English	Review							LEFT-VENTRICULAR DYSFUNCTION; CARDIAC-RESYNCHRONIZATION THERAPY; CONVERTING-ENZYME INHIBITORS; PRESERVED SYSTOLIC FUNCTION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; DIASTOLIC DYSFUNCTION; EJECTION FRACTION; RANDOMIZED-TRIAL; ISOSORBIDE DINITRATE	Despite advances in management of heart failure, the condition remains a major public-health issue, with high prevalence, poor clinical outcomes, and large health-care costs. Risk factors are well known and, thus, preventive strategies should have a positive effect on disease burden. Treatment of established systolic chronic heart failure includes use of agents that block the renin-angiotensin-aldosterone and sympathetic nervous systems to prevent adverse remodelling, to reduce symptoms and prolong survival. Diuretics are used to achieve and maintain euvolaemia. Devices have a key role in management of advanced heart failure and include cardiac resynchronisation in patients with evidence of cardiac dyssynchrony and implantation of a cardioverter defibrillator in individuals with low ejection fraction. Approaches for treatment of acute heart failure and heart failure with preserved ejection fraction are supported by little clinical evidence. Emerging strategies for heart failure management include individualisation of treatment, novel approaches to diagnosis and tracking of therapeutic response, pharmacological agents aimed at new targets, and cell-based and gene-based methods for cardiac regeneration.	[Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Monash University; University System of Ohio; Ohio State University	Krum, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au			National Health and Medical Research Council; National Institutes of Health; Medtronic; Paracor; St Jude Medical	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic(Medtronic); Paracor; St Jude Medical(St. Jude Medical)	H K has received grant and research support within the past 12 months from National Health and Medical Research Council. Medtronic, Scios, BUPA. Pfizer, and GlaxoSmithKline, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic, St Jude Medical, Roche, Novartis, Sanofi-Aventis, Pfizer, Mesoblast, and Gilead. HK is a member of the following advisory boards: Biotronik. Novartis, Sanofi-Aventis, Pfizer, Mesoblast, Apollo Life Sciences, and Gilead. WTA has received grant and research support within the past 12 months from National Institutes of Health, Medtronic, Paracor, and St Jude Medical, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic. Novartis, Pfizer, Respironics, St Jude Medical, and GlaxoSmithKline. WTA is a member of the following advisory boards: BioEnergy, Biotronik, CardioKine, CardioKinetix, CardioMEMS, Department of Veterans Affairs Cooperative Studies Program, Edwards Lifesciences, Inovise, Medtronic, National Institutes of Health, Paracor, St Jude Medical, and Sunshine Heart.	Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; *AIHW, 1999, AIHW HLTH WELF EXP S, V5; Anker SD, 2004, ANN MED, V36, P518, DOI 10.1080/07853890410017467; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Aronow WS, 2005, GERIATRICS, V60, P24; Athanasuleas CL, 2001, J AM COLL CARDIOL, V37, P1199, DOI 10.1016/S0735-1097(01)01119-6; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Belardinelli R, 2006, EUR HEART J, V27, P2675, DOI 10.1093/eurheartj/ehl158; Berg TJ, 1999, DIABETES CARE, V22, P1186, DOI 10.2337/diacare.22.7.1186; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9; BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bristow MR, 2000, J CARD FAIL, V6, P276, DOI 10.1054/jcaf.2000.9501; BYRNE J, 2004, CARING HEART FAILURE, P75; Carson P, 2005, J CARD FAIL, V11, P576, DOI 10.1016/j.cardfail.2005.06.432; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3; Cleland JGF, 2006, EUR J HEART FAIL, V8, P764, DOI 10.1016/j.ejheart.2006.10.001; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Clerico A, 2002, CLIN CHEM LAB MED, V40, P371, DOI 10.1515/CCLM.2002.060; *CLIN GOV, ALD ANT THER AD HEAR; *CLIN GOV, COMP OUTC PAT NYHA C; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 1997, CIRCULATION, V96, P856, DOI 10.1161/01.cir.96.3.856; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Damasceno A, 2007, J AM COLL CARDIOL, V50, P1688, DOI 10.1016/j.jacc.2007.07.030; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Davie AP, 1996, BRIT MED J, V312, P222; Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335; Domanski M, 2006, J CARD FAIL, V12, P327, DOI 10.1016/j.cardfail.2006.03.006; Enck R E, 1999, Am J Hosp Palliat Care, V16, P373, DOI 10.1177/104990919901600102; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; Goodlin SJ, 1998, J PALLIAT CARE, V14, P30, DOI 10.1177/082585979801400106; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Hjalmarson A, 1999, LANCET, V353, P2001; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jougasaki M, 2003, PEPTIDES, V24, P889, DOI 10.1016/S0196-9781(03)00163-3; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KILLIP T, 1985, CIRCULATION, V72, P102; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krum H, 2003, EXPERT OPIN INV DRUG, V12, P751, DOI 10.1517/13543784.12.5.751; Krum H, 2002, J AM COLL CARDIOL, V39, P1567, DOI 10.1016/S0735-1097(02)01827-2; Krum H, 2006, J CARD FAIL, V12, P333, DOI 10.1016/j.cardfail.2006.05.001; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Lechat P, 1999, LANCET, V353, P9; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lyon AR, 2008, HEART, V94, P89, DOI 10.1136/hrt.2007.116483; MacDonald MR, 2008, EUR HEART J, V29, P1224, DOI 10.1093/eurheartj/ehn156; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Massad MG, 2004, CARDIOLOGY, V101, P79, DOI 10.1159/000075988; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McGregor E, 2006, CIRC RES, V98, P309, DOI 10.1161/01.RES.0000201280.20709.26; MCKELVIE RS, 1995, J AM COLL CARDIOL, V25, P789, DOI 10.1016/0735-1097(94)00428-S; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McNamara DM, 2008, CURR OPIN CARDIOL, V23, P261, DOI 10.1097/HCO.0b013e3282fcd662; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Morgan JA, 2003, J THORAC CARDIOV SUR, V126, P1188, DOI 10.1016/S0022-5223(03)00935-8; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nieminen MS, 2005, EUR HEART J, V26, P384; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 2003, CIRCULATION, V108, P2950, DOI 10.1161/01.CIR.0000109205.35813.8E; Packer M, 2006, J AM COLL CARDIOL, V47, P2245, DOI 10.1016/j.jacc.2005.12.071; Parissis JT, 2005, EXPERT OPIN INV DRUG, V14, P567, DOI 10.1517/13543784.14.5.567; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Perry G, 1997, NEW ENGL J MED, V336, P525; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Ritzema J, 2007, CIRCULATION, V116, P2952, DOI 10.1161/CIRCULATIONAHA.107.702191; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Rothenburger M, 2002, THORAC CARDIOV SURG, V50, P351, DOI 10.1055/s-2002-35746; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Schuleri K. H., 2007, V180, P195; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Stevenson WG, 1997, CURR OPIN CARDIOL, V12, P242, DOI 10.1097/00001573-199705000-00005; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2001, EUR HEART J, V22, P209, DOI 10.1053/euhj.2000.2291; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Uretsky BF, 1997, J AM COLL CARDIOL, V30, P1589, DOI 10.1016/S0735-1097(97)00361-6; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Vitarelli A, 1998, AM J CARDIOL, V81, p115G, DOI 10.1016/S0002-9149(98)00067-8; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wexler DJ, 2001, AM HEART J, V142, P350, DOI 10.1067/mhj.2001.116476; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007; White JA, 2007, CARDIOL CLIN, V25, P71, DOI 10.1016/j.ccl.2007.02.003; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145	149	127	137	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					941	955		10.1016/S0140-6736(09)60236-1	http://dx.doi.org/10.1016/S0140-6736(09)60236-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286093				2022-12-28	WOS:000264158700035
J	Achlioptas, D; D'Souza, RM; Spencer, J				Achlioptas, Dimitris; D'Souza, Raissa M.; Spencer, Joel			Explosive Percolation in Random Networks	SCIENCE			English	Article								Networks in which the formation of connections is governed by a random process often undergo a percolation transition, wherein around a critical point, the addition of a small number of connections causes a sizable fraction of the network to suddenly become linked together. Typically such transitions are continuous, so that the percentage of the network linked together tends to zero right above the transition point. Whether percolation transitions could be discontinuous has been an open question. Here, we show that incorporating a limited amount of choice in the classic Erdos-Renyi network formation model causes its percolation transition to become discontinuous.	[D'Souza, Raissa M.] Univ Calif Davis, Dept Mech & Aeronaut Engn, Davis, CA 95616 USA; [Achlioptas, Dimitris] Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; [D'Souza, Raissa M.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Spencer, Joel] NYU, Courant Inst Math Sci, New York, NY 10012 USA	University of California System; University of California Davis; University of California System; University of California Santa Cruz; The Santa Fe Institute; New York University	D'Souza, RM (corresponding author), Univ Calif Davis, Dept Mech & Aeronaut Engn, Davis, CA 95616 USA.	raissa@cse.ucdavis.edu	Achlioptas, Dimitris/AAJ-6358-2020		Microsoft Research; NSF [CCF-0546900]; Alfred P. Sloan [Fellowship]; European Research Council [210743]	Microsoft Research(Microsoft); NSF(National Science Foundation (NSF)); Alfred P. Sloan(Alfred P. Sloan Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank Microsoft Research, where our collaboration initiated, for its support. D.A. is supported in part by NSF CAREER award CCF-0546900, an Alfred P. Sloan Fellowship, and IDEAS grant 210743 from the European Research Council.	Beveridge A, 2007, P AM MATH SOC, V135, P3061, DOI 10.1090/S0002-9939-07-08853-3; ERDOS P, 1960, B INT STATIST INST, V38, P343; KRIVELEVICH M, 2008, HAMILTONICITY THRESH; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016706; Spencer J, 2007, COMBINATORICA, V27, P587, DOI 10.1007/s00493-007-2163-2	6	459	468	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1453	1555		10.1126/science.1167782	http://dx.doi.org/10.1126/science.1167782			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286548				2022-12-28	WOS:000264101700033
J	Blow, N				Blow, Nathan			The digital generation	NATURE			English	Editorial Material																		Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342	7	57	62	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					239	244		10.1038/458239a	http://dx.doi.org/10.1038/458239a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279641				2022-12-28	WOS:000264059700054
J	Gunter, G; Anappara, AA; Hees, J; Sell, A; Biasiol, G; Sorba, L; De Liberato, S; Ciuti, C; Tredicucci, A; Leitenstorfer, A; Huber, R				Guenter, G.; Anappara, A. A.; Hees, J.; Sell, A.; Biasiol, G.; Sorba, L.; De Liberato, S.; Ciuti, C.; Tredicucci, A.; Leitenstorfer, A.; Huber, R.			Sub-cycle switch-on of ultrastrong light-matter interaction	NATURE			English	Article							CAVITY; MICROCAVITY; TECHNOLOGY; PLASMA; SYSTEM	Controlling the way light interacts with material excitations is at the heart of cavity quantum electrodynamics (QED). In the strong-coupling regime, quantum emitters in a microresonator absorb and spontaneously re-emit a photon many times before dissipation becomes effective, giving rise to mixed light-matter eigenmodes(1-12). Recent experiments(13) in semiconductor microcavities reached a new limit of ultrastrong coupling(14), where photon exchange occurs on timescales comparable to the oscillation period of light. In this limit, ultrafast modulation of the coupling strength has been suggested to lead to unconventional QED phenomena(14,15). Although sophisticated light-matter coupling has been achieved in all three spatial dimensions, control in the fourth dimension, time, is little developed. Here we use a quantum-well waveguide structure to optically tune light-matter interaction from weak to ultrastrong and turn on maximum coupling within less than one cycle of light. In this regime, a class of extremely non-adiabatic phenomena becomes observable. In particular, we directly monitor how a coherent photon population converts to cavity polaritons during abrupt switching. This system forms a promising laboratory in which to study novel sub-cycle QED effects and represents an efficient room-temperature switching device operating at unprecedented speed.	[Guenter, G.; Anappara, A. A.; Hees, J.; Sell, A.; Leitenstorfer, A.; Huber, R.] Univ Konstanz, Dept Phys, D-78464 Constance, Germany; [Guenter, G.; Anappara, A. A.; Hees, J.; Sell, A.; Leitenstorfer, A.; Huber, R.] Univ Konstanz, Ctr Appl Photon, D-78464 Constance, Germany; [Anappara, A. A.; Sorba, L.; Tredicucci, A.] CNR, INFM, Lab NEST, I-56127 Pisa, Italy; [Anappara, A. A.; Sorba, L.; Tredicucci, A.] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Biasiol, G.; Sorba, L.] INFM, Lab Nazl TASC, CNR, I-34012 Trieste, Italy; [De Liberato, S.; Ciuti, C.] Univ Paris 07, Lab Mat & Phenomenes Quant, F-75205 Paris, France; [De Liberato, S.] Ecole Normale Super, Lab Pierre Aigrain, UMR 8551, F-75005 Paris, France	University of Konstanz; University of Konstanz; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS)	Huber, R (corresponding author), Univ Konstanz, Dept Phys, Univ Str 10, D-78464 Constance, Germany.	rupert.huber@uni-konstanz.de	Sorba, Lucia/B-8949-2015; Ciuti, Cristiano/GYR-1331-2022; Tredicucci, Alessandro/M-6166-2015; Biasiol, Giorgio/C-5465-2009; Ciuti, Cristiano/GYR-1378-2022; Biasiol, Giorgio/X-8255-2019; Leitenstorfer, Alfred/B-9561-2015; Ciuti, Cristiano/K-7248-2012; Huber, Rupert/N-4126-2018; De Liberato, Simone/L-6453-2013; Anappara, Aji A./I-5671-2017	Sorba, Lucia/0000-0001-6242-9417; Tredicucci, Alessandro/0000-0003-3619-3011; Biasiol, Giorgio/0000-0001-7974-5459; Ciuti, Cristiano/0000-0002-1134-7013; Biasiol, Giorgio/0000-0001-7974-5459; Leitenstorfer, Alfred/0000-0002-9847-257X; Ciuti, Cristiano/0000-0002-1134-7013; Huber, Rupert/0000-0001-6617-9283; De Liberato, Simone/0000-0002-4851-2633; Anappara, Aji A./0000-0001-7129-4307	Deutsche Forschungsgemeinschaft through the Emmy Noether Program; SFB767	Deutsche Forschungsgemeinschaft through the Emmy Noether Program(German Research Foundation (DFG)); SFB767(German Research Foundation (DFG))	The authors wish to thank C. Kubler, S. Leinss, and D. Seletskiy for assistance at an early stage of this experiment, and I. Carusotto for discussions. Support by the Deutsche Forschungsgemeinschaft through the Emmy Noether Program and SFB767 is gratefully acknowledged.	ANAPPARA AA, 2008, LIGHT MATTER EXCITAT; Anappara AA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2367664; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Ciuti C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115303; De Liberato S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.103602; Dini D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.116401; Dupont E, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205325; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; Gaal P, 2007, NATURE, V450, P1210, DOI 10.1038/nature06399; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; Helm M, 2000, SEMICONDUCT SEMIMET, V62, P1; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; Imamoglu A, 1996, PHYS REV A, V53, P4250, DOI 10.1103/PhysRevA.53.4250; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kroll J, 2007, NATURE, V449, P698, DOI 10.1038/nature06208; Kubler C, 2004, APPL PHYS LETT, V85, P3360, DOI 10.1063/1.1808232; PURCELL EM, 1946, PHYS REV, V69, P681; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Sapienza L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136806; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Sell A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3040057; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Tsintzos SI, 2008, NATURE, V453, P372, DOI 10.1038/nature06979; UNRUH WG, 1974, PHYS REV D, V10, P3194, DOI 10.1103/PhysRevD.10.3194; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; YABLONOVITCH E, 1989, PHYS REV LETT, V62, P1742, DOI 10.1103/PhysRevLett.62.1742	29	432	438	1	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					178	181		10.1038/nature07838	http://dx.doi.org/10.1038/nature07838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279631				2022-12-28	WOS:000264059700037
J	Valentin, A; Capuzzo, M; Guidet, B; Moreno, R; Metnitz, B; Bauer, P; Metnitz, P				Valentin, Andreas; Capuzzo, Maurizia; Guidet, Bertrand; Moreno, Rui; Metnitz, Barbara; Bauer, Peter; Metnitz, Philipp		Res Grp Quality Improvement ESICM; SEE Study Investigators	Errors in administration of parenteral drugs in intensive care units: multinational prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION ERRORS; EVENTS; WORKLOAD; SAFETY; SCORE	Objective To assess on a multinational level the frequency, characteristics, contributing factors, and preventive measures of administration errors in parenteral medication in intensive care units. Design Observational, prospective, 24 hour cross sectional study with self reporting by staff. Setting 113 intensive care units in 27 countries. Participants 1328 adults in intensive care. Main outcome measures Number of errors; impact of errors; distribution of error characteristics; distribution of contributing and preventive factors. Results 861 errors affecting 441 patients were reported: 74.5 (95% confidence interval 69.5 to 79.4) events per 100 patient days. Three quarters of the errors were classified as errors of omission. Twelve patients (0.9% of the study population) experienced permanent harm or died because of medication errors at the administration stage. In a multiple logistic regression with patients as the unit of analysis, odds ratios for the occurrence of at least one parenteral medication error were raised for number of organ failures (odds ratio per increase of one organ failure: 1.19, 95% confidence interval 1.05 to 1.34); use of any intravenous medication (yes v no: 2.73, 1.39 to 5.36); number of parenteral administrations (per increase of one parenteral administration: 1.06, 1.04 to 1.08); typical interventions in patients in intensive care (yes v no: 1.50, 1.14 to 1.96); larger intensive care unit (per increase of one bed: 1.01, 1.00 to 1.02); number of patients per nurse (per increase of one patient: 1.30, 1.03 to 1.64); and occupancy rate (per 10% increase: 1.03, 1.00 to 1.05). Odds ratios for the occurrence of parenteral medication errors were decreased for presence of basic monitoring (yes v no: 0.19, 0.07 to 0.49); an existing critical incident reporting system (yes v no: 0.69, 0.53 to 0.90); an established routine of checks at nurses' shift change (yes v no: 0.68, 0.52 to 0.90); and an increased ratio of patient turnover to the size of the unit (per increase of one patient: 0.73, 0.57 to 0.93). Conclusions Parenteral medication errors at the administration stage are common and a serious safety problem in intensive care units. With the increasing complexity of care in critically ill patients, organisational factors such as error reporting systems and routine checks can reduce the risk for such errors.	[Valentin, Andreas] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Valentin, Andreas] Rudolfstiftung Hosp, Dept Med 2, Intens Care Unit, A-1030 Vienna, Austria; [Capuzzo, Maurizia] Univ Hosp Ferrara, Dept Anaesthesia & Intens Care, Ferrara, Italy; [Guidet, Bertrand] INSERM, Unite Rech Epidemiol Syst Informat & Modelisat, Paris, France; [Guidet, Bertrand] Univ Paris 06, Fac Med, Paris, France; [Guidet, Bertrand] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France; [Moreno, Rui] Hosp St Antonio dos Capuchos, Ctr Hosp Lisboa Cent EPE, Dept Intens Care, Lisbon, Portugal; [Metnitz, Barbara; Bauer, Peter] Med Univ Vienna, Sect Med Stat, Vienna, Austria; [Metnitz, Philipp] Med Univ Vienna, Dept Anaesthesiol & Gen Intens Care, Vienna, Austria	Medical University of Vienna; Rudolfstiftung Hospital; University of Ferrara; Arcispedale Sant'Anna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centro Hospitalar de Lisboa Ocidental, EPE; Medical University of Vienna; Medical University of Vienna	Valentin, A (corresponding author), Med Univ Vienna, Dept Emergency Med, Vienna, Austria.	andreas.valentin@meduniwien.ac.at	Monedero, Pablo/A-1696-2008	Monedero, Pablo/0000-0002-1596-5644; Valentin, Andreas/0000-0001-7443-3595; Breen, Dorothy/0000-0001-5010-4017	Austrian Center for Documentation and Quality Assurance in Intensive Care Medicine (ASDI)	Austrian Center for Documentation and Quality Assurance in Intensive Care Medicine (ASDI)	Funding: The SEE study was supported and funded by the Austrian Center for Documentation and Quality Assurance in Intensive Care Medicine (ASDI) and endorsed by the European Society of Intensive Care Medicine (ESICM).	[Anonymous], 1993, AM J HOSP PHARM, V50, P305, DOI DOI 10.1093/AJHP/50.2.305; Beckmann U, 2003, CRIT CARE MED, V31, P1006, DOI 10.1097/01.CCM.0000060016.21525.3C; Bracco D, 2001, INTENS CARE MED, V27, P137, DOI 10.1007/s001340000751; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; DONCHIN Y, 1995, CRIT CARE MED, V23, P294, DOI 10.1097/00003246-199502000-00015; Fahimi Fanak, 2008, Aust Crit Care, V21, P110, DOI 10.1016/j.aucc.2007.10.004; Herout PM, 2004, CRIT CARE MED, V32, P428, DOI 10.1097/01.CCM.0000108876.12846.B7; Hugonnet S, 2007, CRIT CARE MED, V35, P76, DOI 10.1097/01.CCM.0000251125.08629.3F; Kopp BJ, 2006, CRIT CARE MED, V34, P415, DOI 10.1097/01.CCM.0000198106.54306.D7; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; McCauley K, 2006, CHEST, V130, P1571, DOI 10.1378/chest.130.5.1571; Minvielle E, 2008, J CRIT CARE, V23, P236, DOI 10.1016/j.jcrc.2007.11.006; Miranda DR, 1997, INTENS CARE MED, V23, P760, DOI 10.1007/s001340050406; Parshuram CS, 2003, CRIT CARE MED, V31, P2483, DOI 10.1097/01.CCM.0000089638.83803.B2; Ream RS, 2007, PEDIATR CRIT CARE ME, V8, P366, DOI 10.1097/01.PCC.0000269379.40748.AF; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Sheldon Tony, 2007, BMJ, V334, P925, DOI 10.1136/bmj.39199.498137.DB; Stanhope N, 1999, J EVAL CLIN PRACT, V5, P5, DOI 10.1046/j.1365-2753.1999.00146.x; Tang FI, 2007, J CLIN NURS, V16, P447, DOI 10.1111/j.1365-2702.2005.01540.x; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857; Valentin A, 2007, CURR OPIN CRIT CARE, V13, P697, DOI 10.1097/MCC.0b013e3282f12cc8; Valentin A, 2006, INTENS CARE MED, V32, P1591, DOI 10.1007/s00134-006-0290-7; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; Vincent C, 1999, J EVAL CLIN PRACT, V5, P13, DOI 10.1046/j.1365-2753.1999.00147.x; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wasserfallen JB, 2004, CRIT CARE MED, V32, P655, DOI 10.1097/01.CCM.0000114835.97789.AB; Webster CS, 2005, ANAESTHESIA, V60, P1115, DOI 10.1111/j.1365-2044.2005.04301.x; Zohar D, 2007, CRIT CARE MED, V35, P1312, DOI 10.1097/01.CCM.0000262404.10203.C9	31	178	189	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2009	338								b814	10.1136/bmj.b814	http://dx.doi.org/10.1136/bmj.b814			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FV	19282436	Green Published, hybrid			2022-12-28	WOS:000264205400001
J	Hutchins, DCJ; White, SM				Hutchins, David C. J.; White, Stuart M.			Coming round to recycling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATIONAL-HEALTH-SERVICE; CLIMATE-CHANGE; CARE WASTE; CORNWALL; SINGLE; STRATEGIES; MANAGEMENT; DEVICES; NHS		[Hutchins, David C. J.; White, Stuart M.] Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England	University of Brighton	White, SM (corresponding author), Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England.	stuart.white@bsuh.nhs.uk		White, Stuart/0000-0002-0258-8210				BILITEWSKI B, 1996, WASTE MANAGE, P1; Blunt MC, 2003, BRIT J ANAESTH, V90, P1, DOI 10.1093/bja/aeg006; Bogner J, 2008, WASTE MANAGE RES, V26, P11, DOI 10.1177/0734242X07088433; *CARB TRUST, 2007, HOSP HLTH BUDG EN EF; Carey D, 2001, J Contemp Health Law Policy, V17, P657; Coote A, 2008, BRIT MED J, V336, P733, DOI 10.1136/bmj.39538.509456.80; *DEP ENV FOOD RUR, 2003, STUD EST DIS COSTS L; Department of Health, HLTH TECHN MEM 07 01; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Gaiser RR, 2004, BRIT J ANAESTH, V92, P584, DOI 10.1093/bja/aeh103; Griffiths J, 2008, BRIT MED J, V336, P1507; *HOSP EP STAT, DAT 2003 4; Jacobs P, 2008, INFECT CONT HOSP EP, V29, P297, DOI 10.1086/529587; Laupau W, 2006, ANAESTHESIA, V61, P524, DOI 10.1111/j.1365-2044.2006.04642.x; Lee BK, 2002, WASTE MANAGE, V22, P461, DOI 10.1016/S0956-053X(02)00006-5; *MED HEALTHC PROD, 2006, SINGL US MED DEV IMP; *NHS SUST DEV UN, 2008, SAV CARB IMPR HLTH C; Rowley E, 2007, ANAESTHESIA, V62, P569, DOI 10.1111/j.1365-2044.2007.04995.x; Seidman PA, 1998, ANESTH ANALG, V87, P634, DOI 10.1097/00000539-199809000-00027; Tudor TL, 2008, WASTE MANAGE, V28, P1209, DOI 10.1016/j.wasman.2007.04.004; Tudor TL, 2007, WASTE MANAGE RES, V25, P510, DOI 10.1177/0734242X07082030; Tudor TL, 2005, WASTE MANAGE, V25, P606, DOI 10.1016/j.wasman.2004.10.004; Webster J, 2005, AM J INFECT CONTROL, V33, P348, DOI 10.1016/j.ajic.2004.11.010; [No title captured]	24	44	44	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b609	10.1136/bmj.b609	http://dx.doi.org/10.1136/bmj.b609			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278971				2022-12-28	WOS:000264205300003
J	Frisch, M; Pedersen, BV; Andersson, RE				Frisch, Morten; Pedersen, Bo V.; Andersson, Roland E.			Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; APPENDECTOMY; POPULATION; SMOKING; EPIDEMIOLOGY; TWINS	Objective To determine whether the repeatedly observed low risk of ulcerative colitis after appendicectomy is related to the appendicectomy itself or the underlying morbidity, notably appendicitis or mesenteric lymphadenitis. Design Nationwide cohort studies. Setting Sweden and Denmark. Participants 709 353 Swedish (1964-2004) and Danish (1977-2004) patients who had undergone appendicectomy were followed up for subsequent ulcerative colitis. The impact of appendicectomy on risk was also studied in 224 483 people whose parents or siblings had inflammatory bowel disease. Main outcome measures Standardised incidence ratios and rate ratios as measures of relative risk. Results During 11.1 million years of follow-up in the appendicectomy cohort, 1192 patients developed ulcerative colitis (10.8 per 100 000 person years). Appendicectomy without underlying inflammation was not associated with reduced risk (standardised incidence ratio 1.04, 95% confidence interval 0.95 to 1.15). Before the age of 20, however, appendicectomy for appendicitis (0.45, 0.39 to 0.53) or mesenteric lymphadenitis (0.65, 0.46 to 0.90) was associated with significant risk reduction. A similar pattern was seen in those with affected relatives, whose overall risk of ulcerative colitis was clearly higher than the background risk (1404 observed v 446 expected; standardised incidence ratio 3.15, 2.99 to 3.32). In this cohort, appendicectomy without underlying appendicitis did not modify risk (rate ratio 1.04, 0.66 to 1.55, v no appendicectomy), while risk after appendicectomy for appendicitis was halved (0.49, 0.31 to 0.74). Conclusions In individuals with or without a familial predisposition to inflammatory bowel disease, appendicitis and mesenteric lymphadenitis during childhood or adolescence are linked to a significantly reduced risk of ulcerative colitis in adulthood. Appendicectomy itself does not protect against ulcerative colitis.	[Frisch, Morten; Pedersen, Bo V.] Statens Serum Inst, Dept Epidemiol Res, Div Epidemiol, DK-2300 Copenhagen S, Denmark; [Andersson, Roland E.] Cty Hosp Ryhov, Dept Surg, SE-55185 Jonkoping, Sweden; [Andersson, Roland E.] Linkoping Univ Hosp, Dept Surg, SE-58185 Linkoping, Sweden	Statens Serum Institut; Linkoping University	Frisch, M (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Div Epidemiol, DK-2300 Copenhagen S, Denmark.	mfr@ssi.dk	Frisch, Morten/E-9206-2016	Frisch, Morten/0000-0002-3864-8860; Andersson, Roland/0000-0002-1460-0248	Aase and Ejnar Danielsen's Foundation; Civil engineer Frode V. Nyegaard and Wife's Foundation; Gangsted Foundation	Aase and Ejnar Danielsen's Foundation; Civil engineer Frode V. Nyegaard and Wife's Foundation; Gangsted Foundation	The study was supported by unrestricted research grants from Aase and Ejnar Danielsen's Foundation, Civil engineer Frode V. Nyegaard and Wife's Foundation, and the Gangsted Foundation. The funders had no role in the data analysis or interpretation of the data.	Anderberg K, 2003, COMMUN NEWS, V40, P6; Andersen TF, 1999, DAN MED BULL, V46, P263; ANDERSSON R, 1994, BRIT MED J, V308, P107, DOI 10.1136/bmj.308.6921.107; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Baron S, 2005, GUT, V54, P357, DOI 10.1136/gut.2004.054353; *CENTR OFF CIV REG, DAN CIV REG SYST; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; Feeney MA, 2002, EUR J GASTROEN HEPAT, V14, P529, DOI 10.1097/00042737-200205000-00010; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Frisch M, 2006, BMJ-BRIT MED J, V332, P561, DOI 10.1136/bmj.332.7541.561; Frisch M, 2001, SURGERY, V130, P36, DOI 10.1067/msy.2001.115362; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; GILAT T, 1987, SCAND J GASTROENTERO, V22, P1009, DOI 10.3109/00365528708991950; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Koutroubakis IE, 2002, INFLAMM BOWEL DIS, V8, P277, DOI 10.1097/00054725-200207000-00007; Kurina LM, 2002, J EPIDEMIOL COMMUN H, V56, P551, DOI 10.1136/jech.56.7.551; LOGAN R, 1994, GASTROENTEROLOGY, V106, P1382, DOI 10.1016/0016-5085(94)90035-3; MONSEN U, 1987, SCAND J GASTROENTERO, V22, P214, DOI 10.3109/00365528708991882; Montgomery SM, 1999, LANCET, V353, P379, DOI 10.1016/S0140-6736(05)74951-5; National Board of Health andWelfare Centre of Epidemiology, SWED HOSP DISCH REG; Okazaki K, 2000, GASTROENTEROLOGY, V119, P502, DOI 10.1053/gast.2000.9368; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rodu B, 2004, EUR J EPIDEMIOL, V19, P129, DOI 10.1023/B:EJEP.0000017703.13810.97; Ruber M, 2006, CLIN EXP IMMUNOL, V143, P117, DOI 10.1111/j.1365-2249.2005.02957.x; Russel MG, 1997, GASTROENTEROLOGY, V113, P377, DOI 10.1053/gast.1997.v113.pm9247453; Sawa Y, 2003, INT J MOL MED, V11, P175; Schattner A, 1999, LANCET, V353, P674, DOI 10.1016/S0140-6736(05)75471-4; Thompson NP, 1996, BRIT MED J, V312, P95; Timmer A, 2003, DIGEST DIS, V21, P91, DOI 10.1159/000073242; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Uzan A, 2001, GASTROEN CLIN BIOL, V25, P239; Wang Y, 1996, LANCET, V347, P1076, DOI 10.1016/S0140-6736(96)90279-2	36	55	55	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2009	338								b716	10.1136/bmj.b716	http://dx.doi.org/10.1136/bmj.b716			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273506	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264205200001
J	Antonoyiannakis, M; Hemmelskamp, J; Kafatos, FC				Antonoyiannakis, Manolis; Hemmelskamp, Jens; Kafatos, Fotis C.			The European Research Council Takes Flight	CELL			English	Editorial Material								In 2007, the European Research Council (ERC) was launched amid much fanfare with the goal of spearheading Europe's aspirations to become the most dynamic and competitive knowledge-based society in the world. Here, we examine the results of the first two ERC calls for research grants and discuss the latest developments and the challenges that face this unique research council.	[Antonoyiannakis, Manolis] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London SW7 2AZ, England; [Hemmelskamp, Jens] Commiss European Communities, DG RTD S, Unit Strateg Matters & Relat Sci Council S1, B-1049 Brussels, Belgium; [Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London SW7 2AZ, England	Imperial College London; Imperial College London	Antonoyiannakis, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London SW7 2AZ, England.	e.antonogiannakis@imperial.ac.uk	Antonoyiannakis, Manolis/AAD-7561-2019	Antonoyiannakis, Manolis/0000-0001-6174-0668				Gilbert N, 2009, NATURE, V457, P521, DOI 10.1038/457521a; Heldin CH, 2008, NAT REV MOL CELL BIO, V9, P417, DOI 10.1038/nrm2374; May RM, 2004, NATURE, V430, P831, DOI 10.1038/430831a; Simons K, 2005, CELL, V123, P747, DOI 10.1016/j.cell.2005.11.016; Van Dyck L, 2004, NATURE, V432, P15, DOI 10.1038/432015a; Winnacker EL, 2008, EUR EDUC RES J, V7, P124, DOI 10.2304/eerj.2008.7.2.124	6	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					805	809		10.1016/j.cell.2009.02.031	http://dx.doi.org/10.1016/j.cell.2009.02.031			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269357	Bronze			2022-12-28	WOS:000263930900001
J	Boroson, TA; Lauer, TR				Boroson, Todd A.; Lauer, Tod R.			A candidate sub-parsec supermassive binary black hole system	NATURE			English	Article							DIGITAL-SKY-SURVEY; QUASARS; SPECTRA; OJ-287	The role of mergers in producing galaxies, together with the finding that most large galaxies harbour black holes in their nuclei(1), implies that binary supermassive black hole systems should be common. Here we report that the quasar SDSS J153636.22+ 044127.0 is a plausible example of such a system. This quasar shows two broad-line emission systems, separated in velocity by 3,500km s(-1). A third system of unresolved absorption lines has an intermediate velocity. These characteristics are unique among known quasars. We interpret this object as a binary system of two black holes, having masses of 10(7.3) and 10(8.9) solar masses separated by similar to 0.1 parsec with an orbital period of similar to 100 years.	[Boroson, Todd A.; Lauer, Tod R.] Natl Opt Astron Observ, Tucson, AZ 85726 USA	National Optical Astronomy Observatory	Boroson, TA (corresponding author), Natl Opt Astron Observ, Tucson, AZ 85726 USA.	tyb@noao.edu		Lauer, Tod/0000-0003-3234-7247	Alfred P. Sloan Foundation; NSF; US Department of Energy; National Aeronautics and Space Administration (NASA); Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Japanese Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	NOAO is operated by the Association of Universities for Research in Astronomy ( AURA), Inc. under cooperative agreement with the National Science Foundation (NSF). This paper has used data from the SDSS archive, the 2MASS archive, the ROSAT archive at the High Energy Astrophysics Science Archive Research Center (HEASARC), provided by NASA's Goddard Space Flight Center, the FIRST survey, and the NVSS. Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the NSF, the US Department of Energy, the National Aeronautics and Space Administration (NASA), the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS website is at http://www.sdss.org/. The 2MASS is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by NASA and the NSF.	APPENZELLER I, 1991, ASTRON ASTROPHYS, V250, P57; BOGDANOVIC T, 2008, SDSS J092712 65 2943; BOROSON TA, 1992, ASTROPHYS J, V397, P442, DOI 10.1086/171800; CUADRA J, MON NOT R A IN PRESS; DENNEY KD, 2008, SYSTEMATIC UNCERTAIN; DOTTI M, 2008, SDSSJ092712 65 29434; Gould A, 2000, ASTROPHYS J, V532, pL29, DOI 10.1086/312562; HECKMAN TM, 2008, SDSSJ092712 65 29434; Hu C, 2008, ASTROPHYS J, V687, P78, DOI 10.1086/591838; Komossa S, 2008, ASTROPHYS J LETT, V678, pL81, DOI 10.1086/588656; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Milosavljevic M, 2003, ASTROPHYS J, V596, P860, DOI 10.1086/378086; MOORE D, 1994, ASTROPHYS J, V433, P602, DOI 10.1086/174670; PETERS PC, 1964, PHYS REV, V136, P1224; Richards GT, 2006, ASTRON J, V131, P2766, DOI 10.1086/503559; Schneider DP, 2007, ASTRON J, V134, P102, DOI 10.1086/518474; SHIELDS GA, 2008, COMMENT BLACK HOLE R; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167	21	167	167	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					53	55		10.1038/nature07779	http://dx.doi.org/10.1038/nature07779			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262667	Green Submitted			2022-12-28	WOS:000263836000030
J	Moons, KGM; Royston, P; Vergouwe, Y; Grobbee, DE; Altman, DG				Moons, Karel G. M.; Royston, Patrick; Vergouwe, Yvonne; Grobbee, Diederick E.; Altman, Douglas G.			Prognosis and prognostic research: what, why, and how?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTING POSTOPERATIVE NAUSEA; MEDICAL LITERATURE; CLINICAL-PRACTICE; USERS GUIDES; RISK; MODELS; EVENTS; BREAST; RULES; SCORE		[Moons, Karel G. M.; Vergouwe, Yvonne; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Royston, Patrick] MRC, Clin Trials Unit, London NW1 2DA, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England	Utrecht University; Utrecht University Medical Center; Medical Research Council Clinical Trials Unit; University of Oxford	Moons, KGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	k.g.m.moons@umcutrecht.nl	Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468	Cancer Research UK Funding Source: Medline; Medical Research Council [U.1228.06.001.00002.01] Funding Source: Medline; MRC [MC_EX_G0800814] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams F., 1939, GENUINE WORKS HIPPOC; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Biesheuvel CJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-48; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138; Christensen E, 2004, J HEPATOL, V41, P344, DOI 10.1016/j.jhep.2004.06.005; COCKBURN F, 1993, LANCET, V342, P193; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Concato J, 2001, CANCER, V91, P1607, DOI 10.1002/1097-0142(20010415)91:8+<1607::AID-CNCR1174>3.0.CO;2-J; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Grobbee DE, 1997, BRIT MED J, V315, P1151; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; James BC, 2001, NEW ENGL J MED, V345, P991, DOI 10.1056/NEJM200109273451311; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Knottnerus JA, 2002, J CLIN EPIDEMIOL, V55, P1201, DOI 10.1016/S0895-4356(02)00528-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KG, 2005, ORTHOPEDIC KNOWLEDGE, P109; Moons KGM, 2003, ANESTH ANALG, V96, P1843, DOI 10.1213/01.ANE.0000063178.15467.D8; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Randolph AG, 1998, CRIT CARE MED, V26, P1603, DOI 10.1097/00003246-199809000-00036; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SIMON R, 1994, BRIT J CANCER, V69, P979, DOI 10.1038/bjc.1994.192; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Van den Bosch JE, 2005, ANESTH ANALG, V100, P1525, DOI 10.1213/01.ANE.0000149325.20542.D4; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Winzer KJ, 2004, EUR J CANCER, V40, P998, DOI 10.1016/j.ejca.2004.01.007; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	46	745	754	3	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2009	338								b375	10.1136/bmj.b375	http://dx.doi.org/10.1136/bmj.b375			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DP	19237405				2022-12-28	WOS:000264056000016
J	Bosch, X; Titus, SL				Bosch, Xavier; Titus, Sandra L.			Cultural challenges and international research integrity	LANCET			English	Editorial Material							COLLABORATIONS; PROJECT		[Bosch, Xavier] Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Titus, Sandra L.] Off Res Integr, Rockville, MD USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, X (corresponding author), Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	xavbosch@clinic.ub.es						ALTBACK PG, 2008, HIGHER ED MANAGE POL; Balakrishnan R, 1996, Sociol Bull, V45, P87; Glew RH, 2008, EXP BIOL MED, V233, P277, DOI 10.3181/0707-MR-204; Hayashi K, 1996, CONTROL CLIN TRIALS, V17, P99, DOI 10.1016/S0197-2456(96)80001-8; Jones JT, 2004, INT CONGR SER, V1267, P71, DOI 10.1016/j.ics.2004.01.120; Leydesdorff L, 2008, J INFORMETR, V2, P317, DOI 10.1016/j.joi.2008.07.003; Musil CM, 2004, APPL NURS RES, V17, P195, DOI 10.1016/j.apnr.2004.06.005; National Research Council,, 2008, INT COLL BEH SOC SCI; Pignatelli B, 2005, J MED ETHICS, V31, P578, DOI 10.1136/jme.2004.009449; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; *US OFF RES INT, 2008, C CHALL TENS INT RES; Zeanah CH, 2003, DEV PSYCHOPATHOL, V15, P885, DOI 10.1017/S0954579403000452	12	13	15	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					610	612		10.1016/S0140-6736(09)60379-2	http://dx.doi.org/10.1016/S0140-6736(09)60379-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410FS	19231616	Green Submitted			2022-12-28	WOS:000263563500007
J	Tsapas, A				Tsapas, Apostolos			Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Tsapas, Apostolos] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Tsapas, Apostolos] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece	University of Oxford; Aristotle University of Thessaloniki	Tsapas, A (corresponding author), Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.		Tsapas, Apostolos/P-5593-2019	Tsapas, Apostolos/0000-0003-0221-4072				Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-12	10.7326/0003-4819-150-4-200902170-02012	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238610				2022-12-28	WOS:000263562500033
J	Nakahata, Y; Sahar, S; Astarita, G; Kaluzova, M; Sassone-Corsi, P				Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo			Circadian Control of the NAD(+) Salvage Pathway by CLOCK-SIRT1	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN SIR2; CLOCK; DEACETYLASE; BIOSYNTHESIS; MECHANISM	Many metabolic and physiological processes display circadian oscillations. We have shown that the core circadian regulator, CLOCK, is a histone acetyltransferase whose activity is counterbalanced by the nicotinamide adenine dinucleotide (NAD(+))-dependent histone deacetylase SIRT1. Here we show that intracellular NAD(+) levels cycle with a 24-hour rhythm, an oscillation driven by the circadian clock. CLOCK: BMAL1 regulates the circadian expression of NAMPT (nicotinamide phosphoribosyltransferase), an enzyme that provides a rate-limiting step in the NAD(+) salvage pathway. SIRT1 is recruited to the Nampt promoter and contributes to the circadian synthesis of its own coenzyme. Using the specific inhibitor FK866, we demonstrated that NAMPT is required to modulate circadian gene expression. Our findings in mouse embryo fibroblasts reveal an interlocked transcriptional-enzymatic feedback loop that governs the molecular interplay between cellular metabolism and circadian rhythms.	[Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011; Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014	Nakahata, Yasukazu/0000-0003-3814-5822; Astarita, Giuseppe/0000-0001-6700-301X	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad; postdoctoral fellowship from the American Heart Association, Western States Affiliate; Cancer Research Coordinating Committee of the University of California; NIH [R01-GM081634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); postdoctoral fellowship from the American Heart Association, Western States Affiliate(American Heart Association); Cancer Research Coordinating Committee of the University of California(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to D. Piomelli for insightful discussions and help. Thanks also to L. Guarente, K. Yamagata, and members of the Sassone-Corsi's laboratory for help, reagents, and support. Y.N. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. S.S. was supported by a postdoctoral fellowship from the American Heart Association, Western States Affiliate. Work supported by the Cancer Research Coordinating Committee of the University of California and NIH (R01-GM081634 [GenBank] -01).	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; ECKELMAHAN K, NAT STRUCT IN PRESS; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hasmann M, 2003, CANCER RES, V63, P7436; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	27	848	883	6	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					654	657		10.1126/science.1170803	http://dx.doi.org/10.1126/science.1170803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19286518	Green Accepted			2022-12-28	WOS:000265608800048
J	Iglehart, JK				Iglehart, John K.			Budgeting for Change - Obama's Down Payment on Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Americans I of M (US) C on the FHCW for O, 2008, HLTH STATUS HLTH CAR; EMANUEL E, 2008, HEALTHCARE GUARANTEE; *I MED, 2009, AM UN CR CONS HLTH H; Orszag PR, 2007, NEW ENGL J MED, V357, P1885, DOI 10.1056/NEJMp078191; SISKO A, 2009, HLTH AFF MILLWO 0224	5	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1381	1383		10.1056/NEJMp0901927	http://dx.doi.org/10.1056/NEJMp0901927			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427AL	19264681				2022-12-28	WOS:000264751800003
J	Bisgaard, CZ; Clarkin, OJ; Wu, GR; Lee, AMD; Gessner, O; Hayden, CC; Stolow, A				Bisgaard, Christer Z.; Clarkin, Owen J.; Wu, Guorong; Lee, Anthony M. D.; Gessner, Oliver; Hayden, Carl C.; Stolow, Albert			Time-Resolved Molecular Frame Dynamics of Fixed-in-Space CS2 Molecules	SCIENCE			English	Article							PHOTOELECTRON ANGULAR-DISTRIBUTIONS; LASER-PULSES; SPECTROSCOPY; STATE; PREDISSOCIATION; DIFFRACTION; DISSOCIATION; IONIZATION; NM	Random orientation of molecules within a sample leads to blurred observations of chemical reactions studied from the laboratory perspective. Methods developed for the dynamic imaging of molecular structures and processes struggle with this, as measurements are optimally made in the molecular frame. We used laser alignment to transiently fix carbon disulfide molecules in space long enough to elucidate, in the molecular reference frame, details of ultrafast electronic-vibrational dynamics during a photochemical reaction. These three-dimensional photoelectron imaging results, combined with ongoing efforts in molecular alignment and orientation, presage a wide range of insights obtainable from time-resolved studies in the molecular frame.	[Bisgaard, Christer Z.; Clarkin, Owen J.; Wu, Guorong; Lee, Anthony M. D.; Stolow, Albert] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Clarkin, Owen J.; Lee, Anthony M. D.; Stolow, Albert] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Gessner, Oliver] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Hayden, Carl C.] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA	National Research Council Canada; Queens University - Canada; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Stolow, A (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	albert.stolow@nrc.ca	Bisgaard, Christer/G-2099-2010; Stolow, Albert/AAN-5609-2020	Lee, Anthony/0000-0001-6327-2351	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (A.M.D.L. and A.S.). We gratefully acknowledge J. G. Underwood, S. Patchkovskii, C.-Y. Ng, M. Brouard, and D. M. Wardlaw for stimulating discussions.	BARONAVSKI AP, 1994, CHEM PHYS LETT, V221, P419, DOI 10.1016/0009-2614(94)00280-0; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; DILL D, 1976, J CHEM PHYS, V65, P1130, DOI 10.1063/1.433187; ELAND JHD, 1979, J CHEM PHYS, V70, P2926, DOI 10.1063/1.437831; Farmanara P, 1999, J CHEM PHYS, V111, P5338, DOI 10.1063/1.479793; Gessner O, 2006, SCIENCE, V311, P219, DOI 10.1126/science.1120779; HACK E, 1991, INT REV PHYS CHEM, V10, P287, DOI 10.1080/01442359109353260; HEMLEY RJ, 1983, J CHEM PHYS, V79, P5219, DOI 10.1063/1.445710; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; LOW KG, 1985, CHEM PHYS, V100, P401, DOI 10.1016/0301-0104(85)87066-X; Mank A, 1996, J CHEM PHYS, V104, P3609, DOI 10.1063/1.471015; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Rakitzis TP, 2004, SCIENCE, V303, P1852, DOI 10.1126/science.1094186; Reid KL, 2003, ANNU REV PHYS CHEM, V54, P397, DOI 10.1146/annurev.physchem.54.011002.103814; Rosca-Pruna F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.153902; Sadeghi RR, 1997, J CHEM PHYS, V107, P6570, DOI 10.1063/1.474899; Seideman T, 2002, ANNU REV PHYS CHEM, V53, P41, DOI 10.1146/annurev.physchem.53.082101.130051; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Stolow A, 2008, ADV CHEM PHYS, V139, P497, DOI 10.1002/9780470259498.ch6; Sussman BJ, 2006, SCIENCE, V314, P278, DOI 10.1126/science.1132289; Suzuki T, 2006, ANNU REV PHYS CHEM, V57, P555, DOI 10.1146/annurev.physchem.57.032905.104601; Townsend D, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2403137; Vrakking MJJ, 1996, J CHEM PHYS, V105, P5647, DOI 10.1063/1.472374; Xu DD, 2004, J CHEM PHYS, V120, P3051, DOI 10.1063/1.1646671	28	265	265	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1464	1468		10.1126/science.1169183	http://dx.doi.org/10.1126/science.1169183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286552	Green Submitted			2022-12-28	WOS:000264101700037
J	Kwon, YH; Fingert, JH; Kuehn, MH; Alward, WLM				Kwon, Young H.; Fingert, John H.; Kuehn, Markus H.; Alward, Wallace L. M.			Mechanisms of Disease: Primary Open-Angle Glaucoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OPTIC-NERVE HEAD; RETINAL GANGLION-CELLS; ELEVATED INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION TREATMENT; TRABECULAR MESHWORK CELLS; NECROSIS-FACTOR-ALPHA; BALTIMORE EYE SURVEY; GENE-EXPRESSION; MICROARRAY ANALYSIS; AXONAL-TRANSPORT		[Kwon, Young H.; Fingert, John H.; Kuehn, Markus H.; Alward, Wallace L. M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA	University of Iowa	Kwon, YH (corresponding author), Univ Iowa Hlth Care, 200 Hawkins Dr, Iowa City, IA 52242 USA.		Fingert, John/F-8787-2012; Fingert, John/AAX-4750-2021; Alward, Wallace/AAY-4149-2020	Fingert, John/0000-0002-0377-0479; Fingert, John/0000-0002-0377-0479; Alward, Wallace/0000-0001-6368-9018; Kuehn, Markus/0000-0003-3940-198X; Kwon, Young/0000-0002-1116-8250	Glaucoma Research Fund; Research to Prevent Blindness; Clifford M. and Ruth M. Altermatt Professorship; Frederick C. Blodi Chair; NATIONAL EYE INSTITUTE [R01EY019485] Funding Source: NIH RePORTER	Glaucoma Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Clifford M. and Ruth M. Altermatt Professorship; Frederick C. Blodi Chair; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by grants from the Marlene S. and Leonard A. Hadley Glaucoma Research Fund and Research to Prevent Blindness. Dr. Kwon received support from the Clifford M. and Ruth M. Altermatt Professorship, and Dr. Alward received support from the Frederick C. Blodi Chair.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Aldred MA, 2004, HUM GENET, V115, P428, DOI 10.1007/s00439-004-1171-1; Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288; ALLINGHAM RR, 2005, SHIELDS TXB GLAUCOMA, P170; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alward W.L., 2000, GLAUCOMA REQUISITES, P128; Alward WLM, 2003, SCIENCE, V299, P1527, DOI 10.1126/science.1082933; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Alward WLM, 1998, NEW ENGL J MED, V339, P1298, DOI 10.1056/NEJM199810293391808; Bahrami H, 2006, OPHTHAL EPIDEMIOL, V13, P283, DOI 10.1080/09286580600681339; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Challa Pratap, 2008, Int Ophthalmol Clin, V48, P73, DOI 10.1097/IIO.0b013e318187e71a; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; Du J, 2007, INVEST OPHTH VIS SCI, V48, P5567, DOI 10.1167/iovs.07-0442; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Graul TA, 2002, AM J OPHTHALMOL, V134, P884, DOI 10.1016/S0002-9394(02)01754-3; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Huang W, 2006, CURR EYE RES, V31, P265, DOI 10.1080/02713680500545671; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Johnson AT, 1996, OPHTHALMOLOGY, V103, P808; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim C, 2006, MOL VIS, V12, P1640; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Ko ML, 2005, FREE RADICAL BIO MED, V39, P365, DOI 10.1016/j.freeradbiomed.2005.03.025; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Kuehn Markus H, 2005, Ophthalmol Clin North Am, V18, P383, DOI 10.1016/j.ohc.2005.04.002; KWON YH, 1999, DUANES CLIN OPHTHALM, P1; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170; Lutjen-Drecoll E, 1998, INVEST OPHTH VIS SCI, V39, P517; Lutjen-Drecoll E., 1996, GLAUCOMAS, P89; Malone P, 2007, GLIA, V55, P1085, DOI 10.1002/glia.20527; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; MINCKLER DS, 1976, AM J OPHTHALMOL, V82, P179, DOI 10.1016/0002-9394(76)90416-5; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; MORRISON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1020, DOI 10.1001/archopht.1990.01070090122053; Mozaffarieh M, 2008, MOL VIS, V14, P224; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; O'Brien ET, 1999, CURR EYE RES, V19, P517, DOI 10.1076/ceyr.19.6.517.5285; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Paper W, 2008, EXP EYE RES, V87, P257, DOI 10.1016/j.exer.2008.06.006; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pena JDO, 1999, EXP EYE RES, V68, P29, DOI 10.1006/exer.1998.0577; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Rajendram R, 2007, BRIT J OPHTHALMOL, V91, P663, DOI 10.1136/bjo.2006.093930; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; RODRIGUES MM, 1976, T OPHTHAL SOC UK, V96, P245; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2001, MOL VIS, V7, P192; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stoilova D, 1998, J MED GENET, V35, P989, DOI 10.1136/jmg.35.12.989; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wiggs JL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1674; Wilkinson CH, 2003, J GLAUCOMA, V12, P237, DOI 10.1097/00061198-200306000-00010; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P365; Yang P, 2004, PHYSIOL GENOMICS, V17, P157, DOI 10.1152/physiolgenomics.00182.2003; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; ZHANG J, 2005, DUANES FDN CLIN OPHT, P1; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	110	557	588	3	107	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1113	1124		10.1056/NEJMra0804630	http://dx.doi.org/10.1056/NEJMra0804630			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279343	Green Accepted			2022-12-28	WOS:000264051000009
J	Leischow, SJ				Leischow, Scott J.			Setting the National Tobacco Control Agenda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; SMOKING		Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85719 USA	Arizona Center Cancer Care; University of Arizona	Leischow, SJ (corresponding author), Univ Arizona, Arizona Canc Ctr, 1515 N Campbell Ave, Tucson, AZ 85719 USA.	sleischow@azcc.arizona.edu						Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; *AM NONS RIGHTS FD, 2009, SUMM 100 SMOK STAT L; Fiore MC, 2004, AM J PUBLIC HEALTH, V94, P205, DOI 10.2105/AJPH.94.2.205; Flore M, 2008, TREATING TOBACCO USE; Mackay J, 2006, TOBACCO ATLAS; *NAT I ALL INF DIE, TREATM HIV INF; Peto R, 2004, TOBACCO PUBLIC HLTH, P281; REINBERG S, 2008, WASHINGTONPOST  1209; RISBECK CA, 2007, ADHA SMOKING CESSATI, V2; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1281; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; VEVERS V, OBAMA SAYS WH WILL R; *WHO FRAM CONV TOB, 3 SESS C PART WHO FC	13	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1058	1060		10.1001/jama.2009.296	http://dx.doi.org/10.1001/jama.2009.296			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278948				2022-12-28	WOS:000264015800030
J	Molderings, GJ				Molderings, Gerhard J.			Commentary: Condition is often overlooked	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Bonn, Inst Human Genet, D-53111 Bonn, Germany	University of Bonn	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, D-53111 Bonn, Germany.	molderings@uni-bonn.de						Alfter K, 2009, LIVER INT, V29, P181, DOI 10.1111/j.1478-3231.2008.01839.x; Barbara G, 2006, NEUROGASTROENT MOTIL, V18, P6, DOI 10.1111/j.1365-2982.2005.00685.x; Molderings GJ, 2007, SCAND J GASTROENTERO, V42, P1045, DOI 10.1080/00365520701245744; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2009	338								b799	10.1136/bmj.b799	http://dx.doi.org/10.1136/bmj.b799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273524				2022-12-28	WOS:000264205200006
J	D'Amico, N				D'Amico, Nicolo			Pinpointing Gravity	SCIENCE			English	Editorial Material							DOUBLE-PULSAR; SYSTEM		Natl Inst Astrophys, Observ Astron Cagliari, I-09012 Capoterra, Italy		D'Amico, N (corresponding author), Natl Inst Astrophys, Observ Astron Cagliari, Loc Poggio Pini,Str 54, I-09012 Capoterra, Italy.	damico@oa-cagliari.inaf.it	D'Amico, Nichi/A-5715-2009					ABBOTT B, 2007, LIGO SCI COLLABORATI; Breton RP, 2008, SCIENCE, V321, P104, DOI 10.1126/science.1159295; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Ciufolini I, 1996, GRAVITATION INERTIA; Damour T, 1996, PHYS REV D, V54, P1474, DOI 10.1103/PhysRevD.54.1474; Deller AT, 2009, SCIENCE, V323, P1327, DOI 10.1126/science.1167969; Dodelson S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.231301; GIAZOTTO A, 2002, P 14 SIGRAV C GEN RE, P111; HULSE RA, 1975, ASTROPHYS J, V195, pL51, DOI 10.1086/181708; Lorimer DR, 2008, LIVING REV RELATIV, V11, DOI 10.12942/lrr-2008-8; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Smits R, 2009, ASTRON ASTROPHYS, V493, P1161, DOI 10.1051/0004-6361:200810383	12	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1299	1300		10.1126/science.1170936	http://dx.doi.org/10.1126/science.1170936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265008				2022-12-28	WOS:000263876700027
J	Brinster, S; Lamberet, G; Staels, B; Trieu-Cuot, P; Gruss, A; Poyart, C				Brinster, Sophie; Lamberet, Gilles; Staels, Bart; Trieu-Cuot, Patrick; Gruss, Alexandra; Poyart, Claire			Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens	NATURE			English	Article							GROUP-B STREPTOCOCCUS; BIOSYNTHESIS; VIRULENCE; BACTERIA; DISEASE; MUTANS; GROWTH; CONTRIBUTES; INHIBITOR; DISCOVERY	Antimicrobial drugs targeting the reportedly essential type II fatty acid synthesis (FASII) pathway(1-5) have been recently acclaimed for their efficacy against infections caused by multiresistant Gram-positive bacteria(6-8). Our findings show that the strategy for antibiotic development based on FASII pathway targets is fundamentally flawed by the fact that exogenous fatty acids fully bypass inhibition of this pathway in both in vitro and in vivo conditions. We demonstrate that major Gram-positive pathogens-such as streptococci, pneumococci, enterococci and staphylococci-overcome drug-induced FASII pathway inhibition when supplied with exogenous fatty acids, and human serum proves to be a highly effective source of fatty acids. For opportunist pathogen Streptococcus agalactiae, growth in serum leads to an overall decrease of FASII gene expression. No antibiotic inhibitor could have a stronger effect than the inactivation of the target gene, so we challenged the role of FASII using deletion mutants. Our results unequivocally show that the FASII target enzymes are dispensable in vivo during S. agalactiae infection. The results of this study largely compromise the use of FASII-based antimicrobials for treating sepsis caused by Gram-positive pathogens.	[Brinster, Sophie; Poyart, Claire] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Brinster, Sophie; Poyart, Claire] INSERM, U567, Paris, France; [Lamberet, Gilles; Gruss, Alexandra] INRA, Unite Bacteries Lact & Pathogenes Opportunistes, UR888, F-78350 Jouy En Josas, France; [Staels, Bart] Univ Lille 2, Inst Pasteur Lille, UMR545, Lille, France; [Trieu-Cuot, Patrick; Poyart, Claire] Inst Pasteur, CNRS, URA 2172, Unite Biol Bacteries Pathogenes Gram Posi, Paris, France; [Poyart, Claire] Hop Cochin, Ctr Natl Reference Streptocoques, AP HP, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Poyart, C (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	Alexandra.gruss@jouy.inra.fr; claire.poyart@cch.aphp.fr	Staels, Bart/N-9497-2016; POYART, Claire/P-4225-2017	Staels, Bart/0000-0002-3784-1503; POYART, Claire/0000-0003-2158-6293; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Gruss, Alexandra/0000-0001-7426-5229	French Agence Nationale de la Recherche; INSERM; INRA; Universite Paris Descartes; Institut Pasteur; ANR StrepRespire Project	French Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Universite Paris Descartes; Institut Pasteur(European Commission); ANR StrepRespire Project(French National Research Agency (ANR))	We are grateful to I. Tardieux, P. Bouloc and L. Gutmann for critical reading and discussion of the manuscript, and P. Gaudu and Y. Yamamoto for discussion. We thank A. Bouaboud for technical assistance, and C. Fievet and N. Hennuye for mouse serum fatty acid analyses and advice. This work was supported by research funding from the French Agence Nationale de la Recherche (ANR, StrepRespire Project), INSERM, INRA, Universite Paris Descartes, and the Institut Pasteur. S. B. was a recipient of a post-doctoral fellowship from the ANR StrepRespire Project.	Altabe S, 2007, J BACTERIOL, V189, P8139, DOI 10.1128/JB.01275-07; ALTENBERN RA, 1977, ANTIMICROB AGENTS CH, V11, P574, DOI 10.1128/AAC.11.3.574; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Gill CJ, 1998, ANTIMICROB AGENTS CH, V42, P1996, DOI 10.1128/AAC.42.8.1996; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hamilton JA, 2002, PROSTAG LEUKOTR ESS, V67, P65, DOI 10.1054/plef.2002.0400; JOHNSSON T, 1995, APPL ENVIRON MICROB, V61, P4497, DOI 10.1128/AEM.61.12.4497-4499.1995; Kankaanpaa P, 2004, APPL ENVIRON MICROB, V70, P129, DOI 10.1128/AEM.70.1.129-136.2004; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Scortti M, 2006, NAT MED, V12, P515, DOI 10.1038/nm1396; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Tomita Y, 2008, J OLEO SCI, V57, P115, DOI 10.5650/jos.57.115; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	31	234	237	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					83	U5		10.1038/nature07772	http://dx.doi.org/10.1038/nature07772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262672				2022-12-28	WOS:000263836000037
J	Patel, CN; Gerrard, G; Scarsbrook, AF				Patel, Chirag N.; Gerrard, Georgina; Scarsbrook, Andrew F.			Practice Rational Imaging Incidental thyroid nodule	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULTRASOUND; MANAGEMENT; US		[Patel, Chirag N.; Scarsbrook, Andrew F.] St James Univ Hosp, Dept Radiol, Leeds Teaching Hosp, Leeds LS9 7TF, W Yorkshire, England; [Patel, Chirag N.; Scarsbrook, Andrew F.] St James Univ Hosp, Dept Nucl Med, Leeds Teaching Hosp, Leeds LS9 7TF, W Yorkshire, England; [Gerrard, Georgina] St James Univ Hosp, Dept Clin Oncol, Leeds Teaching Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Scarsbrook, AF (corresponding author), St James Univ Hosp, Dept Radiol, Leeds Teaching Hosp, Leeds LS9 7TF, W Yorkshire, England.	andrew.scarsbrook@leedsth.nhs.uk	Scarsbrook, Andrew/I-1660-2019	Scarsbrook, Andrew/0000-0002-4243-032X				Choi JY, 2006, J NUCL MED, V47, P609; de Geus-Oei LF, 2006, J NUCL MED, V47, P770; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Roskell DE, 2004, BRIT MED J, V329, P244, DOI 10.1136/bmj.329.7460.244; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; SOHAIB SAA, 2001, GRAINGER ALLISONS DI; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009	9	1	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2009	338								b611	10.1136/bmj.b611	http://dx.doi.org/10.1136/bmj.b611			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EC	19261672				2022-12-28	WOS:000264058300002
J	Rini, BI; Campbell, SC; Escudier, B				Rini, Brian I.; Campbell, Steven C.; Escudier, Bernard			Renal cell carcinoma	LANCET			English	Review							ENDOTHELIAL GROWTH-FACTOR; DOSE RECOMBINANT INTERLEUKIN-2; NEPHRON SPARING SURGERY; CHRONIC KIDNEY-DISEASE; CARBONIC-ANHYDRASE-IX; TUMOR-SUPPRESSOR GENE; RANDOMIZED PHASE-II; LONG-TERM SURVIVAL; INTERFERON-ALPHA; RADICAL NEPHRECTOMY	Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. In localised disease, partial nephrectomy for small tumours and radical nephrectomy for large tumours continue to be the gold-standard treatments, with emphasis on approaches that have reduced invasiveness and preserve renal function. Additionally, cytoreductive nephrectomy is often indicated before the start of systemic treatment in patients with metastatic disease as part of integrated management strategy. The effectiveness of immunotherapy, although previously widely used for treatment of metastatic renal cell carcinoma, is still controversial, and is mainly reserved for patients with good prognostic factors. Development of treatments that have specific targets in relevant biological pathways has been the main advance in treatment. Targeted drugs, including inhibitors of the vascular endothelial growth factor and mammalian target of rapamycin pathways, have shown robust effectiveness and offer new therapeutic options for the patients with metastatic disease.	[Rini, Brian I.] Glickman Urol & Kidney Inst, Taussig Canc Inst, Cleveland Clin, Dept Solid Tumor Oncol, Cleveland, OH 44195 USA; [Campbell, Steven C.] Glickman Urol & Kidney Inst, Sect Urol Oncol, Cleveland, OH 44195 USA; [Escudier, Bernard] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France	Cleveland Clinic Foundation; UNICANCER; Gustave Roussy	Rini, BI (corresponding author), Glickman Urol & Kidney Inst, Taussig Canc Inst, Cleveland Clin, Dept Solid Tumor Oncol, 9500 Euclid Ave,Desk R35, Cleveland, OH 44195 USA.	rinib2@ccf.org						Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Atkins M, 2005, CLIN CANCER RES, V11, P3714, DOI 10.1158/1078-0432.CCR-04-2019; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Atzpodien J, 2001, BRIT J CANCER, V85, P1130, DOI 10.1054/bjoc.2001.2076; Atzpodien J, 2005, BRIT J CANCER, V92, P843, DOI 10.1038/sj.bjc.6602443; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; ATZPODIEN J, 1993, EUR J CANCER, V29A, pS6, DOI 10.1016/0959-8049(93)90617-O; Bjorge T, 2004, AM J EPIDEMIOL, V160, P1168, DOI 10.1093/aje/kwh345; Blute ML, 2004, BJU INT, V94, P33, DOI 10.1111/j.1464-410X.2004.04897.x; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Bukowski RM, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.5154; Bukowski RM, 2007, J CLIN ONCOL, V25, P4536, DOI 10.1200/JCO.2007.11.5154; BUTLER BP, 1995, UROLOGY, V45, P34, DOI 10.1016/S0090-4295(95)96306-5; CAMPBELL SC, 2007, CAMPBELLS UROLOGY; Chao DH, 2002, UROLOGY, V59, P635, DOI 10.1016/S0090-4295(01)01630-2; Chawla SN, 2006, J UROLOGY, V175, P425, DOI 10.1016/S0022-5347(05)00148-5; Cheville JC, 2004, AM J SURG PATHOL, V28, P435, DOI 10.1097/00000478-200404000-00002; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clark JI, 2003, J CLIN ONCOL, V21, P3133, DOI 10.1200/JCO.2003.02.014; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; DAVIS CJ, 1995, AM J SURG PATHOL, V19, P1, DOI 10.1097/00000478-199501000-00001; de Paulsen N, 2001, P NATL ACAD SCI USA, V98, P1387, DOI 10.1073/pnas.031587498; Escudier B, 1999, J CLIN ONCOL, V17, P2039, DOI 10.1200/JCO.1999.17.7.2039; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; FARROW GM, 1968, CANCER, V22, P556, DOI 10.1002/1097-0142(196809)22:3<556::AID-CNCR2820220310>3.0.CO;2-N; Figlin RA, 2008, 44 AM SOC CLIN ONC A; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Flanigan RC, 2004, J UROLOGY, V171, P1071, DOI 10.1097/01.ju.0000110610.61545.ae; FOSSA SD, 1992, EUR J CANCER, V28A, P878, DOI 10.1016/0959-8049(92)90139-S; Frank I, 2003, J UROLOGY, V170, P2217, DOI 10.1097/01.ju.0000095475.12515.5e; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Fyfe GA, 1996, J CLIN ONCOL, V14, P2410, DOI 10.1200/JCO.1996.14.8.2410; Galligioni E, 1996, CANCER, V77, P2560, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P; Gallou C, 1999, HUM MUTAT, V13, P464, DOI 10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A; Gez E, 2002, TUMORI, V88, P500, DOI 10.1177/030089160208800613; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Gill IS, 2005, J UROLOGY, V173, P1903, DOI 10.1097/01.ju.0000158154.28845.c9; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gore ME, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5039; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hafron J, 2007, NAT CLIN PRACT UROL, V4, P261, DOI 10.1038/ncpuro0802; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hollenbeck BK, 2006, UROLOGY, V67, P254, DOI 10.1016/j.urology.2005.08.050; Hollingsworth JM, 2007, CANCER-AM CANCER SOC, V109, P1763, DOI 10.1002/cncr.22600; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Ishikawa I, 2003, CLIN NEPHROL, V59, P153; Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6; Khakoo AY, 2008, CANCER-AM CANCER SOC, V112, P2500, DOI 10.1002/cncr.23460; KJAER M, 1987, INT J RADIAT ONCOL, V13, P665, DOI 10.1016/0360-3016(87)90283-5; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; Kunkle DA, 2008, J UROLOGY, V179, P1227, DOI 10.1016/j.juro.2007.11.047; LANE BR, 2008, J UROLOGY, V179, P852; Lane BR, 2008, J UROLOGY, V179, P847, DOI 10.1016/j.juro.2007.10.050; Lane BR, 2008, J UROLOGY, V179, P20, DOI 10.1016/j.juro.2007.08.124; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee JE, 2007, INT J CANCER, V121, P2246, DOI 10.1002/ijc.22909; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Leibovich BC, 2004, J UROLOGY, V171, P1066, DOI 10.1097/01.ju.0000113274.40885.db; Lerner SE, 1996, J UROLOGY, V155, P1868, DOI 10.1016/S0022-5347(01)66032-4; Linehan WM, 2003, J UROLOGY, V170, P2163, DOI 10.1097/01.ju.0000096060.92397.ed; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Makarewicz R, 1998, NEOPLASMA, V45, P380; Margulis V, 2007, CANCER-AM CANCER SOC, V109, P2025, DOI 10.1002/cncr.22629; MCCREDIE M, 1995, INT J CANCER, V60, P345, DOI 10.1002/ijc.2910600312; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; MCLAUGHLIN JK, 1995, INT J CANCER, V63, P216, DOI 10.1002/ijc.2910630212; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Messing EM, 2003, J CLIN ONCOL, V21, P1214, DOI 10.1200/JCO.2003.02.005; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Murthy SC, 2005, ANN THORAC SURG, V79, P996, DOI 10.1016/j.athoracsur.2004.08.034; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Negrier S, 2007, CANCER-AM CANCER SOC, V110, P2468, DOI 10.1002/cncr.23056; NEIDHART JA, 1991, J CLIN ONCOL, V9, P832, DOI 10.1200/JCO.1991.9.5.832; PAPAC RJ, 1977, AM J MED SCI, V274, P281, DOI 10.1097/00000441-197711000-00006; Pfannschmidt J, 2002, ANN THORAC SURG, V74, P1653, DOI 10.1016/S0003-4975(02)03803-1; Pizzocaro G, 2001, J CLIN ONCOL, V19, P425, DOI 10.1200/JCO.2001.19.2.425; PIZZOCARO G, 1983, TUMORI, V69, P215, DOI 10.1177/030089168306900307; PIZZOCARO G, 1987, J UROLOGY, V138, P1379, DOI 10.1016/S0022-5347(17)43647-0; Prasad SR, 2008, AM J ROENTGENOL, V190, P158, DOI 10.2214/AJR.07.2724; Presta LG, 1997, CANCER RES, V57, P4593; Pyrhonen S, 1999, J CLIN ONCOL, V17, P2859, DOI 10.1200/JCO.1999.17.9.2859; Rakowski SK, 2006, KIDNEY INT, V70, P1777, DOI 10.1038/sj.ki.5001853; Rashidkhani B, 2005, INT J CANCER, V113, P451, DOI 10.1002/ijc.20577; Remzi M, 2006, J UROLOGY, V176, P896, DOI 10.1016/j.juro.2006.04.047; Renshaw AA, 2002, HISTOPATHOLOGY, V41, P283, DOI 10.1046/j.1365-2559.2002.01420.x; Rini BI, 2000, J CLIN ONCOL, V18, P2419, DOI 10.1200/JCO.2000.18.12.2419; Rini BI, 2005, CANCER, V103, P553, DOI 10.1002/cncr.20795; Rini BI, 2008, CLIN CANCER RES, V14, P1286, DOI 10.1158/1078-0432.CCR-07-4719; Rini BI, 2007, J UROLOGY, V177, P1978, DOI 10.1016/j.juro.2007.01.136; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Ritchie A, 1999, LANCET, V353, P14; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Stadler WM, 2006, CANCER, V107, P1273, DOI 10.1002/cncr.22117; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; SZCYLIK C, 2007, J CLIN ONCOL, V25, P5025; Tamaskar I, 2008, J UROLOGY, V179, P81, DOI 10.1016/j.juro.2007.08.127; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Upton MP, 2005, J IMMUNOTHER, V28, P488, DOI 10.1097/01.cji.0000170357.14962.9b; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; van Dijk BAC, 2004, AM J EPIDEMIOL, V160, P1159, DOI 10.1093/aje/kwh344; van Dijk BAC, 2005, INT J CANCER, V117, P648, DOI 10.1002/ijc.21203; Walther MM, 1999, J UROLOGY, V161, P1475, DOI 10.1016/S0022-5347(05)68930-6; Weight CJ, 2008, J UROLOGY, V179, P1277, DOI 10.1016/j.juro.2007.11.075; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; YAGODA A, 1995, SEMIN ONCOL, V22, P42; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Yuan JM, 1998, CANCER EPIDEM BIOMAR, V7, P429; Zambrano NR, 1999, J UROLOGY, V162, P1246, DOI 10.1016/S0022-5347(05)68259-6; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	135	1098	1146	3	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1119	1132		10.1016/S0140-6736(09)60229-4	http://dx.doi.org/10.1016/S0140-6736(09)60229-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19269025				2022-12-28	WOS:000264773600033
J	Busse, JW; Kaur, J; Mollon, B; Bhandari, M; Tornetta, P; Schuenemann, HJ; Guyatt, GH				Busse, Jason W.; Kaur, Jagdeep; Mollon, Brent; Bhandari, Mohit; Tornetta, Paul, III; Schuenemann, Holger J.; Guyatt, Gordon H.			Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELECTRICAL-STIMULATION; ULTRASOUND THERAPY; METAANALYSIS; RECOMMENDATIONS; STRENGTH; QUALITY	Objective To determine the efficacy of low intensity pulsed ultrasonography for healing of fractures. Design Systematic review of randomised controlled trials. Data sources Electronic literature search without language restrictions of CINAHL, Embase, Medline, HealthSTAR, and the Cochrane Central Registry of Controlled Trials, from inception of the database to 10 September 2008. Review methods Eligible studies were randomised controlled trials that enrolled patients with any kind of fracture and randomly assigned them to low intensity pulsed ultrasonography or to a control group. Two reviewers independently agreed on eligibility; three reviewers independently assessed methodological quality and extracted outcome data. All outcomes were included and meta-analyses done when possible. Results 13 randomised trials, of which five assessed outcomes of importance to patients, were included. Moderate quality evidence from one trial found no effect of low intensity pulsed ultrasonography on functional recovery from conservatively managed fresh clavicle fractures; whereas low quality evidence from three trials suggests benefit in non-operatively managed fresh fractures (faster radiographic healing time mean 36.9%, 95% confidence interval 25.6% to 46.0%). A single trial provided moderate quality evidence suggesting no effect of low intensity pulsed ultrasonography on return to function among non-operatively treated stress fractures. Three trials provided very low quality evidence for accelerated functional improvement after distraction osteogenesis. One trial provided low quality evidence for a benefit of low intensity pulsed ultrasonography in accelerating healing of established non-unions managed with bone graft. Four trials provided low quality evidence for acceleration of healing of operatively managed fresh fractures. Conclusion Evidence for the effect of low intensity pulsed ultrasonography on healing of fractures is moderate to very low in quality and provides conflicting results. Although overall results are promising, establishing the role of low intensity pulsed ultrasonography in the management of fractures requires large, blinded trials, directly addressing patient important outcomes such as return to function.	[Busse, Jason W.] Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; [Busse, Jason W.; Kaur, Jagdeep; Bhandari, Mohit; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mollon, Brent] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Tornetta, Paul, III] Boston Univ, Sch Med, Boston, MA 02215 USA; [Schuenemann, Holger J.] Italian Natl Canc Inst Regina Elena, Unit Clin Res Dev & INFORMAt Translat, Dept Epidemiol, Rome, Italy; [Schuenemann, Holger J.] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, CLAR Res Team, Rome, Italy	Institute for Work & Health; McMaster University; Western University (University of Western Ontario); Boston University	Busse, JW (corresponding author), Inst Work & Hlth, 481 Univ Ave, Toronto, ON M5G 2E9, Canada.	jbusse@iwh.on.ca	Bhandari, Mohit/AAQ-1675-2021; Busse, Jason/CAH-3696-2022	Busse, Jason/0000-0002-0178-8712; Schunemann, Holger/0000-0003-3211-8479; Tornetta, Paul/0000-0002-6448-8864				Akai M, 2002, BIOELECTROMAGNETICS, V23, P132, DOI 10.1002/bem.106; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Basso O, 1998, J HAND SURG-BRIT EUR, V23B, P136, DOI 10.1016/S0266-7681(98)80248-9; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Busse JW, 2008, ACTA ORTHOP, V79, P689, DOI 10.1080/17453670810016722; Busse JW, 2004, ARCH PHYS MED REHAB, V85, P1653, DOI 10.1016/j.apmr.2003.12.040; Busse JW, 2002, CAN MED ASSOC J, V166, P437; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; *COCHR COLL, 2006, COCHR REV HDB; Cook SD, 1997, CLIN ORTHOP RELAT R, P198; Day SM, 2000, ORTHOPAEDIC BASIC SC, P371; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Heckman J D, 1997, Bull Hosp Jt Dis, V56, P63; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P138, DOI 10.2106/JBJS.G.01218; Mollon B, 2008, J BONE JOINT SURG AM, V90A, P2322, DOI 10.2106/JBJS.H.00111; PILLA AA, 1991, ELECTROMAGNETICS IN MEDICINE AND BIOLOGY, P331; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; PRAEMER A, 1999, MUSCULOSKELETAL COND, P83; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; SONG F, 2000, HEALTH TECHNOL ASSES, V4, P111; Wachovia Capital Markets, 2007, EQ RES BON GROWTH ST	27	78	80	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2009	338								b351	10.1136/bmj.b351	http://dx.doi.org/10.1136/bmj.b351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DT	19251751	Green Published, hybrid			2022-12-28	WOS:000264056400003
J	Barker, S; Diz, P; Vautravers, MJ; Pike, J; Knorr, G; Hall, IR; Broecker, WS				Barker, Stephen; Diz, Paula; Vautravers, Maryline J.; Pike, Jennifer; Knorr, Gregor; Hall, Ian R.; Broecker, Wallace S.			Interhemispheric Atlantic seesaw response during the last deglaciation	NATURE			English	Article							SEA-SURFACE TEMPERATURE; PLANKTONIC-FORAMINIFERA; AGE CALIBRATION; BIPOLAR SEESAW; SOUTH ATLANTIC; OCEAN; CIRCULATION; GREENLAND; EVENTS; RESUMPTION	The asynchronous relationship between millennial-scale temperature changes over Greenland and Antarctica during the last glacial period has led to the notion of a bipolar seesaw which acts to redistribute heat depending on the state of meridional overturning circulation within the Atlantic Ocean. Here we present new records from the South Atlantic that show rapid changes during the last deglaciation that were instantaneous (within dating uncertainty) and of opposite sign to those observed in the North Atlantic. Our results demonstrate a direct link between the abrupt changes associated with variations in the Atlantic meridional overturning circulation and the more gradual adjustments characteristic of the Southern Ocean. These results emphasize the importance of the Southern Ocean for the development and transmission of millennial-scale climate variability and highlight its role in deglacial climate change and the associated rise in atmospheric carbon dioxide.	[Barker, Stephen; Diz, Paula; Pike, Jennifer; Knorr, Gregor; Hall, Ian R.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales; [Vautravers, Maryline J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Broecker, Wallace S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Cardiff University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Columbia University	Barker, S (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales.	barkers3@cf.ac.uk	Pike, Jennifer/D-2589-2009; Stephen, Barker/C-2770-2009; Diz, Paula/N-3113-2015; Hall, Ian R/C-2755-2009	Pike, Jennifer/0000-0001-9415-6003; Stephen, Barker/0000-0001-7870-6431; Diz, Paula/0000-0002-7136-0690; Hall, Ian R/0000-0001-6960-1419; Mleneck-Vautravers, Maryline/0000-0003-2534-219X; Knorr, Gregor/0000-0002-8317-5046	US National Science Foundation [OCE00-02380]; Office of Naval Research [N00014-02-1-0073]; National Science Foundation [OCE-0435703]; Natural Environment Research Council [bas010019] Funding Source: researchfish; NERC [bas010019] Funding Source: UKRI	US National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Riker and C. Lear for analytical advice and assistance and H. Medley for help with sediment processing. Sample material used in this project was provided by the Lamont-Doherty Earth Observatory Deep-Sea Sample Repository. We thank R. Lotti and G. Lozefski for help with sampling. Support for the collection and curating facilities of the core collection is provided by the US National Science Foundation through grant OCE00-02380 and the Office of Naval Research through grant N00014-02-1-0073. The work was supported by a National Science Foundation grant (OCE-0435703) to W. S. B. and S. B.	Ahn JH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029551; Andersen K.K., 2007, CLIM PAST DISCUSS, V3, P1235; Arz HW, 1999, EARTH PLANET SC LETT, V167, P105, DOI 10.1016/S0012-821X(99)00025-4; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Barker S, 2005, QUATERNARY SCI REV, V24, P821, DOI 10.1016/j.quascirev.2004.07.016; Barker S, 2007, P NATL ACAD SCI USA, V104, P17278, DOI 10.1073/pnas.0708494104; Bathmann UV, 1997, DEEP-SEA RES PT II, V44, P51, DOI 10.1016/S0967-0645(96)00063-X; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; Cornelius N, 2004, DEEP-SEA RES PT II, V51, P1571, DOI 10.1016/j.dsr2.2004.06.024; COX MD, 1989, J PHYS OCEANOGR, V19, P1730, DOI 10.1175/1520-0485(1989)019<1730:AIMOTW>2.0.CO;2; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Farmer EC, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001049; Froneman PW, 2001, J PLANKTON RES, V23, P611, DOI 10.1093/plankt/23.6.611; GOODAY AJ, 1988, NATURE, V332, P70, DOI 10.1038/332070a0; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; JOHNSEN SJ, 1972, NATURE, V235, P429, DOI 10.1038/235429a0; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kim JH, 2002, EARTH PLANET SC LETT, V194, P383, DOI 10.1016/S0012-821X(01)00545-3; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Knorr G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001604; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Lamy F, 2007, EARTH PLANET SC LETT, V259, P400, DOI 10.1016/j.epsl.2007.04.040; Li C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023492; Llido J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022880; Locarnini R. A., 2006, WORLD OCEAN ATLAS 20, V1; Machu E, 2005, DEEP-SEA RES PT I, V52, P1300, DOI 10.1016/j.dsr.2004.12.008; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; Saraceno M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002736; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Timmermann A, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001090; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067	57	362	383	9	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1097	U50		10.1038/nature07770	http://dx.doi.org/10.1038/nature07770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242468				2022-12-28	WOS:000263680100033
J	Phillips, SP; Austin, EB				Phillips, Susan P.; Austin, Emily B.			The Feminization of Medicine and Population Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORGANIZATION; COUNTRIES; DOCTORS; GENDER		[Phillips, Susan P.] Queens Univ, Dept Family Med, Kingston, ON K7L 5E9, Canada; [Phillips, Susan P.] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 5E9, Canada; [Austin, Emily B.] Queens Univ, Sch Med, Kingston, ON K7L 5E9, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Phillips, SP (corresponding author), Queens Univ, Dept Family Med, 220 Bagot St, Kingston, ON K7L 5E9, Canada.	phillip@post.queensu.ca		Phillips, Susan/0000-0003-4798-1742				Association of American Medical Colleges, WOM US AC MED STAT M; Boerma WGW, 2000, MED CARE, V38, P993, DOI 10.1097/00005650-200010000-00003; *CAN MED ASS, 2008, NUMB PERC DISTR PHYS; *CAN RES MATCH SER, DISC CHOIC MATCH RES; COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200; *GEN MED COUN, LIST REG MED PRACT S; Goodman DC, 2008, JAMA-J AM MED ASSOC, V299, P335, DOI 10.1001/jama.299.3.335; HERBERT C, 2008, CMAJ, V178, P651; Herbert C, 2008, CAN MED ASSOC J, V178, P659, DOI 10.1503/cmaj.080216; Levinson W, 2004, ANN INTERN MED, V141, P471, DOI 10.7326/0003-4819-141-6-200409210-00013; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; McKinstry B, 2008, BRIT MED J, V336, P748, DOI 10.1136/bmj.39505.491065.94; McMurray Julia E, 2002, J Am Med Womens Assoc (1972), V57, P185; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; World Health Organization, WHO STAT INF SYST WH; Zaat J O M, 2008, Ned Tijdschr Geneeskd, V152, P2153	16	53	54	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					863	864		10.1001/jama.2009.155	http://dx.doi.org/10.1001/jama.2009.155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410WV	19244195				2022-12-28	WOS:000263609900029
J	Cros, D; Gonzalez, RG; Mark, EJ; Han, SW; Harris, NL; Sheth, KN				Cros, Didier; Gonzalez, R. Gilberto; Mark, Eugene J.; Han, Sang-Woo (Steve); Harris, Nancy Lee; Sheth, Kevin N.			A Woman with Vertigo, Facial Weakness, and a Generalized Seizure Neurosarcoidosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; MEDICAL PROGRESS; LYME-DISEASE; SARCOIDOSIS; DIAGNOSIS; MANIFESTATIONS; MANAGEMENT; LUPUS		[Cros, Didier] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Div Neuroradiol, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cros, Didier] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Cros, D (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.				Bayer; General Electric	Bayer(Bayer AG); General Electric(General Electric)	Dr. Gonzalez reports receiving lecture fees from Bayer and General Electric. No other potential conflict of interest relevant to this article was reported.	Al Dhanhani A, 2006, J RHEUMATOL, V33, P364; CAPELLAN JIL, 1990, J NEUROSURG, V73, P283, DOI 10.3171/jns.1990.73.2.0283; Hsu RM, 1996, ARCH PATHOL LAB MED, V120, P364; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P605, DOI 10.1093/rheumatology/41.6.605; Joseph FG, 2007, NEUROLOGY, V69, P644, DOI 10.1212/01.wnl.0000267320.48939.d0; JUDD PA, 1975, J PATHOL, V115, P191, DOI 10.1002/path.1711150402; Lower Elyse E., 1997, Archives of Internal Medicine, V157, P1864, DOI 10.1001/archinte.157.16.1864; MIKLOSSY J, 1990, ACTA NEUROPATHOL, V80, P568, DOI 10.1007/BF00294622; MITCHELL DN, 1977, J CLIN PATHOL, V30, P395, DOI 10.1136/jcp.30.5.395; Murialdo G, 2002, J ENDOCRINOL INVEST, V25, P650, DOI 10.1007/BF03345093; PERRY A, 1995, ARCH PATHOL LAB MED, V119, P167; Rosen Y, 1979, Pathol Annu, V14 Pt 1, P405; Scott TF, 2007, ARCH NEUROL-CHICAGO, V64, P691, DOI 10.1001/archneur.64.5.691; Starosta MA, 2007, NEUROLOGY, V68, P1079, DOI 10.1212/01.wnl.0000257824.72457.91; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; STERN BJ, 1985, ARCH NEUROL-CHICAGO, V42, P909, DOI 10.1001/archneur.1985.04060080095022; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103	19	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					802	809		10.1056/NEJMcpc0807823	http://dx.doi.org/10.1056/NEJMcpc0807823			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228624				2022-12-28	WOS:000263411300012
J	Glickman, SW; McHutchison, JG; Peterson, ED; Cairns, CB; Harrington, RA; Califf, RM; Schulman, KA				Glickman, Seth W.; McHutchison, John G.; Peterson, Eric D.; Cairns, Charles B.; Harrington, Robert A.; Califf, Robert M.; Schulman, Kevin A.			Ethical and Scientific Implications of the Globalization of Clinical Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL-RESEARCH; HEALTH RESEARCH; TRIALS; CONDUCT; BARRIERS; DESIGN; FUTURE		[Glickman, Seth W.; McHutchison, John G.; Peterson, Eric D.; Cairns, Charles B.; Harrington, Robert A.; Califf, Robert M.; Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Duke Translat Med Inst,Ctr Clin & Genet Econ, Durham, NC 27715 USA; [McHutchison, John G.; Peterson, Eric D.; Harrington, Robert A.; Califf, Robert M.; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Glickman, Seth W.; Cairns, Charles B.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Schulman, KA (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Duke Translat Med Inst,Ctr Clin & Genet Econ, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu	Peterson, Eric David/ABF-5033-2021					Abbas EE, 2007, CONTEMP CLIN TRIALS, V28, P677, DOI 10.1016/j.cct.2007.02.011; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Annas GJ, 1998, AM J PUBLIC HEALTH, V88, P560, DOI 10.2105/AJPH.88.4.560; Bailey WCC., MAKE YOUR MOVE TAKIN; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Califf RM, 2005, JAMA-J AM MED ASSOC, V293, P489, DOI 10.1001/jama.293.4.489; Council for International Organizations of Medical Sciences (CIOMS), INT ETH GUID BIOM RE; Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093; *DEP HHS, 2007, DHHS PUBL; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Dilts DM, 2006, J CLIN ONCOL, V24, P4553, DOI 10.1200/JCO.2006.06.7819; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Drazen JM, 2002, NEW ENGL J MED, V347, P1362, DOI 10.1056/NEJMe020122; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Eisenstein EL, 2008, CLIN TRIALS, V5, P75, DOI 10.1177/1740774507087551; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; FDA Cardiovascular and Renal Drugs Advisory Committee, 2007 M DOC; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Gershon D., 2001, NATURE, V411, P4; GETZ KA, 2007, GLOB CLIN TRIALS ACT; Goldstein DB, 2004, NAT REV GENET, V5, P76, DOI 10.1038/nrg1253; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; *HLTH IMS, GLOB PHARM SAL REG 2; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hutton JL, 2000, STAT METHODS MED RES, V9, P185; Hyder AA, 2004, J MED ETHICS, V30, P68, DOI 10.1136/jme.2002.001933; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; JACK A, 2008, FINANCIAL TIMES 0128, P58; Jayaraman KS, 2005, NATURE, V434, P259, DOI 10.1038/434259a; Killen J, 2002, NAT REV IMMUNOL, V2, P210, DOI 10.1038/nri745; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; London L, 2002, AM J PUBLIC HEALTH, V92, P1079, DOI 10.2105/AJPH.92.7.1079; MAGOTRA R, 2006, J MED ETHICS, V3, P25; Nuffield Council on Bioethics, 1999, ETH CLIN RES DEV COU; Nundy S, 2005, NEW ENGL J MED, V352, P1633, DOI 10.1056/NEJMp048361; Orr MS, 2007, CLIN PHARMACOL THER, V81, P294, DOI 10.1038/sj.clpt.6100053; Osland JS, 2003, J MANAGE INQUIRY, V12, P137, DOI 10.1177/1056492603012002005; Rai Saritha, 2005, N Y Times Web, pC4; REHNQUIST J, 2001, DHHS PUBLICATION; Rowland C, 2004, INT J HEALTH SERV, V34, P555, DOI 10.2190/N8AU-6AG6-30M9-FN6T; Schmidt CW, 2001, MODERN DRUG DISCOVER, V4, P25; Schulman KA, 2002, NEW ENGL J MED, V347, P1335, DOI 10.1056/NEJMsa020349; Seitz HK, 2001, ALCOHOL CLIN EXP RES, V25, p137S, DOI 10.1097/00000374-200105051-00024; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Shuchman M, 2007, NEW ENGL J MED, V357, P1365, DOI 10.1056/NEJMp078176; Srinivasan S, 2006, LANCET, V367, P1962, DOI 10.1016/S0140-6736(06)68861-2; Stough WG, 2007, AM HEART J, V154, P232, DOI 10.1016/j.ahj.2007.04.028; The World Bank, COUNTR CLASS SHORT H; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Truelove C, 2007, MED AD NEWS, V26, P4; US Dept of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), ICH HARM TRIP GUID G; *WHO, 2006, WORK TOG HLTH WORLD, P66; World Medical Association, DECL HELS ETH PRINC; Yusuf S, 2004, CAN MED ASSOC J, V171, P889, DOI 10.1503/cmaj.1040884; Yusur S, 2008, CLIN TRIALS, V5, P38, DOI 10.1177/1740774507088099; Zhang DL, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-22; 2000, INDIAN J MED ETHICS, V8, P108	58	465	477	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					816	823		10.1056/NEJMsb0803929	http://dx.doi.org/10.1056/NEJMsb0803929			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228627				2022-12-28	WOS:000263411300015
J	Silvester, JA; Rashid, M				Silvester, Jocelyn Anne; Rashid, Mohsin			A Patient's Journey Coeliac disease and a gluten-free diet	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rashid, Mohsin] Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada	Dalhousie University	Rashid, M (corresponding author), Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada.	mohsin.rashid@iwk.nshealth.ca	Silvester, Jocelyn/T-2680-2019	Silvester, Jocelyn/0000-0002-3615-1666				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	4	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b380	10.1136/bmj.b380	http://dx.doi.org/10.1136/bmj.b380			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228765				2022-12-28	WOS:000264052200003
J	Morris, K				Morris, Kelly			Profile Denis Mukwege: caring for victims of sexual violence in the DRC	LANCET			English	Biographical-Item												vital@dircon.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					713	713		10.1016/S0140-6736(09)60425-6	http://dx.doi.org/10.1016/S0140-6736(09)60425-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249620				2022-12-28	WOS:000263725400015
J	Persson, A; Gross, E; Laurent, P; Busch, KE; Bretes, H; de Bono, M				Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario			Natural variation in a neural globin tunes oxygen sensing in wild Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; C-ELEGANS; HUMAN NEUROGLOBIN; BODY-FLUID; EXPRESSION; BEHAVIOR; NEURONS; FAMILY; AGGREGATION; ENVIRONMENT	Behaviours evolve by iterations of natural selection, but we have few insights into the molecular and neural mechanisms involved. Here we show that some Caenorhabditis elegans wild strains switch between two foraging behaviours in response to subtle changes in ambient oxygen. This finely tuned switch is conferred by a naturally variable hexacoordinated globin, GLB-5. GLB-5 acts with the atypical soluble guanylate cyclases(1-3), which are a different type of oxygen binding protein, to tune the dynamic range of oxygen-sensing neurons close to atmospheric (21%) concentrations. Calcium imaging indicates that one group of these neurons is activated when oxygen rises towards 21%, and is inhibited as oxygen drops below 21%. The soluble guanylate cyclase GCY-35 is required for high oxygen to activate the neurons; GLB-5 provides inhibitory input when oxygen decreases below 21%. Together, these oxygen binding proteins tune neuronal and behavioural responses to a narrow oxygen concentration range close to atmospheric levels. The effect of the glb-5 gene on oxygen sensing and foraging is modified by the naturally variable neuropeptide receptor npr-1 (refs 4, 5), providing insights into how polygenic variation reshapes neural circuit function.	[Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Persson, Annelie] Univ Gothenburg, Dept Cell & Mol Biol, S-40530 Gothenburg, Sweden	MRC Laboratory Molecular Biology; University of Gothenburg	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	debono@mrc-lmb.cam.ac.uk	Gross, Einav/AAS-7417-2021; laurent, patrick/ABD-9373-2021	laurent, patrick/0000-0001-5360-5597; Busch, Karl Emanuel/0000-0001-7886-3226; de Bono, Mario/0000-0001-8347-0443	Medical Research Council; EU Marie Curie Actions; European Molecular Biology Organization; Fondation Wiener-Anspach; MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Marie Curie Actions(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fondation Wiener-Anspach; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center, A. Chisholm, M.-A. Felix and E. Dolgin for C. elegans strains, A. Couto, B. Olofsson, I. Rabinovitch and K. Weber for comments on the manuscript, and I. Johnston and C. Tan for microfluidic devices. This work was supported by the Medical Research Council, a Human Frontier Science Program (HFSP) long-term fellowship (E. G.) and program grant (M. d. B.), the EU Marie Curie Actions (K. E. B.), the European Molecular Biology Organization (K. E. B. and P. L.) and the Fondation Wiener-Anspach (P. L.).	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Antonini E, 1971, FRONTIERS BIOL; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUMGARTL H, 1994, ACTA OECOL, V15, P781; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hodgkin J, 1997, GENETICS, V146, P149; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kerr Rex A., 2006, V351, P253; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Korol A, 2006, P NATL ACAD SCI USA, V103, P18184, DOI 10.1073/pnas.0608777103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; OKKEMA PG, 1993, GENETICS, V135, P385; Ota M, 1997, FEBS LETT, V415, P129, DOI 10.1016/S0014-5793(97)01110-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sambrook J., 1989, MOL CLONING LAB MANU; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	33	102	107	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1030	U106		10.1038/nature07820	http://dx.doi.org/10.1038/nature07820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262507				2022-12-28	WOS:000265412900043
J	Kaji, K; Norrby, K; Paca, A; Mileikovsky, M; Mohseni, P; Woltjen, K				Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka; Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut			Virus-free induction of pluripotency and subsequent excision of reprogramming factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; C-MYC; MOUSE; GENERATION; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; BLOCKS	Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS) cells, promises to transform regenerative medicine. Most instances of direct reprogramming have been achieved by forced expression of defined factors using multiple viral vectors(1-7). However, such iPS cells contain a large number of viral vector integrations(1,8), any one of which could cause unpredictable genetic dysfunction. Whereas c-Myc is dispensable for reprogramming(9,10), complete elimination of the other exogenous factors is also desired because ectopic expression of either Oct4 (also known as Pou5f1) or Klf4 can induce dysplasia(11,12). Two transient transfection-reprogramming methods have been published to address this issue(13,14). However, the efficiency of both approaches is extremely low, and neither has been applied successfully to human cells so far. Here we show that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS cells produced with this nonviral vector show robust expression of pluripotency markers, indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and formation of adult chimaeric mice. When the single-vector reprogramming system was combined with a piggyBac transposon(15,16), we succeeded in establishing reprogrammed human cell lines from embryonic fibroblasts with robust expression of pluripotency markers. This system minimizes genome modification in iPS cells and enables complete elimination of exogenous reprogramming factors, efficiently providing iPS cells that are applicable to regenerative medicine, drug screening and the establishment of disease models.	[Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland; [Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mohseni, Paria] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Edinburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Kaji, K (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Wilson, Matthew H/K-3193-2013	Woltjen, Knut/0000-0003-2293-1183; Kaji, Keisuke/0000-0001-5946-8415	MRC; BBSRC; Canadian Stem Cell Network; Juvenile Diabetes Research Foundation; Medical Research Council [G0700672, G0700711B] Funding Source: researchfish; MRC [G0700672] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Stem Cell Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Tsakiridis for advice on using the 2A peptide sequence and A. Nagy for providing data from his laboratory on generating human reprogrammed cell lines by combining the PB transposon system and the 2A-sequence-joined reprogramming factors (or MKOS single vector reprogramming system) as well as for his comments on the manuscript. We also thank I. Chambers for providing TNG MEFs and for discussion and comments on the manuscript, V. Wilson for advice on teratoma analysis, T. Kunath, S. Lowell, C. Blackburn and K. Vintersten for discussions and comments on the manuscript, and B. Hendrich for permission to start preliminary experiments of this work in his laboratory. We also thank J. Ure, L. Robertson, R. McLay and R. Wilkie for technical assistance, and Biomed unit staff for mouse husbandry. K. K. is the recipient of MRC career development fellowship in stem cell research. A. P. is the recipient of a BBSRC CASE PhD studentship. M. M., P. M. and K. W. were supported by grants from the Canadian Stem Cell Network and Juvenile Diabetes Research Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brueckner B, 2007, CANCER J, V13, P17, DOI 10.1097/PPO.0b013e31803c7245; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; SOMMER CA, 2008, STEM CELLS, DOI DOI 10.1634/STEMCELLS.2008; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	919	1102	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					771	U112		10.1038/nature07864	http://dx.doi.org/10.1038/nature07864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252477	Green Accepted			2022-12-28	WOS:000265193600043
J	Brierley, CM; Fedorov, AV; Liu, ZH; Herbert, TD; Lawrence, KT; LaRiviere, JP				Brierley, Chris M.; Fedorov, Alexey V.; Liu, Zhonghui; Herbert, Timothy D.; Lawrence, Kira T.; LaRiviere, Jonathan P.			Greatly Expanded Tropical Warm Pool and Weakened Hadley Circulation in the Early Pliocene	SCIENCE			English	Article							PERMANENT EL-NINO; MIDDLE PLIOCENE; CLIMATE; RECONSTRUCTION; SEA; GLACIATION; PANAMA	The Pliocene warm interval has been difficult to explain. We reconstructed the latitudinal distribution of sea surface temperature around 4 million years ago, during the early Pliocene. Our reconstruction shows that the meridional temperature gradient between the equator and subtropics was greatly reduced, implying a vast poleward expansion of the ocean tropical warm pool. Corroborating evidence indicates that the Pacific temperature contrast between the equator and 32 degrees N has evolved from similar to 2 degrees C 4 million years ago to similar to 8 degrees C today. The meridional warm pool expansion evidently had enormous impacts on the Pliocene climate, including a slowdown of the atmospheric Hadley circulation and El Nino-like conditions in the equatorial region. Ultimately, sustaining a climate state with weak tropical sea surface temperature gradients may require additional mechanisms of ocean heat uptake (such as enhanced ocean vertical mixing).	[Brierley, Chris M.; Fedorov, Alexey V.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Herbert, Timothy D.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Lawrence, Kira T.] Lafayette Coll, Easton, PA 18042 USA; [LaRiviere, Jonathan P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Yale University; University of Hong Kong; Brown University; Lafayette College; University of California System; University of California Santa Cruz	Fedorov, AV (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	alexey.fedorov@yale.edu	Liu, Zhonghui/D-3163-2009; fedorov, alexey/F-1879-2010; Brierley, Chris M/A-8417-2009	Liu, Zhonghui/0000-0002-2168-8305; Brierley, Chris M/0000-0002-9195-6731	NSF [OCE-0550439, OCE-0623487]; U.S. Department of Energy Office of Science [DE-FG02-06ER64238, DE-FG02-08ER64590]; David and Lucile Packard Foundation fellowship; Flint Fellowship at Yale University	NSF(National Science Foundation (NSF)); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); David and Lucile Packard Foundation fellowship(The David & Lucile Packard Foundation); Flint Fellowship at Yale University	A.V.F. thanks G. Philander, M. Barreiro, R. Pacanowski, Y. Rosenthal, C. Ravelo, P. deMenocal, P. Dekens, A. Haywood, and C. Wunsch for numerous discussions of this topic. Supported by NSF grant OCE-0550439, U.S. Department of Energy Office of Science grants DE-FG02-06ER64238 and DE-FG02-08ER64590, and a David and Lucile Packard Foundation fellowship (A.V.F.), NSF grant OCE-0623487 (T.D.H.), and a Flint Fellowship at Yale University (Z.L.).	Barreiro M, 2006, CLIM DYNAM, V26, P349, DOI 10.1007/s00382-005-0086-4; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Clement AC, 2005, J CLIMATE, V18, P5294, DOI 10.1175/JCLI3582.1; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Dowsett H, 1996, MAR MICROPALEONTOL, V27, P13, DOI 10.1016/0377-8398(95)00050-X; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Groeneveld J, 2006, P ODP SCI RESULTS, V202, DOI [DOI 10.2973/ODP.PROC.SR.202.209.2006, 10.2973/odp.proc.sr.202.209.2006]; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Haywood AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001323; Haywood AM, 2000, GLOBAL PLANET CHANGE, V25, P239, DOI 10.1016/S0921-8181(00)00028-X; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Herbert T.D., 1998, P OCEAN DRILLING PRO, V159T, P17, DOI [10.2973/odp.proc.sr.159T.063.1998, DOI 10.2973/ODP.PROC.SR.159T.063.1998]; Marlow JR, 2000, SCIENCE, V290, P2288; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Philander S. C, 1990, NINO NINO SO OSCILLA; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Salzmann U, 2008, GLOBAL ECOL BIOGEOGR, V17, P432, DOI 10.1111/j.1466-8238.2008.00381.x; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Sriver RL, 2007, NATURE, V447, P577, DOI 10.1038/nature05785; Tian J, 2006, EARTH PLANET SC LETT, V252, P72, DOI 10.1016/j.epsl.2006.09.028; Velichko A., 2002, PHYS GEOGRAPHY NO EU, P36; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	27	210	214	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1714	1718		10.1126/science.1167625	http://dx.doi.org/10.1126/science.1167625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19251592	Green Published			2022-12-28	WOS:000264559800036
J	Hai, PN; Ohya, S; Tanaka, M; Barnes, SE; Maekawa, S				Hai, Pham Nam; Ohya, Shinobu; Tanaka, Masaaki; Barnes, Stewart E.; Maekawa, Sadamichi			Electromotive force and huge magnetoresistance in magnetic tunnel junctions	NATURE			English	Article							ROOM-TEMPERATURE; FILMS; GAAS; MNAS	The electromotive force (e.m.f.) predicted by Faraday's law reflects the forces acting on the charge, -e, of an electron moving through a device or circuit, and is proportional to the time derivative of the magnetic field. This conventional e.m.f. is usually absent for stationary circuits and static magnetic fields. There are also forces that act on the spin of an electron; it has been recently predicted(1,2) that, for circuits that are in part composed of ferromagnetic materials, there arises an e.m.f. of spin origin even for a static magnetic field. This e.m.f. can be attributed to a time-varying magnetization of the host material, such as the motion of magnetic domains in a static magnetic field, and reflects the conversion of magnetic to electrical energy. Here we show that such an e.m.f. can indeed be induced by a static magnetic field in magnetic tunnel junctions containing zinc-blende-structured MnAs quantum nanomagnets. The observed e.m.f. operates on a timescale of approximately 10(2)-10(3) seconds and results from the conversion of the magnetic energy of the superparamagnetic MnAs nanomagnets into electrical energy when these magnets undergo magnetic quantum tunnelling. As a consequence, a huge magnetoresistance of up to 100,000 per cent is observed for certain bias voltages. Our results strongly support the contention that, in magnetic nanostructures, Faraday's law of induction must be generalized to account for forces of purely spin origin. The huge magnetoresistance and e.m.f. may find potential applications in high sensitivity magnetic sensors, as well as in new active devices such as 'spin batteries'.	[Hai, Pham Nam; Ohya, Shinobu; Tanaka, Masaaki] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Ohya, Shinobu; Tanaka, Masaaki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Barnes, Stewart E.] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Barnes, Stewart E.] Univ Cambridge, Cavendish Lab, TCM, Cambridge CB3 0HE, England; [Maekawa, Sadamichi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Maekawa, Sadamichi] Japan Sci & Technol Agcy, CREST, Tokyo 1000075, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Miami; University of Cambridge; Tohoku University; Japan Science & Technology Agency (JST)	Tanaka, M (corresponding author), Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	masaaki@ee.t.u-tokyo.ac.jp	Maekawa, Sadamichi/J-6194-2018; PHAM, NAM HAI/AAA-7040-2021; Tanaka, Masaaki/AAT-8301-2021	Maekawa, Sadamichi/0000-0002-4237-7741; PHAM, NAM HAI/0000-0001-6685-4912; Tanaka, Masaaki/0000-0003-3599-663X; Ohya, Shinobu/0000-0003-1417-9403	MEXT, PRESTO of JST, and EPSRC (UK) [18106007, 19048018, 20686002]; JSPS Research Fellowship	MEXT, PRESTO of JST, and EPSRC (UK)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aids for Scientific Research No. 18106007, No. 19048018 and No. 20686002, the Special Coordination Programs for Promoting Science and Technology, and R&D for Next-Generation Information Technology by MEXT, PRESTO of JST, and EPSRC (UK). We thank B.-H. Yu for his help in the transport measurements. P.N.H. acknowledges a JSPS Research Fellowship for Young Scientists and the Global COE Program (CO4).	BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; BARBARA B, 1995, J MAGN MAGN MATER, V140, P1825, DOI 10.1016/0304-8853(94)00585-0; Barnes SE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354036; Barnes SE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.246601; Barnes SE, 2007, J MAGN MAGN MATER, V310, P2035, DOI 10.1016/j.jmmm.2006.10.944; BARNES SE, 2004, CURRENTS INDUCED DOM; BINASCH G, 1989, PHYS REV B, V39, P4828, DOI 10.1103/PhysRevB.39.4828; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; Kwiatkowski A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2739215; MIYAZAKI T, 1995, J MAGN MAGN MATER, V139, pL231, DOI 10.1016/0304-8853(94)01648-8; MOODERA JS, 1995, PHYS REV LETT, V74, P3276; Moreno M, 2002, J APPL PHYS, V92, P4672, DOI 10.1063/1.1506402; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Sanvito S, 2000, PHYS REV B, V62, P15553, DOI 10.1103/PhysRevB.62.15553; Sato K, 2005, JPN J APPL PHYS 2, V44, pL948, DOI 10.1143/JJAP.44.L948; Tanaka M, 2002, SEMICOND SCI TECH, V17, P327, DOI 10.1088/0268-1242/17/4/306; TANAKA M, 1994, APPL PHYS LETT, V65, P1964, DOI 10.1063/1.112831; Tokura Y., 2000, ADV CONDENSED MATTER, V2; Yokoyama M, 2005, J APPL PHYS, V97, DOI 10.1063/1.1852214; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257	21	139	147	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					489	U2		10.1038/nature07879	http://dx.doi.org/10.1038/nature07879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19270681				2022-12-28	WOS:000264532400040
J	Bohman, T				Bohman, Tom			Emergence of Connectivity in Networks	SCIENCE			English	Editorial Material									Carnegie Mellon Univ, Dept Math Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Bohman, T (corresponding author), Carnegie Mellon Univ, Dept Math Sci, Pittsburgh, PA 15213 USA.	tbohman@math.cmu.edu	Bohman, Tom/B-6807-2017; Bohman, Tom/B-6807-2017	Bohman, Tom/0000-0001-5578-4664; Bohman, Tom/0000-0002-4051-2401				Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Alon N., 2008, PROBABILISTIC METHOD, V3rd; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 2001, RANDOM GRAPHS; Bollobas B, 2007, RANDOM STRUCT ALGOR, V31, P3, DOI 10.1002/rsa.20168; Borgs C, 2005, RANDOM STRUCT ALGOR, V27, P137, DOI 10.1002/rsa.20051; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; DYER M, 1991, J ACM, V38, P1, DOI 10.1145/102782.102783; ERDOS P, 1960, B INT STATIST INST, V38, P343; JANSON S, 2000, WIL INT S D, pR5; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mitzenmacher M., 2017, PROBABILITY COMPUTIN; Motwani R., 1995, RANDOMIZED ALGORITHM; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	15	18	18	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1438	1439		10.1126/science.1171297	http://dx.doi.org/10.1126/science.1171297			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286543				2022-12-28	WOS:000264101700027
J	Wang, KC; Dickinson, RE; Liang, SL				Wang, Kaicun; Dickinson, Robert E.; Liang, Shunlin			Clear Sky Visibility Has Decreased over Land Globally from 1973 to 2007	SCIENCE			English	Article							SOLAR-RADIATION; AEROSOL EMISSIONS; TRENDS; INVENTORY; ASIA	Visibility in the clear sky is reduced by the presence of aerosols, whose types and concentrations have a large impact on the amount of solar radiation that reaches Earth's surface. Here we establish a global climatology of inverse visibilities over land from 1973 to 2007 and interpret it in terms of changes in aerosol optical depth and the consequent impacts on incident solar radiation. The aerosol contribution to "global dimming,"first reported in terms of strong decreases in measured incident solar radiation up to the mid-1980s, has monotonically increased over the period analyzed. Since that time, visibility has increased over Europe, consistent with reported European "brightening,"but has decreased substantially over south and east Asia, South America, Australia, and Africa, resulting in net global dimming over land.	[Wang, Kaicun; Liang, Shunlin] Univ Maryland, Dept Geog, College Pk, MD 20742 USA; [Dickinson, Robert E.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Austin	Wang, KC (corresponding author), Univ Maryland, Dept Geog, College Pk, MD 20742 USA.	kcwang@umd.edu	liang, shunlin/C-2809-2015; Wang, Kaicun/F-7813-2012	Wang, Kaicun/0000-0002-7414-5400				Bellouin N, 2005, NATURE, V438, P1138, DOI 10.1038/nature04348; Biggs TW, 2007, INT J CLIMATOL, V27, P1505, DOI 10.1002/joc.1487; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Ito A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002374; Mishchenko MI, 2007, OPT EXPRESS, V15, P7423, DOI 10.1364/OE.15.007423; Mishchenko MI, 2007, SCIENCE, V315, P1543, DOI 10.1126/science.1136709; Norris JR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007794; Novakov T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016345; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Power HC, 2003, THEOR APPL CLIMATOL, V76, P47, DOI 10.1007/s00704-003-0005-8; Qian Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024586; Ruckstuhl C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034228; Stern DI, 2006, GLOBAL ENVIRON CHANG, V16, P207, DOI 10.1016/j.gloenvcha.2006.01.001; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; Venkataraman C, 2005, SCIENCE, V307, P1454, DOI 10.1126/science.1104359; Vestreng V., 2004, INVENTORY REV 2004 E; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Zhao TXP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009061	20	250	281	9	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1468	1470		10.1126/science.1167549	http://dx.doi.org/10.1126/science.1167549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286553				2022-12-28	WOS:000264101700038
J	Shaheen, NJ; Richter, JE				Shaheen, Nicholas J.; Richter, Joel E.			Barrett's oesophagus	LANCET			English	Review							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; SPECIALIZED INTESTINAL METAPLASIA; ENDOSCOPIC MUCOSAL RESECTION; BAND IMAGING ENDOSCOPY; BODY-MASS INDEX; TERM-FOLLOW-UP; PHOTODYNAMIC THERAPY; CAPSULE ENDOSCOPY; HELICOBACTER-PYLORI	Barrett's oesophagus is a metaplastic change of the lining of the oesophagus, such that the normal squamous epithelium is replaced by specialised or intestinalised columnar epithelium. The disorder seems to be a complication of chronic gastro-oesophageal reflux disease, although asymptomatic individuals might also be affected, and it is a risk factor for the development of oesophageal adenocarcinoma, a cancer with rapidly increasing incidence in developed societies. We review the presentation, epidemiology, and risk factors for this condition. We discuss the molecular changes necessary for the development of Barrett's oesophagus and its progression to cancer, and new strides in both the endoscopic detection of the lesion and the treatment of dysplastic disease. Also, we assess the effectiveness of efforts to screen patients at risk of Barrett's oesophagus, and whether such efforts avert cancer death. We conclude with a discussion of future directions for research, focusing on treatment of early neoplasia, and modifications of current practices to show our evolving understanding of this condition.	[Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Ctr Esophageal Dis & Swallowing, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA; [Richter, Joel E.] Temple Univ, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19122 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Shaheen, NJ (corresponding author), CB 7080,UNC CH, Chapel Hill, NC 27599 USA.	nshaheen@med.unc.edu	Shaheen, Nicholas J/A-1898-2013					Ackroyd R, 2004, GASTROINTEST ENDOSC, V59, P1, DOI 10.1016/S0016-5107(03)02528-8; Ackroyd R, 2003, ENDOSCOPY, V35, P496; Attwood SEA, 2003, CLIN GASTROENTEROL H, V1, P258, DOI 10.1016/S1542-3565(03)00128-9; Avidan B, 2002, DIGEST DIS SCI, V47, P256, DOI 10.1023/A:1013797417170; Avidan B, 2001, GASTROENTEROLOGY, V121, P1281, DOI 10.1053/gast.2001.29587; BERENSON MM, 1993, GASTROENTEROLOGY, V104, P1686, DOI 10.1016/0016-5085(93)90646-T; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BREMNER CG, 1970, SURGERY, V68, P209; Buttar NS, 2001, GASTROENTEROLOGY, V120, P1630, DOI 10.1053/gast.2001.25111; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Buttar NS, 2001, GASTROINTEST ENDOSC, V54, P682, DOI 10.1067/mge.2001.119875; Cameron AJ, 1999, AM J GASTROENTEROL, V94, P2054; CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P918, DOI 10.1016/0016-5085(90)90607-3; Canto MIF, 2000, GASTROINTEST ENDOSC, V51, P560, DOI 10.1016/S0016-5107(00)70290-2; Chak A, 2002, GUT, V51, P323, DOI 10.1136/gut.51.3.323; Chen XX, 2002, CARCINOGENESIS, V23, P2095, DOI 10.1093/carcin/23.12.2095; Conio M, 2002, INT J CANCER, V97, P225, DOI 10.1002/ijc.1583; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; Curvers W, 2008, GASTROENTEROLOGY, V134, P670, DOI 10.1053/j.gastro.2008.01.003; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; Eisen GM, 1997, AM J GASTROENTEROL, V92, P27; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Ell C, 2000, GASTROENTEROLOGY, V118, P670, DOI 10.1016/S0016-5085(00)70136-3; Eloubeidi MA, 1999, AM J GASTROENTEROL, V94, P937; Eloubeidi MA, 2001, J CLIN GASTROENTEROL, V33, P306, DOI 10.1097/00004836-200110000-00010; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; Falk GW, 1997, GASTROENTEROLOGY, V112, P1787, DOI 10.1053/gast.1997.v112.pm9178668; Falk GW, 2000, GASTROINTEST ENDOSC, V52, P197, DOI 10.1067/mge.2000.107728; Fass R, 2001, GUT, V48, P310, DOI 10.1136/gut.48.3.310; Fleischer DE, 2008, GASTROINTEST ENDOSC, V68, P867, DOI 10.1016/j.gie.2008.03.008; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Galmiche JP, 2008, AM J GASTROENTEROL, V103, P538, DOI 10.1111/j.1572-0241.2007.01731.x; Ganz RA, 2008, GASTROINTEST ENDOSC, V68, P35, DOI 10.1016/j.gie.2007.12.015; Gerson L, 2007, CLIN GASTROENTEROL H, V5, P319, DOI 10.1016/j.cgh.2006.12.022; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Gough MD, 2005, AM J GASTROENTEROL, V100, P1012, DOI 10.1111/j.1572-0241.2005.40904.x; GRAY MR, 1993, GUT, V34, P727, DOI 10.1136/gut.34.6.727; Guelrud M, 2001, GASTROINTEST ENDOSC, V53, P559, DOI 10.1067/mge.2001.114059; Hamamoto Y, 2004, J GASTROENTEROL, V39, P14, DOI 10.1007/s00535-003-1239-z; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hanna S, 2006, AM J GASTROENTEROL, V101, P1416, DOI 10.1111/j.1572-0241.2006.00631.x; Harrison R, 2007, AM J GASTROENTEROL, V102, P1154, DOI 10.1111/j.1572-0241.2007.01230.x; Heath EI, 2007, J NATL CANCER I, V99, P545, DOI 10.1093/jnci/djk112; Heitmiller RF, 1996, ANN SURG, V224, P66, DOI 10.1097/00000658-199607000-00010; Hillman LC, 2004, MED J AUSTRALIA, V180, P387, DOI 10.5694/j.1326-5377.2004.tb05991.x; Hirota WK, 2006, GASTROINTEST ENDOSC, V63, P570, DOI 10.1016/j.gie.2006.02.004; IASCONE C, 1983, ARCH SURG-CHICAGO, V118, P543; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; Isenberg G, 2005, GASTROINTEST ENDOSC, V62, P825, DOI 10.1016/j.gie.2005.07.048; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Jankowski J, 2006, BRIT MED J, V332, P1512, DOI 10.1136/bmj.332.7556.1512; Jobe BA, 2006, AM J GASTROENTEROL, V101, P2693, DOI 10.1111/j.1572-0241.2006.00890.x; Johnston MH, 2005, GASTROINTEST ENDOSC, V62, P842, DOI 10.1016/j.gie.2005.05.008; Jovov B, 2007, AM J PHYSIOL-GASTR L, V293, pG1106, DOI 10.1152/ajpgi.00158.2007; Kala Z, 2007, J HUM GENET, V52, P527, DOI 10.1007/s10038-007-0148-z; Kara MA, 2005, GASTROINTEST ENDOSC, V61, P679, DOI 10.1016/S0016-5107(04)02577-5; Kara MA, 2006, GASTROINTEST ENDOSC, V64, P155, DOI 10.1016/j.gie.2005.11.049; Keswani RN, 2006, CANCER EPIDEM BIOMAR, V15, P1243, DOI 10.1158/1055-9965.EPI-06-0010; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; KIM SL, 1994, GASTROENTEROLOGY, V107, P945, DOI 10.1016/0016-5085(94)90217-8; Konda VJA, 2008, CLIN GASTROENTEROL H, V6, P159, DOI 10.1016/j.cgh.2007.09.013; Labenz J, 1997, GUT, V41, P277, DOI 10.1136/gut.41.3.277; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lao-Sirieix P, 2007, CLIN CANCER RES, V13, P659, DOI 10.1158/1078-0432.CCR-06-1385; Lim CH, 2006, GASTROINTEST ENDOSC, V64, P195, DOI 10.1016/j.gie.2005.07.025; Lin M, 2004, AM J GASTROENTEROL, V99, P1442, DOI 10.1111/j.1572-0241.2004.04147.x; Lin OS, 2007, GASTROINTEST ENDOSC, V65, P577, DOI 10.1016/j.gie.2006.06.035; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Locke GR, 2003, GASTROINTEST ENDOSC, V58, P661, DOI 10.1016/S0016-5107(03)02011-X; Maaroos HI, 1999, SCAND J GASTROENTERO, V34, P864, DOI 10.1080/003655299750025318; May A, 2002, ENDOSCOPY, V34, P604, DOI 10.1055/s-2002-33236; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Morales TG, 2000, AM J GASTROENTEROL, V95, P1677; Norberto L, 2004, WORLD J SURG, V28, P350, DOI 10.1007/s00268-003-7332-x; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Oberg S, 1999, J THORAC CARDIOV SUR, V117, P572, DOI 10.1016/S0022-5223(99)70337-5; Ormsby AH, 2002, GUT, V51, P671, DOI 10.1136/gut.51.5.671; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Overholt BF, 2003, GASTROINTEST ENDOSC, V58, P183, DOI 10.1067/mge.2003.327; Parrilla P, 2003, ANN SURG, V237, P291, DOI 10.1097/00000658-200303000-00001; PAULL A, 1976, NEW ENGL J MED, V295, P476, DOI 10.1056/NEJM197608262950904; Pera M, 2007, J GASTROINTEST SURG, V11, P869, DOI 10.1007/s11605-007-0162-7; Peyre CG, 2007, ANN SURG, V246, P665, DOI 10.1097/SLA.0b013e318155a7a1; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Playford RJ, 2006, GUT, V55, P442, DOI 10.1136/gut.2005.083600; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Poneros JM, 2001, GASTROENTEROLOGY, V120, P7, DOI 10.1053/gast.2001.20911; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Ragunath K, 2003, ENDOSCOPY, V35, P998, DOI 10.1055/s-2003-44599; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; RITENBAUGH C, 1995, EUR J CANCER PREV, V4, P459, DOI 10.1097/00008469-199512000-00004; Romero Y, 2002, AM J GASTROENTEROL, V97, P1127; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rubenstein JH, 2007, CLIN GASTROENTEROL H, V5, P312, DOI 10.1016/j.cgh.2006.12.008; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; SAMPLINER RE, 1993, DIGEST DIS SCI, V38, P365, DOI 10.1007/BF01307557; Sampliner RE, 1996, GASTROINTEST ENDOSC, V44, P532, DOI 10.1016/S0016-5107(96)70004-4; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Scheil-Bertram S, 2008, MODERN PATHOL, V21, P961, DOI 10.1038/modpathol.2008.73; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2005, GASTROENTEROLOGY, V129, P429, DOI 10.1053/j.gastro.2005.05.055; Shaheen NJ, 2005, AM J GASTROENTEROL, V100, P577, DOI 10.1111/j.1572-0241.2005.41422.x; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Shaheen NJ, 2002, AM J GASTROENTEROL, V97, P1319, DOI 10.1016/S0002-9270(02)04123-0; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Sharma P, 2006, GASTROINTEST ENDOSC, V64, P167, DOI 10.1016/j.gie.2005.10.044; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Sharma VK, 2007, GASTROINTEST ENDOSC, V65, P185, DOI 10.1016/j.gie.2006.09.033; Siahpush SH, 2007, CANCER EPIDEM BIOMAR, V16, P2387, DOI 10.1158/1055-9965.EPI-06-0986; Soni A, 2000, AM J GASTROENTEROL, V95, P2086; Spechler S J, 1997, Semin Gastrointest Dis, V8, P59; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; STEIN HJ, 1993, J THORAC CARDIOV SUR, V105, P107, DOI 10.1016/S0022-5223(19)33854-1; STENELARSEN G, 1988, SCAND J GASTROENTERO, V23, P427, DOI 10.3109/00365528809093890; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; Vaezi MF, 1996, GASTROENTEROLOGY, V111, P1192, DOI 10.1053/gast.1996.v111.pm8898632; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Voutilainen M, 2000, DIGESTION, V61, P6, DOI 10.1159/000007730; Wallner B, 2001, SURG ENDOSC, V15, P886, DOI 10.1007/s004640090025; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Ward EM, 2006, AM J GASTROENTEROL, V101, P12, DOI 10.1111/j.1572-0241.2006.00379.x; Westhoff B, 2005, GASTROINTEST ENDOSC, V61, P226, DOI 10.1016/S0016-5107(04)02589-1; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Williams VA, 2007, J GASTROINTEST SURG, V11, P1589, DOI 10.1007/s11605-007-0330-9; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Zaninotto G, 2000, BRIT J SURG, V87, P1102, DOI 10.1046/j.1365-2168.2000.01470.x	137	242	248	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					850	861		10.1016/S0140-6736(09)60487-6	http://dx.doi.org/10.1016/S0140-6736(09)60487-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269522				2022-12-28	WOS:000263980900036
J	Ju, SY; Kopcha, WP; Papadimitrakopoulos, F				Ju, Sang-Yong; Kopcha, William P.; Papadimitrakopoulos, Fotios			Brightly Fluorescent Single-Walled Carbon Nanotubes via an Oxygen-Excluding Surfactant Organization	SCIENCE			English	Article							OPTICAL SENSORS; SPECTROSCOPY; SUSPENSIONS; DISPERSION; EXCITONS; SPECTRA	Attaining high photoluminescence quantum yields for single-walled carbon nanotubes (SWNTs) in order to broaden their optoelectronics and sensing applications has been a challenging task. Among various nonradiative pathways, sidewall chemisorption of oxygen provides a known defect for exciton quenching through nanotube hole doping. We found that an aliphatic ( dodecyl) analog of flavin mononucleotide, FC12, leads to high dispersion of SWNTs, which tend to aggregate into bundles. Unlike other surfactants, the surface organization of FC12 is sufficiently tight to exclude oxygen from the SWNT surface, which led to quantum yields as high as 20%. Toluene-dispersed, FC12-wrapped nanotubes exhibited an absorption spectrum with ultrasharp peaks (widths of 12 to 25 milli-electron volts) devoid of the characteristic background absorption of most nanotube dispersions.	[Ju, Sang-Yong; Papadimitrakopoulos, Fotios] Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA; [Kopcha, William P.; Papadimitrakopoulos, Fotios] Univ Connecticut, Inst Mat Sci, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Papadimitrakopoulos, F (corresponding author), Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA.	papadim@mail.ims.uconn.edu	Ju, Sang-Yong/GQG-8696-2022; Ju, Sang-Yong/A-5257-2009	Ju, Sang-Yong/0000-0002-6939-5296; Kopcha, William/0000-0001-8811-1669	Air Force Office of Scientific Research [FA9550-06-1-0030]; NSF [NIRT DMI-0422724, CBET-0828771/0828824]; NIH [ES013557]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013557] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vaddiraju, J. Doll, D. Abanulo, A. Nish, and R. J. Nicholas for useful discussions. Supported mainly by Air Force Office of Scientific Research grant FA9550-06-1-0030, and in part by NSF grants NIRT DMI-0422724 and CBET-0828771/0828824 and NIH grant ES013557.	Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Badaire S, 2004, LANGMUIR, V20, P10367, DOI 10.1021/la049096r; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Crochet J, 2007, J AM CHEM SOC, V129, P8058, DOI 10.1021/ja071553d; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Fantini C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147406; Hagen A, 2003, NANO LETT, V3, P383, DOI 10.1021/nl020237o; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148; Kiowski O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075421; Krevelen D.W.V., 1990, PROPERTIES POLYM; Lin CS, 2007, J PHYS CHEM C, V111, P4069, DOI 10.1021/jp068846y; Luo ZT, 2006, J AM CHEM SOC, V128, P15511, DOI 10.1021/ja0657096; Miyamoto Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121413; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Oyama Y, 2006, CARBON, V44, P873, DOI 10.1016/j.carbon.2005.10.024; Perebeinos V, 2005, NANO LETT, V5, P2495, DOI 10.1021/nl051828s; Reich S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tan PH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137402; Tan YQ, 2005, J PHYS CHEM B, V109, P14454, DOI 10.1021/jp052217r; Tsyboulski DA, 2007, NANO LETT, V7, P3080, DOI 10.1021/nl071561s; Wang B, 2007, J AM CHEM SOC, V129, P9014, DOI 10.1021/ja070808k; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Zheng M, 2007, J AM CHEM SOC, V129, P6084, DOI 10.1021/ja071577k	30	192	192	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1319	1323		10.1126/science.1166265	http://dx.doi.org/10.1126/science.1166265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265015				2022-12-28	WOS:000263876700035
J	Schwamborn, JC; Berezikov, E; Knoblich, JA				Schwamborn, Jens C.; Berezikov, Eugene; Knoblich, Juergen A.			The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors	CELL			English	Article							ASYMMETRIC CELL-DIVISION; EMBRYONIC STEM-CELLS; DYSTROPHY TYPE 2H; UBIQUITIN LIGASE; LET-7 MICRORNA; NEURONAL DIFFERENTIATION; PLASMA-MEMBRANE; PAR-COMPLEX; IN-VIVO; DROSOPHILA	In the mouse neocortex, neural progenitor cells generate both differentiating neurons and daughter cells that maintain progenitor fate. Here, we show that the TRIM-NHL protein TRIM32 regulates protein degradation and microRNA activity to control the balance between those two daughter cell types. In both horizontally and vertically dividing progenitors, TRIM32 becomes polarized in mitosis and is concentrated in one of the two daughter cells. TRIM32 overexpression induces neuronal differentiation while inhibition of TRIM32 causes both daughter cells to retain progenitor cell fate. TRIM32 ubiquitinates and degrades the transcription factor c-Myc but also binds Argonaute-1 and thereby increases the activity of specific microRNAs. We show that Let-7 is one of the TRIM32 targets and is required and sufficient for neuronal differentiation. TRIM32 is the mouse ortholog of Drosophila Brat and Mei-P26 and might be part of a protein family that regulates the balance between differentiation and proliferation in stem cell lineages.	[Schwamborn, Jens C.; Knoblich, Juergen A.] IMBA, Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Berezikov, Eugene] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Knoblich, JA (corresponding author), IMBA, Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Schwamborn, Jens C/F-9395-2011; Berezikov, Eugene/D-3363-2013; Knoblich, Juergen A/C-2974-2015	Schwamborn, Jens C/0000-0003-4496-0559; Berezikov, Eugene/0000-0002-1145-2884; Knoblich, Juergen A/0000-0002-6751-3404	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors would like to thank Andrea Ballabio (Milan), Stephen Hann (Nashville), Dirk Bohmann (Rochester), Judy Lieberman (Boston), and Witold Filipowicz ( Basel) for plasmids; Gunter Meister Munich) for the anti- Ago1 antibody; Xiao- Bing Yuan (Shanghai) for teaching the in utero electroporation,; Jo r rg Betschinger for initiating production of the anti- TRIM32 antibody; Maria Novatchkova for sequence analysis; Katrin Heindl for help with the RNA end-labeling; and Angela M. Peer for excellent technical assistance. J. C. S. was supported by EMBO and HFSP. Work in J. A. K.' s lab is supported by the Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF), the Austrian Science Fund (FWF), the EU FP6 network ONCASYM, and the EU FP7 network EUROSYSTEM.	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Coskun Volkan, 2007, Sci STKE, V2007, ppe58, DOI 10.1126/stke.4102007pe58; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Fults D, 2002, NEOPLASIA, V4, P32, DOI 10.1038/sj.neo.7900200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li L, 2000, GENE DEV, V14, P147; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844	74	322	331	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					913	925		10.1016/j.cell.2008.12.024	http://dx.doi.org/10.1016/j.cell.2008.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269368	Green Accepted, Bronze			2022-12-28	WOS:000263930900014
J	van der Flier, LG; van Gijn, ME; Hatzis, P; Kujala, P; Haegebarth, A; Stange, DE; Begthel, H; van den Born, M; Guryev, V; Oving, I; van Es, JH; Barker, N; Peters, PJ; van de Wetering, M; Clevers, H				van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Kujala, Pekka; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; Peters, Peter J.; van de Wetering, Marc; Clevers, Hans			Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; COLORECTAL-CANCER CELLS; MOUSE SMALL INTESTINE; GENE-EXPRESSION; BETA-CATENIN; PANETH CELLS; ADULT-MOUSE; IN-VIVO; DIFFERENTIATION; EPITHELIUM	The small intestinal epithelium is the most rapidly self-renewing tissue of mammals. Proliferative cells are confined to crypts, while differentiated cell types predominantly occupy the villi. We recently demonstrated the existence of a long-lived pool of cycling stem cells defined by Lgr5 expression and intermingled with post-mitotic Paneth cells at crypt bottoms. We have now determined a gene signature for these Lgr5 stem cells. One of the genes within this stem cell signature is the Wnt target Achaete scute-like 2 (Ascl2). Transgenic expression of the Ascl2 transcription factor throughout the intestinal epithelium induces crypt hyperplasia and ectopic crypts on villi. Induced deletion of the Ascl2 gene in adult small intestine leads to disappearance of the Lgr5 stem cells within days. The combined results from these gain- and loss-of-function experiments imply that Ascl2 controls intestinal stem cell fate.	[van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Hubert Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubert Inst KNAW, Uppsalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	van+Es, Johan/ABD-5411-2021; Barker, Nick/AAE-9833-2021; Stange, Daniel E/O-1837-2015; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Stange, Daniel E/0000-0003-4246-2230; Oving, Irma/0000-0002-6149-2171; Guryev, Victor/0000-0002-5810-6022				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAIRNIE AB, 1975, CELL TISSUE KINET, V8, P189, DOI 10.1111/j.1365-2184.1975.tb01219.x; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6	49	506	518	2	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					903	912		10.1016/j.cell.2009.01.031	http://dx.doi.org/10.1016/j.cell.2009.01.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269367	Bronze			2022-12-28	WOS:000263930900013
J	Bartalena, L; Tanda, ML				Bartalena, Luigi; Tanda, Maria Laura			Graves' Ophthalmopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; METHYLPREDNISOLONE PULSE THERAPY; RANDOMIZED CONTROLLED-TRIAL; SINGLE-BLIND TRIAL; EUROPEAN GROUP; ORBITAL RADIOTHERAPY; RADIOIODINE THERAPY; CONSENSUS STATEMENT; ORBITOPATHY EUGOGO; CLINICAL-FEATURES	A 40-year-old woman who recently received a diagnosis of Graves' disease comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg daily, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms, including redness, tearing, grittiness, photophobia, diplopia at the extremes of gaze, and ocular pain with eye movements. She smokes 10 cigarettes per day. Examination reveals exophthalmos, swelling of periorbital tissues, and limitation of eye movements. How should Graves' ophthalmopathy be managed?	[Bartalena, Luigi] Univ Insubria, Dept Clin Med, Div Endocrinol, Osped Circolo, I-21100 Varese, Italy	Ospedale Circolo & Fondazione Macchi; University of Insubria	Bartalena, L (corresponding author), Univ Insubria, Dept Clin Med, Div Endocrinol, Osped Circolo, Viale Borri 57, I-21100 Varese, Italy.	luigi.bartalena@uninsubria.it	Tanda, Maria Laura/AAD-4071-2020		Ministry of Education, University and Research, Rome [PRIN 20074X8RKK]	Ministry of Education, University and Research, Rome(Ministry of Education, Universities and Research (MIUR))	Supported by a grant (PRIN 20074X8RKK, to Dr. Bartalena) from the Ministry of Education, University and Research, Rome.	Bahn RS, 2003, J CLIN ENDOCR METAB, V88, P1939, DOI 10.1210/jc.2002-030010; Bahn RS, 2002, THYROID, V12, P193, DOI 10.1089/105072502753600124; BaIdeschi L, 2006, OPHTHALMOLOGY, V113, P874, DOI 10.1016/j.ophiha.2005.10.060; BALDESCHI L, 2007, GRAVES ORBITOPATHY M, P160; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 1998, ANN INTERN MED, V129, P632, DOI 10.7326/0003-4819-129-8-199810150-00010; BARTALENA L, 1983, J CLIN ENDOCR METAB, V56, P1139, DOI 10.1210/jcem-56-6-1139; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; BARTALENA L, 2007, GRAVES ORBITOPATHY M, P229; Bartalena L, 2008, OPHTHAL PLAST RECONS, V24, P251, DOI 10.1097/IOP.0b013e318179f8a5; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; Bartley GB, 1996, AM J OPHTHALMOL, V121, P284, DOI 10.1016/S0002-9394(14)70276-4; Bradley EA, 2008, OPHTHALMOLOGY, V115, P398, DOI 10.1016/j.ophtha.2007.10.028; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; BURCH HB, 1993, ENDOCR REV, V14, P747, DOI 10.1210/er.14.6.747; Drexhage HA, 2006, ENDOCRINOLOGY, V147, P9, DOI 10.1210/en.2005-1305; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; El Fassi D, 2006, THYROID, V16, P709; Kahaly GJ, 2005, J CLIN ENDOCR METAB, V90, P5234, DOI 10.1210/jc.2005-0148; Kahaly GJ, 2000, J CLIN ENDOCR METAB, V85, P102, DOI 10.1210/jc.85.1.102; Le Moli R, 2007, THYROID, V17, P357, DOI 10.1089/thy.2006.0267; Marcocci C, 2001, J CLIN ENDOCR METAB, V86, P3562, DOI 10.1210/jc.86.8.3562; Marino M, 2004, THYROID, V14, P403, DOI 10.1089/105072504774193276; McKeag D, 2007, BRIT J OPHTHALMOL, V91, P455, DOI 10.1136/bjo.2006.094607; Menconi F, 2007, J CLIN ENDOCR METAB, V92, P1653, DOI 10.1210/jc.2006-1800; Mourits MP, 1997, CLIN ENDOCRINOL, V47, P632; Mourits MP, 2000, LANCET, V355, P1505, DOI 10.1016/S0140-6736(00)02165-6; Mourits MP, 1997, CLIN ENDOCRINOL, V47, P9, DOI 10.1046/j.1365-2265.1997.2331047.x; ORGIAZZI J, 2007, GRAVES ORBITOPATHY M, P41; Paridaens D, 2005, EYE, V19, P1286, DOI 10.1038/sj.eye.6701768; Perros P, 2006, EUR J ENDOCRINOL, V155, P207, DOI 10.1530/eje.1.02201; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; PERROS P, 1995, CLIN ENDOCRINOL, V42, P45, DOI 10.1111/j.1365-2265.1995.tb02597.x; Pfeilschifter J, 1996, CLIN ENDOCRINOL, V45, P477, DOI 10.1046/j.1365-2265.1996.8220832.x; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Prummel MF, 2004, J CLIN ENDOCR METAB, V89, P15, DOI 10.1210/jc.2003-030809; PRUMMEL MF, 1989, NEW ENGL J MED, V321, P1353, DOI 10.1056/NEJM198911163212002; PRUMMEL MF, 1993, LANCET, V342, P949, DOI 10.1016/0140-6736(93)92001-A; PRUMMEL MF, 1989, ACTA ENDOCRINOL-COP, V121, P185; Salvi M, 2007, EUR J ENDOCRINOL, V156, P33, DOI 10.1530/eje.1.02325; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; TALLSTEDT L, 1994, EUR J ENDOCRINOL, V130, P494, DOI 10.1530/eje.0.1300494; Terwee CB, 2005, CLIN ENDOCRINOL, V62, P145, DOI 10.1111/j.1365-2265.2005.02186.x; Terwee CB, 1998, BRIT J OPHTHALMOL, V82, P773, DOI 10.1136/bjo.82.7.773; van Geest RJ, 2008, EUR J ENDOCRINOL, V158, P229, DOI 10.1530/EJE-07-0558; Wakelkamp IMMJ, 2005, CLIN ENDOCRINOL, V63, P323, DOI 10.1111/j.1365-2265.2005.02345.x; WEIGHTMAN DR, 1993, AUTOIMMUNITY, V16, P251, DOI 10.3109/08916939309014643; Weissel M, 2000, THYROID, V10, P521, DOI 10.1089/thy.2000.10.521; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wiersinga WM, 1998, NEW ENGL J MED, V338, P121, DOI 10.1056/NEJM199801083380209	52	193	222	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					994	1001		10.1056/NEJMcp0806317	http://dx.doi.org/10.1056/NEJMcp0806317			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264688				2022-12-28	WOS:000263824500007
J	Weisswange, I; Newsome, TP; Schleich, S; Way, M				Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael			The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility	NATURE			English	Article							VACCINIA VIRUS; INHIBITION; MEMBRANES; PATHWAYS; KINASES; COMPLEX	Understanding cell motility will require detailed knowledge not only of the localization of signalling networks regulating actin polymerization, but also of their dynamics. Unfortunately, many signalling networks are not amenable to such analysis, as they are frequently transient and dispersed. By contrast, the signalling pathways used by pathogens undergoing actin-based motility are highly localized and operate in a constitutive fashion(1-5). Taking advantage of this, we have analysed the dynamics of neuronal Wiskott-Aldrich syndrome protein (N-WASP), WASP-interacting protein (WIP), GRB2 and NCK, which are required to stimulate actin-related protein (ARP) 2/3-complex-dependent actin-based motility of vaccinia virus(6-9), using fluorescence recovery after photobleaching. Here we show that all four proteins are rapidly exchanging, albeit at different rates, and that the turnover of N-WASP depends on its ability to stimulate ARP2/3-complex-mediated actin polymerization. Conversely, disruption of the interaction of N-WASP with GRB2 and/or the barbed ends of actin filaments increases its exchange rate and results in a faster rate of virus movement. We suggest that the exchange rate of N-WASP controls the rate of ARP2/3-complex-dependent actin-based motility by regulating the extent of actin polymerization by antagonizing filament capping.	[Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael] London Res Inst, Canc Res UK, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), London Res Inst, Canc Res UK, Cell Motil Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Way, Michael/0000-0001-7207-2722	Human Frontier Science Program (HFSP); Cancer Research UK	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	We would like to thank T. Pawson and S. Snapper for NCK-and N-WASP-null cell lines and the FACS laboratory (Cancer Research UK, London) for help sorting stable cell lines. We are also very grateful to the members of the Way laboratory, J. Beaudouin, M.- F. Carlier, H. Gerhardt, B. Mayer, K. Rottner, M. Rosen and M. Welch for discussions and comments on the manuscript. T. P. N. was funded in part by a fellowship from the Human Frontier Science Program (HFSP). This work was funded by Cancer Research UK.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	104	104	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					87	U6		10.1038/nature07773	http://dx.doi.org/10.1038/nature07773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262673				2022-12-28	WOS:000263836000038
J	Atlas, SJ; Grant, RW; Ferris, TG; Chang, YC; Barry, MJ				Atlas, Steven J.; Grant, Richard W.; Ferris, Timothy G.; Chang, Yuchiao; Barry, Michael J.			Patient-Physician Connectedness and Quality of Primary Care	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; HEALTH-CARE; PATIENTS EXPERIENCES; GLYCEMIC CONTROL; CONTROLLED-TRIAL; INSURANCE STATUS; PREVENTIVE CARE; AMBULATORY-CARE; REGULAR DOCTOR; MEDICAL-CARE	Background: Valid measurement of physician performance requires accurate identification of patients for whom a physician is responsible. Among all patients seen by a physician, some will be more strongly connected to their physician than others, but the effect of connectedness on measures of physician performance is not known. Objective: To determine whether patient-physician connectedness affects measures of clinical performance. Design: Population-based cohort study. Setting: Academic network of 4 community health centers and 9 hospital-affiliated primary care practices. Patients: 155 590 adults with 1 or more visits to a study practice from 2003 to 2005. Measurements: A validated algorithm was used to connect patients to either 1 of 181 physicians or 1 of 13 practices in which they received most of their care. Performance measures included breast, cervical, and colorectal cancer screening in eligible patients; hemoglobin A(1c) measurement and control in patients with diabetes; and low-density lipoprotein cholesterol measurement and control in patients with diabetes and coronary artery disease. Results: Overall, 92 315 patients (59.3%) were connected to a specific physician, whereas 53 669 patients (34.5%) were connected only to a specific practice and 9606 patients (6.2%) could not be connected to a physician or practice. The proportion of patients in a practice who could be connected to a physician varied markedly (45.6% to 71.2% of patients per practice; P < 0.001). Physician-connected patients were significantly more likely than practice-connected patients to receive guideline-consistent care (for example, adjusted mammography rates were 78.1% vs. 65.9% [P < 0.001] and adjusted hemoglobin A1c rates were 90.3% vs. 74.9% [P < 0.001]). Receipt of preventive care varied more by whether patients were more or less connected to a physician than by race or ethnicity. Limitation: Patient-physician connectedness was assessed in 1 primary care network. Conclusion: Patients seen in primary care practices seem to be variably connected with a specific physician, and less connected patients are less likely to receive guideline-consistent care.	[Atlas, Steven J.] Harvard Univ, Div Gen Med, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Atlas, SJ (corresponding author), Harvard Univ, Div Gen Med, Massachusetts Gen Hosp, Sch Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	satlas@partners.org		Grant, Richard/0000-0002-6164-8025	National Cancer Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015002] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA121908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028717] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: National Cancer Institute.	Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; BEAL AC, 2007, CLOSING DIVIDE MED H; BERNSTEIN AB, 1991, MED CARE, V29, P196; Bindman AB, 1996, J GEN INTERN MED, V11, P269, DOI 10.1007/BF02598266; Bohmer R, 2007, NEW ENGL J MED, V356, P765, DOI 10.1056/NEJMp068289; Casalino LP, 2007, HEALTH AFFAIR, V26, P492, DOI 10.1377/hlthaff.26.2.492; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Cherry Donald K, 2003, Adv Data, P1; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Doescher MP, 2004, J GEN INTERN MED, V19, P632, DOI 10.1111/j.1525-1497.2004.21150.x; Donahue Katrina E, 2005, BMC Fam Pract, V6, P40, DOI 10.1186/1471-2296-6-40; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Forrest CB, 2002, J GEN INTERN MED, V17, P270, DOI 10.1046/j.1525-1497.2002.10309.x; Grant RW, 2004, DIABETES CARE, V27, P2299, DOI 10.2337/diacare.27.10.2299; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Hargraves JL, 2003, HEALTH SERV RES, V38, P809, DOI 10.1111/1475-6773.00148; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lasko TA, 2006, J AM MED INFORM ASSN, V13, P74, DOI 10.1197/jamia.M1876; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Murphy J, 2001, J FAM PRACTICE, V50, P123; Murphy SN, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P552; *NAT COMM QUAL ASS, 2007, HEDIS QUAL MEAS; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Parkerton PH, 2004, FAM MED, V36, P15; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pirraglia PA, 2004, J WOMENS HEALTH, V13, P731, DOI 10.1089/jwh.2004.13.731; Rodriguez HP, 2007, MED CARE, V45, P989, DOI 10.1097/MLR.0b013e318074ce63; Rodriguez HP, 2007, J GEN INTERN MED, V22, P787, DOI 10.1007/s11606-007-0182-8; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Safran DG, 2001, J FAM PRACTICE, V50, P130; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Somkin CP, 2004, MED CARE, V42, P914, DOI 10.1097/01.mlr.0000135832.28672.61; Sox CH, 1997, ARCH FAM MED, V6, P223, DOI 10.1001/archfami.6.3.223; Sox CM, 1998, AM J PUBLIC HEALTH, V88, P364, DOI 10.2105/AJPH.88.3.364; Starfield B., 1992, PRIMARY CARE CONCEPT; Stewart AL, 1997, J FAM PRACTICE, V44, P177; Xu KT, 2002, HEALTH SERV RES, V37, P1509, DOI 10.1111/1475-6773.10524; Yeh DD, 2007, AM J CARDIOL, V99, P1, DOI 10.1016/j.amjcard.2006.07.053; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	53	138	140	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					325	+		10.7326/0003-4819-150-5-200903030-00008	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CC	19258560	Green Accepted			2022-12-28	WOS:000264051700004
J	Batniji, R; Rabaia, Y; Nguyen-Gillham, V; Giacaman, R; Sarraj, E; Punamaki, RL; Saab, H; Boyce, W				Batniji, Rajaie; Rabaia, Yoke; Nguyen-Gillham, Viet; Giacaman, Rita; Sarraj, Eyad; Punamaki, Raija-Leena; Saab, Hana; Boyce, Will			Health in the Occupied Palestinian Territory 4 Health as human security in the occupied Palestinian territory	LANCET			English	Article							WEST-BANK; COLLECTION; RESILIENCE; CONFLICT	We describe the threats to survival, development, and wellbeing in the occupied Palestinian territory using human security as a framework. Palestinian security has deteriorated rapidly since 2000. More than 6000 Palestinians have been killed by the Israeli military, with more than 1300 killed in the Gaza Strip during 22 days of aerial and ground attacks ending in January, 2009: Israeli destruction and control of infrastructure has severely restricted fuel supplies and access to water and sanitation. Palestinians are tortured in prisons and humiliated at Israeli checkpoints. The separation wall and the checkpoints prevent access to work, family, sites of worship, and health-care facilities. Poverty rates have risen sharply, and almost half of Palestinians are dependent on food aid. Social cohesion, which has kept Palestinian society intact, including the health-care system, is now strained. More-than US$9 billion in international aid have not promoted development because Palestinians do not have basic security International efforts focused on prevention of modifiable causes of insecurity, reinvigoration of international norms, support of Palestinian social resilience and institutions that protect them from threats, and a political solution are needed to improve human security in the occupied Palestinian territory.	[Batniji, Rajaie] Univ Oxford Univ Coll, Dept Polit & Int Relat, Oxford OX1 4BH, England; [Rabaia, Yoke; Nguyen-Gillham, Viet; Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Rabaia, Yoke] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Nguyen-Gillham, Viet] Ctr Victims Torture, Minneapolis, MN USA; [Sarraj, Eyad] Gaza Community Mental Hlth Programme, Gaza City, Israel; [Punamaki, Raija-Leena] Univ Tampere, Helsinki Coll Adv Studies, FIN-33101 Tampere, Finland; [Saab, Hana] Queens Univ, Fac Educ, Kingston, ON, Canada; [Boyce, Will] Queens Univ, Social Program Evaluat Grp, Kingston, ON, Canada	University of Oxford; Birzeit University; Vrije Universiteit Amsterdam; Tampere University; Queens University - Canada; Queens University - Canada	Batniji, R (corresponding author), Univ Oxford Univ Coll, Dept Polit & Int Relat, Oxford OX1 4BH, England.	rajaie.batniji@politics.ox.ac.uk			Medical Aid for Palestinians UK; Univeristy of Oslo; Institute for General Practice and Community Medicine; Norwegian Programme for Development, Research and Education	Medical Aid for Palestinians UK; Univeristy of Oslo; Institute for General Practice and Community Medicine; Norwegian Programme for Development, Research and Education	We thank the Lancet Palestine Steering Group (Iain Chalmers, Rita Giacaman, Jennifer Leaning, Harry Shannon, and Huda Zurayk) for reading, discussing, and commenting on drafts of this report; Andrea Becker, Derek Summerfield, and Graham Watt for their valuable comments and support; and Medical Aid for Palestinians UK, Univeristy of Oslo, Institute for General Practice and Community medicine, and the Norwegian Programme for Development, Research and Education for their financial contributions that made the workshops related to this Series possible.	ABDEEN Z, 2003, NUTR FOOD W BANK GAZ; ABDULRAHIM HF, 2009, LANCET; ABUZAYD KK, 2008, GUARDIAN        0123; ABUZULOF G, 2005, DEALING ALLEGED CHIL; ALKIRE S, 2002, CONCEPTUAL FRAMEWORK, P2; [Anonymous], 2005, BBC NEWS         AUG; Ashkar A., 2006, PERPETUAL LIMBO ISRA; *ASS PRESS, 2008, IDF BLOCKS W BANK PA; *B TSEL, 2006, SON BOOMS CONST COLL; *B TSEL, 2008, TORT FAIL INV ALL CA; *B TSEL, 2007, BEAT AB BACKGR DOC; *B TSEL, 2008, PLANN BUILD; *B TSEL, 2007, 1 INT TABL; *B TSEL, 2004, NO FAULT THEIR OWN P; *B TSEL, 2008, TORT BACKGR HIGH COU; *B TSEL, 2007, TEST ARM DEM VILL HO; *B TSEL, 2008, DEM ALL MIL PURP PRI; *B TSEL, 2008, CAM DISTR PROJ; *B TSEL, 2008, HUM SHIELDS; *B TSEL, ADM DET BACKGR; *B TSEL, 2008, B TSEL STAT FAT; *B TSEL, 2008, STAT PAL CUST ISR SE; Batniji R, 2006, SOC SCI MED, V62, P1853, DOI 10.1016/j.socscimed.2005.08.050; Collier P, 2006, WORLD DEV, V34, P1482, DOI 10.1016/j.worlddev.2006.01.002; COOK Catherine, 2004, STOLEN YOUTH POLITIC; CSDH, 2008, CLOS GAP GEN HLTH EQ; Davies Wyre., 2008, BBC NEWS 1002; DEVOE PA, 2002, SYMBOLIC ACTION RELI, P234; *GAZ COMM MENT HLT, 2006, APP INT COMM URG PRO; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; GOZDZIAK EM, 2002, SPIRITUAL EMERGENCY, P136; *HAAR, 2009, EU AID CHIEF HAM EN; Halileh Samia O, 2002, Med Confl Surviv, V18, P239, DOI 10.1080/13623690208409632; Helweg-Larsen K, 2004, SCAND J PUBLIC HEALT, V32, P17, DOI 10.1080/14034940310018048; HIRSCH A, 2009, GUARDIAN        0114; *HUM RIGHTS WATCH, 2009, Q A ISR US WHIT PHOS; *HUM RIGHTS WATCH, 2002, HUM SHIELD US CIV MI; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; *INT COURT JSUT, 2004, LEG CONS CONSTR WALL; *INT MONT FUND WOR, 2007, EC DEV 2006 1 ASS; King G, 2001, POLIT SCI QUART, V116, P585, DOI 10.2307/798222; Leaning J., 2001, HARVARD CTR POPULATI, V11; LEANING J, 2003, GLOBAL HLTH CHALLENG; MANSOUR S, 2003, REV ETUDES PALESTINI, V22, P20; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; McGirk J, 2009, LANCET, V373, P199, DOI 10.1016/S0140-6736(09)60056-8; Nguyen-Gillham V, 2008, HEALTH SOC CARE COMM, V16, P291, DOI 10.1111/j.1365-2524.2008.00767.x; OCHA, 2007, CLOS GAZ STRIP EC HU; *OCHA, 2007, W BANK ACC CLOS DEC; *OCHA, 2009, FIELD UP DAT GAZ HUM; OCHA (Office for the Coordination of Humanitarian Affairs), 2009, FIELD UPD GAZ HUM CO; *PAL CENTR BUR STA, 1995, CURR STAT REP SER PA, V4; *PAL CENTR BUR STA, 1998, CURR STAT REP SER PA, V7; *PAL CTR HUM RIGHT, 2008, BLACK PAG ABS JUST R; *PAL CTR HUM RIGHT, STAT ARR IMPR TORT; *PAL MON, 2007, TORT; *PAL RED CRES SOC, 2007, TOT NUMB DEATHS INJ; *PHYS HUM RIGHTS I, 2008, HOLD HLTH RANS GSS I; Roy S, 2002, MIDDLE EAST POLICY, V9, P122, DOI 10.1111/1475-4967.00087; Roy Sara, 2004, INT J POLITICS CULTU, V17, P365, DOI DOI 10.1023/B%3AIJPS.0000019609.37719.99; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Rytter MJH, 2006, BMJ-BRIT MED J, V332, P1122, DOI 10.1136/bmj.38793.695081.AE; Sayigh Y, 2007, SURVIVAL, V49, P7, DOI 10.1080/00396330701564786; Shaheen A, 2008, East Mediterr Health J, V14, P406; SHUBITA A, 2007, IMPACT CONFLICT PEOP; TAGAR ZKT, 2008, SLEEPING TIME BOMB P; *UN, 2003, COMM HUM SEC HUM SEC; *UN DEV PROGR, 1994, HUM DEV REP 1994, P22; *UN GEN ASS, 2008, HUM RIGHTS SIT PAL O; *UN U, 1993, HYDR JORD RIV SCARC; *UNCTAD, 2008, PROGR ASS PAL PEOPL; United Nations, 1949, GEN CONV REL PROT CI; United Nations Development Programme, 2006, HUM DEV REP 2006; Watts Susan Sameen Siddiqi, 2007, SOCIAL DETERMINANTS; Whitfield L., 2008, MANAGING AID DEPENDE; *WHO, 2009, HLTH SIT GAZ STRIP 1; *WORLD BANK, 2004, STAGN REV ISR DIS PA; World Bank, 2008, EC EFF RESTR ACC LAN; World Bank, 2008, PAL EC PROSP AID ACC; World Health Organization, 1946, AM J PUBLIC HLTH NAT, V36, P1315	80	92	92	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1133	1143		10.1016/S0140-6736(09)60110-0	http://dx.doi.org/10.1016/S0140-6736(09)60110-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19268352				2022-12-28	WOS:000264773600034
J	McCartney, M				McCartney, Margaret			Hospital Hygiene Are superbug fears turning patients into hospital cleaners?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coombes R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b833	1	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2009	338								b729	10.1136/bmj.b729	http://dx.doi.org/10.1136/bmj.b729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244305				2022-12-28	WOS:000264056200002
J	Erb, RM; Son, HS; Samanta, B; Rotello, VM; Yellen, BB				Erb, Randall M.; Son, Hui S.; Samanta, Bappaditya; Rotello, Vincent M.; Yellen, Benjamin B.			Magnetic assembly of colloidal superstructures with multipole symmetry	NATURE			English	Article							PARTICLES; CRYSTALS; CRYSTALLIZATION; CLUSTERS	The assembly of complex structures out of simple colloidal building blocks is of practical interest for building materials with unique optical properties ( for example photonic crystals(1) and DNA biosensors(2)) and is of fundamental importance in improving our understanding of self- assembly processes occurring on molecular to macroscopic length scales(3-5). Here we demonstrate a self-assembly principle that is capable of organizing a diverse set of colloidal particles into highly reproducible, rotationally symmetric arrangements. The structures are assembled using the magneto-static interaction between effectively diamagnetic and paramagnetic particles within a magnetized ferrofluid. The resulting multipolar geometries resemble electrostatic charge configurations such as axial quadrupoles ('Saturn rings'), axial octupoles ('flowers'), linear quadrupoles (poles) and mixed multipole arrangements ('two tone'), which represent just a few examples of the type of structure that can be built using this technique.	[Erb, Randall M.; Son, Hui S.; Yellen, Benjamin B.] Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Samanta, Bappaditya; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Duke University; University of Massachusetts System; University of Massachusetts Amherst	Yellen, BB (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Box 90300,Hudson Hall, Durham, NC 27708 USA.	yellen@duke.edu	Erb, Randall M/E-6337-2014; Erb, Randall M/O-1984-2018; Erb, Randall M/B-1986-2012	Erb, Randall M/0000-0002-6351-395X; 	US National Science Foundation [NSEC DMI-0531171, MRSEC DMR-0213695, CMMI-0608819, CMMI-0625480]	US National Science Foundation(National Science Foundation (NSF))	The authors would like to thank the US National Science Foundation (grants NSEC DMI-0531171 and MRSEC DMR-0213695 to V. M. R. and grants CMMI-0608819 and CMMI-0625480 to B.B.Y.) for supporting this work.	Biswal SL, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041406; Cho YS, 2005, J AM CHEM SOC, V127, P15968, DOI 10.1021/ja0550632; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Erb RM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831789; HALSEY TC, 1992, SCIENCE, V258, P761, DOI 10.1126/science.258.5083.761; HELGESEN G, 1990, PHYS REV A, V42, P7271, DOI 10.1103/PhysRevA.42.7271; Kim SH, 2008, LANGMUIR, V24, P2365, DOI 10.1021/la703037g; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Ozin GA, 2001, ADV FUNCT MATER, V11, P95, DOI 10.1002/1616-3028(200104)11:2<95::AID-ADFM95>3.0.CO;2-O; PANOFSKY WKH, 1955, CLASSICAL ELECT MAGN, P84; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; SKJELTORP AT, 1983, PHYS REV LETT, V51, P2306, DOI 10.1103/PhysRevLett.51.2306; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237; Zhuang JQ, 2008, ANGEW CHEM INT EDIT, V47, P2208, DOI 10.1002/anie.200705049	23	358	371	7	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					999	1002		10.1038/nature07766	http://dx.doi.org/10.1038/nature07766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225522				2022-12-28	WOS:000263425400039
J	Kalaany, NY; Sabatini, DM				Kalaany, Nada Y.; Sabatini, David M.			Tumours with PI3K activation are resistant to dietary restriction	NATURE			English	Article							GROWTH-FACTOR-I; CALORIC RESTRICTION; LIFE-SPAN; PHOSPHATIDYLINOSITOL 3-KINASES; ENERGY RESTRICTION; HUMAN CANCER; CELL-GROWTH; MUTATIONS; INSULIN; GENE	Dietary restriction delays the incidence and decreases the growth of various types of tumours, but the mechanisms underlying the sensitivity of tumours to food restriction remain unknown. Here we show that certain human cancer cell lines, when grown as tumour xenografts in mice, are highly sensitive to the anti-growth effects of dietary restriction, whereas others are resistant. Cancer cells that form dietary-restriction-resistant tumours carry mutations that cause constitutive activation of the phosphatidylinositol-3-kinase (PI3K) pathway and in culture proliferate in the absence of insulin or insulin-like growth factor 1. Substitution of an activated mutant allele of PI3K with wild-type PI3K in otherwise isogenic cancer cells, or the restoration of PTEN expression in a PTEN-null cancer cell line, is sufficient to convert a dietary-restriction-resistant tumour into one that is dietary-restriction-sensitive. Dietary restriction does not affect a PTEN-null mouse model of prostate cancer, but it significantly decreases tumour burden in a mouse model of lung cancer lacking constitutive PI3K signalling. Thus, the PI3K pathway is an important determinant of the sensitivity of tumours to dietary restriction, and activating mutations in the pathway may influence the response of cancers to dietary restriction-mimetic therapies.	[Kalaany, Nada Y.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Kalaany, Nada/0000-0001-7489-1035	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health [R01 AI04389, R01 CA129105]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Vogelstein for providing the isogenic DLD-1 cell lines and M. M. Georgescu for the doxycycline-inducible U87-MG cell line; T. Jacks for the KRAS<SUP>LA2</SUP>; p53<SUP>LSL/WT</SUP> mice and H. Wu for the Pb-Cre; PTEN<SUP>L/L</SUP> mice; F. Reinhardt for assistance with animal experiments; R. Bronson for histological analysis; the Histology Facility at the Koch Institute for Integrative Cancer Research and the Histology Core Laboratory at MIT for assistance with sectioning and immunohistochemistry; the Imaging Platform at the Broad Institute for assistance with image analysis; R. Weinberg, D. Guertin, Y. Chudnovsky and Y. Sancak for critical reading of the manuscript; and members of the Sabatini and Weinberg laboratories for support and discussions. This research is supported by the Alexander and Margaret Stewart Trust Award, the David H. Koch Cancer Research Award and National Institutes of Health grants R01 AI04389 and R01 CA129105. D. M. S. is an investigator of the Howard Hughes Medical Institute.	BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420; CHENEY KE, 1980, EXP GERONTOL, V15, P237, DOI 10.1016/0531-5565(80)90029-7; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; Kritchevsky D, 2001, J NUTR SCI VITAMINOL, V47, P13, DOI 10.3177/jnsv.47.13; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moreschi C., 1909, ZIMMUNITATSFORSCH, V2, P651; Pugh TD, 1999, CANCER RES, V59, P1642; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rous P, 1914, J EXP MED, V20, P413, DOI 10.1084/jem.20.4.413; RUGGERI BA, 1989, CANCER RES, V49, P4130; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sell C, 2003, HORM METAB RES, V35, P705, DOI 10.1055/s-2004-814156; TANNENBAUM A, 1949, CANCER RES, V9, P724; TANNENBAUM A, 1953, CANCER RES, V13, P532; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhu ZJ, 1997, CARCINOGENESIS, V18, P1007, DOI 10.1093/carcin/18.5.1007	38	333	345	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					725	U61		10.1038/nature07782	http://dx.doi.org/10.1038/nature07782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19279572	Green Accepted			2022-12-28	WOS:000265193600032
J	Abdo, AA; Ackermann, M; Arimoto, M; Asano, K; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Band, DL; Barbiellini, G; Baring, MG; Bastieri, D; Battelino, M; Baughman, BM; Bechtol, K; Bellardi, F; Bellazzini, R; Berenji, B; Bhat, PN; Bissaldi, E; Blandford, RD; Bloom, ED; Bogaert, G; Bogart, JR; Bonamente, E; Bonnell, J; Borgland, AW; Bouvier, A; Bregeon, J; Brez, A; Briggs, MS; Brigida, M; Bruel, P; Burnett, TH; Burrows, D; Busetto, G; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Ceccanti, M; Cecchi, C; Celotti, A; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Connaughton, V; Conrad, J; Costamante, L; Cutini, S; DeKlotz, M; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Dingus, BL; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Edmonds, Y; Evans, PA; Fabiani, D; Farnier, C; Favuzzi, C; Finke, J; Fishman, G; Focke, WB; Frailis, M; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giommi, P; Giordano, F; Glanzman, T; Godfrey, G; Goldstein, A; Granot, J; Greiner, J; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Haller, G; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Morata, JAH; Hoover, A; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Kavelaars, A; Kawai, N; Kelly, H; Kennea, J; Kerr, M; Kippen, RM; Knodlseder, J; Kocevski, D; Kocian, ML; Komin, N; Kouveliotou, C; Kuehn, F; Kuss, M; Lande, J; Landriu, D; Larsson, S; Latronico, L; Lavalley, C; Lee, B; Lee, SH; Lemoine-Goumard, M; Lichti, GG; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Marangelli, B; Mazziotta, MN; McBreen, S; McEnery, JE; McGlynn, S; Meegan, C; Meszaros, P; Meurer, C; Michelson, PF; Minuti, M; Mirizzi, N; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Moretti, E; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nelson, D; Nolan, PL; Norris, JP; Nuss, E; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orlando, E; Ormes, JF; Ozaki, M; Paciesas, WS; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Perri, M; Pesce-Rollins, M; Petrosian, V; Pinchera, M; Piron, F; Porter, TA; Preece, R; Raino, S; Ramirez-Ruiz, E; Rando, R; Rapposelli, E; Razzano, M; Razzaque, S; Rea, N; Reimer, A; Reimer, O; Reposeur, T; Reyes, LC; Ritz, S; Rochester, LS; Rodriguez, AY; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Schalk, TL; Segal, KN; Sgro, C; Shimokawabe, T; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Stamatikos, M; Starck, JL; Stecker, FW; Steinle, H; Stephens, TE; Strickman, MS; Suson, DJ; Tagliaferri, G; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Tenze, A; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Turri, M; Tuvi, S; Usher, TL; van der Horst, AJ; Vigiani, L; Vilchez, N; Vitale, V; von Kienlin, A; Waite, AP; Williams, DA; Wilson-Hodge, C; Winer, BL; Wood, KS; Wu, XF; Yamazaki, R; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Arimoto, M.; Asano, K.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Band, D. L.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Battelino, M.; Baughman, B. M.; Bechtol, K.; Bellardi, F.; Bellazzini, R.; Berenji, B.; Bhat, P. N.; Bissaldi, E.; Blandford, R. D.; Bloom, E. D.; Bogaert, G.; Bogart, J. R.; Bonamente, E.; Bonnell, J.; Borgland, A. W.; Bouvier, A.; Bregeon, J.; Brez, A.; Briggs, M. S.; Brigida, M.; Bruel, P.; Burnett, T. H.; Burrows, D.; Busetto, G.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Ceccanti, M.; Cecchi, C.; Celotti, A.; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Connaughton, V.; Conrad, J.; Costamante, L.; Cutini, S.; DeKlotz, M.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; Dingus, B. L.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Edmonds, Y.; Evans, P. A.; Fabiani, D.; Farnier, C.; Favuzzi, C.; Finke, J.; Fishman, G.; Focke, W. B.; Frailis, M.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giommi, P.; Giordano, F.; Glanzman, T.; Godfrey, G.; Goldstein, A.; Granot, J.; Greiner, J.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Haller, G.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Morata, J. A. Hernando; Hoover, A.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kavelaars, A.; Kawai, N.; Kelly, H.; Kennea, J.; Kerr, M.; Kippen, R. M.; Knoedlseder, J.; Kocevski, D.; Kocian, M. L.; Komin, N.; Kouveliotou, C.; Kuehn, F.; Kuss, M.; Lande, J.; Landriu, D.; Larsson, S.; Latronico, L.; Lavalley, C.; Lee, B.; Lee, S. -H.; Lemoine-Goumard, M.; Lichti, G. G.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Marangelli, B.; Mazziotta, M. N.; McBreen, S.; McEnery, J. E.; McGlynn, S.; Meegan, C.; Meszaros, P.; Meurer, C.; Michelson, P. F.; Minuti, M.; Mirizzi, N.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Moretti, E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nelson, D.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orlando, E.; Ormes, J. F.; Ozaki, M.; Paciesas, W. S.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Perri, M.; Pesce-Rollins, M.; Petrosian, V.; Pinchera, M.; Piron, F.; Porter, T. A.; Preece, R.; Raino, S.; Ramirez-Ruiz, E.; Rando, R.; Rapposelli, E.; Razzano, M.; Razzaque, S.; Rea, N.; Reimer, A.; Reimer, O.; Reposeur, T.; Reyes, L. C.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Schalk, T. L.; Segal, K. N.; Sgro, C.; Shimokawabe, T.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Stamatikos, M.; Starck, J. -L.; Stecker, F. W.; Steinle, H.; Stephens, T. E.; Strickman, M. S.; Suson, D. J.; Tagliaferri, G.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Tenze, A.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Turri, M.; Tuvi, S.; Usher, T. L.; van der Horst, A. J.; Vigiani, L.; Vilchez, N.; Vitale, V.; von Kienlin, A.; Waite, A. P.; Williams, D. A.; Wilson-Hodge, C.; Winer, B. L.; Wood, K. S.; Wu, X. F.; Yamazaki, R.; Ylinen, T.; Ziegler, M.		Fermi LAT Collaboration; Fermi GBM Collaboration	Fermi Observations of High-Energy Gamma-Ray Emission from GRB 080916C	SCIENCE			English	Article							BURST SPECTRA; BATSE OBSERVATIONS; SHOCK MODEL; NEUTRINOS; COMPONENT; PHOTONS	Gamma-ray bursts (GRBs) are highly energetic explosions signaling the death of massive stars in distant galaxies. The Gamma-ray Burst Monitor and Large Area Telescope onboard the Fermi Observatory together record GRBs over a broad energy range spanning about 7 decades of gamma-ray energy. In September 2008, Fermi observed the exceptionally luminous GRB 080916C, with the largest apparent energy release yet measured. The high-energy gamma rays are observed to start later and persist longer than the lower energy photons. A simple spectral form fits the entire GRB spectrum, providing strong constraints on emission models. The known distance of the burst enables placing lower limits on the bulk Lorentz factor of the outflow and on the quantum gravity mass.	[Baughman, B. M.; Bhat, P. N.; Briggs, M. S.; Connaughton, V.; Goldstein, A.; Paciesas, W. S.] Univ Alabama, Huntsville, AL 35899 USA; [Abdo, A. A.; Chekhtman, A.; Dermer, C. D.; Finke, J.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Razzaque, S.; Strickman, M. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Blandford, R. D.; Bloom, E. D.; Bogart, J. R.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Haller, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kavelaars, A.; Kelly, H.; Kocevski, D.; Kocian, M. L.; Lande, J.; Lee, S. -H.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nelson, D.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Petrosian, V.; Reimer, A.; Reimer, O.; Rochester, L. S.; Tajima, H.; Tanaka, T.; Turri, M.; Tuvi, S.; Usher, T. L.; Waite, A. P.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Ackermann, M.; Blandford, R. D.; Bloom, E. D.; Bogart, J. R.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Edmonds, Y.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Haller, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kavelaars, A.; Kelly, H.; Kocevski, D.; Kocian, M. L.; Lande, J.; Lee, S. -H.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nelson, D.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Petrosian, V.; Reimer, A.; Reimer, O.; Rochester, L. S.; Tajima, H.; Tanaka, T.; Turri, M.; Tuvi, S.; Usher, T. L.; Waite, A. P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Arimoto, M.; Asano, K.; Bechtol, K.; Berenji, B.; Kataoka, J.; Kawai, N.; Nakamori, T.; Shimokawabe, T.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Atwood, W. B.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Williams, D. A.; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Williams, D. A.; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Axelsson, M.; Battelino, M.; Conrad, J.; Larsson, S.; McGlynn, S.; Meurer, C.] Oskar Klein Ctr Cosmo Particle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Baldini, L.; Bregeon, J.; Brez, A.; Ceccanti, M.; Fabiani, D.; Kuss, M.; Minuti, M.; Omodei, N.; Pesce-Rollins, M.; Pinchera, M.; Rapposelli, E.; Razzano, M.; Sgro, C.; Spandre, G.; Vigiani, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Bellardi, F.; Bellazzini, R.; Casandjian, J. M.; Grenier, I. A.; Komin, N.; Landriu, D.; Starck, J. -L.; Tenze, A.] Univ Paris Diderot, Serv Astrophys, CEA Saclay, Lab AIM,CEA IRFU CNRS, F-91191 Gif Sur Yvette, France; [Band, D. L.; Moiseev, A. A.; Ritz, S.; Segal, K. N.] NASA, Goddard Space Flight Ctr, CRESST, Greenbelt, MD 20771 USA; [Barbiellini, G.; Longo, F.; Moretti, E.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.; Moretti, E.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Busetto, G.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Busetto, G.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Battelino, M.; Conrad, J.; McGlynn, S.; Ryde, F.; Ylinen, T.] Royal Inst Technol, Dept Phys, SE-10691 Stockholm, Sweden; [Hughes, R. E.; Kuehn, F.; Sander, A.; Winer, B. L.] Ohio State Univ, Ctr Cosmol & Astro Particle Phys, Dept Phys, Columbus, OH 43210 USA; [Bissaldi, E.; Greiner, J.; Lichti, G. G.; McBreen, S.; Orlando, E.; Steinle, H.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Bogaert, G.; Bruel, P.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Sez Perugia, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Marangelli, B.; Mirizzi, N.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Marangelli, B.; Mirizzi, N.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Marangelli, B.; Mazziotta, M. N.; Mirizzi, N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Burrows, D.; Kennea, J.; Meszaros, P.; Wu, X. F.] Penn State Univ, University Pk, PA 16802 USA; [Caraveo, P. A.] INAF Ist Astrofis Spaziale Fis Cosm, I-20133 Milan, Italy; [Celotti, A.] Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Farnier, C.; Guiriec, S.; Komin, N.; Lavalley, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab hys Theor & Astroparticules, F-34095 Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Larsson, S.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Cutini, S.; Gasparrini, D.; Giommi, P.; Perri, M.] Agenzia Spaziale Italiana Sci Data Ctr, I-00044 Frascati, Roma, Italy; [DeKlotz, M.] Stellar Solutions Inc, Palo Alto, CA 94306 USA; [de Angelis, A.; Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.; Frailis, M.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dingus, B. L.; Hoover, A.; Kippen, R. M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, CEN Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Evans, P. A.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Fishman, G.; Kouveliotou, C.; Meegan, C.; Preece, R.; van der Horst, A. J.; Wilson-Hodge, C.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; [Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Yamazaki, R.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; [Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Yamazaki, R.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.; Ritz, S.] Univ Maryland, College Pk, MD 20742 USA; Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Morata, J. A. Hernando] European Org Nucl Res CERN, CH-1211 Geneva, Switzerland; [Kawai, N.] Inst Phys & Chem Res RIKEN, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Knoedlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Lee, B.] Orbital Network Engn, Cupertino, CA 95014 USA; [McBreen, S.] Univ Coll Dublin, Dublin 4, Ireland; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Ohno, M.; Ozaki, M.; Takahashi, T.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Okumura, A.] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Ramirez-Ruiz, E.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Rea, N.; Rodriguez, A. Y.; Torres, D. F.] Inst Ciencies Espai IEEC CSIC, Barcelona 08193, Spain; [Reyes, L. C.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Tagliaferri, G.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy; [Torres, D. F.] ICREA, Barcelona 08010, Spain; [Tramacere, A.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Wu, X. F.] J CPNPC, Nanjing 210093, Peoples R China; [Wu, X. F.] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	University of Alabama System; University of Alabama Huntsville; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Tokyo Institute of Technology; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Oskar Klein Centre; Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Royal Institute of Technology; University System of Ohio; Ohio State University; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Istituto Nazionale Astrofisica (INAF); International School for Advanced Studies (SISSA); George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Agenzia Spaziale Italiana (ASI); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Leicester; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Hiroshima University; Hiroshima University; University System of Maryland; University of Maryland College Park; University of Hertfordshire; European Organization for Nuclear Research (CERN); RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University College Dublin; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; University of California System; University of California Santa Cruz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Chicago; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; Istituto Nazionale Astrofisica (INAF); ICREA; University of Rome Tor Vergata; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Linnaeus University; University of Kalmar	Briggs, MS (corresponding author), Univ Alabama, Huntsville, AL 35899 USA.	michael.briggs@nasa.gov; charles.dermer@nrl.navy.mil; htajima@slac.stanford.edu	lubrano, pasquale/F-7269-2012; Tagliaferri, Gianpiero/ABD-7556-2021; Loparco, Francesco/O-8847-2015; Reimer, Olaf/A-3117-2013; Bissaldi, Elisabetta/AAB-2443-2021; Takahashi, Hiromitsu H/T-2713-2017; Ozaki, Masanobu/K-1165-2013; Orlando, Elena/R-5594-2016; Hays, Elizabeth/D-3257-2012; Gargano, Fabio/O-8934-2015; tramacere, andrea/B-9424-2012; Kennea, Jamie/AAF-2090-2019; Funk, Stefan/B-7629-2015; Stecker, Floyd W/D-3169-2012; De Angelis, Alessandro/B-5372-2009; Starck, Jean-Luc/D-9467-2011; Gehrels, Neil/D-2971-2012; Torres, Diego F/ABD-7940-2020; Rando, Riccardo/M-7179-2013; Baldini, Luca/E-5396-2012; Harding, Alice K/D-3160-2012; Rando, Riccardo/O-1302-2019; Nolan, Patrick L/A-5582-2009; Rea, Nanda/I-2853-2015; Reimer, Anita/K-5822-2015; Kuss, Michael W/H-8959-2012; McEnery, Julie E/D-6612-2012; Gargano, Fabio/AAD-5121-2021; Jóhannesson, Guðlaugur/ABC-7216-2020; Cutini, Sara/ABB-1787-2020; Funk, Stefan/AAI-1568-2021; Moskalenko, Igor V/A-1301-2007; Johnson, Neil/G-3309-2014; Jóhannesson, Guðlaugur/O-8741-2015; Bogaert, Gilles/GZA-8066-2022; Bissaldi, Elisabetta/K-7911-2016; giglietto, nicola/I-8951-2012; cohen-tanugi, Johann/ABB-1481-2021; Parkinson, Pablo Miguel Saz/I-7980-2013; Torres, Diego F./O-9422-2016; Gasparrini, Dario/X-6699-2019; Torres, Diego F./AAF-7931-2019; Fukazawa, Yasushi/G-2081-2017; Giglietto, Nicola/Y-2425-2019; Morselli, Aldo/G-6769-2011; Bastieri, Denis/AAC-5917-2020; Thompson, David J/D-2939-2012; Mazziotta, Mario N/O-8867-2015; Caraveo, Patrizia/AAL-5708-2020; Tosti, Gino/E-9976-2013; Okumura, Akira/I-2468-2014; Sgrò, Carmelo/K-3395-2016; Wu, Xuefeng/G-5316-2015; giommi, paolo/L-1006-2018; Komin, Nukri/J-6781-2015	lubrano, pasquale/0000-0003-0221-4806; Tagliaferri, Gianpiero/0000-0003-0121-0723; Loparco, Francesco/0000-0002-1173-5673; Reimer, Olaf/0000-0001-6953-1385; Bissaldi, Elisabetta/0000-0001-9935-8106; Takahashi, Hiromitsu H/0000-0001-6314-5897; Orlando, Elena/0000-0001-6406-9910; Gargano, Fabio/0000-0002-5055-6395; tramacere, andrea/0000-0002-8186-3793; Kennea, Jamie/0000-0002-6745-4790; Funk, Stefan/0000-0002-2012-0080; Starck, Jean-Luc/0000-0003-2177-7794; Rando, Riccardo/0000-0001-6992-818X; Rea, Nanda/0000-0003-2177-6388; Reimer, Anita/0000-0001-8604-7077; Gargano, Fabio/0000-0002-5055-6395; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Cutini, Sara/0000-0002-1271-2924; Funk, Stefan/0000-0002-2012-0080; Moskalenko, Igor V/0000-0001-6141-458X; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Bogaert, Gilles/0000-0003-2507-3866; Bissaldi, Elisabetta/0000-0001-9935-8106; giglietto, nicola/0000-0002-9021-2888; cohen-tanugi, Johann/0000-0001-9022-4232; Torres, Diego F./0000-0002-1522-9065; Gasparrini, Dario/0000-0002-5064-9495; Torres, Diego F./0000-0002-1522-9065; Fukazawa, Yasushi/0000-0002-0921-8837; Giglietto, Nicola/0000-0002-9021-2888; Morselli, Aldo/0000-0002-7704-9553; Bastieri, Denis/0000-0002-6954-8862; Thompson, David J/0000-0001-5217-9135; Mazziotta, Mario N/0000-0001-9325-4672; Caraveo, Patrizia/0000-0003-2478-8018; Okumura, Akira/0000-0002-3055-7964; Wu, Xuefeng/0000-0002-6299-1263; Monzani, Maria Elena/0000-0002-8254-5308; giommi, paolo/0000-0002-2265-5003; Murgia, Simona/0000-0003-0516-9422; Grenier, Isabelle/0000-0003-3274-674X; Cecchi, Claudia/0000-0002-2192-8233; Perri, Matteo/0000-0003-3613-4409; Pepe, Monica/0000-0001-5624-4010; Fusco, Piergiorgio/0000-0002-9383-2425; Katagiri, Hideaki/0000-0003-2347-8819; Casandjian, Jean-Marc/0000-0003-1404-0524; Frailis, Marco/0000-0002-7400-2135; Pesce-Rollins, Melissa/0000-0003-1790-8018; Celotti, Anna Lisa/0000-0002-8106-2777; Pinchera, Michele/0000-0003-0455-2358; Baldini, Luca/0000-0002-9785-7726; Johnson, Tyrel/0000-0002-2771-472X; Berenji, Bijan/0000-0002-4551-772X; Omodei, Nicola/0000-0002-5448-7577; Sadrozinski, Hartmut/0000-0003-0019-5410; Granot, Jonathan/0000-0001-8530-8941; SANCHEZ, David/0000-0002-7210-4496; Dingus, Brenda/0000-0001-8451-7450; Meszaros, Peter/0000-0002-4132-1746; Razzaque, Soebur/0000-0002-0130-2460; Preece, Robert/0000-0003-1626-7335; Ackermann, Markus/0000-0001-8952-588X; Porter, Troy/0000-0002-2621-4440; Petrosian, Vahe'/0000-0002-2670-8942; Cheung, Chi (Teddy)/0000-0002-4377-0174; De Angelis, Alessandro/0000-0002-3288-2517; Minuti, Massimo/0000-0001-9577-2588; Evans, Philip/0000-0002-8465-3353; van der Horst, Alexander/0000-0001-9149-6707; Ciprini, Stefano/0000-0002-0712-2479; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Larsson, Stefan/0000-0003-0716-107X; Charles, Eric/0000-0002-3925-7802; Kerr, Matthew/0000-0002-0893-4073; McBreen, Sheila/0000-0002-1477-618X; Spandre, Gloria/0000-0003-0802-3453; Sgro', Carmelo/0000-0001-5676-6214; Stephens, Thomas/0000-0003-3065-6871; Moretti, Elena/0000-0001-5477-9097; Giordano, Francesco/0000-0002-8651-2394; de Palma, Francesco/0000-0001-5898-2834; Cameron, Robert/0000-0003-0942-2747; Arimoto, Makoto/0000-0003-1250-7872; Komin, Nukri/0000-0003-3280-0582; Lee, Shiu-Hang/0000-0002-2899-4241; SPINELLI, Paolo/0000-0001-6688-8864; Tanaka, Takaaki/0000-0002-4383-0368; Tibaldo, Luigi/0000-0001-7523-570X	NASA; Department of Energy in the United States; Commissariat a lEnergie Atomique; Centre National de la Recherche Scientifique/Institut National de Physique Nucleaire et de Physique des Particules in France; Agenzia Spaziale Italiana; Istituto Nazionale di Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT); High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency (JAXA) in Japan; K. A. Wallenberg Foundation; Swedish Research Council; Swedish National Space Board in Sweden; Deutsches Zentrum fur Luftund Raumfahrt in Germany; STFC [PP/D000920/1, ST/F006489/1, ST/G002630/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000920/1, ST/F006489/1, ST/G002630/1] Funding Source: researchfish; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); Department of Energy in the United States(United States Department of Energy (DOE)); Commissariat a lEnergie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique/Institut National de Physique Nucleaire et de Physique des Particules in France(Centre National de la Recherche Scientifique (CNRS)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Istituto Nazionale di Fisica Nucleare in Italy(Istituto Nazionale di Fisica Nucleare (INFN)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); Japan Aerospace Exploration Agency (JAXA) in Japan; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Space Board in Sweden; Deutsches Zentrum fur Luftund Raumfahrt in Germany; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA)	A. A. Abdo, J. Finke, and S. Razzaque are National Research Council Research Associates. A. J. van der Horst is a NASA Postdoctoral Program Fellow. The Fermi LAT Collaboration acknowledges the support of a number of agencies and institutes. These include NASA and the Department of Energy in the United States; the Commissariat a lEnergie Atomique and the Centre National de la Recherche Scientifique/Institut National de Physique Nucleaire et de Physique des Particules in France; the Agenzia Spaziale Italiana and the Istituto Nazionale di Fisica Nucleare in Italy; the Ministry of Education, Culture, Sports, Science and Technology (MEXT), High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (JAXA) in Japan; and the K. A. Wallenberg Foundation, the Swedish Research Council, and the Swedish National Space Board in Sweden. J.C. is a Royal Swedish Academy of Sciences Research fellow supported by a grant from the K. A. Wallenberg foundation. The Fermi GBM Collaboration acknowledges the support of NASA in the United States and Deutsches Zentrum fur Luftund Raumfahrt in Germany and thanks L. Gibby, A. English, and F. Kroeger.	Amelino-Camelia G, 1998, NATURE, V393, P763, DOI 10.1038/31647; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Baring MG, 2006, ASTROPHYS J, V650, P1004, DOI 10.1086/506960; Bouvier A, 2008, 8183 GCN, P8183; Briggs MS, 1999, ASTROPHYS J, V524, P82, DOI 10.1086/307808; CLEMENS C, 2008, 8257 GCN; CLEMENS C, 2008, 8272 GCN; Connaughton V, 2002, ASTROPHYS J, V567, P1028, DOI 10.1086/338695; CONNAUGHTON V, 2008, 8408 GCN; Dermer CD, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/122; Dermer CD, 2002, ASTROPHYS J, V574, P65, DOI 10.1086/340893; DINGUS BL, 1995, ASTROPHYS SPACE SCI, V231, P187, DOI 10.1007/BF00658613; FENIMORE EE, 1993, ASTRON ASTROPHYS SUP, V97, P59; GIULIANI A, 2008, ASTRON ASTR IN PRESS; GOLDSTEIN A, 2008, 8245 GCN; Gonzalez MM, 2003, NATURE, V424, P749, DOI 10.1038/nature01869; Granot J, 2003, ASTROPHYS J, V598, pL11, DOI 10.1086/380499; Granot J, 2008, ASTROPHYS J, V677, P92, DOI 10.1086/526414; HURLEY K, 1994, NATURE, V372, P652, DOI 10.1038/372652a0; KATZ JI, 1994, ASTROPHYS J, V432, pL27, DOI 10.1086/187503; KROLIK JH, 1991, ASTROPHYS J, V373, P277, DOI 10.1086/170048; Kumar P, 2007, MON NOT R ASTRON SOC, V376, pL57, DOI 10.1111/j.1365-2966.2007.00286.x; Lithwick Y, 2001, ASTROPHYS J, V555, P540, DOI 10.1086/321455; Meszaros P, 2002, ANNU REV ASTRON ASTR, V40, P137, DOI 10.1146/annurev.astro.40.060401.093821; NAGAYAMA T, 2008, 8274 GCN; OMODEI N, 2008, 8407 GCN; Pe'er A, 2004, ASTROPHYS J, V613, P448, DOI 10.1086/422989; PERRI M, 2008, 8261 GCN; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Rachen JP, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.123005; Racusin JL, 2008, NATURE, V455, P183, DOI 10.1038/nature07270; Razzaque S, 2005, MOD PHYS LETT A, V20, P2351, DOI 10.1142/S0217732305018414; RAZZAQUE S, 2008, ASTROPHYS J IN PRESS; Sari R, 2001, ASTROPHYS J, V548, P787, DOI 10.1086/319003; Stecker FW, 2006, ASTROPHYS J, V648, P774, DOI 10.1086/506188; STRATTA G, 2008, 1661 GCN; TAJIMA H, 2008, 8246 GCN; Wang XY, 2006, ASTROPHYS J, V641, pL89, DOI 10.1086/504151; Wren DN, 2002, ASTROPHYS J, V574, pL47, DOI 10.1086/342367	39	521	527	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1688	1693		10.1126/science.1169101	http://dx.doi.org/10.1126/science.1169101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19228997	Green Submitted			2022-12-28	WOS:000264559800029
J	Husseini, A; Abu-Rmeileh, NME; Mikki, N; Ramahi, TM; Abu Ghosh, H; Barghuthi, N; Khalili, M; Bjertness, E; Holmboe-Ottesen, G; Jervell, J				Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed; Ramahi, Tarik M.; Abu Ghosh, Heidar; Barghuthi, Nadim; Khalili, Mohammad; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak			Health in the Occupied Palestinian Territory 3 Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory	LANCET			English	Article							CORONARY-HEART-DISEASE; PREVENTING CHRONIC DISEASES; UNIVERSITY-STUDENTS; MEDITERRANEAN DIET; METABOLIC SYNDROME; PUBLIC-HEALTH; RISK-FACTORS; OBESITY; ADOLESCENTS; UNDERNUTRITION	Heart disease, cerebrovascular disease, and cancer are the major causes of morbidity and mortality in the occupied Palestinian territory, resulting in a high direct cost of care, high indirect cost in loss of production, and much societal stress. The rates of the classic risk factors for atherosclerotic disease-namely, hypertension, diabetes mellitus, tobacco smoking, and dyslipidaemia-are high and similar to those in neighbouring countries. The urbanisation and continuing nutritional change from a healthy Mediterranean diet to an increasingly western-style diet is associated with reduced activity, obesity and a loss of the protective effect of the traditional diet. Rates of cancer seem to be lower than those in neighbouring countries, with the leading causes of death being lung cancer in Palestinian men and breast cancer in women. The response of society and the health-care system to this epidemic is inadequate. A large proportion of health-care expenditure is on expensive curative care outside the area. Effective comprehensive prevention programmes should be implemented, and the health-care system should be redesigned to address these diseases.	[Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed] Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel; [Mikki, Nahed; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak] Univ Oslo, Inst Gen Practice & Community Med, Oslo, Norway; [Ramahi, Tarik M.] Yale Univ, Council Middle E Studies, New Haven, CT USA; [Abu Ghosh, Heidar] Palestinian Med Relief Soc, Chron Dis Ctr, Ramallah, Palestine; [Barghuthi, Nadim] Minist Hlth, Dept Noncommunicable dis, Ramallah, Palestine; [Khalili, Mohammad] UN, Relief & Works Agcy, Jerusalem, Israel; [Bjertness, Espen] Tibet Univ, Coll Med, Lhasa, Peoples R China	Birzeit University; University of Oslo; Yale University; Tibet University	Husseini, A (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel.	abdullatif@birzeit.edu	Abu-Rmeileh, Niveen ME/H-7135-2019; Husseini, Abdullatif/E-8377-2015	Husseini, Abdullatif/0000-0001-8767-5956	Norwegian Programme for Development, Research and Education	Norwegian Programme for Development, Research and Education	We thank the Lancet Palestine Steering Group (lain Chalmers, Rita Giacaman, Jennifer Leaning, Harry Shannon, and Huda Zurayk) for reading, discussing, and commenting on several drafts of this report; Graham Watt, and Karl Sabbagh for their valuable comments and support; Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine, and the Norwegian Programme for Development, Research and Education for their financial contributions that made the workshops related to this Series possible; and the reviewers ofthis report, whose comments improved this final draft substantially for their support and valuable advice.	Abdul-Rahim HF, 2003, INT J OBESITY, V27, P140, DOI 10.1038/sj.ijo.0802160; Abdul-Rahim HF, 2001, DIABETES CARE, V24, P275, DOI 10.2337/diacare.24.2.275; ABDULRAHIM HF, 2002, U OSLO, P35; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abudayya A, 2007, NUTR RES, V27, P762, DOI 10.1016/j.nutres.2007.09.017; ABURMEILEH NME, 2008, PREV CHRONIC DIS, P5; Al Sabbah H, 2007, PUBLIC HEALTH NUTR, V10, P739, DOI 10.1017/S1368980007665501; Al-Isa AN, 2004, EUR J CLIN NUTR, V58, P1273, DOI 10.1038/sj.ejcn.1601961; Al-Rukban MO, 2003, SAUDI MED J, V24, P27; Al-Saeed WY, 2007, OBES REV, V8, P93, DOI 10.1111/j.1467-789X.2006.00287.x; Al-Sendi AM, 2003, EUR J CLIN NUTR, V57, P471, DOI 10.1038/sj.ejcn.1601560; [Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Batniji R, 2008, LANCET, V372, P805, DOI 10.1016/S0140-6736(08)61334-3; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BENDEL M, 2005, BREAST CANC GAZA STR, P1; Berenson GS, 2005, NEUROBIOL AGING, V26, P303, DOI 10.1016/j.neurobiolaging.2004.05.009; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; *CENTR BUR STAT, HLTH SURV 2003 2004; *DEP HLTH, 1946, ANN HLTH REP 1945; Dominguez LJ, 2020, ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 2, P400, DOI 10.1016/B978-0-12-801238-3.62178-5; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; FARRAKH A, GLOBAL BURDEN CANC; Freedman L. S., CANC INCIDENCE 4 MEM; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Giacaman R., 1994, HLTH CONDITIONS SERV; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Hamdan M, 2003, HEALTH POLICY, V64, P243, DOI 10.1016/S0168-8510(03)00004-6; Husseini A, 2000, DIABETIC MED, V17, P746, DOI 10.1046/j.1464-5491.2000.00355.x; HUSSEINI A, 2002, THESIS U OSLO PALEST, P32; Jabara R, 2007, ISRAEL MED ASSOC J, V9, P316; Jackson M, 2002, PUBLIC HEALTH NUTR, V5, P281, DOI 10.1079/PHN2002262; *JORD MED ASS, 2008, MED HUM RES PAL; JUBRAN J, 2005, HLTH SEGREGATION H I; KALUSKI DN, 2008, PUBLIC HEALTH NUTR, P1; Kandela P, 2000, LANCET, V356, P1175, DOI 10.1016/S0140-6736(05)72871-3; Kark JD, 2000, LANCET, V356, P1410, DOI 10.1016/S0140-6736(00)02849-X; Kark JD, 2006, INT J EPIDEMIOL, V35, P448, DOI 10.1093/ije/dyl012; Khatib O, 2004, East Mediterr Health J, V10, P778; Kligler IJ, 1932, ANN AM ACAD POLIT SS, V164, P167, DOI 10.1177/000271623216400119; Kulwicki A, 2003, PUBLIC HEALTH NURS, V20, P177, DOI 10.1046/j.0737-1209.2003.20304.x; La Vecchia C, 2004, PUBLIC HEALTH NUTR, V7, P965, DOI 10.1079/PHN2004562; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MASTERMAN EW, 1920, HYGIENE DIS PALESTIN; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, INT J TUBERC LUNG D, V8, P882; *MIN HLTH, 2004, QUAL IMPR PROGR PAL; *MIN HLTH, 2002, HLTH STAT PAL 2001; *MIN HLTH, 2005, HLTH STAT PAL 2004; *MIN HLTH, 2006, HLTH STAT PAL 2005; *MIN HLTH, 2002, CANC 1995 2000; *MIN HLTH, 2003, HLTH STAT PAL 2002; *MIN HLTH, 2004, HLTH STAT PAL 2003; *MIN HLTH, 2001, CANC INC PAL 1998 19; *MIN HLTH, NAT STRAT HLTH PLAN; Palestinian Central Bureau of Statistics, 2007, PAL FAM HLTH SURV 20; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; RIONDA Z, 2000, BURDEN DIS W BANK GA; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Salameh Shaden, 2008, J Cardiometab Syndr, V3, P26, DOI 10.1111/j.1559-4572.2008.07315.x; SALHAB A, 2005, PALESTINIAN NATL CAN; Sawaya AL, 2003, NUTR REV, V61, P168, DOI 10.1301/nr.2003.may.168-175; Shamseddine A, 2004, ANN EPIDEMIOL, V14, P663, DOI 10.1016/j.annepidem.2003.12.002; Stabouli S, 2005, J PEDIATR-US, V147, P651, DOI 10.1016/j.jpeds.2005.06.008; Stene LCM, 1999, EUR J CLIN NUTR, V53, P953, DOI 10.1038/sj.ejcn.1600878; Stene LCM, 2001, EUR J CLIN NUTR, V55, P805, DOI 10.1038/sj.ejcn.1601230; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; *UN REL WORKS AG, 2007, ANN REP DEP HLTH; *UN REL WORKS AG H, 2005, TECHN INSTR MAN PROT; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; *WFP FAO, 2007, COMPR FOOD SEC VUL A; WHO, 2008, ACC HLTH SERV PAL PE; *WHO EMRO, COUNTR PROF WHO E ME; *WHO EMRO, REG DAT NONC DIS THE; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; BTSELEM SEPARATION B	80	96	97	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1041	1049		10.1016/S0140-6736(09)60109-4	http://dx.doi.org/10.1016/S0140-6736(09)60109-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19268350				2022-12-28	WOS:000264398200032
J	McCartney, M				McCartney, Margaret			Head to Head Will doctor rating sites improve the quality of care? No	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bacon N, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1030; Carvel J., 2008, GUARDIAN        1230; Cheraghi-Sohi S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-179; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; Mercer SW, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-22; Modayil PC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b396; Ness AR, 1999, BRIT MED J, V319, P114, DOI 10.1136/bmj.319.7202.114; *NHS CONN HLTH, CHOOS BOOK BEN NHS; Venn S., 2005, CLIN GOVERNANCE, V10, P118; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012	11	35	35	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2009	338								b1033	10.1136/bmj.b1033	http://dx.doi.org/10.1136/bmj.b1033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422NU	19293224				2022-12-28	WOS:000264435800036
J	Schneider, HG; Lam, L; Lokuge, A; Krum, H; Naughton, MT; Smit, PD; Bystrzycki, A; Eccleston, D; Federman, J; Flannery, G; Cameron, P				Schneider, Hans-Gerhard; Lam, Louisa; Lokuge, Amaali; Krum, Henry; Naughton, Matthew T.; Smit, Pieter De Villiers; Bystrzycki, Adam; Eccleston, David; Federman, Jacob; Flannery, Genevieve; Cameron, Peter			B-Type Natriuretic Peptide Testing, Clinical Outcomes, and Health Services Use in Emergency Department Patients With Dyspnea A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; DIAGNOSIS; MANAGEMENT; UTILITY; PERFORMANCE; DYSFUNCTION; GUIDELINES; ACCURACY; DISEASE; CARE	Background: B-type natriuretic peptide (BNP) is used to diagnose heart failure, but the effects of using the test on all dyspneic patients is uncertain. Objective: To assess whether BNP testing alters clinical outcomes and health services use of acutely dyspneic patients. Design: Randomized, single-blind study. Patients were assigned to a treatment group through randomized numbers in a sealed envelope. Patients were blinded to the intervention, but clinicians and those who assessed trial outcomes were not. Setting: 2 Australian teaching hospital emergency departments. Patients: 612 consecutive patients who presented with acute severe dyspnea from August 2005 to March 2007. Intervention: BNP testing (n = 306) or no testing (n = 306). Measurements: Admission rates, length of stay, and emergency department medications (primary outcomes); mortality and readmission rates (secondary outcomes). Results: There were no between-group differences in hospital admission rates (85.6% [BNP group] vs. 86.6% [control group]; difference,-1.0 percentage point [95% CI,-6.5 to 4.5 percentage points]; P = 0.73), length of admission (median, 4.4 days [interquartile range, 2 to 9 days] vs. 5.0 days [interquartile range, 2 to 9 days]; P = 0.94), or management of patients in the emergency department. Test discrimination was good (area under the receiveroperating characteristic curve, 0.87 [CI, 0.83 to 0.91]). Adverse events were not measured. Limitation: Most patients were very short of breath and required hospitalization; the findings might not apply for evaluating patients with milder degrees of breathlessness. Conclusion: Measurement of BNP in all emergency department patients with severe shortness of breath had no apparent effects on clinical outcomes or use of health services. The findings do not support routine use of BNP testing in all severely dyspneic patients in the emergency department.	Alfred Hlth, Prahran, Vic, Australia; Royal Melbourne Hosp, Parkville, Vic 3050, Australia	Royal Melbourne Hospital	Schneider, HG (corresponding author), Alfred Pathol Serv, POB 315,Commercial Rd, Prahran, Vic 3181, Australia.	schneiderh@alfred.org.au	Lam, Louisa/ADA-7185-2022; Lam, Louisa Lok Yi/R-7147-2018; Bystrzycki, Adam/ABC-5234-2020	Lam, Louisa Lok Yi/0000-0002-1439-0893; Bystrzycki, Adam/0000-0001-5384-9604; Schneider, Hans Gerhard/0000-0002-6048-8744; Cameron, Peter/0000-0002-1443-557X	Janssen-Cilag	Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	By an unrestricted educational grant from Janssen-Cilag to Drs. Schneider and Krum.	Abhayaratna WP, 2006, MED J AUSTRALIA, V184, P151, DOI 10.5694/j.1326-5377.2006.tb00173.x; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Australian Institute of Health and Welfare, 2004, HEART STROK VASC DIS; Burke MA, 2007, HEART FAIL REV, V12, P23, DOI 10.1007/s10741-007-9002-9; Cabanes L, 2001, CHEST, V120, P2047, DOI 10.1378/chest.120.6.2047; Chung T, 2006, AM HEART J, V152, P949, DOI 10.1016/j.ahj.2006.05.020; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21; Green SM, 2008, ARCH INTERN MED, V168, P741, DOI 10.1001/archinte.168.7.741; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Moe GW, 2007, CIRCULATION, V115, P3103, DOI 10.1161/CIRCULATIONAHA.106.666255; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Rawlins ML, 2005, AM J CLIN PATHOL, V123, P439, DOI 10.1309/PDJ2RMM80FVRDH7W; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rutten JHW, 2008, AM HEART J, V156, P71, DOI 10.1016/j.ahj.2008.02.021; Silver MA, 2006, CURR OPIN NEPHROL HY, V15, P14; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; Wright SP, 2003, J AM COLL CARDIOL, V42, P1793, DOI 10.1016/j.jacc.2003.05.011	24	56	58	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					365	W65		10.7326/0003-4819-150-6-200903170-00004	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293069				2022-12-28	WOS:000264468500001
J	Toggweiler, JR				Toggweiler, J. R.			Shifting Westerlies	SCIENCE			English	Editorial Material							LAST GLACIAL TERMINATION; ATMOSPHERIC CO2; SOUTHERN-HEMISPHERE; MODULATION		Princeton Univ, Geophys Fluid Dynam Lab, Natl Ocean & Atmospher Adm, Princeton, NJ 08540 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Toggweiler, JR (corresponding author), Princeton Univ, Geophys Fluid Dynam Lab, Natl Ocean & Atmospher Adm, Princeton, NJ 08540 USA.	robbie.toggweiler@noaa.gov	Toggweiler, J. R./O-5883-2019	Toggweiler, J. R./0000-0001-6345-5756				Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Gillett NP, 2003, NATURE, V422, P292, DOI 10.1038/nature01487; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; HURRELL JW, 1994, TELLUS A, V46, P325, DOI 10.1034/j.1600-0870.1994.t01-1-00007.x; Lamy F, 2007, EARTH PLANET SC LETT, V259, P400, DOI 10.1016/j.epsl.2007.04.040; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; McCabe GJ, 2001, J CLIMATE, V14, P2763, DOI 10.1175/1520-0442(2001)014<2763:TINHSC>2.0.CO;2; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Saenko OA, 2005, CLIM DYNAM, V25, P415, DOI 10.1007/s00382-005-0032-5; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020724; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154	12	118	124	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1434	1435		10.1126/science.1169823	http://dx.doi.org/10.1126/science.1169823			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286540				2022-12-28	WOS:000264101700024
J	Quirke, P; Steele, R; Monson, J; Grieve, R; Khanna, S; Couture, J; O'Callaghan, C; Myint, AS; Bessell, E; Thompson, LC; Parmar, M; Stephens, RJ; Sebag-Montefiore, D				Quirke, Phil; Steele, Robert; Monson, John; Grieve, Robert; Khanna, Subhash; Couture, Jean; O'Callaghan, Chris; Myint, Arthur Sun; Bessell, Eric; Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.; Sebag-Montefiore, David		MRC CR07 NCIC-CTG CO16 Trial; NCRI Colorectal Canc Study Grp	Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; RESECTION MARGIN INVOLVEMENT; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; ABDOMINOPERINEAL EXCISION; SURGICAL RESECTION; SURVIVAL; CARCINOMA; MULTICENTER; STOCKHOLM	Background Local recurrence rates in operable rectal cancer are improved by radiotherapy (with or without chemotherapy) and surgical techniques such as total mesorectal excision. However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved. Methods In this prospective study, the plane of surgery achieved and the involvement of the circumferential resection margin were assessed by local pathologists, using a standard pathological protocol in 1156 patients with operable rectal cancer from the CR07 and NCIC-CTG CO16 trial, which compared short-course (5 days) preoperative radiotherapy and selective postoperative chemoradiotherapy, between March, 1998, and August, 2005. All analyses were by intention to treat. This trial is registered, number ISRCTN 28785842. Findings 128 patients (11%) had involvement of the circumferential resection margin, and the plane of surgery achieved was classified as good (mesorectal) in 604 (52%), intermediate (intramesorectal) in 398 (34%), and poor (muscularis propria plane) in 154 (13%). We found that both a negative circumferential resection margin and a superior plane of surgery achieved were associated with low local recurrence rates. Hazard ratio (HR) was 0 - 32 (95% CI 0.16-0.63, p=0.0011) with 3-year local recurrence rates of 6% (5-8%) and 17% (10-26%) for patients who were negative and positive for circumferential resection margin, respectively. For plane of surgery achieved, HRs for mesorectal and intramesorectal groups compared with the muscularis propria group were 0 - 32 (0.16-0.64) and 0.48 (0.25-0.93), respectively. At 3 years, the estimated local recurrence rates were 4% (3-6%) for mesorectal, 7% (5-11%) for intramesorectal, and 13% (8-21%) for muscularis propria groups. The benefit of short-course preoperative radiotherapy did not differ in the three plane of surgery groups (p=0.30 for trend). Patients in the short-course preoperative radiotherapy group who had a resection in the mesorectal plane had a 3-year local recurrence rate of only 1%. Interpretation In rectal cancer, the plane of surgery achieved is an important prognostic factor for local recurrence. Short-course preoperative radiotherapy reduced the rate of local recurrence for all three plane of surgery groups, almost abolishing local recurrence in short-course preoperative radiotherapy patients who had a resection in the mesorectal plane. The plane of surgery achieved should therefore be assessed and reported routinely. Funding Medical Research Council (UK) and the National Cancer Institute of Canada.	[Quirke, Phil] Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Quirke, Phil] Univ Leeds, Leeds LS9 7TF, W Yorkshire, England; [Steele, Robert] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Monson, John] Castle Hill Hosp, Kingston Upon Hull, N Humberside, England; [Grieve, Robert] Walsgrave Gen Hosp, Coventry CV2 2DY, W Midlands, England; [Khanna, Subhash] Leicester Royal Infirm, Leicester, Leics, England; [Couture, Jean; O'Callaghan, Chris] Natl Canc Inst Canada, Kingston, ON, Canada; [Myint, Arthur Sun] Clatterbridge Ctr Oncol, Wirral, Merseyside, England; [Bessell, Eric] City Hosp Nottingham, Nottingham, England; [Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.] MRC, Clin Trial Unit, London, England	Saint James's University Hospital; University of Leeds; University of Leeds; University of Dundee; University of Hull; University of Leicester; Queens University - Canada; Canadian Cancer Trials Group; Clatterbridge Cancer Centre; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Medical Research Council Clinical Trials Unit	Quirke, P (corresponding author), Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	patpq@leeds.ac.uk	Quirke, Philip/AAI-1362-2019; Myint, Arthur Sun/AAO-7695-2020	Myint, Arthur Sun/0000-0001-5323-5696; Sebag-Montefiore, David/0000-0002-5978-9259; Quirke, Philip/0000-0002-3597-5444; Steele, Robert JC/0000-0003-4248-6785	Medical Research Council (MRC); Canadian Cancer Society; Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC [MC_U122861325] Funding Source: UKRI; Medical Research Council [MC_U122861325] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Medical Research Council (MRC) and the Canadian Cancer Society for supporting this study; the Yorkshire Cancer Research and the Experimental Cancer Medicine Centre programme, ",Inch supported PQ; the Trial Management Group, other members of the Protocol Development Group, the Independent Data Monitoring Committee, the Trial Steering Committee, the staff at the MRC Clinical Trial Unit, arid the oncologists, surgeons, pathologists, research staff. arid all the patients who participated in this trial.	ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Birbeck KF, 2002, ANN SURG, V235, P449, DOI 10.1097/00000658-200204000-00001; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 2002, INT J RADIAT ONCOL, V54, P654, DOI 10.1016/S0360-3016(02)02880-8; Dexter SPL, 2001, GUT, V48, P667, DOI 10.1136/gut.48.5.667; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; HEALD RJ, 1986, LANCET, V1, P1479; HOHENBERGER W, 1997, RECTAL CANC SURG OPT, P353; Kapiteijn E, 2002, BRIT J SURG, V89, P1142, DOI 10.1046/j.1365-2168.2002.02196.x; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Martling A, 2005, BRIT J SURG, V92, P225, DOI 10.1002/bjs.4834; MCCALL JL, 1995, INT J COLORECTAL DIS, V10, P126, DOI 10.1007/BF00298532; Nagtegaal ID, 2005, J CLIN ONCOL, V23, P9257, DOI 10.1200/JCO.2005.02.9231; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Pahlman L, 1997, NEW ENGL J MED, V336, P980; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; Quirke P, 2003, LANCET ONCOL, V4, P695, DOI 10.1016/S1470-2045(03)01248-8; QUIRKE P, 1997, RECTAL CANC SURG OPT, P63; SAGAR PM, 1993, BRIT J SURG, V80, P1386, DOI 10.1002/bjs.1800801109; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; West NP, 2008, LANCET ONCOL, V9, P857, DOI 10.1016/S1470-2045(08)70181-5; West NP, 2008, J CLIN ONCOL, V26, P3517, DOI 10.1200/JCO.2007.14.5961; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1007/s10350-004-6317-7	33	709	738	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					821	828		10.1016/S0140-6736(09)60485-2	http://dx.doi.org/10.1016/S0140-6736(09)60485-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269520	Green Published			2022-12-28	WOS:000263980900032
J	Gunn, PP; Joiner, SD				Gunn, Patrick P.; Joiner, Scott D.			Certificates Should Be Strengthened	SCIENCE			English	Letter									[Gunn, Patrick P.; Joiner, Scott D.] Kronish LLP, San Francisco, CA 94111 USA		Gunn, PP (corresponding author), Kronish LLP, 101 Calif St,5th Floor, San Francisco, CA 94111 USA.	pgunn@cooley.com						BESKOW M, 2008, SCIENCE         1114, P1054; *NIH OFF EXTR RES, FREQ ASK QUEST CERT; Traynor M, 1996, LAW CONTEMP PROBL, V59, P119, DOI 10.2307/1192126	3	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1289	1289		10.1126/science.323.5919.1289	http://dx.doi.org/10.1126/science.323.5919.1289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265003				2022-12-28	WOS:000263876700017
J	Kim, BJ; Ohsumi, H; Komesu, T; Sakai, S; Morita, T; Takagi, H; Arima, T				Kim, B. J.; Ohsumi, H.; Komesu, T.; Sakai, S.; Morita, T.; Takagi, H.; Arima, T.			Phase-Sensitive Observation of a Spin-Orbital Mott State in Sr2IrO4	SCIENCE			English	Article								Measurement of the quantum-mechanical phase in quantum matter provides the most direct manifestation of the underlying abstract physics. We used resonant x-ray scattering to probe the relative phases of constituent atomic orbitals in an electronic wave function, which uncovers the unconventional Mott insulating state induced by relativistic spin-orbit coupling in the layered 5d transition metal oxide Sr2IrO4. A selection rule based on intra-atomic interference effects establishes a complex spin-orbital state represented by an effective total angular momentum = 1/2 quantum number, the phase of which can lead to a quantum topological state of matter.	[Kim, B. J.; Takagi, H.] Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan; [Kim, B. J.; Takagi, H.] RIKEN, Adv Sci Inst, Magnet Mat Lab, Wako, Saitama 3510198, Japan; [Ohsumi, H.; Komesu, T.; Sakai, S.; Morita, T.; Arima, T.] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Sakai, S.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; [Morita, T.] Kwansei Gakuin Univ, Dept Phys, Sanda 6691337, Japan; [Arima, T.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	University of Tokyo; RIKEN; RIKEN; Hiroshima University; Kwansei Gakuin University; Tohoku University	Kim, BJ (corresponding author), Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan.	bjkim6@gmail.com; htakagi@k.u-tokyo.ac.jp	Takagi, Hidenori/B-2935-2010; TAKAGI, HIDENORI/Q-1041-2019; Ohsumi, Hiroyuki/H-2550-2013; Arima, Tala-hisa/G-9217-2012	TAKAGI, HIDENORI/0000-0001-5700-3761; Arima, Tala-hisa/0000-0002-6959-0454; Ohsumi, Hiroyuki/0000-0002-6418-8984	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19104008, 19052001, 19052008]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors gratefully acknowledge discussions with C. Kim, J.-H. Park, S. Fujiyama, J. Matsuno, B. Smith, and G. Khaliullin; preliminary x-ray analysis by D. Hashizume; and continuous encouragement by M. Takata and T. Ishikawa. This work was partly supported by a Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research (S) (19104008) and Grant-in-Aid for Scientific Research on Priority Areas "Novel States of Matter Induced by Frustration" (19052001 and 19052008).	Abbamonte P, 2002, SCIENCE, V297, P581, DOI 10.1126/science.1070903; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Blume M., 1994, RESONANT ANOMALOUS X; Cao G, 1998, PHYS REV B, V57, pR11039, DOI 10.1103/PhysRevB.57.R11039; CRAWFORD MK, 1994, PHYS REV B, V49, P9198, DOI 10.1103/PhysRevB.49.9198; Kim BJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106401; Kim BJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076402; Tokura Y., 2000, COLOSSAL MAGNETORESI	9	909	914	6	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1329	1332		10.1126/science.1167106	http://dx.doi.org/10.1126/science.1167106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265017				2022-12-28	WOS:000263876700038
J	Liu, ZH; Pagani, M; Zinniker, D; DeConto, R; Huber, M; Brinkhuis, H; Shah, SR; Leckie, RM; Pearson, A				Liu, Zhonghui; Pagani, Mark; Zinniker, David; DeConto, Robert; Huber, Matthew; Brinkhuis, Henk; Shah, Sunita R.; Leckie, R. Mark; Pearson, Ann			Global Cooling During the Eocene-Oligocene Climate Transition	SCIENCE			English	Article							ANTARCTIC GLACIATION; SEA TEMPERATURES; ICE; OCEAN; GREENLAND; LIPIDS; HEMISPHERE; EVOLUTION; BOUNDARY; PACIFIC	About 34 million years ago, Earth's climate shifted from a relatively ice-free world to one with glacial conditions on Antarctica characterized by substantial ice sheets. How Earth's temperature changed during this climate transition remains poorly understood, and evidence for Northern Hemisphere polar ice is controversial. Here, we report proxy records of sea surface temperatures from multiple ocean localities and show that the high-latitude temperature decrease was substantial and heterogeneous. High-latitude (45 degrees to 70 degrees in both hemispheres) temperatures before the climate transition were similar to 20 degrees C and cooled an average of similar to 5 degrees C. Our results, combined with ocean and ice-sheet model simulations and benthic oxygen isotope records, indicate that Northern Hemisphere glaciation was not required to accommodate the magnitude of continental ice growth during this time.	[Liu, Zhonghui; Pagani, Mark; Zinniker, David] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [DeConto, Robert; Leckie, R. Mark] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Huber, Matthew] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Brinkhuis, Henk] Univ Utrecht, Palaeobot & Palynol Lab, NL-3584 CD Utrecht, Netherlands; [Shah, Sunita R.; Pearson, Ann] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Yale University; University of Hong Kong; University of Massachusetts System; University of Massachusetts Amherst; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Utrecht University; Harvard University	Liu, ZH (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	zhliu@hku.hk; mark.pagani@yale.edu	Brinkhuis, Henk/B-4223-2009; Shah Walter, Sunita/D-4981-2013; Pearson, Ann/A-6723-2009; Huber, Matthew/A-7677-2008; Pagani, Mark/B-3233-2008; Liu, Zhonghui/D-3163-2009; Walter, Sunita Shah/J-9023-2019	Shah Walter, Sunita/0000-0003-2206-9052; Huber, Matthew/0000-0002-2771-9977; Liu, Zhonghui/0000-0002-2168-8305; Pearson, Ann/0000-0003-2785-8405; Brinkhuis, Henk/0000-0003-0253-6610; Leckie, R. Mark/0000-0002-7311-2180	Yale University [postdoctoral fellowship]; NSF [Major Research Instrumentation]; GNS Science	Yale University; NSF(National Science Foundation (NSF)); GNS Science	The authors thank S. Schouten and E. Hopmans for their assistance in establishing an interlaboratory calibration, J. Eldrett for advice on the site 913 age model, M. Woodruff of the University of Massachussetts Stable Isotope Facility for analyses of site 511 material, and Integrated Ocean Drilling Program for providing samples. The reviews of P. Wilson and one anonymous referee greatly improved the manuscript. This work was supported by a postdoctoral fellowship provided by Yale University and a Major Research Instrumentation grant from NSF. Computing was performed on Rosen Center for Advanced Computing resources within Information Technology at Purdue. M.H.'s contribution is partially supported by the New Zealand's Global Change Through Time Programme at GNS Science.	Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; Brinkhuis H., 1995, SOC ECON PALEONT MIN, V54, P295; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Grimalt J.O., 2000, GEOCHEM GEOPHY GEOSY, V1; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Huber M, 2006, PALAEOGEOGR PALAEOCL, V231, P9, DOI 10.1016/j.palaeo.2005.07.037; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; MUZA JP, 1983, INITIAL REP DEEP SEA, V71, P409; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Prothero DR, 1996, PALAEOGEOGR PALAEOCL, V127, P257, DOI 10.1016/S0031-0182(96)00099-5; Schouten S, 2004, ORG GEOCHEM, V35, P567, DOI 10.1016/j.orggeochem.2004.01.012; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Schouten S, 2008, GEOLOGY, V36, P147, DOI 10.1130/G24332A.1; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; Shah SR, 2008, GEOCHIM COSMOCHIM AC, V72, P4577, DOI 10.1016/j.gca.2008.06.021; Tripati AK, 2008, EARTH PLANET SC LETT, V265, P112, DOI 10.1016/j.epsl.2007.09.045; Turich C, 2007, GEOCHIM COSMOCHIM AC, V71, P3272, DOI 10.1016/j.gca.2007.04.013; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	32	494	519	5	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1187	1190		10.1126/science.1166368	http://dx.doi.org/10.1126/science.1166368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251622	Green Published			2022-12-28	WOS:000263687600031
J	Fisher, ES; Bynum, JP; Skinner, JS				Fisher, Elliott S.; Bynum, Julie P.; Skinner, Jonathan S.			Health Care 2009: Slowing the Growth of Health Care Costs -- Lessons from Regional Variation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS		[Fisher, Elliott S.] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH USA	Dartmouth College	Fisher, ES (corresponding author), Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH USA.				NIA NIH HHS [P01 AG019783, P01 AG019783-08] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; Chernew ME, 1998, MED CARE RES REV, V55, P259, DOI 10.1177/107755879805500301; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34	5	284	287	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					849	852		10.1056/NEJMp0809794	http://dx.doi.org/10.1056/NEJMp0809794			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	411CD	19246356	Green Accepted			2022-12-28	WOS:000263624700001
J	Jeruss, JS; Woodruff, TK				Jeruss, Jacqueline S.; Woodruff, Teresa K.			Current Concepts: Preservation of Fertility in Patients with Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OVARIAN TISSUE CRYOPRESERVATION; LONG-TERM SURVIVORS; TESTICULAR CANCER; HODGKINS LYMPHOMA; CHILDHOOD-CANCER; BREAST-CANCER; YOUNG-WOMEN; TRANSPLANTATION; CHEMOTHERAPY; FAILURE		[Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Jeruss, Jacqueline S.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Inst Womens Hlth Res, Chicago, IL 60611 USA; [Jeruss, Jacqueline S.; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Woodruff, TK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, 303 E Super St,Suite 4-115, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health [UL1 RR024926]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by a grant from the National Institutes of Health (UL1 RR024926).; No potential conflict of interest relevant to this article was reported.; We thank Robert E. Brannigan, M. D., Jeffrey Chang, M. D., William Gradishar, M. D., Laxmi A. Kondapalli, M. D., Thomas O'Halloran, Ph. D., Lonnie D. Shea, Ph. D., and William Small, M. D., for their critical review of an earlier version of the manuscript, and the members of the Oncofertility Consortium.	Agarwal Sanjay K., 2007, V138, P15; Alter Blanche P, 2007, Hematology Am Soc Hematol Educ Program, P29, DOI 10.1182/asheducation-2007.1.29; American Cancer Society, 2008, CANC FACTS FIG 2008; American Cancer Society, 2007, BREAST CANC FACTS FI; Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; Arnon J, 2001, HUM REPROD UPDATE, V7, P394, DOI 10.1093/humupd/7.4.394; ASH P, 1980, BRIT J RADIOL, V53, P271, DOI 10.1259/0007-1285-53-628-271; Backhus Leilah E., 2007, V138, P235; Blakely LJ, 2004, CANCER-AM CANCER SOC, V100, P465, DOI 10.1002/cncr.11929; Blumenfeld Z, 2008, FERTIL STERIL, V89, P166, DOI 10.1016/j.fertnstert.2007.02.010; Brannigan Robert E., 2007, V138, P28; Brown JR, 1996, HUM REPROD, V11, P197; Burstein HJ, 2000, NEW ENGL J MED, V343, P1086, DOI 10.1056/NEJM200010123431506; BYRNE J, 1987, NEW ENGL J MED, V317, P1315, DOI 10.1056/NEJM198711193172104; Chemaitilly W, 2006, J CLIN ENDOCR METAB, V91, P1723, DOI 10.1210/jc.2006-0020; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Colgan TJ, 2001, AM J SURG PATHOL, V25, P1283, DOI 10.1097/00000478-200110000-00009; Davis VL, 2006, CANCER-AM CANCER SOC, V107, P1690, DOI 10.1002/cncr.22105; Demeestere I, 2006, HUM REPROD, V21, P2010, DOI 10.1093/humrep/del092; Donaldson SS, 2007, J CLIN ONCOL, V25, P332, DOI 10.1200/JCO.2006.08.4772; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J, 2004, LANCET, V364, P2020; Elizur SE, 2004, FERTIL STERIL, V82, pS116, DOI 10.1016/j.fertnstert.2004.07.294; Falcone T, 2004, FERTIL STERIL, V81, P243, DOI 10.1016/j.fertnstert.2003.06.031; Feldschuh Joseph, 2005, Fertil Steril, V84, P1017; Gadducci A, 2007, GYNECOL ENDOCRINOL, V23, P625, DOI 10.1080/09513590701582406; Gordon W, 1997, INT J RADIAT ONCOL, V38, P83, DOI 10.1016/S0360-3016(97)00235-6; Goss PE, 2007, BREAST CANCER RES TR, V105, P45, DOI 10.1007/s10549-007-9698-1; Gracia Clarisa R., 2007, V138, P57; Gradishar William J, 2002, Clin Breast Cancer, V2, P282, DOI 10.3816/CBC.2002.n.003; Gupta PB, 2006, J STEROID BIOCHEM, V102, P71, DOI 10.1016/j.jsbmb.2006.09.025; HANSEN PV, 1990, RADIOTHER ONCOL, V18, P117, DOI 10.1016/0167-8140(90)90137-L; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hirt R, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.09.011; Howell SJ, 2001, HUM REPROD UPDATE, V7, P363, DOI 10.1093/humupd/7.4.363; Ives A, 2007, BMJ-BRIT MED J, V334, P194, DOI 10.1136/bmj.39035.667176.55; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KOHRMAN A, 1995, PEDIATRICS, V95, P314; Lampe H, 1997, J CLIN ONCOL, V15, P239, DOI 10.1200/JCO.1997.15.1.239; Lee David, 2007, V138, P110; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nakayama K, 2008, NAT CLIN PRACT ONCOL, V5, P78, DOI 10.1038/ncponc1016; Nalesnik JG, 2004, AM J CLIN ONCOL-CANC, V27, P584, DOI 10.1097/01.coc.0000135736.18493.dd; O'Flaherty C, 2008, HUM REPROD, V23, P1044, DOI 10.1093/humrep/den081; Oktay K, 2005, J CLIN ONCOL, V23, P4347, DOI 10.1200/JCO.2005.05.037; Oktay K, 2004, EUR J OBSTET GYN R B, V113, pS45, DOI 10.1016/j.ejogrb.2003.11.010; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Partridge AH, 2007, BREAST, V16, pS175, DOI 10.1016/j.breast.2007.07.029; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Razzak AR, 2008, BREAST CANCER-TOKYO, V15, P31, DOI 10.1007/s12282-007-0007-y; Roberts Jeffrey E, 2005, J Natl Cancer Inst Monogr, P57; ROWLEY MJ, 1974, RADIAT RES, V59, P665, DOI 10.2307/3574084; Schattman G, 2007, FERTIL STERIL, V88, P1495, DOI 10.1016/j.fertnstert.2007.10.009; Schenker JG, 2004, J ASSIST REPROD GEN, V21, P375, DOI 10.1007/s10815-004-7523-x; Schmiegelow ML, 1998, J PEDIAT HEMATOL ONC, V20, P429, DOI 10.1097/00043426-199809000-00004; Schrader M, 2003, UROLOGY, V61, P421, DOI 10.1016/S0090-4295(02)02264-1; Schroder CP, 2004, HUM REPROD, V19, P1069, DOI 10.1093/humrep/deh244; Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243; Stachecki JJ, 2004, REPROD BIOMED ONLINE, V9, P152, DOI 10.1016/S1472-6483(10)62124-4; Stahl O, 2006, HUM REPROD, V21, P3199, DOI 10.1093/humrep/del292; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Tempest HG, 2008, HUM REPROD, V23, P251, DOI 10.1093/humrep/dem389; Tulandi T, 2004, OBSTET GYN CLIN N AM, V31, P611, DOI 10.1016/j.ogc.2004.05.005; van Beek RD, 2007, J CLIN ENDOCR METAB, V92, P3869, DOI 10.1210/jc.2006-2374; West ER, 2007, SEMIN REPROD MED, V25, P287, DOI 10.1055/s-2007-980222; Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2; Woodruff Teresa K., 2007, V138, P3; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739	75	416	435	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					902	911		10.1056/NEJMra0801454	http://dx.doi.org/10.1056/NEJMra0801454			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246362	Green Accepted			2022-12-28	WOS:000263624700009
J	Kozhimannil, KB; Pereira, MA; Harlow, BL				Kozhimannil, Katy Backes; Pereira, Mark A.; Harlow, Bernard L.			Association Between Diabetes and Perinatal Depression Among Low-Income Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTPARTUM MOOD DISORDERS; ADMINISTRATIVE DATA; PSYCHIATRIC DIAGNOSES; POSTNATAL DEPRESSION; MAJOR DEPRESSION; PREGNANCY; WOMEN; PREVALENCE; RISK; MEDICAID	Context Perinatal depression affects at least 10% to 12% of new mothers, and diabetes complicates up to 9% of pregnancies. Prior research shows a higher rate of major depression among individuals with diabetes. Objective To examine the association between diabetes and depression during pregnancy and the postpartum period among a sample of low- income women. Design, Setting, and Patients Retrospective cohort study using data from New Jersey's Medicaid administrative claims database of 11 024 women who gave birth between July 1, 2004, and September 30, 2006, and who were continuously enrolled in Medicaid for 6 months prior to delivery and 1 year after giving birth. Main Outcome Measures Multivariate logistic regression was used to assess the association between prepregnancy diabetes or gestational diabetes and perinatal depression. Depression was defined as an International Classification of Diseases, Ninth Revision, diagnosis for depression or a prescription drug claim for an antidepressant medication, and diabetes was defined as having a diabetes diagnosis or filling a prescription for a diabetes medication. Both measures were assessed during the 6 months prior to and up to 1 year following delivery. Results In the sample of women who gave birth, 15.2% ( n= 100) with prepregnancy or gestational diabetes and 8.5% ( n= 886) without diabetes were depressed during pregnancy or postpartum. After adjusting for age, race, year of delivery, and gestational age at birth, women with diabetes compared with those without diabetes had nearly double the odds of experiencing depression during the perinatal period ( odds ratio, 1.85; 95% confidence interval, 1.45- 2.36). Women with diabetes and no prenatal indication of depression ( n= 62, 9.6%) had higher odds than their counterparts without diabetes ( n= 604, 5.9%) of receiving a postpartum depression diagnosis or taking an antidepressant medication in the year following delivery ( odds ratio, 1.69; 95% confidence interval, 1.27- 2.23). Conclusion Prepregnancy or gestational diabetes was independently associated with perinatal depression, including new onset of postpartum depression, in our sample of low-income new mothers.	[Pereira, Mark A.; Harlow, Bernard L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Kozhimannil, Katy Backes] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Kozhimannil, Katy Backes] Harvard Pilgrim Hlth Care, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Harlow, BL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S 2nd St,Ste 300, Minneapolis, MN 55454 USA.	harlow@umn.edu		Pereira, Mark/0000-0002-6704-5276; Harlow, Bernard/0000-0002-6735-8862	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	This study was supported by the Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; a Harvard University Dissertation Completion Grant; the Harvard University PhD Program in Health Policy; and the Harvard Pilgrim Health Care Foundation.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; American College of Obstetricians and Gynecologists, 2001, CLIN MAN GUID OBST G; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2005, PERINATAL DEPRESSION; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; Chen TH, 2006, MED HYPOTHESES, V66, P820, DOI 10.1016/j.mehy.2005.09.032; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; Fergerson SS, 2002, AM J OBSTET GYNECOL, V186, P899, DOI 10.1067/mob.2002.123404; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gilmer T, 2001, MED CARE, V39, P1188, DOI 10.1097/00005650-200111000-00006; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; GOTLIB IH, 1989, J CONSULT CLIN PSYCH, V57, P269, DOI 10.1037/0022-006X.57.2.269; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; *KAIS COMM MED UN, 2007, NEW JERS US STAT MED; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Mezey G, 2005, BJOG-INT J OBSTET GY, V112, P197, DOI 10.1111/j.1471-0528.2004.00307.x; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; SCHWARTZ AH, 1980, AM J PUBLIC HEALTH, V70, P406, DOI 10.2105/AJPH.70.4.406; SEGUIN L, 1995, OBSTET GYNECOL, V85, P583, DOI 10.1016/0029-7844(94)00449-N; Setse R, 2008, MATERN CHILD HLTH J, V12, P119, DOI 10.1007/s10995-007-0211-6; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; STEIN A, 1991, BRIT J PSYCHIAT, V158, P46, DOI 10.1192/bjp.158.1.46; STOWE ZN, 1995, AM J OBSTET GYNECOL, V173, P639, DOI 10.1016/0002-9378(95)90296-1; Waldo DP, 2004, HEALTH CARE FINANC R, V26, P61; Walkup JT, 2000, ADM POLICY MENT HLTH, V27, P129, DOI 10.1023/A:1021308007343; Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147; Weinberg MK, 1998, J CLIN PSYCHIAT, V59, P53; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	44	124	130	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					842	847		10.1001/jama.2009.201	http://dx.doi.org/10.1001/jama.2009.201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410WV	19244191				2022-12-28	WOS:000263609900025
J	Heerspink, HL; Ninomiya, T; Zoungas, S; de Zeeuw, D; Grobbee, DE; Jardine, MJ; Gallagher, M; Roberts, MA; Cass, A; Neal, B; Perkovic, V				Heerspink, HiddoJ Lambers; Ninomiya, Toshiharu; Zoungas, Sophia; de Zeeuw, Dick; Grobbee, Diederick E.; Jardine, Meg J.; Gallagher, Martin; Roberts, Matthew A.; Cass, Alan; Neal, Bruce; Perkovic, Vlado			Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials	LANCET			English	Article							CHRONIC KIDNEY-DISEASE; ENZYME-INHIBITOR; CLINICAL-TRIALS; FOLIC-ACID; HEMODIALYSIS; PREVENTION; RAMIPRIL; QUALITY	Background Patients undergoing dialysis have a substantially increased risk of cardiovascular mortality and morbidity. Although several trials have shown the cardiovascular benefits of lowering blood pressure in the general population, there is uncertainty about the efficacy and tolerability of reducing blood pressure in patients on dialysis. We did a systematic review and meta-analysis to assess the effect of blood pressure lowering in patients on dialysis. Methods We systematically searched Medline, Embase, and the Cochrane Library database for trials reported between 1950 and November, 2008, without language restriction. We extracted a standardised dataset from randomised controlled trials of blood pressure lowering in patients on dialysis that reported cardiovascular outcomes. Meta-analysis was done with a random effects model. Findings We identified eight relevant trials, which provided data for 1679 patients and 495 cardiovascular events. Weighted mean systolic blood pressure was 4.5 mm Hg lower and diastolic blood pressure 2.3 mm Hg lower in actively treated patients than in controls. Blood pressure lowering treatment was associated with lower risks of cardiovascular events (RR 0.71, 95% CI 0.55-0.92; p=0.009), all-cause mortality (RR 0.80, 0.66-0.96; p=0.014), and cardiovascular mortality (RR 0.71, 0.50-0.99; p=0.044) than control regimens. The effects seem to be consistent across a range of patient groups included in the studies. Interpretation Treatment with agents that lower blood pressure should routinely be considered for individuals undergoing dialysis to reduce the very high cardiovascular morbidity and mortality rate in this population. Funding National Health and Medical Research Council of Australia Program.	[Heerspink, HiddoJ Lambers; Ninomiya, Toshiharu; Zoungas, Sophia; Grobbee, Diederick E.; Jardine, Meg J.; Gallagher, Martin; Cass, Alan; Neal, Bruce; Perkovic, Vlado] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; [Heerspink, HiddoJ Lambers; de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Grobbee, Diederick E.] Univ Med Ctr Utrecht, Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Zoungas, Sophia] Monash Univ, Melbourne, Vic 3004, Australia; [Roberts, Matthew A.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia	University of Sydney; University of Groningen; Utrecht University; Utrecht University Medical Center; Monash University; University of Melbourne	Perkovic, V (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	vperkovic@george.org.au	Heerspink, Hiddo J Lambers/K-3358-2014; Grobbee, Diederick/C-7651-2014; Jardine, Meg/AAS-1864-2020; de Zeeuw, Dick/E-9080-2014; Perkovic, Vlado/AAY-1933-2021; Jardine, Meg/AFR-1699-2022	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Grobbee, Diederick/0000-0003-4472-4468; Jardine, Meg/0000-0002-0160-2375; de Zeeuw, Dick/0000-0003-3434-7777; Jardine, Meg/0000-0002-0160-2375; Gallagher, Martin/0000-0001-9187-6187; Zoungas, Sophia/0000-0003-2672-0949; Neal, Bruce/0000-0002-0490-7465; Perkovic, Vlado/0000-0002-4257-7620	National Health and Medical Research Council of Australia Program [571281]; the Saal van Zwanenburg Stichting; Dutch Kidney Foundation; International Society of Hypertension Visiting Postdoctoral Fellowship; Foundation for High Blood Pressure Research Council of Australia; National Health and Medical Research Council of Australia Health Professional Research Fellowship; National Heart Foundation of Australia AstraZeneca research fellowship; National Health and Medical Research Council of Australia Senior Research Fellowship	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); the Saal van Zwanenburg Stichting; Dutch Kidney Foundation; International Society of Hypertension Visiting Postdoctoral Fellowship; Foundation for High Blood Pressure Research Council of Australia; National Health and Medical Research Council of Australia Health Professional Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia AstraZeneca research fellowship(National Heart Foundation of Australia); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	HJLH was supported by a Fellowship from the Saal van Zwanenburg Stichting, Dutch Kidney Foundation, and International Society of Hypertension Visiting Postdoctoral Fellowship awarded by the Foundation for High Blood Pressure Research Council of Australia. SZ was supported by a National Health and Medical Research Council of Australia Health Professional Research Fellowship. VP was supported by a National Heart Foundation of Australia AstraZeneca research fellowship. AC was supported by a National Health and Medical Research Council of Australia Senior Research Fellowship. This work was supported in part by a National Health and Medical Research Council of Australia Program grant (ID number 571281).	Agarwal R, 2009, HYPERTENSION, V53, P500, DOI 10.1161/HYPERTENSIONAHA.108.125674; Bakris G, 2008, AM J KIDNEY DIS, V51, pS1, DOI 10.1053/j.ajkd.2008.01.015; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; CICE G, 2006, J HYPERTENS        S, V24, pS56; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Jadad AR, 1996, PAIN, V66, P239, DOI 10.1016/0304-3959(96)03033-3; Li PKT, 2003, ANN INTERN MED, V139, P105, DOI 10.7326/0003-4819-139-2-200307150-00010; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; NAKAO N, 2007, J AM SOC NEPHROL, V18, pA709; Neal B, 2000, LANCET, V356, P1955; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Stidley CA, 2006, J AM SOC NEPHROL, V17, P513, DOI 10.1681/ASN.2004110921; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Tepel M, 2008, NEPHROL DIAL TRANSPL, V23, P3605, DOI 10.1093/ndt/gfn304; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F., 2007, J HYPERTENS, V25, P951, DOI [DOI 10.1097/HJH.0B013E3280BAD9B4, 10.1097/HJH.0b013-3280bad9b4]; Udayaraj UP, 2009, AM J KIDNEY DIS, V53, P70, DOI 10.1053/j.ajkd.2008.08.030; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vianna Areuza C A, 2007, Hemodial Int, V11, P210, DOI 10.1111/j.1542-4758.2007.00171.x; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Woodward M., 2005, EPIDEMIOLOGY DESIGN; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	33	227	248	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1009	1015		10.1016/S0140-6736(09)60212-9	http://dx.doi.org/10.1016/S0140-6736(09)60212-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19249092	Green Published			2022-12-28	WOS:000264398200028
J	Calonge, N; Petitti, DB; DeWitt, TG; Gordis, L; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Siu, AL; Teutsch, SM; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.		US Preventive Serv Task Force	Aspirin for the Prevention of Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; STROKE; RISK; EVENTS; UPDATE	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation about the use of aspirin for the prevention of coronary heart disease. Methods: Review of the literature since 2002, focusing on new evidence on the benefits and harms of aspirin for the primary prevention of cardiovascular disease, including myocardial infarction and stroke. The new evidence was reviewed and synthesized according to sex. Recommendations: Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Encourage women age 55 to 79 years to use aspirin when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (A recommendation) Evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease prevention in men and women 80 years or older. (I statement) Do not encourage aspirin use for cardiovascular disease prevention in women younger than 55 years and in men younger than 45 years. (D recommendation)	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Arizona State Univ, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Gordis, Leon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Augusta, GA 30912 USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Siu, Albert L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Teutsch, Steven M.] Merck & Co Inc, West Point, PA USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN USA	Colorado Department of Public Health & Environment; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Merck & Company; Olmsted Medical Center	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.				USPSTF; U. S. Congress; Agency for Healthcare Research and Quality	USPSTF; U. S. Congress; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial Support: The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009	12	440	451	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					396	W70						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293072				2022-12-28	WOS:000264468500005
J	Waterston, T; Halileh, S; Odeh, J; Rudolf, M; Hamilton, P				Waterston, Tony; Halileh, Samia; Odeh, Jumana; Rudolf, Mary; Hamilton, Patricia			Teaching child health in the occupied Palestinian territory	LANCET			English	Editorial Material									[Waterston, Tony] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Halileh, Samia] Birzeit Univ, Dept Community Hlth, Birzeit, Israel; [Odeh, Jumana] Palestinian Happy Child Programme, Ramallah, Palestine; [Rudolf, Mary] Leeds Primary Care Trust, Dept Community Paediat, Leeds, W Yorkshire, England; [Rudolf, Mary] Univ Leeds, Leeds, W Yorkshire, England; [Hamilton, Patricia] Royal Coll Paediat & Child Hlth, London, England	Newcastle General Hospital; Birzeit University; University of Leeds; University of Leeds	Waterston, T (corresponding author), Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	a.j.r.waterston@ncl.ac.uk						Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Dyer O, 2007, BRIT MED J, V335, P1013, DOI 10.1136/bmj.39398.527778.DB; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Lee JW, 2005, LANCET, V365, P1005; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Waterston T, 2005, LANCET, V365, P473; WATERSTON T, 2006, RCPCH NEWSLETTER SPR, P10; WHITE J, 2000, PROJECT MEMORANDUM C; MED AID PALESTINIANS	11	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					878	880		10.1016/S0140-6736(09)60104-5	http://dx.doi.org/10.1016/S0140-6736(09)60104-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19268355				2022-12-28	WOS:000264158700010
J	Cave, RJ				Cave, Robert J.			Inducing Chirality with Circularly Polarized Light	SCIENCE			English	Editorial Material									Harvey Mudd Coll, Dept Chem, Claremont, CA 91711 USA	Claremont Colleges; Harvey Mudd College	Cave, RJ (corresponding author), Harvey Mudd Coll, Dept Chem, Claremont, CA 91711 USA.	Robert_Cave@HMC.edu						Barth I, 2006, J AM CHEM SOC, V128, P7043, DOI 10.1021/ja057197l; Beratan DN, 1997, CHEM BIOL, V4, P3, DOI 10.1016/S1074-5521(97)90230-1; KITTEL C, 1956, INTRO SOLID STATE PH, P586; NEWTON MD, 1991, CHEM REV, V91, P767, DOI 10.1021/cr00005a007; Quack M, 2002, ANGEW CHEM INT EDIT, V41, P4618, DOI 10.1002/anie.200290005; Ray K, 1999, SCIENCE, V283, P814, DOI 10.1126/science.283.5403.814; SALEM L, 1974, MOL ORBITAL THEORY C, P110; Skourtis SS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238103; Wei JJ, 2006, J PHYS CHEM B, V110, P1301, DOI 10.1021/jp055145c	9	31	31	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1435	1436		10.1126/science.1169338	http://dx.doi.org/10.1126/science.1169338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286541				2022-12-28	WOS:000264101700025
J	Kim, JC; Askew, I; Muvhango, L; Dwane, N; Abramsky, T; Jan, S; Ntlemo, E; Chege, J; Watts, C				Kim, Julia C.; Askew, Ian; Muvhango, Lufuno; Dwane, Ntabozuko; Abramsky, Tanya; Jan, Stephen; Ntlemo, Ennica; Chege, Jane; Watts, Charlotte			Practice Quality Improvement Report Comprehensive care and HIV prophylaxis after sexual assault in rural South Africa: the Refentse intervention study	BRITISH MEDICAL JOURNAL			English	Article							POSTEXPOSURE PROPHYLAXIS; RAPE	Problem Although international guidelines specify the central role of the health sector in providing comprehensive care, including HIV post-exposure prophylaxis (PEP), after sexual assault, in both industrialised and developing countries there are many challenges to providing timely and comprehensive services. Design A nurse driven model of post-rape care was integrated into existing hospital services; the before and after study design evaluated impacts on quality of care, reviewing 334 hospital charts and conducting interviews with 16 service providers and 109 patients. Setting 450 bed district hospital in rural South Africa. Key measures for improvement Quality of care after rape (forensic history and examination, provision of emergency contraception, prophylaxis for sexually transmitted infections, referrals); provision of HIV counselling and testing and provision and completion of full 28 day course of PEP; and service utilisation (number of service providers seen on first visit and number of rape cases presenting to hospital per month). Strategies for change After completing baseline research, we introduced a five part intervention model, consisting of a sexual violence advisory committee, hospital rape management policy, training workshop for service providers, designated examining room, and community awareness campaigns. Effect of change Existing services were fragmented and of poor quality. After the intervention, there were considerable improvements in clinical history and examination, pregnancy testing, emergency contraception, prophylaxis for sexually transmitted infections; HIV counselling and testing, PEP, trauma counselling, and referrals. Completion of the 28 day course of PEP drugs increased from 20% to 58%. Lessons learnt It is possible to improve the quality of care after sexual assault, including HIV prophylaxis, within a rural South African hospital at modest cost, using existing staff. With additional training, nurses can become the primary providers of this care.	[Kim, Julia C.; Muvhango, Lufuno; Dwane, Ntabozuko; Ntlemo, Ennica] Univ Witwatersrand, Sch Publ Hlth, RADAR, Acornhoek, South Africa; [Kim, Julia C.; Watts, Charlotte] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, Gender Violence & Hlth Ctr, London WC1E 7HT, England; [Askew, Ian] Populat Council, FRONTIERS Reprod Hlth Program, Nairobi, Kenya; [Jan, Stephen] George Inst Int Hlth, Sydney, NSW, Australia; [Chege, Jane] Populat Council, FRONTIERS Reprod Hlth Program, Johannesburg, South Africa	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; University of Sydney	Kim, JC (corresponding author), Univ Witwatersrand, Sch Publ Hlth, RADAR, Acornhoek, South Africa.	jkim@agincourt.co.za	Jan, Stephen/AAG-3333-2021	Jan, Stephen/0000-0003-2839-1405				Christofides NJ, 2005, B WORLD HEALTH ORGAN, V83, P495; Derhammer F, 2000, Jt Comm J Qual Improv, V26, P488; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Garcia MT, 2005, SEX TRANSM DIS, V32, P214, DOI 10.1097/01.olq.0000149785.48574.3e; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; Gibb AM, 2003, INT J STD AIDS, V14, P99, DOI 10.1258/095646203321156854; Green WM, 2003, J EMERG MED, V25, P97, DOI 10.1016/S0736-4679(03)00158-6; *INT LAB ORG WHO, 2005, OCC NON POST PROPH H; Kim J.C., 2007, DEV INTEGRATED MODEL; Kim JC, 2003, REPROD HEALTH MATTER, V11, P101, DOI 10.1016/S0968-8080(03)02285-7; Ledray L E, 1997, J Emerg Nurs, V23, P75, DOI 10.1016/S0099-1767(97)90070-2; Linden JA, 2005, ACAD EMERG MED, V12, P640, DOI 10.1197/j.aem.2005.01.015; Martin SL, 2007, TRAUMA VIOLENCE ABUS, V8, P3, DOI 10.1177/1524838006296746; Myles JE, 2000, JAMA-J AM MED ASSOC, V284, P1516, DOI 10.1001/jama.284.12.1516-a; NIU MT, 1993, J INFECT DIS, V168, P1490, DOI 10.1093/infdis/168.6.1490; *POP COUNC, 2007, SEX GEND BAS VIOL E; *POP COUNC FRONT R, 2005, FRONT NEWS INT POSTR, P6; Roland ME, 2007, CURR OPIN INFECT DIS, V20, P39, DOI 10.1097/QCO.0b013e328012c5e0; *S AFR NAT DEP HLT, 2005, NAT MAN GUID SEX ASS; *S AFR NAT DEP HLT, 2005, SEX ASS POL; Suffla S., 2001, EVALUATION MED LEGAL; Wiebe ER, 2000, CAN MED ASSOC J, V162, P641; World Health Organization, 2001, WHOFCHGWH011; World Health Organization, 2003, GUID MED LEG CAR VIC; World Health Organization, 2002, WORLD REPORT VIOLENC	25	30	30	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 13	2009	338								b515	10.1136/bmj.b515	http://dx.doi.org/10.1136/bmj.b515			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GE	19286746	Green Accepted			2022-12-28	WOS:000264206500004
J	Montes-Hugo, M; Doney, SC; Ducklow, HW; Fraser, W; Martinson, D; Stammerjohn, SE; Schofield, O				Montes-Hugo, Martin; Doney, Scott C.; Ducklow, Hugh W.; Fraser, William; Martinson, Douglas; Stammerjohn, Sharon E.; Schofield, Oscar			Recent Changes in Phytoplankton Communities Associated with Rapid Regional Climate Change Along the Western Antarctic Peninsula	SCIENCE			English	Article							SEA-ICE EXTENT; DISTRIBUTIONS; CHLOROPHYLL; VARIABILITY; ECOSYSTEMS; SEDIMENTS; RETREAT; SHELF; OCEAN; KRILL	The climate of the western shelf of the Antarctic Peninsula (WAP) is undergoing a transition from a cold-dry polar-type climate to a warm-humid sub-Antarctic-type climate. Using three decades of satellite and field data, we document that ocean biological productivity, inferred from chlorophyll a concentration (Chl a), has significantly changed along the WAP shelf. Summertime surface Chl a (summer integrated Chl a similar to 63% of annually integrated Chl a) declined by 12% along the WAP over the past 30 years, with the largest decreases equatorward of 63 S and with substantial increases in Chl a occurring farther south. The latitudinal variation in Chl a trends reflects shifting patterns of ice cover, cloud formation, and windiness affecting water-column mixing. Regional changes in phytoplankton coincide with observed changes in krill (Euphausia superba) and penguin populations.	[Montes-Hugo, Martin; Schofield, Oscar] Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Ducklow, Hugh W.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Fraser, William] Polar Oceans Res Grp, Sheridan, MT 59749 USA; [Martinson, Douglas] Lamont Doherty Earth Inst, Palisades, NY 10964 USA; [Stammerjohn, Sharon E.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; University of California System; University of California Santa Cruz	Montes-Hugo, M (corresponding author), Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA.	montes@marine.rutgers.edu	Doney, Scott C/F-9247-2010; Schofield, Oscar/H-4169-2018	Doney, Scott C/0000-0002-3683-2437; STAMMERJOHN, SHARON/0000-0002-1697-8244; Schofield, Oscar/0000-0003-2359-4131	NSF Office of Polar Programs [0217282]; Virginia Institute of Marine Science [0823101]; Marine Biological Laboratory	NSF Office of Polar Programs(National Science Foundation (NSF)); Virginia Institute of Marine Science; Marine Biological Laboratory	This research is part of the Palmer Antarctica Long-Term Ecological Research (LTER) project (http://pal.lternet.edu). It was supported by NSF Office of Polar Programs grants 0217282 to H.W.D. and the Virginia Institute of Marine Science and 0823101 to H.W.D. at the Marine Biological Laboratory.	Barcena MA, 2002, DEEP-SEA RES PT II, V49, P935, DOI 10.1016/S0967-0645(01)00132-1; Bentley MJ, 2005, GEOLOGY, V33, P173, DOI 10.1130/G21203.1; BURKHOLDER PR, 1965, LIMNOL OCEANOGR, V57, P437; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; DOMACK EW, 1996, ANTARCTIC RES SERIES, V70; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dunbar RB, 1998, J GEOPHYS RES-OCEANS, V103, P30741, DOI 10.1029/1998JC900001; Fabres J, 2000, HOLOCENE, V10, P703, DOI 10.1191/09596830094953; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Garibotti IA, 2003, MAR ECOL PROG SER, V261, P21, DOI 10.3354/meps261021; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Knox G.A., 2006, BIOL SO OCEAN, DOI 10.1201/9781420005134; Leventer A, 1996, GEOL SOC AM BULL, V108, P1626, DOI 10.1130/0016-7606(1996)108<1626:PCOYIT>2.3.CO;2; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marrari M, 2008, DEEP-SEA RES PT II, V55, P377, DOI 10.1016/j.dsr2.2007.11.011; MITCHELL G, 1991, DEEP-SEA RES, V38, P981; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; Smith RC, 2008, DEEP-SEA RES PT II, V55, P1949, DOI 10.1016/j.dsr2.2008.04.027; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vernet M, 2008, DEEP-SEA RES PT II, V55, P2068, DOI 10.1016/j.dsr2.2008.05.021	28	475	486	6	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1470	1473		10.1126/science.1164533	http://dx.doi.org/10.1126/science.1164533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286554				2022-12-28	WOS:000264101700039
J	Gornall, J				Gornall, Jonathan			Feature Research Transparency Industry attack on academics	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; PROTOCOLS					Jgornall@mac.com						Chalmers I, 2004, BRIT MED J, V329, P462, DOI 10.1136/bmj.329.7463.462-a; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gotzsche Peter C, 2006, Ugeskr Laeger, V168, P2467; *INT COMM MED J ED, 2006, BIOM J WRIT ED UNPUB; International Federation of Pharmaceutical Manufacturers and Associations, 2005, JOINT POS DISCL CLIN; International Federations of Pharmaceutical Manufacturers and Associations, CLIN TRIALS PORT; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; *LAEG, COCHR CTR VURD UAFH; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; THIMMER N, 2006, JYLLANDSPOSTEN  0620, P5; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	14	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2009	338								b736	10.1136/bmj.b736	http://dx.doi.org/10.1136/bmj.b736			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273522				2022-12-28	WOS:000264205200004
J	Scruggs, J; Jacob, P				Scruggs, Jeff; Jacob, Paul			Harvesting Ocean Wave Energy	SCIENCE			English	Editorial Material							POWER		[Scruggs, Jeff] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; [Jacob, Paul] MMI Engn, Houston, TX 77077 USA	Duke University	Scruggs, J (corresponding author), Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA.	jeff.scruggs@duke.edu; pjacob@mmiengineering.com						BAXTER J, 122 G STEV PRES ADDR; CALLAGHAN J, 2006, CTC601; Cruz J, 2008, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-3-540-74895-3; EVANS DV, 1981, ANNU REV FLUID MECH, V13, P157, DOI 10.1146/annurev.fl.13.010181.001105; Falnes J., 2002, OCEAN WAVES OSCILLAT, DOI DOI 10.1017/CBO9780511754630; HAGERMAN G, 2003, E21 EPRI SPECIFICATI; Pontes MT, 1998, J OFFSHORE MECH ARCT, V120, P226, DOI 10.1115/1.2829544; Ram B., 2005, FINAL SUMMARY REPORT; SALTER SH, 1974, NATURE, V249, P720, DOI 10.1038/249720a0; von Jouanne A, 2006, MECH ENG, V128, P24, DOI 10.1115/1.2006-DEC-1	10	152	161	13	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1176	1178		10.1126/science.1168245	http://dx.doi.org/10.1126/science.1168245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251617				2022-12-28	WOS:000263687600025
J	Brooks, JP; Roehr, B				Brooks, Jay P.; Roehr, Bob			Should men who have ever had sex with men be allowed to give blood? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							DONORS; TRANSFUSION; RIGHTS; IMPACT		Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Brooks, JP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	brooksj@uthscsa.edu						Brooks JP, 2004, VOX SANG, V87, P280, DOI 10.1111/j.1423-0410.2004.00567.x; *CDCP, 2007, HIV AIDS SURV REP, V17, P1; FISHMAN L, 2007, BLOODY TRUTH BLOOD D; *FOOD DRUG ADM CTR, 2007, FDA POL BLOOD DON ME; Franklin IM, 2007, TRANSFUSION MED, V17, P161, DOI 10.1111/j.1365-3148.2007.00754.x; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Hurley R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b779; KASSING DW, OFFICE PRESIDENT PRE; KLEINMAN S, 2006, BEHAV BASED BLOOD DO; KRUPNICK M, 2008, OAKLAND TRIBUNE 1124; Leiss W, 2007, MSM DONOR DEFERRAL R; McCarthy LJ, 2007, TRANSFUSION, V47, P760, DOI 10.1111/j.1537-2995.2007.01187.x; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; Sanchez AM, 2005, TRANSFUSION, V45, P404, DOI 10.1111/j.1537-2995.2005.03421.x; Shilts R., 1987, BAND PLAYED; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; Spencer B, 2006, TRANSFUSION, V46, P869, DOI 10.1111/j.1537-2995.2006.00814.x; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; Titmuss, 1971, GIFT RELATIONSHIP; WRIGHT T, 2008, SPARTAN DAILY   0313	20	12	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b318	10.1136/bmj.b318	http://dx.doi.org/10.1136/bmj.b318			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DS	19246549				2022-12-28	WOS:000264056300005
J	Schiff, GD; Galanter, WL				Schiff, Gordon D.; Galanter, William L.			Promoting More Conservative Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG; TRIAL; CARE		[Schiff, Gordon D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, Boston, MA 02120 USA; [Galanter, William L.] Univ Illinois, Dept Med, Chicago, IL USA; [Galanter, William L.] Univ Illinois, Dept Pharm Practice, Chicago, IL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schiff, GD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, 1620 Tremont,3rd Floor, Boston, MA 02120 USA.	gschiff@partners.org	Callahan, Charles D/L-1641-2013	Galanter, William/0000-0001-7811-5391	AHRQ [5U18HS016973-03, 5U18HS016973-04] Funding Source: Federal RePORTER; AHRQ HHS [U18HS016973] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016973] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Association of American Medical Colleges, 2008, IND FUND MED ED REP; Association of American Medical Colleges, 2008, CONT ISS MED ED SAF; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Jones OAH, 2004, CRIT REV TOXICOL, V34, P335, DOI 10.1080/10408440490464697; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Macht D I, 1994, Osler Libr Newsl, P1; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Schiff GD, 2003, ARCH INTERN MED, V163, P893, DOI 10.1001/archinte.163.8.893; Sigurgceirsson B, 2002, ARCH DERMATOL, V138, P353, DOI 10.1001/archderm.138.3.353; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	14	35	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					865	867		10.1001/jama.2009.195	http://dx.doi.org/10.1001/jama.2009.195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244196				2022-12-28	WOS:000263609900030
J	Panzer, S; Pabinger, I				Panzer, Simon; Pabinger, Ingrid			Eltrombopag in chronic idiopathic thrombocytopenic purpura	LANCET			English	Editorial Material							DOUBLE-BLIND		[Panzer, Simon] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Div Blood Grp Serol, A-1090 Vienna, Austria; [Pabinger, Ingrid] Med Univ Vienna, Clin Div Haematol & Haemostaseol, Dept Med 1, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Panzer, S (corresponding author), Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Div Blood Grp Serol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	simon.panzer@meduniwien.ac.at						Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; George JN, 2006, J THROMB HAEMOST, V4, P1664, DOI 10.1111/j.1538-7836.2006.02013.x; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Sailer T, 2006, HAEMATOLOGICA, V91, P1041; Stasi R, 2008, DRUGS, V68, P901, DOI 10.2165/00003495-200868070-00002	9	3	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					607	608		10.1016/S0140-6736(09)60377-9	http://dx.doi.org/10.1016/S0140-6736(09)60377-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231614				2022-12-28	WOS:000263563500005
J	Bonetta, L				Bonetta, Laura			RNA-Based Therapeutics: Ready for Delivery?	CELL			English	Editorial Material								Delivery of RNA-based therapeutics to specific tissues for treating a variety of diseases faces many hurdles. But with several clinical trials and a slew of studies in animal models underway, the future of RNA-based therapeutics seems bright.											0	46	50	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					581	584		10.1016/j.cell.2009.02.010	http://dx.doi.org/10.1016/j.cell.2009.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239878	Bronze			2022-12-28	WOS:000263688200008
J	Reiner, JW; Walker, FJ; Ahn, CH				Reiner, J. W.; Walker, F. J.; Ahn, C. H.			MATERIALS SCIENCE Atomically Engineered Oxide Interfaces	SCIENCE			English	Editorial Material							THIN-FILMS; SUPERCONDUCTIVITY; HETEROSTRUCTURES; FERROELECTRICITY; MODULATION; BATIO3		[Reiner, J. W.; Walker, F. J.; Ahn, C. H.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Reiner, J. W.; Walker, F. J.; Ahn, C. H.] Yale Univ, Ctr Interface Phenomena & Struct, New Haven, CT 06520 USA	Yale University; Yale University	Reiner, JW (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	james.reiner@yale.edu; fred.walker@yale.edu; charles.ahn@yale.edu		Walker, Frederick/0000-0002-8094-249X				Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Ahn CH, 1997, SCIENCE, V276, P1100, DOI 10.1126/science.276.5315.1100; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Cen C, 2009, SCIENCE, V323, P1026, DOI 10.1126/science.1168294; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Chu YH, 2008, NAT MATER, V7, P478, DOI 10.1038/nmat2184; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; McKee RA, 1998, PHYS REV LETT, V81, P3014, DOI 10.1103/PhysRevLett.81.3014; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Schlom DG, 2001, MAT SCI ENG B-SOLID, V87, P282, DOI 10.1016/S0921-5107(01)00726-7; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357; Takahashi KS, 2006, NATURE, V441, P195, DOI 10.1038/nature04731; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; ZHONG W, 1994, PHYS REV LETT, V73, P1861, DOI 10.1103/PhysRevLett.73.1861	18	58	58	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1018	1019		10.1126/science.1169058	http://dx.doi.org/10.1126/science.1169058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229025				2022-12-28	WOS:000263478400027
J	Westerheide, SD; Anckar, J; Stevens, SM; Sistonen, L; Morimoto, RI				Westerheide, Sandy D.; Anckar, Julius; Stevens, Stanley M., Jr.; Sistonen, Lea; Morimoto, Richard I.			Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1	SCIENCE			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR-1; IN-VIVO; INHIBITION; ACTIVATION; LONGEVITY; SIRTUINS; DOMAIN; P53	Heat shock factor 1 ( HSF1) is essential for protecting cells from protein- damaging stress associated with misfolded proteins and regulates the insulin- signaling pathway and aging. Here, we show that human HSF1 is inducibly acetylated at a critical residue that negatively regulates DNA binding activity. Activation of the deacetylase and longevity factor SIRT1 prolonged HSF1 binding to the heat shock promoter Hsp70 by maintaining HSF1 in a deacetylated, DNA- binding competent state. Conversely, down- regulation of SIRT1 accelerated the attenuation of the heat shock response ( HSR) and release of HSF1 from its cognate promoter elements. These results provide a mechanistic basis for the requirement of HSF1 in the regulation of life span and establish a role for SIRT1 in protein homeostasis and the HSR.	[Westerheide, Sandy D.; Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Anckar, Julius; Sistonen, Lea] Abo Akad Univ, Dept Biol, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Stevens, Stanley M., Jr.] Univ Florida, Prot Chem Core Facil, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	Northwestern University; Abo Akademi University; University of Turku; State University System of Florida; University of Florida	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010; Stevens, Stanley M./E-4120-2013	Stevens, Stanley/0000-0002-1399-0256; Sistonen, Lea/0000-0003-1341-2867	NIH; Turku Graduate School of Biomedical Sciences; Academy of Finland; Sigrid Juselius Foundation; Abo Akademi University; National Institute for General Medical Science; National Institute for Aging; Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Turku Graduate School of Biomedical Sciences; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Abo Akademi University; National Institute for General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Denslow, S. McClung, A. Schilling, and the Chicago Biomedical Consortium for assistance with the mass spectrometry; A. Mondragon for assistance with the molecular modeling; S. Raju for technical assistance; I. Benjamin for the hsf1<SUP>-/-</SUP> fibroblasts; and J. Brickner and members of the Morimoto laboratory for critical reading of the manuscript. This work was supported by an NIH training grant (S.D.W); Turku Graduate School of Biomedical Sciences (J.A.); Academy of Finland, Sigrid Juselius Foundation, and Abo Akademi University (L.S.); and the National Institute for General Medical Science, the National Institute for Aging, and the Rice Institute for Biomedical Research (R.I.M.).	Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; HUBL ST, 1994, NAT STRUCT BIOL, V1, P615, DOI 10.1038/nsb0994-615; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	23	528	556	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1063	1066		10.1126/science.1165946	http://dx.doi.org/10.1126/science.1165946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229036	Green Accepted			2022-12-28	WOS:000263478400043
J	McGirk, J				McGirk, Jan			Gaza's health and humanitarian situation remains fragile	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					531	531		10.1016/S0140-6736(09)60182-3	http://dx.doi.org/10.1016/S0140-6736(09)60182-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230075				2022-12-28	WOS:000263333600012
J	Gelardi, M; Fiorella, ML; Tarasco, E; Passalacqua, G; Porcelli, F				Gelardi, Matteo; Fiorella, Maria Luisa; Tarasco, Eustachio; Passalacqua, Giovanni; Porcelli, Francesco			Blowing a nose black and blue	LANCET			English	Editorial Material									[Passalacqua, Giovanni] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Gelardi, Matteo; Fiorella, Maria Luisa] Univ Bari, Dept Ophthalmol & Otolaryngol, I-70121 Bari, Italy; [Tarasco, Eustachio; Porcelli, Francesco] Univ Bari, Dept Biol & Agroforestry & Environm Chem, I-70121 Bari, Italy	University of Genoa; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Passalacqua, G (corresponding author), Univ Genoa, Dept Internal Med, L Go R Benzi 10, I-16132 Genoa, Italy.	passalacqua@unige.it	Porcelli, Francesco/A-4376-2016; Tarasco, Eustachio/T-8588-2019; Francesco, Porcelli/AAD-8403-2019	Francesco, Porcelli/0000-0001-5620-7826; Tarasco, Eustachio/0000-0001-6310-186X; gelardi, matteo/0000-0003-4406-0008				Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; NEVILL E M, 1969, South African Medical Journal, V43, P512; Thomas Mike, 2008, Prim Care Respir J, V17, P79, DOI 10.3132/pcrj.2008.00029	3	6	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					780	780		10.1016/S0140-6736(09)60444-X	http://dx.doi.org/10.1016/S0140-6736(09)60444-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249636				2022-12-28	WOS:000263725400038
J	Ritz, E; Bakris, G				Ritz, E.; Bakris, G.			World Kidney Day: hypertension and chronic kidney disease	LANCET			English	Editorial Material							CKD		[Ritz, E.] Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany; [Bakris, G.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Ritz, E (corresponding author), Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany.	prof.e.ritz@t-online.de						Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P229, DOI 10.2215/CJN.00840805; KLAHR S, 1989, NEW ENGL J MED, V320, P731, DOI 10.1056/NEJM198903163201110; Lea JP, 2006, AM J KIDNEY DIS, V47, P72, DOI 10.1053/j.ajkd.2005.09.027; Perico N, 2005, KIDNEY INT, V68, pS87, DOI 10.1111/j.1523-1755.2005.09715.x; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415	9	33	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1157	1158		10.1016/S0140-6736(09)60355-X	http://dx.doi.org/10.1016/S0140-6736(09)60355-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19282027				2022-12-28	WOS:000264940600009
J	Meuwese, MC; de Groot, E; Duivenvoorden, R; Trip, MD; Ose, L; Maritz, FJ; Basart, DCG; Kastelein, JJP; Habib, R; Davidson, MH; Zwinderman, AH; Schwocho, LR; Stein, EA				Meuwese, Marijn C.; de Groot, Eric; Duivenvoorden, Raphael; Trip, Mieke D.; Ose, Leiv; Maritz, Frans J.; Basart, Dick C. G.; Kastelein, John J. P.; Habib, Rafik; Davidson, Michael H.; Zwinderman, Aeilko H.; Schwocho, Lee R.; Stein, Evan A.		CAPTIVATE Investigators	ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia The CAPTIVATE Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A-CHOLESTEROL ACYLTRANSFERASE; INTIMA-MEDIA THICKNESS; ACYL-COA; MICE; MACROPHAGES; LESIONS; METAANALYSIS; AVASIMIBE; XANTHOMATOSIS; TORCETRAPIB	Context Inhibition of acyl coenzyme A: cholesterol acyltransferase (ACAT), an intracellular enzyme involved in cholesterol accumulation, with pactimibe was developed to assist in the prevention of cardiovascular disease. Objective To evaluate the efficacy and safety of pactimibe in inhibition of atherosclerosis. Design, Setting, and Patients A prospective, randomized, stratified, double-blind, placebo-controlled study (Carotid Atherosclerosis Progression Trial Investigating Vascular ACAT Inhibition Treatment Effects [CAPTIVATE]) of 892 patients heterozygous for familial hypercholesterolemia conducted at 40 lipid clinics in the United States, Canada, Europe, South Africa, and Israel between February 1, 2004, and December 31, 2005. Study was terminated on October 26, 2005. Intervention Participants received either 100 mg/d of pactimibe (n=443) or matching placebo (n=438), in addition to standard lipid-lowering therapy. Main Outcome Measures Carotid atherosclerosis, assessed by ultrasound carotid intima-media thickness (CIMT), at baseline, 12, 18, and 24 months. Maximum CIMT was the primary end point and mean CIMT the secondary end point. Results Because pactimibe failed to show efficacy in the intravascular coronary ultrasound ACTIVATE study, the CAPTIVATE study was terminated prematurely after a follow-up of 15 months. After 6 months of treatment with pactimibe, low-density lipoprotein cholesterol increased by 7.3% (SD, 23%) compared with 1.4% (SD, 28%) in the placebo group (P = .001). The carotid ultrasonographic scans of the 716 patients with at least 2 scans and obtained at least 40 weeks apart were analyzed. Maximum CIMT measurements did not show a pactimibe treatment effect (difference, 0.004 mm; 95% confidence interval [CI], -0.023 to 0.015 mm; P = .64); however, the less variable mean CIMT measurement revealed an increase of 0.014 mm (95% CI, -0.027 to 0.000 mm; P = .04) in patients administered pactimibe vs placebo. Major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) occurred more often in patients administered pactimibe vs placebo (10/443 [2.3%] vs 1/438 [0.2%]; P = .01). Conclusions In patients with familial hypercholesterolemia, pactimibe had no effect on atherosclerosis as assessed by changes in maximum CIMT compared with placebo but was associated with an increase in mean CIMT as well as increased incidence of major cardiovascular events. Trial Registration clinicaltrials.gov Identifier: NCT00151788	[Meuwese, Marijn C.; de Groot, Eric; Duivenvoorden, Raphael; Trip, Mieke D.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands; [Ose, Leiv] Univ Oslo, Rikshosp, Lipid Clin, N-0027 Oslo, Norway; [Maritz, Frans J.] Karl Bremer Hosp, Dept Internal Med, Bellville, South Africa; [Basart, Dick C. G.] Westfries Gasthuis, Dept Cardiol, Hoorn, Netherlands; [Habib, Rafik] Cardiovasc Ctr Laval, Laval, PQ, Canada; [Davidson, Michael H.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Schwocho, Lee R.] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Oslo; National Hospital Norway; University of Chicago; Daiichi Sankyo Company Limited	de Groot, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Room F4-159-2,Meibergdreef 9,Box 22700, NL-1100 DE Amsterdam, Netherlands.	ericdegroot@amc.uva.nl	Duivenvoorden, Raphaël/B-5154-2019; Sijbrands, Eric/A-1065-2009; Kastelein, John/AAF-7950-2020	Duivenvoorden, Raphaël/0000-0003-1446-8336; Sijbrands, Eric/0000-0001-8857-7389; Ballantyne, Christie/0000-0002-6432-1730	AstraZeneca; Merck; Pfizer; Roche; Schering-Plough; Sankyo; Takeda; ISIS; Novartis; Reliant; Abbott	AstraZeneca(AstraZeneca); Merck(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Sankyo; Takeda(Takeda Pharmaceutical Company Ltd); ISIS; Novartis(Novartis); Reliant; Abbott(Abbott Laboratories)	Dr de Groot reports serving as a consultant to Wyeth and being paid lecture fees from MSD. Dr Ose reports receiving consulting fees from Kowa, Merck, and Genzyme. Dr Kastelein reports receiving consulting fees from Sankyo, ISIS, Novartis, Genzyme, Pfizer, Roche, AstraZeneca, Merck, and Schering- Plough; being paid lecture fees from Pfizer, Roche, AstraZeneca, Genzyme, Merck, and Schering-Plough; and receiving grant support from AstraZeneca, Merck, Pfizer, Roche, and Schering-Plough. Dr Schwocho is an employee at Daiichi Sankyo Pharma Development. Dr Stein reports receiving consulting and speakers fees and research funding from Sankyo, AstraZeneca, Merck, Schering-Plough, Roche, Takeda, ISIS, Novartis, Reliant, and Abbott. No other authors reported any financial disclosures.	Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2008, CIRCULATION, V117, P2458, DOI 10.1161/CIRCULATIONAHA.108.773747; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; Duivenvoorden R, 2007, CURR OPIN LIPIDOL, V18, P613, DOI 10.1097/MOL.0b013e3282f19608; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Nicolosi RJ, 1998, ATHEROSCLEROSIS, V137, P77, DOI 10.1016/S0021-9150(97)00279-7; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Ramharack R, 1998, ATHEROSCLEROSIS, V136, P79, DOI 10.1016/S0021-9150(97)00189-5; Sakashita N, 2003, LAB INVEST, V83, P1569, DOI 10.1097/01.LAB.0000095687.17383.39; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200	29	113	118	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1131	1139		10.1001/jama.301.11.1131	http://dx.doi.org/10.1001/jama.301.11.1131			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293413	Bronze			2022-12-28	WOS:000264244200018
J	Grossniklaus, U				Grossniklaus, Ueli			Paternal Patterning Cue	SCIENCE			English	Editorial Material									[Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Zurich; University of Zurich	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Grossniklaus, Ueli/E-9995-2016; Grossniklaus, Ueli/A-2736-2012	Grossniklaus, Ueli/0000-0002-0522-8974; 				Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Brukhin V, 2005, CURR SCI INDIA, V89, P1844; Cobb M, 2006, NAT REV GENET, V7, P953, DOI 10.1038/nrg1948; Engel ML, 2003, PLANT J, V34, P697, DOI 10.1046/j.1365-313X.2003.01761.x; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Grossniklaus U, 2005, ANNU PLANT REV, V19, P174, DOI 10.1002/9780470988626.ch6; Harvey EB, 1936, BIOL BULL-US, V71, P101, DOI 10.2307/1537411; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; SAVORY TH, 1970, SCI AM, V223, P102, DOI 10.1038/scientificamerican1270-102; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298	15	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1439	1440		10.1126/science.1171412	http://dx.doi.org/10.1126/science.1171412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286544				2022-12-28	WOS:000264101700028
J	Zaghloul, KA; Blanco, JA; Weidemann, CT; McGill, K; Jaggi, JL; Baltuch, GH; Kahana, MJ				Zaghloul, Kareem A.; Blanco, Justin A.; Weidemann, Christoph T.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.; Kahana, Michael J.			Human Substantia Nigra Neurons Encode Unexpected Financial Rewards	SCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASAL GANGLIA; PARKINSONS-DISEASE; AVERSIVE STIMULI; PREDICTION ERROR; MONKEY; MEDICATION; ACTIVATION; RESPONSES; TASK	The brain's sensitivity to unexpected outcomes plays a fundamental role in an organism's ability to adapt and learn new behaviors. Emerging research suggests that midbrain dopaminergic neurons encode these unexpected outcomes. We used microelectrode recordings during deep brain stimulation surgery to study neuronal activity in the human substantia nigra (SN) while patients with Parkinson's disease engaged in a probabilistic learning task motivated by virtual financial rewards. Based on a model of the participants' expected reward, we divided trial outcomes into expected and unexpected gains and losses. SN neurons exhibited significantly higher firing rates after unexpected gains than unexpected losses. No such differences were observed after expected gains and losses. This result provides critical support for the hypothesized role of the SN in human reinforcement learning.	[Zaghloul, Kareem A.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Blanco, Justin A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Zaghloul, KA (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	zaghlouk@uphs.upenn.edu; kahana@psych.upenn.edu	Zaghloul, Kareem/AAV-4208-2020; Weidemann, Christoph T./E-8857-2011	Weidemann, Christoph T./0000-0002-4280-2744	NIH [MH61975]; Conte Center [MH062196]; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Center; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is partially supported by NIH grant MH61975, Conte Center grant MH062196, and the Dana Foundation. We thank the staff of the Pennsylvania Neurological Institute for their assistance. We also thank J. Wachter and A. Krieger for statistical advice, A. Geller for cognitive task programming, and M. Kilpatrick and P. Connolly for assistance with DBS surgery.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1983, EXP BRAIN RES, V51, P377; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	26	147	149	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1496	1499		10.1126/science.1167342	http://dx.doi.org/10.1126/science.1167342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286561	Green Accepted			2022-12-28	WOS:000264101700046
J	Saito, T; Fujii, T; Kanatani, Y; Saijo, M; Morikawa, S; Yokote, H; Takeuchi, T; Kuwabara, N				Saito, Tomoya; Fujii, Tatsuya; Kanatani, Yasuhiro; Saijo, Masayuki; Morikawa, Shigeru; Yokote, Hiroyuki; Takeuchi, Tsutomu; Kuwabara, Noriyuki			Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ANTIVIRAL IMMUNITY; REVACCINATION; DURATION; PROTECTION; STRAIN	Context The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. It is a good candidate for use as part of a prevention plan for bio-terrorism. Objective To assess the immunogenicity and frequency of adverse events of LC16m8 vaccine in unvaccinated and previously vaccinated adults. Design, Setting, and Participants Between 2002 and 2005 we vaccinated and revaccinated 1529 and 1692 adults, respectively, in the Japan Self-Defense Forces with LC16m8 vaccine, given intraepidermally using a bifurcated needle. Vaccinees were examined 10 to 14 days after vaccination to determine if they had developed a major skin reaction ("take"). Neutralizing antibody responses among 200 participants were assessed using a plaque-reduction neutralization test 30 days postvaccination. We monitored vaccinees for adverse events for 30 days postvaccination. Main Outcome Measures Documentation of a vaccine take, presence of neutralizing antibody response, and frequency of adverse events. Results The proportions of take in vaccinia-naive and previously vaccinated individuals were 1443 of 1529 (94.4% [95% confidence interval {CI}, 93.2%-95.9%] and 1465 of 1692 (86.6% [95% CI, 85.0%-88.2%]), respectively. Seroconversion or an effective booster response among the individuals with take was elicited in 37 of 41 (90.2% [95% CI, 81.2%-99.3%]) vaccinia-naive participants and in 93 of 155 (60.0% [95% CI, 52.3%-67.7%]) previously vaccinated participants. One case of allergic dermatitis and another of erythema multiforme, both of which were mild and self-limited, were suspected to be caused by vaccination. No severe adverse events were observed. Conclusion Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals.	[Kanatani, Yasuhiro] Natl Def Med Coll, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Saito, Tomoya; Takeuchi, Tsutomu] Keio Univ, Dept Trop Med & Parasitol, Sch Med, Biopreparedness Res Lab, Tokyo, Japan; [Fujii, Tatsuya] Japan Self Def Forces Cen Hosp, Dept Internal Med, Tokyo, Japan; [Kuwabara, Noriyuki] Japan Self Def Forces Cen Hosp, Ctr Hlth Management, Tokyo, Japan; [Saijo, Masayuki; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Yokote, Hiroyuki] Chemosero Therapeut Res Inst Kaketsuken, Kumamoto, Japan	National Defense Medical College - Japan; Keio University; National Institute of Infectious Diseases (NIID)	Kanatani, Y (corresponding author), Natl Def Med Coll, Res Inst, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ykanatan@ndmc.ac.jp	Saijo, Masayuki/L-2697-2019; Kanatani, Yasuhiro/AAE-5551-2019; 金谷, 泰宏/GQZ-8179-2022	Kanatani, Yasuhiro/0000-0001-5790-4084; Saito, Tomoya/0000-0001-6250-4464; MORIKAWA, SHIGERU/0000-0001-6249-6716	Japan Ministry of Health, Labour and Welfare	Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by research funding from the Japan Ministry of Health, Labour and Welfare in fiscal year 2004-2006.	*AC INC, VACC REL BIOL PROD A; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Arita I, 2005, LANCET INFECT DIS, V5, P647, DOI 10.1016/S1473-3099(05)70242-5; Arita I, 2002, JPN J INFECT DIS, V55, P112; Balicer RD, 2005, HUM VACCINES, V1, P224, DOI 10.4161/hv.1.6.2279; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hashizume S., 1985, VACCINIA VIRUSES VEC, P87; Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HIRAYAMA M, 1975, SMALLPOX VACCINATION; *JAP DEF AG, 2002, GUID SMALLP VACC; *JAP DEF AG, 2005, DEF JAP 2005; Jezek Z, 1988, HUMAN MONKEYPOX; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; Nishiura H, 2006, EPIDEMIOLOGY, V17, P576, DOI 10.1097/01.ede.0000229196.41862.c2; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; SHINMURA Y, 2007, 55 ANN M JAP SOC VIR; *WHO ADV COMM VAR, 2007, REP 9 M NOV 29 30 GE; Yamaguchi M, 1975, RINSHO UIRUSU, V3, P269	31	47	48	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1025	1033		10.1001/jama.2009.289	http://dx.doi.org/10.1001/jama.2009.289			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278946	Bronze			2022-12-28	WOS:000264015800026
J	Barroso; Villar, SS				Barroso; Serrano Villar, Sergio			Commentary: Patient's view	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Serrano Villar, Sergio] Hosp Clin San Carlos, Madrid 28040, Spain	Hospital Clinico San Carlos	Villar, SS (corresponding author), Hosp Clin San Carlos, Madrid 28040, Spain.	sergio1serrano@yahoo.es	Serrano-Villar, Sergio/AEU-8833-2022	Serrano-Villar, Sergio/0000-0002-5447-3554					0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2009	338								b867	10.1136/bmj.b867	http://dx.doi.org/10.1136/bmj.b867			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419FT	19273526				2022-12-28	WOS:000264205200008
J	Madoff, RD				Madoff, Robert D.			Rectal cancer: optimum treatment leads to optimum results	LANCET			English	Editorial Material							TOTAL MESORECTAL EXCISION; SHORT-TERM RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; LOCAL RECURRENCE; POSTOPERATIVE CHEMORADIOTHERAPY; IRRADIATED PATIENTS; FOLLOW-UP; MRC CR07; MULTICENTER		Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Madoff, RD (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	madoff@umn.edu						ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Bujko K, 2004, RADIOTHER ONCOL, V72, P15, DOI 10.1016/j.radonc.2003.12.006; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Fowler JM, 2007, RADIOLOGY, V243, P132, DOI 10.1148/radiol.2431051825; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Martling A, 2005, BRIT J SURG, V92, P225, DOI 10.1002/bjs.4834; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1007/s10350-004-6317-7	16	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					790	792		10.1016/S0140-6736(09)60459-1	http://dx.doi.org/10.1016/S0140-6736(09)60459-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269501				2022-12-28	WOS:000263980900007
J	Tylianakis, JM				Tylianakis, Jason M.			Warming Up Food Webs	SCIENCE			English	Editorial Material							RECENT CLIMATE-CHANGE; HABITAT MODIFICATION; SPECIES INTERACTIONS; RESPONSES; EVOLUTION		Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand	University of Canterbury	Tylianakis, JM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand.	jason.tylianakis@canterbury.ac.nz	Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620				Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	11	16	17	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1300	1301		10.1126/science.1170909	http://dx.doi.org/10.1126/science.1170909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265009				2022-12-28	WOS:000263876700028
J	Christensen, J; Pedersen, MG; Pedersen, CB; Sidenius, P; Olsen, J; Vestergaard, M				Christensen, Jakob; Pedersen, Marianne G.; Pedersen, Carsten B.; Sidenius, Per; Olsen, Jorn; Vestergaard, Mogens			Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study	LANCET			English	Article							POSTTRAUMATIC EPILEPSY; PUBLIC-HEALTH; SEIZURES; EPIDEMIOLOGY; PREVENTION; DENMARK; DRUGS	Background The risk of epilepsy shortly after traumatic brain injury is high, but how long this high risk lasts is unknown. We aimed to assess the risk of epilepsy up to 10 years or longer after traumatic brain injury, taking into account sex, age, severity and family history. Methods We identified 1605 216 people born in Denmark (1977-2002) from the Civil Registration System. We obtained information on traumatic brain injury and epilepsy from the National Hospital Register and estimated relative risks (RR) with Poisson analyses. Findings Risk of epilepsy was increased after a mild brain injury (RR 2.22, 95% CI 2.07-2.38), severe brain injury (7.40, 6.16-8.89), and skull fracture (2.17, 1.73-2.71). The risk was increased more than 10 years after mild brain injury (1.51, 1.24-1.85), severe brain injury (4.29, 2.04-9.00), and skull fracture (2.06, 1.37-3.11). RR increased with age at mild and severe injury and was especially high among people older than 15 years of age with mild (3.51, 2.90-4.26) and severe (12.24, 8.52-17.57) injury. The risk was slightly higher in women (2.49, 2.25-2.76) than in men (2.01, 1.83-2.22). Patients with a family history of epilepsy had a notably high risk of epilepsy after mild (5.75, 4.56-7.27) and severe brain injury (10.09, 4.20-24.26). Interpretation The longlasting high risk of epilepsy after brain injury might provide a window for prevention of post-traumatic epilepsy. Funding Danish Research Agency, P A Messerschmidt and Wife's Foundation, Mrs Grethe Bonnelycke's Foundation.	[Christensen, Jakob; Sidenius, Per] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Univ Aarhus, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark; [Pedersen, Marianne G.; Pedersen, Carsten B.] Univ Aarhus, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, So Calif Injury Prevent Res Ctr, Los Angeles, CA 90024 USA; [Olsen, Jorn] Univ Aarhus, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Vestergaard, Mogens] Univ Aarhus, Inst Publ Hlth, Dept Gen Practice, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk	Pedersen, Carsten Bøcker/B-8441-2013; Vestergaard, Mogens/M-9333-2014	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Vestergaard, Mogens/0000-0001-8830-2174; Christensen, Jakob/0000-0002-9385-6435				Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andersen TF, 1999, DAN MED BULL, V46, P263; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Breslow N E, 1987, IARC Sci Publ, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; *DAN NAT BOARD HLT, 1997, 1208 DAN NAT BOARD H; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Hills, 1993, STAT MODELS EPIDEMIO; Kjeldsen MJ, 2003, EPILEPSY RES, V55, P137, DOI 10.1016/S0920-1211(03)00117-7; Macpherson A., 2008, COCHRANE DB SYST REV, V3; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00010]; Pedersen CB, 2006, DAN MED BULL, V53, P441; PINNER M, KONSENSUSRAPPORT COM; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; ROBINSON DL, 2006, BRIT MED J, V332, P722; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson DC, 2000, COCHRANE DB SYST REV, V2; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086	37	229	238	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1105	1110		10.1016/S0140-6736(09)60214-2	http://dx.doi.org/10.1016/S0140-6736(09)60214-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19233461				2022-12-28	WOS:000264773600031
J	Baerlocher, MO; Detsky, AS				Baerlocher, Mark O.; Detsky, Allan S.			Professional Monopolies in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSPLANTATION CENTERS; PHARMACISTS; MORTALITY; SPECIALTY; VOLUME		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Baerlocher, Mark O.] Univ Toronto, Dept Radiol, Toronto, ON M5S 1A1, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 427, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Ariano R E, 1995, Can J Hosp Pharm, V48, P284; Cooper R, 2008, J HEALTH SERV RES PO, V13, P215, DOI 10.1258/jhsrp.2008.008004; Dukes G., 2006, LAW ETHICS PHARM IND; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Frances CD, 2000, HEALTH SERV RES, V35, P1093; Hillebrand DJ, 2000, NEW ENGL J MED, V342, P1527; Huckman RS, 2005, NEW ENGL J MED, V352, P857, DOI 10.1056/NEJMp048242; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; KONDRO W, 2007, CMAJ, V177, P558; Laks MP, 2000, NEW ENGL J MED, V342, P1527; MCGHAN WF, 1983, MED CARE, V21, P435, DOI 10.1097/00005650-198304000-00006; ROSENBERG J, SPEAKERS DEBATE NEW; Torchinsky A, 1991, Can J Hosp Pharm, V44, P245; Wells DA, 2007, JAMA-J AM MED ASSOC, V298, P2785, DOI 10.1001/jama.298.23.2785; Yuksel N, 2008, AM J HEALTH-SYST PH, V65, P2126, DOI 10.2146/ajhp080247	15	11	11	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					858	860		10.1001/jama.2009.223	http://dx.doi.org/10.1001/jama.2009.223			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244193				2022-12-28	WOS:000263609900027
J	Hawkes, N				Hawkes, Nigel			Quality of Care Measuring up the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Darzi A., 2008, HIGH QUALITY CARE AL; Department of Health, 1997, NEW NHS MOD DEP; GODBER G, 1988, BRIT MED J, V297, P37, DOI 10.1136/bmj.297.6640.37; GODBER G, 1998, BRIT MED J, V297, P37; *NHS INF CTR, FULL LIST IND; Shekelle P, 2008, DOES PUBLIC RELEASE	6	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2009	338								b703	10.1136/bmj.b703	http://dx.doi.org/10.1136/bmj.b703			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244304				2022-12-28	WOS:000264056200007
J	Currie, GP; Douglas, JG; Heaney, LG				Currie, Graeme P.; Douglas, J. Graham; Heaney, Liam G.			Difficult to treat asthma in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXHALED NITRIC-OXIDE; ALLERGIC RHINITIS; HYPERRESPONSIVENESS; THERAPY; GUIDE		[Currie, Graeme P.; Douglas, J. Graham] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Heaney, Liam G.] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland	University of Aberdeen; Belfast City Hospital	Currie, GP (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	Graeme.currie@nhs.net		Currie, Graeme P/0000-0002-5711-9147				Barnes PJ, 1998, EUR RESPIR J, V12, P1209, DOI 10.1183/09031936.98.12051209; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Corren J, 1997, J ALLERGY CLIN IMMUN, V99, pS781, DOI 10.1016/S0091-6749(97)70127-1; Coughlan JL, 2001, THORAX, V56, P198, DOI 10.1136/thorax.56.3.198; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Currie GP, 2003, CLIN EXP ALLERGY, V33, P1405, DOI 10.1046/j.1365-2222.2003.01772.x; Currie Graeme P, 2005, Ther Clin Risk Manag, V1, P83, DOI 10.2147/tcrm.1.2.83.62909; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Heaney LG, 2005, LANCET, V365, P974, DOI 10.1016/S0140-6736(05)71087-4; Heaney LG, 2003, THORAX, V58, P561, DOI 10.1136/thorax.58.7.561; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; Morjaria JB, 2008, THORAX, V63, P584, DOI 10.1136/thx.2007.086314; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Roberts NJ, 2006, EUR RESPIR J, V28, P968, DOI 10.1183/09031936.06.00003706; Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; WENZEL SE, 2009, AM J RESP CRIT  0108; Woodcock A, 2003, NEW ENGL J MED, V349, P225, DOI 10.1056/NEJMoa023175	25	22	22	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2009	338								b494	10.1136/bmj.b494	http://dx.doi.org/10.1136/bmj.b494			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19240094				2022-12-28	WOS:000264056100009
J	Disis, ML; Bernhard, H; Jaffee, EM				Disis, Mary L.; Bernhard, Helga; Jaffee, Elizabeth M.			Use of tumour-responsive T cells as cancer treatment	LANCET			English	Review							COLONY-STIMULATING FACTOR; DONOR LYMPHOCYTE INFUSIONS; ANTIGEN-PRESENTING CELLS; NODE-NEGATIVE MELANOMA; IN-VIVO PERSISTENCE; ANTITUMOR IMMUNITY; DENDRITIC CELLS; BREAST-CANCER; ADJUVANT IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY	The stimulation of a tumour-specific T-cell response has several theoretical advantages over other forms of cancer treatment. First, T cells can home in to antigen-expressing tumour deposits no matter where they are located in the body-even in deep tissue beds. Additionally, T cells can continue to proliferate in response to immunogenic proteins expressed in cancer until all the tumour cells are eradicated. Finally, immunological memory can be generated, allowing for eradication of antigen-bearing tumours if they reoccur. We will highlight two direct methods of stimulating tumour-specific T-cell immunity: active immunisation with cancer vaccines and infusion of competent T cells via adoptive T-cell treatment. Preclinical and clinical studies have shown that modulation of the tumour microenvironment to support the immune response is as important as stimulation of the most appropriate effector T cells. The future of T-cell immunity stimulation to treat cancer will need combination approaches focused on both the tumour and the T cell.	[Disis, Mary L.] Univ Washington, Ctr Translat Med Womens Hlth, Tumor Vaccine Grp, Seattle, WA 98109 USA; [Bernhard, Helga] Tech Univ Munich, Dept Haematol Oncol, Klinikum Rechts Isar, Munich, Germany; [Bernhard, Helga] GSF Munich, Inst Hlth & Environm, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Jaffee, Elizabeth M.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA	University of Washington; University of Washington Seattle; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University	Disis, ML (corresponding author), Univ Washington, Ctr Translat Med Womens Hlth, Tumor Vaccine Grp, Seattle, WA 98109 USA.	ndisis@u.washington.edu		Jaffee, Elizabeth/0000-0003-3841-6549	US National Institutes of Health [CA85374, CA101190, U19CA72108, P50CA88843, CA62924]; Athena Water; Research Council of Germany [SFB 456]; Wilhelm Sander Foundation; CSF National Research Center for Environment and Health-Clinical Cooperation Group Vaccinology; Sol Goldman Pancreatic Cancer Research Center; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA101190, U19CA072108, R01CA085374, P50CA088843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319, UL1TR000423] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Athena Water; Research Council of Germany; Wilhelm Sander Foundation; CSF National Research Center for Environment and Health-Clinical Cooperation Group Vaccinology; Sol Goldman Pancreatic Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MLD is supported by US National Institutes of Health (NIH) grants CA85374 and CA101190, and Athena Water. HB is supported by grants from the Research Council of Germany SFB 456, the Wilhelm Sander Foundation and the CSF National Research Center for Environment and Health-Clinical Cooperation Group Vaccinology. EMJ is supported by the Dana and Albert "Cubby" Broccoli Professorship; NIH grants U19CA72108, P50CA88843, and CA62924; and the Sol Goldman Pancreatic Cancer Research Center. We thank Sally Zebrick, Molly Boettcher, and Julia Muller for assistance in manuscript preparation.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Banerjea A, 2005, DIS COLON RECTUM, V48, P2322, DOI 10.1007/s10350-005-0203-9; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Behn U, 2007, IMMUNOL REV, V216, P142; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; BERD D, 1984, CANCER RES, V44, P5439; Bishop MR, 2004, J CLIN ONCOL, V22, P3886, DOI 10.1200/JCO.2004.01.127; Bocchia M, 2005, LANCET, V365, P657; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Cesana GC, 2006, J CLIN ONCOL, V24, P1169, DOI 10.1200/JCO.2005.03.6830; Chakraborty NG, 2004, HUM IMMUNOL, V65, P794, DOI 10.1016/j.humimm.2004.05.012; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; Coccoris M, 2005, CURR GENE THER, V5, P583, DOI 10.2174/156652305774964730; Cohen PA, 2000, CRIT REV IMMUNOL, V20, P17; Coulie PG, 1999, ADV CANCER RES, V76, P213, DOI 10.1016/S0065-230X(08)60778-2; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dang YS, 2007, CLIN CANCER RES, V13, P1883, DOI 10.1158/1078-0432.CCR-06-2083; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dazzi F, 2000, BLOOD, V96, P2712; Disis ML, 2004, J CLIN IMMUNOL, V24, P571, DOI 10.1023/B:JOCI.0000040928.67495.52; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Duval L, 2006, CLIN CANCER RES, V12, P1229, DOI 10.1158/1078-0432.CCR-05-1485; EHRKE MJ, 1989, SEMIN ONCOL, V16, P230; Ellyard JI, 2007, TISSUE ANTIGENS, V70, P1, DOI 10.1111/j.1399-0039.2007.00869.x; Engels B, 2007, MOL ASPECTS MED, V28, P115, DOI 10.1016/j.mam.2006.12.006; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; Fiore F, 2007, BLOOD, V110, P921, DOI 10.1182/blood-2006-09-044321; Foss FM, 2002, SEMIN ONCOL, V29, P5, DOI 10.1053/sonc.2002.33076; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Goodell V, 2008, MOL CANCER THER, V7, P449, DOI 10.1158/1535-7163.MCT-07-0386; Greten TF, 1999, J CLIN ONCOL, V17, P1047, DOI 10.1200/JCO.1999.17.3.1047; Harris JE, 2000, J CLIN ONCOL, V18, P148, DOI 10.1200/JCO.2000.18.1.148; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Hersey P, 2002, J CLIN ONCOL, V20, P4181, DOI 10.1200/JCO.2002.12.094; Hollatz G, 2008, J IMMUNOL METHODS, V331, P69, DOI 10.1016/j.jim.2007.11.007; Inoges S, 2006, J NATL CANCER I, V98, P1292, DOI 10.1093/jnci/djj358; Inokuma M, 2007, J IMMUNOL, V179, P2627, DOI 10.4049/jimmunol.179.4.2627; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jocham D, 2004, LANCET, V363, P594, DOI 10.1016/S0140-6736(04)15590-6; Kaufman HL, 2005, J CLIN INVEST, V115, P1903, DOI 10.1172/JCI24624; Kaufman HL, 2004, J CLIN INVEST, V113, P664, DOI 10.1172/JCI200421148; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Knutson KL, 2002, CLIN CANCER RES, V8, P1014; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Kolenko V, 1997, J IMMUNOL, V159, P3057; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3; Lesimple T, 2006, CLIN CANCER RES, V12, P7380, DOI 10.1158/1078-0432.CCR-06-1879; Loftus DJ, 1996, J EXP MED, V184, P647, DOI 10.1084/jem.184.2.647; Lokhorst HM, 2000, J CLIN ONCOL, V18, P3031, DOI 10.1200/JCO.2000.18.16.3031; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Matar P, 2000, EUR J CANCER, V36, P1060, DOI 10.1016/S0959-8049(00)00044-7; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mullins DW, 1999, J IMMUNOL, V162, P6811; Munz C, 1999, J IMMUNOL, V162, P25; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Ohlen C, 2001, J IMMUNOL, V166, P2863, DOI 10.4049/jimmunol.166.4.2863; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Palena C, 2005, BLOOD, V106, P3515, DOI 10.1182/blood-2005-03-1214; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; POLAK L, 1975, IMMUNOLOGY, V28, P939; Quintarelli C, 2007, BLOOD, V110, P2793, DOI 10.1182/blood-2007-02-072843; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Redfern CH, 2006, J CLIN ONCOL, V24, P3107, DOI 10.1200/JCO.2005.04.4289; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Roszkowski JJ, 2005, CANCER RES, V65, P1570, DOI 10.1158/0008-5472.CAN-04-2076; Sadovnikova E, 1998, EUR J IMMUNOL, V28, P193, DOI 10.1002/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.3.CO;2-B; Salazar LG, 2003, CLIN CANCER RES, V9, P5559; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; SCHWARTZ RH, 1993, SCI AM, V269, P62, DOI 10.1038/scientificamerican0893-62; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Simons JW, 1997, CANCER RES, V57, P1537; Slingluff CL, 2004, J CLIN ONCOL, V22, P4474, DOI 10.1200/JCO.2004.10.212; Smith JW, 2003, J CLIN ONCOL, V21, P1562, DOI 10.1200/JCO.2003.09.020; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Sondak VK, 2006, CLIN CANCER RES, V12, p2337S, DOI 10.1158/1078-0432.CCR-05-2555; Sondak VK, 2002, J CLIN ONCOL, V20, P2058, DOI 10.1200/JCO.2002.08.071; Sosman JA, 2002, J CLIN ONCOL, V20, P2067, DOI 10.1200/JCO.2002.08.072; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Sprangers B, 2007, NAT CLIN PRACT ONCOL, V4, P404, DOI 10.1038/ncponc0848; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Toes REM, 1996, CANCER RES, V56, P3782; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Weinschenk T, 2002, CANCER RES, V62, P5818; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863, DOI 10.4049/jimmunol.174.11.6863; Yang SX, 2005, J IMMUNOL, V175, P3715, DOI 10.4049/jimmunol.175.6.3715; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Yu P, 2006, CURR OPIN IMMUNOL, V18, P226, DOI 10.1016/j.coi.2006.01.004; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	129	127	137	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					673	683		10.1016/S0140-6736(09)60404-9	http://dx.doi.org/10.1016/S0140-6736(09)60404-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231634	Green Accepted			2022-12-28	WOS:000263563500032
J	Malone, CD; Hannon, GJ				Malone, Colin D.; Hannon, Gregory J.			Small RNAs as Guardians of the Genome	CELL			English	Review							DOUBLE-STRANDED-RNA; PROGRAMMED DNA ELIMINATION; MENDELIAN FEMALE STERILITY; SMALL INTERFERING RNA; R HYBRID DYSGENESIS; DICER-LIKE PROTEIN; DROSOPHILA-MELANOGASTER; GERM-LINE; ENDOGENOUS SIRNAS; TRANSPOSABLE ELEMENTS	Transposons populate the landscape of all eukaryotic genomes. Often considered purely genomic parasites, transposons can also benefit their hosts, playing roles in gene regulation and in genome organization and evolution. Peaceful coexistence with mobile elements depends upon adaptive control mechanisms, since unchecked transposon activity can impact long-term fitness and acutely reduce the fertility of progeny. Here, we review the conserved roles played by small RNAs in the adaptation of eukaryotes to coexist with their genomic colonists. An understanding of transposon-defense pathways has uncovered recurring themes in the mechanisms by which genomes distinguish "self'' from "non-self'' and selectively silence the latter.	[Malone, Colin D.; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019		National Science Foundation Graduate Research Fellowship; National Institutes of Health; Kathryn W. Davis; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathryn W. Davis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Douglas Chalker for critical reading of the manuscript and members of the Hannon Laboratory for helpful discussion. C. D. M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by a National Science Foundation Graduate Research Fellowship. This work was supported in part by grants from the National Institutes of Health to G. J. H. and a kind gift from Kathryn W. Davis ( G. J. H.).	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BIEMONT C, 1990, GENET RES, V56, P3, DOI 10.1017/S0016672300028822; BINGHAM PM, 1982, CELL, V29, P995, DOI 10.1016/0092-8674(82)90463-9; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BREGLIANO JC, 1980, SCIENCE, V207, P606, DOI 10.1126/science.6766221; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; BUCHETON A, 1978, HEREDITY, V41, P357, DOI 10.1038/hdy.1978.106; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; CLARKE L, 1986, P NATL ACAD SCI USA, V83, P8253, DOI 10.1073/pnas.83.21.8253; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Coyne RS, 1996, ANNU REV GENET, V30, P557, DOI 10.1146/annurev.genet.30.1.557; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDWELL MG, 1983, GENETICS, V104, P317; KIDWELL MG, 1977, GENETICS, V86, P813; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; Lin HF, 1997, DEVELOPMENT, V124, P2463; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; MEYER E, 1992, GENE DEV, V6, P211, DOI 10.1101/gad.6.2.211; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pardue ML, 1999, GENETICA, V107, P189, DOI 10.1023/A:1003905210770; PELISSON A, 1987, MOL GEN GENET, V207, P306, DOI 10.1007/BF00331594; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; PICARD G, 1976, GENETICS, V83, P107; PRUDHOMME N, 1995, GENETICS, V139, P697; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; RONSSERAY S, 1991, GENETICS, V129, P501; ROSE MR, 1983, SCIENCE, V220, P157, DOI 10.1126/science.220.4593.157; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; SCHLAPPI M, 1994, CELL, V77, P427, DOI 10.1016/0092-8674(94)90157-0; Sigova A, 2006, COLD SPRING HARB SYM, V71, P335, DOI 10.1101/sqb.2006.71.031; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Theurkauf WE, 2006, COLD SPRING HARB SYM, V71, P171, DOI 10.1101/sqb.2006.71.066; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Villasante A, 2008, CELL CYCLE, V7, P2134, DOI 10.4161/cc.7.14.6275; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	141	577	609	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					656	668		10.1016/j.cell.2009.01.045	http://dx.doi.org/10.1016/j.cell.2009.01.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239887	Bronze, Green Accepted			2022-12-28	WOS:000263688200017
J	Granwehr, BP				Granwehr, Bruno P.			Influenza immunization during pregnancy reduced influenza in infants and respiratory illness in mothers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Granwehr, BP (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.		Granwehr, Bruno/S-3997-2019	Granwehr, Bruno/0000-0002-5143-6416				Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Healy CM, 2007, PEDIATR INFECT DIS J, V26, P945, DOI 10.1097/INF.0b013e318156c18c	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-5	10.7326/0003-4819-150-4-200902170-02005	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238603				2022-12-28	WOS:000263562500026
J	Marmor, T; Oberlander, J; White, J				Marmor, Theodore; Oberlander, Jonathan; White, Joseph			The Obama Administration's Options for Health Care Cost Control: Hope Versus Reality	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; UNITED-STATES	Controlling the costs of medical care has long been an elusive goal in U. S. health policy. This article examines the options for health care cost control under the Obama administration. The authors argue that the administration's approach to health reform offers some potential for cost control but also embraces many strategies that are not likely to be successful. Lessons the United States can learn from other countries' experiences in constraining medical care spending are then explored.	Yale Univ, New Haven, CT USA; [Oberlander, Jonathan] UNC, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University	Oberlander, J (corresponding author), UNC, Sch Med, Dept Social Med, CB 7240, Chapel Hill, NC 27599 USA.	oberland@med.unc.edu						Anderson GF, 2008, HEALTH AFFAIR, V27, P1718, DOI 10.1377/hlthaff.27.6.1718; Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Angrisano C, 2007, ACCOUNTING COST HLTH; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; [Anonymous], 2008, B OBAMA J BIDENS PLA; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; Claxton G, 2002, PRIVATE INSURANCE WO; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Congressional Budget Office, 2008, BUDG OPT, V1; Congressional Budget Office,, 2005, HIGH COST MED BEN; Davis K, 2008, NEW ENGL J MED, V359, P1751, DOI 10.1056/NEJMp0805261; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; EVANS RG, 1984, STRAINED MERCY EC CA; Evidence on the costs and benefits of health information technology, 2008, EV COSTS BEN HLTH IN; Galvin R, 2006, HEALTH AFFAIR, V25, pW412, DOI 10.1377/hlthaff.25.w412; Ginsburg PB, 2008, HIGH RISING HLTH CAR; HOLAHAN J, 2008, CAN PUBL INS PLAN IN; *I MED ROUNDT EV B, 2007, LEARN WHAT WORKS BES; JOHNSON H, 1996, SYSTEM AM WAY POLITI; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; MARMOR T, 1994, UNDERSTANDING HLTH C; MARMOR TR, 1983, POLITICAL ANAL AM ME; Neumann PJ, 2005, USING COST EFFECTIVE; NICHOLS L, 2007, SUSTAINABLE HLTH SYS; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Oberlander J, 2008, HEALTH AFFAIR, V27, pW544, DOI 10.1377/hlthaff.27.6.w544; Oliver A, 2007, MILBANK Q, V85, P5, DOI 10.1111/j.1468-0009.2007.00475.x; *ORG EC COOP DEV, 2008, GROWTH HLTH SPEND SL; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Russell LB., 2007, PREVENTIONS POTENTIA; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Starr P, 1982, SOCIAL TRANSFORMATIO; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Thorpe KE, 2004, HLTH AFF MILLWOOD S; TOLLEN L, 2002, HLTH AFF MILLWOOD S, pW383; WELCH HG, 2008, NY TIMES         OCT, P7; White Joseph, 1995, COMPETING SOLUTIONS; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572	42	57	58	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					485	+		10.7326/0003-4819-150-7-200904070-00114	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00114			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432EZ	19258549				2022-12-28	WOS:000265117600006
J	Choi, T; Lee, S; Choi, YJ; Kiryukhin, V; Cheong, SW				Choi, T.; Lee, S.; Choi, Y. J.; Kiryukhin, V.; Cheong, S. -W.			Switchable Ferroelectric Diode and Photovoltaic Effect in BiFeO3	SCIENCE			English	Article							OPTICAL RECTIFICATION	Unidirectional electric current flow, such as that found in a diode, is essential for modern electronics. It usually occurs at asymmetric interfaces such as p-n junctions or metal/semiconductor interfaces with Schottky barriers. We report on a diode effect associated with the direction of bulk electric polarization in BiFeO3: a ferroelectric with a small optical gap edge of similar to 2.2 electron volts. We found that bulk electric conduction in ferroelectric monodomain BiFeO3 crystals is highly nonlinear and unidirectional. This diode effect switches its direction when the electric polarization is flipped by an external voltage. A substantial visible-light photovoltaic effect is observed in BiFeO3 diode structures. These results should improve understanding of charge conduction mechanisms in leaky ferroelectrics and advance the design of switchable devices combining ferroelectric, electronic, and optical functionalities.	[Cheong, S. -W.] Rutgers State Univ, Rutgers Ctr Emergent Mat, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cheong, SW (corresponding author), Rutgers State Univ, Rutgers Ctr Emergent Mat, Piscataway, NJ 08854 USA.	sangc@physics.rutgers.edu	Choi, Taekjib/H-8791-2012	Choi, Taekjib/0000-0001-6912-3322	NSF [NSF-DMR-0804109, 0704487]; Korean government [KRF-2007-357-C00023]	NSF(National Science Foundation (NSF)); Korean government(Korean Government)	This work was funded by NSF (grants NSF-DMR-0804109 and 0704487). T.C. was partially supported by a Korea Research Foundation Grant funded by the Korean government (MOEHRD, grant KRF-2007-357-C00023).	BASS M, 1962, PHYS REV LETT, V9, P446, DOI 10.1103/PhysRevLett.9.446; Basu SR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887908; Belinicher V. I., 1980, Soviet Physics - Uspekhi, V23, P199, DOI 10.1070/PU1980v023n03ABEH004703; DALBA G, 1995, PHYS REV LETT, V74, P988, DOI 10.1103/PhysRevLett.74.988; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Fridkin V.M., 1978, SOV PHYS USP, V21, P981, DOI 10.1070/PU1978v021n12ABEH005722; Gao F, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345825; GLASS AM, 1974, APPL PHYS LETT, V25, P233, DOI 10.1063/1.1655453; Hauser AJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939101; Lee S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.100101; Lee S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2930678; Noginova N, 1997, J OPT SOC AM B, V14, P1390, DOI 10.1364/JOSAB.14.001390; Pintilie L, 2007, J APPL PHYS, V101, DOI 10.1063/1.2560217; Poosanaas P, 1998, J APPL PHYS, V84, P1508, DOI 10.1063/1.368216; RICE A, 1994, APPL PHYS LETT, V64, P1324, DOI 10.1063/1.111922; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Scott J.F., 2000, FERROELECTRIC MEMORI; Tonooka K, 1998, P SOC PHOTO-OPT INS, V3324, P224, DOI 10.1117/12.316867; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Xie YW, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/19/196223; Yang YS, 2000, APPL PHYS LETT, V76, P774, DOI 10.1063/1.125891	21	1467	1503	36	1244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					63	66		10.1126/science.1168636	http://dx.doi.org/10.1126/science.1168636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19228998				2022-12-28	WOS:000264802100031
J	Sheridan, DJ; Heusch, G				Sheridan, Desmond John; Heusch, Gerd			Threats to the future of cardiovascular research	LANCET			English	Editorial Material							ACADEMIC MEDICINE; DISEASE; BURDEN		[Sheridan, Desmond John] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Heusch, Gerd] Univ Klinikum Essen, Inst Pathophysiol, Essen, Germany	Imperial College London; University of Duisburg Essen	Sheridan, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	d.sheridan@ic.ac.uk	Heusch, Gerd/ABE-6675-2020					Garnier JP, 2008, HARVARD BUS REV, V86, P68; HERPER M, 2008, FORBES          0930; Heusch G, 2008, CIRCULATION, V117, pF67, DOI 10.1161/CIRCULATIONAHA.107.189067; Kaplan W., 2004, PRIORITY MED EUROPE; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; OXTOBY K, 2009, BMJ CAREERS, V338, P11; Sheridan DJ, 2006, LANCET, V367, P1698, DOI 10.1016/S0140-6736(06)68739-4; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					875	876		10.1016/S0140-6736(09)60525-0	http://dx.doi.org/10.1016/S0140-6736(09)60525-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286070				2022-12-28	WOS:000264158700008
J	Di Fede, G; Catania, M; Morbin, M; Rossi, G; Suardi, S; Mazzoleni, G; Merlin, M; Giovagnoli, AR; Prioni, S; Erbetta, A; Falcone, C; Gobbi, M; Colombo, L; Bastone, A; Beeg, M; Manzoni, C; Francescucci, B; Spagnoli, A; Cantu, L; Del Favero, E; Levy, E; Salmona, M; Tagliavini, F				Di Fede, Giuseppe; Catania, Marcella; Morbin, Michela; Rossi, Giacomina; Suardi, Silvia; Mazzoleni, Giulia; Merlin, Marco; Giovagnoli, Anna Rita; Prioni, Sara; Erbetta, Alessandra; Falcone, Chiara; Gobbi, Marco; Colombo, Laura; Bastone, Antonio; Beeg, Marten; Manzoni, Claudia; Francescucci, Bruna; Spagnoli, Alberto; Cantu, Laura; Del Favero, Elena; Levy, Efrat; Salmona, Mario; Tagliavini, Fabrizio			A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis	SCIENCE			English	Article							ALZHEIMERS-DISEASE; AGGREGATION; PEPTIDES; THERAPY	beta-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly complete penetrance. We found an APP mutation [alanine-673 -> valine-673 (A673V)] that causes disease only in the homozygous state, whereas heterozygous carriers were unaffected, consistent with a recessive Mendelian trait of inheritance. The A673V mutation affected APP processing, resulting in enhanced beta-amyloid (A beta) production and formation of amyloid fibrils in vitro. Coincubation of mutated and wild-type peptides conferred instability on A beta aggregates and inhibited amyloidogenesis and neurotoxicity. The highly amyloidogenic effect of the A673V mutation in the homozygous state and its anti-amyloidogenic effect in the heterozygous state account for the autosomal recessive pattern of inheritance and have implications for genetic screening and the potential treatment of Alzheimer's disease.	[Di Fede, Giuseppe; Catania, Marcella; Morbin, Michela; Rossi, Giacomina; Suardi, Silvia; Mazzoleni, Giulia; Merlin, Marco; Giovagnoli, Anna Rita; Prioni, Sara; Tagliavini, Fabrizio] Ist Nazl Neurol Carlo Besta, Div Neurol & Neuropathol, I-20133 Milan, Italy; [Erbetta, Alessandra] Ist Nazl Neurol Carlo Besta, Div Neuroradiol, I-20133 Milan, Italy; [Falcone, Chiara] Ist Nazl Neurol Carlo Besta, Div Neuroepidemiol, I-20133 Milan, Italy; [Gobbi, Marco; Colombo, Laura; Bastone, Antonio; Beeg, Marten; Manzoni, Claudia; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Pharmacol & Biochem, I-20156 Milan, Italy; [Francescucci, Bruna; Spagnoli, Alberto] Ctr St Ambrogio Fatebenefratelli, Div Cognit Disorders, I-20063 Milan, Italy; [Cantu, Laura; Del Favero, Elena] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy; [Levy, Efrat] NYU, Sch Med, Dept Pharmacol, Orangeburg, NY 10962 USA; [Levy, Efrat] NYU, Sch Med, Dept Psychiat, Orangeburg, NY 10962 USA; [Levy, Efrat] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Tagliavini, F (corresponding author), Ist Nazl Neurol Carlo Besta, Div Neurol & Neuropathol, I-20133 Milan, Italy.	ftagliavini@istituto-besta.it	Rossi, Giacomina/I-2783-2012; Gobbi, Marco/J-2638-2016; salmona, mario/AAA-7116-2020; manzoni, claudia/F-4831-2014; Di Fede, Giuseppe/O-7772-2016; Di Fede, Giuseppe/K-1394-2016; PRIONI, SARA/ABR-1748-2022; DEL FAVERO, ELENA/AAR-3567-2020; Beeg, Marten/AAA-9269-2020; Catania, Marcella/K-1430-2016; Tagliavini, Fabrizio/AAO-7891-2021; Giovagnoli, Anna Rita/AAP-2442-2021; colombo, laura/AAA-6716-2020; DEL FAVERO, ELENA/R-4991-2017; salmona, mario/ABI-4066-2020; Di Fede, Giuseppe/A-4471-2019; Erbetta, Alessandra/K-6787-2016	Rossi, Giacomina/0000-0001-6680-2725; Gobbi, Marco/0000-0003-1014-6225; salmona, mario/0000-0002-9098-9873; Di Fede, Giuseppe/0000-0003-3537-6713; Di Fede, Giuseppe/0000-0003-3537-6713; PRIONI, SARA/0000-0001-9632-0591; DEL FAVERO, ELENA/0000-0002-6584-1869; Beeg, Marten/0000-0001-7201-6704; Catania, Marcella/0000-0003-0370-1905; Tagliavini, Fabrizio/0000-0003-1039-7315; Giovagnoli, Anna Rita/0000-0002-5719-0998; colombo, laura/0000-0002-3243-0270; DEL FAVERO, ELENA/0000-0002-6584-1869; Di Fede, Giuseppe/0000-0003-3537-6713; Morbin, Michela/0000-0001-8034-3123; Manzoni, Claudia/0000-0001-5367-4023; Erbetta, Alessandra/0000-0003-3155-4850; Del Favero, jurgen/0000-0002-7427-7489	Italian Ministry of Health [533F/Q/1, 71.6/2006, RFPS 2007/02]; CARIPLO Foundation; ERA-Net Neuron (nEUROsyn); Negri-Weizmann Foundation; National Institute of Neurological Disorders and Stroke [NS42029]; American Heart Association [0040102N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); CARIPLO Foundation(Fondazione Cariplo); ERA-Net Neuron (nEUROsyn); Negri-Weizmann Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Italian Ministry of Health (533F/Q/1 to F.T. and M.S., and 71.6/2006 and RFPS 2007/02 to F.T.), CARIPLO Foundation (Guard) to F.T. and M.S., ERA-Net Neuron (nEUROsyn) to F.T., Negri-Weizmann Foundation to M.S., the National Institute of Neurological Disorders and Stroke (NS42029) to E.L., and the American Heart Association (0040102N) to E.L. A patent application related to this work has been filed by Fondazione IRCCS Istituto Nazionale Neurologico "Carlo Besta."	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Cecchini M, 2006, J MOL BIOL, V357, P1306, DOI 10.1016/j.jmb.2006.01.009; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lim KH, 2006, CHEMBIOCHEM, V7, P1662, DOI 10.1002/cbic.200600270; Meinhardt J, 2007, PROTEIN SCI, V16, P1214, DOI 10.1110/ps.062734207; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	18	305	309	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1473	1477		10.1126/science.1168979	http://dx.doi.org/10.1126/science.1168979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286555	Green Submitted, Green Accepted			2022-12-28	WOS:000264101700040
J	Ghosh, B; Urban, MW				Ghosh, Biswajit; Urban, Marek W.			Self-Repairing Oxetane-Substituted Chitosan Polyurethane Networks	SCIENCE			English	Article								Polyurethanes have many properties that qualify them as high-performance polymeric materials, but they still suffer from mechanical damage. We report the development of polyurethane networks that exhibit self-repairing characteristics upon exposure to ultraviolet light. The network consists of an oxetane-substituted chitosan precursor incorporated into a two-component polyurethane. Upon mechanical damage of the network, four-member oxetane rings open to create two reactive ends. When exposed to ultraviolet light, chitosan chain scission occurs, which forms crosslinks with the reactive oxetane ends, thus repairing the network. These materials are capable of repairing themselves in less than an hour and can be used in many coatings applications, ranging from transportation to packaging or fashion and biomedical industries.	[Ghosh, Biswajit; Urban, Marek W.] Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Urban, MW (corresponding author), Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA.	marek.urban@usm.edu			National Science Foundation MRSEC [DMR 0213883]; Materials Research Instrumentation (MRI) program [DMR 0215873]; Mississippi Division of Marine Resources	National Science Foundation MRSEC(National Science Foundation (NSF)); Materials Research Instrumentation (MRI) program; Mississippi Division of Marine Resources	These studies were primarily supported by the National Science Foundation MRSEC under DMR 0213883 and the Materials Research Instrumentation (MRI) Program under DMR 0215873. We thank the Mississippi Division of Marine Resources for partial support.	Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc; Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Gheneim R, 2002, MACROMOLECULES, V35, P7246, DOI 10.1021/ma020343c; Henry G, 2003, LANCET, V361, P574, DOI 10.1016/S0140-6736(03)12510-X; Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Mann KG, 2006, BLOOD CELL MOL DIS, V36, P108, DOI 10.1016/j.bcmd.2005.12.034; Nagaya K, 2006, JSME INT J C-MECH SY, V49, P379, DOI 10.1299/jsmec.49.379; Otts DB, 2002, LANGMUIR, V18, P6473, DOI 10.1021/la025684y; Pang JWC, 2005, COMPOS PART A-APPL S, V36, P183, DOI 10.1016/j.compositesa.2004.06.016; Pang JWC, 2005, COMPOS SCI TECHNOL, V65, P1791, DOI 10.1016/j.compscitech.2005.03.008; Paris R, 2007, PLANT PHYSIOL BIOCH, V45, P80, DOI 10.1016/j.plaphy.2006.12.001; Sonntag P, 2004, NAT MATER, V3, P311, DOI 10.1038/nmat1113; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01; Urban MW., 1996, ATTENUATED TOTAL REF; Wan Y, 2004, J POLYM SCI POL PHYS, V42, P1379, DOI 10.1002/polb.20007	20	553	576	16	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1458	1460		10.1126/science.1167391	http://dx.doi.org/10.1126/science.1167391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286550				2022-12-28	WOS:000264101700035
J	Tsuji, M; Komatsu, N; Kawamoto, S; Suzuki, K; Kanagawa, O; Honjo, T; Hori, S; Fagarasan, S				Tsuji, Masayuki; Komatsu, Noriko; Kawamoto, Shimpei; Suzuki, Keiichiro; Kanagawa, Osami; Honjo, Tasuku; Hori, Shohei; Fagarasan, Sidonia			Preferential Generation of Follicular B Helper T Cells from Foxp3(+) T Cells in Gut Peyer's Patches	SCIENCE			English	Article							GERMINAL CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; RETINOIC-ACID; DENDRITIC CELLS; LAMINA PROPRIA; DIFFERENTIATION; INTERLEUKIN-21; POPULATION; ACTIVATION; EXPRESSION	Most of the immunoglobulin A (IgA) in the gut is generated by B cells in the germinal centers of Peyer's patches through a process that requires the presence of CD4(+) follicular B helper T (T-FH) cells. The nature of these T-FH cells in Peyer's patches has been elusive. Here, we demonstrate that suppressive Foxp3(+)CD4(+) T cells can differentiate into T-FH cells in mouse Peyer's patches. The conversion of Foxp3(+) T cells into T-FH cells requires the loss of Foxp3 expression and subsequent interaction with B cells. Thus, environmental cues present in gut Peyer's patches promote the selective differentiation of distinct helper T cell subsets, such as T-FH cells.	[Komatsu, Noriko; Hori, Shohei] RIKEN, Res Unit Immune Homeostasis, Yokohama, Kanagawa 2300045, Japan; [Tsuji, Masayuki; Kawamoto, Shimpei; Suzuki, Keiichiro; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Kanagawa, Osami] RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa 2300045, Japan; [Kawamoto, Shimpei; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dep Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; RIKEN; RIKEN; Kyoto University	Hori, S (corresponding author), RIKEN, Res Unit Immune Homeostasis, Yokohama 1-7-22, Yokohama, Kanagawa 2300045, Japan.	shohei@rcai.riken.jp; sidonia-f@rcai.riken.jp	Hori, Shohei/O-6163-2019; Honjo, Tasuku/N-4470-2016; Fagarasan, Sidonia/A-5258-2016	Hori, Shohei/0000-0001-8770-4593; Fagarasan, Sidonia/0000-0003-2086-6402	Uehara Memorial Foundation;  [Grants-in-Aid]	Uehara Memorial Foundation(Uehara Memorial Foundation); 	We thank Y. Doi, A. Yagisawa, T. Miyao, and H. Fujimoto for technical assistance; B. Malissen and K. Itoh for mice; D. Littman and A. Coutinho for inspiring discussions; I. Taniuchi for discussion and for critically reading of the manuscript. This work is supported in part by Grants-in-Aid for Scientific Research in Priority Areas (S.F., S.H.) and for Young Scientists (A) (S.H.), and by the Uehara Memorial Foundation (S.H.). S.H. and S.F. contributed as senior authors.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fagarasan S, 2006, CURR TOP MICROBIOL, V308, P137; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	29	455	477	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1488	1492		10.1126/science.1169152	http://dx.doi.org/10.1126/science.1169152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286559				2022-12-28	WOS:000264101700044
J	Hubbard, J; Shaw, JH				Hubbard, Judith; Shaw, John H.			Uplift of the Longmen Shan and Tibetan plateau, and the 2008 Wenchuan (M=7.9) earthquake	NATURE			English	Article							LOWER CRUSTAL FLOW; EASTERN MARGIN; DEFORMATION; TOPOGRAPHY; KINEMATICS; EVOLUTION	The Longmen Shan mountain range, site of the devastating 12 May 2008 Wenchuan (M = 7.9) earthquake, defines the eastern margin of the Himalayan orogen and exhibits greater topographic relief than anywhere else in the Tibetan plateau. However, before the earthquake, geodetic and geologic surveys measured little shortening across the range front(1-3), inspiring a vigorous debate about the process by which the topography of the mountain belt is produced and maintained. Two endmember models have been proposed: (1) brittle crustal thickening, in which thrust faults with large amounts of slip that are rooted in the lithosphere cause uplift(4), and (2) crustal flow, in which low-viscosity material in the lower crust extrudes outward from the Tibetan plateau and inflates the crust north and east of the Himalayas(5-7). Here we use balanced geologic cross-sections to show that crustal shortening, structural relief, and topography are strongly correlated in the range front. This suggests that crustal shortening is a primary driver for uplift and topography of the Longmen Shan on the flanks of the plateau. The 2008 Wenchuan (M = 7.9) earthquake, which ruptured a large thrust fault along the range front causing tens of thousands of fatalities and widespread damage, is an active manifestation of this shortening process.	[Hubbard, Judith; Shaw, John H.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Hubbard, J (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jhubbard@fas.harvard.edu	Hubbard, Judith/H-2837-2012	Hubbard, Judith/0000-0002-9980-1654				BIRD P, 1991, J GEOPHYS RES-SOLID, V96, P10275, DOI 10.1029/91JB00370; Burchfiel B.C., 1995, INT GEOL REV, V37, P661, DOI [10.1080/00206819509465424, DOI 10.1080/00206819509465424]; Burchfiel B.C., 2008, GSA TODAY GEOL SOC A, V18, P4, DOI [10.1130/GSATG18A.1, DOI 10.1130/GSATG18A.1]; Burchfiel B. C., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014<4:PANNGC>2.0.C0;2; Chen SF, 1996, J STRUCT GEOL, V18, P413, DOI 10.1016/0191-8141(95)00096-V; Chen Z, 2000, J GEOPHYS RES-SOL EA, V105, P16215, DOI 10.1029/2000JB900092; Clark MK, 2005, GEOPHYS J INT, V162, P575, DOI 10.1111/j.1365-246X.2005.02580.x; Densmore AL, 2007, TECTONICS, V26, DOI 10.1029/2006TC001987; Kirby E, 2002, TECTONICS, V21, DOI 10.1029/2000TC001246; Meade BJ, 2007, GEOLOGY, V35, P81, DOI 10.1130/G22924A.1; Medvedev S, 2006, GEOL SOC SPEC PUBL, V268, P147, DOI 10.1144/GSL.SP.2006.268.01.06; Rapine R, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000445; Royden LH, 1997, SCIENCE, V276, P788, DOI 10.1126/science.276.5313.788; Shaw J., 2005, STUD GEOL TULSA OKLA, V53, P1; Shen ZK, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003421; SUPPE J, 1983, AM J SCI, V283, P684, DOI 10.2475/ajs.283.7.684; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Xu LL, 2007, PHYS EARTH PLANET IN, V165, P176, DOI 10.1016/j.pepi.2007.09.002; Yao HJ, 2008, GEOPHYS J INT, V173, P205, DOI 10.1111/j.1365-246X.2007.03696.x; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211	20	470	567	6	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					194	197		10.1038/nature07837	http://dx.doi.org/10.1038/nature07837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279635	Green Accepted			2022-12-28	WOS:000264059700041
J	van Daele, PLA				van Daele, Paul L. A.			Commentary: Think anaphylaxis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[van Daele, Paul L. A.] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands; [van Daele, Paul L. A.] Erasmus MC, Dept Immunol, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Daele, PLA (corresponding author), Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands.	p.l.a.vandaele@erasmusmc.nl						Lieberman P, 2005, ANN ALLERG ASTHMA IM, V95, P217, DOI 10.1016/S1081-1206(10)61217-3; Reed MJ, 2006, EMERG MED J, V23, P589, DOI 10.1136/emj.2005.032136; Villar SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b6; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; 2009, BMJ	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2009	338								b846	10.1136/bmj.b846	http://dx.doi.org/10.1136/bmj.b846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273525	Green Submitted			2022-12-28	WOS:000264205200007
J	Krattinger, SG; Lagudah, ES; Spielmeyer, W; Singh, RP; Huerta-Espino, J; McFadden, H; Bossolini, E; Selter, LL; Keller, B				Krattinger, Simon G.; Lagudah, Evans S.; Spielmeyer, Wolfgang; Singh, Ravi P.; Huerta-Espino, Julio; McFadden, Helen; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat			A Putative ABC Transporter Confers Durable Resistance to Multiple Fungal Pathogens in Wheat	SCIENCE			English	Article							LEAF RUST RESISTANCE; TRITICUM-AESTIVUM L.; NONHOST RESISTANCE; COMMON WHEAT; BREAD WHEAT; STRIPE RUST; GENE LR34; SENESCENCE; ASSOCIATION; LOCUS	Agricultural crops benefit from resistance to pathogens that endures over years and generations of both pest and crop. Durable disease resistance, which may be partial or complete, can be controlled by several genes. Some of the most devastating fungal pathogens in wheat are leaf rust, stripe rust, and powdery mildew. The wheat gene Lr34 has supported resistance to these pathogens for more than 50 years. Lr34 is now shared by wheat cultivars around the world. Here, we show that the LR34 protein resembles adenosine triphosphate-binding cassette transporters of the pleiotropic drug resistance subfamily. Alleles of Lr34 conferring resistance or susceptibility differ by three genetic polymorphisms. The Lr34 gene, which functions in the adult plant, stimulates senescence-like processes in the flag leaf tips and edges.	[Lagudah, Evans S.; Spielmeyer, Wolfgang; McFadden, Helen] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Krattinger, Simon G.; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Singh, Ravi P.] CIMMYT, Int Maize & Wheat Improvement Ctr, Mexico City 06600, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo 56230, Edo De Mexico, Mexico	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Zurich; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Lagudah, ES (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	evans.lagudah@csiro.au; bkeller@botinst.uzh.ch	Huerta-Espino, Julio JH/N-9840-2018; Huerta-Espino, Julio/E-7345-2010; Keller, Beat/K-3093-2019; Lagudah, Evans/A-2007-2010; Singh, Ravi Prakash/I-5575-2019; Krattinger, Simon/AAA-2098-2021; Krattinger, Simon/C-2863-2012; Spielmeyer, Wolfgang/M-3254-2018	Huerta-Espino, Julio JH/0000-0001-8334-9862; Huerta-Espino, Julio/0000-0001-8334-9862; Keller, Beat/0000-0003-2379-9225; Lagudah, Evans/0000-0002-6234-1789; Spielmeyer, Wolfgang/0000-0002-5115-7820; Krattinger, Simon/0000-0001-6912-7411	Swiss National Science Foundation; Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia(Grains R&D Corp)	This work was supported by the Swiss National Science Foundation (B.K.), the Indo-Swiss Collaboration in Biotechnology (B.K.), and the Grains Research and Development Corporation, Australia (E.S.L and R.P.S.). We thank B. Senger for support in field experiments; P. Streckeisen for advice on infection; L. Viccars and S. Chandramohan for technical assistance; M. Ayliffe, M. Talbot, and R. White for assistance with histology; T. Wicker for bioinformatic support; and S. Hortensteiner for nonfluorescent chlorophyll catabolite analysis. GenBank accession numbers: FJ436983 and FJ436985. Patents: CSIRO, Grains Research and Development Corporation, University of Zurich, Australian Provisional Patent Application 2008904364.	Bossolini E, 2006, THEOR APPL GENET, V113, P1049, DOI 10.1007/s00122-006-0364-5; BOWDEN RL, 2007, PLANT BIOTECHNOL J, V1083, P5; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; GREGERSEN PL, 2007, ANNU REV PLANT BIOL, P192; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Keller Beat, 2007, P103, DOI 10.1007/978-1-4020-6297-1_5; Krupinska K, 2002, PLANT PHYSIOL, V130, P1172, DOI 10.1104/pp.008565; KRUPINSKA K, 2002, REV PLANT BIOL, V1172, P57; LIM PO, 2007, PLANT PHYSIOL, V115, P130; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lipka U, 2008, CURR OPIN PLANT BIOL, V11, P404, DOI 10.1016/j.pbi.2008.04.004; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Singh Ravi P., 2007, P109; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1992, CROP SCI, V32, P874, DOI 10.2135/cropsci1992.0011183X003200040008x; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Webb CA, 2002, GENETICS, V162, P381	29	811	895	12	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1360	1363		10.1126/science.1166453	http://dx.doi.org/10.1126/science.1166453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19229000				2022-12-28	WOS:000263876700047
J	Soldner, F; Hockemeyer, D; Beard, C; Gao, Q; Bell, GW; Cook, EG; Hargus, G; Blak, A; Cooper, O; Mitalipova, M; Isacson, O; Jaenisch, R				Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Mitalipova, Maisam; Isacson, Ole; Jaenisch, Rudolf			Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors	CELL			English	Article							HUMAN SOMATIC-CELLS; DOPAMINERGIC-NEURONS; HUMAN FIBROBLASTS; GENERATION; MOUSE; INDUCTION; EXPRESSION; EFFICIENT; UPDATE; SYSTEM	Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a powerful tool for biomedical research and may provide a source for replacement therapies. However, the use of viruses encoding the reprogramming factors represents a major limitation of the current technology since even low vector expression may alter the differentiation potential of the iPSCs or induce malignant transformation. Here, we show that fibroblasts from five patients with idiopathic Parkinson's disease can be efficiently reprogrammed and subsequently differentiated into dopaminergic neurons. Moreover, we derived hiPSCs free of reprogramming factors using Cre-recombinase excisable viruses. Factor-free hiPSCs maintain a pluripotent state and show a global gene expression profile, more closely related to hESCs than to hiPSCs carrying the transgenes. Our results indicate that residual transgene expression in virus-carrying hiPSCs can affect their molecular characteristics and that factor-free hiPSCs therefore represent a more suitable source of cells for modeling of human disease.	[Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Mitalipova, Maisam; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Isacson, Ole] Harvard Univ, Sch Med, McLean Hosp, Ctr Neurodegenerat Res,Udall Parkinson Dis Res Ct, Belmont, MA 02478 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; McLean Hospital	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Hockemeyer, Dirk/0000-0002-5598-5092; Isacson, Ole/0000-0001-8091-8302; Cooper, Oliver/0000-0001-6567-7491	NIH [R37-CA084198, RO1-CA087869, RO1-HD045022]; Udall Parkinson's Disease Center [P50NS39793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Parkinson's Disease Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Tobias Brambrink for providing the FUGW- loxP plasmid. We thank Raaji Alagappan, Ping Xu, Kristen Lee, and Elizabeth Marlow for technical support and Jessica Daussman, Ruth Flannery, and Dongdong Fu for their help with animal husbandry and processing of teratomas. We would like to thank the members of the Whitehead Genome Technology Core for their help with the microarray expression analysis. We thank all the members of the Jaenisch lab for helpful discussions and comments on the manuscript. D. H. is a Merck Fellow of the Life Science Research Foundation. R. J. was supported by NIH grants R37-CA084198, RO1-CA087869, and RO1-HD045022. This research was supported in part by a Collaborative Innovation Award from the Howard Hughes Medical Institute. O. I. is supported by Udall Parkinson's Disease Center of Excellence grant P50NS39793 and the Michael Stern Foundation. R. J. is an advisor to Stemgent, which has obtained a license from the Massachusetts Institute of Technology (MIT) to distribute some of the reagents used in this paper. F. S., D. H., and R. J. designed the experiments and wrote the paper. C. B. designed and performed Southern blot analysis. Q. G. analyzed all teratomas. G. B. analyzed the gene expression profile. E. G. C. assisted with the NotI/BSU36I sites of the FUGW- loxP, which contains a loxP site in the 30 LTR (Hanna et al., 2007).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim BK, 2006, FEBS LETT, V580, P5869, DOI 10.1016/j.febslet.2006.09.053; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Trounson A, 2009, CELL STEM CELL, V4, P3, DOI 10.1016/j.stem.2008.12.002; von Kalle C, 2004, SEMIN HEMATOL, V41, P303, DOI 10.1053/j.seminhematol.2004.07.007; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	1126	1242	1	218	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					964	977		10.1016/j.cell.2009.02.013	http://dx.doi.org/10.1016/j.cell.2009.02.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269371	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000263930900018
J	Kump, LR				Kump, Lee R.			Tipping Pointedly Colder	SCIENCE			English	Editorial Material							ANTARCTIC GLACIATION; OLIGOCENE; TRANSITION; FEEDBACKS; CALCITE; OCEAN		[Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Kump, Lee R.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012					Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; Kump LR, 2008, SCIENCE, V320, P195, DOI 10.1126/science.1153883; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Pagani M, 2008, GEOCHIM COSMOCHIM AC, V72, pA716; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; Turich C, 2007, GEOCHIM COSMOCHIM AC, V71, P3272, DOI 10.1016/j.gca.2007.04.013; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001	13	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1175	1176		10.1126/science.1170613	http://dx.doi.org/10.1126/science.1170613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251616				2022-12-28	WOS:000263687600024
J	Lovett, BW; Benjamin, SC				Lovett, Brendon W.; Benjamin, Simon C.			Comment on "Multipartite Entanglement Among Single Spins in Diamond"	SCIENCE			English	Editorial Material								Neumann et al. (Reports, 6 June 2008, p. 1326) recently reported the preparation of multiparticle entanglement among single spins in diamond. However, two of the system's nuclear eigenstates are incorrectly described as product states when they are inherently entangled. Consequently, three of the six states reported, namely the odd-parity Bell states and the W state, were not actually produced.	[Lovett, Brendon W.; Benjamin, Simon C.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Benjamin, Simon C.] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore	University of Oxford; National University of Singapore	Lovett, BW (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.	brendon.lovett@materials.ox.ac.uk	Benjamin, Simon/A-8673-2008	Benjamin, Simon/0000-0002-7766-5348; Lovett, Brendon/0000-0001-5142-9585				Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233	2	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918								10.1126/science.1168458	http://dx.doi.org/10.1126/science.1168458			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251613				2022-12-28	WOS:000263687600018
J	Davis, K				Davis, Karen			Health Care 2009: Investing in Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Davis, K (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Americans I of M (US) C on the FHCW for O, 2008, HLTH STATUS HLTH CAR; Congressional Budget Office, 2008, BUDG OPT, V1; Davis K, 2008, NEW ENGL J MED, V359, P1751, DOI 10.1056/NEJMp0805261; *LEW GROUP, 2009, PATH HIGH PERF HLTH; The Commonwealth Fund Commission on a High Performance Health System, 2009, PATH HIGH PERF US HL	5	8	8	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					852	855		10.1056/NEJMp0900309	http://dx.doi.org/10.1056/NEJMp0900309			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	411CD	19228700				2022-12-28	WOS:000263624700002
J	Luddi, A; Margollicci, M; Gambera, L; Serafini, F; Cioni, M; De Leo, V; Balestri, P; Piomboni, P				Luddi, Alice; Margollicci, Maria; Gambera, Laura; Serafini, Francesca; Cioni, Maddalena; De Leo, Vincenzo; Balestri, Paolo; Piomboni, Paola			Brief Report: Spermatogenesis in a Man with Complete Deletion of USP9Y.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							Y-CHROMOSOME; MALE-INFERTILITY; GENE; MEN; MICRODELETIONS; PERSPECTIVE; SEQUENCE; INTERVAL; SPERM	Deletions in the azoospermia factor region AZFa on the human Y chromosome and, more specifically, in the region that encompasses the ubiquitin-specific peptidase 9, Y-linked gene USP9Y have been implicated in infertility associated with oligospermia and azoospermia. We have characterized in detail a deletion in AZFa that results in an absence of USP9Y in a normospermic man and his brother and father. The association of this large deletion with normal fertility shows that USP9Y, hitherto considered a candidate gene for infertility and azoospermia, does not have a key role in male reproduction. These results suggest that it may not be necessary to consider USP9Y when screening the Y chromosome of infertile or subfertile men for microdeletions.	[Luddi, Alice; Margollicci, Maria; Gambera, Laura; Serafini, Francesca; Cioni, Maddalena; De Leo, Vincenzo; Balestri, Paolo] Univ Siena, Dept Pediat Obstet & Reprod Med, I-53100 Siena, Italy; [Piomboni, Paola] Univ Siena, Dept Biomed Sci, Appl Biol Sect, I-53100 Siena, Italy; [Gambera, Laura; Serafini, Francesca; De Leo, Vincenzo; Piomboni, Paola] Siena Hosp, Ctr Diag & Treatment Couple Steril, Siena, Italy	University of Siena; University of Siena	Piomboni, P (corresponding author), Univ Siena, Dept Biomed Sci, Appl Biol Sect,Policlin S Maria alle Scotte, Siena Hosp,Ctr Diag & Treatment Couple Steril, Viale Bracci 14, I-53100 Siena, Italy.	piomboni@unisi.it	piomboni, paola/AAB-9868-2019; Luddi, Alice/AAC-7835-2019	Luddi, Alice/0000-0002-4946-7336; De Leo, Vincenzo/0000-0001-8522-9370	Monte dei Paschi di Siena Bank [0405]	Monte dei Paschi di Siena Bank	Supported in part by a grant (0405) from Monte dei Paschi di Siena Bank.; No potential conflict of interest relevant to this article was reported.; We thank Csilla Krausz for helpful discussions, Elvira Costantino-Ceccarini for her extensive assistance in the preparation of a previous draft of the manuscript, and Carlo Alessandrini for participation in the ultrastructural studies.	Baccetti B, 2003, HUM REPROD, V18, P2302, DOI 10.1093/humrep/deg460; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Hall NM, 2003, MAMM GENOME, V14, P437, DOI 10.1007/s00335-002-3068-4; Kamp C, 2001, MOL HUM REPROD, V7, P987, DOI 10.1093/molehr/7.10.987; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kuo PL, 2004, UROLOGY, V63, P131, DOI 10.1016/j.urology.2003.08.048; Sargent CA, 1999, J MED GENET, V36, P670; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Tyler-Smith C, 2008, INT J ANDROL, V31, P376, DOI 10.1111/j.1365-2605.2008.00889.x; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1999, WHO LAB MAN EX HUM S	17	94	115	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					881	885		10.1056/NEJMoa0806218	http://dx.doi.org/10.1056/NEJMoa0806218			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246359	Bronze			2022-12-28	WOS:000263624700006
J	Garvin, J; Buick, R; Anbar, AD; Arnold, GL; Kaufman, AJ				Garvin, Jessica; Buick, Roger; Anbar, Ariel D.; Arnold, Gail L.; Kaufman, Alan J.			Isotopic Evidence for an Aerobic Nitrogen Cycle in the Latest Archean	SCIENCE			English	Article							FIXATION; PARTICLES; EVOLUTION; SINKING; RECORD; OCEAN	The nitrogen cycle provides essential nutrients to the biosphere, but its antiquity in modern form is unclear. In a drill core though homogeneous organic- rich shale in the 2.5- billion- year- old Mount McRae Shale, Australia, nitrogen isotope values vary from +1.0 to +7.5 per mil (parts per thousand) and back to +2.5 parts per thousand over similar to 30 meters. These changes evidently record a transient departure from a largely anaerobic to an aerobic nitrogen cycle complete with nitrification and denitrification. Complementary molybdenum abundance and sulfur isotopic values suggest that nitrification occurred in response to a small increase in surface- ocean oxygenation. These data imply that nitrifying and denitrifying microbes had already evolved by the late Archean and were present before oxygen first began to accumulate in the atmosphere.	[Garvin, Jessica; Buick, Roger] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Garvin, Jessica; Buick, Roger] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kaufman, Alan J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park	Buick, R (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	buick@ess.washington.edu	Arnold, Gail L/A-5572-2010	Arnold, Gail L/0000-0001-9631-9830; Buick, Roger/0000-0003-0139-1659	NASA Astrobiology Drilling Program; NSF Geobiology and Low Temperature Geochemistry	NASA Astrobiology Drilling Program(National Aeronautics & Space Administration (NASA)); NSF Geobiology and Low Temperature Geochemistry(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank L. C. Bonser, J.S.R. Dunlop, A. H. Hickman, M. van Kranendonk, the Geological Survey of Western Australia, P. van Loenhout, and Mount Magnet Drilling for assistance with core recovery; the NASA Astrobiology Drilling Program and NSF Geobiology and Low Temperature Geochemistry for funding; and H. Knoll, J. Farquhar, R. E. Summons, and T. W. Lyons for advice.	Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; BEBOUT GE, 1992, GEOCHIM COSMOCHIM AC, V56, P2839, DOI 10.1016/0016-7037(92)90363-N; Berman-Frank I., 2005, BIOGEOSCIENCES DISCU, V2005, P261, DOI DOI 10.5194/BGD-2-261-2005; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Fogel M.L., 1993, ORGANIC GEOCHEMISTRY, P73, DOI DOI 10.1007/978-1-4615-2890-6_3; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Jia YF, 2004, TERRA NOVA, V16, P102, DOI 10.1111/j.1365-3121.2004.00535.x; Kaplan WA., 1983, NITROGEN MARINE ENV, P139; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Navarro-Gonzalez R, 2001, NATURE, V412, P61, DOI 10.1038/35083537; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PINTI DL, 2005, LECT ASTROBIOLOGY, V1; Rasmussen B, 2005, GEOLOGY, V33, P725, DOI 10.1130/G21616.1; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; SHEN Y, 2005, ARCHEAN GEODYNAMIC E, P309; Sigman D.M., 2001, ENCY OCEAN SCI, P1884, DOI DOI 10.1006/RWOS.2001.0172; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; WADA E., 1990, NITROGEN SEA FORMS A; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	27	163	172	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1045	1048		10.1126/science.1165675	http://dx.doi.org/10.1126/science.1165675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229033				2022-12-28	WOS:000263478400037
J	Parati, G; Pickering, TG				Parati, Gianfranco; Pickering, Thomas G.			Home blood-pressure monitoring: US and European consensus	LANCET			English	Editorial Material							HYPERTENSION; SOCIETY		[Parati, Gianfranco] Univ Milan, Dept Clin Med & Prevent, Milan, Italy; [Parati, Gianfranco] IRCCS, Ist Auxol Italiano, S Luca Hosp, Dept Cardiol, I-20149 Milan, Italy; [Pickering, Thomas G.] Columbia Presbyterian Med Ctr, Behav Cardiovasc Hlth & Hypertens Program, New York, NY 10032 USA	University of Milan; IRCCS Istituto Auxologico Italiano; Columbia University; NewYork-Presbyterian Hospital	Parati, G (corresponding author), Univ Milan, Dept Clin Med & Prevent, Milan, Italy.	gianfranco.parati@unimib.it	Parati, Gianfranco/K-7151-2016	Parati, Gianfranco/0000-0001-9402-7439				O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Parati G, 2004, CURR OPIN NEPHROL HY, V13, P343, DOI 10.1097/00041552-200405000-00013; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Stergiou G, 2004, BMJ-BRIT MED J, V329, P870, DOI 10.1136/bmj.329.7471.870	5	63	63	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					876	878		10.1016/S0140-6736(09)60526-2	http://dx.doi.org/10.1016/S0140-6736(09)60526-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286071				2022-12-28	WOS:000264158700009
J	Bayer, M; Nawy, T; Giglione, C; Galli, M; Meinnel, T; Lukowitz, W				Bayer, Martin; Nawy, Tal; Giglione, Carmela; Galli, Mary; Meinnel, Thierry; Lukowitz, Wolfgang			Paternal Control of Embryonic Patterning in Arabidopsis thaliana	SCIENCE			English	Article							RECEPTOR-LIKE KINASES; SEED DEVELOPMENT; STOMATAL DEVELOPMENT; PROTEIN-KINASES; MAPKK KINASE; PLANTS; ELEMENTS	The YODA (YDA) mitogen-activated protein kinase pathway promotes elongation of the Arabidopsis zygote and development of its basal daughter cell into the extra-embryonic suspensor. Here, we show that the interleukin-1 receptor-associated kinase (IRAK)/Pelle-like kinase gene SHORT SUSPENSOR (SSP) regulates this pathway through a previously unknown parent-of-origin effect. SSP transcripts are produced in mature pollen but do not appear to be translated. Instead, they are delivered via the sperm cells to the zygote and the endosperm, where SSP protein transiently accumulates. Ectopic expression of SSP protein in the leaf epidermis is sufficient to activate YDA-dependent signaling. We propose that SSP protein produced from paternal transcripts upon fertilization triggers zygotic YDA activity, providing an essential temporal cue for the regulation of the asymmetric first division.	[Bayer, Martin; Nawy, Tal; Galli, Mary; Lukowitz, Wolfgang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Giglione, Carmela; Meinnel, Thierry] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Lukowitz, Wolfgang] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University System of Georgia; University of Georgia	Lukowitz, W (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lukowitz@uga.edu	Meinnel, Thierry/B-9813-2016; Bayer, Martin/AAP-3372-2020	Bayer, Martin/0000-0001-5806-2253; Meinnel, Thierry/0000-0001-5642-8637; Nawy, Tal/0000-0003-3720-3699; Giglione, Carmela/0000-0002-7475-1558	NSF [IOB-0446103]; Deutsche Forschungsgemeinschaft; Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer [4920]	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the NSF (grant IOB-0446103 to W.L.), the Deutsche Forschungsgemeinschaft (M.B.), the Cold Spring Harbor Laboratory Association (T.N.), and the Association pour le Recherche sur le Cancer (grant 4920 to T.M.). Seed of ssp-1 have been deposited with the Arabidopsis stock center. Materials were kindly made available by P. Das (Caltech), F. Besnard and T. Vernoux (Ecole Normale Superieure Lyon, pENTR triple Venus), S. McCormick (University of California Berkeley, GEX2 marker), N. Sauer (Erlangen University, SUC3 marker), A. Schnittger (Strasbourg University, cdc2a;fie1), and K. Slotkin and R. Martienssen (Cold Spring Harbor Laboratory, met1, ddm1, cmt3, drm2, and rdr1; rdr2; rdr6). S. Alabaster and J. A. Traverso provided help in the early phases of the project. We thank T. Berleth (University of Toronto), C. S. Gillmor and M. Willman (University of Pennsylvania), S. Jeong and C. Schulz (University of Georgia), R. Schwab (Cold Spring Harbor Laboratory), and D. Weijers (Wageningen University) for comments on the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Boisson B, 2003, ANAL BIOCHEM, V322, P116, DOI 10.1016/j.ab.2003.07.007; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Meyer S, 2004, PLANT PHYSIOL, V134, P684, DOI 10.1104/pp.103.033399; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wardlaw CW, 1955, EMBRYOGENESIS PLANTS	21	249	260	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1485	1488		10.1126/science.1167784	http://dx.doi.org/10.1126/science.1167784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286558				2022-12-28	WOS:000264101700043
J	De Backer, T; Stichele, RV; Lehert, P; Van Bortel, L				De Backer, T.; Stichele, R. Vander; Lehert, P.; Van Bortel, L.			Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERIPHERAL ARTERIAL-DISEASE; QUALITY-OF-LIFE; OCCLUSIVE DISEASE; EXERCISE REHABILITATION; CLINICAL-TRIALS; DRUG-TREATMENT; FUNCTIONAL OUTCOMES; MEDICAL-TREATMENT; CALCIUM-OXALATE; PREVALENCE	Objective To assess the efficacy of naftidrofuryl compared with placebo in treating the symptoms of intermittent claudication. Design Meta-analysis based on individual patient data. Data sources Medline, International Pharmaceutical Abstracts, Embase, Science Citation Index, and the Cochrane trial registers. Reference lists of retrieved articles were checked. Authors and companies were approached for additional information and individual patient data. Inclusion criteria Double blind, randomised controlled trials in patients with intermittent claudication receiving oral naftidrofuryl or placebo and with pain-free walking distance as primary outcome. Data collection Individual patient data were collected from electronic data or from case report forms and checked for integrity. Analysis All randomised patients were analysed following the intention to treat principle. Efficacy was assessed by the ratio of geometric mean of the relative improvement in pain-free walking distance after use of naftidrofuryl compared with placebo. In the analysis of responders, therapeutic success was defined as an improvement of walking distance at baseline by at least 50%. Results In total, 1266 patients were randomised (1083 in the main analysis). The ratio of relative improvement in pain-free walking distance after use of naftidrofuryl compared with placebo was 1.37 (95% confidence interval 1.27 to 1.49). The difference in response rate was 22.3% (95% confidence interval 17.1% to 27.6%) and the number needed to treat for relief of symptoms during six months of treatment was 4.48 (95% confidence interval 3.62 to 5.85). Conclusion This meta-analysis of individual patient data provides evidence that naftidrofuryl has a clinically meaningful effect compared with placebo in improving walking distance in patients with intermittent claudication.	[De Backer, T.; Van Bortel, L.] Ghent Univ Hosp, Dept Cardiovasc Dis, B-9000 Ghent, Belgium; [De Backer, T.; Van Bortel, L.] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; [Lehert, P.] Leuven Acad, Fac Univ Catholiques Mons, Dept Stat, Mons, Belgium	Ghent University; Ghent University Hospital; Ghent University; University of Mons	De Backer, T (corresponding author), Ghent Univ Hosp, Dept Cardiovasc Dis, Pintelaan 185, B-9000 Ghent, Belgium.	tine.debacker@Ugent.be	Stichele, Robert Vander/K-7203-2015	Stichele, Robert Vander/0000-0001-9118-9651	Ghent University, Belgium; Chief Scientist Office, Health Department, the Scottish Executive, UK	Ghent University, Belgium(Ghent University); Chief Scientist Office, Health Department, the Scottish Executive, UK	Funding: This study was funded by Ghent University, Belgium. The Cochrane Collaboration is supported by the Chief Scientist Office, Health Department, the Scottish Executive, UK.	ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Annemans L, 2007, EUR J CARDIOV PREV R, V14, P815, DOI 10.1097/HJR.0b013e3282ef514f; Aung PP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000123.pub2; Barradell LB, 1996, DRUG AGING, V8, P299, DOI 10.2165/00002512-199608040-00005; BEVAN EG, 1992, DRUG AGING, V2, P125, DOI 10.2165/00002512-199202020-00006; BOOBIS LH, 1982, BRIT J SURG, V69, pS17, DOI 10.1002/bjs.1800691308; CAMERON HA, 1988, BRIT J CLIN PHARMACO, V26, P569, DOI 10.1111/j.1365-2125.1988.tb05297.x; Carman TL, 2000, AM FAM PHYSICIAN, V61, P1027; Cholongitas E, 2003, AM J GASTROENTEROL, V98, P1448; Christman S K, 2001, J Cardiovasc Nurs, V15, P64; Clement DL, 2007, CURR HYPERTENS REP, V9, P190, DOI 10.1007/s11906-007-0034-2; Clement DL, 2000, ACTA CHIR BELG, V100, P190; COFFMAN JD, 1979, NEW ENGL J MED, V300, P713; Committee for Proprietary Medicinal Products, 2002, NOT GUID CLIN INV ME; CRIQUI MH, 1985, CIRCULATION, V72, P768, DOI 10.1161/01.CIR.72.4.768; De Backer TL, 2000, EUR J CLIN PHARMACOL, V56, P199, DOI 10.1007/s002280000114; DECAESTECKER JS, 1986, POSTGRAD MED J, V62, P309, DOI 10.1136/pgmj.62.726.309; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DORMANDY IA, 2000, J VASC SURG, V31, pS1; Fletcher J, 2007, BMJ-BRIT MED J, V334, P94, DOI 10.1136/bmj.39057.406644.68; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gardner AW, 2001, J AM GERIATR SOC, V49, P755, DOI 10.1046/j.1532-5415.2001.49152.x; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Gardner AW, 2000, J GERONTOL A-BIOL, V55, pM570, DOI 10.1093/gerona/55.10.M570; Gartenmann L, 2002, VASA-J VASCULAR DIS, V31, P29; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; Goldsmith DR, 2005, DRUG AGING, V22, P967, DOI 10.2165/00002512-200522110-00006; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; HEBUTERNE X, 1990, GASTROEN CLIN BIOL, V14, P514; Heidrich H, 2006, Hamostaseologie, V26, P220; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Hood SC, 1996, CAN MED ASSOC J, V155, P1053; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Jacoby D, 2004, DRUGS, V64, P1657, DOI 10.2165/00003495-200464150-00004; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lee HLD, 2007, EUR J VASC ENDOVASC, V33, P202, DOI 10.1016/j.ejvs.2006.08.005; LEHERT P, 1990, J CARDIOVASC PHARM, V16, pS81, DOI 10.1097/00005344-199000163-00019; LENG G, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000990; Li Xiao-ying, 2003, Zhonghua Yi Xue Za Zhi, V83, P1847; Madiba TE, 2001, SAMJ S AFR MED J, V91, P785; MOESCH C, 1991, LANCET, V338, P1219, DOI 10.1016/0140-6736(91)92093-H; MOESCH C, 1995, AGE AGEING, V24, P464, DOI 10.1093/ageing/24.6.464; Moher D, 2000, DRUGS, V59, P1057, DOI 10.2165/00003495-200059050-00003; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Muller-Buhl U, 2003, FAM PRACT, V20, P36, DOI 10.1093/fampra/20.1.36; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; REY JL, 1989, ARCH MAL COEUR VAISS, V82, P1467; ROBBS JV, 1985, S AFR MED J, V67, P797; Robless P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub2; *SCOTT INT GUID NE, 2006, DIAGN MAN PER ART DI, P1; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Spengel F, 2002, INT ANGIOL, V21, P20; SPITZER S, 1992, INT ANGIOL, V11, P204; Sprynger M, 2007, INT ANGIOL, V26, P239; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; Verhaeghe R, 1998, DRUGS, V56, P1, DOI 10.2165/00003495-199856003-00001; WALKER GA, 1995, FUNDAM CLIN PHARM, V9, P387, DOI 10.1111/j.1472-8206.1995.tb00515.x	61	23	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b603	10.1136/bmj.b603	http://dx.doi.org/10.1136/bmj.b603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19276131	Green Published, hybrid			2022-12-28	WOS:000264205300001
J	Villar, SS				Serrano Villar, Sergio			Commentary: Managing clinician's assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENSTRUATION; ANAPHYLAXIS		Hosp Clin San Carlos, Madrid 28040, Spain	Hospital Clinico San Carlos	Villar, SS (corresponding author), Hosp Clin San Carlos, Madrid 28040, Spain.	sergio1serrano@yahoo.es	Serrano-Villar, Sergio/AEU-8833-2022	Serrano-Villar, Sergio/0000-0002-5447-3554				BASOMBA A, 1987, ALLERGY, V42, P477, DOI 10.1111/j.1398-9995.1987.tb00367.x; SCHWARTZ HJ, 1995, CLIN EXP ALLERGY, V25, P866, DOI 10.1111/j.1365-2222.1995.tb00029.x; Simpson G, 2001, MED J AUSTRALIA, V175, P415, DOI 10.5694/j.1326-5377.2001.tb143647.x; Sonneck K, 2007, INT ARCH ALLERGY IMM, V142, P158, DOI 10.1159/000096442; 2009, BMJ	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2009	338								b868	10.1136/bmj.b868	http://dx.doi.org/10.1136/bmj.b868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419FT	19273527				2022-12-28	WOS:000264205200009
J	Powers, AF; Franck, AD; Gestaut, DR; Cooper, J; Gracyzk, B; Wei, RR; Wordeman, L; Davis, TN; Asbury, CL				Powers, Andrew F.; Franck, Andrew D.; Gestaut, Daniel R.; Cooper, Jeremy; Gracyzk, Beth; Wei, Ronnie R.; Wordeman, Linda; Davis, Trisha N.; Asbury, Charles L.			The Ndc80 Kinetochore Complex Forms Load-Bearing Attachments to Dynamic Microtubule Tips via Biased Diffusion	CELL			English	Article							CHROMOSOME MOTION; BUDDING YEAST; DAM1 COMPLEX; MITOSIS; DEPOLYMERIZATION; MOVEMENT; DRIVEN; HEC1; ARCHITECTURE; CHECKPOINT	Kinetochores couple chromosomes to the assembling and disassembling tips of microtubules, a dynamic behavior that is fundamental to mitosis in all eukaryotes but poorly understood. Genetic, biochemical, and structural studies implicate the Ndc80 complex as a direct point of contact between kinetochores and microtubules, but these approaches provide only a static view. Here, using techniques for manipulating and tracking individual molecules in vitro, we demonstrate that the Ndc80 complex is capable of forming the dynamic, load-bearing attachments to assembling and disassembling tips required for coupling in vivo. We also establish that Ndc80-based coupling likely occurs through a biased diffusion mechanism and that this activity is conserved from yeast to humans. Our findings demonstrate how an ensemble of Ndc80 complexes may provide the combination of plasticity and strength that allows kinetochores to maintain load-bearing tip attachments during both microtubule assembly and disassembly.	[Powers, Andrew F.; Franck, Andrew D.; Cooper, Jeremy; Wordeman, Linda; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gestaut, Daniel R.; Gracyzk, Beth; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wei, Ronnie R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Asbury, CL (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	casbury@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152; Wordeman, Linda/0000-0002-9444-0650	NIH [T32 GM07270]; NSF IGERT [DGE-0504573]; Packard Fellowship for Science and Engineering [2006-30521]; National Institute of General Medical Sciences [R01GM40506, R01GM79373, R01GM69429]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040506, R01GM069429, T32GM007270, R01GM079373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen Harrison and Jennifer DeLuca for plasmids, Anthony Azevedo for conducting early experiments with the 2NCC: 2S construct, Ryan Lemke for technical assistance, Jason Stumpff for helpful comments on the manuscript, and all members of the Seattle Mitosis Club for valuable discussion. This work was supported by an NIH traineeship (T32 GM07270 awarded to A. F. P.), an NSF IGERT traineeship (DGE-0504573 to A. D. F.), a Searle Scholar Award (06- L-111 to C. L. A.), a Packard Fellowship for Science and Engineering (2006-30521 to C. L. A.), and by grants R01GM40506, R01GM79373, and R01GM69429 from the National Institute of General Medical Sciences (to T. N. D., C. L. A., and L. W., respectively).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	39	203	204	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					865	875		10.1016/j.cell.2008.12.045	http://dx.doi.org/10.1016/j.cell.2008.12.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269365	Bronze, Green Accepted			2022-12-28	WOS:000263930900010
J	Schwenk, J; Harmel, N; Zolles, G; Bildl, W; Kulik, A; Heimrich, B; Chisaka, O; Jonas, P; Schulte, U; Fakler, B; Klocker, N				Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Kulik, Akos; Heimrich, Bernd; Chisaka, Osamu; Jonas, Peter; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj			Functional Proteomics Identify Cornichon Proteins as Auxiliary Subunits of AMPA Receptors	SCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KINETIC-PROPERTIES; CA2+ PERMEABILITY; GAMMA-SUBUNIT; MUTANT MOUSE; ION CHANNELS; TIME-COURSE; STARGAZIN	Glutamate receptors of the AMPA-subtype (AMPARs), together with the transmembrane AMPAR regulatory proteins (TARPs), mediate fast excitatory synaptic transmission in the mammalian brain. Here, we show by proteomic analysis that the majority of AMPARs in the rat brain are coassembled with two members of the cornichon family of transmembrane proteins, rather than with the TARPs. Coassembly with cornichon homologs 2 and 3 affects AMPARs in two ways: Cornichons increase surface expression of AMPARs, and they alter channel gating by markedly slowing deactivation and desensitization kinetics. These results demonstrate that cornichons are intrinsic auxiliary subunits of native AMPARs and provide previously unknown molecular determinants for glutamatergic neurotransmission in the central nervous system.	[Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Schulte, Uwe] Logopharm GmbH, D-79108 Freiburg, Germany; [Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79108 Freiburg, Germany; [Kulik, Akos; Heimrich, Bernd] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Chisaka, Osamu] Kyoto Univ, Dept Cell & Dev Biol, Kyoto 6068502, Japan	University of Freiburg; University of Freiburg; University of Freiburg; Kyoto University	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol 2, Engesserstr 4, D-79108 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; kloecker@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Schwenk, Jochen/0000-0003-3664-9795	Deutsche Forschungsgemeinschaft [SFB 746/TP16, SFB780/TPA3, EXC 294, SFB780/TPB4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. P. Adelman for insightful comments and critical reading of the manuscript and A. Haupt for help with bioinformatics. This work was supported by grants of the Deutsche Forschungsgemeinschaft to B.F. (SFB 746/TP16, SFB780/TPA3, EXC 294) and to N.K. (SFB780/TPB4).	Antz C, 1999, NAT STRUCT BIOL, V6, P146; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Menuz K, 2009, NEUROPHARMACOLOGY, V56, P22, DOI 10.1016/j.neuropharm.2008.06.037; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102	49	289	301	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1313	1319		10.1126/science.1167852	http://dx.doi.org/10.1126/science.1167852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265014				2022-12-28	WOS:000263876700034
J	Noon, GP				Noon, George P.			Evolution of Surgical Treatment of Coronary Artery Occlusive Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANGINA-PECTORIS; HEART; BYPASS	A 42-year-old man had extensive occlusive disease of the coronary artery and angina pectoris. An autogenous saphenous vein bypass from the ascending aorta to the anterior descending coronary artery was performed on Nov 23, 1964. The patient suffered an asymptomatic anterior myocardial infarction during operation but made an uncomplicated recovery. Seven years after the operation, the graft functions with normal left ventricular hemodynamics, while the occlusive process has produced obstruction of the left main coronary artery and almost complete occlusion of the right coronary artery. To our knowledge, this is the first successful case of a saphenous vein-coronary artery bypass with the longest follow-up of a functioning coronary vein bypass graft.	Baylor Coll Med, Div Transplant & Assist Devices, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine	Noon, GP (corresponding author), Baylor Coll Med, Div Transplant & Assist Devices, Michael E DeBakey Dept Surg, 6560 Fannin,Ste 1860, Houston, TX 77030 USA.	gnoon@bcm.edu						BAILEY CP, 1957, JAMA-J AM MED ASSOC, V164, P641, DOI 10.1001/jama.1957.02980060017005; Beck CS, 1935, ANN SURG, V102, P801, DOI 10.1097/00000658-193511000-00001; Carrel A, 1910, ANN SURG, V52, P83, DOI 10.1097/00000658-191007000-00009; Centers for Disease Control and Prevention, LEAD CAUS DEATH 1900; CRAWFORD ES, 1960, SURG FORUM, V10, P671; DEBAKEY ME, 1961, CIRCULATION, V23, P111, DOI 10.1161/01.CIR.23.1.111; GARRETT HE, 1973, JAMA-J AM MED ASSOC, V223, P792, DOI 10.1001/jama.223.7.792; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Jonnesco T., 1920, B ACAD MED, V84, P93; Ochsner A, 1937, SURGERY, V2, P428; Parsons WH, 1937, ANN SURG, V105, P722, DOI 10.1097/00000658-193705000-00008; SABISTON DC, 1974, JOHNS HOPKINS MED J, V134, P314; SONES FM, 1959, CIRCULATION, V20, P773; Weinstein AA, 1934, AM J MED SCI, V187, P753	15	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					970	971		10.1001/jama.2009.245	http://dx.doi.org/10.1001/jama.2009.245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19258588				2022-12-28	WOS:000263784600030
J	O'Donnell, M				O'Donnell, Michael			Commentary: Standing up for free speech	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mod@doctors.org.uk						Clarfield AM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b722; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b500; Freedland J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b524; HOFFENBERG R, 1983, COMMUNICATION; JACOBSON B, 1973, WORLD MED, V9, P15; LOCK S, 1982, BRIT MED J, V284, P370, DOI 10.1136/bmj.284.6313.370; ODONNELL M, 1973, WORLD MED, V8, P3; SABBAGH K, 1981, WORLD MED, V17, P93; Sabbagh K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a2066; WILKES M, 2002, BRIT MED J, V324, P431; 1981, WORLD MED, V17, P5	11	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2009	338								a2094	10.1136/bmj.a2094	http://dx.doi.org/10.1136/bmj.a2094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DQ	19244220				2022-12-28	WOS:000264056100007
J	Ravaud, P; Flipo, RM; Boutron, I; Roy, C; Mahmoudi, A; Giraudeau, B				Ravaud, P.; Flipo, R-M; Boutron, I.; Roy, C.; Mahmoudi, A.; Giraudeau, B.			ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							WEIGHT-LOSS; COMPLEX INTERVENTIONS; CONSORT STATEMENT; PHYSICAL-ACTIVITY; LOSE WEIGHT; MANAGEMENT; RECOMMENDATIONS; ARTHRITIS; EXERCISE; PROGRAM	Objective To evaluate the impact of standardised consultations on patients with osteoarthritis of the knee. Design Open pragmatic cluster randomised controlled trial. Setting Primary care in France. Participants 198 primary care rheumatologists, each of whom had to include two consecutive patients who met the American College of Rheumatology criteria for osteoarthritis of the knee. Interventions Standardised consultation was provided during three goal oriented visits (education on osteoarthritis and treatment management; information on physical exercises; information on weight loss) or usual care. Main outcome measures Change in body weight and in time spent on physical exercises (Baecke index) at four months. Results 336 patients were included (154 allocated to standardised consultation and 182 to usual care). Nine patients were excluded because of lack of baseline data (standardised consultation, n=8; usual care, n=1). At four months, taking into account the clustering effect, the decrease in weight was greater in the standardised consultation group than in the usual care group (mean-1.11 (SD 2.49) kg v-0.37 (2.39) kg; P=0.007). The physical activity score was higher for the standardised consultation group than for the usual care group (mean 0.20 (0.65) v 0.04 (0.78); P=0.013). The standardised consultation and usual care groups did not differ in secondary outcomes, except for global assessment of disease activity (0-10 numeric scale: mean-1.66 (2.26) v-0.90 (2.48); P=0.003) and pain level (0-10 numeric scale: mean-1.65 (2.32) v-1.18 (2.58); P=0.04). Conclusions A structured consultation programme for patients with osteoarthritis of the knee resulted in short term improvement in weight loss and time spent on physical activity. Trial registration Clinical trials NCT00462319.	[Ravaud, P.] Grp Hosp Bichat Claude Bernard, Dpt Epidemiol, Biostat & Rech Clin, INSERM,U738, F-75877 Paris 18, France; [Ravaud, P.; Boutron, I.; Roy, C.] Univ Paris 07, UFR Med, Paris, France; [Ravaud, P.; Boutron, I.; Roy, C.] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol, Biostat & Rech Clin, F-75877 Paris, France; [Flipo, R-M] CHU Lille, Serv Rhumatol, F-59037 Lille, France; [Mahmoudi, A.] SAS, Paris, France; [Giraudeau, B.] INSERM, CIC 202, F-75654 Paris 13, France; [Giraudeau, B.] Univ Tours, Tours, France; [Giraudeau, B.] CHRU Tours, Tours, France; [Giraudeau, B.] INSERM, U717, Paris, France; [Giraudeau, B.] Hop Conception, Serv Rhumatol, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ravaud, P (corresponding author), Grp Hosp Bichat Claude Bernard, Dpt Epidemiol, Biostat & Rech Clin, INSERM,U738, 46 Rue Henri Huchard, F-75877 Paris 18, France.	philippe.ravaud@bch.ap-hop-paris.fr	ravaud, philippe/C-1694-2009; Giraudeau, Bruno/L-9003-2015	Giraudeau, Bruno/0000-0003-3031-8258; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	Almirall SAS, Paris, France	Almirall SAS, Paris, France	This trial was funded by Almirall SAS, Paris, France. The researchers were independent from funders. The sponsor was not involved in the design of the trial; collection, analysis, or interpretation of data; the writing of the report; or the decision to submit the manuscript. The sponsor was responsible for supervising the conduct of the trial.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BROSSEAU L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004259; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Denoeud L, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2003.015263; Deyle GD, 2000, ANN INTERN MED, V132, P173, DOI 10.7326/0003-4819-132-3-200002010-00002; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; Florindo AA, 2004, REV SAUDE PUBL, V38, P307, DOI 10.1590/S0034-89102004000200022; Florindo Alex Antonio, 2006, Cad. Saúde Pública, V22, P535, DOI 10.1590/S0102-311X2006000300008; Fontaine KR, 2007, JCR-J CLIN RHEUMATOL, V13, P12, DOI 10.1097/01.rhu.0000256168.74277.15; Fransen M, 2002, J RHEUMATOL, V29, P1737; Fransen M, 2003, COCHRANE DB SYST REV; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gross DA, 1998, J FAM PRACTICE, V47, P133; Guittet Lydia, 2005, BMC Med Res Methodol, V5, P25, DOI 10.1186/1471-2288-5-25; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Messier SP, 2005, ARTHRITIS RHEUM, V52, P2026, DOI 10.1002/art.21139; Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0; POLS MA, 1995, INT J EPIDEMIOL, V24, P381, DOI 10.1093/ije/24.2.381; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Ravaud P, 2006, NAT CLIN PRACT RHEUM, V2, P313, DOI 10.1038/ncprheum0194; Ravaud P, 2004, BRIT J SURG, V91, P692, DOI 10.1002/bjs.4506; Ravaud P, 2004, ANN RHEUM DIS, V63, P703, DOI 10.1136/ard.2003.009803; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Serdula MK, 2003, JAMA-J AM MED ASSOC, V289, P1747, DOI 10.1001/jama.289.14.1747; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420	43	51	52	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2009	338								b421	10.1136/bmj.b421	http://dx.doi.org/10.1136/bmj.b421			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DP	19237406	hybrid, Green Published			2022-12-28	WOS:000264056000006
J	Kim, JH; Woo, HR; Kim, J; Lim, PO; Lee, IC; Choi, SH; Hwang, D; Nam, HG				Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lim, Pyung Ok; Lee, In Chul; Choi, Seung Hee; Hwang, Daehee; Nam, Hong Gil			Trifurcate Feed-Forward Regulation of Age-Dependent Cell Death Involving miR164 in Arabidopsis	SCIENCE			English	Article							LATERAL ROOT DEVELOPMENT; LEAF SENESCENCE; SIGNALING PATHWAYS; STRESS RESPONSES; THALIANA; MICRORNA; ETHYLENE; TRANSCRIPTOME; TARGETS	Aging induces gradual yet massive cell death in higher organisms, including annual plants. Even so, the underlying regulatory mechanisms are barely known, despite the long- standing interest in this topic. Here, we demonstrate that ORE1, which is a NAC ( NAM, ATAF, and CUC) transcription factor, positively regulates aging- induced cell death in Arabidopsis leaves. ORE1 expression is up- regulated concurrently with leaf aging by EIN2 but is negatively regulated by miR164. miR164 expression gradually decreases with aging through negative regulation by EIN2, which leads to the elaborate up- regulation of ORE1 expression. However, EIN2 still contributes to aging- induced cell death in the absence of ORE1. The trifurcate feed- forward pathway involving ORE1, miR164, and EIN2 provides a highly robust regulation to ensure that aging induces cell death in Arabidopsis leaves.	[Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lee, In Chul; Choi, Seung Hee; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Lim, Pyung Ok] Cheju Natl Univ, Dept Sci Educ, Cheju, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea; [Hwang, Daehee; Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH); Jeju National University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Nam, HG (corresponding author), Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea.	nam@postech.ac.kr	Kim, Jeongsik/I-6184-2019	Kim, Jeongsik/0000-0002-2729-6003	Korea Science and Engineering Foundation National Core Research Center [R15-2004-033-05002-0)]; Crop Functional Genomics Frontier Research Program [CG3132]	Korea Science and Engineering Foundation National Core Research Center(Korea Science and Engineering Foundation); Crop Functional Genomics Frontier Research Program	We thank E. M. Meyerowitz and P. Sieber for the mir164abc triple mutant line; J. Traas for the miR164A- and miR164B-overexpressing lines; and K. H. Suh, B. H. Kim, and Y. S. Park for technical assistance. This research was supported by grants from the Korea Science and Engineering Foundation National Core Research Center (no. R15-2004-033-05002-0) and the Crop Functional Genomics Frontier Research Program (CG3132) from the Korean government (Ministry of Education, Science, and Technology).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521	20	481	523	8	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1053	1057		10.1126/science.1166386	http://dx.doi.org/10.1126/science.1166386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229035				2022-12-28	WOS:000263478400040
J	Cosmi, B				Cosmi, Benilde			Review: Low-molecular-weight heparin reduces risk for venous thromboembolism in adults with leg immobilization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Orsola Marcello Malpighi Hosp, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Cosmi, B (corresponding author), St Orsola Marcello Malpighi Hosp, Bologna, Italy.		Cosmi, Benilde/K-9459-2016	Cosmi, Benilde/0000-0003-0606-6038				*BRIT COMM STAND H, GUID US MON HEP; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goodacre S, 2006, HEALTH TECHNOL ASSES, V10, P1; *SIGN, 2002, SIGN PUBL, V62	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2- 4	10.7326/0003-4819-150-4-200902170-02004	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238602				2022-12-28	WOS:000263562500025
J	Slights, WWE				Slights, William W. E.			Deep in the heart of Shakespeare	LANCET			English	Editorial Material									[Slights, William W. E.] Dept English, Saskatoon, SK S7N 5A5, Canada	University of Saskatchewan	Slights, WWE (corresponding author), Dept English, Saskatoon, SK S7N 5A5, Canada.	william.slights@ns.sympatico.ca						Erickson Robert, 1997, LANGUAGE HEART 1600; FLETCHER P, 1983, PURPLE ISLAND 1633 P; FORD J, 1995, BROKEN HEART 1633; Peto J., 2007, HEART; Slights WWE, 2008, HEART IN THE AGE OF SHAKESPEARE, P1	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					538	539		10.1016/S0140-6736(09)60190-2	http://dx.doi.org/10.1016/S0140-6736(09)60190-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19248244	Bronze			2022-12-28	WOS:000263333600018
J	Nienborg, H; Cumming, BG				Nienborg, Hendrikje; Cumming, Bruce G.			Decision-related activity in sensory neurons reflects more than a neuron's causal effect	NATURE			English	Article							EARLY VISUAL-CORTEX; PERCEPTUAL DECISION; TASK STRATEGY; V2 NEURONS; AREA MT; CHOICE; RESPONSES; DISCRIMINATION; REPRESENTATION; VARIABILITY	During perceptual decisions, the activity of sensory neurons correlates with a subject's percept, even when the physical stimulus is identical(1-9). The origin of this correlation is unknown. Current theory proposes a causal effect of noise in sensory neurons on perceptual decisions(10-12), but the correlation could result from different brain states associated with the perceptual choice(13) (a top-down explanation). These two schemes have very different implications for the role of sensory neurons in forming decisions(14). Here we use white-noise analysis(15) to measure tuning functions of V2 neurons associated with choice and simultaneously measure how the variation in the stimulus affects the subjects' (two macaques) perceptual decisions(16-18). In causal models, stronger effects of the stimulus upon decisions, mediated by sensory neurons, are associated with stronger choice-related activity. However, we find that over the time course of the trial these measures change in different directions-at odds with causal models. An analysis of the effect of reward size also supports this conclusion. Finally, we find that choice is associated with changes in neuronal gain that are incompatible with causal models. All three results are readily explained if choice is associated with changes in neuronal gain caused by top-down phenomena that closely resemble attention(19). We conclude that top-down processes contribute to choice-related activity. Thus, even forming simple sensory decisions involves complex interactions between cognitive processes and sensory neurons.	[Nienborg, Hendrikje; Cumming, Bruce G.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nienborg, H (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	hnienb@gmail.com			US National Institutes of Health; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000404] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Eye Institute. We are grateful to J.A. Movshon and M. Shadlen for discussions and to the members of the Laboratory of Sensorimotor Research for comments on an earlier version of this manuscript. We also thank D. Parker and B. Nagy for excellent animal care.	AHUMADA AJ, 1996, PERCEPTION, V26, P18; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cumming BG, 1999, J NEUROSCI, V19, P5602; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	31	212	213	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					89	U93		10.1038/nature07821	http://dx.doi.org/10.1038/nature07821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270683	Green Accepted			2022-12-28	WOS:000265801300035
J	Li, QS; Estes, JD; Schlievert, PM; Duan, LJ; Brosnahan, AJ; Southern, PJ; Reilly, CS; Peterson, ML; Schultz-Darken, N; Brunner, KG; Nephew, KR; Pambuccian, S; Lifson, JD; Carlis, JV; Haase, AT				Li, Qingsheng; Estes, Jacob D.; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Reilly, Cavan S.; Peterson, Marnie L.; Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.; Pambuccian, Stefan; Lifson, Jeffrey D.; Carlis, John V.; Haase, Ashley T.			Glycerol monolaurate prevents mucosal SIV transmission	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; VAGINAL TRANSMISSION; EPITHELIAL-CELLS; INFECTION; HIV; RESPONSES; INNATE	Although there has been great progress in treating human immunodeficiency virus 1 (HIV-1) infection(1), preventing transmission has thus far proven an elusive goal. Indeed, recent trials of a candidate vaccine and microbicide have been disappointing, both for want of efficacy and concerns about increased rates of transmission(2-4). Nonetheless, studies of vaginal transmission in the simian immunodeficiency virus (SIV)-rhesus macaque (Macacca mulatta) model point to opportunities at the earliest stages of infection in which a vaccine or microbicide might be protective, by limiting the expansion of infected founder populations at the portal of entry(5,6). Here we show in this SIV-macaque model, that an outside-in endocervical mucosal signalling system, involving MIP-3 alpha (also known as CCL20), plasmacytoid dendritic cells and CCR5(+) cell-attracting chemokines produced by these cells, in combination with the innate immune and inflammatory responses to infection in both cervix and vagina, recruits CD4(+) T cells to fuel this obligate expansion. We then show that glycerol monolaurate-a widely used antimicrobial compound(7) with inhibitory activity against the production of MIP-3 alpha and other proinflammatory cytokines(8)-can inhibit mucosal signalling and the innate and inflammatory response to HIV-1 and SIV in vitro, and in vivo it can protect rhesus macaques from acute infection despite repeated intra-vaginal exposure to high doses of SIV. This new approach, plausibly linked to interfering with innate host responses that recruit the target cells necessary to establish systemic infection, opens a promising new avenue for the development of effective interventions to blockHIV-1 mucosal transmission.	[Li, Qingsheng; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Estes, Jacob D.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Pambuccian, Stefan] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Haase, AT (corresponding author), Univ Minnesota, Dept Microbiol, MMC 196,420 Delaware St SE, Minneapolis, MN 55455 USA.	haase001@umn.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institute of Health (NIH) [R21 AI071976, P01 AI066314]; National Cancer Institute, NIH [N01-CO-12400, HHSN266200400088C]; National Center for Research Resources [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, P51RR000167, C06RR015459, G20RR022780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314, R21AI071976] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Miller and D. Lu at the California National Primate Research Center, for helpful discussion and virus stocks, J. Kemnitz at the Wisconsin National Primate Research Center, for discussion and administrative support, and C. O'Neill and T. Leonard for help with the manuscript and figures. This work was supported in part by National Institute of Health (NIH) grants R21 AI071976 and P01 AI066314 (A. T. H.), funds from the National Cancer Institute, NIH, under contracts N01-CO-12400 and HHSN266200400088C (J. D. L.), and grant number P51 RR000167 from the National Center for Research Resources, a component of the NIH, to the Wisconsin National Primate Research Center. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH.	CHECK E, 2007, NATURE, V446, P12; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cohen J, 2008, SCIENCE, V319, P1026, DOI 10.1126/science.319.5866.1026b; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crane-Godreau MA, 2005, INFECT IMMUN, V73, P476, DOI 10.1128/IAI.73.1.476-484.2005; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Johnston R, 2002, AIDS PATIENT CARE ST, V16, P419, DOI 10.1089/108729102760330263; KABARA JJ, 1984, COSMETIC DRUG PRESER, P305; Klasse PJ, 2006, PLOS MED, V3, P1501, DOI 10.1371/journal.pmed.0030351; Ledford H, 2007, NATURE, V450, P325, DOI 10.1038/450325a; Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	26	494	516	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1034	U113		10.1038/nature07831	http://dx.doi.org/10.1038/nature07831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262509	Green Published, Green Accepted			2022-12-28	WOS:000265412900044
J	Baugh, LR; DeModena, J; Sternberg, PW				Baugh, L. Ryan; DeModena, John; Sternberg, Paul W.			RNA Pol II Accumulates at Promoters of Growth Genes During Developmental Arrest	SCIENCE			English	Article							POLYMERASE-II; IN-VIVO; RECEPTOR NHR-49; HUMAN GENOME; C-ELEGANS; TRANSCRIPTION; DROSOPHILA; NELF; PHOSPHORYLATION	When Caenorhabditis elegans larvae hatch from the egg case in the absence of food, their development is arrested (L1 arrest), and they show increased stress resistance until food becomes available. To study nutritional control of larval development, we analyzed growth and gene expression profiles during L1 arrest and recovery. Larvae that were fed responded relatively slowly to starvation compared with the rapid response of arrested larvae to feeding. Chromatin immunoprecipitation of RNA polymerase II (Pol II) followed by deep sequencing showed that during L1 arrest, Pol II continued transcribing starvation-response genes, but the enzyme accumulated on the promoters of growth and development genes. In response to feeding, promoter accumulation decreased, and elongation and messenger RNA levels increased. Therefore, accumulation of Pol II at promoters anticipates nutritionally controlled gene expression during C. elegans development.	[Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	American Cancer Society; Howard Hughes Medical Institute	American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank L. Schaeffer, D. Trout, A. Mortazavi, J. L. Riechmann, and B. Wold for assistance and discussions. We thank E. H. Davidson for sharing his COPAS Biosorter and B. Hwang for sharing his destabilized YFP plasmid. L.R.B. was supported by the American Cancer Society. P.W.S. is an investigator with the Howard Hughes Medical Institute, which supported this work. Microarray analysis and sequencing were performed in the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech. Data and analysis available for download from NCBI Gene Expression Omnibus (accession GSE14009) at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14009.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	20	128	130	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					92	94		10.1126/science.1169628	http://dx.doi.org/10.1126/science.1169628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19251593				2022-12-28	WOS:000264802100039
J	Starr, TK; Allaei, R; Silverstein, KAT; Staggs, RA; Sarver, AL; Bergemann, TL; Gupta, M; O'Sullivan, MG; Matise, I; Dupuy, AJ; Collier, LS; Powers, S; Oberg, AL; Asmann, YW; Thibodeau, SN; Tessarollo, L; Copeland, NG; Jenkins, NA; Cormier, RT; Largaespada, DA				Starr, Timothy K.; Allaei, Raha; Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.; Bergemann, Tracy L.; Gupta, Mihir; O'Sullivan, M. Gerard; Matise, Ilze; Dupuy, Adam J.; Collier, Lara S.; Powers, Scott; Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.; Tessarollo, Lino; Copeland, Neal G.; Jenkins, Nancy A.; Cormier, Robert T.; Largaespada, David A.			A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer	SCIENCE			English	Article							TUMOR-SUPPRESSOR; EXPRESSION; CELLS; METHYLATION; INSTABILITY; MUTAGENESIS; EPITHELIUM; MOUSE	Human colorectal cancers (CRCs) display a large number of genetic and epigenetic alterations, some of which are causally involved in tumorigenesis (drivers) and others that have little functional impact (passengers). To help distinguish between these two classes of alterations, we used a transposon-based genetic screen in mice to identify candidate genes for CRC. Mice harboring mutagenic Sleeping Beauty (SB) transposons were crossed with mice expressing SB transposase in gastrointestinal tract epithelium. Most of the offspring developed intestinal lesions, including intraepithelial neoplasia, adenomas, and adenocarcinomas. Analysis of over 16,000 transposon insertions identified 77 candidate CRC genes, 60 of which are mutated and/or dysregulated in human CRC and thus are most likely to drive tumorigenesis. These genes include APC, PTEN, and SMAD4. The screen also identified 17 candidate genes that had not previously been implicated in CRC, including POLI, PTPRK, and RSPO2.	[Starr, Timothy K.; Allaei, Raha; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.] Univ Minnesota, Dept Biostat & Informat, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bergemann, Tracy L.] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN 55455 USA; [Gupta, Mihir] Harvard Univ, Dept Phys & Chem Biol, Cambridge, MA 02138 USA; [O'Sullivan, M. Gerard; Matise, Ilze] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; [Powers, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Tessarollo, Lino] NCI, Neural Dev Grp, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Copeland, Neal G.; Jenkins, Nancy A.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cormier, Robert T.] Univ Minnesota, Sch Med, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Minnesota System; University of Minnesota Duluth	Starr, TK (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	star0044@umn.edu; larga002@umn.edu	Starr, Tim/AAX-9342-2021; Largaespada, David/C-9832-2014	Dupuy, Adam/0000-0002-8561-4911; Powers, Scott/0000-0003-2769-1932; Starr, Timothy/0000-0002-6308-3451; Bergemann, Tracy/0000-0003-3902-2605	American Cancer Society fellowship [PF-06-282-01-MGO]; NIH [R01CA113636-01A1]; NCI [K01CA122183-03]; Biomedical Research Council of A*STAR, Singapore; NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE [R01CA113636, ZICBC011198] Funding Source: NIH RePORTER	American Cancer Society fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Insertion data are deposited in the Retrovirus Tagged Cancer Gene Database (RTCGD). We thank S. Singh for help with GSFlex 454 sequencing; K. Akagi for maintaining the RTCGD; A. Weber-Main and K. Stone for editing assistance; the Masonic Cancer Center shared resources including Biostatistics and Bioinformatics, Comparative Pathology, and the Mouse Genetics Laboratory; and the Minnesota Supercomputing Institute for providing computational resources. Research was funded by the American Cancer Society fellowship PF-06-282-01-MGO (to T.K.S.), NIH grant R01CA113636-01A1 (to D.A.L.), NCI grant K01CA122183-03 (to L.S.C.), the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research) Singapore (N.A.J. and N.G.C.), and the NCI Intramural Research Program of NIH (L.T.). A University of Minnesota Academic Health Center Faculty Development Grant provided additional funding to D.A.L. and R.T.C. D.A.L. is a cofounder of, and has an equity interest in, Discovery Genomics, Inc., a biotechnology company that is pursuing SB technology for human gene therapy. The University of Minnesota has filed a patent related to the work described in this paper.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Staub E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-79; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	25	263	270	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1747	1750		10.1126/science.1163040	http://dx.doi.org/10.1126/science.1163040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19251594	Green Accepted			2022-12-28	WOS:000264559800045
J	Lourenco, D; Brauner, R; Lin, L; De Perdigo, A; Weryha, G; Muresan, M; Boudjenah, R; Guerra, G; Maciel-Guerra, AT; Achermann, JC; McElreavey, K; Bashamboo, A				Lourenco, Diana; Brauner, Raja; Lin, Lin; De Perdigo, Arantzazu; Weryha, Georges; Muresan, Mihaela; Boudjenah, Radia; Guerra-Junior, Gil; Maciel-Guerra, Andrea T.; Achermann, John C.; McElreavey, Ken; Bashamboo, Anu			Mutations in NR5A1 Associated with Ovarian Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEROIDOGENIC FACTOR-I; LIGAND-BINDING DOMAIN; XY SEX REVERSAL; ADRENAL INSUFFICIENCY; NUCLEAR RECEPTOR; GONADAL DEVELOPMENT; GENETIC-DISEASE; 46,XY PATIENT; FACTOR-1; FAILURE	Background The genetic causes of nonsyndromic ovarian insufficiency are largely unknown. A nuclear receptor, NR5A1 (also called steroidogenic factor 1), is a key transcriptional regulator of genes involved in the hypothalamic-pituitary-steroidogenic axis. Mutation of NR5A1 causes 46, XY disorders of sex development, with or without adrenal failure, but growing experimental evidence from studies in mice suggests a key role for this factor in ovarian development and function as well. Methods To test the hypothesis that mutations in NR5A1 cause disorders of ovarian development and function, we sequenced NR5A1 in four families with histories of both 46, XY disorders of sex development and 46, XX primary ovarian insufficiency and in 25 subjects with sporadic ovarian insufficiency. None of the affected subjects had clinical signs of adrenal insufficiency. Results Members of each of the four families and 2 of the 25 subjects with isolated ovarian insufficiency carried mutations in the NR5A1 gene. In-frame deletions and frame-shift and missense mutations were detected. Functional studies indicated that these mutations substantially impaired NR5A1 transactivational activity. Mutations were associated with a range of ovarian anomalies, including 46, XX gonadal dysgenesis and 46, XX primary ovarian insufficiency. We did not observe these mutations in more than 700 control alleles. Conclusions NR5A1 mutations are associated with 46, XX primary ovarian insufficiency and 46, XY disorders of sex development.	[Lourenco, Diana; Boudjenah, Radia; McElreavey, Ken; Bashamboo, Anu] Inst Pasteur, F-75724 Paris, France; [Brauner, Raja] Univ Paris 05, Paris, France; [Brauner, Raja] AP HP, Paris, France; [Brauner, Raja] Hop Bicetre, Le Kremlin Bicetre, France; [Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [De Perdigo, Arantzazu] Lab Cytogenet, Luxembourg, Luxembourg; [Weryha, Georges] CHU Brabois, Serv Endocrinol, Vandoeuvre Les Nancy, France; [Muresan, Mihaela] Hop Notre Dame de Bon Secours, Unite Endocrinol, Metz, France; [Guerra-Junior, Gil] Univ Estadual Campinas, Dept Pediat, Fac Med Sci, Campinas, Brazil; [Maciel-Guerra, Andrea T.] Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; CHU de Nancy; CHR Metz-Thionville; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas	Bashamboo, A (corresponding author), Inst Pasteur, 25 Rue Doctor Roux, F-75724 Paris, France.	kenmce@pasteur.fr	Maciel-Guerra, Andrea T/E-9130-2016; Guerra-Junior, Gil/C-1609-2012; Achermann, John/C-5476-2008; Achermann, John/N-2906-2019; Lin, Lin/A-3532-2010	Maciel-Guerra, Andrea T/0000-0002-4850-8079; Guerra-Junior, Gil/0000-0002-2991-7678; Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; WERYHA, Georges/0000-0003-2062-3419	March of Dimes Foundation [1-FY07-490)]; National Institute for Health Research; Wellcome Trust Senior Research Fellowship in Clinical Science [079666]	March of Dimes Foundation(March of Dimes); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	Supported by grants from the Agence Nationale de la Recherche- GIS Institut des Maladies Rares (to Dr. McElreavey and Ms. Lourenco); by a research grant (1-FY07-490) from the March of Dimes Foundation (to Dr. McElreavey); by the National Institute for Health Research (to UCL Institute of Child Health Biomedical Research Centre); and a Wellcome Trust Senior Research Fellowship in Clinical Science (079666, to Dr. Achermann).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; COULAM CB, 1983, FERTIL STERIL, V40, P693; Coutant R, 2007, J CLIN ENDOCR METAB, V92, P2868, DOI 10.1210/jc.2007-0024; Desclozeaux M, 2002, MOL CELL BIOL, V22, P7193, DOI 10.1128/MCB.22.20.7193-7203.2002; Fan WQ, 2003, BIOCHEM BIOPH RES CO, V311, P987, DOI 10.1016/j.bbrc.2003.10.096; Fogli Anne, 2004, BMC Womens Health, V4, P8, DOI 10.1186/1472-6874-4-8; Gurates B, 2003, MOL CELL ENDOCRINOL, V208, P61, DOI 10.1016/S0303-7207(03)00198-9; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hasegawa T, 2004, J CLIN ENDOCR METAB, V89, P5930, DOI 10.1210/jc.2004-0935; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laissue P, 2008, MOL CELL ENDOCRINOL, V282, P101, DOI 10.1016/j.mce.2007.11.005; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Leslie ND, 2003, ANNU REV NUTR, V23, P59, DOI 10.1146/annurev.nutr.23.011702.073135; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Mallet D, 2004, J CLIN ENDOCR METAB, V89, P4829, DOI 10.1210/jc.2004-0670; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Reuter AL, 2007, EUR J ENDOCRINOL, V157, P233, DOI 10.1530/EJE-07-0113; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; TAKAYAMA K, 1995, J CLIN ENDOCR METAB, V80, P2815, DOI 10.1210/jc.80.9.2815; Toniolo D, 2007, SEMIN REPROD MED, V25, P264, DOI 10.1055/s-2007-980220; van Kasteren YM, 1999, HUM REPROD, V14, P2455, DOI 10.1093/humrep/14.10.2455; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Zhao HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3398, DOI 10.2741/2321	39	252	272	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1200	1210		10.1056/NEJMoa0806228	http://dx.doi.org/10.1056/NEJMoa0806228			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19246354	Green Accepted, Bronze			2022-12-28	WOS:000264283400006
J	Richter, DD; Jenkins, DH; Karakash, JT; Knight, J; McCreery, LR; Nemestothy, KP				Richter, Daniel deB., Jr.; Jenkins, Dylan H.; Karakash, John T.; Knight, Josiah; McCreery, Lew R.; Nemestothy, Kasimir P.			Wood Energy in America	SCIENCE			English	Editorial Material									[Richter, Daniel deB., Jr.] Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA; [Jenkins, Dylan H.] Penn Forest Conservat Program, Nat Conservancy, Williamsport, PA 17701 USA; [Karakash, John T.] Resource Profess Grp, Durham, NC 27707 USA; [Knight, Josiah] Duke Univ, Pratt Sch Engn, Durham, NC 27708 USA; [McCreery, Lew R.] USDA, Forest Serv, State & Private Forestry, Morgantown, WV 26505 USA; [Nemestothy, Kasimir P.] Austrian Chamber Agr, Dept Forestry & Energy, A-1014 Vienna, Austria	Duke University; Nature Conservancy; Duke University; United States Department of Agriculture (USDA); United States Forest Service	Richter, DD (corresponding author), Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA.	drichter@duke.edu	Richter, D.D./AAN-4583-2021					*EIA, 2008, ANN EN REV 2007; *EIA, 2008, NAT GAS PRIC; *EIA, 2008, HEAT OIL PROP UPD; *EN EFF REN EN OFF, 2007, BUILD EN DAT BOOK; HACKSTOCK R, 2008, RENEWABLE ENERGY WAY; Hagauer D, 2008, INSTRUCTION MANUAL C; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; KIPPEL N, 2007, EINFLUSS BETRIEBSWEI; *LACAPRA ASS TEAM, 2006, AN REN PORTF STAND N; Madlener R, 2007, ENERG POLICY, V35, P1075, DOI 10.1016/j.enpol.2006.01.022; *NAT COMM SCI SUST, 2007, CONS BIOD SUST FOR; PERLACK RD, 2005, TM200566 ORNL USDA D; Perlin J., 1989, FOREST JOURNEY ROLE; Perry DA, 2008, FOREST ECOSYSTEMS; Rakos C, 2005, BIOENERGY - REALIZING THE POTENTIAL, P47, DOI 10.1016/B978-008044661-5/50005-2; *REN21 CENT, 2008, REN 2007 GLOB STAT R; RISTINEN RA, 2005, ENERGY ENV; SCHILL SR, 2008, BIOMASS; Serup H., 2002, WOOD ENERGY PRODUCTI, VSecond Revised; Victor DG, 2008, FOREIGN AFF, V87, P70; VOGLAUER B, 2004, AUSTRIAN BIOMASS BOI; WORGETTER M, 2002, BIOENERGY AUSTRIA PO; 2008, TIMBER MART S	23	58	60	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1432	1433		10.1126/science.1166214	http://dx.doi.org/10.1126/science.1166214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286539				2022-12-28	WOS:000264101700023
J	Petrisor, BA; Bhandari, M				Petrisor, B. A.; Bhandari, M.			Picture quiz Imaging after trauma to the pelvis and hip	BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURE-DISLOCATION; POSTERIOR DISLOCATION; ACETABULAR FRACTURES; INJURY		[Petrisor, B. A.] McMaster Univ, Hamilton Hlth Sci Gen Hosp, Orthopaed Trauma Serv, Hamilton, ON L8S 4L8, Canada	McMaster University	Petrisor, BA (corresponding author), McMaster Univ, Hamilton Hlth Sci Gen Hosp, Orthopaed Trauma Serv, Hamilton, ON L8S 4L8, Canada.	BAPetrisorpetrisor@hhsc.ca	Petrisor, Brad/AAQ-2278-2021; Bhandari, Mohit/AAQ-1675-2021					[Anonymous], 2004, ATLS ADV TRAUM LIF S; Bhandari M, 2006, J BONE JOINT SURG BR, V88B, P1618, DOI 10.1302/0301-620X.88B12.17309; Bucholz RW, 2001, ROCKWOOD GREENS FRAC; Cornwall R, 2000, CLIN ORTHOP RELAT R, P84; Court--Brown C, 2006, ORTHOPAEDIC SURG ESS; Dwyer AJ, 2006, INT ORTHOP, V30, P224, DOI 10.1007/s00264-005-0056-9; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Hillyard RF, 2003, AM J EMERG MED, V21, P545, DOI 10.1016/j.ajem.2003.08.014; Letournel E., 1993, FRACTURES ACETABULUM, V2nd; McKee MD, 1998, J ORTHOP TRAUMA, V12, P223, DOI 10.1097/00005131-199805000-00001; Patel NH, 1998, J ORTHOP TRAUMA, V12, P59, DOI 10.1097/00005131-199801000-00011; Petrisor BA, 2003, ARCH ORTHOP TRAUM SU, V123, P228, DOI 10.1007/s00402-003-0507-y; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Tornetta 3rd, 1997, J Am Acad Orthop Surg, V5, P27; Tornetta P, 1999, J BONE JOINT SURG BR, V81B, P67, DOI 10.1302/0301-620X.81B1.8805	15	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 11	2009	338								b289	10.1136/bmj.b289	http://dx.doi.org/10.1136/bmj.b289			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GA	19282276				2022-12-28	WOS:000264206100007
J	Sugarman, J				Sugarman, Jeremy			Commentary: A call for preventive ethics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sugarman, Jeremy] Berman Inst Bioeth, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Dept Med, Baltimore, MD 21205 USA		Sugarman, J (corresponding author), Berman Inst Bioeth, 624 N Broadway, Baltimore, MD 21205 USA.	jsugarm1@jhmi.edu		Sugarman, Jeremy/0000-0001-7022-8332				Keshtgar M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b630	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b753	10.1136/bmj.b753	http://dx.doi.org/10.1136/bmj.b753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278974				2022-12-28	WOS:000264205300005
J	Guikema, SD				Guikema, Seth D.			Infrastructure Design Issues in Disaster-Prone Regions	SCIENCE			English	Editorial Material							WETLANDS; KATRINA		Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Guikema, SD (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA.	sguikema@jhu.edu	Guikema, Seth a/A-8890-2009					*ASCE, 2006, ASCE 7 05 MIN DES LO; Augustin LN, 2009, COAST ENG, V56, P332, DOI 10.1016/j.coastaleng.2008.09.004; BAKER P, 2007, BUILDING DURABLE ENE; Bourne J, 2000, SCIENCE, V289, P1860, DOI 10.1126/science.289.5486.1860; Chang S.E., 2003, NATURAL HAZARDS REV, V4, P186, DOI [DOI 10.1061/(ASCE)1527-6988(2003)4:4(186), 10.1061/(ASCE)1527-6988(2003)4:4(186)]; Chang S. E., 1996, J INFRASTRUCT SYST, V2, P118, DOI [10.1061/(ASCE)1076-0342(1996)2:3(118), DOI 10.1061/(ASCE)1076-0342(1996)2:3(118)]; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Costanza R, 2006, FRONT ECOL ENVIRON, V4, P465, DOI 10.1890/1540-9295(2006)4[465:ANVFNO]2.0.CO;2; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; FEHRENBACHER J, 2005, INHABITAT        OCT; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; HORVATH A, 1997, THESIS CARNEGIE MELL; Horvath A., 1998, J INFRASTRUCT SYST, V4, P111, DOI DOI 10.1061/(ASCE)1076-0342(1998)4:3(111); Junnila S., 2003, J INFRASTRUCT SYST, V9, P157, DOI DOI 10.1061/(ASCE)1076-0342(2003)9:4(157); Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; Robertson IN, 2007, J WATERW PORT C-ASCE, V133, P463, DOI 10.1061/(ASCE)0733-950X(2007)133:6(463); *US BUR CENS, 2008, 2008 STAT ABSTR	17	23	24	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1302	1303		10.1126/science.1169057	http://dx.doi.org/10.1126/science.1169057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265011				2022-12-28	WOS:000263876700030
J	Iglehart, JK				Iglehart, John K.			Health Insurers and Medical-Imaging Policy - A Work in Progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANGIOGRAPHY; TECHNOLOGY											ABELSON R, 2004, NY TIMES        0313; [Anonymous], 2008, GAO08452; [Anonymous], 2007, REP C MED PAYM POL; Appleby J, 2008, HEALTH AFFAIR, V27, P1515, DOI 10.1377/hlthaff.27.6.1515; ARMSTRONG D, 2005, WALL STREET J   1212, pA1; BACH PB, 2008, NY TIMES        0724; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; CASALINO LP, 2008, PHYS SELF REFERRAL P; Congressional Budget Office, 2007, FACT UND GROWTH MED; *CTR MED MED SERV, 2007, CAG00385N CTR MED ME; *CTR MED MED SERV, 2008, CMS PUBL; Demmerle C., 2008, DIAGNOSTIC IMAGING S; Douglas PS, 2006, J AM COLL CARDIOL, V48, P2152, DOI 10.1016/j.jacc.2006.04.107; Gazelle GS, 2007, RADIOLOGY, V245, P517, DOI 10.1148/radiol.2452070193; *GEN ACC OFF, 1994, GAOHEHS952; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Iglehart JK, 2008, NEW ENGL J MED, V359, P556, DOI 10.1056/NEJMp0805760; Levin David C, 2008, J Am Coll Radiol, V5, P972, DOI 10.1016/j.jacr.2008.02.019; Levin David C, 2008, J Am Coll Radiol, V5, P105, DOI 10.1016/j.jacr.2007.09.017; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mitchell JM, 2007, HEALTH AFFAIR, V26, pW415, DOI 10.1377/hlthaff.26.3.w415; *OFF INSP GEN, 2008, OEI010600261 OFF INS; *ORG EC COOP DEV, 2008, ORG EC COOP DEV HLTH; Pear Robert, 2008, NY TIMES, pA18; Pham HH, 2004, HEALTH AFFAIR, V23, P70, DOI 10.1377/hlthaff.23.2.70; Plans AsHI,, 2008, ENS QUAL APPR US DIA; Redberg RF, 2008, NEW ENGL J MED, V359, P2309, DOI 10.1056/NEJMp0805920; Redberg RF, 2007, HEALTH AFFAIR, V26, P86, DOI 10.1377/hlthaff.26.1.86; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; WINTER A, 2008, MED PAYM ADV COMM WA; Winter A, 2008, HEALTH AFFAIR, V27, P1479, DOI 10.1377/hlthaff.27.6.1479; ZIMMERMAN M, 1989, MEDICARE REFERRING P	35	254	256	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					1030	1037		10.1056/NEJMhpr0808703	http://dx.doi.org/10.1056/NEJMhpr0808703			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19264694				2022-12-28	WOS:000263824500015
J	Serruys, PW; Morice, MC; Kappetein, AP; Colombo, A; Holmes, DR; Mack, MJ; Stahle, E; Feldman, TE; van den Brand, M; Bass, EJ; Van Dyck, N; Leadley, K; Dawkins, KD; Mohr, FW				Serruys, Patrick W.; Morice, Marie-Claude; Kappetein, A. Pieter; Colombo, Antonio; Holmes, David R.; Mack, Michael J.; Stahle, Elisabeth; Feldman, Ted E.; van den Brand, Marcel; Bass, Eric J.; Van Dyck, Nic; Leadley, Katrin; Dawkins, Keith D.; Mohr, Friedrich W.		SYNTAX Investigators	Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG-ELUTING STENTS; FOLLOW-UP; SURGERY; 3-VESSEL; SYNTAX; REVASCULARIZATION; THROMBOSIS; STENOSIS; OUTCOMES; RISK	Background Percutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although coronary-artery bypass grafting (CABG) has been the treatment of choice historically. Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both). Methods We randomly assigned 1800 patients with three-vessel or left main coronary artery disease to undergo CABG or PCI (in a 1: 1 ratio). For all these patients, the local cardiac surgeon and interventional cardiologist determined that equivalent anatomical revascularization could be achieved with either treatment. A noninferiority comparison of the two groups was performed for the primary end point - a major adverse cardiac or cerebrovascular event (i.e., death from any cause, stroke, myocardial infarction, or repeat revascularization) during the 12-month period after randomization. Patients for whom only one of the two treatment options would be beneficial, because of anatomical features or clinical conditions, were entered into a parallel, nested CABG or PCI registry. Results Most of the preoperative characteristics were similar in the two groups. Rates of major adverse cardiac or cerebrovascular events at 12 months were significantly higher in the PCI group (17.8%, vs. 12.4% for CABG; P = 0.002), in large part because of an increased rate of repeat revascularization (13.5% vs. 5.9%, P<0.001); as a result, the criterion for noninferiority was not met. At 12 months, the rates of death and myocardial infarction were similar between the two groups; stroke was significantly more likely to occur with CABG ( 2.2%, vs. 0.6% with PCI; P = 0.003). Conclusions CABG remains the standard of care for patients with three-vessel or left main coronary artery disease, since the use of CABG, as compared with PCI, resulted in lower rates of the combined end point of major adverse cardiac or cerebrovascular events at 1 year. (ClinicalTrials. gov number, NCT00114972.)	[Serruys, Patrick W.; Kappetein, A. Pieter; van den Brand, Marcel] Erasmus Univ, Med Ctr, NL-3015 CE Rotterdam, Netherlands; [Morice, Marie-Claude] Inst Cardiovasc Paris Sud, Massy, France; [Colombo, Antonio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Holmes, David R.] Mayo Clin, Rochester, MN USA; [Mack, Michael J.] Med City Hosp, Dallas, TX USA; [Stahle, Elisabeth] Univ Uppsala Hosp, Uppsala, Sweden; [Feldman, Ted E.] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA; [Bass, Eric J.; Van Dyck, Nic; Leadley, Katrin; Dawkins, Keith D.] Boston Sci, Marlborough, MA USA; [Mohr, Friedrich W.] Herzzentrum Univ Leipzig, Leipzig, Germany	Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Universite Paris Saclay; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Mayo Clinic; Medical City Dallas Hospital; Uppsala University; Uppsala University Hospital; NorthShore University Health System; Northwestern University; Boston Scientific; Leipzig University	Serruys, PW (corresponding author), Erasmus Univ, Med Ctr, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	serruys@erasmusmc.nl	Suryapranata, H./H-8095-2014; Colombo, Antonio/N-2960-2015; Kappetein, Arie Pieter/B-5534-2008; Tosovsky, Jan/G-2882-2017; Oldroyd, Keith G/C-2281-2014; Beyersdorf, Friedhelm/AAK-3718-2020	Colombo, Antonio/0000-0002-2940-2455; Kappetein, Arie Pieter/0000-0003-3545-2229; Tosovsky, Jan/0000-0002-3548-8507; Oldroyd, Keith G/0000-0002-7842-3463; Beyersdorf, Friedhelm/0000-0003-2975-2751; Banning, Adrian/0000-0002-2842-7861; Ingemansson, Richard/0000-0001-7623-8953; Bochenek, Andrzej/0000-0002-3046-3001; CARRIE, didier/0000-0003-2479-8144				American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Barner HB, 2008, ANN THORAC SURG, V85, P1473, DOI 10.1016/j.athoracsur.2008.01.014; Bittl JA, 1996, NEW ENGL J MED, V335, P1290, DOI 10.1056/NEJM199610243351707; Bittl JA, 1997, NEW ENGL J MED, V336, P670; Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054; Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcard.2006.10.031; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Buxton BF, 1998, CIRCULATION, V98, pII1; Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONAHA.105.595694; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Daemen J, 2008, CIRCULATION, V118, P1146, DOI 10.1161/CIRCULATIONAHA.107.752147; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Favaloro R G, 1968, Ann Thorac Surg, V5, P334; Flynn M, 2004, EUR J CARDIO-THORAC, V25, P116, DOI 10.1016/S1010-7940(03)00608-0; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Herz I, 2005, ANN THORAC SURG, V80, P2086, DOI 10.1016/j.athoracsur.2005.05.053; Janssen DPB, 2004, EUR J CARDIO-THORAC, V25, P203, DOI 10.1016/j.ejcts.2003.11.005; Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148; Kappetein AP, 2006, EUR J CARDIO-THORAC, V29, P486, DOI 10.1016/j.ejcts.2006.01.047; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; LEAMAN DM, 1981, CIRCULATION, V63, P285, DOI 10.1161/01.CIR.63.2.285; Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103; Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Palmerini T, 2007, EUR HEART J, V28, P2714, DOI 10.1093/eurheartj/ehm403; PARSONNET V, 1989, CIRCULATION, V79, P3; PARSONNET V, 1990, CIRCULATION, V82, P1078; Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037; Serruys Patrick W, 2008, EuroIntervention, V3, P450; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Sianos Georgios, 2005, EuroIntervention, V1, P219; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Tavilla G, 2004, ANN THORAC SURG, V77, P794, DOI 10.1016/S0003-4975(03)01659-X; Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062; van den Brand MJBM, 2002, J AM COLL CARDIOL, V39, P559, DOI 10.1016/S0735-1097(01)01785-5; Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x	41	2881	3093	2	187	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					961	972		10.1056/NEJMoa0804626	http://dx.doi.org/10.1056/NEJMoa0804626			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19228612				2022-12-28	WOS:000263824500004
J	Silverberg, MJ; Leyden, W; Hurley, L; Go, AS; Quesenberry, CP; Klein, D; Horberg, MA				Silverberg, Michael J.; Leyden, Wendy; Hurley, Leo; Go, Alan S.; Quesenberry, Charles P., Jr.; Klein, Daniel; Horberg, Michael A.			Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; MYOCARDIAL-INFARCTION; PROTEASE INHIBITORS; STATINS; RISK; HYPERLIPIDEMIA; DYSLIPIDEMIA; PRAVASTATIN; MANAGEMENT	Background: Antiretroviral agents, particularly protease inhibitors (PIs), may adversely affect lipid levels in patients with HIV infection. However, it is not known whether HIV-associated dyslipidemia is more difficult to treat. Objective: To compare the effectiveness and safety of lipid-lowering therapy in patients with and without HIV infection. Design: Retrospective cohort study. Setting: Integrated health care delivery system from 1996 to 2005. Patients: 829 patients with HIV infection and 6941 patients without HIV infection beginning lipid-lowering therapy for elevated low-density lipoprotein cholesterol or triglyceride levels. Measurements: Percentage change in lipids within 12 months and adverse liver- and muscle-related clinical and laboratory events. Results: Compared with patients without HIV infection, patients with HIV infection beginning statin therapy had smaller reductions in low-density lipoprotein cholesterol levels (25.6% vs. 28.3%; P = 0.001), which did not vary by antiretroviral therapy class. Patients with HIV infection beginning gemfibrozil therapy had substantially smaller reductions in triglyceride levels than patients without HIV infection (44.2% vs. 59.3%; P < 0.001), and reductions with gemfibrozil varied by antiretroviral therapy class (44.0% [P = 0.001] in patients receiving PIs only, 26.4% [P < 0.001] in patients receiving PIs and nonnucleoside reverse transcriptase inhibitors [NNRTIs], and 60.3% [P = 0.94] in patients receiving NNRTIs only). Rhabdomyolysis was diagnosed in 3 patients with HIV infection and 1 patient without HIV infection. No clinically recognized cases of myositis or myopathy were observed. The risk for laboratory adverse events was low (< 5%), although it was increased in patients with HIV infection. Limitations: Laboratory measurements were not uniformly performed according to HIV status, and adequate fasting before lipoprotein testing could not be verified. Results may not be completely generalizable to uninsured persons, women, or certain racial or ethnic minorities. Conclusion: Dyslipidemia, particularly hypertriglyceridemia, is more difficult to treat in patients with HIV infection than in the general population. However, patients with HIV infection receiving NNRTI-based antiretroviral therapy and gemfibrozil had triglyceride responses similar to those in patients without HIV infection.	[Silverberg, Michael J.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco	Silverberg, MJ (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	Michael.J.Silverberg@kp.org	Go, Alan S./AAE-7745-2019		GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding: GlaxoSmithKline.	Aberg JA, 2005, AIDS RES HUM RETROV, V21, P757, DOI 10.1089/aid.2005.21.757; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Badiou S, 2004, ATHEROSCLEROSIS, V172, P273, DOI 10.1016/j.atherosclerosis.2003.10.006; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Benesic A, 2004, INFECTION, V32, P229, DOI 10.1007/s15010-004-3136-7; Bennett MT, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-15; Bonnet F, 2004, HIV MED, V5, P133, DOI 10.1111/j.1468-1293.2004.00200.x; *CAL DEP HLTH SERV, 2005, CAL AIDS SURV REP CU; Calza L, 2005, AIDS, V19, P1103, DOI 10.1097/01.aids.0000174458.86121.43; Calza L, 2003, AIDS, V17, P851, DOI 10.1097/00002030-200304110-00010; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gerber MT, 2004, CLIN INFECT DIS, V39, P419, DOI 10.1086/422144; Gordon N, 2006, KAISER PERMANENTE ME; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hurlimann D, 2006, HEART, V92, P110, DOI 10.1136/hrt.2004.056523; Johns KW, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-27; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kamal-Bahl SJ, 2007, AM J CARDIOL, V99, P530, DOI 10.1016/j.amjcard.2006.08.063; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Miller J, 2002, AIDS, V16, P2195, DOI 10.1097/00002030-200211080-00012; *NAT I ALL INF DIS, 2004, TABL GRAD SEV AD PED; Negredo E, 2006, AIDS, V20, P2159, DOI 10.1097/01.aids.0000247573.95880.db; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, DEP HLTH HUMAN  0109, P1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Riddler SA, 2007, HIV MED, V8, P280, DOI 10.1111/j.1468-1293.2007.00470.x; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2006, AIDS CARE, V18, P149, DOI 10.1080/09540120500161843; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Stein JH, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.018; Townsend ML, 2007, INT J STD AIDS, V18, P851, DOI 10.1258/095646207782716974; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Visnegarwala F, 2004, J INFECTION, V49, P283, DOI 10.1016/j.jinf.2003.09.006	39	76	77	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					301	+		10.7326/0003-4819-150-5-200903030-00006	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19258558				2022-12-28	WOS:000264051700002
J	Antonakis, J; Dalgas, O				Antonakis, John; Dalgas, Olaf			Predicting Elections: Child's Play!	SCIENCE			English	Article							INTELLIGENCE; ORIGINS		[Antonakis, John; Dalgas, Olaf] Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland	University of Lausanne	Antonakis, J (corresponding author), Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland.	john.antonakis@unil.ch	Antonakis, John/B-3409-2008	Antonakis, John/0000-0001-8811-5117				PLATO, 1901, REPUBLIC; Ramsey JL, 2004, DEVELOPMENTAL SCI, V7, P201, DOI 10.1111/j.1467-7687.2004.00339.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Simonton DK, 2002, ADV PSY RES, V14, P143; Slater A, 2001, INFANT CHILD DEV, V10, P21, DOI 10.1002/icd.241; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	7	236	237	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1183	1183		10.1126/science.1167748	http://dx.doi.org/10.1126/science.1167748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251621	Green Submitted			2022-12-28	WOS:000263687600029
J	Baillargeon, J; Giordano, TP; Rich, JD; Wu, ZH; Wells, K; Pollock, BH; Paar, DP				Baillargeon, Jacques; Giordano, Thomas P.; Rich, Josiah D.; Wu, Z. Helen; Wells, Katherine; Pollock, Brad H.; Paar, David P.			Accessing Antiretroviral Therapy Following Release From Prison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; ADHERENCE; INFECTION; STIGMA; COHORT; INCARCERATION; INTERRUPTION; COMMUNITY; OUTCOMES; INMATES	from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus ( HIV), and drug- resistant HIV reservoirs in the community. The extent to which HIV- infected inmates experience ART interruption following release from prison is unknown. Objectives To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome. Design, Setting, and Participants Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release. Main Outcome Measure Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison. Results Among the entire study cohort ( N= 2115), an initial prescription for ART was filled by 115 ( 5.4%) inmates within 10 days of release ( 95% confidence interval [ CI], 4.5%- 6.5%), by 375 ( 17.7%) within 30 days ( 95% CI, 16.2%- 19.4%), and by 634 ( 30.0%) within 60 days ( 95% CI, 28.1%- 32.0%). In a multivariate analysis of predictors ( including sex, age, race/ ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days ( adjusted estimated risk ratio [ RR], 0.4 [ 95% CI, 0.2- 0.8] and 0.4 [ 95% CI, 0.3- 0.7], respectively) and 30 days ( adjusted estimated RR, 0.7 [ 95% CI, 0.5- 0.9] and 0.7 [ 95% CI, 0.5- 0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days ( adjusted estimated RR, 1.8 [ 95% CI, 1.2- 2.7]), 30 days ( 1.5 [ 95% CI, 1.2- 1.8]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.5]). Inmates released on parole were more likely to fill a prescription within 30 days ( adjusted estimated RR, 1.3 [ 95% CI, 1.1- 1.6]) and 60 days ( 1.5 [ 95% CI, 1.4- 1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days ( adjusted estimated RR, 3.1 [ 95% CI, 2.0- 4.9]), 30 days ( 1.8 [ 95% CI, 1.4- 2.2]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.4]). Conclusion Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.	[Baillargeon, Jacques] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Baillargeon, Jacques; Paar, David P.] Univ Texas Med Branch, Correct Managed Care Div, Galveston, TX 77555 USA; [Wu, Z. Helen] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Paar, David P.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA; [Rich, Josiah D.] Brown Med Sch, Dept Med, Providence, RI USA; [Wells, Katherine] Dept State Hlth Serv, Texas HIV Medicat Program, Austin, TX USA; [Pollock, Brad H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Brown University; University of Texas System; University of Texas Health San Antonio	Baillargeon, J (corresponding author), Univ Texas Med Branch, Dept Prevent Med & Community Hlth, 301 Univ Blvd,Mail Route 1007, Galveston, TX 77555 USA.	jbaillar@utmb.edu		Giordano, Thomas/0000-0002-9346-5530	National Institute on Drug Abuse [R03DA023870-02, K24DA022112]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023870, K24DA022112] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant R03DA023870-02 from the National Institute on Drug Abuse. Dr Rich was supported by National Institute on Drug Abuse grant K24DA022112.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Baillargeon J, 2000, CLIN INFECT DIS, V31, P1476, DOI 10.1086/317478; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell A, 2004, CLIN INFECT DIS, V38, P1761, DOI 10.1086/421410; *COUNC STAT GOV JU, EXPL FED MED DIS PRO; Derlega VJ, 2008, INT J STD AIDS, V19, P259, DOI 10.1258/ijsa.2007.007141; DIXON PS, 1993, AM J MED, V95, P629, DOI 10.1016/0002-9343(93)90359-W; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; *HJ KAIS FAM FDN N, 2008, NAT ADAP MON PROJ AN; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kahn JG, 2002, PUBLIC HEALTH REP, V117, P252, DOI 10.1016/S0033-3549(04)50159-0; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; MacGowan RJ, 2003, INT J STD AIDS, V14, P519, DOI 10.1258/095646203767869110; Mallik-Kane K, 2008, HLTH PRISONER REENTR; MARUSCHAK L, 2007, HIV PRISONS 2005; Menke TJ, 2003, J NATL MED ASSOC, V95, P853; Morrow K. M., 2007, Journal of Correctional Health Care, V13, P27, DOI 10.1177/1078345807299457; Mumola C. J., 1999, SUBSTANCE ABUSE TREA; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Palepu A, 2004, ANTIVIR THER, V9, P713; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; *PEW CTR STAT, ONE 100 BARS AM 2008; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485; Rao D, 2008, AIDS BEHAV, V12, P265, DOI 10.1007/s10461-007-9268-x; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Shannon Kate, 2005, J Int Assoc Physicians AIDS Care (Chic), V4, P66, DOI 10.1177/1545109705284353; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Stokes ME, 2000, CATEGORICAL DATA ANA; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; WOHL DA, 2003, 10 C RETR OPP INF FE; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	202	205	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					848	857		10.1001/jama.2009.202	http://dx.doi.org/10.1001/jama.2009.202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244192	Green Accepted			2022-12-28	WOS:000263609900026
J	Bergkessel, M; Wilmes, GM; Guthrie, C				Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine			SnapShot: Formation of mRNPs	CELL			English	Editorial Material							MESSENGER-RNA; CYTOPLASM; CODE		[Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bergkessel, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Bergkessel, Megan/0000-0002-4530-1224				Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Rougemaille M, 2008, BIOL CELL, V100, P327, DOI 10.1042/BC20070143; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308	10	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					794	U1	794.e1	10.1016/j.cell.2009.01.047	http://dx.doi.org/10.1016/j.cell.2009.01.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239896	Bronze			2022-12-28	WOS:000263688200026
J	Mark, DB; Pan, WQ; Clapp-Channing, NE; Anstrom, KJ; Ross, JR; Fox, RS; Devlin, GP; Martin, CE; Adlbrecht, C; Cowper, PA; Ray, LD; Cohen, EA; Lamas, GA; Hochman, JS				Mark, Daniel B.; Pan, Wenqin; Clapp-Channing, Nancy E.; Anstrom, Kevin J.; Ross, John R.; Fox, Rebecca S.; Devlin, Gerard P.; Martin, C. Edwin; Adlbrecht, Christopher; Cowper, Patricia A.; Ray, Linda Davidson; Cohen, Eric A.; Lamas, Gervasio A.; Hochman, Judith S.		Occluded Artery Trial Investigator	Quality of Life after Late Invasive Therapy for Occluded Arteries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COST-EFFECTIVENESS; CORONARY INTERVENTION; DEFIBRILLATOR THERAPY; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; MEDICAL THERAPY; HEART-FAILURE; DISEASE; ANGIOPLASTY; AMIODARONE	Background The open- artery hypothesis postulates that late opening of an infarct- related artery after myocardial infarction will improve clinical outcomes. We evaluated the quality-of- life and economic outcomes associated with the use of this strategy. Methods We compared percutaneous coronary intervention ( PCI) plus stenting with medical therapy alone in high- risk patients in stable condition who had a totally occluded infarct- related artery 3 to 28 days after myocardial infarction. In 951 patients ( 44% of those eligible), we assessed quality of life by means of a battery of tests that included two principal outcome measures, the Duke Activity Status Index ( DASI) ( which measures cardiac physical function on a scale from 0 to 58, with higher scores indicating better function) and the Medical Outcomes Study 36- Item Short- Form Mental Health Inventory 5 ( which measures psychological well- being). Structured quality- of-life interviews were performed at baseline and at 4, 12, and 24 months. Costs of treatment were assessed for 458 of 469 patients in the United States ( 98%), and 2- year cost- effectiveness was estimated. Results At 4 months, the medical- therapy group, as compared with the PCI group, had a clinically marginal decrease of 3.4 points in the DASI score ( P = 0.007). At 1 and 2 years, the differences were smaller. No significant differences in psychological well- being were observed. For the 469 patients in the United States, cumulative 2- year costs were approximately $7,000 higher in the PCI group ( P< 0.001), and the quality- adjusted survival was marginally longer in the medical- therapy group. Conclusions PCI was associated with a marginal advantage in cardiac physical function at 4 months but not thereafter. At 2 years, medical therapy remained significantly less expensive than routine PCI and was associated with marginally longer quality- adjusted survival. ( ClinicalTrials. gov number, NCT00004562.).	[Mark, Daniel B.; Pan, Wenqin; Clapp-Channing, Nancy E.; Anstrom, Kevin J.; Cowper, Patricia A.; Ray, Linda Davidson] Duke Univ, Med Ctr, Outcomes Res Grp, Durham, NC 27710 USA; [Mark, Daniel B.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Mark, Daniel B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Pan, Wenqin; Anstrom, Kevin J.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Ross, John R.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Cohen, Eric A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Fox, Rebecca S.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Devlin, Gerard P.] Waikato Hosp, Hamilton, New Zealand; [Martin, C. Edwin] Cardiac Diagnost Assoc, York, PA USA; [Adlbrecht, Christopher] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Lamas, Gervasio A.] Columbia Univ, Div Cardiol, Mt Sinai Med Ctr, Miami Beach, FL USA; [Hochman, Judith S.] NYU, Sch Med, New York, NY USA	Duke University; Duke University; Duke University; Duke University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; Waikato Hospital; Medical University of Vienna; Columbia University; Mount Sinai Medical Center; New York University	Mark, DB (corresponding author), Duke Univ, Med Ctr, Outcomes Res Grp, Durham, NC 27710 USA.		Adlbrecht, Christopher/D-3971-2009	Adlbrecht, Christopher/0000-0003-3743-3881; Hochman, Judith/0000-0002-5889-5981; Mark, Daniel/0000-0001-6340-8087	National Heart, Lung, and Blood Institute [U01-HL062257, U01-HL062509]; Eli Lilly; Merck; Medtronic; Pfizer; Medtronic Vascular; CV Therapeutics; United Healthcare; Bristol-Myers Squibb Medical Imaging; Millennium Pharmaceuticals; Schering-Plough; Guidant; GlaxoSmithKline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL062257, U01HL062509] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eli Lilly(Eli Lilly); Merck(Merck & Company); Medtronic(Medtronic); Pfizer(Pfizer); Medtronic Vascular; CV Therapeutics; United Healthcare; Bristol-Myers Squibb Medical Imaging(Bristol-Myers Squibb); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Schering-Plough(Merck & CompanySchering Plough Corporation); Guidant; GlaxoSmithKline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (U01-HL062257, to Dr. Mark; and U01-HL062509, to Dr. Hochman). Eli Lilly donated replacement doses of abciximab ( ReoPro) and funding for meetings (in 2001, 2002, and 2006); Guidant donated stent reimbursement for one site and stents for OAT sites; Medtronic (Canada) donated stents for the Canadian sites; Merck donated funding for training meetings; and Millennium Pharmaceuticals and Schering- Plough donated replacement doses of eptifibatide (Integrilin).; Dr. Mark reports receiving lecture fees and grant support from Medtronic; Dr. Anstrom, grant support from Eli Lilly, Pfizer, and Medtronic Vascular; Dr. Cowper, grant support from CV Therapeutics, Eli Lilly, United Healthcare, and Pfizer; and Dr. Hochman, grant support from Eli Lilly and Bristol-Myers Squibb Medical Imaging product donations from Millennium Pharmaceuticals, Schering-Plough, Guidant, and Merck, consulting fees from Bristol-Myers Squibb, and honoraria from CV Therapeutics, Eli Lilly, GlaxoSmithKline, and Schering-Plough. No other potential conflict of interest relevant to this article was reported.; The content is solely the responsibility of the authors and does not necessarily represent the official views of the National, Heart, Lung, and Blood Institute or the National Institute of Health. We thank Jason Blevins for coordinating the economic and quality- of- life outcomes study; Heather Read for collecting the economic data; Judith Stafford for preparing the data for analysis; Melanie R. Daniels for editing an earlier version of the manuscript; the OAT site coordinators, who worked to collect the data for this study; and the OAT patients who volunteered to participate in the study.	Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; HLATKY MA, 1995, AM J CARDIOL, V75, pC34; Hochman JS, 2005, AM HEART J, V150, P627, DOI 10.1016/j.ahj.2005.07.002; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Mark DB, 2008, NEW ENGL J MED, V359, P999, DOI 10.1056/NEJMoa0706719; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; Mark DB, 2002, CIRCULATION, V106, P516, DOI 10.1161/01.CIR.0000021407.93752.7B; Pfisterer M, 2004, CIRCULATION, V110, P1213, DOI 10.1161/01.CIR.0000140983.69571.BA; Pfisterer M, 2001, LANCET, V358, P951; ROSE GA, 1982, CARDIOVASCULAR SURVE, P162; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Ware JE, 1993, SF36 HLTH SURVEY MAN; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Weintraub WS, 2008, CIRC-CARDIOVASC QUAL, V1, P12, DOI 10.1161/CIRCOUTCOMES.108.798462	16	31	32	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					774	783		10.1056/NEJMoa0805151	http://dx.doi.org/10.1056/NEJMoa0805151			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228620	Green Accepted, Bronze			2022-12-28	WOS:000263411300007
J	Gao, B; Hu, JX; Stricker, S; Cheung, M; Ma, G; Law, KF; Witte, F; Briscoe, J; Mundlos, S; He, L; Cheah, KSE; Chan, D				Gao, Bo; Hu, Jianxin; Stricker, Sigmar; Cheung, Martin; Ma, Gang; Law, Kit Fong; Witte, Florian; Briscoe, James; Mundlos, Stefan; He, Lin; Cheah, Kathryn S. E.; Chan, Danny			A mutation in Ihh that causes digit abnormalities alters its signalling capacity and range	NATURE			English	Article							SONIC HEDGEHOG; INDIAN HEDGEHOG; ENDOCHONDRAL BONE; GROWTH-PLATE; EXPRESSION; GENE; DIFFERENTIATION; CARTILAGE; PROTEIN; EMBRYO	Brachydactyly type A1 (BDA1) was the first recorded disorder of the autosomal dominant Mendelian trait in humans, characterized by shortened or absent middle phalanges in digits. It is associated with heterozygous missense mutations in indian hedgehog (IHH)(1,2). Hedgehog proteins are important morphogens for a wide range of developmental processes(3,4). The capacity and range of signalling is thought to be regulated by its interaction with the receptor PTCH1 and antagonist HIP1. Here we show that a BDA1 mutation (E95K) in Ihh impairs the interaction of IHH with PTCH1 and HIP1. This is consistent with a recent paper showing that BDA1 mutations cluster in a calcium-binding site essential for the interaction with its receptor and cell-surface partners(5). Furthermore, we show that in a mouse model that recapitulates the E95K mutation, there is a change in the potency and range of signalling. The mice have digit abnormalities consistent with the human disorder.	[Gao, Bo; Hu, Jianxin; Cheung, Martin; Law, Kit Fong; Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Gao, Bo; Hu, Jianxin; Ma, Gang; He, Lin] Shanghai Jiao Tong Univ, BioX Ctr, Shanghai 200030, Peoples R China; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, LKS Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Witte, Florian] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Briscoe, James] Natl Inst Med Res, London NW7 1AA, England; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	University of Hong Kong; Shanghai Jiao Tong University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hong Kong; Free University of Berlin; MRC National Institute for Medical Research; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Chan, D (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	helinhelin@gmail.com; chand@hkusua.hku.hk	Stricker, Sigmar/B-9169-2009; Mundlos, Stefan/ABH-9585-2020; Gao, Bo/F-4688-2013; Chan, Danny/C-4203-2009	Stricker, Sigmar/0000-0002-7174-5363; Mundlos, Stefan/0000-0002-9788-3166; Gao, Bo/0000-0002-8684-5199; Briscoe, James/0000-0002-1020-5240; Chan, Danny/0000-0003-3824-5778	Research Grants Council [N_HKU705/02, HKU2/02C]; University Grants Council of Hong Kong [AoE/M-04/04]; National Key Scientific Program [2007CB947300]; MRC [MC_U117560541] Funding Source: UKRI; Medical Research Council [MC_U117560541] Funding Source: researchfish	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Hong Kong; National Key Scientific Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Research Grants Council and University Grants Council of Hong Kong (N_HKU705/02, HKU2/02C and AoE/M-04/04), and The National Key Scientific Program (2007CB947300). We thank P. Tam for suggestions and comments, P. Beachy and D. Leahy for sharing unpublished data, and K. Leung for blastocyst injections.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Haaf T, 1996, BIOTECHNIQUES, V21, P1050; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; McCready ME, 2005, HUM GENET, V117, P285, DOI 10.1007/s00439-005-1289-9; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mundlos S, 2000, METH MOL B, V136, P61; Nagy A., 2003, MANIPULATING MOUSE E; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schmahl J, 2000, DEVELOPMENT, V127, P65; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; St-Jacques B, 1999, GENE DEV, V13, P2617; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wai AWK, 1998, DEV GENET, V22, P349, DOI 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	44	70	78	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1196	U136		10.1038/nature07862	http://dx.doi.org/10.1038/nature07862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252479				2022-12-28	WOS:000265754600052
J	Lyras, D; O'Connor, JR; Howarth, PM; Sambol, SP; Carter, GP; Phumoonna, T; Poon, R; Adams, V; Vedantam, G; Johnson, S; Gerding, DN; Rood, JI				Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Sambol, Susan P.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.; Rood, Julian I.			Toxin B is essential for virulence of Clostridium difficile	NATURE			English	Article							ESCHERICHIA-COLI; EXPRESSION; HAMSTERS; DISEASE; SYSTEM; STRAIN; INFECTION; EPIDEMIC	Clostridium difficile is the leading cause of infectious diarrhoea in hospitals worldwide, because of its virulence, spore-forming ability and persistence(1,2). C. difficile-associated diseases are induced by antibiotic treatment or disruption of the normal gastrointestinal flora(3,4). Recently, morbidity and mortality resulting from C. difficile-associated diseases have increased significantly due to changes in the virulence of the causative strains and antibiotic usage patterns(1,2,5,6). Since 2002, epidemic toxinotype III NAP1/027 strains(1,2), which produce high levels of the major virulence factors, toxin A and toxin B, have emerged. These toxins have 63 % amino acid sequence similarity(7) and are members of the large clostridial glucosylating toxin family, which are monoglucosyltransferases that are pro-inflammatory, cytotoxic and enterotoxic in the human colon(8-10). Inside host cells, both toxins catalyse the transfer of glucose onto the Rho family of GTPases, leading to cell death(8,11). However, the role of these toxins in the context of a C. difficile infection is unknown. Here we describe the construction of isogenic tcdA and tcdB (encoding toxin A and B, respectively) mutants of a virulent C. difficile strain and their use in the hamster disease model to show that toxin B is a key virulence determinant. Previous studies showed that purified toxin A alone can induce most of the pathology observed after infection of hamsters with C. difficile(8,9,12) and that toxin B is not toxic in animals unless it is co-administered with toxin A, suggesting that the toxins act synergistically(12). Our work provides evidence that toxin B, not toxin A, is essential for virulence. Furthermore, it is clear that the importance of these toxins in the context of infection cannot be predicted exclusively from studies using purified toxins, reinforcing the importance of using the natural infection process to dissect the role of toxins in disease.	[Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia; [Poon, Rachael; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Med Serv, Hines, IL 60141 USA; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Res Serv, Hines, IL 60141 USA; Loyola Univ, Stritch Sch Med, Infect Dis Sect, Maywood, IL 60153 USA	Monash University; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Rood, JI (corresponding author), Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.	julian.rood@med.monash.edu.au	Adams, Vicki/V-7077-2019; Rood, Julian I/A-4858-2008	Adams, Vicki/0000-0002-1506-1864; Rood, Julian I/0000-0003-2126-7209; Carter, Glen/0000-0002-7306-9362; Lyras, Dena/0000-0003-2345-9271; Das, Tongted/0000-0002-5331-4420; Johnson, Stuart/0000-0001-9548-229X	Australian National Health and Medical Research Council [284214]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; United States National Institute of Allergy and Infectious Diseases [AIO57637]; United States Department of Veterans Affairs Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057637] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research at Monash University was supported by Program Grant 284214 from the Australian National Health and Medical Research Council, funding from the ARC Centre of Excellence in Structural and Functional Microbial Genomics and grant AIO57637 from the United States National Institute of Allergy and Infectious Diseases. S.J., D.N.G., and G.V. were supported by Merit Review Grants from the United States Department of Veterans Affairs Research Service. We thank D. Lyerly, K. Aktories and C. von-Eichel Streiber for providing toxin-A-specific and toxin-B-specific antibodies, K. Nagaro and A. Cheknis for assistance with the hamster experiments, V.K. Viswanathan for providing intestinal epithelial cell lines, E. Hartland for providing the HT29 cell line, and M. Merrigan for adherence assays.	Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Benson L, 2007, INFECT CONT HOSP EP, V28, P1233, DOI 10.1086/520732; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Du Tim, 2004, Can J Infect Dis, V15, P83; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2000, MOL MICROBIOL, V38, P588, DOI 10.1046/j.1365-2958.2000.02154.x; Lyras D, 1998, PLASMID, V39, P160, DOI 10.1006/plas.1997.1325; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sambrook J., 2001, MOL CLONING LAB MANU; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Tang-Feldman YJ, 2002, MOL CELL PROBE, V16, P179, DOI 10.1006/mcpr.2002.0409; TORRES J, 1992, TOXICON, V30, P419, DOI 10.1016/0041-0101(92)90538-G; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	38	533	572	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1176	1181		10.1038/nature07822	http://dx.doi.org/10.1038/nature07822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252482	Green Accepted			2022-12-28	WOS:000265754600055
J	Bacon, N				Bacon, Neil			Head to Head Will doctor rating sites improve standards of care? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY; SATISFACTION; PHYSICIANS; COMPLAINTS				Bacon, N (corresponding author), Summertown Pavil, Oxford OX2 7LG, England.	info@iwantgreatcare.org						BRIGHT B, 2008, WALL ST J       0223; Caldwell G, 2006, CLIN TEACH, V3, P185, DOI 10.1111/j.1743-498X.2006.00100.x; COOK S, 2008, HARVARD BUSINESS OCT; Coombes R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1102; DARZI A, 2008, HIGH QUALIT CARE ALL; GAWANDE A, 2004, NEW YORKER      1206; GODLEE F, 2009, BRIT MED J, V338, pB1140; *HEALTC COMM, 2007, NHS ANN HLTH CHECK 2; Howell E, 2007, QUAL SAF HEALTH CARE, V16, P450, DOI 10.1136/qshc.2006.022079; *IPS MORI SOC RES, 2008, FRONT PERF NHS 2; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; KAPLAN RS, 1992, HARVARD BUSINESS JAN, P71; Kinnersley P, 2008, BMJ-BRIT MED J, V336, P841, DOI 10.1136/bmj.39525.658565.80; McCartney M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1033; McKinstry B, 2006, FAM PRACT, V23, P240, DOI 10.1093/fampra/cmi111; Shannon SE, 2002, J NURS SCHOLARSHIP, V34, P173, DOI 10.1111/j.1547-5069.2002.00173.x; Tamblyn R, 2007, JAMA-J AM MED ASSOC, V298, P993, DOI 10.1001/jama.298.9.993; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665; WINEFIELD HR, 1995, SOC SCI MED, V41, P969, DOI 10.1016/0277-9536(94)00403-G; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798	20	32	34	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2009	338								b1030	10.1136/bmj.b1030	http://dx.doi.org/10.1136/bmj.b1030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422NU	19293223				2022-12-28	WOS:000264435800037
J	Meguid, T				Meguid, Tarek			Lack of political will is a clinical issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL MORTALITY; SAFE MOTHERHOOD; HUMAN-RIGHTS; HEALTH; CARE; ACCESS		[Meguid, Tarek] Kamuzu Cent Hosp, Lilongwe, Malawi; [Meguid, Tarek] Bwaila Hosp, Lilongwe, Malawi		Meguid, T (corresponding author), Kamuzu Cent Hosp, Lilongwe, Malawi.	meguid@globemw.net		McAuliffe, Eilish/0000-0002-9714-5040				AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; ANDERSON T, 2005, ACTA OBSTET GYNECOL, V70, P679; BERGSTROM S, 2007, ACTA OBSTET GYNECOL, V84, P105; Bhutta ZA, 2000, BRIT MED J, V321, P809, DOI 10.1136/bmj.321.7264.809; Bristol N, 2008, LANCET, V371, P2162, DOI 10.1016/S0140-6736(08)60937-X; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; Centre on Housing Rights and Evictions, 2003, LIT EC SOC CULT RIGH; Cook RJ, 2006, INT J GYNECOL OBSTET, V94, P216, DOI 10.1016/j.ijgo.2006.04.009; Daniels Norman, 2008, JUST HLTH M HLTH NEE; EISENBERG L, 1984, AM J MED, V77, P524, DOI 10.1016/0002-9343(84)90114-1; Farmer Paul, 2008, Health Hum Rights, V10, P5; FATHALLA MF, 1997, OBSTET GYNECOLOGY WO; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Freedman LP, 2003, INT J GYNECOL OBSTET, V82, P111, DOI 10.1016/S0020-7292(03)00147-4; HELLMAN H, 2002, GREAT FEUDS MED; HERRING J, 2008, MED LAW ETHICS; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hurwitz B, 1997, BRIT MED J, V315, P1671, DOI 10.1136/bmj.315.7123.1671; Kassirer JP, 1998, NEW ENGL J MED, V339, P397, DOI 10.1056/NEJM199808063390608; Marmot MG., 2006, SOCIAL DETERMINANTS; Meguid Tarek, 2007, Malawi Med J, V19, P9; Meguid Tarek, 2008, Health Hum Rights, V10, P105; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Pond B, 2006, LANCET, V367, P1448, DOI 10.1016/S0140-6736(06)68346-3; Record R, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-12; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Singer Peter, 2004, ETHICS ASSISTANCE MO; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Tita ATN, 2007, OBSTET GYNECOL, V110, P972, DOI 10.1097/01.AOG.0000281668.71111.ea; UDOMBANA NJ, 2007, CASTING NET WIDER HU; Van Dillen J, 2006, ACTA OBSTET GYN SCAN, V85, P499, DOI 10.1080/00016340600555884; VANROOSMALEN J, 2008, ORATIE HOOGLERAARSCH; Weise S, 2007, AM J PHYS ANTHROPOL, P246; *WHO, MAT MORT RAT FALL TO; Winterton W R, 1980, Hist Med, V8, P11; WYKLICKY H, 1983, Infection Control (Thorofare), V4, P367; Yamin AE, 2005, HUM RIGHTS QUART, V27, P1200, DOI 10.1353/hrq.2005.0056; YAMIN AE, 2005, LEARNING DANCE ADV W	40	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2009	338								b1013	10.1136/bmj.b1013	http://dx.doi.org/10.1136/bmj.b1013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GA	19279055				2022-12-28	WOS:000264206100006
J	Ramamurthi, KS; Lecuyer, S; Stone, HA; Losick, R				Ramamurthi, Kumaran S.; Lecuyer, Sigolene; Stone, Howard A.; Losick, Richard			Geometric Cue for Protein Localization in a Bacterium	SCIENCE			English	Article							BACILLUS-SUBTILIS; SUBCELLULAR-LOCALIZATION; MEMBRANE; CURVATURE; SPORULATION; INHIBITOR	Proteins in bacteria often deploy to particular places within the cell, but the cues for localization are frequently mysterious. We found that the peripheral membrane protein SpoVM (VM) recognizes a geometric cue when localizing to a particular membrane during sporulation in Bacillus subtilis. Sporulation involves an inner cell maturing into a spore and an outer cell nurturing the developing spore. VM is produced in the outer cell, where it embeds in the membrane that surrounds the inner cell but not in the cytoplasmic membrane of the outer cell. We found that VM localized by discriminating between the positive curvature of the membrane surrounding the inner cell and the negative curvature of the cytoplasmic membrane. Membrane curvature could be a general cue for protein localization in bacteria.	[Ramamurthi, Kumaran S.; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lecuyer, Sigolene; Stone, Howard A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	Ramamurthi, Kumaran/P-3516-2015; lecuyer, sigolene/E-7626-2012	lecuyer, sigolene/0000-0001-7393-2667	arvard Nanoscale Science and Engineering Center [Fulbright grant]; NIH [GM18568]; NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER	arvard Nanoscale Science and Engineering Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Gaudet, D. Rudner, C. Schmidt, L. Shapiro, R. Schekman, D. Weitz, and N. Wingreen for discussions and S. Lacefield, B. Scheid, and P. de Boer for advice. This work was supported by the Harvard Nanoscale Science and Engineering Center, a Fulbright grant to S.L., and NIH grant GM18568 to R.L.	BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; Parthasarathy R, 2007, SOFT MATTER, V3, P24, DOI 10.1039/b608631d; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Ramamurthi KS, 2006, MOL MICROBIOL, V62, P1547, DOI 10.1111/j.1365-2958.2006.05468.x; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003	17	162	163	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1354	1357		10.1126/science.1169218	http://dx.doi.org/10.1126/science.1169218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265022	Green Accepted			2022-12-28	WOS:000263876700045
J	Kritek, PA; Slutsky, AS; Hudson, LD				Kritek, Patricia A.; Slutsky, Arthur S.; Hudson, Leonard D.			Care of an Unresponsive Patient with a Poor Prognosis - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Slutsky, Arthur/M-3325-2019					Slutsky AS, 2009, NEW ENGL J MED, V360, P527, DOI 10.1056/NEJMclde0808330	1	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					E15	U99		10.1056/NEJMclde0900810	http://dx.doi.org/10.1056/NEJMclde0900810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264684				2022-12-28	WOS:000263824500016
J	Crowther, MA; Ageno, W; Garcia, D; Wang, LQ; Witt, DM; Clark, NP; Blostein, MD; Kahn, SR; Vesely, SK; Schulman, S; Kovacs, MJ; Rodger, MA; Wells, P; Anderson, D; Ginsberg, J; Selby, R; Siragusa, S; Silingardi, M; Dowd, MB; Kearon, C				Crowther, Mark A.; Ageno, Walter; Garcia, David; Wang, Luqi; Witt, Dan M.; Clark, Nathan P.; Blostein, Mark D.; Kahn, Susan R.; Vesely, Sara K.; Schulman, Sam; Kovacs, Michael J.; Rodger, Marc A.; Wells, Phillip; Anderson, David; Ginsberg, Jeffery; Selby, Rita; Siragusa, Sergio; Silingardi, Mauro; Dowd, Mary Beth; Kearon, Clive			Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MECHANICAL HEART-VALVES; INTERNATIONAL NORMALIZED RATIO; OVER-ANTICOAGULATION; COAGULOPATHY; MANAGEMENT; THERAPY; SURGERY; RISK	Background: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain. Objective: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients with warfarin-associated coagulopathy. Design: Multicenter, randomized, placebo-controlled trial. Randomization was computer-generated, and participants were allocated to trial groups by using sequentially numbered study drug containers. Patients, caregivers, and those who assessed outcomes were blinded to treatment assignment. Setting: 14 anticoagulant therapy clinics in Canada, the United States, and Italy. Patients: Nonbleeding patients with INR values of 4.5 to 10.0. Intervention: Oral vitamin K, 1.25 mg (355 patients randomly assigned; 347 analyzed), or matching placebo (369 patients randomly assigned; 365 analyzed). Measurements: Bleeding events (primary outcome), thromboembolism, and death (secondary outcomes). Results: 56 patients (15.8%) in the vitamin K group and 60 patients (16.3%) in the placebo group had at least 1 bleeding complication (absolute difference, -0.5 percentage point [95% CI, -6.1 to 5.1 percentage points]); major bleeding events occurred in 9 patients (2.5%) in the vitamin K group and 4 patients (1.1%) in the placebo group (absolute difference, 1.5 percentage points [CI, -0.8 to 3.7 percentage points]). Thromboembolism occurred in 4 patients (1.1%) in the vitamin K group and 3 patients (0.8%) in the placebo group (absolute difference, 0.3 percentage point [CI, -1.4 to 2.0 percentage points]). Other adverse effects were not assessed. The day after treatment, the INR had decreased by a mean of 1.4 in the placebo group and 2.8 in the vitamin K group (P < 0.001). Limitation: Patients who were actively bleeding were not included, and warfarin dosing after enrollment was not mandated or followed. Conclusion: Low-dose oral vitamin K did not reduce bleeding in warfarin recipients with INRs of 4.5 to 10.0.	[Crowther, Mark A.] McMaster Univ, St Josephs Hosp, Fac Hlth Sci, Div Hematol & Thromboembolism, Hamilton, ON L8N 4A6, Canada; Univ Insubria, Varese, Italy; Univ New Mexico, Albuquerque, NM 87131 USA; Kaiser Permanente, Denver, CO USA; McGill Univ, Montreal, PQ, Canada; Univ Western Ontario, London, ON, Canada; Univ Ottawa, Ottawa, ON, Canada; Dalhousie Univ, Halifax, NS, Canada; Univ Toronto, Toronto, ON, Canada; Univ Palermo, Palermo, Italy; Reggio Emilia Hosp, Reggio Emilia, Italy; Univ Oklahoma, Oklahoma City, OK USA	McGill University; McMaster University; University of Insubria; University of New Mexico; Kaiser Permanente; McGill University; Western University (University of Western Ontario); University of Ottawa; Dalhousie University; University of Toronto; University of Palermo; University of Oklahoma System; University of Oklahoma Health Sciences Center	Crowther, MA (corresponding author), McMaster Univ, St Josephs Hosp, Fac Hlth Sci, Div Hematol & Thromboembolism, Room L208,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	crowthrm@mcmaster.ca	ginsberg, jeffrey s/ABC-1065-2020; Kovacs, Michael/G-3315-2011	Silingardi, Mauro/0000-0002-9518-8725; Rodger, Marc/0000-0001-8166-3487; Vesely, Sara/0000-0003-3448-0156; Anderson, David/0000-0003-0845-1722; Schulman, Sam/0000-0002-8512-9043; ageno, walter/0000-0002-1922-8879	Canadian Institutes of Health Research; Italian Ministry of Universities and Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Italian Ministry of Universities and Research(Ministry of Education, Universities and Research (MIUR))	Canadian Institutes of Health Research and Italian Ministry of Universities and Research.	Ageno W, 2005, J AM COLL CARDIOL, V46, P732, DOI 10.1016/j.jacc.2005.05.022; Ageno W, 2004, BLOOD COAGUL FIBRIN, V15, P623, DOI 10.1097/00001721-200412000-00001; Ageno W, 2002, THROMB HAEMOSTASIS, V88, P48; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; COSGRIFF SW, 1956, ANN INTERN MED, V45, P14, DOI 10.7326/0003-4819-45-1-14; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; Crowther MA, 2002, ANN INTERN MED, V137, P251, DOI 10.7326/0003-4819-137-4-200208200-00009; Dentali F, 2006, J THROMB HAEMOST, V4, P1853, DOI 10.1111/j.1538-7836.2006.01986.x; DeZee KJ, 2006, ARCH INTERN MED, V166, P391; FLEISS JL, 2008, STAT METHODS RATES P; Garcia DA, 2006, J AM COLL CARDIOL, V47, P804, DOI 10.1016/j.jacc.2005.09.058; Garcia DA, 2005, J THROMB THROMBOLYS, V18, P199, DOI 10.1007/s11239-005-0346-5; Gunther KE, 2004, THROMB RES, V113, P205, DOI 10.1016/j.thromres.2004.03.004; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; Libby EN, 2002, ARCH INTERN MED, V162, P1893, DOI 10.1001/archinte.162.16.1893; LOUSBERG TR, 2007, ANN INTERN MED, V147, P38; Oden A, 2002, BMJ-BRIT MED J, V325, P1073, DOI 10.1136/bmj.325.7372.1073; Oh DY, 2005, YONSEI MED J, V46, P66, DOI 10.3349/ymj.2005.46.1.66; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; Whitlock RP, 2007, ANN THORAC SURG, V84, P103, DOI 10.1016/j.athoracsur.2007.03.014; Witt DM, 2005, CHEST, V127, P1515, DOI 10.1378/chest.127.5.1515; Woods K, 2007, J THROMB THROMBOLYS, V24, P93, DOI 10.1007/s11239-007-0022-z; Yiu KH, 2006, AM J CARDIOL, V97, P409, DOI 10.1016/j.amjcard.2005.08.062	25	114	115	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					293	+		10.7326/0003-4819-150-5-200903030-00005	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19258557				2022-12-28	WOS:000264051700001
J	Bennett, MR; Harris, JWK; Richmond, BG; Braun, DR; Mbua, E; Kiura, P; Olago, D; Kibunjia, M; Omuombo, C; Behrensmeyer, AK; Huddart, D; Gonzalez, S				Bennett, Matthew R.; Harris, John W. K.; Richmond, Brian G.; Braun, David R.; Mbua, Emma; Kiura, Purity; Olago, Daniel; Kibunjia, Mzalendo; Omuombo, Christine; Behrensmeyer, Anna K.; Huddart, David; Gonzalez, Silvia			Early Hominin Foot Morphology Based on 1.5-Million-Year-Old Footprints from Ileret, Kenya	SCIENCE			English	Article							TURKANA-BASIN; PLIOPLEISTOCENE HOMINIDS; LAKE TURKANA; KOOBI FORA; LAETOLI; AUSTRALOPITHECUS; CHIMPANZEE; BIPEDALISM; ETHIOPIA; WALKING	Hominin footprints offer evidence about gait and foot shape, but their scarcity, combined with an inadequate hominin fossil record, hampers research on the evolution of the human gait. Here, we report hominin footprints in two sedimentary layers dated at 1.51 to 1.53 million years ago (Ma) at Ileret, Kenya, providing the oldest evidence of an essentially modern human-like foot anatomy, with a relatively adducted hallux, medial longitudinal arch, and medial weight transfer before push-off. The size of the Ileret footprints is consistent with stature and body mass estimates for Homo ergaster/erectus, and these prints are also morphologically distinct from the 3.75-million-year-old footprints at Laetoli, Tanzania. The Ileret prints show that by 1.5 Ma, hominins had evolved an essentially modern human foot function and style of bipedal locomotion.	[Bennett, Matthew R.] Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England; [Harris, John W. K.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Richmond, Brian G.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Braun, David R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Mbua, Emma; Kiura, Purity; Kibunjia, Mzalendo] Natl Museums Kenya, Nairobi, Kenya; [Olago, Daniel; Omuombo, Christine] Univ Nairobi, Dept Geol, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA; [Huddart, David; Gonzalez, Silvia] Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Bournemouth University; Rutgers State University New Brunswick; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; University of Nairobi; Smithsonian Institution; Smithsonian National Museum of Natural History; Liverpool John Moores University	Bennett, MR (corresponding author), Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England.	mbennett@bmth.ac.uk	Braun, David/C-9680-2009	Omuombo, Christine Atieno/0000-0003-3966-2610; Bennett, Matthew/0000-0002-3063-8844	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council [NE/C519446/1] Funding Source: researchfish	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project is part of the Koobi Fora Research and Training Program, which is jointly run by the National Museum of Kenya and Rutgers University and supported by the Holt Family Foundation, M. Weiss, B. Mortenson, G. Noland, C. Chip, and the Wenner-Gren Foundation for Anthropological Research. B. Wood provided valuable comments on a draft of the paper, and the dating was undertaken by F. Brown. The field assistance of H. Manley, S. A. Morse, and M. J. Steele is acknowledged.	Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; BRAUN DR, 2008, ARCHAEOMETRY, DOI DOI 10.1111/J.1475-4754.2008.00399; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Griffin N., 2006, HUMAN FOOT COMPANION, P27; Harris JWK, 2002, J HUM EVOL, V42, pA15; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; ROGERS MJ, 1994, J HUM EVOL, V27, P139, DOI 10.1006/jhev.1994.1039; Ruff Christopher B., 1993, P234; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409	27	151	153	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1197	1201		10.1126/science.1168132	http://dx.doi.org/10.1126/science.1168132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	411XT	19251625				2022-12-28	WOS:000263687600034
J	Clausen, J				Clausen, Jens			Man, machine and in between	NATURE			English	Editorial Material							DEEP BRAIN-STIMULATION		Univ Tubingen, Inst Ethics & Hist Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Clausen, J (corresponding author), Univ Tubingen, Inst Ethics & Hist Med, Tubingen, Germany.	jens.clausen@uni-tuebingen.de	Clausen, Jens/I-4858-2012	Clausen, Jens/0000-0002-2621-4563				Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; BOORSE C, 1977, PHILOS SCI, V44, P542, DOI 10.1086/288768; Clausen Jens, 2008, Biotechnology Journal, V3, P1493, DOI 10.1002/biot.200800244; DANIELS N, 1985, JUST HLTH CARE; GREELY HT, 2006, MINNESOTA J LAW SCI, V7, P599; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Mandat TS, 2006, ACTA NEUROCHIR, V148, P895, DOI 10.1007/s00701-006-0795-4; Silvers Anita, 1998, ENHANCING HUMAN TRAI, P95; Synofzik Matthis, 2008, Biotechnology Journal, V3, P1511, DOI 10.1002/biot.200800187; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929	13	74	75	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1080	1081		10.1038/4571080a	http://dx.doi.org/10.1038/4571080a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411VI	19242454				2022-12-28	WOS:000263680100019
J	Huemer, J; Karnik, N; Steiner, H				Huemer, Julia; Karnik, Niranjan; Steiner, Hans			Unaccompanied refugee children	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; BEHAVIORAL-PROBLEMS; ADOLESCENTS		[Huemer, Julia] Med Univ Vienna, Dept Child & Adolescent Psychiat, A-1090 Vienna, Austria; [Karnik, Niranjan] Univ Calif San Francisco, Sch Med, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Karnik, Niranjan] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Steiner, Hans] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Medical University of Vienna; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Huemer, J (corresponding author), Med Univ Vienna, Dept Child & Adolescent Psychiat, A-1090 Vienna, Austria.	julia.huemer@meduniwien.ac.at	Karnik, Niranjan/N-4103-2019; Huemer, Julia/N-7521-2015; Karnik, Niranjan S/A-1074-2011	Karnik, Niranjan/0000-0001-7650-3008; Huemer, Julia/0000-0003-1942-763X; Karnik, Niranjan S/0000-0001-7650-3008				[Anonymous], 2007 GLOB TRENDS REF; Byrne O., 2008, UNACCOMPANIED CHILDR; Cauffman E, 1998, J AM ACAD CHILD PSY, V37, P1209, DOI 10.1097/00004583-199811000-00022; Derluyn I, 2008, INT J LAW PSYCHIAT, V31, P319, DOI 10.1016/j.ijlp.2008.06.006; Derluyn I, 2008, EUR CHILD ADOLES PSY, V17, P54, DOI 10.1007/s00787-007-0636-x; Derluyn I, 2007, ETHNIC HEALTH, V12, P141, DOI 10.1080/13557850601002296; *SAV CHILDR, SEP CHILDR EUR PROGR; Sourander A, 1998, CHILD ABUSE NEGLECT, V22, P719, DOI 10.1016/S0145-2134(98)00053-2; Steiner H, 1997, J AM ACAD CHILD PSY, V36, P357, DOI 10.1097/00004583-199703000-00014; STEINER H, 2004, HDB MENTAL HLTH INTE; UNICEF, CONV RIGHTS CHILD; Vostanis P., 2007, MENTAL HLTH INTERVEN	12	15	16	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					612	614		10.1016/S0140-6736(09)60380-9	http://dx.doi.org/10.1016/S0140-6736(09)60380-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410FS	19231617				2022-12-28	WOS:000263563500008
J	Sonenberg, N; Hinnebusch, AG				Sonenberg, Nahum; Hinnebusch, Alan G.			Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets	CELL			English	Review							MESSENGER-RNA TRANSLATION; CAP-INDEPENDENT TRANSLATION; TERM SYNAPTIC PLASTICITY; DIET-INDUCED OBESITY; RIBOSOMAL-SUBUNIT; BINDING-PROTEIN; LIFE-SPAN; PREINITIATION COMPLEX; DEPENDENT TRANSLATION; DROSOPHILA CUP	Translational control in eukaryotic cells is critical for gene regulation during nutrient deprivation and stress, development and differentiation, nervous system function, aging, and disease. We describe recent advances in our understanding of the molecular structures and biochemical functions of the translation initiation machinery and summarize key strategies that mediate general or gene-specific translational control, particularly in mammalian systems.	[Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Hinnebusch, Alan G.] NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	nahum.sonenberg@mcgill.ca; alanh@mail.nih.gov			Intramural Research Program of the National Institutes of Health; Canadian Institutes of Health Research; The National Cancer Institute of Canada; Howard Hughes Medical Institute; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The National Cancer Institute of Canada; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Intramural Research Program of the National Institutes of Health ( A. G. H.) and the Canadian Institutes of Health Research, The National Cancer Institute of Canada, the Howard Hughes Medical Institute, and the National Institutes of Health ( N. S.).	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Antoun A, 2006, MOL CELL, V23, P183, DOI 10.1016/j.molcel.2006.05.030; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Bergsten SE, 1999, DEVELOPMENT, V126, P659; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Clouse KN, 2008, DEV BIOL, V313, P713, DOI 10.1016/j.ydbio.2007.11.008; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FOX PL, 2007, TRANSLATIONAL CONTRO, P804; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fringer JM, 2007, MOL CELL BIOL, V27, P2384, DOI 10.1128/MCB.02254-06; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; MOHR IJ, 2007, TRANSLATIONAL CONTRO, P545; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Norsgaard H, 1996, EXP GERONTOL, V31, P563, DOI 10.1016/0531-5565(96)00011-3; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; PELLETIER J, 2007, TRANSLATION CONTROL, P830; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; THOMPSON B, 2007, TRANSLATIONAL CONTRO, P486; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	143	2154	2205	14	285	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					731	745		10.1016/j.cell.2009.01.042	http://dx.doi.org/10.1016/j.cell.2009.01.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239892	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000263688200022
J	Ventura, A; Jacks, T				Ventura, Andrea; Jacks, Tyler			MicroRNAs and Cancer: Short RNAs Go a Long Way	CELL			English	Article							MIR-17-92 CLUSTER; MIR-200 FAMILY; LET-7; EXPRESSION; GENE; MYC; ACTIVATION; SUPPRESSOR; PROFILES; PROLIFERATION	MicroRNAs (miRNAs) may be important regulators of gene expression. By modulating oncogenic and tumor suppressor pathways they could, in principle, contribute to tumorigenesis. Consistent with this hypothesis, recurrent genetic and epigenetic alterations of individual miRNAs are found in some tumors. Functional studies are now elucidating the mechanism of action of putative oncogenic and tumor suppressor miRNAs.	[Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011	Ventura, Andrea/0000-0003-4320-9907	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	50	753	797	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					586	591		10.1016/j.cell.2009.02.005	http://dx.doi.org/10.1016/j.cell.2009.02.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239879	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000263688200009
J	Voinnet, O				Voinnet, Olivier			Origin, Biogenesis, and Activity of Plant MicroRNAs	CELL			English	Review							SMALL RNA DUPLEXES; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL INHIBITION; LEAF DEVELOPMENT; MIRNA PATHWAY; ARABIDOPSIS; GENE; IDENTIFICATION; SIRNA	MicroRNAs (miRNAs) are key posttranscriptional regulators of eukaryotic gene expression. Plants use highly conserved as well as more recently evolved, species-specific miRNAs to control a vast array of biological processes. This Review discusses current advances in our understanding of the origin, biogenesis, and mode of action of plant miRNAs and draws comparisons with their metazoan counterparts.	Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544	European Research Council [210890]; European Union [LSHG-CT-2006037900]; Agence Nationale de la Recherche/Genoplante (ACKROSS and MicroTRAC); Foundation Liliane Bettencourt; Schlumberger Foundation	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Agence Nationale de la Recherche/Genoplante (ACKROSS and MicroTRAC)(French National Research Agency (ANR)); Foundation Liliane Bettencourt; Schlumberger Foundation(Schlumberger)	O.V. thanks T. Dalmay, H. Takahashi, Z. Havelda, and M. Timmermans. O. V. is supported by a starting grant from the European Research Council ( Frontiers of RNAi, No. 210890), the European Union ( SIROCCO LSHG-CT-2006037900), and Agence Nationale de la Recherche/Genoplante (ACKROSS and MicroTRAC). O. V. also acknowledges the support of Foundation Liliane Bettencourt and the Schlumberger Foundation.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; de Meaux J, 2008, P NATL ACAD SCI USA, V105, P8994, DOI 10.1073/pnas.0803218105; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Oparka KJ, 1999, CELL, V97, P743, DOI 10.1016/S0092-8674(00)80786-2; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tretter EM, 2008, PLANT PHYSIOL, V147, P58, DOI 10.1104/pp.108.117119; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	111	1615	1765	22	322	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					669	687		10.1016/j.cell.2009.01.046	http://dx.doi.org/10.1016/j.cell.2009.01.046			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239888	Bronze			2022-12-28	WOS:000263688200018
J	Davis, J				Davis, Jane			The art of medicine Enjoying and enduring: groups reading aloud for wellbeing	LANCET			English	Editorial Material									The Reader, Liverpool L69 7ZG, Merseyside, England		Davis, J (corresponding author), The Reader, 19 Abercromby Sq, Liverpool L69 7ZG, Merseyside, England.	janedavis@thereader.org.uk							0	23	23	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					714	715		10.1016/S0140-6736(09)60426-8	http://dx.doi.org/10.1016/S0140-6736(09)60426-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19263586	Bronze			2022-12-28	WOS:000263725400016
J	Povelones, M; Waterhouse, RM; Kafatos, FC; Christophides, GK				Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.			Leucine-Rich Repeat Protein Complex Activates Mosquito Complement in Defense Against Plasmodium Parasites	SCIENCE			English	Article							VECTOR ANOPHELES-GAMBIAE; IMMUNE-RESPONSES; MALARIA; PHAGOCYTOSIS; LAMPREY; GENES	Leucine-rich repeat-containing proteins are central to host defense in plants and animals. We show that in the mosquito Anopheles gambiae, two such proteins that antagonize malaria parasite infections, LRIM1 and APL1C, circulate in the hemolymph as a high-molecular-weight complex held together by disulfide bridges. The complex interacts with the complement C3-like protein, TEP1, promoting its cleavage or stabilization and its subsequent localization on the surface of midgut-invading Plasmodium berghei parasites, targeting them for destruction. LRIM1 and APL1C are members of a protein family with orthologs in other disease vector mosquitoes and appear to be important effectors in innate mosquito defenses against human pathogens.	[Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Christophides, GK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England.	g.christophides@imperial.ac.uk	Waterhouse, Robert M/A-1858-2010	Waterhouse, Robert M/0000-0003-4199-9052; Christophides, George/0000-0002-3323-1687; Povelones, Michael/0000-0002-3766-2097	Wellcome Trust Program [GR077229/Z/05/Z]; NIH [2PO1AI044220-06A1]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	Wellcome Trust Program(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. C. Koutsos for generating the LRIM1 antibody and sharing it before publication and F. M. Ausubel for critically reviewing the manuscript. Fluorescence microscopy was performed at the Imperial College Facility for Imaging by Light Microscopy imaging facility. This work was supported by a Wellcome Trust Program grant (GR077229/Z/05/Z), an NIH Program Project (2PO1AI044220-06A1), and a Biotechnology and Biological Sciences Research Council grant (BB/E002641/1). R.M.W. was supported by a Wellcome Trust Ph.D. fellowship.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; DONG Y, J BIOL CHEM; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006	22	181	183	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					258	261		10.1126/science.1171400	http://dx.doi.org/10.1126/science.1171400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264986	Green Accepted			2022-12-28	WOS:000265024400048
J	Cole, A				Cole, Andrew			Feature Environment Saving the planet as well as lives	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.cole71@ntlworld.com						Hutchins DCJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b609; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH N	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2009	338								b933	10.1136/bmj.b933	http://dx.doi.org/10.1136/bmj.b933			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NT	19289415				2022-12-28	WOS:000264435700004
J	Hengge, UR; Bardeli, V				Hengge, Ulrich R.; Bardeli, Virginia			Green Nails.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hengge, Ulrich R.] Hautzentrum Duesseldorf, D-40210 Dusseldorf, Germany; [Bardeli, Virginia] Univ Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Hengge, UR (corresponding author), Hautzentrum Duesseldorf, D-40210 Dusseldorf, Germany.	henuli@web.de							0	13	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1125	1125		10.1056/NEJMicm0706497	http://dx.doi.org/10.1056/NEJMicm0706497			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279344				2022-12-28	WOS:000264051000010
J	Parashar, UD; Glass, RI				Parashar, Umesh D.; Glass, Roger I.			Global Health: Rotavirus Vaccines - Early Success, Remaining Questions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY; SAFETY		[Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA.							Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P398; Haber P, 2008, PEDIATRICS, V121, P1206, DOI 10.1542/peds.2007-3793; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	5	60	62	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1063	1065		10.1056/NEJMp0810154	http://dx.doi.org/10.1056/NEJMp0810154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417BW	19279338				2022-12-28	WOS:000264051000003
J	Wu, PYJ; Nurse, P				Wu, Pei-Yun Jenny; Nurse, Paul			Establishing the Program of Origin Firing during S Phase in Fission Yeast	CELL			English	Article							DNA-REPLICATION ORIGINS; CYCLE-DEPENDENT REGULATION; CEREVISIAE CHROMOSOME VI; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; EGG EXTRACTS; CHROMATIN; PROTEINS	Initiation of eukaryotic DNA synthesis occurs at origins of replication that are utilized with characteristic times and frequencies during S phase. We have investigated origin usage by evaluating the kinetics of replication factor binding in fission yeast and show that similar to metazoa, ORC binding is periodic during the cell cycle, increasing during mitosis and peaking at M/G1. At an origin, the timing of ORC binding in M and pre-RC assembly in G1 correlates with the timing of firing during S, and the level of pre-IC formation reflects origin efficiency. Extending mitosis allows ORC to become more equally associated with origins and leads to genome-wide changes in origin usage, while overproduction of pre-IC factors increases replication of both efficient and inefficient origins. We propose that differential recruitment of ORC to origins during mitosis followed by competition among origins for limiting replication factors establishes the timing and efficiency of origin firing.	[Wu, Pei-Yun Jenny; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Wu, PYJ (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	pwu@rockefeller.edu		Wu, Pei-Yun/0000-0002-7965-583X	National Institutes of Health Postdoctoral Fellowship [GM075572]; Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075572] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shah-an Yang for help with the bioinformatics analysis. We are grateful to Supriya Prasanth and Bruce Stillman for sharing unpublished data and to all the members of the Laboratory of Yeast Genetics and Cell Biology for critical reading of the manuscript. This study was supported by National Institutes of Health Postdoctoral Fellowship GM075572, the Sydney and Stanley Shuman Postdoctoral Fellowship, and the Breast Cancer Research Foundation.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; DIFFLEY JFX, 1994, CURR OPIN CELL BIOL, V6, P368, DOI 10.1016/0955-0674(94)90028-0; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Lygerou Z, 1999, J CELL SCI, V112, P3703; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; MAUNDRELL K, 1988, EMBO J, V7, P2203, DOI 10.1002/j.1460-2075.1988.tb03059.x; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Mesner LD, 2006, MOL CELL, V21, P719, DOI 10.1016/j.molcel.2006.01.015; Mickle KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-112; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Okuno Y, 1997, NUCLEIC ACIDS RES, V25, P530, DOI 10.1093/nar/25.3.530; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; SHINOMIYA T, 1991, NUCLEIC ACIDS RES, V19, P3935, DOI 10.1093/nar/19.14.3935; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	56	103	103	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					852	864		10.1016/j.cell.2009.01.017	http://dx.doi.org/10.1016/j.cell.2009.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269364	Green Accepted, Bronze			2022-12-28	WOS:000263930900009
J	Wang, Z; Tobler, S; Roayaei, J; Eick, A				Wang, Zhong; Tobler, Steven; Roayaei, Jean; Eick, Angelia			Live Attenuated or Inactivated Influenza Vaccines and Medical Encounters for Respiratory Illnesses Among US Military Personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPENSITY SCORE; ANTIBODY-RESPONSES; BASIC TRAINEES; MONTE-CARLO; CHILDREN; VACCINATION; SURVEILLANCE; PREVENTION; HEALTHY; TRIVALENT	Context Since 2004, increasing numbers of military personnel have been immunized with the intranasal live attenuated influenza vaccine (LAIV) while most others received the trivalent inactivated vaccine (TIV). However, data about live virus vaccine effectiveness among healthy adults are limited. Objective To monitor the effectiveness of vaccines to better inform military vaccination policy. Design, Setting, and Participants Surveillance of population-based, propensity-matched, and/or vaccine-naive cohorts of more than a million active-duty, nonrecruit military service members aged 17 to 49 years stationed in the United States during the 2004-2005, 2005-2006, or 2006-2007 influenza season. Main Outcome Measures Incidence of health care encounters resulting in a primary diagnostic code consistent with pneumonia or influenza. Incident hospitalizations was a secondary outcome. Results In all 3 seasons, immunization with TIV was associated with lower incidence rates of health care encounters for pneumonia and influenza when compared with no immunization: 8.6 vs 19.4 for 2004-2005, 7.8 vs 10.9 for 2005-2006, and 8.0 vs. 11.7 per 1000 person-years for 2006-2007 (all P < .001). Similar estimates were obtained from propensity-matched and/or vaccine-naive cohorts. Consistently lower vaccine effect following LAIV immunization was only seen during the 2006-2007 influenza season in the total (10.7; 95% confidence interval [CI], 2.72 to 18.1; P = .03) and propensity-matched cohorts (11.8; 95% CI, 0.85 to 21.5; P =. 04), and was less than effect from TIV (TIV vs LAIV, 19.8; 95% CI, 13.6 to 25.5; P < .001). Among vaccine-naive service members, however, estimates for LAIV effect were more robust for both the 2005- 2006 and 2006-2007 seasons (P = .01) and were comparable with TIV (eg, LAIV, 30.2; 95% CI, 11.2 to 45.2; vs TIV, 35.3; 95% CI, 25.9 to 43.6; in 2005- 2006). Conclusions Vaccination with TIV was associated with fewer medical encounters related to pneumonia and influenza compared with LAIV or no immunization. In this annually immunized population, this effect was less apparent in those vaccinated with LAIV.	[Wang, Zhong; Tobler, Steven; Roayaei, Jean; Eick, Angelia] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20910 USA; [Wang, Zhong; Eick, Angelia] Henry M Jackson Fdn Advancement Mil Med Inc, Rockville, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Wang, Z (corresponding author), Armed Forces Hlth Surveillance Ctr, Suite 200,2900 Linden Ln, Silver Spring, MD 20910 USA.	zhong.wang@us.army.mil						Allison MA, 2006, J PEDIATR-US, V149, P755, DOI 10.1016/j.jpeds.2006.06.036; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07; *CDCP, 2004 2005 US INFL SE; *DEP DEF, POL US INFL VACC 200; *DEP DEF, POL GUID FLUMIST INF; Didierlaurent A, 2007, IMMUNOLOGY, V122, P457, DOI 10.1111/j.1365-2567.2007.02729.x; FINE PE, 2004, VACCINES, P1443; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; McNeill M, 2005, MIL MED, V170, P94, DOI 10.7205/MILMED.170.1.94; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nichol KL, 2006, VACCINE, V24, P6726, DOI 10.1016/j.vaccine.2006.05.064; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Parsons L, REDUCING BIAS PROPEN; Payne DC, 2007, PHARMACOEPIDEM DR S, V16, P605, DOI 10.1002/pds.1395; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Russell KL, 2005, VACCINE, V23, P1981, DOI 10.1016/j.vaccine.2004.10.023; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Strickler JK, 2007, EMERG INFECT DIS, V13, P617, DOI 10.3201/eid1304.061308; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5	35	60	65	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					945	953		10.1001/jama.2009.265	http://dx.doi.org/10.1001/jama.2009.265			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19255113	Bronze			2022-12-28	WOS:000263784600024
J	Knight, M; Kurinczuk, JJ; Spark, P; Brocklehurst, P				Knight, Marian; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter		UKOSS	Inequalities in maternal health: national cohort study of ethnic variation in severe maternal morbidities	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; PREGNANCY; NETHERLANDS; MORTALITY; DELIVERY	Objective To describe on a national basis ethnic differences in severe maternal morbidity in the United Kingdom. Design National cohort study using the UK Obstetric Surveillance System (UKOSS). Setting All hospitals with consultant led maternity units in the UK. Participants 686 women with severe maternal morbidity between February 2005 and February 2006. Main outcome measures Rates, risk ratios, and odds ratios of severe maternal morbidity in different ethnic groups. Results 686 cases of severe maternal morbidity were reported in an estimated 775 186 maternities, representing an estimated incidence of 89 (95% confidence interval 82 to 95) cases per 100 000 maternities. 74% of women were white, and 26% were non-white. The estimated risk of severe maternal morbidity in white women was 80 cases per 100 000 maternities, and that in non-white women was 126 cases per 100 000 (risk difference 46 (27 to 66) cases per 100 000; risk ratio 1.58, 95% confidence interval 1.33 to 1.87). Black African women (risk difference 108 (18 to 197) cases per 100 000 maternities; risk ratio 2.35, 1.45 to 3.81) and black Caribbean women (risk difference 116 (59 to 172) cases per 100 000 maternities; risk ratio 2.45, 1.81 to 3.31) had the highest risk compared with white women. The risk in non-white women remained high after adjustment for differences in age, socioeconomic and smoking status, body mass index, and parity (odds ratio 1.50, 1.15 to 1.96). Conclusions Severe maternal morbidity is significantly more common among non-white women than among white women in the UK, particularly in black African and Caribbean ethnic groups. This pattern is very similar to reported ethnic differences in maternal death rates. These differences may be due to the presence of pre-existing maternal medical factors or to factors related to care during pregnancy, labour, and birth; they are unlikely to be due to differences in age, socioeconomic or smoking status, body mass index, or parity. This highlights to clinicians and policy makers the importance of tailored maternity services and improved access to care for women from ethnic minorities. National information on the ethnicity of women giving birth in the UK is needed to enable ongoing accurate study of these inequalities.	[Knight, Marian; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; UKOSS] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England	University of Oxford	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England.	marian.knight@npeu.ox.ac.uk	Brocklehurst, Peter/B-5804-2011; Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575; Pebody, Richard/0000-0002-9069-2885	National Coordinating Centre for Research Capacity Development of the Department of Health; Department of Health; NHS RD [PHCS 022]; Policy Research Programme in the Department of Health	National Coordinating Centre for Research Capacity Development of the Department of Health; Department of Health; NHS RD; Policy Research Programme in the Department of Health	Funding: MK is funded by the National Coordinating Centre for Research Capacity Development of the Department of Health. JJK was partially funded by a national public health career scientist award from the Department of Health and NHS R&D (PHCS 022). This paper reports on an independent study which is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the department. The authors are independent of all funders.	Berg CJ, 2003, OBSTET GYNECOL, V101, P289, DOI 10.1016/S0029-7844(02)02587-5; Brace V, 2004, BJOG-INT J OBSTET GY, V111, P481, DOI 10.1111/j.1471-0528.2004.00101.x; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; DRIFE JO, 1993, BRIT MED J, V307, P1087, DOI 10.1136/bmj.307.6912.1087; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; *INF CTR HLTH SOC, 2006, STAT B; *INF CTR HLTH SOC, HOSP EP STAT 2005 6; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Lewis G., 2007, 7 CONFIDENTIAL ENQUI; Moser K, 2008, HLTH STAT Q, V39, P34; Moser Kath, 2008, Health Stat Q, P22; *OFF NAT STAT, 2007, KEY POP VIT STAT 200; Office for National Statistics, 2000, STAND OCC CLASS 2000; Office for National Statistics, 2003, ETHN GROUP STAT GUID; Redshaw M., 2007, RECORDED DELIVERY NA; Rosenberg TJ, 2005, AM J PUBLIC HEALTH, V95, P1545, DOI 10.2105/AJPH.2005.065680; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Schuitemaker N, 1998, EUR J OBSTET GYN R B, V76, P61, DOI 10.1016/S0301-2115(97)00155-3; Sullivan E, 2007, MATERNAL DEATHS AUST; van Roosmalen J, 2002, BJOG-INT J OBSTET GY, V109, P212, DOI 10.1016/S1470-0328(02)01025-X; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	26	92	93	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2009	338								b542	10.1136/bmj.b542	http://dx.doi.org/10.1136/bmj.b542			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EB	19261591	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264058200004
J	Arnold, J; Goodacre, S; Bath, P; Price, J				Arnold, Jane; Goodacre, Steve; Bath, Peter; Price, Jonathan			Information sheets for patients with acute chest pain: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PANIC DISORDER; EMERGENCY; DEPRESSION	Objectives To determine whether providing an information sheet to patients with acute chest pain reduces anxiety, improves health related quality of life, improves satisfaction with care, or alters subsequent symptoms or actions. Design Single centre, non-blinded, randomised controlled trial. Setting Chest pain unit of an emergency department. Participants 700 consecutive patients with acute chest pain and no clear diagnosis at initial presentation. Interventions After a diagnostic assessment patients were randomised to receive either standard verbal advice or verbal advice followed by an information sheet. Main outcome measures The primary outcome was anxiety (hospital anxiety and depression scale). Secondary outcomes were depression (hospital anxiety and depression scale), health related quality of life (SF-36), patient satisfaction, presentation with further chest pain within one month, lifestyle change (smoking cessation, diet, exercise), further information sought from other sources, and planned healthcare seeeking behaviour in response to further pain. Results 494 of 700 (70.6%) patients responded. Compared with those receiving standard verbal advice those receiving advice and an information sheet had lower mean hospital anxiety and depression scale scores for anxiety (7.61v8.63, difference 1.02, 95% confidence interval 0.20 to 1.84) and depression (4.14 v 5.28, difference 1.14, 0.41 to 1.86) and higher scores for mental health and perception of general health on the SF-36. The information sheet had no significant effect on satisfaction with care, subsequent symptoms, lifestyle change, information seeking, or planned actions in the event of further pain. Conclusions Provision of an information sheet to patients with acute chest pain can reduce anxiety and depression and improve mental health and perception of general health but does not alter satisfaction with care or other outcomes. Trial registration Current Controlled Trials ISRCTN85248020.	[Arnold, Jane] No Gen Hosp, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield S5 7AU, S Yorkshire, England; [Goodacre, Steve] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England; [Bath, Peter] Univ Sheffield, Dept Informat Studies, Sheffield S10 2TN, S Yorkshire, England; [Price, Jonathan] Univ Oxford, Dept Psychiat, Oxford OX1 2JD, England	Northern General Hospital; Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Sheffield; University of Sheffield; University of Oxford	Arnold, J (corresponding author), No Gen Hosp, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield S5 7AU, S Yorkshire, England.	Jane.Arnold@sth.nhs.uk		Goodacre, Steve/0000-0003-0803-8444; Bath, Peter/0000-0002-6310-7396	Health Foundation	Health Foundation	Funding: JA was supported by a Health Foundation Leadership through Practice Award. The funders played no part in the study design, the collection or analysis of data, the writing of the report, or the decision to submit for publication. All the authors are independent of the funders.	ARNOLD J, 2008, LEADING PRACTICE RES; Boter H, 2003, BRIT MED J, V327, P284, DOI 10.1136/bmj.327.7409.284; DAVIES AR, 1991, GHAA CONSUMER SATISF; Fleet RP, 1996, AM J MED, V101, P371, DOI 10.1016/S0002-9343(96)00224-0; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Goodacre S, 2004, BRIT MED J, V328, P254, DOI 10.1136/bmj.37956.664236.EE; Goodacre S, 2001, ANN EMERG MED, V38, P369, DOI 10.1067/mem.2001.118010; Goodacre SW, 2004, ACAD EMERG MED, V11, P827, DOI 10.1197/j.aem.2004.02.525; JOHNSON A, 2005, COCHRANE DB SYST REV; Kologlu M, 1999, Eur J Emerg Med, V6, P245; KRISHEL S, 1993, ANN EMERG MED, V22, P568, DOI 10.1016/S0196-0644(05)81943-2; Petrie KJ, 2007, BRIT MED J, V334, P352, DOI 10.1136/bmj.39093.464190.55; Price JR, 2005, J PSYCHOSOM RES, V59, P237, DOI 10.1016/j.jpsychores.2005.04.004; Raynor DK, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11050; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; SMITH J, 2007, COCHRANE DB SYST REV; Sun BC, 2004, ANN EMERG MED, V44, P378, DOI 10.1016/j.annemergmed.2004.02.002; Ware J. E., 1993, SF36 HLTH SURVEY MAN; YINGLING KW, 1993, J GEN INTERN MED, V8, P231; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	20	29	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2009	338								b541	10.1136/bmj.b541	http://dx.doi.org/10.1136/bmj.b541			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DS	19246544	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000264056300002
J	Cen, C; Thiel, S; Mannhart, J; Levy, J				Cen, Cheng; Thiel, Stefan; Mannhart, Jochen; Levy, Jeremy			Oxide Nanoelectronics on Demand	SCIENCE			English	Article							ELECTRON; HETEROSTRUCTURES; NANOSTRUCTURES; INTERFACES; MODULATION	Electronic confinement at nanoscale dimensions remains a central means of science and technology. We demonstrate nanoscale lateral confinement of a quasi-two-dimensional electron gas at a lanthanum aluminate-strontium titanate interface. Control of this confinement using an atomic force microscope lithography technique enabled us to create tunnel junctions and field-effect transistors with characteristic dimensions as small as 2 nanometers. These electronic devices can be modified or erased without the need for complex lithographic procedures. Our on-demand nanoelectronics fabrication platform has the potential for widespread technological application.	[Cen, Cheng; Levy, Jeremy] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Thiel, Stefan; Mannhart, Jochen] Univ Augsburg, Ctr Elect Correlat & Magnetism, Inst Phys, D-86135 Augsburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Augsburg	Levy, J (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	jlevy@pitt.edu		Mannhart, Jochen/0000-0001-6331-2640	NSF [0704022]; Deutsche Forschungsgemeinschaft [SFB 484]; European Community NANOXIDE	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community NANOXIDE	Supported by NSF grant 0704022, Deutsche Forschungsgemeinschaft grant SFB 484, and the European Community NANOXIDE project.	Albina JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165103; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Basletic M, 2008, NAT MATER, V7, P621, DOI 10.1038/nmat2223; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Cen C, 2008, NAT MATER, V7, P298, DOI 10.1038/nmat2136; Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605; Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100; DINGLE R, 1978, APPL PHYS LETT, V33, P665, DOI 10.1063/1.90457; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Huijben M, 2006, NAT MATER, V5, P556, DOI 10.1038/nmat1675; Kalabukhov A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121404; Klein DL, 1997, NATURE, V389, P699, DOI 10.1038/39535; LEONARD D, 1993, APPL PHYS LETT, V63, P3203, DOI 10.1063/1.110199; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2006, NATURE, V441, P120, DOI 10.1038/nature04773; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Schneider CW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354422; SIEMONS W, 2007, NAT MATER, V7; SNOW ES, 1994, APPL PHYS LETT, V64, P1932, DOI 10.1063/1.111746; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191	26	405	408	1	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1026	1030		10.1126/science.1168294	http://dx.doi.org/10.1126/science.1168294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229030				2022-12-28	WOS:000263478400032
J	Durham, WM; Kessler, JO; Stocker, R				Durham, William M.; Kessler, John O.; Stocker, Roman			Disruption of Vertical Motility by Shear Triggers Formation of Thin Phytoplankton Layers	SCIENCE			English	Article							MICROORGANISMS; BLOOM; MECHANISMS; PATTERNS; PLANKTON; MODEL; FLOW	Thin layers of phytoplankton are important hotspots of ecological activity that are found in the coastal ocean, meters beneath the surface, and contain cell concentrations up to two orders of magnitude above ambient concentrations. Current interpretations of their formation favor abiotic processes, yet many phytoplankton species found in these layers are motile. We demonstrated that layers formed when the vertical migration of phytoplankton was disrupted by hydrodynamic shear. This mechanism, which we call gyrotactic trapping, can be responsible for the thin layers of phytoplankton commonly observed in the ocean. These results reveal that the coupling between active microorganism motility and ambient fluid motion can shape the macroscopic features of the marine ecological landscape.	[Durham, William M.; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Kessler, John O.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Massachusetts Institute of Technology (MIT); University of Arizona	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; 	National Defense Science and Engineering Graduate Fellowship; Department of Energy [W31-109-ENG38]; NSF [OCE 0526241, OCE CAREER 0744641]; MIT's Earth Systems Initiative; Doherty Professorship	National Defense Science and Engineering Graduate Fellowship; Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); MIT's Earth Systems Initiative; Doherty Professorship	We thank P. Franks, W. Young, D. Grunbaum, T. Cowles, R. Bearon, M. Bees, D. Hader, D. Anderson, M. McManus, and L. Karp-Boss for helpful discussions; T. Peacock for the loan of experimental equipment; T. Clay and S. Stransky for developing BacTrack; R. A. Cattolico for providing H. akashiwo; and J. Mitchell, E. DeLong, S. Chisholm, M. Polz, H. Nepf, J. Seymour, J. Bragg, B. Kirkup, P. Reis, D. Birch, and S. Sunghwan for comments on the manuscript. W. M. D. acknowledges a National Defense Science and Engineering Graduate Fellowship. J.O.K. acknowledges support from Department of Energy grant W31-109-ENG38. R. S. acknowledges support from NSF (OCE 0526241 and OCE CAREER 0744641), MIT's Earth Systems Initiative, and a Doherty Professorship.	Alldredge AL, 2002, MAR ECOL PROG SER, V233, P1, DOI 10.3354/meps233001; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Birch DA, 2008, DEEP-SEA RES PT I, V55, P277, DOI 10.1016/j.dsr.2007.11.009; BJORNSEN PK, 1991, MAR ECOL PROG SER, V73, P263, DOI 10.3354/meps073263; Cowles T., 2003, HDB SCALING METHODS, P31; Cowles T.J., 1998, OCEANOGRAPHY, V11, P4, DOI [DOI 10.5670/OCEANOG.1998.08, DOI 10.5670/0CEAN0G.1998.08]; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; FRANKS PJS, 1995, DEEP-SEA RES PT I, V42, P75, DOI 10.1016/0967-0637(94)00028-Q; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; JONES MS, 1994, J FLUID MECH, V281, P137, DOI 10.1017/S002211209400306X; KAMYKOWSKI D, 1992, MAR BIOL, V113, P319; Kessler J.O., 1986, Progress phycol. Res., V4, P257; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; LASKER R, 1975, FISH B-NOAA, V73, P453; Lebert M, 1996, NATURE, V379, P590, DOI 10.1038/379590a0; McManus MA, 2003, MAR ECOL PROG SER, V261, P1, DOI 10.3354/meps261001; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; Mouritsen LT, 2003, J PLANKTON RES, V25, P783, DOI 10.1093/plankt/25.7.783; NIELSEN TG, 1990, MAR ECOL PROG SER, V62, P21, DOI 10.3354/meps062021; PEDLEY TJ, 1988, J FLUID MECH, V195, P223, DOI 10.1017/S0022112088002393; Roberts AM, 2002, J FLUID MECH, V452, P405, DOI 10.1017/S0022112001006772; Ryan JP, 2008, MAR ECOL PROG SER, V354, P21, DOI 10.3354/meps07222; Stacey MT, 2007, LIMNOL OCEANOGR, V52, P1523, DOI 10.4319/lo.2007.52.4.1523; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2603, DOI 10.1016/j.dsr2.2005.06.028; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457	30	204	206	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1067	1070		10.1126/science.1167334	http://dx.doi.org/10.1126/science.1167334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229037				2022-12-28	WOS:000263478400044
J	Bristol, N				Bristol, Nellie			Medicare drug expansion causes controversy in the USA	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					532	532		10.1016/S0140-6736(09)60183-5	http://dx.doi.org/10.1016/S0140-6736(09)60183-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230076	Green Submitted			2022-12-28	WOS:000263333600013
J	Parker, SCJ; Hansen, L; Abaan, HO; Tullius, TD; Margulies, EH				Parker, Stephen C. J.; Hansen, Loren; Abaan, Hatice Ozel; Tullius, Thomas D.; Margulies, Elliott H.			Local DNA Topography Correlates with Functional Noncoding Regions of the Human Genome	SCIENCE			English	Article							REGULATORY SEQUENCES; MOUSE GENOME; CONSTRAINT; ELEMENTS; SITES; IDENTIFICATION; TRANSCRIPTION; RECOGNITION; 1-PERCENT	The three-dimensional molecular structure of DNA, specifically the shape of the backbone and grooves of genomic DNA, can be dramatically affected by nucleotide changes, which can cause differences in protein-binding affinity and phenotype. We developed an algorithm to measure constraint on the basis of similarity of DNA topography among multiple species, using hydroxyl radical cleavage patterns to interrogate the solvent-accessible surface area of DNA. This algorithm found that 12% of bases in the human genome are evolutionarily constrained-double the number detected by nucleotide sequence-based algorithms. Topography-informed constrained regions correlated with functional noncoding elements, including enhancers, better than did regions identified solely on the basis of nucleotide sequence. These results support the idea that the molecular shape of DNA is under selection and can identify evolutionary history.	[Parker, Stephen C. J.; Hansen, Loren; Tullius, Thomas D.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Hansen, Loren] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Abaan, Hatice Ozel; Margulies, Elliott H.] NIH, NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Tullius, Thomas D.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University	Margulies, EH (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	tullius@bu.edu; elliott@nhgri.nih.gov	Tullius, Thomas D./A-9685-2008; Parker, Stephen/ABF-1063-2021	Tullius, Thomas D./0000-0003-4425-796X; 	National Human Genome Research Institute (NHGRI), NIH [R01 HG003541]; Research Corporation for Science Advancement; Intramural Research Program of the NHGRI, NIH; National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003541, ZIAHG200341] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. D. Green and L. C. Brody for feedback on the manuscript, E. Bishop and D. Landsman for discussion, and G. K. McEwen for assistance with experimental steps. Funded by the National Human Genome Research Institute (NHGRI) of the NIH (grant R01 HG003541) to T.D.T. and by the Research Corporation for Science Advancement. E.H.M. was supported by the Intramural Research Program of the NHGRI, NIH. S.C.J.P. was supported by a National Academies Ford Foundation Dissertation Fellowship.	Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DICKERSON RE, 1992, METHOD ENZYMOL, V211, P67; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Greenbaum JA, 2007, GENOME RES, V17, P947, DOI 10.1101/gr.6073107; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Ohyama T., 2005, DNA CONFORMATION TRA; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930	27	152	159	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					389	392		10.1126/science.1169050	http://dx.doi.org/10.1126/science.1169050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286520	Green Accepted			2022-12-28	WOS:000265221600043
J	Flames, N; Hobert, O				Flames, Nuria; Hobert, Oliver			Gene regulatory logic of dopamine neuron differentiation	NATURE			English	Article							OLFACTORY-BULB INTERNEURONS; C-ELEGANS; TRANSCRIPTIONAL CODES; EXPRESSION; BRAIN; ARCHITECTURE; INSIGHTS; IDENTITY; ER81; AXON	Dopamine signalling regulates a variety of complex behaviours, and defects in dopamine neuron function or survival result in severe human pathologies, such as Parkinson's disease(1). The common denominator of all dopamine neurons is the expression of dopamine pathway genes, which code for a set of phylogenetically conserved proteins involved in dopamine synthesis and transport. Gene regulatory mechanisms that result in the direct activation of dopamine pathway genes and thereby ultimately determine the identity of dopamine neurons are poorly understood in all systems studied so far(2). Here we show that a simple cis-regulatory element, the dopamine (DA) motif, controls the expression of all dopamine pathway genes in all dopaminergic cell types in Caenorhabditis elegans. The DA motif is activated by the ETS transcription factor AST-1. Loss of ast-1 results in the failure of all distinct dopaminergic neuronal subtypes to terminally differentiate. Ectopic expression of ast-1 is sufficient to activate the dopamine pathway in some cellular contexts. Vertebrate dopamine pathway genes also contain phylogenetically conserved DA motifs that can be activated by the mouse ETS transcription factor Etv1 (also known as ER81), and a specific class of dopamine neurons fails to differentiate in mice lacking Etv1. Moreover, ectopic Etv1 expression induces dopaminergic fate marker expression in neuronal primary cultures. Mouse Etv1 can also functionally substitute for ast-1 in C. elegans. Our studies reveal a simple and apparently conserved regulatory logic of dopamine neuron terminal differentiation and may provide new entry points into the diagnosis or therapy of conditions in which dopamine neurons are defective.	[Flames, Nuria; Hobert, Oliver] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Flames, N (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, 630 W 168th St, New York, NY 10032 USA.	nf2171@columbia.edu; or38@columbia.edu	Flames, Nuria/L-2290-2017	Flames, Nuria/0000-0003-0961-0609; Hobert, Oliver/0000-0002-7634-2854	National Institutes of Health [R01NS039996-05, R01NS050266-03]; Howard Hughes Medical Institute; EMBO; Marie Curie Outgoing International fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Outgoing International fellowship(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for injection assistance, M. Doitsidou and J. Chen for providing the ot417 allele, E. Savner for initiating some of the promoter analysis, A. Kruyer for technical help, the CGC for strains, the C. elegans Gene Knockout Consortia, led by S. Mitani at Tokyo Women's Medical University School of Medicine and by D. Moerman at the University of British Columbia, for knockout alleles, H. Hutter, N. Tavernarakis and T. Jessell for strains and reagents, several members of Columbia University community for sharing their equipment, Hobert laboratory members, especially M. Doitsidou, for discussion, and A. Abeliovich, R. J. Johnston and I. Greenwald for comments on the manuscript. This work was funded by the National Institutes of Health (R01NS039996-05; R01NS050266-03), the Howard Hughes Medical Institute and a EMBO long term fellowship and Marie Curie Outgoing International fellowship to N. F.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Allen ZJ, 2007, J MOL HISTOL, V38, P517, DOI 10.1007/s10735-007-9115-4; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duggan A, 1998, DEVELOPMENT, V125, P4107; Etchberger JF, 2008, NAT METHODS, V5, P3, DOI 10.1038/nmeth0108-3; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Saino-Saito S, 2007, J COMP NEUROL, V502, P485, DOI 10.1002/cne.21293; Schmid C, 2006, DEV BIOL, V293, P403, DOI 10.1016/j.ydbio.2006.02.042; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Voglis G, 2008, EMBO J, V27, P3288, DOI 10.1038/emboj.2008.252; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004	25	163	180	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					885	U7		10.1038/nature07929	http://dx.doi.org/10.1038/nature07929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19287374	Green Accepted			2022-12-28	WOS:000265182500042
J	Pouget, EM; Bomans, PHH; Goos, JACM; Frederik, PM; de With, G; Sommerdijk, NAJM				Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.			The Initial Stages of Template-Controlled CaCO3 Formation Revealed by Cryo-TEM	SCIENCE			English	Article							CRYSTALLIZATION; MONOLAYERS; CALCITE; PHASE; MINERALIZATION; NANOSCALE	Biogenic calcium carbonate forms the inorganic component of seashells, otoliths, and many marine skeletons, and its formation is directed by an ordered template of macromolecules. Classical nucleation theory considers crystal formation to occur from a critical nucleus formed by the assembly of ions from solution. Using cryotransmission electron microscopy, we found that template-directed calcium carbonate formation starts with the formation of prenucleation clusters. Their aggregation leads to the nucleation of amorphous nanoparticles in solution. These nanoparticles assemble at the template and, after reaching a critical size, develop dynamic crystalline domains, one of which is selectively stabilized by the template. Our findings have implications for template-directed mineral formation in biological as well as in synthetic systems.	[Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Lab Mat & Interface Chem, NL-5600 MB Eindhoven, Netherlands; [Pouget, Emilie M.; Bomans, Paul H. H.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, SoftMatter CryoTEM Unit, NL-5600 MB Eindhoven, Netherlands; [Frederik, Peter M.] Univ Maastricht, Dept Pathol, EM Unit, NL-6229 ER Maastricht, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Maastricht University	Sommerdijk, NAJM (corresponding author), Eindhoven Univ Technol, Lab Mat & Interface Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	n.sommerdijk@tue.nl	de With, G./E-3235-2014; Sommerdijk, Nico A.J.M./B-7239-2013; goos, jeroen/AAL-8405-2020	Sommerdijk, Nico A.J.M./0000-0002-8956-195X; Goos, Jeroen/0000-0003-2010-7377; Pouget, Emilie/0000-0002-3175-6201	European Community [NMP4-CT-2006-033277]; Netherlands Organization for Scientific Research (NWO)	European Community(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Supported by the European Community (project code NMP4-CT-2006-033277) and the Netherlands Organization for Scientific Research (NWO). We thank A. Volkel and H. Colfen for performing and evaluating the ultracentrifugation measurements; D. Gebauer and A. Verch for time-dependent solution composition determination of the mineralization solutions; F. L. Boogaard, E. J. Creusen, J. J. van Roosmalen, and P. Moeskops for their contribution to the 3D reconstructions of the tomograms; and P. T. K. Chin for providing the CdSe nanorods.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Davis ME, 2004, SCIENCE, V305, P480, DOI 10.1126/science.1099773; DiMasi E, 2003, CRYSTENGCOMM, V5, P346, DOI 10.1039/b309800a; Donners JJJM, 2002, CHEM-EUR J, V8, P2561, DOI 10.1002/1521-3765(20020603)8:11<2561::AID-CHEM2561>3.0.CO;2-3; Freeman CL, 2008, LANGMUIR, V24, P9607, DOI 10.1021/la800389g; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; Lee JRI, 2007, J AM CHEM SOC, V129, P10370, DOI 10.1021/ja071535w; Loste E, 2003, LANGMUIR, V19, P2830, DOI 10.1021/la026837k; Lowenstam HA, 1989, BIOMINERALIZATION; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; Michel FM, 2008, CHEM MATER, V20, P4720, DOI 10.1021/cm800324v; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Pichon BP, 2008, J AM CHEM SOC, V130, P4034, DOI 10.1021/ja710416h; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Quigley D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940322; RAJAM S, 1991, J CHEM SOC FARADAY T, V87, P727, DOI 10.1039/ft9918700727; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652; VOLMER M, 1939, KINETIK PHASENDBILDU; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	29	690	703	22	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1455	1458		10.1126/science.1169434	http://dx.doi.org/10.1126/science.1169434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286549				2022-12-28	WOS:000264101700034
J	Asimaki, A; Tandri, H; Huang, HD; Halushka, MK; Gautam, S; Basso, C; Thiene, G; Tsatsopoulou, A; Protonotarios, N; McKenna, WJ; Calkins, H; Saffitz, JE				Asimaki, Angeliki; Tandri, Harikrishna; Huang, Hayden; Halushka, Marc K.; Gautam, Shiva; Basso, Cristina; Thiene, Gaetano; Tsatsopoulou, Adalena; Protonotarios, Nikos; McKenna, William J.; Calkins, Hugh; Saffitz, Jeffrey E.			A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TASK-FORCE CRITERIA; INTERCALATED DISC; GAP-JUNCTIONS; DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; MULTIDISCIPLINARY; ARVD/C; HEART	Background: The diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) can be challenging because the clinical presentation is highly variable and genetic penetrance is often low. Methods: To determine whether a change in the distribution of desmosomal proteins can be used as a sensitive and specific diagnostic test for ARVC, we performed immunohistochemical analysis of human myocardial samples. Results: We first tested myocardium from 11 subjects with ARVC; of these samples, 8 had desmosomal gene mutations. We also tested myocardium obtained at autopsy from 10 subjects with no clinical or pathological evidence of heart disease as control samples. All ARVC samples but no control samples showed a marked reduction in immunoreactive signal levels for plakoglobin (also known as (gamma)-catenin), a protein that links adhesion molecules at the intercalated disk to the cytoskeleton. Other desmosomal proteins showed variable changes, but signal levels for the nondesmosomal adhesion molecule N-cadherin were normal in all subjects with ARVC. To determine whether a diminished plakoglobin signal level was specific for ARVC, we analyzed myocardium from 15 subjects with hypertrophic, dilated, or ischemic cardiomyopathies. In every sample, levels of N-cadherin and plakoglobin signals at junctions were indistinguishable from those in control samples. Finally, we performed blinded immunohistochemical analysis of heart-biopsy samples from the Johns Hopkins ARVC registry. We made the correct diagnosis in 10 of 11 subjects with definite ARVC on the basis of clinical criteria and correctly ruled out ARVC in 10 of 11 subjects without ARVC, for a sensitivity of 91%, a specificity of 82%, a positive predictive value of 83%, and a negative predictive value of 90%. The plakoglobin signal level was reduced diffusely in ARVC samples, including those obtained in the left ventricle and the interventricular septum. Conclusions: Routine immunohistochemical analysis of a conventional endomyocardial-biopsy sample appears to be a highly sensitive and specific diagnostic test for ARVC. N Engl J Med 2009;360:1075-84.	[Asimaki, Angeliki; Saffitz, Jeffrey E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Gautam, Shiva] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Huang, Hayden] Harvard Univ, Sch Med, Boston, MA USA; [Asimaki, Angeliki; McKenna, William J.] Univ Coll London Hosp, Natl Hlth Serv Trust, Heart Hosp, London, England; [Tandri, Harikrishna; Calkins, Hugh] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Halushka, Marc K.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Huang, Hayden] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Basso, Cristina; Thiene, Gaetano] Univ Padua, Sch Med, Cardiovasc Pathol Unit, Padua, Italy; [Tsatsopoulou, Adalena; Protonotarios, Nikos] Yiannis Protonotarios Med Ctr, Naxos, Greece	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; University of Padua	Saffitz, JE (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	jsaffitz@bidmc.harvard.edu	McKenna, William J/C-3243-2008; ASIMAKI, ANGELIKI/J-7140-2016	McKenna, William J/0000-0001-7994-2460; basso, cristina/0000-0002-0195-9753; Halushka, Marc/0000-0002-7112-7389; ASIMAKI, ANGELIKI/0000-0001-9886-6870	March of Dimes; British Heart Foundation and the Heart Rhythm Society; National Institutes of Health [K23HL093350]; Lerner Fund; Bogle Foundation; St. Jude Medical Foundation,; Healing Hearts Foundation; Campanella family; Wilmerding Endowments; Cassa di Risparmio de Padova e Rovigo (CARIPARO) Foundation; British Heart Foundation and United Kingdom National Institute for Health Research Biomedical Research Centres; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093350] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); British Heart Foundation and the Heart Rhythm Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner Fund(March of Dimes); Bogle Foundation; St. Jude Medical Foundation,(St. Jude Medical); Healing Hearts Foundation; Campanella family; Wilmerding Endowments; Cassa di Risparmio de Padova e Rovigo (CARIPARO) Foundation(Fondazione Cariparo); British Heart Foundation and United Kingdom National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the March of Dimes ( to Dr. Saffitz); from the British Heart Foundation and the Heart Rhythm Society ( to Dr. Asimaki); from the National Institutes of Health ( K23HL093350, to Dr. Tandri); from the Lerner Fund ( to Dr. Huang); from the Bogle Foundation, St. Jude Medical Foundation, the Healing Hearts Foundation, the Campanella family, and the Wilmerding Endowments ( to Drs. Halushka and Calkins); from the Cassa di Risparmio de Padova e Rovigo (CARIPARO) Foundation ( to Drs. Basso and Thiene); and from the British Heart Foundation and United Kingdom National Institute for Health Research Biomedical Research Centres ( to Dr. McKenna).	Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Dalal D, 2005, CIRCULATION, V112, P3823, DOI 10.1161/CIRCULATIONAHA.105.542266; Dewillde W, 2008, ACTA CARDIOL, V63, P181, DOI 10.2143/AC.63.2.2029526; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maksimovic R, 2006, EUR RADIOL, V16, P560, DOI 10.1007/s00330-005-0018-z; Marcus F, 2003, CIRCULATION, V107, P2975, DOI 10.1161/01.CIR.0000071380.43086.29; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nasir, 2004, CIRCULATION, V110, P3384, DOI 10.1161/01.CIR.0000150165.62432.3D; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Oxford EM, 2007, HEART RHYTHM, V4, P1196, DOI 10.1016/j.hrthm.2007.05.025; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; Peters S, 2007, J ELECTROCARDIOL, V40, P34, DOI 10.1016/j.jelectrocard.2006.10.002; Sen-Chowdhry S, 2007, J AM COLL CARDIOL, V50, P1813, DOI 10.1016/j.jacc.2007.08.008; Tandri H, 2003, J CARDIOVASC ELECTR, V14, P476, DOI 10.1046/j.1540-8167.2003.02560.x; Tandri H, 2008, J CARDIOVASC ELECTR, V19, P1212, DOI 10.1111/j.1540-8167.2008.01207.x; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Yoerger DM, 2005, J AM COLL CARDIOL, V45, P860, DOI 10.1016/j.jacc.2004.10.070	23	312	323	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1075	1084		10.1056/NEJMoa0808138	http://dx.doi.org/10.1056/NEJMoa0808138			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279339	Bronze			2022-12-28	WOS:000264051000005
J	Matsuoka, T; Shimizu, K				Matsuoka, Takahiro; Shimizu, Katsuya			Direct observation of a pressure-induced metal-to-semiconductor transition in lithium	NATURE			English	Article							ALKALI-METALS; DENSE LITHIUM; GPA; PHASE; SUPERCONDUCTIVITY; TEMPERATURE; RESISTANCE	Lithium, the lightest metal, has long been considered to have a 'simple' electronic structure that can be well explained within the nearly-free-electron model. But lithium does not stay 'simple' under compression: rather than becoming more free-electron-like as pressure is increased, first-principles calculations(1,2) suggest that it transforms into a semi-metal or semiconductor. Experimentally, it has been shown that dense lithium adopts low-symmetry structures(3,4); there is also evidence that its resistivity increases with pressure(5-8). However, the electronic transport properties of lithium have so far not been directly monitored as a function of increasing static pressure. Here we report electrical resistance measurements on lithium in a diamond anvil cell up to pressures of 105 GPa, which reveal a significant increase in electrical resistivity and a change in its temperature dependence near 80 GPa. Our data thus provide unambiguous experimental evidence for a pressure-induced metal-to-semiconductor transition in a 'simple' metallic element.	[Matsuoka, Takahiro; Shimizu, Katsuya] Osaka Univ, Ctr Quantum Sci & Technol Extreme Condit, KYOKUGEN, Osaka 5608531, Japan	Osaka University	Matsuoka, T (corresponding author), Osaka Univ, Ctr Quantum Sci & Technol Extreme Condit, KYOKUGEN, 1-3 Machikaneyama, Osaka 5608531, Japan.	matsuoka@djebel.mp.es.osaka-u.ac.jp	Matsuoka, Takahiro/W-3155-2019	Matsuoka, Takahiro/0000-0002-1279-6734; Shimizu, Katsuya/0000-0003-0560-8325	Grant-in-Aid for Scientific Research [19104009]; Global COE Program Core Research and Engineering of Advanced Materials-Interdisciplinary Education Center for Materials Science), MEXT, Japan; Grant-in-Aid for JSPS Fellows [19.52753]	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program Core Research and Engineering of Advanced Materials-Interdisciplinary Education Center for Materials Science), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. W. Ashcroft and J. S. Schilling for discussions. This work was supported in part by a Grant-in-Aid for Scientific Research ( S), 19104009 and Global COE Program (Core Research and Engineering of Advanced Materials-Interdisciplinary Education Center for Materials Science), MEXT, Japan, and a Grant-in-Aid for JSPS Fellows (19.52753). We acknowledge J. Tse, Y. Yao and D. Klug for discussions and suggestions.	Akahama Y, 2004, J APPL PHYS, V96, P3748, DOI 10.1063/1.1778482; Bastea M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.193104; Christensen NE, 2001, SOLID STATE COMMUN, V119, P477, DOI 10.1016/S0038-1098(01)00277-0; Cottrell A. H., 1997, INTRO METALLURGY; Deemyad S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167001; Fortov VE, 1999, JETP LETT+, V70, P628, DOI 10.1134/1.568226; GONCHAROV AF, 2005, PHYS REV B, V74; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Hanfland M, 1999, SOLID STATE COMMUN, V112, P123, DOI 10.1016/S0038-1098(99)00322-1; LIN TH, 1986, PHYS REV B, V33, P807, DOI 10.1103/PhysRevB.33.807; Ma YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014102; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Matsuoka T, 2008, J PHYS CONF SER, V121, DOI 10.1088/1742-6596/121/5/052003; MORI Y, 2000, SCI TECHNOLOGY HIGH, P421; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; OVERHAUSER AW, 1984, PHYS REV LETT, V53, P64, DOI 10.1103/PhysRevLett.53.64; Rousseau R, 2005, CHEMPHYSCHEM, V6, P1703, DOI 10.1002/cphc.200500117; Shimizu K, 2002, NATURE, V419, P597, DOI 10.1038/nature01098; SMITH HG, 1990, PHYS REV B, V41, P1231, DOI 10.1103/PhysRevB.41.1231; STAGER RA, 1963, PHYS REV, V132, P124, DOI 10.1103/PhysRev.132.124; Struzhkin VV, 2002, SCIENCE, V298, P1213, DOI 10.1126/science.1078535; VAKS VG, 1989, J PHYS-CONDENS MAT, V1, P5319, DOI 10.1088/0953-8984/1/32/001	22	196	201	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					186	189		10.1038/nature07827	http://dx.doi.org/10.1038/nature07827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279633				2022-12-28	WOS:000264059700039
J	Boase, T				Boase, Tessa			Commentary: The lay view	BRITISH MEDICAL JOURNAL			English	Editorial Material												tessa.boase@tiscali.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 10	2009	338								b776	10.1136/bmj.b776	http://dx.doi.org/10.1136/bmj.b776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278976				2022-12-28	WOS:000264205300007
J	Harmon, JP; Moran, NA; Ives, AR				Harmon, Jason P.; Moran, Nancy A.; Ives, Anthony R.			Species Response to Environmental Change: Impacts of Food Web Interactions and Evolution	SCIENCE			English	Article							CLIMATE-CHANGE; GENETIC RESPONSES; PLANT; BIODIVERSITY; POPULATIONS; SYMBIONTS; STRESS; APHIDS; COSTS	How environmental change affects species abundances depends on both the food web within which species interact and their potential to evolve. Using field experiments, we investigated both ecological and evolutionary responses of pea aphids (Acyrthosiphon pisum), a common agricultural pest, to increased frequency of episodic heat shocks. One predator species ameliorated the decrease in aphid population growth with increasing heat shocks, whereas a second predator did not, with this contrast caused by behavioral differences between predators. We also compared aphid strains with stably inherited differences in heat tolerance caused by bacterial endosymbionts and showed the potential for rapid evolution for heat-shock tolerance. Our results illustrate how ecological and evolutionary complexities should be incorporated into predictions of the consequences of environmental change for species' populations.	[Harmon, Jason P.; Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Wisconsin System; University of Wisconsin Madison; University of Arizona	Harmon, JP (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jharmon@wisc.edu	Harmon, Jason/AAW-3036-2021; Moran, Nancy A/G-1591-2010; Ives, Anthony/A-5698-2008	Harmon, Jason/0000-0002-2533-5005; Ives, Anthony/0000-0001-9375-9523	US-NSF;  [0313737]	US-NSF(National Science Foundation (NSF)); 	We thank G. Burke for screening aphids for symbionts; M. Meisner, D. Rowlands, and K. Smith for assistance with experiments; D. Frye and the staff of the University of Wisconsin Arlington Research Station for establishment and maintenance of alfalfa fields; and K. C. Abbott, S. R. Carpenter, M. A. Duffy, R. T. Gilman, C. Gratton, and W. E Snyder for insights and help with the manuscript. Supported by US-NSF grants 0313737 to N.A.M. and A.R.I.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; DAVIS JJ, 1915, USDA B, V276, P5; de Mazancourt C, 2008, ECOL LETT, V11, P380, DOI 10.1111/j.1461-0248.2008.01152.x; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Millenium Ecosystem Assessment, 2005, EC HUM WELLB GEN SYN; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x	27	167	178	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1347	1350		10.1126/science.1167396	http://dx.doi.org/10.1126/science.1167396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265021				2022-12-28	WOS:000263876700043
J	Spertus, JA; Jones, PG; Masoudi, FA; Rumsfeld, JS; Krumholz, HM				Spertus, John A.; Jones, Philip G.; Masoudi, Frederick A.; Rumsfeld, John S.; Krumholz, Harlan M.			Factors Associated With Racial Differences in Myocardial Infarction Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; CORONARY REVASCULARIZATION; CLINICAL-TRIALS; END-POINTS; RACE; HEART; CARE; DISPARITIES; MORTALITY	Background: Little information is available about factors associated with racial differences across a broad spectrum of post-myocardial infarction outcomes, including patients' symptoms and quality of life. Objective: To determine racial differences in mortality, rehospitalization, angina, and quality of life after myocardial infarction and identify the factors associated with these differences. Design: Prospective cohort study. Setting: 10 hospitals in the United States. Patients: 1849 patients who had myocardial infarction, 28% of whom were black. Measurements: Demographic, economic, clinical, psychosocial, and treatment characteristics and outcomes were prospectively collected. Outcomes included time to 2-year all-cause mortality, 1-year rehospitalization, and Seattle Angina Questionnaire-assessed angina and quality of life. Results: Black patients had higher unadjusted mortality (19.9% vs. 9.3%; P < 0.001) and rehospitalization rates (45.4% vs. 40.4%; P = 0.130), more angina (28.0% vs. 17.8%; P < 0.001), and worse mean quality of life (80.6 [SD, 22.5] vs. 85.9 [SD, 17.2]; P < 0.001). After adjustment for patient characteristics, black patients trended toward greater mortality (hazard ratio, 1.29 [95% CI, 0.92 to 1.81]; P = 0.142), fewer rehospitalizations (hazard ratio, 0.82 [CI, 0.66 to 1.02]; P = 0.071), and higher likelihood of angina at 1 year (odds ratio, 1.41 [CI, 1.03 to 1.94]; P = 0.032) but similar quality of life (mean difference, -0.6 [CI, -3.4 to 2.2]). Adjustment for site of care further attenuated mortality differences (hazard ratio, 1.04 [CI, 0.71 to 1.52]; P = 0.84). Adjustment for treatments had minimal effect on any association. Limitation: Residual confounding and missing data may have introduced bias. Conclusion: Although black patients with myocardial infarction have worse outcomes than white patients, these differences did not persist after adjustment for patient factors and site of care. Further adjustment for treatments received minimally influenced observed differences. Strategies that focus on improving baseline cardiac risk and hospital factors may do more than treatment-focused strategies to attenuate racial differences in myocardial infarction outcomes.	[Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Univ Missouri, Kansas City, MO 64110 USA; Univ Colorado, Denver Hlth Med Ctr, Hlth Sci Ctr, Denver, CO 80202 USA; Denver Vet Affairs Med Ctr, Denver, CO USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Yale Univ, Sch Med, New Haven, CT USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Yale University; Yale University	Spertus, JA (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd,5th Floor, Kansas City, MO 64111 USA.	Spertusj@umkc.edu	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019		The National Heart, Lung, and Blood Institute; Cardiac Dysfunction and Disease; CV Therapeutics; Cardiovascular Outcomes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER	The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cardiac Dysfunction and Disease; CV Therapeutics; Cardiovascular Outcomes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: The National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease, CV Therapeutics, and Cardiovascular Outcomes.	Anand IS, 2002, J AM COLL CARDIOL, V39, P1414, DOI 10.1016/S0735-1097(02)01773-4; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P3078, DOI 10.1002/sim.2781; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Barnhart JM, 2003, ARCH INTERN MED, V163, P461, DOI 10.1001/archinte.163.4.461; Berkman LF, 2000, AM HEART J, V139, P1; Bernheim SM, 2007, AM HEART J, V153, P313, DOI 10.1016/j.ahj.2006.10.037; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Centers for Medicare and Medicaid Services, 2006, OV SPEC MEAS DISPL H; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; *I MED, 2003, UN TREATM CONFR RAC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Iribarren C, 2005, ARCH INTERN MED, V165, P2105, DOI 10.1001/archinte.165.18.2105; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Jones CP, 2001, AM J EPIDEMIOL, V154, P299, DOI 10.1093/aje/154.4.299; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Krumholz HM, 2005, CIRCULATION, V111, P3158, DOI 10.1161/CIRCULATIONAHA.105.536102; LaVeist TA, 2003, J AM COLL CARDIOL, V41, P1159, DOI 10.1016/S0735-1097(03)00042-1; Lewis EF, 2001, J HEART LUNG TRANSPL, V20, P1016, DOI 10.1016/S1053-2498(01)00298-4; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Mehta RH, 2006, AM J MED, V119, p70e1; Mukamel DB, 2006, HEALTH SERV RES, V41, P1276, DOI 10.1111/j.1475-6773.2006.00535.x; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Petersen LA, 2002, MED CARE, V40, P86; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Popescu I, 2006, JAMA-J AM MED ASSOC, V295, P2141, DOI 10.1001/jama.295.18.2141; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; ROSENBAUM PR, 1991, J ROY STAT SOC B MET, V53, P597; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sabatine MS, 2005, CIRCULATION, V111, P1217, DOI 10.1161/01.CIR.0000157733.50479.B9; Scheier MF, 1999, ARCH INTERN MED, V159, P829, DOI 10.1001/archinte.159.8.829; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Spertus J, 2005, J AM COLL CARDIOL, V46, P1838, DOI 10.1016/j.jacc.2005.05.092; Spertus J, 2005, CIRCULATION, V111, P2572, DOI 10.1161/CIRCULATIONAHA.104.474775; Spertus J, 2001, AM HEART J, V142, P745, DOI 10.1067/mhj.2001.119135; Spertus JA, 2006, AM HEART J, V151, P589, DOI 10.1016/j.ahj.2005.05.026; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Spertus JA, 2002, AM HEART J, V143, P636, DOI 10.1067/mhj.2002.120775; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; The Henry J. Kaiser Family Foundation, 2002, RAC ETHN DIFF CARD C; Tsevat J, 1998, JAMA-J AM MED ASSOC, V279, P371, DOI 10.1001/jama.279.5.371; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006	55	49	49	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					314	+		10.7326/0003-4819-150-5-200903030-00007	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19258559	Green Accepted			2022-12-28	WOS:000264051700003
J	Kwiatkowski, TJ; Bosco, DA; LeClerc, AL; Tamrazian, E; Vanderburg, CR; Russ, C; Davis, A; Gilchrist, J; Kasarskis, EJ; Munsat, T; Valdmanis, P; Rouleau, GA; Hosler, BA; Cortelli, P; de Jong, PJ; Yoshinaga, Y; Haines, JL; Pericak-Vance, MA; Yan, J; Ticozzi, N; Siddique, T; McKenna-Yasek, D; Sapp, PC; Horvitz, HR; Landers, JE; Brown, RH				Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Vanderburg, C. R.; Russ, C.; Davis, A.; Gilchrist, J.; Kasarskis, E. J.; Munsat, T.; Valdmanis, P.; Rouleau, G. A.; Hosler, B. A.; Cortelli, P.; de Jong, P. J.; Yoshinaga, Y.; Haines, J. L.; Pericak-Vance, M. A.; Yan, J.; Ticozzi, N.; Siddique, T.; McKenna-Yasek, D.; Sapp, P. C.; Horvitz, H. R.; Landers, J. E.; Brown, R. H., Jr.			Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis	SCIENCE			English	Article							RNA-BINDING PROTEIN; PRO-ONCOPROTEIN TLS/FUS; TARDBP MUTATIONS; TLS; IDENTIFICATION; TRANSCRIPTION; LIPOSARCOMA; ACTIVATION; NUCLEAR; DISEASE	Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 (TDP43), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.	[Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Russ, C.; Davis, A.; Hosler, B. A.; Yan, J.; Ticozzi, N.; McKenna-Yasek, D.; Sapp, P. C.; Landers, J. E.; Brown, R. H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Bosco, D. A.; LeClerc, A. L.; Landers, J. E.; Brown, R. H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Vanderburg, C. R.] Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat, Charlestown, MA 02129 USA; [Russ, C.] MIT, Broad Inst, Cambridge, MA 02141 USA; [Gilchrist, J.] Rhode Isl Hosp, Dept Neurol, Providence, RI 02912 USA; [Kasarskis, E. J.] Univ Kentucky, Vet Affairs Med Ctr, Dept Neurol, Lexington, KY 40511 USA; [Munsat, T.] Tufts Univ, Tufts New England Med Ctr, Dept Neurol, Boston, MA 02111 USA; [Valdmanis, P.; Rouleau, G. A.] Univ Montreal, Ctr Hosp, Ctr Rech, Dept Neurol, Montreal, PQ H2L 4M1, Canada; [Cortelli, P.] Univ Bologna, Dipartimento Sci Neurol, Neurol Clin, I-40123 Bologna, Italy; [de Jong, P. J.; Yoshinaga, Y.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Haines, J. L.] Vanderbilt Univ, Ctr Human Genet Res Mol Physiol & Biophys, Nashville, TN 37240 USA; [Pericak-Vance, M. A.] Miami Inst Human Genet, Miami, FL 33136 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Mol & Cell Biol, Chicago, IL 60611 USA; [Ticozzi, N.] Univ Milan, Sch Med, Dept Neurol, Dino Ferrari Ctr,Ist Auxol Italiano, I-20149 Milan, Italy; [Sapp, P. C.; Horvitz, H. R.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lifespan Health Rhode Island; Rhode Island Hospital; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; Tufts Medical Center; Tufts University; Universite de Montreal; University of Bologna; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; IRCCS Istituto Auxologico Italiano; University of Milan; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kwiatkowski, TJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 114 16th St, Charlestown, MA 02129 USA.	tkwiatkowski@partners.org; robert.brown@umassmed.edu	Ticozzi, Nicola/K-8094-2016; Siddique, Teepu/AAT-8166-2021; Cortelli, Pietro/K-6063-2016; Haines, Jonathan/C-3374-2012; Vanderburg, Charles/C-4516-2013	Ticozzi, Nicola/0000-0001-5963-7426; Haines, Jonathan/0000-0002-4351-4728; Valdmanis, Paul/0000-0001-8840-6969; Landers, John/0000-0001-8084-5043; Siddique, Teepu/0000-0001-7293-9146; Vanderburg, Charles/0000-0001-8979-5054; Cortelli, Pietro/0000-0002-3633-8818; Tamrazian, Eric/0000-0003-1935-5277	NIH [NS050557, NS050641]; Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We gratefully acknowledge I. Carr (University of Leeds, UK) for support with AutoSNPa and IBDfinder software, A. Storey for assistance with sequencing, C. LeClerc for genealogical investigations, and D. Crowe for administrative assistance. This work was supported by NIH grants NS050557 (R.H.B. and T.K.) and NS050641 (T.S., R.H.B., J.L. H., and M.P.-V.). R.H.B. also receives support from the Angel Fund, the ALS Therapy Alliance, the ALS Association Project ALS, the Al-Athel ALS Research Foundation, and the Pierre L. de Bourgknecht ALS Research Foundation. T.S. also receives support from The Les Turner ALS Foundation, Vena E. Schaff ALS Research Fund, Harold Post Research Professorship, Herbert and Florence C. Wenske Foundation, Ralph and Marian Falk Medical Research Trust, The David C. Asselin M.D. Memorial Fund, Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship, Help America Foundation and the ALS Therapy Alliance, Inc. H.R.H. is an investigator of and was supported by the Howard Hughes Medical Institute. R.H.B. is a cofounder of AviTx Inc., which targets development of ALS therapies. R.H.B. and T.J.K. have applied for a patent covering FUS mutations in ALS. We dedicate this report to the memories of Jimmy and Christopher Kennedy, Sharon Timlin, and Ginny Delvecchio.	Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	22	1853	1915	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1205	1208		10.1126/science.1166066	http://dx.doi.org/10.1126/science.1166066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251627				2022-12-28	WOS:000263687600036
J	Catalano, R				Catalano, Ralph			Health, Medical Care, and Economic Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNEMPLOYMENT		[Catalano, Ralph] Univ Calif Berkeley, Robert Wood Johnson Hlth & Soc Program, Berkeley, CA 94720 USA	Robert Wood Johnson Foundation (RWJF); University of California System; University of California Berkeley	Catalano, R (corresponding author), Univ Calif Berkeley, Robert Wood Johnson Hlth & Soc Program, Berkeley, CA 94720 USA.							Bruckner TA, 2008, ANN EPIDEMIOL, V18, P678, DOI 10.1016/j.annepidem.2008.07.001; Catalano RA, 2003, ANN EPIDEMIOL, V13, P8, DOI 10.1016/S1047-2797(02)00273-9; Catalano R, 2007, AGGRESSIVE BEHAV, V33, P272, DOI 10.1002/ab.20188; Dooley D, 1996, ANNU REV PUBL HEALTH, V17, P449, DOI 10.1146/annurev.pu.17.050196.002313; Murphy GC, 1999, J OCCUP ORGAN PSYCH, V72, P83, DOI 10.1348/096317999166518	5	85	90	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					749	751		10.1056/NEJMp0809122	http://dx.doi.org/10.1056/NEJMp0809122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228617				2022-12-28	WOS:000263411300003
J	Harnden, A; Lehman, R				Harnden, Anthony; Lehman, Richard			Easily Missed? New primary care series: Easily Missed?	BRITISH MEDICAL JOURNAL			English	Editorial Material							JOURNEY CELIAC-DISEASE		[Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk						Fry J., 1993, COMMON DIS THEIR NAT; GODLEE F, 2009, BRIT MED J, V338, pB821; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380; THOMAS KB, 1978, BRIT MED J, V1, P1327, DOI 10.1136/bmj.1.6123.1327; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	7	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b491	10.1136/bmj.b491	http://dx.doi.org/10.1136/bmj.b491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228766				2022-12-28	WOS:000264052200007
J	Myint, PK; Luben, RN; Wareham, NJ; Bingham, SA; Khaw, KT				Myint, Phyo K.; Luben, Robert N.; Wareham, Nicholas J.; Bingham, Sheila A.; Khaw, Kay-Tee			Combined effect of health behaviours and risk of first ever stroke in 20 040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; VITAMIN-C; MORTALITY; REPEATABILITY; VALIDITY; MARKERS	Objective To quantify the potential combined impact of four health behaviours on incidence of stroke in men and women living in the general community. Design Population based prospective study (EPIC-Norfolk). Setting Norfolk, United Kingdom. Participants 20 040 men and women aged 40-79 with no known stroke or myocardial infarction at baseline survey in 1993-7, living in the general community, and followed up to 2007. Main outcome measure Participants scored one point for each health behaviour: current non-smoking, physically not inactive, moderate alcohol intake (1-14 units a week), and plasma concentration of vitamin C >= 50 mu mol/l, indicating fruit and vegetable intake of at least five servings a day, for a total score ranging from 0 to 4. Results There were 599 incident strokes over 229 993 person years of follow-up; the average follow-up was 11. 5 years. After adjustment for age, sex, body mass index (BMI), systolic blood pressure, cholesterol concentration, history of diabetes and aspirin use, and social class, compared with people with the four health behaviours the relative risks for stroke for men and women were 1.15 (95% confidence interval 0.89 to 1.49) for three health behaviours, 1.58 (1.22 to 2.05) for two, 2.18 (1.63 to 2.92) for one, and 2.31 (1.33 to 4.02) for none (P<0.001 for trend). The relations were consistent in subgroups stratified by sex, age, body mass index, and social class, and after exclusion of deaths within two years. Conclusion Four health behaviours combined predict more than a twofold difference in incidence of stroke in men and women.	[Myint, Phyo K.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo K.; Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Wareham, Nicholas J.] MRC, Epidemiol Unit, Cambridge, England; [Bingham, Sheila A.] MRC, Ctr Nutr Epidemiol Canc Prevent & Survival, Cambridge, England	University of East Anglia; University of Cambridge	Myint, PK (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	phyo.k.myint@uea.ac.uk	Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021	Luben, Robert N/0000-0002-5088-6343; 	Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Research Into Ageing; Academy of Medical Sciences; Wellcome Trust; MRC [MC_U105630924] Funding Source: UKRI; Medical Research Council [MC_U105630924, G0401527, MC_U106179471] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Research Into Ageing; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EPIC-Norfolk is supported by research programme grant funding from Cancer Research UK and the Medical Research Council with additional support from the Stroke Association, British Heart Foundation, Research Into Ageing, Academy of Medical Sciences, and Wellcome Trust.	Andersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980; BAIN C, 1978, LANCET, V1, P1087; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Day N, 1999, BRIT J CANCER, V80, P95; *DEP HLTH, 2005, NAT AUD OFF REP RED; Department of Health, 1999, SAV LIV OUR HLTH NAT; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kelly TN, 2008, STROKE, V39, P1688, DOI 10.1161/STROKEAHA.107.505305; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Liu S, 2000, AM J CLIN NUTR, V72, P922; Myint PK, 2008, AM J CLIN NUTR, V87, P64, DOI 10.1093/ajcn/87.1.64; Myint PK, 2006, NEUROEPIDEMIOLOGY, V27, P122, DOI 10.1159/000095551; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; PURDON S, 1997, HLTH SURVEY ENGLAND, P123; RIEMERSMA RA, 1990, EUR J CLIN NUTR, V44, P143; Sauvaget C, 2003, STROKE, V34, P2355, DOI 10.1161/01.STR.0000089293.29739.97; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Wagner A, 2002, CIRCULATION, V105, P2247, DOI 10.1161/01.CIR.0000016345.58696.4F; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168	25	108	110	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b349	10.1136/bmj.b349	http://dx.doi.org/10.1136/bmj.b349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228771	hybrid, Green Published			2022-12-28	WOS:000264052200001
J	Solberg, KE				Solberg, Kristin Elisabeth			Iranian doctors' conviction could damage public health	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					533	533		10.1016/S0140-6736(09)60184-7	http://dx.doi.org/10.1016/S0140-6736(09)60184-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230077	Green Published, Bronze			2022-12-28	WOS:000263333600014
J	Goodman, AD; Brown, TR; Krupp, LB; Schapiro, RT; Schwid, SR; Cohen, R; Marinucci, LN; Blight, AR				Goodman, Andrew D.; Brown, Theodore R.; Krupp, Lauren B.; Schapiro, Randall T.; Schwid, Steven R.; Cohen, Ron; Marinucci, Lawrence N.; Blight, Andrew R.		Fampridine MS F203 Investigators	Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial	LANCET			English	Article							DISABILITY STATUS SCALE; TIMED 25-FOOT WALK; SPINAL-CORD-INJURY; FUNCTIONAL COMPOSITE; SYMPTOMATIC TREATMENT; OUTCOME MEASURE; 4-AMINOPYRIDINE; MS; EDSS; PHARMACOKINETICS	Background Clinical studies suggested that fampridine (4-aminopyridine) improves motor function in people with multiple sclerosis. This phase III study assessed efficacy and safety of oral, sustained-release fampridine in people with ambulatory deficits due to multiple sclerosis. Methods We undertook a randomised, multicentre, double-blind, controlled phase III trial. We randomly assigned 301 patients with any type of multiple sclerosis to 14 weeks of treatment with either fampridine (10 mg twice daily; n=229) or placebo (n=72), using a computer-generated sequence stratified by centre. We used consistent improvement on timed 25-foot walk to define response, with proportion of timed walk responders in each treatment group as the primary outcome. We used the 12-item multiple sclerosis walking scale to validate the clinical significance of the response criterion. Efficacy analyses were based on a modified intention-to-treat population (n=296), which included all patients with any post-treatment efficacy data. The study is registered with ClinicalTrials.gov, number NCT00127530. Findings The proportion of timed walk responders was higher in the fampridine group (78/224 or 35%) than in the placebo group (6/72 or 8%; p<0.0001). Improvement in walking speed in fampridine-treated timed walk responders, which was maintained throughout the treatment period, was 25.2% (95% CI 21.5% to 28.8%) and 4.7% (1.0% to 8.4%) in the placebo group. Timed walk responders showed greater improvement in 12-item multiple sclerosis walking scale scores (-6.84, 95% CI-9.65 to -4.02) than timed walk non-responders (0.05, -1.48 to 1.57; p=0.0002). Safety data were consistent with previous studies. Interpretation Fampridine improved walking ability in some people with multiple sclerosis. This improvement was associated with a reduction of patients' reported ambulatory disability and is a clinically meaningful therapeutic benefit.	[Goodman, Andrew D.] Univ Rochester, Med Ctr, Neuroimmunol Unit, Multiple Sclerosis Ctr, Rochester, NY 14642 USA; [Brown, Theodore R.] Evergreen Hosp, Med Ctr, Kirkland, WA USA; [Krupp, Lauren B.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Schapiro, Randall T.] Minneapolis Clin Neurol, Minneapolis, MN USA; [Cohen, Ron; Marinucci, Lawrence N.; Blight, Andrew R.] Acorda Therapeut Inc, Hawthorne, NY USA	University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goodman, AD (corresponding author), Univ Rochester, Med Ctr, Neuroimmunol Unit, Multiple Sclerosis Ctr, 601 Elmwood Ave,Room 6-8521,Box 605, Rochester, NY 14642 USA.	andrew_goodman@urmc.rochester.edu	Macedo, Ana/L-9912-2018; Lublin, Fred/L-8405-2017	Macedo, Ana/0000-0002-6978-8989; Lindsey, John/0000-0001-6856-0811; GOODMAN, ANDREW/0000-0001-7642-4502; krupp, lauren/0000-0001-7003-807X	Acorda Therapeutics Inc	Acorda Therapeutics Inc	Acorda Therapeutics Inc.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BEVER CT, 1994, NEUROLOGY, V44, P1054, DOI 10.1212/WNL.44.6.1054; Cohen JA, 2000, NEUROLOGY, V54, P802, DOI 10.1212/WNL.54.4.802; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; COHEN RA, 1993, J NEUROL SCI, V115, P132, DOI 10.1016/0022-510X(93)90215-K; Creange A, 2007, MULT SCLER, V13, P220, DOI 10.1177/1352458506070667; Dobkin BH, 2006, NEUROLOGY, V66, P584, DOI 10.1212/01.wnl.0000198502.88147.dd; Fahey MC, 2007, NEUROLOGY, V68, P705, DOI 10.1212/01.wnl.0000256037.63832.6f; Fischer J.S., 2001, MULTIPLE SCLEROSIS F; Goodman AD, 2008, NEUROLOGY, V71, P1134, DOI 10.1212/01.wnl.0000326213.89576.0e; Goodman AD, 2007, MULT SCLER, V13, P357, DOI 10.1177/1352458506069538; Hayes KC, 2004, ARCH PHYS MED REHAB, V85, P29, DOI 10.1016/S0003-9993(03)00651-8; Hayes KC, 2003, J CLIN PHARMACOL, V43, P379, DOI 10.1177/0091270003251388; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411; Koch M, 2008, EPILEPSIA, V49, P948, DOI 10.1111/j.1528-1167.2008.01565.x; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lechat P., 1982, AMINOPYRIDINES SIMIL; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; *MRC, 1976, AIDS INV PER NERV IN; Ozakbas S, 2004, J NEUROL SCI, V218, P3, DOI 10.1016/j.jns.2003.09.015; Schwid SR, 1997, NEUROLOGY, V48, P817, DOI 10.1212/WNL.48.4.817; Schwid SR, 1997, NEUROLOGY, V49, P1419, DOI 10.1212/WNL.49.5.1419; Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294; SOLARI A, 2002, COCHRANE DB SYST REV, V2; STEFOSKI D, 1991, NEUROLOGY, V41, P1344, DOI 10.1212/WNL.41.9.1344; VANDIEMEN HAM, 1992, ANN NEUROL, V32, P123, DOI 10.1002/ana.410320203	30	372	384	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					732	738		10.1016/S0140-6736(09)60442-6	http://dx.doi.org/10.1016/S0140-6736(09)60442-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249634				2022-12-28	WOS:000263725400032
J	Thompson, A; Polman, C				Thompson, Alan; Polman, Chris			Improving function: a new treatment era for multiple sclerosis?	LANCET			English	Editorial Material							4-AMINOPYRIDINE; FAMPRIDINE; MS		[Thompson, Alan] UCL, Inst Neurol, London WC1N 3BG, England; [Polman, Chris] VU Med Ctr, Amsterdam, Netherlands	University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Thompson, A (corresponding author), UCL, Inst Neurol, London WC1N 3BG, England.	A.Thompson@ion.ucl.ac.uk	Thompson, Alan J/C-2654-2008	Thompson, Alan J/0000-0002-4333-8496				Burton JM, 2008, NEUROLOGY, V71, P1833, DOI 10.1212/01.wnl.0000339380.23073.58; Goodman AD, 2008, NEUROLOGY, V71, P1134, DOI 10.1212/01.wnl.0000326213.89576.0e; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Kryscio RJ, 2008, NEUROLOGY, V71, P1130, DOI 10.1212/01.wnl.0000326215.57202.2d; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P292, DOI 10.1001/archneur.1994.00540150090022; Solari A, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001330; *US FDA, 2006, GUID IND PAT REP OUT	8	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					697	698		10.1016/S0140-6736(09)60414-1	http://dx.doi.org/10.1016/S0140-6736(09)60414-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249614				2022-12-28	WOS:000263725400005
J	Gu, YY; Harley, ITW; Henderson, LB; Aronow, BJ; Vietor, I; Huber, LA; Harley, JB; Kilpatrick, JR; Langefeld, CD; Williams, AH; Jegga, AG; Chen, J; Wills-Karp, M; Arshad, SH; Ewart, SL; Thio, CL; Flick, LM; Filippi, MD; Grimes, HL; Drumm, ML; Cutting, GR; Knowles, MR; Karp, CL				Gu, YuanYuan; Harley, Isaac T. W.; Henderson, Lindsay B.; Aronow, Bruce J.; Vietor, Ilja; Huber, Lukas A.; Harley, John B.; Kilpatrick, Jeffrey R.; Langefeld, Carl D.; Williams, Adrienne H.; Jegga, Anil G.; Chen, Jing; Wills-Karp, Marsha; Arshad, S. Hasan; Ewart, Susan L.; Thio, Chloe L.; Flick, Leah M.; Filippi, Marie-Dominique; Grimes, H. Leighton; Drumm, Mitchell L.; Cutting, Garry R.; Knowles, Michael R.; Karp, Christopher L.			Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease	NATURE			English	Article							GENOME-WIDE ASSOCIATION; EPITHELIAL-CELLS; NADPH OXIDASE; DIFFERENTIATION; TIS7; MICE; REGENERATION; NEUTROPHILS; SEVERITY; DEFECTS	Lung disease is the major cause of morbidity and mortality in cystic fibrosis, an autosomal recessive disease caused by mutations in CFTR. In cystic fibrosis, chronic infection and dysregulated neutrophilic inflammation lead to progressive airway destruction. The severity of cystic fibrosis lung disease has considerable heritability, independent of CFTR genotype(1). To identify genetic modifiers, here we performed a genome-wide single nucleotide polymorphism scan in one cohort of cystic fibrosis patients, replicating top candidates in an independent cohort. This approach identified IFRD1 as a modifier of cystic fibrosis lung disease severity. IFRD1 is a histone-deacetylase-dependent transcriptional co-regulator expressed during terminal neutrophil differentiation. Neutrophils, but not macrophages, from Ifrd1-deficient mice showed blunted effector function, associated with decreased NF-kappa B p65 transactivation. In vivo, IFRD1 deficiency caused delayed bacterial clearance from the airway, but also less inflammation and disease-a phenotype primarily dependent on haematopoietic cell expression, or lack of expression, of IFRD1. In humans, IFRD1 polymorphisms were significantly associated with variation in neutrophil effector function. These data indicate that IFRD1 modulates the pathogenesis of cystic fibrosis lung disease through the regulation of neutrophil effector function.	[Gu, YuanYuan; Harley, Isaac T. W.; Flick, Leah M.; Karp, Christopher L.] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Aronow, Bruce J.; Jegga, Anil G.; Chen, Jing] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA; [Wills-Karp, Marsha; Grimes, H. Leighton] Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH 45229 USA; [Filippi, Marie-Dominique] Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Thio, Chloe L.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Henderson, Lindsay B.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Vietor, Ilja; Huber, Lukas A.] Innsbruck Med Univ, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Harley, John B.; Kilpatrick, Jeffrey R.] Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA; [Harley, John B.; Kilpatrick, Jeffrey R.] JK Autoimmun Inc, Oklahoma City, OK 73104 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Arshad, S. Hasan] David Hide Asthma & Allergy Res Ctr, Newport PO30 5TG, Isle of Wight, England; [Ewart, Susan L.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; Medical University of Innsbruck; Oklahoma Medical Research Foundation; Wake Forest University; Michigan State University; Case Western Reserve University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill	Karp, CL (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Chen, Jing/A-7928-2013; Aronow, Bruce J/F-8438-2012; Jegga, Anil/H-6140-2011; Huber, Lukas Alfons/AAM-3499-2021	Jegga, Anil/0000-0002-4881-7752; Karp, Christopher/0000-0002-0832-2659; Huber, Lukas Alfons/0000-0003-1116-2120; Grimes, H. Leighton/0000-0001-8162-6758; Harley, Isaac/0000-0003-1282-5395	NHLBI NIH HHS [R01 HL068890-01, R01 HL079312, R01 HL068927-01, R01 HL068927, R01 HL079312-01A1, R01 HL068890] Funding Source: Medline; NIAID NIH HHS [R01 AI024717, R37 AI024717] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927, R01HL079312, R01HL068890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024717, R37AI024717] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Atabani SF, 2001, J INFECT DIS, V184, P1, DOI 10.1086/321009; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Finkelman FD, 1999, INT IMMUNOL, V11, P1811, DOI 10.1093/intimm/11.11.1811; Gronert K, 1999, METH MOL B, V120, P119; Hillian AD, 2008, GENES IMMUN, V9, P501, DOI 10.1038/gene.2008.42; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kurukulaaratchy RJ, 2004, THORAX, V59, P563, DOI 10.1136/thx.2003.010462; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Muhlebach MS, 2002, AM J RESP CRIT CARE, V165, P911, DOI 10.1164/ajrccm.165.7.2107114; Mullins DN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-141; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461; Vietor I, 2007, DIFFERENTIATION, V75, P891, DOI 10.1111/j.1432-0436.2007.00205.x; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yang HC, 2005, GENETICS, V169, P399, DOI 10.1534/genetics.104.032052; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	34	99	103	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1039	U119		10.1038/nature07811	http://dx.doi.org/10.1038/nature07811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19242412	Green Accepted			2022-12-28	WOS:000265412900045
J	Toor, R				Toor, Rachel			Apostrophe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												racheltoor@earthlink.net							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1105	1106		10.1001/jama.2009.350	http://dx.doi.org/10.1001/jama.2009.350			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293404				2022-12-28	WOS:000264244200001
J	Gooskens, J; Jonges, M; Claas, ECJ; Meijer, A; van den Broek, PJ; Kroes, ACM				Gooskens, Jairo; Jonges, Marcel; Claas, Eric C. J.; Meijer, Adam; van den Broek, Peterhans J.; Kroes, Aloys C. M.			Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; NEURAMINIDASE; VIVO	Context The sudden emergence and rapid spread of oseltamivir-resistant influenza A(H1N1) viruses with neuraminidase (NA) gene H274Y amino acid substitution is the hallmark of global seasonal influenza since January 2008. Viruses carrying this mutation are widely presumed to exhibit attenuated pathogenicity, compromised transmission, and reduced lethality. Objective To investigate nosocomial viral transmission in a cluster of patients with influenza A(H1N1) virus infection. Design, Setting, and Patients Descriptive outbreak investigation of 2 hematopoietic stem cell transplant recipients and an elderly patient who developed hospital-acquired influenza A virus infection following exposure to an index patient with community-acquired H274Y-mutated influenza A(H1N1) virus infection in a medical ward at a Dutch university hospital in February 2008. The investigation included a review of the medical records, influenza virus polymerase chain reaction and culture, phenotypic oseltamivir and zanamivir susceptibility determination, and hemagglutinin chain 1(HA(1)) gene and NA gene sequence analysis. Main Outcome Measure Phylogenetic relationship of patient cluster influenza A(H1N1) viruses and other 2007-2008 seasonal influenza A(H1N1) viruses. Results Viral HA1 and NA gene sequence analysis from the 4 patients revealed indistinguishable nucleotide sequences and phylogenetic clustering of H274Y-mutated, oseltamivir-resistant influenza A(H1N1) virus, confirming nosocomial transmission. Influenza virus pneumonia (3 patients) and attributable mortality (2 patients) during active infection was observed in patients with lymphocytopenia at onset. Conclusion Seasonal oseltamivir-resistant influenza A(H1N1) viruses with NA gene H274Y mutation are transmitted and retain significant pathogenicity and lethality in high-risk patients.	[Gooskens, Jairo; Claas, Eric C. J.; Kroes, Aloys C. M.] Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [van den Broek, Peterhans J.] Leiden Univ, Med Ctr, Dept Infect Dis, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [Jonges, Marcel; Meijer, Adam] Natl Inst Publ Hlth & Environm, Virol Sect, NL-3720 BA Bilthoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	Gooskens, J (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, E4-65,POB 9600, NL-2300 RC Leiden, Netherlands.	j.gooskens@lumc.nl	Gooskens, Jairo/A-6634-2009	Gooskens, Jairo/0000-0002-8381-7870; Kroes, Aloysius/0000-0002-9866-2461				*CDCP, 2008, CDC ISS INT REC US I; Gooskens J, 2007, J CLIN VIROL, V39, P136, DOI 10.1016/j.jcv.2007.03.010; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Lackenby A., 2008, Eurosurveillance, V13, P8026; Nicoll A., 2008, EUROSURVEILLANCE, V13, P8025, DOI [10.2807/ese.13.05.08025-en, DOI 10.2807/ESE.13.05.08025-EN]; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; *WHO, 2008, EP PAND AL RESP INFL; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07	12	80	88	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1042	1046		10.1001/jama.2009.297	http://dx.doi.org/10.1001/jama.2009.297			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19255111	Bronze			2022-12-28	WOS:000264015800028
J	Tigaret, C; Choquet, D				Tigaret, Cezar; Choquet, Daniel			More AMPAR Garnish	SCIENCE			English	Editorial Material							RECEPTOR; STARGAZIN; PROTEINS; TARPS		[Tigaret, Cezar; Choquet, Daniel] Univ Bordeaux, CNRS, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Tigaret, C (corresponding author), Univ Bordeaux, CNRS, UMR 5091, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Tigaret, Cezar/AAS-6577-2021; Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013; Choquet, Daniel/GOJ-8825-2022	Tigaret, Cezar/0000-0001-5848-6697; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763				Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Dingledine R, 1999, PHARMACOL REV, V51, P7; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	16	18	18	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1295	1296		10.1126/science.1171519	http://dx.doi.org/10.1126/science.1171519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265005				2022-12-28	WOS:000263876700024
J	Erhard, KF; Stonaker, JL; Parkinson, SE; Lim, JP; Hale, CJ; Hollick, JB				Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.			RNA Polymerase IV Functions in Paramutation in Zea mays	SCIENCE			English	Article							ALPHA-AMANITIN; MAIZE; DNA; TRANSCRIPTION; STATES; REPRESSION; PATHWAY; PLANTS; GENES	Plants have distinct RNA polymerase complexes (Pol IV and Pol V) with largely unknown roles in maintaining small RNA-associated gene silencing. Curiously, the eudicot Arabidopsis thaliana is not affected when either function is lost. By use of mutation selection and positional cloning, we showed that the largest subunit of the presumed maize Pol IV is involved in paramutation, an inherited epigenetic change facilitated by an interaction between two alleles, as well as normal maize development. Bioinformatics analyses and nuclear run-on transcription assays indicate that Pol IV does not engage in the efficient RNA synthesis typical of the three major eukaryotic DNA-dependent RNA polymerases. These results indicate that Pol IV employs abnormal RNA polymerase activities to achieve genome-wide silencing and that its absence affects both maize development and heritable epigenetic changes.	[Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hollick, JB (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	hollick@nature.berkeley.edu			National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service [99-35301-7753, 2001-35301-10641, 2006-35304-17399]; NSF [MCB-0419909]	National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF))	We thank X. Parisky for technical assistance; N. Bolduc for providing nucleic acid samples; S. McCormick and D. Zilberman for comments; and the maize, Sorghum bicolor, and Brachypodium genome-sequencing projects for providing sequence information before publication. Brachypodium and Sorghum bicolor sequences were produced by the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/). cDNA sequences for Rmr6-A619, rmr6-1, rmr6-7, rmr6-8, and rmr6-14 are archived under GenBank accession numbers FJ426107 to FJ426111, respectively. Germ plasm containing mutations in the rmr6 gene is covered by U.S. patent 07264970 awarded to the Regents of the University of California. Supported by the National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service (grants 99-35301-7753, 2001-35301-10641, and 2006-35304-17399) and NSF (grant MCB-0419909).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; BRINK RA, 1964, AM NAT, V98, P193, DOI 10.1086/282320; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; CONE KC, 1993, PLANT CELL, V5, P1807, DOI 10.1105/tpc.5.12.1807; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollick JB, 2005, GENETICS, V171, P725, DOI 10.1534/genetics.105.045260; Hollick JB, 2001, GENETICS, V157, P369; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; KERMICLE JL, 1990, DEVELOPMENT, P9; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCMULLEN MD, 1986, NUCLEIC ACIDS RES, V14, P4953, DOI 10.1093/nar/14.12.4953; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mroczek RJ, 2003, GENETICS, V165, P809; Parkinson SE, 2007, DEV BIOL, V308, P462, DOI 10.1016/j.ydbio.2007.06.004; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	31	109	110	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1201	1205		10.1126/science.1164508	http://dx.doi.org/10.1126/science.1164508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251626				2022-12-28	WOS:000263687600035
J	Kuchibhotla, KV; Lattarulo, CR; Hyman, BT; Bacskai, BJ				Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.			Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice	SCIENCE			English	Article							MOUSE MODEL; AMYLOID DEPOSITION; BETA-PLAQUES; IN-VIVO; DISEASE; PROPAGATION	Although senile plaques focally disrupt neuronal health, the functional response of astrocytes to Alzheimer's disease pathology is unknown. Using multiphoton fluorescence lifetime imaging microscopy in vivo, we quantitatively imaged astrocytic calcium homeostasis in a mouse model of Alzheimer's disease. Resting calcium was globally elevated in the astrocytic network, but was independent of proximity to individual plaques. Time-lapse imaging revealed that calcium transients in astrocytes were more frequent, synchronously coordinated across long distances, and uncoupled from neuronal activity. Furthermore, rare intercellular calcium waves were observed, but only in mice with amyloid-beta plaques, originating near plaques and spreading radially at least 200 micrometers. Thus, although neurotoxicity is observed near amyloid-beta deposits, there exists a more general astrocyte-based network response to focal pathology.	[Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA; [Kuchibhotla, Kishore V.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bacskai, BJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, 114 16th St, Charlestown, MA 02129 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021		NIH [EB000768, AG08487, NS580752]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG008487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. O. Ohki and R. C. Reid for assistance with the multicell bolus loading technique. This work was supported by NIH grants EB000768 (B.J.B.), AG08487 (B.T.H.), and NS580752 (K.V.K.).	Abramov AY, 2003, J NEUROSCI, V23, P5088; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Garcia-Alloza M, 2006, J NEUROPATH EXP NEUR, V65, P1082, DOI 10.1097/01.jnen.0000240468.12543.af; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	24	485	496	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1211	1215		10.1126/science.1169096	http://dx.doi.org/10.1126/science.1169096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251629	Green Accepted			2022-12-28	WOS:000263687600038
J	Rozin, P; Haidt, J; Fincher, K				Rozin, Paul; Haidt, Jonathan; Fincher, Katrina			From Oral to Moral	SCIENCE			English	Editorial Material							DISGUST		[Rozin, Paul; Fincher, Katrina] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Haidt, Jonathan] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	University of Pennsylvania; University of Virginia	Rozin, P (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	rozin@psych.upenn.edu	Haidt, Jonathan/B-2835-2013					Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Royzman EB, 2001, J THEOR SOC BEHAV, V31, P29, DOI 10.1111/1468-5914.00145; Royzman EB, 2008, MOTIV EMOTION, V32, P100, DOI 10.1007/s11031-008-9089-x; ROZIN P, 1986, J PERS SOC PSYCHOL, V50, P703, DOI 10.1037/0022-3514.50.4.703; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Rozin P., 1993, HDB EMOTIONS, P575; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Shweder R.A., 1997, MORALITY HLTH, P119, DOI DOI 10.4324/9780203707463; Simpson J, 2006, MOTIV EMOTION, V30, P31, DOI 10.1007/s11031-006-9005-1; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	12	164	174	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1179	1180		10.1126/science.1170492	http://dx.doi.org/10.1126/science.1170492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251619				2022-12-28	WOS:000263687600027
J	Klein, TE; Altman, RB; Eriksson, N; Gage, BF; Kimmel, SE; Lee, MTM; Limdi, NA; Page, D; Roden, DM; Wagner, MJ; Caldwell, MD; Johnson, JA; Chen, YT; Wen, MS; Caraco, Y; Achache, I; Blotnick, S; Muszkat, M; Shin, JG; Kim, HS; Suarez-Kurtz, G; Perini, JA; Silva-Assuncao, E; Anderson, JL; Horne, BD; Carlquist, JF; Caldwell, MD; Berg, RL; Burmester, JK; Goh, BC; Lee, SC; Kamali, F; Sconce, E; Daly, AK; Wu, AHB; Langaee, TY; Feng, H; Cavallari, L; Momary, K; Pirmohamed, M; Jorgensen, A; Toh, CH; Williamson, P; McLeod, H; Evans, JP; Weck, KE; Brensinger, C; Nakamura, Y; Mushiroda, T; Veenstra, D; Meckley, L; Rieder, MJ; Rettie, AE; Wadelius, M; Melhus, H; Stein, CM; Schwartz, U; Kurnik, D; Deych, E; Lenzini, P; Eby, C; Chen, LY; Deloukas, P; Motsinger-Reif, A; Sagreiya, H; Srinivasan, BS; Lantz, E; Chang, T; Ritchie, M; Lu, LS; Shin, JG				Klein, T. E.; Altman, R. B.; Eriksson, N.; Gage, B. F.; Kimmel, S. E.; Lee, M. -T. M.; Limdi, N. A.; Page, D.; Roden, D. M.; Wagner, M. J.; Caldwell, M. D.; Johnson, J. A.; Chen, Y. T.; Wen, M. S.; Caraco, Y.; Achache, I.; Blotnick, S.; Muszkat, M.; Shin, J. G.; Kim, H. S.; Suarez-Kurtz, G.; Perini, J. A.; Silva-Assuncao, E.; Anderson, J. L.; Horne, B. D.; Carlquist, J. F.; Caldwell, M. D.; Berg, R. L.; Burmester, J. K.; Goh, B. C.; Lee, S. C.; Kamali, F.; Sconce, E.; Daly, A. K.; Wu, A. H. B.; Langaee, T. Y.; Feng, H.; Cavallari, L.; Momary, K.; Pirmohamed, M.; Jorgensen, A.; Toh, C. H.; Williamson, P.; McLeod, H.; Evans, J. P.; Weck, K. E.; Brensinger, C.; Nakamura, Y.; Mushiroda, T.; Veenstra, D.; Meckley, L.; Rieder, M. J.; Rettie, A. E.; Wadelius, M.; Melhus, H.; Stein, C. M.; Schwartz, U.; Kurnik, D.; Deych, E.; Lenzini, P.; Eby, C.; Chen, L. Y.; Deloukas, P.; Motsinger-Reif, A.; Sagreiya, H.; Srinivasan, B. S.; Lantz, E.; Chang, T.; Ritchie, M.; Lu, L. S.; Shin, J. G.		Int Warfarin Pharmacogenetics Cons	Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							K EPOXIDE REDUCTASE; GAMMA-GLUTAMYL CARBOXYLASE; AFRICAN-AMERICANS; CYTOCHROME P4502C9; COAGULATION-FACTOR; PRIME-TIME; VKORC1; POLYMORPHISMS; REQUIREMENTS; RESISTANCE	Background Genetic variability among patients plays an important role in determining the dose of warfarin that should be used when oral anticoagulation is initiated, but practical methods of using genetic information have not been evaluated in a diverse and large population. We developed and used an algorithm for estimating the appropriate warfarin dose that is based on both clinical and genetic data from a broad population base. Methods Clinical and genetic data from 4043 patients were used to create a dose algorithm that was based on clinical variables only and an algorithm in which genetic information was added to the clinical variables. In a validation cohort of 1009 subjects, we evaluated the potential clinical value of each algorithm by calculating the percentage of patients whose predicted dose of warfarin was within 20% of the actual stable therapeutic dose; we also evaluated other clinically relevant indicators. Results In the validation cohort, the pharmacogenetic algorithm accurately identified larger proportions of patients who required 21 mg of warfarin or less per week and of those who required 49 mg or more per week to achieve the target international normalized ratio than did the clinical algorithm ( 49.4% vs. 33.3%, P< 0.001, among patients requiring <= 21 mg per week; and 24.8% vs. 7.2%, P< 0.001, among those requiring >= 49 mg per week). Conclusions The use of a pharmacogenetic algorithm for estimating the appropriate initial dose of warfarin produces recommendations that are significantly closer to the required stable therapeutic dose than those derived from a clinical algorithm or a fixed- dose approach. The greatest benefits were observed in the 46.2% of the population that required 21 mg or less of warfarin per week or 49 mg or more per week for therapeutic anticoagulation.	[Lee, M. -T. M.; Chen, Y. T.; Lu, L. S.] Acad Sinica, Taipei 115, Taiwan; [Wen, M. S.] Chang Gung Univ, Chang Gung Mem Hosp, Taipei, Taiwan; [Lee, M. -T. M.] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Caraco, Y.; Achache, I.; Blotnick, S.; Muszkat, M.] Hadassah Med Org, Jerusalem, Israel; [Shin, J. G.; Kim, H. S.; Shin, J. G.] Inje Univ, Pusan, South Korea; [Suarez-Kurtz, G.; Perini, J. A.] Inst Nacl Canc, Rio De Janeiro, Brazil; [Silva-Assuncao, E.] Inst Nacl Cardiol Laranjeiras, Rio De Janeiro, Brazil; [Anderson, J. L.; Horne, B. D.; Carlquist, J. F.] Intermt Healthcare, Salt Lake City, UT USA; [Caldwell, M. D.; Caldwell, M. D.; Berg, R. L.; Burmester, J. K.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Goh, B. C.; Lee, S. C.] Natl Univ Singapore Hosp, Singapore, Singapore; [Kamali, F.; Sconce, E.; Daly, A. K.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Limdi, N. A.] Univ Alabama, Birmingham, AL USA; [Wu, A. H. B.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Johnson, J. A.; Langaee, T. Y.; Feng, H.] Univ Florida, Gainesville, FL USA; [Cavallari, L.; Momary, K.] Univ Illinois, Chicago, IL USA; [Pirmohamed, M.; Jorgensen, A.; Toh, C. H.; Williamson, P.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Wagner, M. J.; McLeod, H.; Evans, J. P.; Weck, K. E.] Univ N Carolina, Chapel Hill, NC USA; [Kimmel, S. E.; Brensinger, C.] Univ Penn, Philadelphia, PA 19104 USA; [Nakamura, Y.; Mushiroda, T.] Univ Tokyo, Tokyo, Japan; [Nakamura, Y.; Mushiroda, T.] RIKEN, Ctr Genom Med, Tokyo, Japan; [Veenstra, D.; Meckley, L.; Rieder, M. J.; Rettie, A. E.] Univ Washington, Seattle, WA 98195 USA; [Eriksson, N.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Roden, D. M.; Stein, C. M.; Schwartz, U.; Kurnik, D.; Ritchie, M.] Vanderbilt Univ, Nashville, TN USA; [Gage, B. F.; Deych, E.; Lenzini, P.; Eby, C.] Washington Univ, St Louis, MO USA; [Chen, L. Y.; Deloukas, P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Motsinger-Reif, A.] N Carolina State Univ, Raleigh, NC 27695 USA; [Klein, T. E.; Altman, R. B.; Sagreiya, H.; Srinivasan, B. S.] Stanford Univ, Palo Alto, CA 94304 USA; [Page, D.; Lantz, E.; Chang, T.] Univ Wisconsin, Madison, WI USA	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; Hebrew University of Jerusalem; Hadassah University Medical Center; Inje University; National Cancer Institute (Inca); Intermountain Healthcare; Intermountain Medical Center; Marshfield Clinic; National University of Singapore; Newcastle University - UK; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Tokyo; RIKEN; University of Washington; University of Washington Seattle; Uppsala University; Vanderbilt University; Washington University (WUSTL); Wellcome Trust Sanger Institute; University of North Carolina; North Carolina State University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Klein, TE (corresponding author), Warfarin Pharmacogenet Consortium, 300 Pasteur Dr,Ln 301,Mailstop 5120, Stanford, CA 94305 USA.		Suarez-Kurtz, Guilherme/P-4620-2019; Daly, Ann/H-3144-2011; Mushiroda, Taisei/E-3022-2010; Suarez-Kurtz, Guilherme/J-6648-2012; McLeod, Howard/ABD-8364-2021; Williamson, Paula R/B-6425-2016; Deloukas, Panos/B-2922-2013; Horne, Benjamin/GQP-7851-2022; Sagreiya, Hersh/Z-1641-2019; Wadelius, Mia/C-7740-2016; Roden, Dan/ABD-5412-2021; Motsinger-Reif, Alison/I-4167-2018; Pirmohamed, Munir/H-6004-2011; Ritchie, Marylyn/C-1114-2012; Caldwell, Michael DeFoix/ABB-1906-2021; Lee, Ming Ta Michael/N-5396-2015	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Daly, Ann/0000-0002-7321-0629; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; McLeod, Howard/0000-0002-9004-9232; Williamson, Paula R/0000-0001-9802-6636; Deloukas, Panos/0000-0001-9251-070X; Wadelius, Mia/0000-0002-6368-2622; Motsinger-Reif, Alison/0000-0003-1346-2493; Pirmohamed, Munir/0000-0002-7534-7266; Meckley, Lisa/0000-0002-4791-4294; Chang, Timothy/0000-0002-9225-9874; Klein, Teri/0000-0001-5527-6475; Lee, Ming Ta Michael/0000-0003-2510-8977; Muszkat, Mordechai/0000-0002-9520-1379	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, R01HL092173, R01HL074724, R01HL071083, R01HL066176, K24HL070936, K24HL068834, U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, P01GM032165, R01GM068797, U01GM074492, U01GM063340, R24GM061374, T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045598, R01NS053646] Funding Source: NIH RePORTER; MRC [G0800792] Funding Source: UKRI; Medical Research Council [G0800792] Funding Source: Medline; NCRR NIH HHS [P20 RR020741-03, P20 RR020741] Funding Source: Medline; NHLBI NIH HHS [R01 HL071083-03, R01 HL066176-05, U01 HL065962-08, U19 HL065962, R01 HL092173, R01 HL066176, K24 HL068834, U01 HL065962, R01 HL074724-04, R01 HL074724, K24 HL070936, K24 HL068834-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM068797-04, T32 GM008692, U01 GM061374, R01 GM068797, P01 GM032165-26, U01 GM061374-09, U01 GM074492-04, P01 GM032165, U01 GM063340, U01 GM063340-08, U01 GM074492, R24 GM061374] Funding Source: Medline; NINDS NIH HHS [K23 NS045598-01, R01 NS053646-03, R01 NS053646, K23 NS045598] Funding Source: Medline; Wellcome Trust [077011] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Bussey HI, 2008, PHARMACOTHERAPY, V28, P141, DOI 10.1592/phco.28.2.141; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Caldwell MD, 2007, CLIN MED RES, V5, P142, DOI 10.3121/cmr.2007.724.corr; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; COOK RJ, 1995, BRIT MED J, V310, P1056; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Herman D, 2006, THROMB HAEMOSTASIS, V95, P782, DOI 10.1160/TH05-10-0678; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Kimmel SE, 2008, PHARMACOGENOMICS J, V8, P53, DOI 10.1038/sj.tpj.6500445; Kimura R, 2007, THROMB RES, V120, P181, DOI 10.1016/j.thromres.2006.09.007; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; McWilliam A, 2008, PERS MED, V5, P279, DOI 10.2217/17410541.5.3.279; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Momary KM, 2007, PHARMACOGENOMICS, V8, P1535, DOI 10.2217/14622416.8.11.1535; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schelleman H, 2007, CLIN PHARMACOL THER, V81, P742, DOI 10.1038/sj.clpt.6100144; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Sconce EA, 2006, PHARMACOGENET GENOM, V16, P609, DOI 10.1097/01.fpc.0000220567.98089.b5; Scott SA, 2008, AM J HUM GENET, V82, P495, DOI 10.1016/j.ajhg.2007.10.002; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Tham LS, 2006, CLIN PHARMACOL THER, V80, P346, DOI 10.1016/j.clpt.2006.06.009; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wu AHB, 2007, PHARMACOGENOMICS, V8, P851, DOI 10.2217/14622416.8.7.851; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414	33	1155	1230	5	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					753	764						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228618	Green Published, Green Accepted			2022-12-28	WOS:000263411300005
J	Moloney, A				Moloney, Anastasia			Unsafe abortions Common in Colombia despite law change	LANCET			English	Editorial Material																			0	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					534	534		10.1016/S0140-6736(09)60185-9	http://dx.doi.org/10.1016/S0140-6736(09)60185-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230078				2022-12-28	WOS:000263333600015
J	Stone, GW				Stone, Gregg W.			Ischaemia versus bleeding: the art of clinical decision-making	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; PLATELET INHIBITION; CLOPIDOGREL; PRASUGREL; THERAPY; PCI; PRETREATMENT; ANGIOPLASTY; DISEASE		Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.	gs2184@columbia.edu						Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Stone GW, 2008, CIRCULATION, V118, P538, DOI 10.1161/CIRCULATIONAHA.107.756494; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	15	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					695	696		10.1016/S0140-6736(09)60413-X	http://dx.doi.org/10.1016/S0140-6736(09)60413-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249613				2022-12-28	WOS:000263725400004
J	Canto, C; Gerhart-Hines, Z; Feige, JN; Lagouge, M; Noriega, L; Milne, JC; Elliott, PJ; Puigserver, P; Auwerx, J				Canto, Carles; Gerhart-Hines, Zachary; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Milne, Jill C.; Elliott, Peter J.; Puigserver, Pere; Auwerx, Johan			AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MITOCHONDRIAL-FUNCTION; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; RECEPTOR-GAMMA; PGC-1-ALPHA; MECHANISM; OXIDATION	AMP-activated protein kinase (AMPK) is a metabolic fuel gauge conserved along the evolutionary scale in eukaryotes that senses changes in the intracellular AMP/ATP ratio(1). Recent evidence indicated an important role for AMPK in the therapeutic benefits of metformin(2,3), thiazolidinediones(4) and exercise(5), which form the cornerstones of the clinical management of type 2 diabetes and associated metabolic disorders. In general, activation of AMPK acts to maintain cellular energy stores, switching on catabolic pathways that produce ATP, mostly by enhancing oxidative metabolism and mitochondrial biogenesis, while switching off anabolic pathways that consume ATP(1). This regulation can take place acutely, through the regulation of fast post-translational events, but also by transcriptionally reprogramming the cell to meet energetic needs. Here we demonstrate that AMPK controls the expression of genes involved in energy metabolism in mouse skeletal muscle by acting in coordination with another metabolic sensor, the NAD(+)-dependent type III deacetylase SIRT1. AMPK enhances SIRT1 activity by increasing cellular NAD(+) levels, resulting in the deacetylation and modulation of the activity of downstream SIRT1 targets that include the peroxisome proliferator-activated receptor-gamma coactivator 1 alpha and the forkhead box O1 (FOXO1) and O3 (FOXO3a) transcription factors. The AMPK-induced SIRT1-mediated deacetylation of these targets explains many of the convergent biological effects of AMPK and SIRT1 on energy metabolism.	[Canto, Carles; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Auwerx, Johan] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Canto, Carles; Noriega, Lilia; Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Milne, Jill C.; Elliott, Peter J.] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Auwerx, J (corresponding author), CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Noriega, Lilia G./ABF-4876-2020	Noriega, Lilia G./0000-0003-2156-9872; Canto, Carles/0000-0002-5167-7922; Auwerx, Johan/0000-0002-5065-5393	CNRS; Ecole Polytechnique Federale de Lausanne; INSERM; ULP; NIH [DK59820, DK069966]; EU [LSHM-CT-2004-512013, ERC-2008-AdG-23118]; Fondation de la Recherche Medicale (FRM); EMBO; FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966, P01DK059820] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Polytechnique Federale de Lausanne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ULP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants of CNRS, Ecole Polytechnique Federale de Lausanne, INSERM, ULP, NIH (DK59820 and DK069966), EU FP6 (EUGENE2; LSHM-CT-2004-512013) and EU Ideas programme (sirtuins; ERC-2008-AdG-23118). C. C. has been supported by grants of Fondation de la Recherche Medicale (FRM) and EMBO. J. N. F. was supported by a FEBS grant. The authors thank F. Foufelle and P. Ferre, B. Spiegelman, D. P. Kelly, S.-i. Imai, G. Hardie, C. Ammann (Topotarget) and F. Alt for providing materials, and members of the Auwerx and Puigserver laboratories for discussion.	Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasmann M, 2003, CANCER RES, V63, P7436; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	33	2202	2299	17	493	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					1056	U140		10.1038/nature07813	http://dx.doi.org/10.1038/nature07813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262508	Green Accepted			2022-12-28	WOS:000265412900049
J	Scott-Browne, JP; White, J; Kappler, JW; Gapin, L; Marrack, P				Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa			Germline-encoded amino acids in the alpha beta T-cell receptor control thymic selection	NATURE			English	Article							POSITIVE SELECTION; MHC; ANTIGEN; RECOGNITION; REPERTOIRE; H-2-ANTIGENS; HYBRIDOMAS; PEPTIDE	An alpha beta T-cell response depends on the recognition of antigen plus major histocompatibility complex (MHC) proteins(1) by its antigen receptor (TCR). The ability of peripheral alpha beta T cells to recognize MHC is at least partly determined by MHC-dependent thymic selection, by which an immature T cell survives only if its TCR can recognize self MHC2-7. This process may allow MHC-reactive TCRs to be selected from a repertoire with completely random and unbiased specificities. However, analysis of thymocytes before positive selection indicated that TCR proteins might have a predetermined ability to bind MHC8-11. Here we show that specific germline-encoded amino acids in the TCR promote 'generic' MHC recognition and control thymic selection. In mice expressing single, rearranged TCR beta-chains, individual mutation of amino acids in the complementarity-determining region (CDR) 2 beta to Ala reduced development of the entire TCR repertoire. Altogether, these results show that thymic selection is controlled by germline-encoded MHC contact points in the alpha beta TCR and indicate that the diversity of the peripheral T-cell repertoire is enhanced by this 'built-in' specificity.	[Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa] Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Howard Hughes Med Inst, Aurora, CO 80220 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Dept Med, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Program Biomol Struct, Aurora, CO 80220 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80220 USA	National Jewish Health; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Marrack, P (corresponding author), Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA.	james.scott-browne@ucdenver.edu; marrackp@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI18785, AI22295, AI057485]; NIH [T32 AI07405]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI017134, R56AI018785, R37AI018785, T32AI007405, P01AI022295, R21AI076463, R01AI018785, R01AI057485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Acknowledgements We thank E. Huseby, K. Urdahl, C. Hsieh, G. Hernandez-Hoyos and members of the Kappler/Marrack and Gapin laboratories for discussion. We thank the flow cytometry facilities at NJH and UCD for technical assistance with cell sorting and E. Kushnir for assistance with generating bone marrow chimaeras. We thank R. O'Brien and W. Born for providing Tcrb<SUP>-/-</SUP> Tcrd<SUP>-/-</SUP> mice and Y. Refaeli for providing stem cell cytokines. This work was supported by grants from the National Institutes of Health (AI18785 and AI22295 to P. M. and J. W. K. and AI057485 to L. G.). P. M. and J. W. K. are investigators of the Howard Hughes Medical Institute. J. P. S.-B. was supported by an NIH training grant (T32 AI07405).	Arden Bernhard, 1995, Immunogenetics, V42, P501; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MARCIN P, 2006, BMC BIOINFORMATICS, V7, P225; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; WHITE J, 1989, J IMMUNOL, V143, P1822; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	29	123	124	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1043	U124		10.1038/nature07812	http://dx.doi.org/10.1038/nature07812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262510	Green Accepted			2022-12-28	WOS:000265412900046
J	Sanghavi, P; Bhalla, K; Das, V				Sanghavi, Prachi; Bhalla, Kavi; Das, Veena			Fire-related deaths in India in 2001: a retrospective analysis of data	LANCET			English	Article							BURN MORTALITY; EPIDEMIOLOGY; SUICIDE; AUTOPSY; RATES	Background Hospital-based studies have suggested that fire-related deaths might be a neglected public-health issue in India. However, no national estimates of these deaths exist and the only numbers reported in published literature come from the Indian police. We combined multiple health datasets to assess the extent of the problem. Methods We computed age-sex-specific fire-related mortality fractions nationally using a death registration system based on medically certified causes of death in urban areas and a verbal autopsy based sample survey for rural populations. We combined these data with all-cause mortality estimates based on the sample registration system and the population census. We adjusted for ill-defined injury categories that might contain misclassified fire-related deaths, and estimated the proportion of suicides due to self-immolation when deaths were reported by external causes. Findings We estimated over 163 000 fire-related deaths in 2001 in India, which is about 2% of all deaths. This number was six times that reported by police. About 106 000 of these deaths occurred in women, mostly between 15 and 34 years of age. This age-sex pattern was consistent across multiple local studies, and the average ratio of fire-related deaths of young women to young men was 3:1. Interpretation The high frequency of fire-related deaths in young women suggests that these deaths share common causes, including kitchen accidents, self-immolation, and different forms of domestic violence. Identification of populations at risk and description of structural determinants from existing data sources are urgently needed so that interventions can be rapidly implemented.	[Bhalla, Kavi] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; [Das, Veena] Johns Hopkins Univ, Dept Anthropol, Baltimore, MD USA	Harvard University; Johns Hopkins University	Sanghavi, P (corresponding author), 15-42 Everett St, Cambridge, MA 02138 USA.	prachi.sanghavi@gmail.com						Ahuja RB, 2002, BURNS, V28, P555, DOI 10.1016/S0305-4179(02)00069-4; Alexandrescu R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-80; Ambade VN, 2006, BURNS, V32, P902, DOI 10.1016/j.burns.2006.03.001; Amoros E, 2007, ACCIDENT ANAL PREV, V39, P483, DOI 10.1016/j.aap.2006.09.006; Batra AK, 2003, BURNS, V29, P270, DOI 10.1016/S0305-4179(02)00306-6; BAWABHALLA KS, 2000, ACCIDENT ANAL PREV, V32, P407; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; GUPTA M, 1993, BURNS, V19, P47, DOI 10.1016/0305-4179(93)90100-M; GUPTA RK, 1988, FORENSIC SCI INT, V37, P81, DOI 10.1016/0379-0738(88)90096-5; GURURAJ G, 2005, INJURIES INDIA NATL; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; *INT I POP STUD, 1999, NAT FAM HLTH SURV, V2; JAYARAMAN V, 1993, BURNS, V19, P339, DOI 10.1016/0305-4179(93)90124-Q; Kumar V, 2004, LANCET, V364, P18, DOI 10.1016/S0140-6736(04)17625-3; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; MAHAPATRA P, 2001, ESTIMATING NATL BURD; *MIN HOM AFF REG G, 2001, SAMPL REG SYST; *MIN HOM AFF REG G, 1999, CIV REG SYST; *MIN HOM AFF REG G, 2001, CENS IND; *MIN HOM AFF REG G, 2001, MED CERT CAUS DEATH; *MIN HOM NAT CRIM, 2005, CRIM IND; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; Oldenburg V.T., 2002, DOWRY MURDER IMPERIA; Prasad S, 1999, Violence Against Women, V5, P478, DOI 10.1177/10778019922181338; Runyan C W, 1998, Inj Prev, V4, P302; SAWHNEY CP, 1989, BURNS, V15, P362, DOI 10.1016/0305-4179(89)90099-5; Sharma BR, 2002, BURNS, V28, P250, DOI 10.1016/S0305-4179(02)00003-7; Singh D, 1998, BURNS, V24, P150, DOI 10.1016/S0305-4179(97)00106-X; Subrahmanyam M, 1996, BURNS, V22, P439, DOI 10.1016/0305-4179(96)00001-0; SUBRAHMANYAM M, 2003, ANN BURNS FIRE DISAS, V16, P74; *VIT STAT DIV REG, 1998, SURV CAUS DEATH; *WHO, 2005, WORLD HLTH SURV	35	72	72	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1282	1288		10.1016/S0140-6736(09)60235-X	http://dx.doi.org/10.1016/S0140-6736(09)60235-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19250664				2022-12-28	WOS:000265146300031
J	Lancaster, GI; O'Connell, R; Katz, DL; Manson, JE; Hutchison, WR; Landau, C; Yonkers, KA				Lancaster, Gilead I.; O'Connell, Ryan; Katz, David L.; Manson, JoAnn E.; Hutchison, William R.; Landau, Charles; Yonkers, Kimberly A.		Healthcare Professionals Healthcar	The Expanding Medical and Behavioral Resources with Access to Care for Everyone Health Plan	ANNALS OF INTERNAL MEDICINE			English	Article								Healthcare Professionals for Healthcare Reform is a group of physicians and others interested in health care reform who, recognizing the urgent need for change, convened to propose a universal health care plan that builds on the strengths of the U.S. health care system and improves on its coverage, efficiency, and capacity for patient choice. The group proposes a tiered plan, the core of which (Tier 1) would be lifetime, basic, publicly funded coverage for the entire population on the basis of the best evidence about which therapies are considered life saving, life-sustaining, or preventive. Optional coverage (Tier 2) would be funded by private insurance and cover all therapies considered to help with quality of life and functional impairment. Items considered to be luxury or cosmetic (Tier 3) would generally not be covered, as is the case under the current system. The entire system would be overseen by a quasi-governmental, largely independent organization known as "The Board," which would resemble the Federal Reserve and interact with U. S. Department of Health and Human Services agencies to oversee implementation and coverage. By building on the current health care system while introducing other features and efficiencies, the Expanding Medical and Behavioral Resources with Access to Care for Everyone (EMBRACE) plan for universal health insurance coverage offers several advantages over alternative plans that have been proposed.	[Lancaster, Gilead I.] Bridgeport Hosp, Inst Heart, Bridgeport, CT 06610 USA; Yale Univ, Sch Publ Hlth, New Haven, CT USA; Yale Univ, Sch Med, New Haven, CT USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; W Virginia Coll Business, Morgantown, WV USA; W Virginia Univ, Morgantown, WV 26506 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; West Virginia University; Columbia University	Lancaster, GI (corresponding author), Bridgeport Hosp, Inst Heart, 267 Grant St, Bridgeport, CT 06610 USA.	pglanc@bpthosp.org		Katz, David/0000-0001-6845-6192; Lancaster, Gilead/0000-0003-4211-6207				*CTR MED MED SERV, 2008, CHOOS MED POL GUID H; Daschle Tom, 2008, CRITICAL WE CAN HLTH, P169; Evans T., 2006, WORLD HLTH REPORT 20; LYALL S, 2008, NY TIMES        0221; Oberlander J, 2000, HEALTH AFFAIR, V19, P84, DOI 10.1377/hlthaff.19.5.84; Oberlander J, 2007, NEW ENGL J MED, V357, P2101, DOI 10.1056/NEJMp078202; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Woolhandler S, 2003, JAMA-J AM MED ASSOC, V290, P798	8	8	8	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					490	+		10.7326/0003-4819-150-7-200904070-00113	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00113			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432EZ	19258548				2022-12-28	WOS:000265117600007
J	Wilson, JF				Wilson, Jennifer Fisher			More Cases of Drug-Resistant Tuberculosis Complicate Care but Spur Global Research and Innovation	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P245; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721	7	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					433	436		10.7326/0003-4819-150-6-200903170-00031	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293087				2022-12-28	WOS:000264468500025
J	Fromherz, P; Voelker, M				Fromherz, Peter; Voelker, Moritz			Comment on "Detection, Stimulation, and Inhibition of Neuronal Signals with High-Density Nanowire Transistor Arrays"	SCIENCE			English	Editorial Material							CELL		[Fromherz, Peter; Voelker, Moritz] Max Planck Inst Biochem, Dept Membrane & Neurophys, D-82152 Martinsried, Germany	Max Planck Society	Fromherz, P (corresponding author), Max Planck Inst Biochem, Dept Membrane & Neurophys, D-82152 Martinsried, Germany.	fromherz@biochem.mpg.de						Borkovec M, 2001, SURF COLLOID SCI, V16, P99; Braun D, 2004, BIOPHYS J, V87, P1351, DOI 10.1529/biophysj.104.039990; Claverol-Tinture E, 2002, J NEUROSCI METH, V117, P13, DOI 10.1016/S0165-0270(02)00043-2; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Hill J R, 2001, Cloning, V3, P83, DOI 10.1089/15204550152475581; Nam Y, 2004, IEEE T BIO-MED ENG, V51, P158, DOI 10.1109/TBME.2003.820336; Patolsky F, 2007, SCIENCE, V317, P320; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Pierret R. F., 1996, SEMICONDUCTOR DEVICE; Schatzthauer R, 1998, EUR J NEUROSCI, V10, P1956, DOI 10.1046/j.1460-9568.1998.00205.x; Schmidtner M, 2006, BIOPHYS J, V90, P183, DOI 10.1529/biophysj.105.068361; Voelker M, 2005, SMALL, V1, P206, DOI 10.1002/smll.200400077; Weis R, 1997, PHYS REV E, V55, P877, DOI 10.1103/PhysRevE.55.877; WOIAS P, 1995, SENSOR ACTUAT B-CHEM, V24, P211, DOI 10.1016/0925-4005(95)85045-7	14	10	10	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920								10.1126/science.1155416	http://dx.doi.org/10.1126/science.1155416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286538				2022-12-28	WOS:000264101700019
J	Rees, MA; Kopke, JE; Pelletier, RP; Segev, DL; Rutter, ME; Fabrega, AJ; Rogers, J; Pankewycz, OG; Hiller, J; Roth, AE; Sandholm, T; Unver, MU; Montgomery, RA				Rees, Michael A.; Kopke, Jonathan E.; Pelletier, Ronald P.; Segev, Dorry L.; Rutter, Matthew E.; Fabrega, Alfredo J.; Rogers, Jeffrey; Pankewycz, Oleh G.; Hiller, Janet; Roth, Alvin E.; Sandholm, Tuomas; Uenver, M. Utku; Montgomery, Robert A.			A Nonsimultaneous, Extended, Altruistic-Donor Chain.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KIDNEY PAIRED DONATION; NONDIRECTED DONATION; EXCHANGE	We report a chain of 10 kidney transplantations, initiated in July 2007 by a single altruistic donor (i.e., a donor without a designated recipient) and coordinated over a period of 8 months by two large paired-donation registries. These transplantations involved six transplantation centers in five states. In the case of five of the transplantations, the donors and their coregistered recipients underwent surgery simultaneously. In the other five cases, ``bridge donors'' continued the chain as many as 5 months after the coregistered recipients in their own pairs had received transplants. This report of a chain of paired kidney donations, in which the transplantations were not necessarily performed simultaneously, illustrates the potential of this strategy.	[Rees, Michael A.; Rutter, Matthew E.] Univ Toledo, Med Ctr, Dept Urol, Toledo, OH 43614 USA; [Rees, Michael A.; Pelletier, Ronald P.; Rutter, Matthew E.; Rogers, Jeffrey; Pankewycz, Oleh G.] Alliance Paired Donat, Maumee, OH USA; [Kopke, Jonathan E.] Univ Cincinnati, Dept Publ Hlth Sci, Cincinnati, OH USA; [Pelletier, Ronald P.] Ohio State Univ, Dept Gen Surg, Columbus, OH 43210 USA; [Segev, Dorry L.; Hiller, Janet; Montgomery, Robert A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Fabrega, Alfredo J.] Banner Good Samaritan Transplant Serv, Phoenix, AZ USA; [Rogers, Jeffrey] Wake Forest Univ, Baptist Med Ctr, Transplantat Serv, Dept Gen Surg, Winston Salem, NC 27109 USA; [Pankewycz, Oleh G.] SUNY Buffalo, Dept Surg, Buffalo, NY USA; [Roth, Alvin E.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Roth, Alvin E.] Harvard Sch Business, Boston, MA USA; [Sandholm, Tuomas] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Uenver, M. Utku] Boston Coll, Dept Econ, Chestnut Hill, MA 02167 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Johns Hopkins University; Banner Research; Banner Health; Wake Forest University; Wake Forest Baptist Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard University; Carnegie Mellon University; Boston College	Rees, MA (corresponding author), Univ Toledo, Med Ctr, Dept Urol, Mail Stop 1091,3000 Arlington Ave, Toledo, OH 43614 USA.	michael.rees2@utoledo.edu	Unver, M. Utku/AEK-9237-2022; Rees, Michael/AAW-1385-2021	Unver, M. Utku/0000-0001-7693-1635; Roth, Alvin/0000-0002-8834-6481	Alliance for Paired Donation; Life Connection of Ohio; University of Toledo; Charles T. Bauer Foundation; National Science Foundation; Sloan Foundation Fellowship; Novartis; Bristol-Myers Squibb, Wyeth; Novartis; Dr. Pankewycz; Novartis, Astellas; Genzyme and consulting fees from Genzyme and Astellas	Alliance for Paired Donation; Life Connection of Ohio; University of Toledo; Charles T. Bauer Foundation; National Science Foundation(National Science Foundation (NSF)); Sloan Foundation Fellowship(Alfred P. Sloan Foundation); Novartis(Novartis); Bristol-Myers Squibb, Wyeth(WyethBristol-Myers Squibb); Novartis; Dr. Pankewycz; Novartis, Astellas(Astellas Pharmaceuticals); Genzyme and consulting fees from Genzyme and Astellas(Sanofi-AventisGenzyme Corporation)	Supported by the Alliance for Paired Donation, Life Connection of Ohio, the University of Toledo, and the Charles T. Bauer Foundation and in part by grants from the National Science Foundation ( to Drs. Roth, sover, and Sandholm) and a Sloan Foundation Fellowship ( to Dr. Sandholm).; Dr. Rees reports receiving grant support from Novartis; Dr. Pelletier, grant support from Bristol-Myers Squibb, Wyeth, and Novartis; Dr. Pankewycz, grant support from Novartis, Astellas, and Wyeth; Dr. Rogers, consulting fees from Genzyme and Wyeth; and Dr. Montgomery, grant support from Genzyme and consulting fees from Genzyme and Astellas. No other potential conflict of interest relevant to this article was reported.	Abraham DJ, 2007, EC'07: PROCEEDINGS OF THE EIGHTH ANNUAL CONFERENCE ON ELECTRONIC COMMERCE, P295; Adams PL, 2002, TRANSPLANTATION, V74, P582, DOI 10.1097/00007890-200208270-00030; [Anonymous], 1992, TRANSPLANT P, V24, P2227; Clemens KK, 2006, AM J TRANSPLANT, V6, P2965, DOI 10.1111/j.1600-6143.2006.01567.x; de Klerk M, 2005, AM J TRANSPLANT, V5, P2302, DOI 10.1111/j.1600-6143.2005.01024.x; Gentry SE, 2007, AM J TRANSPLANT, V7, P2361, DOI 10.1111/j.1600-6143.2007.01935.x; Matas AJ, 2000, NEW ENGL J MED, V343, P433, DOI 10.1056/NEJM200008103430611; Montgomery RA, 2008, AM J TRANSPLANT, V8, P2163, DOI 10.1111/j.1600-6143.2008.02347.x; Montgomery RA, 2005, JAMA-J AM MED ASSOC, V294, P1655, DOI 10.1001/jama.294.13.1655; Montgomery RA, 2006, LANCET, V368, P419, DOI 10.1016/S0140-6736(06)69115-0; Park K, 1999, TRANSPLANTATION, V67, P336, DOI 10.1097/00007890-199901270-00027; RAPAPORT FT, 1986, TRANSPLANT P, V18, P5; Roth AE, 2006, AM J TRANSPLANT, V6, P2694, DOI 10.1111/j.1600-6143.2006.01515.x; Roth AE, 2005, J ECON THEORY, V125, P151, DOI 10.1016/j.jet.2005.04.004; Roth AE, 2005, AM ECON REV, V95, P376, DOI 10.1257/000282805774669989; Roth AE, 2007, AM ECON REV, V97, P828, DOI 10.1257/aer.97.3.828; Saidman SL, 2006, TRANSPLANTATION, V81, P773, DOI 10.1097/01.tp.0000195775.77081.25; Segev DL, 2005, JAMA-J AM MED ASSOC, V293, P1883, DOI 10.1001/jama.293.15.1883; Simpkins CE, 2007, AM J TRANSPLANT, V7, P99, DOI 10.1111/j.1600-6143.2006.01597.x; Wolfe RA, 2008, AM J TRANSPLANT, V8, P997, DOI 10.1111/j.1600-6143.2008.02177.x	20	217	220	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1096	1101		10.1056/NEJMoa0803645	http://dx.doi.org/10.1056/NEJMoa0803645			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279341	Green Published			2022-12-28	WOS:000264051000007
J	Carter, J				Carter, Jimmy			Peace and health in the occupied Palestinian territory	LANCET			English	Editorial Material									Carter Ctr, Atlanta, GA 30307 USA		Carter, J (corresponding author), Carter Ctr, Atlanta, GA 30307 USA.	carterweb@emory.edu						[Anonymous], 2009, PRESS BRIEF PRESS SE; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; GIACAMAN R, 2009, LANCET; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; *J CART LIB MUS, CAMP DAV ACC; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; *UN SECR GEN, 2008, STAT MIDDL E Q; 2009, PALESTINIANS 1300 KI	9	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					783	784		10.1016/S0140-6736(09)60106-9	http://dx.doi.org/10.1016/S0140-6736(09)60106-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416BT	19268359				2022-12-28	WOS:000263980900004
J	McGirk, J				McGirk, Jan			Rita Giacaman and Rana Khatib: promoting health for Palestinians Profile	LANCET			English	Biographical-Item												mcgirk@mac.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					801	801		10.1016/S0140-6736(09)60466-9	http://dx.doi.org/10.1016/S0140-6736(09)60466-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269504				2022-12-28	WOS:000263980900013
J	Bartels, C; Hock, C; Huwer, J; Kuhnen, R; Schwobel, J; von Issendorff, B				Bartels, C.; Hock, C.; Huwer, J.; Kuhnen, R.; Schwoebel, J.; von Issendorff, B.			Probing the Angular Momentum Character of the Valence Orbitals of Free Sodium Nanoclusters	SCIENCE			English	Article							SIMPLE METAL-CLUSTERS; ALKALI CLUSTERS; PHOTOELECTRON; MODEL; ELECTRONS; SPECTRA; PHYSICS	Although many properties of polyatomic metal clusters have been rationalized by an electron shell model resembling that used for free atoms, it remained unclear how reliable this analogy is with respect to the angular momentum eigenstate character of the electronic wave functions. We studied free size-selected negatively charged clusters of sodium atoms (Na-n(-)) of approximately spherical shape (n = 19, 40, 55, 58, 147) by angle-resolved photoelectron spectroscopy over a broad range of photon energies (1.5 to 5 electron volts). Highly anisotropic, state-and energy-dependent angular distributions emerged for all sizes. Well-defined classes of energy dependence related to the approximate angular momenta of the bound-state orbitals indicate that the overall character of the valence electron wave functions is not appreciably influenced by the interaction with the ion background. The measured distributions nevertheless deviate strongly from the predictions of single-electron models, hinting at a distinct role of correlated multielectron effects in the photoemission process.	[Bartels, C.] Univ Freiburg, Dept Phys, D-79104 Freiburg, Germany; Univ Freiburg, Freiburg Mat Res Ctr, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	von Issendorff, B (corresponding author), Univ Freiburg, Dept Phys, Stefan Meier Str 21, D-79104 Freiburg, Germany.	bernd.von.issendorff@uni-freiburg.de	von Issendorff, Bernd/B-1941-2015	von Issendorff, Bernd/0000-0002-4358-4494	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Ashcroft N.W., 1976, SOLID STATE PHYS; BERKOWTIZ J, 1979, PHOTABSORPTION PHOTO; Bethe H., 1933, HDB PHYS, P475; BRACK M, 1993, REV MOD PHYS, V65, P677, DOI 10.1103/RevModPhys.65.677; COOPER J, 1968, J CHEM PHYS, V48, P942, DOI 10.1063/1.1668742; COOPER JW, 1962, PHYS REV, V128, P681, DOI 10.1103/PhysRev.128.681; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; EATON JG, 1992, LECTURE NOTES PHYSIC, V404, P291; EKARDT W, 1984, PHYS REV B, V29, P1558, DOI 10.1103/PhysRevB.29.1558; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Garcia GA, 2004, REV SCI INSTRUM, V75, P4989, DOI 10.1063/1.1807578; HALL WD, 1974, PHYS REV A, V10, P1141, DOI 10.1103/PhysRevA.10.1141; HANDSCHUH H, 1995, J CHEM PHYS, V102, P6406, DOI 10.1063/1.469356; HECK AJR, 1995, ANNU REV PHYS CHEM, V46, P335, DOI 10.1146/annurev.pc.46.100195.002003; HELM H, 1993, PHYS REV LETT, V70, P3221, DOI 10.1103/PhysRevLett.70.3221; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; KNIGHT WD, 1985, PHYS REV B, V31, P2539, DOI 10.1103/PhysRevB.31.2539; KNIGHT WD, 1984, PHYS REV LETT, V52, P2141, DOI 10.1103/PhysRevLett.52.2141; Kostko O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043401; McEuen PL, 1997, SCIENCE, V278, P1729, DOI 10.1126/science.278.5344.1729; Moseler M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165413; PETTIETTE CL, 1988, J CHEM PHYS, V88, P5377, DOI 10.1063/1.454575; Schmidt M, 1999, EUR PHYS J D, V6, P109; Wrigge G, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063201; YANG CN, 1948, PHYS REV, V74, P764, DOI 10.1103/PhysRev.74.764; YANNOULEAS C, 1992, CHEM PHYS LETT, V193, P587, DOI 10.1016/0009-2614(92)85852-2	26	71	71	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1323	1327		10.1126/science.1168080	http://dx.doi.org/10.1126/science.1168080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265016				2022-12-28	WOS:000263876700036
J	Long, TC; Errami, M; George, AC; Sun, ZH; Garner, HR				Long, Tara C.; Errami, Mounir; George, Angela C.; Sun, Zhaohui; Garner, Harold R.			Responding to Possible Plagiarism	SCIENCE			English	Editorial Material							DEJA-VU; CITATIONS; MEDLINE		[Long, Tara C.; George, Angela C.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Errami, Mounir; Sun, Zhaohui; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garner, HR (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	harold.garner@utsouthwestern.edu	jalali, fatemeh/AAV-9835-2021		NLM NIH HHS [5R01LM009758-02] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM009758] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Errami M, 2007, NUCLEIC ACIDS RES, V35, pW12, DOI 10.1093/nar/gkm221; Errami M, 2008, BIOINFORMATICS, V24, P243, DOI 10.1093/bioinformatics/btm574; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; Errami M, 2009, NUCLEIC ACIDS RES, V37, pD921, DOI 10.1093/nar/gkn546; Gollogly L, 2006, REV SAUDE PUBL, V40, P24, DOI 10.1590/S0034-89102006000400004; Lewis J, 2006, BIOINFORMATICS, V22, P2298, DOI 10.1093/bioinformatics/btl388; ORI, 2000, MAN ALL SCI MISC GUI; *THOMS REUT, 2008, ISI WEB KNOWL; *THOMS REUT, 2008, J CIT REP ISI WEB KN; White Caroline, 2008, BMJ, V336, P797, DOI 10.1136/bmj.39546.337963.DB	10	42	43	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1293	1294		10.1126/science.1167408	http://dx.doi.org/10.1126/science.1167408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414PC	19265004				2022-12-28	WOS:000263876700023
J	Meloso, D; Copic, J; Bossaerts, P				Meloso, Debrah; Copic, Jernej; Bossaerts, Peter			Promoting Intellectual Discovery: Patents Versus Markets	SCIENCE			English	Article							INNOVATION	Because they provide exclusive property rights, patents are generally considered to be an effective way to promote intellectual discovery. Here, we propose a different compensation scheme, in which everyone holds shares in the components of potential discoveries and can trade those shares in an anonymous market. In it, incentives to invent are indirect, through changes in share prices. In a series of experiments, we used the knapsack problem ( in which participants have to determine the most valuable subset of objects that can fit in a knapsack of fixed volume) as a typical representation of intellectual discovery problems. We found that our "markets system" performed better than the patent system.	[Meloso, Debrah] Bocconi Univ, I-20136 Milan, Italy; [Copic, Jernej] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Bossaerts, Peter] CALTECH, Pasadena, CA 91125 USA; [Bossaerts, Peter] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Bocconi University; University of California System; University of California Los Angeles; California Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Meloso, D (corresponding author), Bocconi Univ, I-20136 Milan, Italy.	debrah.meloso@unibocconi.it	Bossaerts, Peter/O-9964-2015; Bossaerts, Peter/AAZ-9851-2020	Bossaerts, Peter/0000-0003-2308-2603; Meloso, Debrah/0000-0001-8025-1667	U.S. NSF [SES-0616431, SES-0317715]; Swiss Finance Institute	U.S. NSF(National Science Foundation (NSF)); Swiss Finance Institute	This study was partly funded by the U.S. NSF (grants SES-0616431 and SES-0317715) and the Swiss Finance Institute.	ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952; Biais B, 2005, REV ECON STUD, V72, P287, DOI 10.1111/j.1467-937X.2005.00333.x; Boldrin M, 2002, AM ECON REV, V92, P209, DOI 10.1257/000282802320189267; Gallini N., 2002, INNOVATION POLICY EC, V2, P51, DOI DOI 10.1162/153134602753396976; GILBERT RJ, 1982, AM ECON REV, V72, P514; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Jaffe AB, 2000, RES POLICY, V29, P531, DOI 10.1016/S0048-7333(99)00088-8; Kellerer H., 2004, KNAPSACK PROBLEMS, P235; Nuvolari A, 2004, CAMB J ECON, V28, P347, DOI 10.1093/cje/28.3.347; SAHMI S, 1975, J ASSOC COMPUT MACH, V22, P115; Siddall R, 2000, GEOL SOC SPEC PUBL, V171, P339, DOI 10.1144/GSL.SP.2000.171.01.24	11	32	32	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1335	1339		10.1126/science.1158624	http://dx.doi.org/10.1126/science.1158624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414PC	19265019				2022-12-28	WOS:000263876700040
J	Collins, H				Collins, Harry			We cannot live by scepticism alone	NATURE			English	Editorial Material									Cardiff Univ, Ctr Study Knowledge Expertise Sci, Cardiff, S Glam, Wales	Cardiff University	Collins, H (corresponding author), Cardiff Univ, Ctr Study Knowledge Expertise Sci, Cardiff, S Glam, Wales.	collinshm@cf.ac.uk			ESRC [ES/F024738/1] Funding Source: UKRI; Economic and Social Research Council [ES/F024738/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Collins H. M, 2012, GOLEM WHAT YOU SHOUL, V2nd; Evans R, 2007, RETHINKING EXPERTISE; LABINGER JA, 2001, ONE CULTURE CONVERSA	3	38	39	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					30	31		10.1038/458030a	http://dx.doi.org/10.1038/458030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414AJ	19262652	Bronze			2022-12-28	WOS:000263836000015
J	Sciaini, G; Harb, M; Kruglik, SG; Payer, T; Hebeisen, CT; Heringdorf, FJMZ; Yamaguchi, M; Hoegen, MHV; Ernstorfer, R; Miller, RJD				Sciaini, German; Harb, Maher; Kruglik, Sergei G.; Payer, Thomas; Hebeisen, Christoph T.; Heringdorf, Frank-J. Meyer Zu; Yamaguchi, Mariko; Hoegen, Michael Horn-von; Ernstorfer, Ralph; Miller, R. J. Dwayne			Electronic acceleration of atomic motions and disordering in bismuth	NATURE			English	Article							FEMTOSECOND; VISUALIZATION	The development of X-ray and electron diffraction methods with ultrahigh time resolution has made it possible to map directly, at the atomic level, structural changes in solids induced by laser excitation(1-8). This has resulted in unprecedented insights into the lattice dynamics of solids undergoing phase transitions. In aluminium, for example, femtosecond optical excitation hardly affects the potential energy surface of the lattice; instead, melting of the material is governed by the transfer of thermal energy between the excited electrons and the initially cold lattice(1). In semiconductors, in contrast, exciting similar to 10 per cent of the valence electrons results in non-thermal lattice collapse owing to the anti-bonding character of the conduction band(2-5,9,10). These different material responses raise the intriguing question of how Peierls-distorted systems(11) such as bismuth(12) will respond to strong excitations. The evolution of the atomic configuration of bismuth upon excitation of its A(1g) lattice mode, which involves damped oscillations of atoms along the direction of the Peierls distortion of the crystal, has been probed(6-8), but the actual melting of the material has not yet been investigated. Here we present a femtosecond electron diffraction study of the structural changes in crystalline bismuth as it undergoes laser-induced melting. We find that the dynamics of the phase transition depend strongly on the excitation intensity, with melting occurring within 190 fs ( that is, within half a period of the unperturbed A(1g) lattice mode(6-8)) at the highest excitation. We attribute the surprising speed of the melting process to laser-induced changes in the potential energy surface of the lattice, which result in strong acceleration of the atoms along the longitudinal direction of the lattice and efficient coupling of this motion to an unstable transverse vibrational mode. That is, the atomic motions in crystalline bismuth can be electronically accelerated so that the solid-to-liquid(13) phase transition occurs on a sub-vibrational timescale.	[Sciaini, German; Harb, Maher; Kruglik, Sergei G.; Hebeisen, Christoph T.; Yamaguchi, Mariko; Ernstorfer, Ralph; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Sciaini, German; Harb, Maher; Kruglik, Sergei G.; Hebeisen, Christoph T.; Yamaguchi, Mariko; Ernstorfer, Ralph; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Sciaini, German; Harb, Maher; Kruglik, Sergei G.; Hebeisen, Christoph T.; Yamaguchi, Mariko; Ernstorfer, Ralph; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; [Payer, Thomas; Heringdorf, Frank-J. Meyer Zu; Hoegen, Michael Horn-von] Univ Duisburg Essen, Fachbereich Phys, D-47057 Duisburg, Germany; [Payer, Thomas; Heringdorf, Frank-J. Meyer Zu; Hoegen, Michael Horn-von] Univ Duisburg Essen, Ctr Nanointegrat, D-47057 Duisburg, Germany	University of Toronto; University of Toronto; University of Toronto; University of Duisburg Essen; University of Duisburg Essen	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, 80 St George St, Toronto, ON M5S 3H6, Canada.	dmiller@lphys.chem.utoronto.ca	von Hoegen, Michael Horn/E-4969-2012; Kruglik, Sergei/F-7042-2012; Yamaguchi, Mariko/G-3135-2010; Heringdorf, Frank Meyer zu/AAE-5657-2019; Ernstorfer, Ralph/D-1590-2009	von Hoegen, Michael Horn/0000-0003-0324-3457; Kruglik, Sergei/0000-0002-2945-3092; Ernstorfer, Ralph/0000-0001-6665-3520; Sciaini, German/0000-0002-2120-3996; Harb, Maher/0000-0002-6853-9454	Natural Science and Engineering Research Council; Deutsche Forschungsgemeinschaft; Energy Dissipation at Surfaces; Alexander-von-Humboldt foundation	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Energy Dissipation at Surfaces; Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation)	We thank A.-A. Dhirani for the use of his deposition chamber. We acknowledge financial support provided by the Natural Science and Engineering Research Council and the Deutsche Forschungsgemeinschaft within the SFB 616, Energy Dissipation at Surfaces. R. E. thanks the Alexander-von-Humboldt foundation for financial support.	Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Gao HX, 1999, ACTA CRYSTALLOGR A, V55, P926, DOI 10.1107/S0108767399005176; Harb M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155504; Hebeisen CT, 2008, OPT EXPRESS, V16, P3334, DOI 10.1364/OE.16.003334; Hillyard PB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.125501; John E., 2007, CRC HDB CHEM PHYS; Johnson SL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155501; Kammler M, 2005, SURF SCI, V576, P56, DOI 10.1016/j.susc.2004.11.033; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; MADELUNG O, 1990, SEMICONDUCTORS C, V41, P1; Murray ED, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060301; Payer T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976558; Peierls R. E., 1991, MORE SURPRISES THEOR, P24; SHARRAH PC, 1960, J CHEM PHYS, V32, P241, DOI 10.1063/1.1700908; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; STAMPFLI P, 1995, APPL PHYS A-MATER, V60, P191, DOI 10.1007/BF01538245; Wu AQ, 2007, APPL SURF SCI, V253, P6301, DOI 10.1016/j.apsusc.2007.01.043; ZEIGER HJ, 1992, PHYS REV B, V45, P768, DOI 10.1103/PhysRevB.45.768; Zijlstra ES, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.220301; Zijlstra ES, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135701; ZIJLSTRA ES, 2006, P SPIE, V6261	23	225	227	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					56	U2		10.1038/nature07788	http://dx.doi.org/10.1038/nature07788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262668				2022-12-28	WOS:000263836000031
J	Steitz, TA				Steitz, Thomas A.			RETROSPECTIVE Frederic M. Richards (1925-2009)	SCIENCE			English	Biographical-Item									Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009					RICHARDS FM, PUBLICATION LIST	1	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1181	1181		10.1126/science.1171157	http://dx.doi.org/10.1126/science.1171157			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251620				2022-12-28	WOS:000263687600028
J	Vance, C; Rogelj, B; Hortobagyi, T; De Vos, KJ; Nishimura, AL; Sreedharan, J; Hu, X; Smith, B; Ruddy, D; Wright, P; Ganesalingam, J; Williams, KL; Tripathi, V; Al-Saraj, S; Al-Chalabi, A; Leigh, PN; Blair, IP; Nicholson, G; de Belleroche, J; Gallo, JM; Miller, CC; Shaw, CE				Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; De Vos, Kurt J.; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Williams, Kelly L.; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Blair, Ian P.; Nicholson, Garth; de Belleroche, Jackie; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.			Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6	SCIENCE			English	Article							FRONTOTEMPORAL DEMENTIA; TARDBP MUTATIONS; CHROMOSOME 9P; TDP-43; LOCUS; ALS; ACCUMULATION; DEGENERATION; PATIENT; LINKAGE	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is familial in 10% of cases. We have identified a missense mutation in the gene encoding fused in sarcoma (FUS) in a British kindred, linked to ALS6. In a survey of 197 familial ALS index cases, we identified two further missense mutations in eight families. Postmortem analysis of three cases with FUS mutations showed FUS-immunoreactive cytoplasmic inclusions and predominantly lower motor neuron degeneration. Cellular expression studies revealed aberrant localization of mutant FUS protein. FUS is involved in the regulation of transcription and RNA splicing and transport, and it has functional homology to another ALS gene, TARDBP, which suggests that a common mechanism may underlie motor neuron degeneration.	[Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England; [De Vos, Kurt J.; Miller, Christopher C.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Neurosci,MRC, London SE5 8AF, England; [Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth] ANSAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2139, Australia; [Nicholson, Garth] Concord Hosp, Mol Med Lab, Sydney, NSW 2139, Australia; [Blair, Ian P.; Nicholson, Garth] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [de Belleroche, Jackie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Neurosci & Mental Hlth, London W12 0NN, England	University of London; King's College London; University of London; King's College London; Concord Repatriation General Hospital; University of Sydney; Imperial College London	Shaw, CE (corresponding author), Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England.	chris.shaw@iop.kcl.ac.uk	Vance, Caroline/C-3047-2012; Vance, Caroline/Q-2633-2019; Al-Chalabi, Ammar/E-5361-2010; Miller, Christopher/H-5733-2012; Nishimura, Agnes L/B-2905-2011; Smith, Bradley/H-6107-2013; Wright, Paul/K-9171-2013; Williams, Kelly L/A-5545-2010; Leigh, Peter/AAD-5638-2019; De Vos, Kurt/D-8380-2011; Rogelj, Boris/G-9252-2011; sreedharan, jemeen/E-7327-2016	Vance, Caroline/0000-0001-5780-6951; Vance, Caroline/0000-0001-5780-6951; Al-Chalabi, Ammar/0000-0002-4924-7712; Wright, Paul/0000-0002-0359-9683; Williams, Kelly L/0000-0001-6319-9473; De Vos, Kurt/0000-0003-2161-6309; Rogelj, Boris/0000-0003-3898-1943; Wright, Paul/0000-0001-8367-5529; Shaw, Christopher/0000-0003-0251-0146; Nicholson, Garth/0000-0001-9694-066X; Smith, Bradley/0000-0002-6980-2453; Nishimura, Agnes/0000-0001-5295-797X; Blair, Ian/0000-0003-3083-0075; Miller, Christopher/0000-0002-5130-1845; sreedharan, jemeen/0000-0002-8682-6844; Gallo, Jean-Marc/0000-0003-0214-4545	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust; European Union [LSHM-CT-2003-503330]; National Institute for Health Research Biomedical Research Centre for Mental Health; The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK; King's College Hospital Charity [Jack Cigman]; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council [CDA 511941]; Motor Neuron Disease Research Institute of Australia [Peter Stearne]; MRC [G0600676, G0501573, G0300329, G0600974, G0900688, MC_G1000733, G0500289] Funding Source: UKRI; Medical Research Council [G0600676, G0300329, G0500289B, G0500289, G0900688, G0501573, G0600974, MC_G1000733] Funding Source: researchfish	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College Hospital Charity; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute of Australia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This publication is dedicated to the patients and families who have contributed to this project and to B. Coote and C. Cecere for blood sample collection. Postmortem tissues were provided by MRC Neurodegenerative Diseases Brain Bank. This work was supported in the United Kingdom by grants from the American ALS Association, the Middlemass family, Lady Edith Wolfson Trust, Motor Neurone Disease Association UK, The Wellcome Trust, European Union (APOPIS consortium, contract LSHM-CT-2003-503330, and NeuroNE Consortium), National Institute for Health Research Biomedical Research Centre for Mental Health, The South London and Maudsley National Health Service Foundation Trust, Medical Research Council UK, a Jack Cigman grant from King's College Hospital Charity, The Heaton-Ellis Trust, and The Psychiatry Research Trust of the Institute of Psychiatry. In Australia the work was supported by the Australian National Health and Medical Research Council (CDA 511941) and a Peter Stearne grant from the Motor Neuron Disease Research Institute of Australia.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	27	1835	1884	9	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1208	1211		10.1126/science.1165942	http://dx.doi.org/10.1126/science.1165942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251628	Green Accepted			2022-12-28	WOS:000263687600037
J	Licht, JD				Licht, Jonathan D.			Acute Promyelocytic Leukemia -- Weapons of Mass Differentiation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENES		Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Licht, JD (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA.		Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NATIONAL CANCER INSTITUTE [R01CA059936] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA059936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Yuan W, 2007, BLOOD, V109, P961, DOI 10.1182/blood-2006-07-036640; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541	5	37	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					928	930		10.1056/NEJMcibr0810371	http://dx.doi.org/10.1056/NEJMcibr0810371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246367				2022-12-28	WOS:000263624700015
J	Sacks, FM; Bray, GA; Carey, VJ; Smith, SR; Ryan, DH; Anton, SD; McManus, K; Champagne, CM; Bishop, LM; Laranjo, N; Leboff, MS; Rood, JC; de Jonge, L; Greenway, FL; Loria, CM; Obarzanek, E; Williamson, DA				Sacks, Frank M.; Bray, George A.; Carey, Vincent J.; Smith, Steven R.; Ryan, Donna H.; Anton, Stephen D.; McManus, Katherine; Champagne, Catherine M.; Bishop, Louise M.; Laranjo, Nancy; Leboff, Meryl S.; Rood, Jennifer C.; de Jonge, Lilian; Greenway, Frank L.; Loria, Catherine M.; Obarzanek, Eva; Williamson, Donald A.			Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; RANDOMIZED-TRIAL; MONOUNSATURATED FAT; BODY-COMPOSITION; GLYCEMIC LOAD; OBESE ADULTS; DISEASE RISK; VEGAN DIET; MAINTENANCE; OVERWEIGHT	Background: The possible advantage for weight loss of a diet that emphasizes protein, fat, or carbohydrates has not been established, and there are few studies that extend beyond 1 year. Methods: We randomly assigned 811 overweight adults to one of four diets; the targeted percentages of energy derived from fat, protein, and carbohydrates in the four diets were 20, 15, and 65%; 20, 25, and 55%; 40, 15, and 45%; and 40, 25, and 35%. The diets consisted of similar foods and met guidelines for cardiovascular health. The participants were offered group and individual instructional sessions for 2 years. The primary outcome was the change in body weight after 2 years in two-by-two factorial comparisons of low fat versus high fat and average protein versus high protein and in the comparison of highest and lowest carbohydrate content. Results: At 6 months, participants assigned to each diet had lost an average of 6 kg, which represented 7% of their initial weight; they began to regain weight after 12 months. By 2 years, weight loss remained similar in those who were assigned to a diet with 15% protein and those assigned to a diet with 25% protein (3.0 and 3.6 kg, respectively); in those assigned to a diet with 20% fat and those assigned to a diet with 40% fat (3.3 kg for both groups); and in those assigned to a diet with 65% carbohydrates and those assigned to a diet with 35% carbohydrates (2.9 and 3.4 kg, respectively) (P>0.20 for all comparisons). Among the 80% of participants who completed the trial, the average weight loss was 4 kg; 14 to 15% of the participants had a reduction of at least 10% of their initial body weight. Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets; attendance was strongly associated with weight loss (0.2 kg per session attended). The diets improved lipid-related risk factors and fasting insulin levels. Conclusions: Reduced-calorie diets result in clinically meaningful weight loss regardless of which macronutrients they emphasize. (ClinicalTrials.gov number, NCT00072995.) N Engl J Med 2009;360:859-73.	[Sacks, Frank M.; Bishop, Louise M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sacks, Frank M.; Carey, Vincent J.; Laranjo, Nancy] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Leboff, Meryl S.] Brigham & Womens Hosp, Dept Med, Div Endocrine, Boston, MA USA; [McManus, Katherine] Harvard Univ, Sch Med, Boston, MA USA; [McManus, Katherine] Brigham & Womens Hosp, Dept Nutr, Boston, MA 02115 USA; [Bray, George A.; Smith, Steven R.; Ryan, Donna H.; Anton, Stephen D.; Champagne, Catherine M.; Rood, Jennifer C.; de Jonge, Lilian; Greenway, Frank L.; Williamson, Donald A.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Loria, Catherine M.; Obarzanek, Eva] NHLBI, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sacks, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.		Smith, Steven/HDM-9496-2022; Champagne, Catherine/N-1956-2017; Biguzzi, Felipe A/E-4724-2015; Greenway, Frank/N-1966-2017; Rood, Jennifer/N-1989-2017	Champagne, Catherine/0000-0001-6127-1072; Greenway, Frank/0000-0002-1766-6111; Rood, Jennifer/0000-0001-5848-2987; Smith, Steven/0000-0002-5098-8147; Ryan, Donna/0000-0001-8374-2277; de Jonge, Lilian/0000-0001-5900-0695	National Heart, Lung, and Blood Institute [HL073286]; General Clinical Research Center, National Institutes of Health [RR-02635]; Anian; Bristol-Myers Squibb; Clarus Health; Encore Pharmaceutical; Leptos Biomedical; MDRNA; Nuovo Nordisk; General Nutrition Corporation; Catalyst; Jenny Craig; Orexigen; Lithera; Basic Research; BAROnova; Lazard; Biologene; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL073286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); General Clinical Research Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Anian; Bristol-Myers Squibb(Bristol-Myers Squibb); Clarus Health; Encore Pharmaceutical; Leptos Biomedical; MDRNA; Nuovo Nordisk; General Nutrition Corporation; Catalyst; Jenny Craig; Orexigen; Lithera; Basic Research; BAROnova; Lazard; Biologene; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Heart, Lung, and Blood Institute (HL073286) and the General Clinical Research Center, National Institutes of Health (RR-02635). Dr. Greenway reports receiving consulting fees from or serving on a paid advisory board for Anian, Bristol-Myers Squibb, Clarus Health, Encore Pharmaceutical, Leptos Biomedical, MDRNA, Nuovo Nordisk, General Nutrition Corporation, Catalyst, Jenny Craig, Orexigen, Lithera, and Basic Research, receiving lecture fees from BAROnova, Lazard, and Biologene, and owning equity in Lithera. No other potential conflict of interest relevant to this article was reported.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Champagne CM, 2004, J AM DIET ASSOC, V104, P199, DOI 10.1016/j.jada.2003.11.011; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; de Souza RJ, 2008, AM J CLIN NUTR, V88, P1; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FREEDMAN M, 2001, OBESITY REV S1, V9, P1, DOI DOI 10.1038/0BY.2001.113; GARDNER CD, 2007, JAMA-J AM MED ASSOC, V298, P178; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Jequier E, 2002, AM J MED, V113, P41, DOI 10.1016/S0002-9343(01)00991-3; Keogh JB, 2007, BRIT J NUTR, V97, P405, DOI 10.1017/S0007114507252687; KINSELL LW, 1964, METABOLISM, V13, P195, DOI 10.1016/0026-0495(64)90098-8; LeCheminant JD, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-36; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Luscombe-Marsh ND, 2005, AM J CLIN NUTR, V81, P762, DOI 10.1093/ajcn/81.4.762; McLaughlin T, 2006, AM J CLIN NUTR, V84, P813, DOI 10.1093/ajcn/84.4.813; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; *NCEP EXP PAN DET, 2002, NIH PUBL; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Ornish D, 1999, JAMA-J AM MED ASSOC, V281, P1380; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Toubro S, 1997, BRIT MED J, V314, P29, DOI 10.1136/bmj.314.7073.29; Turner-McGrievy GM, 2007, OBESITY, V15, P2276, DOI 10.1038/oby.2007.270; URBAN N, 1992, PREV MED, V21, P279, DOI 10.1016/0091-7435(92)90027-F; Volek Js, 2004, Nutr Metab (Lond), V1, P13, DOI 10.1186/1743-7075-1-13; Wadden TA, 2001, ARCH INTERN MED, V161, P218, DOI 10.1001/archinte.161.2.218; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	42	1189	1205	6	332	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					859	873		10.1056/NEJMoa0804748	http://dx.doi.org/10.1056/NEJMoa0804748			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246357	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000263624700004
J	Bussel, JB; Provan, D; Shamsi, T; Cheng, G; Psaila, B; Kovaleva, L; Salama, A; Jenkins, JM; Roychowdhury, D; Mayer, B; Stone, N; Arning, M				Bussel, James B.; Provan, Drew; Shamsi, Tahir; Cheng, Gregory; Psaila, Bethan; Kovaleva, Lidia; Salama, Abdulgabar; Jenkins, Julian M.; Roychowdhury, Debasish; Mayer, Bhabita; Stone, Nicole; Arning, Michael			Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article; Proceedings Paper	12th Congress of the European-Hematology-Association	JUN 07-10, 2007	Vienna, AUSTRIA	European Hematol Assoc			QUALITY-OF-LIFE; RECEPTOR AGONIST; TPOR AGONIST; IN-VITRO; ADULTS; EFFICACY; AMG-531; GROWTH; SAFETY; ITP	Background Eltrombopag is an oral, non-pepticle, thrombopoietin- receptor agonist that stimulates thrombopoiesis, leading to increased platelet production. This study assessed the efficacy, safety, and tolerability of once daily eltrombopag 50 mg, and explored the efficacy of a dose increase to 75 mg. Methods In this phase 111, randomised, double-blind, placebo-controlled study, adults from 63 sites in 23 countries with chronic idiopathic thrombocytopenic purpura (ITP), platelet counts less than 30000 per mu L of blood, and one or more previous ITP treatment received standard care plus once-daily eltrombopag 50 mg (n=76) or placebo (n=38) for up to 6 weeks. Patients were randomly assigned in a 2:1 ratio of eltrombopag: placebo by a validated randomisation system. After 3 weeks, patients with platelet counts less than 50000 per mu L could increase study drug to 75 mg. The primary endpoint was the proportion of patients achieving platelet counts 50000 per mu L or more at day 43. All participants who received at least one dose of their allocated treatment were included in the analysis. This study is registered with ClinicalTrials.gov, number NCT00102739. Findings 73 patients in the eltrombopag group and 37 in the placebo group were included in the efficacy population and were evaluable for day-43 analyses. 43 (59%) eltrombopag patients and six (16%) placebo patients responded (ie achieved platelet counts 2:50000 per mu L; odds ratio [OR] 9.61 [95% Cl 3.31-27.86]; p<0.0001). Response to eltrombopag compared with placebo was not affected by predefined study stratification variables (baseline platelet counts, concomitant ITP drugs, and splenectomy status) or by the number of previous ITP treatments. Of the 34 patients in the efficacy analysis who increased their dose of eltrombopag, ten (29%) responded. Platelet counts generally returned to baseline values within 2 weeks after the end of treatment. Patients receiving eltrombopag had less bleeding at any time during the study than did those receiving placebo (OR 0.49 [ 95% CI 0 . 26-0.89]; p=0. 021). The frequency of grade 3-4 adverse events during treatment (eltrombopag, two [3%]; placebo, one [3%]) and adverse events leading to study discontinuation (eltrombopag, three [4%]; placebo, two [5%]), were similar in both groups. Interpretation Eltrombopag is an effective treatment for managment of thrombocytopenia in chronic ITP. Funding GlaxoSmithKline.	[Bussel, James B.; Psaila, Bethan] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Provan, Drew] Barts & London Queen Marys Sch Med & Dent, London, England; [Shamsi, Tahir] Bismillah Taqee Inst Hlth Sci & Blood Dis Ctr, Karachi, Pakistan; [Cheng, Gregory] Chinese Univ Hong Kong, Shatin, Peoples R China; [Psaila, Bethan] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Sch Med, London, England; [Kovaleva, Lidia] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia; [Salama, Abdulgabar] Charite Univ Med Berlin, D-13353 Berlin, Germany; [Jenkins, Julian M.; Roychowdhury, Debasish; Stone, Nicole; Arning, Michael] GlaxoSmithKline Inc, Collegeville, PA USA; [Mayer, Bhabita] GlaxoSmithKline Inc, Stokley Park, England	Cornell University; University of London; Queen Mary University London; Chinese University of Hong Kong; Imperial College London; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; GlaxoSmithKline; GlaxoSmithKline	Bussel, JB (corresponding author), Cornell Univ, Weill Cornell Med Coll, 525 E 68th St,P695, New York, NY 10021 USA.	jbussel@med.cornell.edu	Provan, Drew/AAF-2766-2021	Provan, Drew/0000-0002-5110-8455; Psaila, Beth/0000-0001-8198-9663				Andemariam Biree, 2007, Hematology Am Soc Hematol Educ Program, P106; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Bussel JB, 2008, BLOOD, V112, P1177; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Cheng G, 2008, BLOOD, V112, P153; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Cohen YC, 2000, ARCH INTERN MED, V160, P1630, DOI 10.1001/archinte.160.11.1630; Erhardt J, 2004, BLOOD, V104, p59B, DOI 10.1182/blood.V104.11.3888.3888; ERICKSONMILLER CL, 2005, 96 AM ASS CANC RES A; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Kalota A, 2004, BLOOD, V104, p796A, DOI 10.1182/blood.V104.11.2913.2913; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; McMillan R, 2008, AM J HEMATOL, V83, P150, DOI 10.1002/ajh.20992; Newland A, 2006, BRIT J HAEMATOL, V135, P547, DOI 10.1111/j.1365-2141.2006.06339.x; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; PROVAN D, 2006, J CLIN ONCOL, V24; Sellers T, 2004, BLOOD, V104, p568A, DOI 10.1182/blood.V104.11.2063.2063; Stasi R, 2004, MAYO CLIN PROC, V79, P504, DOI 10.4065/79.4.504; Ware Jr JE, 2001, SCORE VERSION 2 SF 3	26	377	398	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					641	648		10.1016/S0140-6736(09)60402-5	http://dx.doi.org/10.1016/S0140-6736(09)60402-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	410FS	19231632				2022-12-28	WOS:000263563500029
J	Bar-Yam, Y; Harmon, D; de Bivort, B				Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin			SYSTEMS BIOLOGY Attractors and Democratic Dynamics	SCIENCE			English	Editorial Material							TRANSCRIPTIONAL REGULATORY NETWORK; ESCHERICHIA-COLI; CELL FATE; EVOLUTION		[Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin] New England Complex Syst Inst, Cambridge, MA 02138 USA; [de Bivort, Benjamin] Harvard Univ, Roland Inst, Cambridge, MA 02139 USA	Harvard University	Bar-Yam, Y (corresponding author), New England Complex Syst Inst, 24 Mt Auburn St, Cambridge, MA 02138 USA.	yaneer@necsi.edu						Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bang AG, 2008, SCIENCE, V320, P58, DOI 10.1126/science.1157042; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Waddington C.H., 1956, PRINCIPLES EMBRYOLOG	14	70	73	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1016	1017		10.1126/science.1163225	http://dx.doi.org/10.1126/science.1163225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	409AK	19229023				2022-12-28	WOS:000263478400025
J	Grunbaum, D				Grunbaum, Daniel			ECOLOGY Peter Principle Packs a Peck of Phytoplankton	SCIENCE			English	Editorial Material							GRAVITAXIS; MOTION; LAYERS; SHEAR		[Grunbaum, Daniel] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Grunbaum, D (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	grunbaum@ocean.washington.edu						Birch DA, 2008, DEEP-SEA RES PT I, V55, P277, DOI 10.1016/j.dsr.2007.11.009; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; KAMYKOWSKI D, 1992, MAR BIOL, V113, P319; Karp-Boss L, 1998, LIMNOL OCEANOGR, V43, P1767, DOI 10.4319/lo.1998.43.8.1767; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Pahlow M, 1997, LIMNOL OCEANOGR, V42, P1660, DOI 10.4319/lo.1997.42.8.1660; PETER LJ, 1968, PETER PRINCIPLE WHY; Roberts AM, 2006, BIOL BULL-US, V210, P78, DOI 10.2307/4134597; Roberts AM, 2002, J FLUID MECH, V452, P405, DOI 10.1017/S0022112001006772; Stacey MT, 2007, LIMNOL OCEANOGR, V52, P1523, DOI 10.4319/lo.2007.52.4.1523	14	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1022	1023		10.1126/science.1170662	http://dx.doi.org/10.1126/science.1170662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229028				2022-12-28	WOS:000263478400030
J	Bates, ER				Bates, Eric R.			Review: Sgarbossa scores >= 3 have low sensitivity and high specificity for predicting MI in left bundle branch block	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							[Anonymous], 1988, LANCET, V2, P349	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-15	10.7326/0003-4819-150-4-200902170-02015	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238613				2022-12-28	WOS:000263562500036
J	Kastrinos, F; Lebwohl, B; Neugut, AI				Kastrinos, Fay; Lebwohl, Benjamin; Neugut, Alfred I.			CT colonography had 90% sensitivity and 86% specificity for diagnosing large adenomas and cancer in asymptomatic adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kastrinos, Fay; Lebwohl, Benjamin; Neugut, Alfred I.] Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Kastrinos, F (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.							Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-13	10.7326/0003-4819-150-4-200902170-02013	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238611				2022-12-28	WOS:000263562500034
J	Woltjen, K; Michael, IP; Mohseni, P; Desai, R; Mileikovsky, M; Hamalainen, R; Cowling, R; Wang, W; Liu, PT; Gertsenstein, M; Kaji, K; Sung, HK; Nagy, A				Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Wang, Wei; Liu, Pentao; Gertsenstein, Marina; Kaji, Keisuke; Sung, Hoon-Ki; Nagy, Andras			piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; MOUSE; EXPRESSION; GENERATION; INDUCTION; MICE; INSERTIONS; VECTORS; GENE	Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state(1-4). The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral(1), lentiviral(5), adenoviral(6) and plasmid(7) transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines(8-11). The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events(12). Here we demonstrate successful and efficient reprogramming of murine and human embryonic fibroblasts using doxycycline-inducible transcription factors delivered by PB transposition(13). Stable iPS cells thus generated express characteristic pluripotency markers and succeed in a series of rigorous differentiation assays. By taking advantage of the natural propensity of the PB system for seamless excision(12), we show that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery. In addition, we have demonstrated the traceless removal of reprogramming factors joined with viral 2A sequences(14) delivered by a single transposon from murine iPS lines. We anticipate that the unique properties of this virus-independent simplification of iPS cell production will accelerate this field further towards full exploration of the reprogramming process and future cell-based therapies.	[Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Gertsenstein, Marina; Sung, Hoon-Ki; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wang, Wei; Liu, Pentao] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaji, Keisuke] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Wellcome Trust Sanger Institute; University of Edinburgh	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@lunenfeld.ca	Wilson, Matthew H/K-3193-2013; Martikainen, Riikka/AAR-8397-2020; Sung, Hoon-Ki/G-3049-2013; Sung, Hoon-Ki/A-1922-2016; Nagy, Andras/G-6465-2013; Michael, Iacovos P/C-8695-2016	Martikainen, Riikka/0000-0002-5102-0672; Sung, Hoon-Ki/0000-0001-6677-9385; Nagy, Andras/0000-0003-4311-0413; Michael, Iacovos P/0000-0001-7674-1233; Kaji, Keisuke/0000-0001-5946-8415; Woltjen, Knut/0000-0003-2293-1183	Wellcome Trust; Canadian Stem Cell Network; JDRF; Medical Research Council [G0700711B, G0700672] Funding Source: researchfish; MRC [G0700672] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Stem Cell Network; JDRF(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Moffat for time-lapse image acquisition, P.-A. Pentilla for cell sorting, M.-S. Eiymo for assisting with initial PB test vector construction, J. Ure and M. Kownacka for technical assistance, M. Kibschull for establishing human embryonic fibroblasts, A. Cheung for discussions, and K. Vintersten for critical reading of the manuscript. This work was supported by the Wellcome Trust to P. L., and grants awarded to A. N. from the Canadian Stem Cell Network and JDRF.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103	29	1297	1538	4	340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					766	U106		10.1038/nature07863	http://dx.doi.org/10.1038/nature07863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252478	Green Accepted			2022-12-28	WOS:000265193600042
J	Okie, S				Okie, Susan			A To-Do List for the New FDA Commissioner	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2007, FDA SCI MISS RISK RE; [Anonymous], 2009, PUBL GOV ACC OFF; *GOV ACC OFF, 2008, PUBL GOV ACC OFF; GREEN M, 2009, CHANGE AM PROGR BLUE; Harris Gardiner, 2009, NEW YORK TIMES  0128, pA15	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1373	1378		10.1056/NEJMp0810755	http://dx.doi.org/10.1056/NEJMp0810755			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19287021				2022-12-28	WOS:000264751800001
J	McClung, CR				McClung, C. Robertson			Linking the Loops	SCIENCE			English	Editorial Material							CIRCADIAN CLOCKS; ARABIDOPSIS; COMPONENT; GROWTH; TOC1; ELF4		Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	McClung, CR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	c.robertson.mcclung@dartmouth.edu		McClung, C. Robertson/0000-0002-7875-3614				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	14	9	10	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1440	1441		10.1126/science.1171418	http://dx.doi.org/10.1126/science.1171418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286545				2022-12-28	WOS:000264101700029
J	Yorozu, S; Wong, A; Fischer, BJ; Dankert, H; Kernan, MJ; Kamikouchi, A; Ito, K; Anderson, DJ				Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Kernan, Maurice J.; Kamikouchi, Azusa; Ito, Kei; Anderson, David J.			Distinct sensory representations of wind and near-field sound in the Drosophila brain	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MELANOGASTER; HEARING; TRANSDUCTION; DISPERSAL; SONG; MAP	Behavioural responses to wind are thought to have a critical role in controlling the dispersal and population genetics of wild Drosophila species(1,2), as well as their navigation in flight(3), but their underlying neurobiological basis is unknown. We show that Drosophila melanogaster, like wild-caught Drosophila strains(4), exhibits robust wind-induced suppression of locomotion in response to air currents delivered at speeds normally encountered in nature(1,2). Here we identify wind-sensitive neurons in Johnston's organ, an antennal mechanosensory structure previously implicated in near-field sound detection (reviewed in refs 5 and 6). Using enhancer trap lines targeted to different subsets of Johnston's organ neurons(7), and a genetically encoded calcium indicator(8), we show that wind and near-field sound (courtship song) activate distinct populations of Johnston's organ neurons, which project to different regions of the antennal and mechanosensory motor centre in the central brain. Selective genetic ablation of wind-sensitive Johnston's organ neurons in the antenna abolishes wind-induced suppression of locomotion behaviour, without impairing hearing. Moreover, different neuronal subsets within the wind-sensitive population respond to different directions of arista deflection caused by air flow and project to different regions of the antennal and mechanosensory motor centre, providing a rudimentary map of wind direction in the brain. Importantly, sound- and wind-sensitive Johnston's organ neurons exhibit different intrinsic response properties: the former are phasically activated by small, bi-directional, displacements of the aristae, whereas the latter are tonically activated by unidirectional, static deflections of larger magnitude. These different intrinsic properties are well suited to the detection of oscillatory pulses of near-field sound and laminar air flow, respectively. These data identify wind-sensitive neurons in Johnston's organ, a structure that has been primarily associated with hearing, and reveal how the brain can distinguish different types of air particle movements using a common sensory organ.	[Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Yorozu, Suzuko; Wong, Allan; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Dankert, Heiko] CALTECH, Div Engn & Appl Sci 136 93, Pasadena, CA 91125 USA; [Kernan, Maurice J.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Kamikouchi, Azusa; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; University of Cologne	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	yorozu@caltech.edu; mancusog@caltech.edu		Dankert, Heiko/0000-0002-0096-8455; Kamikouchi, Azusa/0000-0003-1552-6892; Kernan, Maurice/0000-0002-1546-6159	NSF [EF-0623527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank U. Heberlein and F. Wolf for hosting a sabbatical that led to the discovery of WISL; J. S. Johnson for helpful discussions; L. Zelnik, M. Reiser and P. Perona for creating locomotor tracking software; D. Eberl and J. Hall for D. melanogaster courtship song recordings; G. Maimon for making fly holders for imaging experiments; M. Roy for building behavioral chambers for WISL and female receptivity assays; H. Inagaki for JO-CE-GAL4; eyFLP flies; B. Hay for UAS-hid flies; D. Berdnik for UAS-FRT-STOP-FRT-Ricin flies; M. Dickinson for anemometers and discussions; J. L. Anderson for advice on fluid mechanics; M. Gopfert for providing a pressure gradient microphone; M. Konishi for advice and use of laboratory facilities; and G. Mosconi for laboratory management. D. J. A. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by NSF grant EF-0623527.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Budick SA, 2007, J EXP BIOL, V210, P4092, DOI 10.1242/jeb.006502; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; EWING AW, 1978, PHYSIOL ENTOMOL, V3, P33, DOI 10.1111/j.1365-3032.1978.tb00129.x; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Hoffmann JN, 2004, ANAT REC PART A, V281A, P1138, DOI 10.1002/ar.a.20119; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johnston J.S., 1982, P241; JOHNSTON JS, 1976, AM NAT, V110, P629, DOI 10.1086/283095; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Mamiya A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004063; MANNING A, 1967, SCIENCE, V158, P136, DOI 10.1126/science.158.3797.136; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; RICHARDSON RH, 1975, OECOLOGIA, V20, P287, DOI 10.1007/BF00345519; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	25	168	171	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					201	U4		10.1038/nature07843	http://dx.doi.org/10.1038/nature07843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279637	Green Accepted			2022-12-28	WOS:000264059700043
J	Chang, RSK; Lui, MMS; Lam, DCL; Cheung, RTF; Ho, SL				Chang, Richard S. K.; Lui, Macy M. S.; Lam, David C. L.; Cheung, Raymond T. F.; Ho, Shu-Leong			Can clubbing tell you about ears?	LANCET			English	Editorial Material							FACIAL-PAIN		[Chang, Richard S. K.; Lui, Macy M. S.; Lam, David C. L.; Cheung, Raymond T. F.; Ho, Shu-Leong] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chang, RSK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, 4-F Prof Block, Hong Kong, Hong Kong, Peoples R China.	richardcsk@gmail.com	Lam, David/AAI-3657-2020; Ho, Shu-Leong/AFK-8146-2022; /E-9868-2010; /C-4136-2009	/0000-0002-0004-2660; Lui, Macy/0000-0002-7150-9360; /0000-0001-6783-5668				BINDOFF LA, 1988, LANCET, V1, P812; BONGERS KM, 1992, NEUROLOGY, V42, P1841; Eross EJ, 2003, CEPHALALGIA, V23, P2, DOI 10.1046/j.1468-2982.2003.00478.x; GREENBERG HS, 1981, NEUROLOGY, V31, P530, DOI 10.1212/WNL.31.5.530; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					866	866		10.1016/S0140-6736(09)60489-X	http://dx.doi.org/10.1016/S0140-6736(09)60489-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269524				2022-12-28	WOS:000263980900038
J	Luo, J; Solimini, NL; Elledge, SJ				Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.			Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction	CELL			English	Review							DNA-DAMAGE RESPONSE; GROWTH-FACTOR RECEPTOR; HUMAN BREAST; NEOPLASTIC PHENOTYPE; GENOMIC INSTABILITY; SIGNALING PATHWAYS; MITOTIC CHECKPOINT; INDUCED SENESCENCE; RNA INTERFERENCE; P53 RESTORATION	Cancer is a complex collection of distinct genetic diseases united by common hallmarks. Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis. We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells. In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets. Finally, we discuss the path ahead to therapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies.	[Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu			NIH; HHMI; NATIONAL CANCER INSTITUTE [R33CA140039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank O.Cohen-Fix, J. Glaven, S. M. Lewis, W. G. Kaelin, and G. M. Wahl for critical reading of the manuscript. J. L. is supported by a fellowship from the American Association of Cancer Research. N. L. S. is a fellow of the Susan G. Komen for the Cure Foundation. This work is supported by grants from the NIH and the U.S. Department of Defense to S. J. E. S. J. E. is an investigator with HHMI. We dedicate this review to I. Bernard Weinstein for his contributions to cancer biology.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fiorentini Giammaria, 2006, J Cancer Res Ther, V2, P41; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Komarova NL, 2002, CANCER BIOL THER, V1, P685, DOI 10.4161/cbt.321; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MACDONALD C, 2005, NATURE, V438, P820; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Moreira JN, 2006, REV RECENT CLIN TRIA, V1, P217, DOI 10.2174/157488706778250050; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Nava-Parada P, 2007, CURR OPIN MOL THER, V9, P490; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roccaro AM, 2006, CURR PHARM BIOTECHNO, V7, P441, DOI 10.2174/138920106779116865; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Stauffer SR, 2007, CURR TOP MED CHEM, V7, P961, DOI 10.2174/156802607780906843; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	124	1289	1455	4	201	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					823	837		10.1016/j.cell.2009.02.024	http://dx.doi.org/10.1016/j.cell.2009.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269363	Bronze, Green Accepted			2022-12-28	WOS:000263930900007
J	Nair, P; Pizzichini, MMM; Kjarsgaard, M; Inman, MD; Efthimiadis, A; Pizzichini, E; Hargreave, FE; O'Byrne, PM				Nair, Parameswaran; Pizzichini, Marcia M. M.; Kjarsgaard, Melanie; Inman, Mark D.; Efthimiadis, Ann; Pizzichini, Emilio; Hargreave, Frederick E.; O'Byrne, Paul M.			Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-INTERLEUKIN-5; ANTIBODY; EFFICACY; SCH55700; SAFETY	Background Eosinophilic inflammation, which may be a consequence of interleukin-5 action, is a characteristic feature of some forms of asthma. However, in three previous clinical trials involving patients with asthma, blockade of this cytokine did not result in a significant improvement in outcomes. We studied the prednisone-sparing effect of mepolizumab, a monoclonal antibody against interleukin-5, in a rare subgroup of patients who have sputum eosinophilia and airway symptoms despite continued treatment with prednisone. Secondary objectives were to examine its effect on the number of eosinophils in sputum and blood, symptoms, and airflow limitation. Methods In this randomized, double-blind, parallel-group trial involving patients with persistent sputum eosinophilia and symptoms despite prednisone treatment, we assigned 9 patients to receive mepolizumab (administered in five monthly infusions of 750 mg each) and 11 patients to receive placebo. Results There were 12 asthma exacerbations in 10 patients who received placebo, 9 of whom had sputum eosinophilia at the time of exacerbation. In comparison, only one patient who received mepolizumab had an asthma exacerbation, and this episode was not associated with sputum eosinophilia (P = 0.002). Patients who received mepolizumab were able to reduce their prednisone dose by a mean (+/- SD) of 83.8 +/- 33.4% of their maximum possible dose, as compared with 47.7 +/- 40.5% in the placebo group (P = 0.04). The use of mepolizumab was associated with a significant decrease in the number of sputum and blood eosinophils. Improvements in eosinophil numbers, asthma control, and forced expiratory volume in 1 second were maintained for 8 weeks after the last infusion. There were no serious adverse events. Conclusions Mepolizumab reduced the number of blood and sputum eosinophils and allowed prednisone sparing in patients who had asthma with sputum eosinophilia despite prednisone treatment. (ClinicalTrials.gov number, NCT00292877.)	[Nair, Parameswaran] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University	Nair, P (corresponding author), St Josephs Healthcare, Firestone Inst Resp Hlth, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	parames@mcmaster.ca	Pizzichini, Emilio/L-2252-2014; Pizzichini, Marcia/K-5168-2013	Pizzichini, Emilio/0000-0001-7046-9996; Pizzichini, Marcia/0000-0001-7409-7536; O'Byrne, Paul/0000-0003-0979-281X; Pizzichini, Marcia/0000-0001-6336-7203				[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Garrett JK, 2004, J ALLERGY CLIN IMMUN, V113, P115, DOI 10.1016/j.jaci.2003.10.049; GUYATT GH, 1987, J CHRON DIS, V40, P1129, DOI 10.1016/0021-9681(87)90080-4; Hargreave FE, 2004, CLIN EXP ALLERGY, V34, P1807; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kips JC, 2003, AM J RESP CRIT CARE, V167, P1655, DOI 10.1164/rccm.200206-525OC; Klion AD, 2004, BLOOD, V103, P2939, DOI 10.1182/blood-2003-10-3620; KORN S, 2007, AM J RESP CRIT CARE, V175, pA486; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Pizzichini E, 1996, EUR RESPIR J, V9, P1174, DOI 10.1183/09031936.96.09061174; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; ROTHENBERG ME, 2008, NEW ENGL J MED, V358, P2530	16	1032	1077	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					985	993		10.1056/NEJMoa0805435	http://dx.doi.org/10.1056/NEJMoa0805435			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264687				2022-12-28	WOS:000263824500006
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man Rethinking ward rounds	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						GODLEE F, 2009, BRIT MED J, V338, pB913; Soar J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b220	2	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 4	2009	338								b879	10.1136/bmj.b879	http://dx.doi.org/10.1136/bmj.b879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417EC	19261674				2022-12-28	WOS:000264058300005
J	Shorvon, S; Neligan, A				Shorvon, Simon; Neligan, Aidan			Risk of epilepsy after head trauma	LANCET			English	Editorial Material							PREVENTION; SEIZURES		[Shorvon, Simon; Neligan, Aidan] UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Shorvon, S (corresponding author), UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.	s.shorvon@ion.ucl.ac.uk		Neligan, Aidan/0000-0003-3390-5589				Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Metcalfe C, 2008, J MED ETHICS, V34, P37, DOI 10.1136/jme.2006.019661; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x	5	3	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1060	1061		10.1016/S0140-6736(09)60215-4	http://dx.doi.org/10.1016/S0140-6736(09)60215-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19233462				2022-12-28	WOS:000264773600007
J	Lowman, M; D'Avanzo, C; Brewer, C				Lowman, Margaret; D'Avanzo, Charlene; Brewer, Carol			A National Ecological Network for Research and Education	SCIENCE			English	Editorial Material							OBSERVATORY NETWORK; NEON		[Lowman, Margaret] New Coll Florida, Dept Biol, Sarasota, FL 34243 USA; [Lowman, Margaret] New Coll Florida, Dept Environm Studies, Sarasota, FL 34243 USA; [D'Avanzo, Charlene] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA; [Brewer, Carol] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	State University System of Florida; New College Florida; State University System of Florida; New College Florida; University of Montana System; University of Montana	Lowman, M (corresponding author), New Coll Florida, Dept Biol, Sarasota, FL 34243 USA.	canopymeg@gmail.com						American Association for the Advancement of Science. (AAAS), 1993, 2061 AAAS; BOTKIN D, 1995, OUR NATL HIST LESSON; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; D'Avanzo C, 2003, FRONT ECOL ENVIRON, V1, P533, DOI 10.1890/1540-9295(2003)001[0533:ROLPFI]2.0.CO;2; DAVANZO C, 2008, NEON ED OUTREACH STR; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Mervis J, 2003, SCIENCE, V300, P1869, DOI 10.1126/science.300.5627.1869; National Research Council, 2000, INQ NAT SCI ED STAND; National Research Council, 2001, GRAND CHALL ENV SCI; National Research Council (NRC), 1996, NAT SCI ED STAND; *NEON, NEON INT SCI ED PLAN; Senkowsky S, 2005, BIOSCIENCE, V55, P106, DOI 10.1641/0006-3568(2005)055[0106:PONMA]2.0.CO;2; Teeri JA, 2002, SCIENCE, V298, P1893, DOI 10.1126/science.298.5600.1893; THOREAU HD, 1865, W POND	14	20	24	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1172	1173		10.1126/science.1166945	http://dx.doi.org/10.1126/science.1166945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251614				2022-12-28	WOS:000263687600022
J	Lim, CCT; Lim, SA				Lim, C. C. Tchoyoson; Lim, Su Ann			Pendular Nystagmus and Palatomyoclonus from Hypertrophic Olivary Degeneration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lim, C. C. Tchoyoson; Lim, Su Ann] Natl Inst Neurosci, Singapore 308433, Singapore	National Neuroscience Institute (NNI)	Lim, CCT (corresponding author), Natl Inst Neurosci, Singapore 308433, Singapore.	tchoyoson_lim@nni.com.sg		Lim, CC Tchoyoson/0000-0001-9355-6988					0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					E12	E12		10.1056/NEJMicm072125	http://dx.doi.org/10.1056/NEJMicm072125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246355				2022-12-28	WOS:000263624700011
J	Long, JA; Trinajstic, K; Johanson, Z				Long, John A.; Trinajstic, Kate; Johanson, Zerina			Devonian arthrodire embryos and the origin of internal fertilization in vertebrates	NATURE			English	Article							LIVE BIRTH; FISHES; VIVIPARITY; PHYLOGENY; AUSTRALIA; EVOLUTION; FOSSIL	Evidence of reproductive biology is extremely rare in the fossil record. Recently the first known embryos were discovered within the Placodermi(1), an extinct class of armoured fish, indicating a viviparous mode of reproduction in a vertebrate group outside the crown-group Gnathostomata (Chondrichthyes and Osteichthyes). These embryos were found in ptyctodontids, a small group of placoderms phylogenetically basal to the largest group, the Arthrodira(2,3). Here we report the discovery of embryos in the Arthrodira inside specimens of Incisoscutum ritchiei from the Upper Devonian Gogo Formation of Western Australia(4) (approximately 380 million years ago), providing the first evidence, to our knowledge, for reproduction using internal fertilization in this diverse group. We show that Incisoscutum and some phyllolepid arthrodires possessed pelvic girdles with long basipterygia that articulated distally with an additional cartilaginous element or series, as in chondrichthyans, indicating that the pelvic fin was used in copulation. As homology between similar pelvic girdle skeletal structures in ptyctodontids, arthrodires and chondrichthyans is difficult to reconcile in the light of current phylogenies of lower gnathostomes(2,3,5), we explain these similarities as being most likely due to convergence (homoplasy). These new finds confirm that reproduction by internal fertilization and viviparity was much more widespread in the earliest gnathostomes than had been previously appreciated.	[Long, John A.] Victoria & Albert Museum, Melbourne, Vic 3001, Australia; [Long, John A.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2600, Australia; [Long, John A.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Trinajstic, Kate] Univ Western Australia, Sch Earth & Geog Sci, Perth, WA 6009, Australia; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England	Australian National University; Monash University; University of Western Australia; Natural History Museum London	Long, JA (corresponding author), Victoria & Albert Museum, POB 666, Melbourne, Vic 3001, Australia.	jlong@museum.vic.gov.au	Trinajstic, Kate/B-2537-2009	Johanson, Zerina/0000-0002-8444-6776; Trinajstic, Kate/0000-0002-6519-6396; Long, John/0000-0001-8012-0114	Australian Research Council	Australian Research Council(Australian Research Council)	We thank M. Brazeau for access to his manuscript before publication, A. Ritchie for discussions, and G. Young and G. Edgecombe for reviewing the manuscript. We also thank K. Bifield for the photograph of WAM 04.10.02, and the Centre for Microscopy, Characterisation and Analysis, UWA, for microscopy assistance. J.A.L. and K.T. are supported by Australian Research Council Discovery grants.	Blackburn D.G., 2005, VIVIPAROUS FISHES, P287; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BURGIN T, 1990, ZOOL J LINN SOC-LOND, V100, P379, DOI 10.1111/j.1096-3642.1990.tb01866.x; Chiappe LM, 2004, NATURE, V432, P571, DOI 10.1038/432571a; Davidson RG, 2005, SCOT J GEOL, V41, P129, DOI 10.1144/sjg41020129; DENNIS K, 1981, ZOOL J LINN SOC-LOND, V73, P213, DOI 10.1111/j.1096-3642.1981.tb01594.x; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; LEE MYS, 1998, HERPETOLOGICA, V55, P538; Long J.A., 1984, Proceedings of the Linnean Society of New South Wales, V107, P263; LONG JA, 2006, SWIMMING STONE AMAZI, P320; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Lopez JA, 2006, MOL PHYLOGENET EVOL, V40, P50, DOI 10.1016/j.ympev.2006.02.011; LUND R, 1980, SCIENCE, V209, P697, DOI 10.1126/science.209.4457.697; Mank JE, 2006, J EVOLUTION BIOL, V19, P734, DOI 10.1111/j.1420-9101.2005.01060.x; Maxwell EE, 2003, P ROY SOC B-BIOL SCI, V270, pS104, DOI 10.1098/rsbl.2003.0029; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; Ritchie A, 2005, P LINN SOC N S W, V126, P215; SCHULTZE HP, 1972, NATURE-NEW BIOL, V236, P90, DOI 10.1038/newbio236090a0; Sewertzoff AN, 1926, J MORPHOL PHYSIOL, V41, P547, DOI 10.1002/jmor.1050410208; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; WOURMS JP, 1981, AM ZOOL, V21, P473; YOUNG G C, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V202, P1; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	27	54	56	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1124	1127		10.1038/nature07732	http://dx.doi.org/10.1038/nature07732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242474				2022-12-28	WOS:000263680100039
J	Corson, MA				Corson, Marshall A.			Phospholipase A(2) inhibitors in atherosclerosis: the race is on	LANCET			English	Editorial Material							CORONARY ATHEROSCLEROSIS; DARAPLADIB; PLAQUE; RISK		[Corson, Marshall A.] Univ Washington, Harborview Med Ctr, Div Cardiol, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Corson, MA (corresponding author), Univ Washington, Harborview Med Ctr, Div Cardiol, 325 9Th Ave, Seattle, WA 98104 USA.	mcorson@u.washington.edu						*CLINICALTRIALS GO, 2008, STAB ATH PLAQ IN DAR; *CLINTRIALS GOV, 2008, FRANCIS ACS TRIAL ST; Crandall Mark A, 2008, Curr Treat Options Cardiovasc Med, V10, P304; Jonsson-Rylander AC, 2008, CURR ATHEROSCLER REP, V10, P252, DOI 10.1007/s11883-008-0039-6; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Menschikowski M, 2006, PROSTAG OTH LIPID M, V79, P1, DOI 10.1016/j.prostaglandins.2005.10.005; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870	14	19	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					608	610		10.1016/S0140-6736(09)60378-0	http://dx.doi.org/10.1016/S0140-6736(09)60378-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231615				2022-12-28	WOS:000263563500006
J	Schlosser, RJ				Schlosser, Rodney J.			Epistaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TOXIC-SHOCK-SYNDROME; MANAGEMENT; HYPERTENSION	A 61-year-old man presents to the emergency room with left- sided epistaxis that has continued for 1 hour. He estimates having lost approximately 1/2 cup of blood and reports no history of nasal obstruction, epistaxis, trauma, bleeding diathesis, or easy bruising. He has a history of hypertension. Medications include atenolol and baby aspirin. How should this patient be evaluated and treated?	[Schlosser, Rodney J.] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA	Medical University of South Carolina	Schlosser, RJ (corresponding author), Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.				Medtronic	Medtronic(Medtronic)	Dr. Schlosser reports receiving consulting fees and research support from Medtronic. No other potential conflict of interest relevant to this article was reported.	Awan MS, 2008, EMERG MED J, V25, P156, DOI 10.1136/emj.2006.038828; Badran K, 2005, CLIN OTOLARYNGOL, V30, P333, DOI 10.1111/j.1365-2273.2005.01019.x; Burton MJ, 2004, COCHRANE DB SYST REV, V1, P1; Cullen MM, 1998, OTOLARYNG HEAD NECK, V118, P636, DOI 10.1016/S0194-5998(98)70233-5; Douglas Richard, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P180, DOI 10.1097/MOO.0b013e32814b06ed; Fuchs FD, 2003, BLOOD PRESSURE, V12, P145, DOI 10.1080/08037050310001750; Gifford TO, 2008, OTOLARYNG CLIN N AM, V41, P525, DOI 10.1016/j.otc.2008.01.003; Herkner H, 2002, AM J EMERG MED, V20, P92, DOI 10.1053/ajem.2002.31577; Herkner H, 2000, ANN EMERG MED, V35, P126, DOI 10.1016/S0196-0644(00)70131-4; JACOBSON JA, 1986, ARCH OTOLARYNGOL, V112, P329; KNOPFHOLZ J, 2008, INT J CARDIOL   0520; KREMPL GA, 1995, ANN OTO RHINOL LARYN, V104, P704, DOI 10.1177/000348949510400906; Kubba H, 2001, CLIN OTOLARYNGOL, V26, P465, DOI 10.1046/j.1365-2273.2001.00502.x; Kumar S, 2003, CLIN OTOLARYNGOL, V28, P360, DOI 10.1046/j.1365-2273.2003.00724.x; Mathiasen RA, 2005, LARYNGOSCOPE, V115, P899, DOI 10.1097/01.MLG.0000160528.50017.3C; Moshaver A, 2004, J OTOLARYNGOL, V33, P185, DOI 10.2310/7070.2004.00185; Oneal RM, 1999, OTOLARYNG CLIN N AM, V32, P145, DOI 10.1016/S0030-6665(05)70119-5; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Srinivasan V, 2000, J LARYNGOL OTOL, V114, P697; Thong JF, 2007, J LARYNGOL OTOL, V121, P124, DOI 10.1017/S0022215106004099; VIDUCICH RA, 1995, ANN EMERG MED, V25, P592, DOI 10.1016/S0196-0644(95)70169-9; Viehweg TL, 2006, J ORAL MAXIL SURG, V64, P511, DOI 10.1016/j.joms.2005.11.031; Waddell AN, 2003, J LARYNGOL OTOL, V117, P843, DOI 10.1258/002221503322542818; Walker TWM, 2007, CLIN OTOLARYNGOL, V32, P361, DOI 10.1111/j.1749-4486.2007.01530.x; Younis RT, 1996, ARCH OTOLARYNGOL, V122, P83	25	85	86	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					784	789		10.1056/NEJMcp0807078	http://dx.doi.org/10.1056/NEJMcp0807078			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228621				2022-12-28	WOS:000263411300008
J	Brieger, DB; Ben Freedman, S				Brieger, David B.; Ben Freedman, S.			Delirium cordis: can we predict the onset of atrial fibrillation?	LANCET			English	Editorial Material							RHYTHM CONTROL; PREVENTION; METAANALYSIS; PREVALENCE; TRIAL		[Brieger, David B.; Ben Freedman, S.] Univ Sydney, ANZAC Res Inst, Vasc Biol Grp, Sydney, NSW 2006, Australia; [Ben Freedman, S.] Concord Repatriat Gen Hosp, Concord Clin Sch, Dept Cardiol, Concord, NSW 2137, Australia	University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital	Brieger, DB (corresponding author), Univ Sydney, ANZAC Res Inst, Vasc Biol Grp, Sydney, NSW 2006, Australia.	ben@med.usyd.edu.au	Ekanayake, Kanchana/P-8817-2016; Freedman, Saul B/C-1625-2013; Research Institute, ANZAC/CAE-9030-2022	Freedman, Saul B/0000-0002-3809-2911; 				Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Hohnloser SH, 2008, J CARDIOVASC ELECTR, V19, P69, DOI 10.1111/j.1540-8167.2007.01016.x; Karjalainen J, 1998, BMJ-BRIT MED J, V316, P1784, DOI 10.1136/bmj.316.7147.1784; Mayson Sarah E, 2007, Cardiol Rev, V15, P231, DOI 10.1097/CRD.0b013e31813e62bb; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Organization WH, 2006, NEUR DIS PUBL HLTH C, DOI 10.1001/archneurol.2007.19; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	14	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					698	700		10.1016/S0140-6736(09)60415-3	http://dx.doi.org/10.1016/S0140-6736(09)60415-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249615				2022-12-28	WOS:000263725400006
J	Woodcock, A				Woodcock, Ashley			The Montreal Protocol: getting over the finishing line?	LANCET			English	Editorial Material							OZONE DEPLETION		Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Woodcock, A (corresponding author), Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	ashley.woodcock@manchester.ac.uk		Woodcock, Ashley/0000-0002-5428-8578				Anderson SO, 2007, TECHNOLOGY TRANSFER, P23; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; LePrestre P, 1998, PROTECTING OZONE LAY; LLOYD SA, 1993, LANCET, V342, P1156, DOI 10.1016/0140-6736(93)92130-L; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Slaper H, 1996, NATURE, V384, P256, DOI 10.1038/384256a0; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104	8	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					705	706		10.1016/S0140-6736(09)60418-9	http://dx.doi.org/10.1016/S0140-6736(09)60418-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249618	Green Submitted			2022-12-28	WOS:000263725400010
J	Kawashima, Y; Pfafferott, K; Frater, J; Matthews, P; Payne, R; Addo, M; Gatanaga, H; Fujiwara, M; Hachiya, A; Koizumi, H; Kuse, N; Oka, S; Duda, A; Prendergast, A; Crawford, H; Leslie, A; Brumme, Z; Brumme, C; Allen, T; Brander, C; Kaslow, R; Tang, J; Hunter, E; Allen, S; Mulenga, J; Branch, S; Roach, T; John, M; Mallal, S; Ogwu, A; Shapiro, R; Prado, JG; Fidler, S; Weber, J; Pybus, OG; Klenerman, P; Ndung'u, T; Phillips, R; Heckerman, D; Harrigan, PR; Walker, BD; Takiguchi, M; Goulder, P				Kawashima, Yuka; Pfafferott, Katja; Frater, John; Matthews, Philippa; Payne, Rebecca; Addo, Marylyn; Gatanaga, Hiroyuki; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Oka, Shinichi; Duda, Anna; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Kaslow, Richard; Tang, James; Hunter, Eric; Allen, Susan; Mulenga, Joseph; Branch, Songee; Roach, Tim; John, Mina; Mallal, Simon; Ogwu, Anthony; Shapiro, Roger; Prado, Julia G.; Fidler, Sarah; Weber, Jonathan; Pybus, Oliver G.; Klenerman, Paul; Ndung'u, Thumbi; Phillips, Rodney; Heckerman, David; Harrigan, P. Richard; Walker, Bruce D.; Takiguchi, Masafumi; Goulder, Philip			Adaptation of HIV-1 to human leukocyte antigen class I	NATURE			English	Article							T-LYMPHOCYTE RESPONSE; MHC-CLASS-I; ESCAPE MUTATIONS; CELL RESPONSES; VIRAL LOAD; HLA-B; GAG; TRANSMISSION; POLYMORPHISMS; ASSOCIATIONS	The rapid and extensive spread of the human immunodeficiency virus (HIV) epidemic provides a rare opportunity to witness host-pathogen co-evolution involving humans. A focal point is the interaction between genes encoding human leukocyte antigen (HLA) and those encoding HIV proteins. HLA molecules present fragments (epitopes) of HIV proteins on the surface of infected cells to enable immune recognition and killing by CD8(+) T cells; particular HLA molecules, such as HLA-B*57, HLA-B*27 and HLA-B*51, are more likely to mediate successful control of HIV infection(1). Mutation within these epitopes can allow viral escape from CD8(+) T-cell recognition. Here we analysed viral sequences and HLA alleles from. 2,800 subjects, drawn from 9 distinct study cohorts spanning 5 continents. Initial analysis of the HLA-B*51-restricted epitope, TAFTIPSI (reverse transcriptase residues 128135), showed a strong correlation between the frequency of the escape mutation I135X and HLA-B*51 prevalence in the 9 study cohorts (P=0.0001). Extending these analyses to incorporate other well-defined CD8(+) T-cell epitopes, including those restricted by HLA-B*57 and HLA-B*27, showed that the frequency of these epitope variants (n=14) was consistently correlated with the prevalence of the restricting HLA allele in the different cohorts (together, P < 0.0001), demonstrating strong evidence of HIV adaptation to HLA at a population level. This process of viral adaptation may dismantle the well-established HLA associations with control of HIV infection that are linked to the availability of key epitopes, and highlights the challenge for a vaccine to keep pace with the changing immunological landscape presented by HIV.	[Pfafferott, Katja; Matthews, Philippa; Payne, Rebecca; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Prado, Julia G.; Goulder, Philip] Dept Paediat, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] Nuffield Dept Clin Med, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] James Martin 21st Century Sch, Oxford OX1 3SY, England; [Kawashima, Yuka; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Takiguchi, Masafumi] Kumamoto Univ, Div Viral Immunol, Kumamoto 8600811, Japan; [Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Div Infect Dis, Ctr AIDS Res, Kumamoto 8600811, Japan; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Murdoch Univ, Murdoch, WA 6000, Australia; [Addo, Marylyn; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02129 USA; [Gatanaga, Hiroyuki; Hachiya, Atsuko; Oka, Shinichi] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa HIVACAT, Badalona, Spain; [Brander, Christian] ICREA, Barcelona 08916, Spain; [Kaslow, Richard; Tang, James] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Hunter, Eric] Emory Univ, Vaccine Ctr, Atlanta, GA 30329 USA; [Hunter, Eric] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Allen, Susan; Mulenga, Joseph] Zambia Emory HIV Res Project, Lusaka, Zambia; [Allen, Susan; Mulenga, Joseph] Zambia Blood Transfus Serv, Lusaka, Zambia; [Branch, Songee; Roach, Tim] Univ W Indies, Ladymeade Reference Unit, BB-11156 Bridgetown, Barbados; [Ogwu, Anthony; Shapiro, Roger] Botswana Harvard Sch Publ Hlth, AIDS Initiat Partnership, Gaborone, Botswana; [Fidler, Sarah; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Wright Fleming Inst, Div Med, London W2 1PG, England; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England; [Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Harrigan, P. Richard] Miscrosoft Res, Redmond, WA USA; [Heckerman, David] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	University of Oxford; University of Oxford; Kumamoto University; Kumamoto University; Royal Perth Hospital; University of Western Australia; Murdoch University; Harvard University; Massachusetts General Hospital; National Center for Global Health & Medicine - Japan; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; University of Alabama System; University of Alabama Birmingham; Emory University; University West Indies Mona Jamaica; University of the West Indies Open Campus; Imperial College London; University of Oxford; University of Kwazulu Natal; B.C. Centre for Excellence in HIV/AIDS; Howard Hughes Medical Institute	Goulder, P (corresponding author), Dept Paediat, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.	philip.goulder@paediatrics.ox.ac.uk	Pybus, Oliver G/B-2640-2012; Matthews, Philippa/P-7810-2019; Prado, Julia Garcia/R-7177-2019; Addo, Marylyn M./GNP-2548-2022; Takiguchi, Masafumi/E-7468-2013; Payne, Rebecca/AAC-4783-2022; Tang, Jianming "James"/O-4980-2019; Mallal, Simon Alexander/HDM-9561-2022; Allen, Todd/F-5473-2011	Pybus, Oliver G/0000-0002-8797-2667; Matthews, Philippa/0000-0002-4036-4269; Prado, Julia Garcia/0000-0002-5439-4645; Payne, Rebecca/0000-0002-9037-7367; Tang, Jianming "James"/0000-0003-0137-7486; Mallal, Simon Alexander/0000-0002-7036-1309; Allen, Todd/0000-0002-6609-1318; Brumme, Chanson/0000-0003-2722-5288; Fidler, Sarah/0000-0003-1676-7583; klenerman, paul/0000-0003-4307-9161; Oka, Shinichi/0000-0002-9283-2167; Brander, Christian/0000-0002-0548-5778; Brumme, Zabrina/0000-0002-8157-1037; Frater, John/0000-0001-7163-7277; Addo, Marylyn/0000-0003-2836-9224; Prendergast, Andrew/0000-0001-7904-7992; Ndung'u, Thumbi/0000-0003-2962-3992	National Institutes of Health [RO1AI46995, 1 R01 AI067073, R01AI64060]; Wellcome Trust; UK Medical Research Council; Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare [012]; Ministry of Education, Science, Sports and Culture [18390141]; NIHR Biomedical Research Centre Programme; Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow [IEF-041811]; MRC [G0501777, G0500384, G108/626] Funding Source: UKRI; Medical Research Council [G0501777, G0500384, G108/626] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067073, R01AI064060, R01AI046995, R01AI060460] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This work is funded by grants from the National Institutes of Health (RO1AI46995 ( P. G.), 1 R01 AI067073 ( B. D. W.), R01AI64060 ( E. H.)), the Wellcome Trust ( P. G., P. K.), the UK Medical Research Council (J.F., A. P. and P. M.), and the Mark and Lisa Schwartz Foundation, the Ministry of Health, Labour and Welfare (Health and Labour HIV/AIDS Research Grants 012), the NIHR Biomedical Research Centre Programme and the Ministry of Education, Science, Sports and Culture ( number 18390141), Japan ( M. T.). P. G. is an Elizabeth Glaser Pediatric AIDS Foundation Scientist; J.G.P. is a Marie Curie Fellow (contract number IEF-041811). The authors are also grateful to A. McLean and H. Fryer for discussions of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Gallimore A, 1998, J EXP MED, V187, P1647; Gatanaga H, 2006, VIROLOGY, V344, P354, DOI 10.1016/j.virol.2005.09.005; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Seki S, 2008, J VIROL, V82, P5093, DOI 10.1128/JVI.02607-07; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tomiyama H, 2002, J VIROL, V76, P7535, DOI 10.1128/JVI.76.15.7535-7543.2002; Tomiyama H, 1999, HUM IMMUNOL, V60, P177, DOI 10.1016/S0198-8859(98)00113-X	30	344	360	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					641	U108		10.1038/nature07746	http://dx.doi.org/10.1038/nature07746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242411	Green Accepted			2022-12-28	WOS:000264796200043
J	Katz, PR; Karuza, J; Intrator, O; Mor, V				Katz, Paul R.; Karuza, Jurgis; Intrator, Orna; Mor, Vincent			Nursing Home Physician Specialists: A Response to the Workforce Crisis in Long-Term Care	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL MEDICINE; INTERNAL-MEDICINE; RESIDENTS; QUALITY; PATTERNS; STATE; STAFF	Marginalization of physicians in the nursing home threatens the overall care of increasingly frail nursing home residents who have medically complex illnesses. The authors propose that creating a nursing home medicine specialty, which recognizes the nursing home as a unique practice site, would go a long way toward remedying existing problems with care in skilled nursing facilities and would best serve the needs of the 1.6 million nursing home residents in the United States. Reviewing what is known about physician practice in nursing homes and hospitals, and taking a lead from the hospitalist movement, the specialty would be characterized in 3 dimensions: the degree of physicians' commitment, physicians' practice competencies, and the structure of the medical staff organization in which they practice. Challenges to the adoption of a nursing home specialist model include mainstream medicine's failure to recognize the nursing home as a legitimate medical practice, the need for the nursing home industry and policymakers to appreciate the links between physician practice and quality, and assurance of financial viability. Implications for quality of care, health policy, and research needs are discussed in this article.	[Katz, Paul R.] Univ Rochester, Sch Med & Dent, Rochester, NY 14620 USA; SUNY Buffalo, Buffalo, NY 14260 USA; Brown Univ, Providence, RI 02912 USA	University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Brown University	Katz, PR (corresponding author), Univ Rochester, Sch Med & Dent, 435 E Henrietta Rd, Rochester, NY 14620 USA.	Paul_Katz@urmc.rochester.edu			National Institute on Aging [R21 AG025246]; NATIONAL INSTITUTE ON AGING [R21AG025246] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: Dr. Katz was supported by the National Institute on Aging (grant R21 AG025246).	*AM MED DIR ASS, CMS IMPL REV SURV GU; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Borger C, 2006, HEALTH AFFAIR, V25, pW61, DOI 10.1377/hlthaff.25.w61; Caprio T. V., 2006, ANNALS OF LONG TERM, V14, P17; Caprio TV, 2009, J AM MED DIR ASSOC, V10, P93, DOI 10.1016/j.jamda.2008.07.007; DeFrances C. J, 2007, 2005 NATL HOSP DISCH, V385; FLOOD AB, 1978, J HEALTH SOC BEHAV, V19, P240, DOI 10.2307/2136557; Glasheen JJ, 2008, J GEN INTERN MED, V23, P1110, DOI 10.1007/s11606-008-0646-5; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Intrator O, 1999, MED CARE, V37, P228, DOI 10.1097/00005650-199903000-00003; Jones Adrienne, 2002, Vital Health Stat 13, P1; KARUZA J, 1994, J AM GERIATR SOC, V42, P787, DOI 10.1111/j.1532-5415.1994.tb06543.x; Kasper J, 2007, CHANGES CHARACTERIST; Katz PR, 2006, J AM MED DIR ASSOC, V7, P394, DOI 10.1016/j.jamda.2006.05.003; Katz Paul R, 2003, J Am Med Dir Assoc, V4, P115, DOI 10.1016/S1525-8610(04)70288-1; Katz PR, 1997, J AM GERIATR SOC, V45, P911, DOI 10.1111/j.1532-5415.1997.tb02958.x; KATZ PR, 1993, J GEN INTERN MED, V8, P691, DOI 10.1007/BF02598291; Katz PR, 2005, J AM GERIATR SOC, V53, P1826, DOI 10.1111/j.1532-5415.2005.53509.x; Kirch DG, 2008, JAMA-J AM MED ASSOC, V299, P2680, DOI 10.1001/jama.299.22.2680; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Leibovitz A, 2004, AGING CLIN EXP RES, V16, P314; *MED PAYM ADV COMM, 2008, DAT BOOK HLTH CAR SP; Medina-Walpole A, 2002, J AM GERIATR SOC, V50, P949, DOI 10.1046/j.1532-5415.2002.50225.x; Roemer M., 1971, DOCTORS HOSP MED STA; Schmidt IK, 2002, SOC SCI MED, V54, P1767, DOI 10.1016/S0277-9536(01)00146-0; Schols J M G A, 2004, J Am Med Dir Assoc, V5, P207, DOI 10.1097/01.JAM.0000123031.43619.60; SHORTELL S, 1976, ORG RES HOSP; SHORTELL SM, 1981, MED CARE, V19, P1041, DOI 10.1097/00005650-198110000-00006; Shortell SM, 2005, MED CARE RES REV, V62, P407, DOI 10.1177/1077558705277389; Sloane PD, 2003, J AM GERIATR SOC, V51, P1587, DOI 10.1046/j.1532-5415.2003.51511.x; Spillman BC, 2000, NEW ENGL J MED, V342, P1409, DOI 10.1056/NEJM200005113421906; Spillman BC, 2002, MED CARE, V40, P965, DOI 10.1097/00005650-200210000-00013; *US, 1987, ANN REV POPUL LAW, V14, P473; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008; Zimmerman S, 2002, J AM GERIATR SOC, V50, P1987, DOI 10.1046/j.1532-5415.2002.50610.x; CERTIFIED MED DIRECT	39	81	81	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					411	W73		10.7326/0003-4819-150-6-200903170-00010	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293074	Green Accepted			2022-12-28	WOS:000264468500007
J	Mehanna, HM; Jain, A; Morton, RP; Watkinson, J; Shaha, A				Mehanna, H. M.; Jain, A.; Morton, R. P.; Watkinson, J.; Shaha, A.			Investigating the thyroid nodule	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FINE-NEEDLE-ASPIRATION; PATHOLOGICAL FINDINGS; ULTRASOUND; MALIGNANCY; FEATURES; ULTRASONOGRAPHY; MANAGEMENT; DIAGNOSIS; CYTOLOGY; BIOPSY		[Mehanna, H. M.] Univ Hosp Coventry, Inst Head & Neck Studies & Educ, Coventry CV2 2DX, W Midlands, England; [Morton, R. P.] Manukau Super Clin, Counties Manukau Dist Hlth Board ENT, Papakura, Franklin, New Zealand; [Watkinson, J.] Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Birmingham, W Midlands, England; [Shaha, A.] Mem Sloan Kettering Canc Ctr, Div Head & Neck Surg, New York, NY 10021 USA	University of Warwick; University of Birmingham; Memorial Sloan Kettering Cancer Center	Mehanna, HM (corresponding author), Univ Hosp Coventry, Inst Head & Neck Studies & Educ, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.	Hisham.Mehanna@uhcw.nhs.uk		Mehanna, Hisham/0000-0002-5544-6224				AHUJA AT, 2003, IMAGING HEAD NECK CA; Alexander EK, 2003, ANN INTERN MED, V138, P315, DOI 10.7326/0003-4819-138-4-200302180-00010; Baskin H Jack, 2004, Endocr Pract, V10, P242; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; *BRIT THYR ASS ROY, 2007, BRIT THYR ASS GUID M; CHEUNG PSY, 1989, WORLD J SURG, V13, P818, DOI 10.1007/BF01658447; Deandrea Maurilio, 2002, Endocr Pract, V8, P282; DELOSSANTOS ET, 1990, ARCH INTERN MED, V150, P1422, DOI 10.1001/archinte.150.7.1422; HALL TL, 1989, CANCER, V63, P718, DOI 10.1002/1097-0142(19890215)63:4<718::AID-CNCR2820630420>3.0.CO;2-N; Jun Peter, 2005, Ultrasound Q, V21, P39; Koike E, 2001, EUR J SURG, V167, P656; Kountakis Stilianos E, 2002, Ear Nose Throat J, V81, P151; Leenhardt L, 1999, J CLIN ENDOCR METAB, V84, P24, DOI 10.1210/jc.84.1.24; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Mehrotral P, 2005, SURG-J R COLL SURG E, V3, P1, DOI 10.1016/S1479-666X(05)80002-2; Nam-Goong IS, 2004, CLIN ENDOCRINOL, V60, P21, DOI 10.1046/j.1365-2265.2003.01912.x; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Prinz R A, 2001, Endocr Pract, V7, P318; Sahin M, 2006, ENDOCR PATHOL, V17, P67, DOI 10.1385/EP:17:1:67; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; WATKINSON JC, 2000, TUMOURS THYROID PARA; Wienke JR, 2003, J ULTRAS MED, V22, P1027, DOI 10.7863/jum.2003.22.10.1027; Yeh MW, 2004, THYROID, V14, P207, DOI 10.1089/105072504773297885	25	27	29	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2009	338								b733	10.1136/bmj.b733	http://dx.doi.org/10.1136/bmj.b733			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GE	19286747				2022-12-28	WOS:000264206500005
J	Inomata, K; Ohno, A; Tochio, H; Isogai, S; Tenno, T; Nakase, I; Takeuchi, T; Futaki, S; Ito, Y; Hiroaki, H; Shirakawa, M				Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Tenno, Takeshi; Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro			High-resolution multi-dimensional NMR spectroscopy of proteins in human cells	NATURE			English	Article							INTERNALIZATION MECHANISMS; PENETRATING PEPTIDES; LIVING CELLS; UBIQUITIN; DELIVERY; TRANSDUCTION; DOMAINS; OOCYTES; DESIGN; FK506	In-cell NMR is an isotope-aided multi-dimensional NMR technique that enables observations of conformations and functions of proteins in living cells at the atomic level(1). This method has been successfully applied to proteins overexpressed in bacteria, providing information on protein-ligand interactions(2) and conformations(3,4). However, the application of in-cell NMR to eukaryotic cells has been limited to Xenopus laevis oocytes(5-7). Wider application of the technique is hampered by inefficient delivery of isotope-labelled proteins into eukaryote somatic cells. Here we describe a method to obtain high-resolution two-dimensional (2D) heteronuclear NMR spectra of proteins inside living human cells. Proteins were delivered to the cytosol by the pyrenebutyrate-mediated action of cell-penetrating peptides(8) linked covalently to the proteins. The proteins were subsequently released from cell-penetrating peptides by endogenous enzymatic activity or by autonomous reductive cleavage. The heteronuclear 2D spectra of three different proteins inside human cells demonstrate the broad application of this technique to studying interactions and protein processing. The in-cell NMR spectra of FKBP12 (also known as FKBP1A) show the formation of specific complexes between the protein and extracellularly administered immunosuppressants, demonstrating the utility of this technique in drug screening programs. Moreover, in-cell NMRspectroscopy demonstrates that ubiquitin has much higher hydrogen exchange rates in the intracellular environment, possibly due to multiple interactions with endogenous proteins.	[Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Inomata, Kohsuke; Tochio, Hidehito; Tenno, Takeshi; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Futaki, Shiroh] JST, SORST, Kawaguchi, Saitama 3320012, Japan; [Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe University; Kyoto University; Tokyo Metropolitan University; RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	tochio@moleng.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Tochio, Hidehito/GWV-0429-2022; HIROAKI, HIDEKAZU/N-1658-2019; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011; Inomata, Kohsuke/H-9189-2017; Ito, Yutaka/P-2604-2015	Tochio, Hidehito/0000-0003-3843-3330; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Inomata, Kohsuke/0000-0002-6816-7961; Ito, Yutaka/0000-0002-1030-4660; Isogai, Shin/0000-0002-3768-6427; Futaki, Shiroh/0000-0002-0124-4002	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [B-09]; Japan Society for the Promotion of Science; Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT; MEXT;  [FKBP12]	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We thank M. Waelchli, A. Kidera and H. Akutsu for discussion, T. Kokubo for monkey COS-7 cells, H. Ohnishi for the plasmid for production of FKBP12 and M. Imanishi for taking gel fluorimaging. This work was supported by grants to M. S. from Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), and also in part by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' ( No. B-09) of MEXT, administered by the Japan Society for the Promotion of Science. This work was partly supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT to A. O. and M. S., and by grants from MEXT to S. F. and H. T.	Bai YW, 1995, METHOD ENZYMOL, V259, P344; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Goddard T. D., 1999, SPARKY 3; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; ITOH S, 1995, PROTEIN SCI, V4, P2261, DOI 10.1002/pro.5560041103; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Loison F, 2005, MOL THER, V11, P205, DOI 10.1016/j.ymthe.2004.10.010; Mezo G, 2000, BIOCONJUGATE CHEM, V11, P484, DOI 10.1021/bc990116o; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; ROSEN MK, 1991, BIOCHEMISTRY-US, V30, P4774, DOI 10.1021/bi00233a020; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016	28	331	336	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					106	U11		10.1038/nature07839	http://dx.doi.org/10.1038/nature07839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262675				2022-12-28	WOS:000263836000042
J	Kahal, H; Cooper, E; Sriraman, R; Coppini, DV				Kahal, H.; Cooper, E.; Sriraman, R.; Coppini, D. V.			Endgames Picture Quiz A woman with a suprarenal mass and hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; NEUROFIBROMATOSIS TYPE-1; SURGICAL-MANAGEMENT; C-KIT; PHEOCHROMOCYTOMA; ADRENALECTOMY; DISEASE; GENETICS; MUTATION; PATIENT		[Kahal, H.; Cooper, E.; Sriraman, R.; Coppini, D. V.] Poole Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Poole BH15 2JB, Dorset, England		Kahal, H (corresponding author), Poole Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Poole BH15 2JB, Dorset, England.	hassoon011@yahoo.com						[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Brunt LM, 2002, ANN SURG, V235, P713, DOI 10.1097/00000658-200205000-00014; Bumming P, 2006, SCAND J GASTROENTERO, V41, P626, DOI 10.1080/00365520500434838; CARNEY JA, 1977, NEW ENGL J MED, V296, P1517, DOI 10.1056/NEJM197706302962609; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Duh QY, 2001, J CLIN ENDOCR METAB, V86, P1477, DOI 10.1210/jc.86.4.1477; Ekeblad S, 2006, ENDOCR-RELAT CANCER, V13, P963, DOI 10.1677/erc.1.01201; Fukasawa T, 2000, JPN J CANCER RES, V91, P1241, DOI 10.1111/j.1349-7006.2000.tb00910.x; FULLER CE, 1991, HISTOPATHOLOGY, V19, P1; GHRIST TD, 1963, ARCH INTERN MED, V112, P357, DOI 10.1001/archinte.1963.03860030111011; Giuly JA, 2003, AM J SURG, V185, P86, DOI 10.1016/S0002-9610(02)01111-X; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Janetschek G, 1998, J UROLOGY, V160, P330, DOI 10.1016/S0022-5347(01)62886-6; Karagiannis A, 2007, ENDOCR-RELAT CANCER, V14, P935, DOI 10.1677/ERC-07-0142; Karatzas G, 2000, EUR J SURG ONCOL, V26, P428, DOI 10.1053/ejso.1999.0911; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kramer K, 2005, Z GASTROENTEROL, V43, P281, DOI 10.1055/s-2004-813810; Kramer K, 2007, WORLD J GASTROENTERO, V13, P3384, DOI 10.3748/wjg.v13.i24.3384; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lisewski Dean, 2006, Int Semin Surg Oncol, V3, P11, DOI 10.1186/1477-7800-3-11; Miettinen M, 2006, AM J SURG PATHOL, V30, P90, DOI 10.1097/01.pas.0000176433.81079.bd; Nemoto H, 2006, J GASTROENTEROL, V41, P378, DOI 10.1007/s00535-006-1772-7; Pacak K, 2001, ANN INTERN MED, V134, P315, DOI 10.7326/0003-4819-134-4-200102200-00016; Pacak K, 2007, NAT CLIN PRACT ENDOC, V3, P92, DOI 10.1038/ncpendmet0396; Rizzo S, 2001, Chir Ital, V53, P243; Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728; Teramoto S, 2007, INT J UROL, V14, P73, DOI 10.1111/j.1442-2042.2006.01601.x; THOMAS PK, 2003, OXFORD TXB MED, V3, P934; Usui M, 2002, J GASTROENTEROL, V37, P947, DOI 10.1007/s005350200159; Walther MM, 2000, J UROLOGY, V164, P14, DOI 10.1016/S0022-5347(05)67438-1; WHALEN RK, 1992, J UROLOGY, V147, P1, DOI 10.1016/S0022-5347(17)37119-7; Yantiss RK, 2005, MODERN PATHOL, V18, P475, DOI 10.1038/modpathol.3800334; Yip L, 2004, J AM COLL SURGEONS, V198, P525, DOI 10.1016/j.jamcollsurg.2003.12.001; Zoller MET, 1997, CANCER-AM CANCER SOC, V79, P2125	35	17	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2009	338								b333	10.1136/bmj.b333	http://dx.doi.org/10.1136/bmj.b333			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EC	19261665				2022-12-28	WOS:000264058300001
J	Delmo, MP; Yamamoto, S; Kasai, S; Ono, T; Kobayashi, K				Delmo, Michael P.; Yamamoto, Shinpei; Kasai, Shinya; Ono, Teruo; Kobayashi, Kensuke			Large positive magnetoresistive effect in silicon induced by the space-charge effect	NATURE			English	Article							ROOM-TEMPERATURE; GIANT MAGNETORESISTANCE; LIMITED CURRENTS; MAGNETIC-FIELD; SEMICONDUCTORS; SOLIDS; INHOMOGENEITIES; SENSORS; FILMS; INSB	Recent discoveries of large magnetoresistance in non-magnetic semiconductors(1-8) have gained much attention because the size of the effect is comparable to, or even larger than, that of magnetoresistance in magnetic systems(9-14). Conventional magnetoresistance in doped semiconductors is straightforwardly explained as the effect of the Lorentz force on the carrier motion(15), but the reported unusually large effects imply that the underlying mechanisms have not yet been fully explored. Here we report that a simple device, based on a lightly doped silicon substrate between two metallic contacts, shows a large positive magnetoresistance of more than 1,000 per cent at room temperature (300 K) and 10,000 per cent at 25 K, for magnetic fields between 0 and 3 T. A high electric field is applied to the device, so that conduction is space-charge limited(16-18). For substrates with a charge carrier density below similar to 10(13) cm(-3), the magnetoresistance exhibits a linear dependence on the magnetic field between 3 and 9 T. We propose that the observed large magnetoresistance can be explained by quasi-neutrality breaking of the space-charge effect, where insufficient charge is present to compensate the electrons injected into the device. This introduces an electric field inhomogeneity, analogous to the situation in other semiconductors in which a large, non-saturating magnetoresistance was observed(1-5,19). In this regime, the motions of electrons become correlated, and thus become dependent on magnetic field. Although large positive magnetoresistance at room temperature has been achieved in metal-semiconductor hybrid devices(6-8), we have now realized it in a simpler structure and in a way different from other known magnetoresistive effects(9-14,20). It could be used to develop new magnetic devices from silicon, which may further advance silicon technology.	[Delmo, Michael P.; Kasai, Shinya; Ono, Teruo; Kobayashi, Kensuke] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Yamamoto, Shinpei] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Kobayashi, K (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	kensuke@scl.kyoto-u.ac.jp	Kobayashi, Kensuke/E-5404-2010; Ono, Teruo/AAR-1164-2020; KASAI, Shinya/H-2808-2011	Kobayashi, Kensuke/0000-0001-7072-5945; KASAI, Shinya/0000-0001-7149-4800; Delmo, Michael/0000-0002-1815-4580	KAKENHI; ICR; Asahi Glass Foundation; Sumitomo Foundation; JSPS	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ICR; Asahi Glass Foundation; Sumitomo Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We appreciate discussions with T. Shinjo, H. Akinaga, H. Sakakima, Y. Iye, J. Ohe, S. Takahashi and T. Susaki. This work was partly supported by KAKENHI, ICR Grants for Young Scientists, the Asahi Glass Foundation and the Sumitomo Foundation. M. P. D. acknowledges support from JSPS Research Fellowships for Young Scientists.	Ashcroft N.W., 1976, SOLID STATE PHYS; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Bergman DJ, 2000, PHYS REV B, V62, P6603, DOI 10.1103/PhysRevB.62.6603; BERKOWITZ AE, 1992, PHYS REV LETT, V68, P3745, DOI 10.1103/PhysRevLett.68.3745; HERRING C, 1960, J APPL PHYS, V31, P1939, DOI 10.1063/1.1735477; Husmann A, 2002, NATURE, V417, P421, DOI 10.1038/417421a; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; LAMPERT MA, 1961, PHYS REV, V121, P26, DOI 10.1103/PhysRev.121.26; LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648; Moussa J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184410; Parish MM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094417; Parish MM, 2003, NATURE, V426, P162, DOI 10.1038/nature02073; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; PAYLING CA, 1986, SUPERLATTICE MICROST, V2, P415, DOI 10.1016/0749-6036(86)90003-0; ROSE A, 1955, PHYS REV, V97, P1538, DOI 10.1103/PhysRev.97.1538; SAMPSELL JB, 1976, PHYS REV B, V13, P583, DOI 10.1103/PhysRevB.13.583; Schoonus JJHM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127202; Shklovskii B.I., 1984, ELECT PROPERTIES DOP, P202; SLADEK RJ, 1958, J PHYS CHEM SOLIDS, V5, P157, DOI 10.1016/0022-3697(58)90065-9; Solin SA, 2002, APPL PHYS LETT, V80, P4012, DOI 10.1063/1.1481238; Solin SA, 2000, SCIENCE, V289, P1530, DOI 10.1126/science.289.5484.1530; STROUD D, 1976, PHYS REV B, V13, P1434, DOI 10.1103/PhysRevB.13.1434; Sun ZG, 2004, APPL PHYS LETT, V85, P5643, DOI 10.1063/1.1834733; Sze S. M., 2021, PHYS SEMICONDUCTOR D, DOI DOI 10.1002/0470068329; Tornow M, 1996, PHYS REV LETT, V77, P147, DOI 10.1103/PhysRevLett.77.147; XIAO JQ, 1992, PHYS REV LETT, V68, P3752; Xu R, 1997, NATURE, V390, P57, DOI 10.1038/36306; YAFET Y, 1956, J PHYS CHEM SOLIDS, V1, P137, DOI 10.1016/0022-3697(56)90020-8; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257; Zhang T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162666	30	142	149	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1112	U65		10.1038/nature07711	http://dx.doi.org/10.1038/nature07711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242471				2022-12-28	WOS:000263680100036
J	Eisenberg, MS; Psaty, BM				Eisenberg, Mickey S.; Psaty, Bruce M.			Defining and Improving Survival Rates From Cardiac Arrest in US Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CARE COMMITTEE; RESUSCITATION; STATEMENT; CARDIOPULMONARY; OUTCOMES; COUNCIL		[Eisenberg, Mickey S.] Seattle King Cty Dept Publ Hlth, King Cty Emergency Med Serv Div, Seattle, WA USA; [Eisenberg, Mickey S.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [HL085251, HL087652, HL74745, HL080295] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL087652, U01HL080295, R01HL074745, R01HL085251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Holzer M, 2002, NEW ENGL J MED, V346, P549; Institute of Medicine, EM MED SERV CROSSR; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lombardi Gary, 1994, JAMA (Journal of the American Medical Association), V271, P678, DOI 10.1001/jama.271.9.678; National Cancer Institute, 1975, SEER CANC STAT REV; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018	15	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					860	862		10.1001/jama.2009.193	http://dx.doi.org/10.1001/jama.2009.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244194				2022-12-28	WOS:000263609900028
J	Josephson, CB; Salman, RAS; Phillips, SJ				Josephson, Colin B.; Salman, Rustam Al-Shahi; Phillips, Stephen J.			Case report An episode of transient neurological symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ISCHEMIC ATTACK; MINOR STROKE; VASCULAR EVENTS; RISK; ENDARTERECTOMY; DIPYRIDAMOLE; ASPIRIN; CARE; MRI		[Josephson, Colin B.; Phillips, Stephen J.] Dalhousie Univ, Div Neurol, Dept Med, Halifax, NS B3H 3A7, Canada; [Salman, Rustam Al-Shahi] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Dalhousie University; University of Edinburgh	Phillips, SJ (corresponding author), Dalhousie Univ, Div Neurol, Dept Med, Halifax, NS B3H 3A7, Canada.	stephen.phillips@cdha.nshealth.ca		Al-Shahi Salman, Rustam/0000-0002-2108-9222	MRC [G108/613] Funding Source: UKRI; Medical Research Council [G108/613] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; CHANDRATHEVA A, 2008, INT J STROKE S1, V3, P153; Collins R, 2004, LANCET, V363, P757; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Flossmann E, 2008, STROKE, V39, P2457, DOI 10.1161/STROKEAHA.107.511428; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; GODLEE F, 2009, BRIT MED J, V338, pB821; Halkes PHA, 2006, LANCET, V367, P1665; Hankey G., 2000, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001246, 10.1002/14651858.CD001246]; Hjort N, 2005, ANN NEUROL, V58, P462, DOI 10.1002/ana.20595; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kapral MK, 1999, CAN MED ASSOC J, V161, P989; Kidwell CS, 1999, STROKE, V30, P1174, DOI 10.1161/01.STR.30.6.1174; Lindsay P, 2008, CAN MED ASSOC J, V179, pS1, DOI 10.1503/cmaj.081148.R2; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Prabhakaran S, 2007, ARCH NEUROL-CHICAGO, V64, P1105, DOI 10.1001/archneur.64.8.1105; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; *ROYAL COLL PHYS C, 2008, NAT CLIN GUID STROK; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Saxena R, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000185.pub2, DOI 10.1002/14651858.CD000185.PUB2]; Schaer B, 2009, EUR J NEUROL, V16, P268, DOI 10.1111/j.1468-1331.2008.02413.x; Schulz UG, 2004, STROKE, V35, P2459, DOI 10.1161/01.STR.0000143455.55877.b9; Warlow C, 2008, STROKE PRACTICAL MAN	31	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2009	338								b616	10.1136/bmj.b616	http://dx.doi.org/10.1136/bmj.b616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244298				2022-12-28	WOS:000264056200001
J	Bruix, J; Llovet, JM				Bruix, Jordi; Llovet, Josep M.			Major achievements in hepato cellular carcinoma	LANCET			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CLASSIFICATION; CIRRHOSIS; COHORT; NODULES; CANCER; RISK; HCC		[Bruix, Jordi; Llovet, Josep M.] Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain; [Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA; [Llovet, Josep M.] ICREA, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; ICREA	Bruix, J (corresponding author), Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es	Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Bruix, Jordi/0000-0002-9826-0753	ICREA Funding Source: Custom	ICREA(ICREA)		Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruno S, 2007, HEPATOLOGY, V46, P1350, DOI 10.1002/hep.21826; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243	20	247	264	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					614	616		10.1016/S0140-6736(09)60381-0	http://dx.doi.org/10.1016/S0140-6736(09)60381-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231618				2022-12-28	WOS:000263563500009
J	Park, BS; Song, DH; Kim, HM; Choi, BS; Lee, H; Lee, JO				Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Hayyoung; Lee, Jie-Oh			The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex	NATURE			English	Article							TOLL-LIKE RECEPTORS; CRYSTAL-STRUCTURE; HUMAN MD-2; LIPID-A; ENDOTOXIN; RESPONSIVENESS; BINDING; ROLES; TLR4; BACTERIAL	The lipopolysaccharide (LPS) of Gram negative bacteria is a well-known inducer of the innate immune response(1). Toll-like receptor (TLR) 4 and myeloid differentiation factor 2 (MD-2) form a heterodimer that recognizes a common 'pattern' in structurally diverse LPS molecules. To understand the ligand specificity and receptor activation mechanism of the TLR4-MD-2-LPS complex we determined its crystal structure. LPS binding induced the formation of an m-shaped receptor multimer composed of two copies of the TLR4-MD-2-LPS complex arranged symmetrically. LPS interacts with a large hydrophobic pocket in MD-2 and directly bridges the two components of the multimer. Five of the six lipid chains of LPS are buried deep inside the pocket and the remaining chain is exposed to the surface of MD-2, forming a hydrophobic interaction with the conserved phenylalanines of TLR4. The F126 loop of MD-2 undergoes localized structural change and supports this core hydrophobic interface by making hydrophilic interactions with TLR4. Comparison with the structures of tetra-acylated antagonists bound to MD-2 indicates that two other lipid chains in LPS displace the phosphorylated glucosamine backbone by similar to 5 angstrom towards the solvent area(2,3). This structural shift allows phosphate groups of LPS to contribute to receptor multimerization by forming ionic interactions with a cluster of positively charged residues in TLR4 and MD-2. The TLR4-MD-2-LPS structure illustrates the remarkable versatility of the ligand recognition mechanisms employed by the TLR family(4,5), which is essential for defence against diverse microbial infection.	[Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Lee, Hayyoung] Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Lee, Jie-Oh/C-1581-2011; Kim, Ho Min/G-2712-2011; Choi, Byong-Seok/C-1937-2011; Lee, Jie-Oh/AAG-4302-2020	Lee, Jie-Oh/0000-0001-6519-6049	Ministry of Education, Science and Technology of Korea	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank the staff of beamline 4A at the Pohang Accelerator Laboratory and beamline ID23-2 at ESRF for help with data collection. We thank J. Gross for critical reading of the manuscript. J.-O.L and co-workers are funded by the Creative Research Initiative (Center for Membrane Receptor Research) from the Ministry of Education, Science and Technology of Korea.	Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEDZHITOV R, 1997, NATURE, V388, P397; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; ULMER AJ, 1992, INFECT IMMUN, V60, P3309, DOI 10.1128/IAI.60.8.3309-3314.1992; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	34	1484	1554	8	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1191	U130		10.1038/nature07830	http://dx.doi.org/10.1038/nature07830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252480				2022-12-28	WOS:000265754600051
J	Arrow, K; Auerbach, A; Bertko, J; Brownlee, S; Casalino, LP; Cooper, J; Crosson, FJ; Enthoven, A; Falcone, E; Feldman, RC; Fuchs, VR; Garber, AM; Gold, MR; Goldman, D; Hadfield, GK; Hall, MA; Horwitz, RI; Hooven, M; Jacobson, PD; Jost, TS; Kotlikoff, LJ; Levin, J; Levine, S; Levy, R; Linscott, K; Luft, HS; Mashal, R; McFadden, D; Mechanic, D; Meltzer, D; Newhouse, JP; Noll, RG; Pietzsch, JB; Pizzo, P; Reischauer, RD; Rosenbaum, S; Sage, W; Schaeffer, LD; Sheen, E; Silber, M; Skinner, J; Shortell, SM; Thier, SO; Tunis, S; Wulsin, L; Yock, P; Bin Nun, G; Bryan, S; Luxenburg, O; van de Ven, WPMM				Arrow, Kenneth; Auerbach, Alan; Bertko, John; Brownlee, Shannon; Casalino, Lawrence P.; Cooper, Jim; Crosson, Francis J.; Enthoven, Alain; Falcone, Elizabeth; Feldman, Robert C.; Fuchs, Victor R.; Garber, Alan M.; Gold, Marthe R.; Goldman, Dana; Hadfield, Gillian K.; Hall, Mark A.; Horwitz, Ralph I.; Hooven, Michael; Jacobson, Peter D.; Jost, Timothy Stoltzfus; Kotlikoff, Lawrence J.; Levin, Jonathan; Levine, Sharon; Levy, Richard; Linscott, Karen; Luft, Harold S.; Mashal, Robert; McFadden, Daniel; Mechanic, David; Meltzer, David; Newhouse, Joseph P.; Noll, Roger G.; Pietzsch, Jan B.; Pizzo, Philip; Reischauer, Robert D.; Rosenbaum, Sara; Sage, William; Schaeffer, Leonard D.; Sheen, Edward; Silber, Michael; Skinner, Jonathan; Shortell, Stephen M.; Thier, Samuel O.; Tunis, Sean; Wulsin, Lucien, Jr.; Yock, Paul; Bin Nun, Gabi; Bryan, Stirling; Luxenburg, Osnat; van de Ven, Wynand P. M. M.			Toward a 21st-Century Health Care System: Recommendations for Health Care Reform	ANNALS OF INTERNAL MEDICINE			English	Article								The coverage, cost, and quality problems of the U. S. health care system are evident. Sustainable health care reform must go beyond financing expanded access to care to substantially changing the organization and delivery of care. The FRESH-Thinking Project (www.fresh-thinking.org) held a series of workshops during which physicians, health policy experts, health insurance executives, business leaders, hospital administrators, economists, and others who represent diverse perspectives came together. This group agreed that the following 8 recommendations are fundamental to successful reform: 1. Replace the current fee-for-service payment system with a payment system that encourages and rewards innovation in the efficient delivery of quality care. The new payment system should invest in the development of outcome measures to guide payment. 2. Establish a securely funded, independent agency to sponsor and evaluate research on the comparative effectiveness of drugs, devices, and other medical interventions. 3. Simplify and rationalize federal and state laws and regulations to facilitate organizational innovation, support care coordination, and streamline financial and administrative functions. 4. Develop a health information technology infrastructure with national standards of interoperability to promote data exchange. 5. Create a national health database with the participation of all payers, delivery systems, and others who own health care data. Agree on methods to make de-identified information from this database on clinical interventions, patient outcomes, and costs available to researchers. 6. Identify revenue sources, including a cap on the tax exclusion of employer-based health insurance, to subsidize health care coverage with the goal of insuring all Americans. 7. Create state or regional insurance exchanges to pool risk, so that Americans without access to employer-based or other group insurance could obtain a standard benefits package through these exchanges. Employers should also be allowed to participate in these exchanges for their employees' coverage. 8. Create a health coverage board with broad stakeholder representation to determine and periodically update the affordable standard benefit package available through state or regional insurance exchanges.	Stanford Univ, Stanford, CA 94305 USA; [Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ So Calif, Los Angeles, CA USA; Permanente Med Grp Inc, Oakland, CA USA; Hill Phys Med Grp, San Ramon, CA USA; Varian Med Syst & Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; Insure Uninsured Project, Santa Monica, CA USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Chicago, Chicago, IL 60637 USA; Humana, Louisville, KY USA; Enable Med Technol, Cincinnati, OH USA; Univ Texas Austin, Austin, TX 78712 USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Washington & Lee Univ, Lexington, VA 24450 USA; George Washington Univ, New Amer Fdn, Leapfrog Grp, Urban Inst, Washington, DC USA; US House Representatives, Washington, DC 20515 USA; Ctr Med Technol Policy, Baltimore, MD USA; Rutgers State Univ, New Brunswick, NJ 08903 USA; Weill Cornell Med Coll, Ithaca, NY USA; CUNY, New York, NY 10021 USA; Boston Univ, NKT Therapeut, Boston, MA 02215 USA; Harvard Univ, Boston, MA 02115 USA; Dartmouth Med Sch, Hanover, NH USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; Minist Hlth, Jerusalem, Israel; Univ Birmingham, Birmingham, W Midlands, England; Erasmus Univ, Rotterdam, Netherlands	Stanford University; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of Southern California; Permanente Medical Groups; Palo Alto Medical Foundation Research Institute; University of Michigan System; University of Michigan; University of Chicago; Humana Inc.; University of Texas System; University of Texas Austin; Wake Forest University; Washington & Lee University; George Washington University; Urban Institute; Rutgers State University New Brunswick; Cornell University; City University of New York (CUNY) System; Boston University; Harvard University; Dartmouth College; Dartmouth College; Ben Gurion University; University of Birmingham; Erasmus University Rotterdam	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall, Berkeley, CA 94720 USA.		Garber, Alan M/F-1476-2010; Newhouse, Joseph/AAD-9763-2019; Meltzer, David/C-2926-2009; Goldman, Dana P/E-7667-2013; Casalino, Lawrence/ABE-1245-2020; Newhouse, Joseph/AGJ-5632-2022	Meltzer, David/0000-0003-2790-7393; Goldman, Dana P/0000-0001-8498-6396; Casalino, Lawrence/0000-0002-7927-7859; Noll, Roger/0000-0001-9012-3773; Pietzsch, Jan Benjamin/0000-0002-5078-1939; Hall, Mark A./0000-0001-6277-144X	Robert Wood Johnson Foundation; The California Endowment; California Wellness Foundation; L. A. Care Health Plan; Blue Shield of California Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); The California Endowment; California Wellness Foundation; L. A. Care Health Plan; Blue Shield of California Foundation	Potential Financial Conflicts of Interest: Employment: F.J. Crosson (Kaiser Permanente); R. Mashal (NKT Therapeutics); L. Wulsin Jr. (Director, Insure the Uninsured Project). Consultancies: J.P. Newhouse (Director, Aetna); L. Schaeffer (consultant to private equity firm). Stock ownership or options: R. Mashal (equity ownership, public and private biotechnology companies); D. Mechanic (McKesson Corporation); J.P. Newhouse (equity ownership, Aetna); L. Schaeffer (Pharmaceutical companies and outpatient surgery centers); S.O. Thier (Director, Charles River Laboratories; Director, Merck & Co.). Grants received: D. Mechanic (Robert Wood Johnson Foundation); L. Wulsin Jr. (The California Endowment, The California Wellness Foundation, L. A. Care Health Plan, Blue Shield of California Foundation). Royalties: D. Mechanic (The Truth about Health Care: Why Reform is Not Working in America. Piscataway, NJ: Rutgers Univ Pr; 2006.) Other: J.P. Newhouse (Director of NCQA [unpaid]).		0	52	52	3	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					493	+		10.7326/0003-4819-150-7-200904070-00115	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432EZ	19258550	Green Published			2022-12-28	WOS:000265117600008
J	Wolff, T; Miller, T; Ko, S				Wolff, Tracy; Miller, Therese; Ko, Stephen			Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ASPIRIN; RANDOMIZED-TRIAL; DISEASE; STROKE	Background: Coronary heart disease and cerebrovascular disease are leading causes of death in the United States. In 2002, the U. S. Preventive Services Task Force (USPSTF) strongly recommended that clinicians discuss aspirin with adults who are at increased risk for coronary heart disease. Purpose: To determine the benefits and harms of taking aspirin for the primary prevention of myocardial infarctions, strokes, and death. Data Sources: MEDLINE and Cochrane Library (search dates, 1 January 2001 to 28 August 2008), recent systematic reviews, reference lists of retrieved articles, and suggestions from experts. Study Selection: English-language randomized, controlled trials (RCTs); case-control studies; meta-analyses; and systematic reviews of aspirin versus control for the primary prevention of cardiovascular disease (CVD) were selected to answer the following questions: Does aspirin decrease coronary heart events, strokes, death from coronary heart events or stroke, or all-cause mortality in adults without known CVD? Does aspirin increase gastrointestinal bleeding or hemorrhagic strokes? Data Extraction: All studies were reviewed, abstracted, and rated for quality by using predefined USPSTF criteria. Data Synthesis: New evidence from 1 good-quality RCT, 1 good-quality meta-analysis, and 2 fair-quality subanalyses of RCTs demonstrates that aspirin use reduces the number of CVD events in patients without known CVD. Men in these studies experienced fewer myocardial infarctions and women experienced fewer ischemic strokes. Aspirin does not seem to affect CVD mortality or all-cause mortality in either men or women. The use of aspirin for primary prevention increases the risk for major bleeding events, primarily gastrointestinal bleeding events, in both men and women. Men have an increased risk for hemorrhagic strokes with aspirin use. A new RCT and meta-analysis suggest that the risk for hemorrhagic strokes in women is not statistically significantly increased. Limitations: New evidence on aspirin for the primary prevention of CVD is limited. The dose of aspirin used in the RCTs varied, which prevented the estimation of the most appropriate dose for primary prevention. Several of the RCTs were conducted within populations of health professionals, which potentially limits generalizability. Conclusion: Aspirin reduces the risk for myocardial infarction in men and strokes in women. Aspirin use increases the risk for serious bleeding events.	Agcy Healthcare Res & Qual, Rockville, MD USA; New York Presbyterian Hosp Cornell, New York, NY USA	Agency for Healthcare Research & Quality; NewYork-Presbyterian Hospital	Wolff, T (corresponding author), Agcy Hlth Res & Qual, 540 Gaither Rd, Rockville, MD 20850 USA.							Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris RP., 2001, US PREVENTIVE SERVIC; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Meade TW, 1998, LANCET, V351, P233; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zanchetti A, 2002, J HYPERTENS, V20, P2301, DOI 10.1097/00004872-200211000-00031	15	171	191	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					405	W72		10.7326/0003-4819-150-6-200903170-00009	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293073				2022-12-28	WOS:000264468500006
J	Becker, RC; Moliterno, DJ; Jennings, LK; Pieper, KS; Pei, JL; Niederman, A; Ziada, KM; Berman, G; Strony, J; Joseph, D; Mahaffey, KW; Van de Werf, F; Veltri, E; Harrington, RA				Becker, Richard C.; Moliterno, David J.; Jennings, Lisa K.; Pieper, Karen S.; Pei, Jinglan; Niederman, Alan; Ziada, Khaled M.; Berman, Gail; Strony, John; Joseph, Diane; Mahaffey, Kenneth W.; Van de Werf, Frans; Veltri, Enrico; Harrington, Robert A.		TRA-PCI Investigators	Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study	LANCET			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; CLOPIDOGREL; ANTAGONIST; ASPIRIN; P2Y(12); INHIBITION; PRASUGREL; BLOCKADE; BINDING	Background An antithrombotic drug is needed that safely reduces cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). We therefore assessed the tolerability and safety of SCH 530348-an oral platelet protease-activated receptor-1 antagonist. Methods We randomly assigned patients aged 45 years or older and undergoing non-urgent PCI or Coronary angiography with planned PCI to an oral loading dose of SCH 530348 (10 mg, 20 mg, or 40 mg) or matching placebo in a 3:1 ratio in a multicentre international study. Those in the SCH 530348 group who subsequently underwent PCI (primary PCI cohort) continued taking an oral maintenance dose (0.5 mg, 1.0 mg, or 2.5 mg per day), and patients in the placebo group continued placebo for 60 days. The primary endpoint was the incidence of clinically significant major or minor bleeding according to the thrombolysis in myocardial infarction (TIMI) scale. Both investigators and patients were unaware of treatment allocation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00132912. Findings 257 patients were assigned to placebo and 773 to SCH 530348. The primary endpoint occurred in 2 (2%) of 129, 3 (3%) of 120, and 7 (4%) of 173 patients, respectively, in the SCH 530348 10 mg, 20 mg, and 40 mg groups compared with 5 (3%) of 151 patients in the placebo group (p=0.5786). TIMI major plus minor bleeding occurred in 3 (2%) of 136, 5 (4%) of 139, and 4 (3%) of 138 patients given SCH 530348 0.5 mg, 1.0 mg, and 2.5 mg once per day, respectively (p=0.7561). Interpretation Oral SCH 530348 was generally well tolerated and did not cause increased TIMI bleeding, even when administered concomitantly with aspirin and clopidogrel. Further testing in phase III trials to accurately define the safety and efficacy of SCH 530348 is warranted.	[Becker, Richard C.] Duke Clin Res Inst, Div Cardiol, Duke Cardiovasc Thrombosis Inst, Durham, NC 27705 USA; [Moliterno, David J.; Ziada, Khaled M.] Univ Kentucky, Lexington, KY USA; [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Pei, Jinglan; Berman, Gail; Strony, John; Veltri, Enrico] Schering Plough Corp, Kenilworth, NJ 07033 USA; [Niederman, Alan] Jim Moran Heart & Vasc Res Inst, Ft Lauderdale, FL USA; [Van de Werf, Frans] Katholieke Univ Leuven Hosp, Leuven, Belgium	Duke University; University of Kentucky; University of Tennessee System; University of Tennessee Health Science Center; Merck & Company; Schering Plough Corporation; KU Leuven; University Hospital Leuven	Becker, RC (corresponding author), Duke Clin Res Inst, Div Cardiol, Duke Cardiovasc Thrombosis Inst, 2400 Pratt St, Durham, NC 27705 USA.	richard.becker@duke.edu		Van de Werf, Frans/0000-0001-9479-7767	Schering-Plough Research Institute	Schering-Plough Research Institute(Merck & Company)	Funding Schering-Plough Research Institute.	Anderluh M, 2002, CURR MED CHEM, V9, P1229, DOI 10.2174/0929867023369934; Andersen H, 1999, P NATL ACAD SCI USA, V96, P11189, DOI 10.1073/pnas.96.20.11189; Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chackalamannil S, 1996, J AM CHEM SOC, V118, P9812, DOI 10.1021/ja962542f; CHINTALA M, 2007, EUR SOC CARD C 2007; CHINTALA M, 2008, ART THROMB VAS UNPUB; Day JRS, 2004, CIRCULATION, V110, P2597, DOI 10.1161/01.CIR.0000138027.80056.31; Derian CK, 2003, J PHARMACOL EXP THER, V304, P855, DOI 10.1124/jpet.102.042663; Doller D, 1999, BIOORG MED CHEM LETT, V9, P901, DOI 10.1016/S0960-894X(99)00101-8; Eikelboom JW, 2002, EUR HEART J, V23, P1771, DOI 10.1053/euhj.2000.3234; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Goto S, 2002, CIRCULATION, V105, P2531, DOI 10.1161/01.CIR.0000016703.93845.AF; Kato Y, 2003, EUR J PHARMACOL, V473, P163, DOI 10.1016/S0014-2999(03)01973-3; Kosoglou T, 2005, CIRCULATION, V112, pU80; KOSOGLOU T, 2005, P03449 SCHER RES I; LANDEFELD CS, 1987, AM J MED, V82, P703, DOI 10.1016/0002-9343(87)90004-0; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Maurice P, 2004, FASEB J, V18, P1339, DOI 10.1096/fj.03-1151com; Newby LK, 2002, AM J MED, V112, P647, DOI 10.1016/S0002-9343(02)01106-3; Simoons ML, 1997, LANCET, V349, P1429; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tcheng JE, 2000, LANCET, V356, P2037; Topol E, 1998, NEW ENGL J MED, V339, P436; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; *WHO, 2004, ATL HEART DIS STROK; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	32	264	280	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					919	928		10.1016/S0140-6736(09)60230-0	http://dx.doi.org/10.1016/S0140-6736(09)60230-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286091				2022-12-28	WOS:000264158700033
J	Villar, SS; Perez-Somarriba, J; Costa, TS; Winstanley, S; Lopez, TS; Mora, LE; Gonzalez, BO				Serrano Villar, Sergio; Perez-Somarriba, Juncal; Sainz Costa, Talia; Winstanley, Sarah; Santillana Lopez, Tomas; Escribano Mora, Luis; Orejas Gonzalez, Baltasar			A 38 year old woman with hypotensive shock at the onset of menstruation: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Serrano Villar, Sergio; Perez-Somarriba, Juncal; Sainz Costa, Talia; Santillana Lopez, Tomas; Orejas Gonzalez, Baltasar] Hosp Clin San Carlos, Madrid 28040, Spain; [Winstanley, Sarah] Kingston Gen Hosp, London, England; [Escribano Mora, Luis] Hosp Virgen Valle, Ctr Estudios Mastocitosis Castilla la Mancha, Toledo, Spain	Hospital Clinico San Carlos; Complejo Hospitalario de Toledo	Villar, SS (corresponding author), Hosp Clin San Carlos, Madrid 28040, Spain.	sergio1serrano@yahoo.es	Serrano-Villar, Sergio/AEU-8833-2022	Serrano-Villar, Sergio/0000-0002-5447-3554				Riccioni G, 2007, CURR MED CHEM, V14, P1966	1	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2009	338								b247	10.1136/bmj.b247	http://dx.doi.org/10.1136/bmj.b247			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273521				2022-12-28	WOS:000264205200003
J	Kliebenstein, DJ; Rowe, HC				Kliebenstein, Daniel J.; Rowe, Heather C.			Anti-Rust Antitrust	SCIENCE			English	Editorial Material							RESISTANCE		[Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, 1 Shields Ave, Davis, CA 95616 USA.	kliebenstein@ucdavis.edu	Rowe, Heather C/C-9284-2011	Kliebenstein, Daniel/0000-0001-5759-3175				Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043	10	10	10	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1301	1302		10.1126/science.1171410	http://dx.doi.org/10.1126/science.1171410			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265010				2022-12-28	WOS:000263876700029
J	Panstruga, R; Parker, JE; Schulze-Lefert, P				Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul			SnapShot: Plant Immune Response Pathways	CELL			English	Editorial Material							RESISTANCE		[Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Max Planck Society	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany.		Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957	Deutsche Forschungsgemeinschaft [SFB670]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Authors are supported by the Deutsche Forschungsgemeinschaft (SFB670).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042	9	74	81	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					978	U6	978.e1	10.1016/j.cell.2009.02.020	http://dx.doi.org/10.1016/j.cell.2009.02.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269372	Bronze			2022-12-28	WOS:000263930900019
J	Saito, K; Chen, M; Bard, F; Chen, SH; Zhou, HL; Woodley, D; Polischuk, R; Schekman, R; Malhotra, V				Saito, Kota; Chen, Mei; Bard, Fred; Chen, Shenghong; Zhou, Huilin; Woodley, David; Polischuk, Roman; Schekman, Randy; Malhotra, Vivek			TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit Sites	CELL			English	Article							VII COLLAGEN EXPRESSION; COPII COAT; PROTEIN SECRETION; ER; TRANSPORT; ERGIC-53; GOLGI; IDENTIFICATION; FIBROBLASTS; VESICLES	A genome-wide screen revealed previously unidentified components required for transport and Golgi organization ( TANGO). We now provide evidence that one of these proteins, TANGO1, is an integral membrane protein localized to endoplasmic reticulum ( ER) exit sites, with a luminal SH3 domain and a cytoplasmic proline-rich domain (PRD). Knockdown of TANGO1 inhibits export of bulky collagen VII from the ER. The SH3 domain of TANGO1 binds to collagen VII; the PRD binds to the COPII coat subunits, Sec23/24. In this scenario, PRD binding to Sec23/24 subunits could stall COPII carrier biogenesis to permit the luminal domain of TANGO1 to guide SH3-bound cargo into a growing carrier. All cells except those of hematopoietic origin express TANGO1. We propose that TANGO1 exports other cargoes in cells that do not secrete collagen VII. However, TANGO1 does not enter the budding carrier, which represents a unique mechanism to load cargo into COPII carriers.	[Saito, Kota; Malhotra, Vivek] CRG, Dept Cell & Dev Biol, Barcelona 08003, Spain; [Malhotra, Vivek] Inst Catalana Rec & Estudis Avancats, Barcelona 08003, Spain; [Chen, Mei; Woodley, David] Univ So Calif, USC Norris Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90033 USA; [Bard, Fred] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Chen, Shenghong; Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Polischuk, Roman] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Schekman, Randy] Univ Calif Berkeley, HHMI, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; University of Southern California; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Malhotra, V (corresponding author), CRG, Dept Cell & Dev Biol, Dr Aiguader 88, Barcelona 08003, Spain.	vivek.malhotra@crg.es	BARD, Frederic/G-9914-2011; Malhotra, Vivek/O-9811-2014; Chen, Sheng-hong/AAU-4018-2021	BARD, Frederic/0000-0002-3783-4805; Malhotra, Vivek/0000-0001-6198-7943; Chen, Sheng-hong/0000-0002-7722-2221; Saito, Kota/0000-0003-2478-2687; Zhou, Huilin/0000-0002-1350-4430	Japanese Society for Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We thank members of the Malhotra lab, especially Yuichi Wakana and Matt Pecot, for valuable discussions and Anne-Marie Alleaume for drawing the model shown in Figure 7. We also thank Kanika Bajaj of the Schekman lab for technical help. K. S. was supported by a fellowship from the Japanese Society for Promotion of Science.	Baines AC, 2007, TRENDS BIOCHEM SCI, V32, P381, DOI 10.1016/j.tibs.2007.06.006; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041; Chen M, 1997, J INVEST DERMATOL, V108, P125, DOI 10.1111/1523-1747.ep12332300; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shugrue CA, 1999, J CELL SCI, V112, P4547; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Woodley DT, 2007, CLIN REV ALLERG IMMU, V33, P78, DOI 10.1007/s12016-007-0027-6	29	239	244	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					891	902		10.1016/j.cell.2008.12.025	http://dx.doi.org/10.1016/j.cell.2008.12.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269366	Bronze			2022-12-28	WOS:000263930900012
J	Moscona, A				Moscona, Anne			Global Transmission of Oseltamivir-Resistant Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS NEURAMINIDASE		[Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA.							Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; DIAS A, 2009, NATURE          0204; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6	5	380	439	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					953	956		10.1056/NEJMp0900648	http://dx.doi.org/10.1056/NEJMp0900648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19258250				2022-12-28	WOS:000263824500002
J	Ho, PM; Maddox, TM; Wang, L; Fihn, SD; Jesse, RL; Peterson, ED; Rumsfeld, JS				Ho, P. Michael; Maddox, Thomas M.; Wang, Li; Fihn, Stephan D.; Jesse, Robert L.; Peterson, Eric D.; Rumsfeld, John S.			Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; OF-FUNCTION POLYMORPHISM; MEDICATION NONADHERENCE; ANTIPLATELET ACTION; TRIAL; ATORVASTATIN; THERAPY; ASPIRIN; RESISTANCE; REGRESSION	Context Prior mechanistic studies reported that omeprazole decreases the platelet inhibitory effects of clopidogrel, yet the clinical significance of these findings is not clear. Objective To assess outcomes of patients taking clopidogrel with or without a proton pump inhibitor (PPI) after hospitalization for acute coronary syndrome (ACS). Design, Setting, and Patients Retrospective cohort study of 8205 patients with ACS taking clopidogrel after discharge from 127 Veterans Affairs hospitals between October 1, 2003, and January 31, 2006. Vital status information was available for all patients through September 30, 2006. Main Outcome Measures All-cause mortality or rehospitalization for ACS. Results Of 8205 patients taking clopidogrel after discharge, 63.9% (n = 5244) were prescribed PPI at discharge, during follow-up, or both and 36.1% (n = 2961) were not prescribed PPI. Death or rehospitalization for ACS occurred in 20.8% (n = 615) of patients taking clopidogrel without PPI and 29.8% (n = 1561) of patients taking clopidogrel plus PPI. In multivariable analyses, use of clopidogrel plus PPI was associated with an increased risk of death or rehospitalization for ACS compared with use of clopidogrel without PPI ( adjusted odds ratio [AOR], 1.25; 95% confidence interval [CI], 1.11-1.41). Among patients taking clopidogrel after hospital discharge and prescribed PPI at any point during follow-up (n = 5244), periods of use of clopidogrel plus PPI ( compared with periods of use of clopidogrel without PPI) were associated with a higher risk of death or rehospitalization for ACS (adjusted hazard ratio, 1.27; 95% CI, 1.10-1.46). In analyses of secondary outcomes, patients taking clopidogrel plus PPI had a higher risk of hospitalizations for recurrent ACS compared with patients taking clopidogrel without PPI (14.6% vs 6.9%; AOR, 1.86 [ 95% CI, 1.57-2.20]) and revascularization procedures (15.5% vs 11.9%; AOR, 1.49 [ 95% CI, 1.30-1.71]), but not for all-cause mortality (19.9% vs 16.6%; AOR, 0.91 [ 95% CI, 0.80-1.05]). The association between use of clopidogrel plus PPI and increased risk of adverse outcomes also was consistent using a nested case-control study design (AOR, 1.32; 95% CI, 1.14-1.54). In addition, use of PPI without clopidogrel was not associated with death or rehospitalization for ACS among patients not taking clopidogrel after hospital discharge (n = 6450) ( AOR, 0.98; 95% CI, 0.85-1.13). Conclusion Concomitant use of clopidogrel and PPI after hospital discharge for ACS was associated with an increased risk of adverse outcomes than use of clopidogrel without PPI, suggesting that use of PPI may be associated with attenuation of benefits of clopidogrel after ACS.	[Ho, P. Michael; Maddox, Thomas M.; Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA; [Ho, P. Michael; Maddox, Thomas M.; Rumsfeld, John S.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Wang, Li; Fihn, Stephan D.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Fihn, Stephan D.; Jesse, Robert L.] VA Cent Off, Washington, DC USA; [Jesse, Robert L.] Richmond VA Med Ctr, Richmond, VA USA; [Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Hunter Holmes McGuire Veterinary Affairs Medical Center; Duke University	Ho, PM (corresponding author), Dept Cardiol 111B, 1055 Clermont St, Denver, CO 80220 USA.	michael.ho@va.gov	Fihn, Stephan/ABA-1040-2020; Peterson, Eric David/ABF-5033-2021		Quality Enhancement Research Initiative of the US Department of Veterans Affairs; VA Health Services Research and Development Career Development Award; National Institute on Aging and from an Agency for Healthcare Research and Quality Center for Education and Research on Therapeutics [RO1]	Quality Enhancement Research Initiative of the US Department of Veterans Affairs; VA Health Services Research and Development Career Development Award(US Department of Veterans Affairs); National Institute on Aging and from an Agency for Healthcare Research and Quality Center for Education and Research on Therapeutics(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by the Quality Enhancement Research Initiative of the US Department of Veterans Affairs. Dr Ho is supported by VA Health Services Research and Development Career Development Award. Dr Peterson is supported by an RO1 grant from the National Institute on Aging and from an Agency for Healthcare Research and Quality Center for Education and Research on Therapeutics.	AALEN O, 1978, ANN STAT, V6, P534, DOI 10.1214/aos/1176344198; *AM COLL CARD CV N, FDA INV INT PLAV HEA; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Aubert RE, 2008, CIRCULATION, V118, pS815; Barragan P, 2003, CATHETER CARDIO INTE, V59, P295, DOI 10.1002/ccd.10497; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; *FOOD DRUS ADM, EARL COMM ONG SAF RE; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Furuta T, 2007, PHARMACOGENOMICS, V8, P1199, DOI 10.2217/14622416.8.9.1199; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2008, JAMA-J AM MED ASSOC, V299, P532, DOI 10.1001/jama.299.5.532; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Ho PM, 2007, AM HEART J, V154, P489, DOI 10.1016/j.ahj.2007.05.018; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; LANGHOLZ B, 1990, AM J EPIDEMIOL, V131, P169, DOI 10.1093/oxfordjournals.aje.a115471; Lau WC, 2003, CIRCULATION, V107, P32, DOI 10.1161/01.CIR.0000047060.60595.CC; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; MCGILCHRIST CA, 1991, BIOMETRICS, V47, P461, DOI 10.2307/2532138; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Saw J, 2003, CIRCULATION, V108, P921, DOI 10.1161/01.CIR.0000088780.57432.43; Saw J, 2007, J AM COLL CARDIOL, V50, P291, DOI 10.1016/j.jacc.2007.01.097; Schillinger W, 2007, CIRCULATION, V116, P57, DOI 10.1161/CIRCULATIONAHA.106.666008; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	34	767	836	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					937	944		10.1001/jama.2009.261	http://dx.doi.org/10.1001/jama.2009.261			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19258584	Bronze			2022-12-28	WOS:000263784600023
J	Crompton, RH; Pataky, TC				Crompton, Robin Huw; Pataky, Todd C.			Stepping Out	SCIENCE			English	Editorial Material							LOCOMOTION; EVOLUTION; FOOT; ARCH		[Crompton, Robin Huw; Pataky, Todd C.] Univ Liverpool, Sch Biomed Sci, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Crompton, RH (corresponding author), Univ Liverpool, Sch Biomed Sci, Liverpool L69 3GE, Merseyside, England.	rhcromp@liverpool.ac.uk		Pataky, Todd/0000-0002-8292-7189				Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Crompton RH, 2008, J ANAT, V212, P501, DOI 10.1111/j.1469-7580.2008.00870.x; Deloison Y., 1991, P177; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Klenerman L., 2006, HUMAN FOOT COMPANION; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; ROBBINS LM, 1987, LAETOLI PLIOCENE SIT, P496; Small C. G., 1996, STAT THEORY SHAPE	13	8	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1174	1175		10.1126/science.1170916	http://dx.doi.org/10.1126/science.1170916			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251615				2022-12-28	WOS:000263687600023
J	Buckley, NJ; Johnson, R; Sun, YM; Stanton, LW				Buckley, Noel J.; Johnson, Rory; Sun, Yuh-Man; Stanton, Lawrence W.			Is REST a regulator of pluripotency?	NATURE			English	Letter							EMBRYONIC STEM-CELLS; IN-VIVO; TRANSCRIPTION; NETWORKS; GENOME; GENES		[Buckley, Noel J.; Sun, Yuh-Man] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, James Black Ctr, London SE5 9NU, England; [Johnson, Rory; Stanton, Lawrence W.] Genome Inst Singapore, Singapore 138672, Singapore	University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Buckley, NJ (corresponding author), Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, James Black Ctr, 125 Coldharbour Lane, London SE5 9NU, England.	noel.buckley@iop.kcl.ac.uk	Johnson, Rory/ABE-2503-2021; Buckley, Noel J/B-9675-2012; Sun, Yuh-Man/N-1579-2014	Johnson, Rory/0000-0003-4607-2782; Buckley, Noel J/0000-0003-1152-0653; 				Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	11	46	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					E5	E6		10.1038/nature07784	http://dx.doi.org/10.1038/nature07784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242418				2022-12-28	WOS:000263680100054
J	Harnett, A; Smallwood, J; Titshall, V; Champion, A				Harnett, Adrian; Smallwood, James; Titshall, Victoria; Champion, Andrew			Guidelines Diagnosis and treatment of early breast cancer, including locally advanced disease-summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harnett, Adrian] Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England; [Smallwood, James] Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England; [Titshall, Victoria; Champion, Andrew] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Harnett, A (corresponding author), Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England.	adrian.harnett@nnuh.nhs.uk	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474				*ADJ ONL, 2003, DEC MAK TOOLS HLTH C; Department of Health, 2007, CANC REF STRAT; Murray N, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b509; *NAT I CLIN EXC, 2002, GUID CANC SERV IMPR; National Institute for Health and Clinical Excellence, 2007, GUID MAN; *NIH CLIN EXC, 2009, CLIN GUID NICE, V80; *NIH CLIN EXC, 2009, CLIN GUID NICE, V81; *OFF NAT STAT, 2008, SER MB1 ONS, V36; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; *SLOAN PROJ, UND NON BREAST DIS; *WELSH CANC INT SU, 2008, CANC INC WAL	11	56	58	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2009	338								b438	10.1136/bmj.b438	http://dx.doi.org/10.1136/bmj.b438			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244302	Green Published			2022-12-28	WOS:000264056200004
J	Neovius, M; Sundstrom, J; Rasmussen, F				Neovius, Martin; Sundstrom, Johan; Rasmussen, Finn			Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; FOLLOW-UP; OBESITY; MEN; UNDERWEIGHT; WEIGHT; METAANALYSIS; PREVALENCE; HEIGHT; TRENDS	Objective To investigate the combined effects on adult mortality of overweight and smoking in late adolescence. Design Record linkage study with Cox proportional hazard ratios adjusted for muscle strength, socioeconomic position, and age. Setting Swedish military service conscription register, cause of death register, and census data. Participants 45920 Swedish men (mean age 18.7, SD 0.5) followed for 38 years. Main outcome measures Body mass index (underweight (BMI < 18.5), normal weight (18.5-24.9), overweight (25-29.9), and obesity (>= 30)), muscle strength, and self reported smoking (non-smoker, light smoker (1-10 cigarettes/day), heavy smoker (> 10/day)) at mandatory military conscription tests in 1969-70. All cause mortality. Results Over 1.7 million person years, 2897 men died. Compared with normal weight men (incidence rate 17/10000 person years, 95% confidence interval 16 to 18), risk of mortality was increased in overweight (hazard ratio 1.33, 1.15 to 1.53; incidence rate 23, 20 to 26) and obese men (hazard ratio 2.14,1.61 to 2.85; incidence rate 38,27 to 48), with similar relative estimates in separate analyses of smokers and non-smokers. No increased risk was detected in underweight men (hazard ratio 0.97, 0.86 to 1.08; incidence rate 18, 16 to 19), though extreme underweight (BMI < 17) was associated with increased mortality (hazard ratio 1.33, 1.07 to 1.64; incidence rate 24, 19 to 29). The relative excess risk due to interaction between BMI and smoking status was not significant in any stratum. Furthermore, all estimates of interaction were of small magnitude, except for the combination of obesity and heavy smoking (relative excess risk 1.5,-0.7 to 3.7). Compared with non-smokers (incidence rate 14, 13 to 15), risk was increased in both light (hazard ratio 1.54, 1.41 to 1.70; incidence rate 15, 14 to 16) and heavy smokers (hazard ratio 2.11, 1.92 to 2.31; incidence rate 26, 24 to 27). Conclusions Regardless of smoking status, overweight and obesity in late adolescence increases the risk of adult mortality. Obesity and overweight were as hazardous as heavy and light smoking, respectively, but there was no interaction between BMI and smoking status. The global obesity epidemic and smoking among adolescents remain important targets for intensified public health initiatives.	[Sundstrom, Johan] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital		martin.neovius@ki.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Rasmussen, Finn/0000-0001-7915-7809; Neovius, Martin/0000-0003-2300-3055	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council [2007-5942]	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council	MN was funded by Arbetsmarknadens Forsakrings-och Aktiebolag (AFA) and JS by the Swedish Heart-Lung Foundation and the Swedish Research Council (2007-5942). The funding sources did not read or comment on any version of the manuscript, nor influence the analyses in any way.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; *CAN, 2006, 95 CAN; COX DR, 1972, J R STAT SOC B, V34, P187; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hublet A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-280; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Neovius M, 2008, INT J OBESITY, V32, P1319, DOI 10.1038/ijo.2008.70; Neovius M, 2008, OBESITY, V16, P671, DOI 10.1038/oby.2007.115; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nyholm M, 2008, OBESITY, V16, P896, DOI 10.1038/oby.2007.134; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Rasmussen F, 2007, EUR J CLIN NUTR, V61, P870, DOI 10.1038/sj.ejcn.1602595; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	34	82	84	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2009	338								b496	10.1136/bmj.b496	http://dx.doi.org/10.1136/bmj.b496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19244221	Green Published, hybrid			2022-12-28	WOS:000264056100004
J	Carthew, RW; Sontheimer, EJ				Carthew, Richard W.; Sontheimer, Erik J.			Origins and Mechanisms of miRNAs and siRNAs	CELL			English	Review							TARGET MESSENGER-RNAS; DOUBLE-STRANDED-RNA; MICRORNA-DEPENDENT LOCALIZATION; ARGONAUTE SILENCING COMPLEX; EMBRYONIC STEM-CELLS; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; HUMAN RISC; STRUCTURAL BASIS; SLICER ACTIVITY	Over the last decade, similar to 20-30 nucleotide RNA molecules have emerged as critical regulators in the expression and function of eukaryotic genomes. Two primary categories of these small RNAs short interfering RNAs (siRNAs) and microRNAs (miRNAs)-act in both somatic and germline lineages in a broad range of eukaryotic species to regulate endogenous genes and to defend the genome from invasive nucleic acids. Recent advances have revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access. Our understanding of siRNA- and miRNA-based regulation has direct implications for fundamental biology as well as disease etiology and treatment.	[Carthew, Richard W.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu; erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	National Institutes of Health [GM077581, GM068743, GM072830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072830, R01GM068743, R01GM077581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of our laboratories for stimulating discussions. This work was supported by National Institutes of Health grants GM077581 and GM068743 to R. W. C. and GM072830 to E. J. S.	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; PARKER JS, 2005, MOL CELL, V21, P533; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2008, P NATL ACAD SCI USA, V105, P5343, DOI 10.1073/pnas.0801102105; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	105	3493	3770	28	1342	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					642	655		10.1016/j.cell.2009.01.035	http://dx.doi.org/10.1016/j.cell.2009.01.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239886	Bronze, Green Accepted			2022-12-28	WOS:000263688200016
J	Grande, D; Asch, DA				Grande, David; Asch, David A.			Commercial versus Social Goals of Tracking What Doctors Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grande, David] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Grande, D (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Asch, David/0000-0002-7970-286X				*IMS HLTH, IMS CORP OV; POTTENGER B, FREECONOMICS HLTH CA	2	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					747	749		10.1056/NEJMp0810410	http://dx.doi.org/10.1056/NEJMp0810410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228616				2022-12-28	WOS:000263411300002
J	Becker, A; Al Ju'beh, K; Watt, G				Becker, Andrea; Al Ju'beh, Katherine; Watt, Graham			Keys to health: justice, sovereignty, and self-determination	LANCET			English	Editorial Material									[Watt, Graham] Univ Glasgow, Glasgow, Lanark, Scotland; [Becker, Andrea; Al Ju'beh, Katherine] Med Aid Palestinians, London N1 1QB, England	University of Glasgow	Watt, G (corresponding author), Univ Glasgow, Glasgow, Lanark, Scotland.	gcmwlj@clinmed.gla.ac.uk						Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Giacaman R, 2004, EUR J PUBLIC HEALTH, V14, P286, DOI 10.1093/eurpub/14.3.286; Giacaman R, 2007, EUR J PUBLIC HEALTH, V17, P361, DOI 10.1093/eurpub/ckl260; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Halileh Samia O, 2002, Med Confl Surviv, V18, P239, DOI 10.1080/13623690208409632; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; MATARIA A, 2009, LANCET, DOI DOI 10.1016/S014O-6736(09)60111-2; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; TAYLOR R, 1985, INT J HEALTH SERV, V15, P547, DOI 10.2190/XX9V-ACD4-KUXD-C0E5	11	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					985	987		10.1016/S0140-6736(09)60103-3	http://dx.doi.org/10.1016/S0140-6736(09)60103-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19268351				2022-12-28	WOS:000264398200007
J	Song, AH; Wang, D; Chen, G; Li, Y; Luo, J; Duan, SM; Poo, MM				Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Luo, Jianhong; Duan, Shumin; Poo, Mu-ming			A Selective Filter for Cytoplasmic Transport at the Axon Initial Segment	CELL			English	Article							HIPPOCAMPAL-NEURONS; ANKYRIN-G; MEMBRANE-PROTEINS; GLUTAMATE RECEPTORS; DIFFUSION BARRIER; LATERAL DIFFUSION; KINESIN; TRAFFICKING; MECHANISMS; CHANNELS	Distinct molecules are segregated into somatodendritic and axonal compartments of polarized neurons, but mechanisms underlying the development and maintenance of such segregation remain largely unclear. In cultured hippocampal neurons, we observed an ankyrin G-and F-actin-dependent structure that emerged in the cytoplasm of the axon initial segment (AIS) within 2 days after axon/dendrite differentiation, imposing a selective filter for diffusion of macromolecules and transport of vesicular carriers into the axon. Axonal entry was allowed for KIF5-driven carriers of synaptic vesicle protein VAMP2, but not for KIF17-driven carriers of dendrite-targeting NMDA receptor subunit NR2B. Comparisons of transport rates between chimeric forms of KIF17 and KIF5B, with the motor and cargo-binding domains switched, and between KIF5 loaded with VAMP2 versus GluR2 suggest that axonal entry of vesicular carriers depends on the transport efficacy of KIF-cargo complexes. This selective AIS filtering may contribute to preferential trafficking and segregation of cellular components in polarized neurons.	[Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Duan, Shumin; Poo, Mu-ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Luo, Jianhong] Zhejiang Univ, Dept Neurobiol, Sch Med, Hangzhou 310031, Zhejiang, Peoples R China; [Poo, Mu-ming] Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn; mpoo@berkeley.edu		Chen, Gang/0000-0003-3669-5687	Major State Basic Research Program of China [2006CB806600]; National Natural Science Foundation of China [30730037]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J.G. Chen, V. Bennett, C. Gu, and D. B. Arnold for providing cDNA clones and J.Y. Shen for technical assistance with siRNA constructs. This work was supported by grants from the Major State Basic Research Program of China (2006CB806600) and the National Natural Science Foundation of China (30730037).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BENSHALOM G, 1985, J NEUROCYTOL, V14, P943, DOI 10.1007/BF01224806; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brown MD, 1997, BRAIN RES, V747, P313, DOI 10.1016/S0006-8993(96)01321-2; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Guillaud L, 2003, J NEUROSCI, V23, P131; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hemar A, 1997, J NEUROSCI, V17, P9026; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nishimura K, 2007, MOL CELL NEUROSCI, V34, P422, DOI 10.1016/j.mcn.2006.11.017; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POPOV S, 1992, J NEUROSCI, V12, P77; PROVANCE DW, 1993, J CELL SCI, V106, P565; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143	40	243	250	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1148	1160		10.1016/j.cell.2009.01.016	http://dx.doi.org/10.1016/j.cell.2009.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19268344	Bronze			2022-12-28	WOS:000264403900019
J	Colombo, A; Sharp, ASP				Colombo, Antonio; Sharp, Andrew S. P.			The bioabsorbable stent as a virtual prosthesis	LANCET			English	Editorial Material							CORONARY-ARTERY; ELUTING STENTS; TRIAL; ANGIOPLASTY; HUMANS		[Colombo, Antonio; Sharp, Andrew S. P.] Ist Sci San Raffaele, I-20132 Milan, Italy; [Colombo, Antonio; Sharp, Andrew S. P.] EMO GVM Ctr Cuore Columbus Hosp, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Colombo, A (corresponding author), Ist Sci San Raffaele, I-20132 Milan, Italy.	colombo@emocolumbus.it	Colombo, Antonio/N-2960-2015	Colombo, Antonio/0000-0002-2940-2455				Colombo A, 2000, CIRCULATION, V102, P371; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Tamai H, 2000, CIRCULATION, V102, P399; Tanguay Jean Francois, 1994, Cardiology Clinics, V12, P699; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					869	870		10.1016/S0140-6736(09)60521-3	http://dx.doi.org/10.1016/S0140-6736(09)60521-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286066				2022-12-28	WOS:000264158700004
J	Jerrett, M; Burnett, RT; Pope, CA; Ito, K; Thurston, G; Krewski, D; Shi, YL; Calle, E; Thun, M				Jerrett, Michael; Burnett, Richard T.; Pope, C. Arden, II; Ito, Kazuhiko; Thurston, George; Krewski, Daniel; Shi, Yuanli; Calle, Eugenia; Thun, Michael			Long-Term Ozone Exposure and Mortality.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIR-POLLUTION; LUNG-FUNCTION; CANCER PREVENTION; SPATIAL-ANALYSIS; AMBIENT OZONE; CHILDREN; ASSOCIATION; POLLUTANTS; HEALTH; FEV1	Background: Although many studies have linked elevations in tropospheric ozone to adverse health outcomes, the effect of long-term exposure to ozone on air pollution-related mortality remains uncertain. We examined the potential contribution of exposure to ozone to the risk of death from cardiopulmonary causes and specifically to death from respiratory causes. Methods: Data from the study cohort of the American Cancer Society Cancer Prevention Study II were correlated with air-pollution data from 96 metropolitan statistical areas in the United States. Data were analyzed from 448,850 subjects, with 118,777 deaths in an 18-year follow-up period. Data on daily maximum ozone concentrations were obtained from April 1 to September 30 for the years 1977 through 2000. Data on concentrations of fine particulate matter (particles that are lessthan/equal 2.5 microm in aerodynamic diameter [PM(sub 2.5)]) were obtained for the years 1999 and 2000. Associations between ozone concentrations and the risk of death were evaluated with the use of standard and multilevel Cox regression models. Results: In single-pollutant models, increased concentrations of either PM(sub 2.5) or ozone were significantly associated with an increased risk of death from cardiopulmonary causes. In two-pollutant models, PM(sub 2.5) was associated with the risk of death from cardiovascular causes, whereas ozone was associated with the risk of death from respiratory causes. The estimated relative risk of death from respiratory causes that was associated with an increment in ozone concentration of 10 ppb was 1.040 (95% confidence interval, 1.010 to 1.067). The association of ozone with the risk of death from respiratory causes was insensitive to adjustment for confounders and to the type of statistical model used. Conclusions: In this large study, we were not able to detect an effect of ozone on the risk of death from cardiovascular causes when the concentration of PM(sub 2.5) was taken into account. We did, however, demonstrate a significant increase in the risk of death from respiratory causes in association with an increase in ozone concentration. N Engl J Med 2009;360:1085-95.	[Jerrett, Michael] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Burnett, Richard T.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Pope, C. Arden, II] Brigham Young Univ, Provo, UT 84602 USA; [Ito, Kazuhiko; Thurston, George] NYU, Sch Med, New York, NY USA; [Krewski, Daniel; Shi, Yuanli] Univ Ottawa, Ottawa, ON, Canada; [Calle, Eugenia; Thun, Michael] Amer Canc Soc, Atlanta, GA 30329 USA	University of California System; University of California Berkeley; Health Canada; Brigham Young University; New York University; University of Ottawa; American Cancer Society	Jerrett, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, 710 Univ Hall, Berkeley, CA 94720 USA.	jerrett@berkeley.edu	Jerrett, Michael/CAA-2482-2022; Pope, C. Arden/ABD-5522-2021; Thurston, George/ABB-1359-2021		Health Effects Institute; Natural Sciences and Engineering Research Council of Canada; National Institute of Environmental Health Sciences [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Health Effects Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Health Effects Institute. Dr. Krewski reports receiving grant support from the Natural Sciences and Engineering Research Council of Canada as holder of the Industrial Research Chair in Risk Science. This chair is funded by a peer- reviewed university- industry partnership program. No other potential conflict of interest relevant to this article was reported. We thank the National Institute of Environmental Health Sciences for providing grant support ( ES00260) to the New York University School of Medicine.	Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; *AM CANC SOC, 2009, CANC PREV STUD OV; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brown JS, 2008, ENVIRON HEALTH PERSP, V116, P1023, DOI 10.1289/ehp.11396; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; *COMM MED EFF AIR, 2007, EFF HLTH LONG TERM E; Committee on Estimating Mortality Risk Reduction Benefits from Decreasing Tropospheric Ozone Exposure, 2008, EST MORT RISK RED EC; Delfino RJ, 2004, ENVIRON HEALTH PERSP, V112, P932, DOI 10.1289/ehp.6815; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; *ENV PROT AG, 2007, EPA452R07007; Galizia A, 1999, ENVIRON HEALTH PERSP, V107, P675, DOI 10.2307/3434461; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2003, J TOXICOL ENV HEAL A, V66, P1735, DOI 10.1080/15287390306438; KREWSKI D, EXTENDED FO IN PRESS; Krewski D, 2000, REANALYSIS HARVARD 2; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Ma RJ, 2003, BIOMETRIKA, V90, P157, DOI 10.1093/biomet/90.1.157; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; McConnell R, 2002, LANCET, V359, P896; McConnell R, 2006, SCI TOTAL ENVIRON, V363, P166, DOI 10.1016/j.scitotenv.2005.06.028; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Schachter J., 2001, GEOGRAPHICAL MOBILIT; Siemiatycki J, 2003, J TOXICOL ENV HEAL A, V66, P1591, DOI 10.1080/15287390306428; SPEKTOR DM, 1988, AM REV RESPIR DIS, V137, P313, DOI 10.1164/ajrccm/137.2.313; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Willis A, 2003, J TOXICOL ENV HEAL A, V66, P1563, DOI 10.1080/15287390306425; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zidek JV, 1996, ENVIRONMETRICS, V7, P441, DOI 10.1002/(SICI)1099-095X(199607)7:4<441::AID-ENV226>3.0.CO;2-V	39	928	959	19	409	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1085	1095		10.1056/NEJMoa0803894	http://dx.doi.org/10.1056/NEJMoa0803894			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279340	Bronze, Green Accepted			2022-12-28	WOS:000264051000006
J	Keshtgar, M; Jahromi, AH; Davidson, T; Escobar, P; Mallucci, P; Mosahebi, A; Baum, M				Keshtgar, Mohammed; Jahromi, Alireza Hamidian; Davidson, Tim; Escobar, Paula; Mallucci, Patrick; Mosahebi, Afshin; Baum, Michael			Tissue screening after breast reduction	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLASTIC SURGEONS; MAMMAPLASTY; CANCER; CARCINOMA		[Keshtgar, Mohammed] Royal Free Hampstead NHS Trust, Univ Dept Surg, London NW3 2QG, England; Royal Free & Univ Coll Med Sch, London NW3 2QG, England	University of London; University College London; University of London; University College London	Keshtgar, M (corresponding author), Royal Free Hampstead NHS Trust, Univ Dept Surg, London NW3 2QG, England.	keshtgar@royalfree.nhs.uk	Jahromi, Alireza Hamidian/AAK-1030-2020; Jahromi, Alireza Hamidian/F-3387-2010	Jahromi, Alireza Hamidian/0000-0002-7585-847X; 				Colwell AS, 2004, PLAST RECONSTR SURG, V113, P1984, DOI 10.1097/01.prs.0000122212.37703.6e; Cruz N I, 1989, Bol Asoc Med P R, V81, P387; DINNER MI, 1989, PLAST RECONSTR SURG, V83, P1042, DOI 10.1097/00006534-198906000-00020; Hage JJ, 2006, PLAST RECONSTR SURG, V117, P727, DOI 10.1097/01.prs.0000200060.33601.2a; Jansen DA, 1998, PLAST RECONSTR SURG, V101, P361, DOI 10.1097/00006534-199802000-00014; MALINIAC JW, 1953, PLAST RECONSTR SURG, V12, P110, DOI 10.1097/00006534-195308000-00003; SNYDERMAN R K, 1960, Plast Reconstr Surg Transplant Bull, V25, P253, DOI 10.1097/00006534-196003000-00006; STROMBECK JO, 1964, ACTA CHIR SCAND    S, V341, P1; Tang CL, 1999, PLAST RECONSTR SURG, V103, P1682, DOI 10.1097/00006534-199905060-00016; Titley OG, 1996, BRIT J PLAST SURG, V49, P447, DOI 10.1016/S0007-1226(96)90028-4; vanderTorre PM, 1997, EUR J SURG ONCOL, V23, P341, DOI 10.1016/S0748-7983(97)90885-4; White RR, 1998, PLAST RECONSTR SURG, V102, P1774, DOI 10.1097/00006534-199810000-00093	12	7	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2009	338								b630	10.1136/bmj.b630	http://dx.doi.org/10.1136/bmj.b630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278972				2022-12-28	WOS:000264205300004
J	Park, CY; Hoover, PJ; Mullins, FM; Bachhawat, P; Covington, ED; Raunser, S; Walz, T; Garcia, KC; Dolmetsch, RE; Lewis, RS				Park, Chan Young; Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Raunser, Stefan; Walz, Thomas; Garcia, K. Christopher; Dolmetsch, Ricardo E.; Lewis, Richard S.			STIM1 Clusters and Activates CRAC Channels via Direct Binding of a Cytosolic Domain to Orai1	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; STORE DEPLETION; PORE SUBUNIT; I-CRAC; OLIGOMERIZATION; TERMINUS; RECEPTOR; SENSOR	Store-operated Ca2+ channels activated by the depletion of Ca2+ from the endoplasmic reticulum (ER) are a major Ca2+ entry pathway in nonexcitable cells and are essential for T cell activation and adaptive immunity. After store depletion, the ER Ca2+ sensor STIM1 and the CRAC channel protein Orai1 redistribute to ER-plasma membrane (PM) junctions, but the fundamental issue of how STIM1 activates the CRAC channel at these sites is unresolved. Here, we identify a minimal, highly conserved 107-aa CRAC activation domain (CAD) of STIM1 that binds directly to the N and C termini of Orai1 to open the CRAC channel. Purified CAD forms a tetramer that clusters CRAC channels, but analysis of STIM1 mutants reveals that channel clustering is not sufficient for channel activation. These studies establish a molecular mechanism for store-operated Ca2+ entry in which the direct binding of STIM1 to Orai1 drives the accumulation and the activation of CRAC channels at ER-PM junctions.	[Park, Chan Young; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Garcia, K. Christopher; Lewis, Richard S.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Mullins, Franklin M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Bachhawat, Priti; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Raunser, Stefan; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu; rslewis@stanford.edu	Raunser, Stefan/AHE-1573-2022; Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665; Walz, Thomas/0000-0003-2606-2835; Raunser, Stefan/0000-0001-9373-3016; Lewis, Richard/0000-0002-6010-7403	National Science Foundation and Stanford University; NIH Medical Scientist Training Program; Korea Research Foundation [KRF-2005-214-C00222]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	National Science Foundation and Stanford University(National Science Foundation (NSF)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank M. Wu for early Ca<SUP>2+</SUP> imaging experiments on CT- STIM1, D. Oh for helpful comments, and M. Cahalan, S. Feske, T. Meyer, S. Muallem, C. Romanin, and T. Xu for cDNA constructs. This work was supported by grants from the National Institutes of Health (NIH; R. E. D. and R. S. L.) and the Mathers Charitable Foundation (R. S. L.), graduate fellowships from the National Science Foundation and Stanford University (E.D.C.), an NIH Medical Scientist Training Program Grant (P.J.H.), and the Korea Research Foundation (KRF-2005-214-C00222) and the SPARK program (C.Y.P.). T. W. and K. C. G. are Investigators of the Howard Hughes Medical Institute.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; PRAKRIYA M, 2004, MOL CELLULAR INSIGHT, P121; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	38	712	737	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					876	890		10.1016/j.cell.2009.02.014	http://dx.doi.org/10.1016/j.cell.2009.02.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249086	Green Accepted, Bronze			2022-12-28	WOS:000263930900011
J	Desai, NR; Cheng, S; Nohria, A; Halperin, F; Giugliano, RP				Desai, Nihar R.; Cheng, Susan; Nohria, Anju; Halperin, Florencia; Giugliano, Robert P.			When Past Is Prologue	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEART-FAILURE; GROWTH-HORMONE; CARDIOMYOPATHY; DEFICIENCY; DISEASE; MEN		[Giugliano, Robert P.] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Dept Med, Boston, MA 02115 USA; [Halperin, Florencia] Brigham & Womens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Giugliano, RP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Dept Med, 350 Longwood Ave,1st Fl Off, Boston, MA 02115 USA.	rgiugliano@partners.org	Nohria, Anju/AAD-4925-2022; Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675; Cheng, Susan/0000-0002-4977-036X				ABELMANN WH, 1995, CURRENT MED, P1; Anker SD, 1997, CIRCULATION, V96, P526; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Eto K, 2000, ANGIOLOGY, V51, P319, DOI 10.1177/000331970005100407; Jankowska EA, 2006, CIRCULATION, V114, P1829, DOI 10.1161/CIRCULATIONAHA.106.649426; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; LADENSON PW, 1992, P NATL ACAD SCI USA, V89, P5251, DOI 10.1073/pnas.89.12.5251; LADENSON PW, 1992, P NATL ACAD SCI USA, V89, P8856; MACKERROW SD, 1992, ANN INTERN MED, V117, P1014, DOI 10.7326/0003-4819-117-12-1014; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Malkin CJ, 2006, EUR HEART J, V27, P57, DOI 10.1093/eurheartj/ehi443; Meyers DE, 2005, J HEART LUNG TRANSPL, V24, P110, DOI 10.1016/j.healun.2003.09.035; Rao MK, 2001, AM J PHYSIOL-HEART C, V281, pH325, DOI 10.1152/ajpheart.2001.281.1.H325; Schenck JB, 2006, AM J MED SCI, V331, P154, DOI 10.1097/00000441-200603000-00008	16	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					1016	1022		10.1056/NEJMcps0805508	http://dx.doi.org/10.1056/NEJMcps0805508			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264691				2022-12-28	WOS:000263824500011
J	Zhang, ZY; Lan, Y; Chai, Y; Jiang, RL				Zhang, Zunyi; Lan, Yu; Chai, Yang; Jiang, Rulang			Antagonistic Actions of Msx1 and Osr2 Pattern Mammalian Teeth into a Single Row	SCIENCE			English	Article							EARLY TOOTH DEVELOPMENT; MORPHOGENESIS; EXPRESSION; DIVERSITY; DENTITION; ECTODIN; SIGNALS; GENES; MODEL; CUSP	Mammals have single-rowed dentitions, whereas many nonmammalian vertebrates have teeth in multiple rows. Neither the molecular mechanism regulating iterative tooth initiation nor that restricting mammalian tooth development in one row is known. We found that mice lacking the transcription factor odd-skipped related-2 (Osr2) develop supernumerary teeth lingual to their molars because of expansion of the odontogenic field. Osr2 was expressed in a lingual-to-buccal gradient and restricted expression of bone morphogenetic protein 4 (Bmp4), an essential odontogenic signal, in the developing tooth mesenchyme. Expansion of odontogenic field in Osr2-deficient mice required Msx1, a feedback activator of Bmp4 expression. These findings suggest that the Bmp4-Msx1 pathway propagates mesenchymal activation for sequential tooth induction and that spatial modulation of this pathway provides a mechanism for patterning vertebrate dentition.	[Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Chai, Yang] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Rochester; University of Rochester; University of Southern California	Jiang, RL (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Rulang_Jiang@urmc.rochester.edu		Jiang, Rulang/0000-0001-7842-4696	NIH [R01DE013681, T32DE007202]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants R01DE013681 (R.J.) and T32DE007202 (Z.Z.). We thank K. Maltby for technical assistance and K. Ackerman, C. E. Ovitt, and M. Dixon for comments.	Bei M, 1998, DEVELOPMENT, V125, P4325; Chen YP, 1996, DEVELOPMENT, V122, P3035; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-32; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kulesa PM, 1996, J THEOR BIOL, V180, P287, DOI 10.1006/jtbi.1996.0103; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Streelman JT, 2003, EVOL DEV, V5, P600, DOI 10.1046/j.1525-142X.2003.03065.x; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289	22	90	95	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1232	1234		10.1126/science.1167418	http://dx.doi.org/10.1126/science.1167418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251632	Green Accepted			2022-12-28	WOS:000263687600044
J	Minton, DA; Malhotra, R				Minton, David A.; Malhotra, Renu			A record of planet migration in the main asteroid belt	NATURE			English	Article							LATE HEAVY BOMBARDMENT; SOLAR-SYSTEM; ORIGIN; NEPTUNE; URANUS; ORBIT	The main asteroid belt lies between the orbits of Mars and Jupiter, but the region is not uniformly filled with asteroids. There are gaps, known as the Kirkwood gaps, in distinct locations that are associated with orbital resonances with the giant planets(1); asteroids placed in these locations will follow chaotic orbits and be removed(2). Here we show that the observed distribution of main belt asteroids does not fill uniformly even those regions that are dynamically stable over the age of the Solar System. We find a pattern of excess depletion of asteroids, particularly just outward of the Kirkwood gaps associated with the 5:2, the 7:3 and the 2:1 Jovian resonances. These features are not accounted for by planetary perturbations in the current structure of the Solar System, but are consistent with dynamical ejection of asteroids by the sweeping of gravitational resonances during the migration of Jupiter and Saturn similar to 4 Gyr ago.	[Minton, David A.; Malhotra, Renu] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85716 USA	University of Arizona	Minton, DA (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85716 USA.	daminton@lpl.arizona.edu		Minton, David A/0000-0003-1656-9704; Malhotra, Renu/0000-0002-1226-3305	NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We acknowledge research funding from NASA and NSF.	FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Franklin FA, 2004, ASTRON J, V128, P1391, DOI 10.1086/422920; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; HEPPENHEIMER TA, 1980, ICARUS, V41, P76, DOI 10.1016/0019-1035(80)90160-8; KIRKWOOD D, 1967, METEORIC ASTRONOMY T; Knezevic Z, 2003, ASTRON ASTROPHYS, V403, P1165, DOI 10.1051/0004-6361:20030475; Levison HF, 2001, ICARUS, V151, P286, DOI 10.1006/icar.2001.6608; Liou JC, 1997, SCIENCE, V275, P375, DOI 10.1126/science.275.5298.375; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; MALHOTRA R, 1989, ASTRON ASTROPHYS, V221, P348; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Murray-Clay RA, 2005, ASTROPHYS J, V619, P623, DOI 10.1086/426425; O'Brien DP, 2007, ICARUS, V191, P434, DOI 10.1016/j.icarus.2007.05.005; SAHA P, 1992, ASTRON J, V104, P1633, DOI 10.1086/116347; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; WISDOM J, 1987, PROC R SOC LON SER-A, V413, P109, DOI 10.1016/0920-5632(87)90030-2	20	103	103	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1109	1111		10.1038/nature07778	http://dx.doi.org/10.1038/nature07778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242470	Green Submitted			2022-12-28	WOS:000263680100035
J	Ponting, CP; Oliver, PL; Reik, W				Ponting, Chris P.; Oliver, Peter L.; Reik, Wolf			Evolution and Functions of Long Noncoding RNAs	CELL			English	Review							REPRESSIVE HISTONE METHYLATION; NATURAL ANTISENSE TRANSCRIPTS; X-INACTIVATION CENTER; GENOME-WIDE ANALYSIS; MESSENGER-RNA; XIST-RNA; INTERGENIC TRANSCRIPTION; NUCLEAR DOMAIN; POLYMERASE-II; BC1 RNA	RNA is not only a messenger operating between DNA and protein. Transcription of essentially the entire eukaryotic genome generates a myriad of non-protein-coding RNA species that show complex overlapping patterns of expression and regulation. Although long noncoding RNAs (lncRNAs) are among the least well-understood of these transcript species, they cannot all be dismissed as merely transcriptional "noise.'' Here, we review the evolution of lncRNAs and their roles in transcriptional regulation, epigenetic gene regulation, and disease.	[Ponting, Chris P.; Oliver, Peter L.] Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, Oxford OX1 3QX, England; [Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 3EG, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Ponting, CP (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, S Parks Rd, Oxford OX1 3QX, England.	chris.ponting@dpag.ox.ac.uk	jia, xu/A-8386-2016; Oliver, Peter/AAS-4022-2020; Oliver, Peter/F-1453-2010; Ponting, Chris/AAV-2621-2021; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Oliver, Peter/0000-0003-3347-2461; Ponting, Chris/0000-0003-0202-7816	BBSRC; MRC; EU NoE The Epigenome; BBSRC [BBS/E/B/0000M226] Funding Source: UKRI; MRC [MC_U137761446, G0700760] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M226] Funding Source: researchfish; Medical Research Council [MC_U137761446, G0300723B, G0700760] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	W. R. thanks L. Redrup and M. Branco for discussions and advice and BBSRC, MRC, and EU NoE The Epigenome for funding. C. P. P. and P. L. O. are funded by the MRC.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Green K, 2007, MAMM GENOME, V18, P32, DOI 10.1007/s00335-006-0092-9; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Gruber AR, 2008, J MOL EVOL, V66, P107, DOI 10.1007/s00239-007-9052-6; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Peters J, 2008, MAMM GENOME, V19, P493, DOI 10.1007/s00335-008-9139-4; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponjavic J, 2007, BIOESSAYS, V29, P1077, DOI 10.1002/bies.20669; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Szymanski M, 2005, BBA-REV CANCER, V1756, P65, DOI 10.1016/j.bbcan.2005.07.005; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	104	3857	4176	38	1019	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					629	641		10.1016/j.cell.2009.02.006	http://dx.doi.org/10.1016/j.cell.2009.02.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239885	Bronze			2022-12-28	WOS:000263688200015
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			Fidelity at the Molecular Level: Lessons from Protein Synthesis	CELL			English	Review							AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR TU; 16S RIBOSOMAL-RNA; ESCHERICHIA-COLI RIBOSOMES; STOP CODON RECOGNITION; RELEASE FACTORS RF1; E-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PEPTIDE RELEASE	The faithful and rapid translation of genetic information into peptide sequences is an indispensable property of the ribosome. The mechanistic understanding of strategies used by the ribosome to achieve both speed and fidelity during translation results from nearly a half century of biochemical and structural studies. Emerging from these studies is the common theme that the ribosome uses local as well as remote conformational switches to govern induced-fit mechanisms that ensure accuracy in codon recognition during both tRNA selection and translation termination.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			NIH; HHMI; Natural Sciences and Engineering Research Council of Canada ( NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425, K99GM094210] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada ( NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank K. Fredrick for valuable comments on the manuscript. R. G. is funded by the NIH and HHMI. H. S. Z. is supported by a Natural Sciences and Engineering Research Council of Canada ( NSERC) fellowship.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Bacher JM, 2007, P NATL ACAD SCI USA, V104, P1907, DOI 10.1073/pnas.0610835104; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BILGIN N, 1992, J MOL BIOL, V224, P1011, DOI 10.1016/0022-2836(92)90466-W; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Cochella L, 2007, NAT STRUCT MOL BIOL, V14, P30, DOI 10.1038/nsmb1183; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; DAVIES J, 1968, J BIOL CHEM, V243, P3312; DAVIES J, 1965, MOL PHARMACOL, V1, P93; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Di Giacco V, 2008, P NATL ACAD SCI USA, V105, P10715, DOI 10.1073/pnas.0801974105; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; GORINI L, 1964, P NATL ACAD SCI USA, V51, P487, DOI 10.1073/pnas.51.3.487; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, NAT STRUCT MOL BIOL, V11, P316, DOI 10.1038/nsmb742; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; KURLAND CG, 1984, PROG NUCLEIC ACID RE, V31, P191, DOI 10.1016/S0079-6603(08)60378-5; LAUGHREA M, 1987, EUR J BIOCHEM, V169, P59, DOI 10.1111/j.1432-1033.1987.tb13580.x; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; LIPSETT MN, 1960, BIOCHIM BIOPHYS ACTA, V41, P175, DOI 10.1016/0006-3002(60)90394-2; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; MCLAUGHLIN CS, 1966, COLD SPRING HARB SYM, V31, P601, DOI 10.1101/SQB.1966.031.01.078; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nierhaus KH, 2006, BIOCHIMIE, V88, P1013, DOI 10.1016/j.biochi.2006.02.009; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Orlova M, 2003, CELL, V115, P319, DOI 10.1016/S0092-8674(03)00805-5; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; PAULSEN H, 1986, BIOCHEMISTRY-US, V25, P2749, DOI 10.1021/bi00358a002; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; POWERS T, 1994, J MOL BIOL, V235, P156, DOI 10.1016/S0022-2836(05)80023-3; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9133; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; ROSENBERGER RF, 1981, MOL GEN GENET, V183, P561, DOI 10.1007/BF00268784; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; SPOTTS CR, 1961, NATURE, V192, P633, DOI 10.1038/192633a0; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; THOMPSON RC, 1988, TRENDS BIOCHEM SCI, V13, P91, DOI 10.1016/0968-0004(88)90047-3; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; THOMPSON RC, 1981, J BIOL CHEM, V256, P6676; Triman KL, 2007, ADV GENET, V58, P89, DOI 10.1016/S0065-2660(06)58004-6; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Youngman EM, 2006, COLD SPRING HARB SYM, V71, P545, DOI 10.1101/sqb.2006.71.036; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	121	261	271	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					746	762		10.1016/j.cell.2009.01.036	http://dx.doi.org/10.1016/j.cell.2009.01.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239893	Green Accepted, Bronze			2022-12-28	WOS:000263688200023
J	Steinhubl, SR; Bhatt, DL; Brennan, DM; Montalescot, G; Hankey, GJ; Eikelboom, JW; Berger, PB; Topol, EJ				Steinhubl, Steven R.; Bhatt, Deepak L.; Brennan, Danielle M.; Montalescot, Gilles; Hankey, Graeme J.; Eikelboom, John W.; Berger, Peter B.; Topol, Eric J.		CHARISMA Investigators	Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding	ANNALS OF INTERNAL MEDICINE			English	Article							PLATELET-FUNCTION; CORONARY; RISK; BIOSYNTHESIS; PROSTACYCLIN; EVENTS; ANGINA	Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversial. Objective: To assess the incidence of and risk factors for adverse clinical outcomes by investigator-determined aspirin dose in a primary prevention trial. Design: Post hoc observational analyses of data from a doubleblind, placebo-controlled, randomized trial. Setting: Outpatient. Patients: 15 595 patients with cardiovascular disease or multiple risk factors. Intervention: Clopidogrel, 75 mg/d, or placebo, with aspirin, 75 to 162 mg/d, as selected by the investigators. Measurements: Incidence of the composite outcome of myocardial infarction, stroke, or cardiovascular death (efficacy end point), and incidence of severe or life-threatening bleeding (safety end point), at a median of 28 months (interquartile range, 23 to 31 months) of follow-up. Results: Daily aspirin doses were categorized as less than 100 mg (75 or 81 mg) (n = 7180), 100 mg (n = 4961), and greater than 100 mg (150 or 162 mg) (n = 3454). The hazard of the primary efficacy end point was the same regardless of dose (adjusted hazard ratio, 0.95 [95% CI, 0.80 to 1.13] for 100 mg vs. less than 100 mg, and 1.0 [CI, 0.85 to 1.18] for greater than 100 mg vs. less than 100 mg). The hazard of the primary safety end point also did not depend on dose (adjusted hazard ratio, 0.85 [CI, 0.57 to 1.26] for 100 mg vs. less than 100 mg and 1.05 [CI, 0.74 to 1.48] for greater than 100 mg vs. less than 100 mg). In patients also receiving clopidogrel, daily aspirin doses greater than 100 mg seemed to be non- statistically significantly associated with reduced efficacy (adjusted hazard ratio, 1.16 [CI, 0.93 to 1.44]) and increased harm (adjusted hazard ratio, 1.30 [CI, 0.83 to 2.04]). Limitation: The analysis was post hoc, and aspirin use was not randomized or blinded. Conclusion: Daily aspirin doses of 100 mg or greater were associated with no clear benefit in patients taking aspirin only and possibly with harm in patients taking clopidogrel. Daily doses of 75 to 81 mg may optimize efficacy and safety for patients requiring aspirin for long-term prevention, especially for those receiving dual antiplatelet therapy.	[Steinhubl, Steven R.] Medicines Co, CH-8058 Zurich, Switzerland; Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; CHU Pitie Salpetriere, Inst Cardiol, Paris, France; Royal Perth Hosp, Perth, WA, Australia; McMaster Univ, Hamilton, ON, Canada; Scripps Clin, Scripps Translat Sci Inst, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Royal Perth Hospital; University of Western Australia; McMaster University; Scripps Research Institute	Steinhubl, SR (corresponding author), Medicines Co, CH-8058 Zurich, Switzerland.	steven.steinhubl@themedco.com	Walker, Philip J/F-3034-2010; Eikelboom, John/AAG-6117-2019; Hankey, Graeme J/H-4968-2014	Eikelboom, John/0000-0003-4126-1285; Hankey, Graeme J/0000-0002-6044-7328; Topol, Eric/0000-0002-1478-4729	Sanofi-Aventis; Bristol-Myers Squibb	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb)	Grant Support: The CHARISMA study was funded by Sanofi-Aventis and Bristol-Myers Squibb.	Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belton O, 2000, CIRCULATION, V102, P840; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cox D, 2006, STROKE, V37, P2153, DOI 10.1161/01.STR.0000231683.43347.ec; DiChiara J, 2007, DIABETES, V56, P3014, DOI 10.2337/db07-0707; Eikelboom JW, 2008, CIRCULATION, V118, P1705, DOI 10.1161/CIRCULATIONAHA.108.768283; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; GIBSON PC, 1949, LANCET, V257, P1172; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; LEE M, 1994, ANN INTERN MED, V120, P184, DOI 10.7326/0003-4819-120-3-199402010-00002; MONTALESCOT G, 1991, CIRCULATION, V84, P2054, DOI 10.1161/01.CIR.84.5.2054; Ng W, 2006, WORLD J GASTROENTERO, V12, P2923, DOI 10.3748/wjg.v12.i18.2923; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Rao SV, 2006, REV CARDIOVASC MED, V7, pS12; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; *US FDA, FIN RUL PROF LAB ASP; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827	28	124	131	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					379	W68		10.7326/0003-4819-150-6-200903170-00006	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293071				2022-12-28	WOS:000264468500003
J	Peile, E				Peile, Ed			Commentary: The value of complexity	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOTENSIVE SHOCK; OLD WOMAN; KNOWLEDGE; ONSET		Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk						Cox K, 2001, MED EDUC, V35, P862, DOI 10.1046/j.1365-2923.2001.01016.x; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Fraser SW, 2001, BRIT MED J, V323, P799, DOI 10.1136/bmj.323.7316.799; Schmidt HG, 2007, MED EDUC, V41, P1133, DOI 10.1111/j.1365-2923.2007.02915.x; Villar SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b246; Villar SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b6	6	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2009	338								b796	10.1136/bmj.b796	http://dx.doi.org/10.1136/bmj.b796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FT	19273523				2022-12-28	WOS:000264205200005
J	Rosenberg, C				Rosenberg, Charles			The art of medicine Managed fear	LANCET			English	Editorial Material									Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University	Rosenberg, C (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.	rosenb3@fas.harvard.edu						Aronowitz R. A., 2007, UNNATURAL HIST BREAS; Feudtner C., 2003, BITTERSWEET DIABETES; PEITZMAN SJ, 2007, DROPSY DIALSIS TRANS; Rosenberg C., 2007, OUR PRESENT COMPLAIN; Timmermans S, 2003, GOLD STANDARD CHALLE	5	27	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					802	803		10.1016/S0140-6736(09)60467-0	http://dx.doi.org/10.1016/S0140-6736(09)60467-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416BT	19278033				2022-12-28	WOS:000263980900014
J	Sakakibara, D; Sasaki, A; Ikeya, T; Hamatsu, J; Hanashima, T; Mishima, M; Yoshimasu, M; Hayashi, N; Mikawa, T; Walchli, M; Smith, BO; Shirakawa, M; Guntert, P; Ito, Y				Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Yoshimasu, Masatoshi; Hayashi, Nobuhiro; Mikawa, Tsutomu; Waelchli, Markus; Smith, Brian O.; Shirakawa, Masahiro; Guentert, Peter; Ito, Yutaka			Protein structure determination in living cells by in-cell NMR spectroscopy	NATURE			English	Article							TRIPLE-RESONANCE SPECTRA; TORSION ANGLE DYNAMICS; SUBCELLULAR-LOCALIZATION; ESCHERICHIA-COLI; SIGNAL PEPTIDES; PREDICTION; ASSIGNMENT; RESOLUTION; PROGRAM; DOMAIN	Investigating proteins 'at work' in a living environment at atomic resolution is a major goal of molecular biology, which has not been achieved even though methods for the three-dimensional (3D) structure determination of purified proteins in single crystals or in solution are widely used. Recent developments in NMR hardware and methodology have enabled the measurement of high-resolution heteronuclear multi-dimensional NMR spectra of macromolecules in living cells (in-cell NMR)(1-5). Various intracellular events such as conformational changes, dynamics and binding events have been investigated by this method. However, the low sensitivity and the short lifetime of the samples have so far prevented the acquisition of sufficient structural information to determine protein structures by in-cell NMR. Here we show the first, to our knowledge, 3D protein structure calculated exclusively on the basis of information obtained in living cells. The structure of the putative heavy-metal binding protein TTHA1718 from Thermus thermophilus HB8 overexpressed in Escherichia coli cells was solved by in-cell NMR. Rapid measurement of the 3D NMR spectra by nonlinear sampling of the indirectly acquired dimensions was used to overcome problems caused by the instability and low sensitivity of living E. coli samples. Almost all of the expected backbone NMR resonances and most of the side-chain NMR resonances were observed and assigned, enabling high quality (0.96 angstrom backbone root mean squared deviation) structures to be calculated that are very similar to the in vitro structure of TTHA1718 determined independently. The in-cell NMR approach can thus provide accurate high-resolution structures of proteins in living environments.	[Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Guentert, Peter; Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Sakakibara, Daisuke; Sasaki, Atsuko; Hamatsu, Junpei; Mishima, Masaki; Shirakawa, Masahiro; Ito, Yutaka] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Yoshimasu, Masatoshi] RIKEN, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; [Hayashi, Nobuhiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Toyoake, Aichi 4701192, Japan; [Mikawa, Tsutomu; Ito, Yutaka] RIKEN, Res Grp Biosupramol Struct Funct, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Waelchli, Markus] Bruker BioSpin, Tsukuba, Ibaraki 3050051, Japan; [Smith, Brian O.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Guentert, Peter] Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Goethe University Frankfurt; Goethe University Frankfurt; RIKEN; Fujita Health University; RIKEN; Bruker Corporation; Bruker BioSpin GmbH; University of Glasgow; Kyoto University	Ito, Y (corresponding author), Tokyo Metropolitan Univ, Dept Chem, 1-1 Minami Osawa, Tokyo 1920397, Japan.	ito-yutaka@tmu.ac.jp	Güntert, Peter/L-5577-2013; Ito, Yutaka/P-2604-2015; Smith, Brian O/J-1899-2015; Smith, Brian/AAJ-9393-2020; Hayashi, Nobuhiro/F-6088-2011; Mikawa, Tsutomu/E-6510-2013	Güntert, Peter/0000-0002-2911-7574; Ito, Yutaka/0000-0002-1030-4660; Smith, Brian O/0000-0003-3363-4168; Smith, Brian/0000-0003-3363-4168; Hayashi, Nobuhiro/0000-0002-9950-094X; Mikawa, Tsutomu/0000-0003-2325-5084	CREST, Japan Science and Technology Agency (JST); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology; Volkswagen Foundation;  [TTHA1718]	CREST, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Volkswagen Foundation(Volkswagen); 	The authors thank S. Kuramitsu for providing the plasmid encoding TTHA1718, and D. Nietlispach for setting up 3D NMR experiments with nonlinear sampling schemes and <SUP>15</SUP>N relaxation experiments, T. Anzai for assistance with NMR measurements, and H. Koyama and A. Iwasaki for sample preparations. This work was supported in part by CREST, Japan Science and Technology Agency (JST), the Molecular Ensemble Program, RIKEN, Grants-in-Aid for Scientific Research of Priority Areas from the Japanese Ministry of Education, Sports, Culture, Science, and Technology on 'Molecular Soft Interactions Regulating Membrane Interface of Biological Systems' and 'Molecular Science for Supra Functional Systems - Development of Advanced Methods for Exploring Elementary Process', and by the Volkswagen Foundation.	BARNA JCJ, 1987, J MAGN RESON, V73, P69, DOI 10.1016/0022-2364(87)90225-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Reardon PN, 2005, J AM CHEM SOC, V127, P10848, DOI 10.1021/ja053145k; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; SCHMEIDER P, 1994, J BIOMOL NMR, V4, P483, DOI 10.1007/BF00156615; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Serber Z, 2004, J AM CHEM SOC, V126, P7119, DOI 10.1021/ja049977k; Serber Z, 2001, J AM CHEM SOC, V123, P8895, DOI 10.1021/ja0112846; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; Wuthrich K, 1986, NMR PROTEINS NUCL AC	37	270	277	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					102	U10		10.1038/nature07814	http://dx.doi.org/10.1038/nature07814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262674				2022-12-28	WOS:000263836000041
J	Oldham, J				Oldham, John			Achieving Large System Change in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Quest4Quality Ltd, Glossop, England		Oldham, J (corresponding author), Quest4Quality Ltd, Glossop, England.	john.oldham@quest4quality.co.uk						Askham J, 2008, WHO MIN C HLTH SYST; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Fraser S., 2006, UNDRESSING ELEPHANT; Oldham J., 2004, SIC EVENIT RATIO UT; OLDHAM J, 2004, I HEALTHC IMPR NAT F; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; ROWLANDS J, 2005, NEXUS            SUM, P13; ZEITHAML VA, 1988, J MARKETING, V52, P35, DOI 10.2307/1251263	8	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					965	966		10.1001/jama.2009.228	http://dx.doi.org/10.1001/jama.2009.228			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19258586				2022-12-28	WOS:000263784600028
J	Lafferentz, L; Ample, F; Yu, H; Hecht, S; Joachim, C; Grill, L				Lafferentz, Leif; Ample, Francisco; Yu, Hao; Hecht, Stefan; Joachim, Christian; Grill, Leonhard			Conductance of a Single Conjugated Polymer as a Continuous Function of Its Length	SCIENCE			English	Article							ELECTRON-TRANSPORT; TRANSPARENCY; RESISTANCE	The development of electronic devices at the single-molecule scale requires detailed understanding of charge transport through individual molecular wires. To characterize the electrical conductance, it is necessary to vary the length of a single molecular wire, contacted to two electrodes, in a controlled way. Such studies usually determine the conductance of a certain molecular species with one specific length. We measure the conductance and mechanical characteristics of a single polyfluorene wire by pulling it up from a Au(111) surface with the tip of a scanning tunneling microscope, thus continuously changing its length up to more than 20 nanometers. The conductance curves show not only an exponential decay but also characteristic oscillations as one molecular unit after another is detached from the surface during stretching.	[Lafferentz, Leif; Grill, Leonhard] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Ample, Francisco; Joachim, Christian] CEMES CNRS, Nanosci Grp, F-31055 Toulouse, France; [Yu, Hao; Hecht, Stefan] Humboldt Univ, Dept Chem, D-12489 Berlin, Germany	Free University of Berlin; Centre National de la Recherche Scientifique (CNRS); Humboldt University of Berlin	Grill, L (corresponding author), Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany.	leonhard.grill@physik.fu-berlin.de	Hecht, Stefan/A-4029-2013; Grill, Leonhard/A-9014-2012	Hecht, Stefan/0000-0002-6124-0222; Grill, Leonhard/0000-0002-9247-6502	European Integrated Project PICO INSIDE; Deutsche Forschungsgemeinschaft (DFG) [SFB 658, GR 2697/1-2]	European Integrated Project PICO INSIDE; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support from the European Integrated Project PICO INSIDE and the Deutsche Forschungsgemeinschaft (DFG) through SFB 658 and contract GR 2697/1-2 is gratefully acknowledged.	Choi SH, 2008, SCIENCE, V320, P1482, DOI 10.1126/science.1156538; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Haiss W, 2003, J AM CHEM SOC, V125, P15294, DOI 10.1021/ja038214e; Haiss W, 2006, NAT MATER, V5, P995, DOI 10.1038/nmat1781; He J, 2005, J AM CHEM SOC, V127, P1384, DOI 10.1021/ja043279i; Joachim C, 2005, P NATL ACAD SCI USA, V102, P8801, DOI 10.1073/pnas.0500075102; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Joachim C, 2002, CHEM PHYS, V281, P347, DOI 10.1016/S0301-0104(02)00372-5; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; Kiguchi M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.046801; Kuhner F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218301; Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424; Limot L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.126102; Magoga M, 1997, PHYS REV B, V56, P4722, DOI 10.1103/PhysRevB.56.4722; Magoga M, 1998, PHYS REV B, V57, P1820, DOI 10.1103/PhysRevB.57.1820; Neher D, 2001, MACROMOL RAPID COMM, V22, P1366; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Nitzan A, 2001, ANNU REV PHYS CHEM, V52, P681, DOI 10.1146/annurev.physchem.52.1.681; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Reichert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176804; Tao NJ, 2006, NAT NANOTECHNOL, V1, P173, DOI 10.1038/nnano.2006.130; Temirov R, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/6/065401; Wu SM, 2008, NAT NANOTECHNOL, V3, P569, DOI 10.1038/nnano.2008.237; Xiao XY, 2004, J AM CHEM SOC, V126, P5370, DOI 10.1021/ja049469a; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; ZAMBELLI T, 2004, INT J NANOSCI, V3, P331, DOI DOI 10.1142/S0219581X04002115	26	413	415	9	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1193	1197		10.1126/science.1168255	http://dx.doi.org/10.1126/science.1168255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251624				2022-12-28	WOS:000263687600033
J	Edwards, JK; Solsona, B; N, EN; Carley, AF; Herzing, AA; Kiely, CJ; Hutchings, GJ				Edwards, Jennifer K.; Solsona, Benjamin; N, Edwin Ntainjua; Carley, Albert F.; Herzing, Andrew A.; Kiely, Christopher J.; Hutchings, Graham J.			Switching Off Hydrogen Peroxide Hydrogenation in the Direct Synthesis Process	SCIENCE			English	Article							AU-PD CATALYSTS; SELECTIVE OXIDATION; COLLOIDAL PALLADIUM; AQUEOUS-MEDIUM; H2O2 FORMATION; H-2; O-2; GOLD; NANOPARTICLES; DESTRUCTION	Hydrogen peroxide (H2O2) is an important disinfectant and bleach and is currently manufactured from an indirect process involving sequential hydrogenation/ oxidation of anthaquinones. However, a direct process in which H-2 and O-2 are reacted would be preferable. Unfortunately, catalysts for the direct synthesis of H2O2 are also effective for its subsequent decomposition, and this has limited their development. We show that acid pretreatment of a carbon support for gold- palladium alloy catalysts switches off the decomposition of H2O2. This treatment decreases the size of the alloy nanoparticles, and these smaller nanoparticles presumably decorate and inhibit the sites for the decomposition reaction. Hence, when used in the direct synthesis of H2O2, the acid- pretreated catalysts give high yields of H2O2 with hydrogen selectivities greater than 95%.	[Edwards, Jennifer K.; Solsona, Benjamin; N, Edwin Ntainjua; Carley, Albert F.; Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, Wales; [Herzing, Andrew A.] NIST, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA; [Herzing, Andrew A.; Kiely, Christopher J.] Lehigh Univ, Ctr Adv Mat & Nanotechnol, Bethlehem, PA 18015 USA	Cardiff University; National Institute of Standards & Technology (NIST) - USA; Lehigh University	Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Main Bldg,Park Pl, Cardiff CF10 3AT, Wales.	hutch@cardiff.ac.uk	Carley, Albert/A-7372-2010; Edwards, Jennifer/F-4518-2011; Espriu, Benjamin Solsona/H-2201-2015; Herzing, Andrew/D-6239-2012	Espriu, Benjamin Solsona/0000-0001-7235-2038; Kiely, Christopher/0000-0001-5412-0970	Engineering and Physical Sciences Research Council of the United Kingdom; Johnson Matthey PLC (project ATHENA); European Union project AURICAT [HPRN-CT-2002-00174]; NSF [DMR-0079996, DMR-0304738, DMR-0320906]	Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Johnson Matthey PLC (project ATHENA); European Union project AURICAT(European Commission); NSF(National Science Foundation (NSF))	Supported by the Engineering and Physical Sciences Research Council of the United Kingdom and Johnson Matthey PLC (project ATHENA) and the European Union (project AURICAT, HPRN-CT-2002-00174). C.J.K. and A.A.H. are funded by: NSF DMR-0079996, NSF DMR-0304738,and NSF-DMR-0320906. A.A.H. thanks the NRC for support through the postdoctoral associate program. We thank A. Roberts and C. Blomfield (Kratos Analytical) for assistance with XPS measurements, and P. Collier, P. Ellis, and P. Johnston (Johnson Matthey) for discussions on analysis, provision of ICP analysis data, and design of the sequential experiments.	Chen MS, 2005, SCIENCE, V310, P291, DOI 10.1126/science.1115800; Choudhary VR, 2007, J CATAL, V246, P434, DOI 10.1016/j.jcat.2006.12.012; Choudhary VR, 2007, APPL CATAL A-GEN, V317, P234, DOI 10.1016/j.apcata.2006.10.022; Choudhary VR, 2006, J CATAL, V238, P28, DOI 10.1016/j.jcat.2005.11.024; Choudhary VR, 2004, CHEM COMMUN, P2054, DOI 10.1039/b405415f; Dissanayake DP, 2003, J CATAL, V214, P113, DOI 10.1016/S0021-9517(02)00171-9; Dissanayake DP, 2002, J CATAL, V206, P173, DOI 10.1006/jcat.2001.3501; Edwards JK, 2008, GREEN CHEM, V10, P388, DOI 10.1039/b714553p; Edwards JK, 2008, FARADAY DISCUSS, V138, P225, DOI 10.1039/b705915a; Edwards JK, 2007, CATAL TODAY, V122, P397, DOI 10.1016/j.cattod.2007.01.046; Edwards JK, 2005, J CATAL, V236, P69, DOI 10.1016/j.jcat.2005.09.015; Edwards JK, 2005, J MATER CHEM, V15, P4595, DOI 10.1039/b509542e; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Herzing AA, 2008, FARADAY DISCUSS, V138, P337, DOI 10.1039/b706293c; HESS HT, 1995, KIRKOTHMER ENCY CHEM; Landon P, 2003, PHYS CHEM CHEM PHYS, V5, P1917, DOI 10.1039/b211338b; Liu QS, 2008, ANGEW CHEM INT EDIT, V47, P6221, DOI 10.1002/anie.200801517; Lunsford JH, 2003, J CATAL, V216, P455, DOI 10.1016/S0021-9517(02)00070-2; MARASCHINO MJ, 1992, Patent No. 5169618; Solsona BE, 2006, CHEM MATER, V18, P2689, DOI 10.1021/cm052633o; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194; Van WJ, 1992, U. S. Patent, Patent No. 5447706; 2005, CHEM ENG, V766, P16	23	640	652	29	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1037	1041		10.1126/science.1168980	http://dx.doi.org/10.1126/science.1168980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229032				2022-12-28	WOS:000263478400035
J	Willis, HWM; Willis, NM; Willis, GW; Ali, FR; Ball, C				Willis, Henry W. M.; Willis, Nichola M.; Willis, George W.; Ali, Faisal R.; Ball, Colin			A Patient's Journey Coeliac disease in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ali, Faisal R.; Ball, Colin] Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Ali, FR (corresponding author), Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England.	f.r.ali.01@cantab.net		Ali, Faisal/0000-0002-8588-791X				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2009	338								a3066	10.1136/bmj.a3066	http://dx.doi.org/10.1136/bmj.a3066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228764				2022-12-28	WOS:000264052200004
J	Salvi, V				Salvi, Vinita			Child marriage in India: a tradition with alarming implications	LANCET			English	Editorial Material									[Salvi, Vinita] Seth G S Med Coll, Dept Obstet & Gynaecol, Mumbai 400012, Maharashtra, India; [Salvi, Vinita] King Edward Mem Hosp Women, Mumbai 400012, Maharashtra, India	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Salvi, V (corresponding author), Seth G S Med Coll, Dept Obstet & Gynaecol, Mumbai 400012, Maharashtra, India.	vinitasalvigsmc@hotmail.com						*INT I POP SCI IND, NAT FAM HLTH SURV 2; *INT I POP SCI IND, NAT FAM HLTH SURV NF, pCH4; *INT I POP SCI IND, NAT FAM HLTH SURV 3; *OFF REG GEN CENS, CENS IND MAP 2 POP D; Office of the Registrar General and Census Commissioner of India, 2001, CENS IND 2001; RAJ A, 2009, LANCET; STECK TL, 2008, ENCY EARTH; *UN POP DIV DEP EC, 2007, WORLD POP PROSP 2006; *UN POP DIV DEP EC, IND BEC BILL; *UN STAT DIV, 2008, LEG AG MARR IND WOM	10	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1826	1827		10.1016/S0140-6736(09)60452-9	http://dx.doi.org/10.1016/S0140-6736(09)60452-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19278722				2022-12-28	WOS:000266616400007
J	Herzog, F; Primorac, I; Dube, P; Lenart, P; Sander, B; Mechtler, K; Stark, H; Peters, JM				Herzog, Franz; Primorac, Ivana; Dube, Prakash; Lenart, Peter; Sander, Bjoern; Mechtler, Karl; Stark, Holger; Peters, Jan-Michael			Structure of the Anaphase-Promoting Complex/Cyclosome Interacting with a Mitotic Checkpoint Complex	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DESTRUCTION BOX; BUDDING YEAST; PROTEIN MAD2; AURORA-B; APC/C; CDC20; INHIBITION; MITOSIS; BUBR1	Once all chromosomes are connected to the mitotic spindle (bioriented), anaphase is initiated by the protein ubiquitylation activity of the anaphase-promoting complex/cyclosome (APC/C) and its coactivator Cdc20 (APC/C-Cdc20). Before chromosome biorientation, anaphase is delayed by a mitotic checkpoint complex (MCC) that inhibits APC/C-Cdc20. We used single-particle electron microscopy to obtain three-dimensional models of human APC/C in various functional states: bound to MCC, to Cdc20, or to neither (apo-APC/C). These experiments revealed that MCC associates with the Cdc20 binding site on APC/C, locks the otherwise flexible APC/C in a "closed" state, and prevents binding and ubiquitylation of a wide range of different APC/C substrates. These observations clarify the structural basis for the inhibition of APC/C by spindle checkpoint proteins.	[Dube, Prakash; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Herzog, Franz; Primorac, Ivana; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Lenart, Peter] European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL)	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de; peters@imp.univie.ac.at	Sander, Bjoern/AAO-9021-2021; Herzog, Franz/G-4832-2012; Mechtler, Karl/AAF-2717-2019	Sander, Bjoern/0000-0001-8495-2321; Herzog, Franz/0000-0001-8270-1449; Mechtler, Karl/0000-0002-3392-9946; Lenart, Peter/0000-0002-3927-248X; Holger, Stark/0000-0002-6161-1118	Federal Ministry of Education and Research, Germany; Sixth Framework Programme of the European Union; Boehringer Ingelheim; Vienna Spots of Excellence Programme; Austrian Science Fund	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Sixth Framework Programme of the European Union(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Vienna Spots of Excellence Programme; Austrian Science Fund(Austrian Science Fund (FWF))	We are grateful to M. Madalinski, M. Gmachl, and G. Kohlmaier for reagents; J. Deckert and R. Luhrmann for support; and S. Westermann for comments on the manuscript. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research, Germany, and the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire. Research in the laboratories of J.-M.P. and K.M. were supported by Boehringer Ingelheim, the Vienna Spots of Excellence Programme, and the Austrian Science Fund. The structural coordinates have been deposited in the Electron Microscopy Data Bank Database at the European Molecular Biology Laboratory European Bioinformatics Institute. The structures of APC/CMCC and apo-APC/C can be accessed under the codes EMD-1591 and EMD-1592, respectively.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5	28	170	177	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1477	1481		10.1126/science.1163300	http://dx.doi.org/10.1126/science.1163300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286556	Green Accepted			2022-12-28	WOS:000264101700041
J	Sanchez, PA				Sanchez, Pedro A.			A smarter way to combat hunger	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, Palisades, NY 10964 USA	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, 61 Route 9W, Palisades, NY 10964 USA.	psanchez@ei.columbia.edu						*CHIC IN GLOB AGR, 2009, REN AM LEAD FIGHT GL; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; DIOUF J, 2009, HIGH LEV M FOOD SEC; Garrett Laurie, 2008, FOOD FAILURES FUTURE; JURY A, 2008, WORLD FOOD PRIZ S 22; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Sanchez PA, 2009, FOOD SECUR, V1, P37, DOI 10.1007/s12571-009-0011-5; von Braun J, 2008, NATURE, V456, P701, DOI 10.1038/456701a	8	11	11	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					148	148		10.1038/458148a	http://dx.doi.org/10.1038/458148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279615	Bronze			2022-12-28	WOS:000264059700022
J	Pierson, RN				Pierson, Richard N., III			Current Status of Xenotransplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENE-KNOCKOUT PIGS; NONHUMAN-PRIMATES; PORCINE ISLETS; BABOONS; DONORS; SURVIVAL; FAILURE; RISK		[Pierson, Richard N., III] Univ Maryland, Med Ctr, Div Cardiac Surg, Baltimore, MD 21201 USA; [Pierson, Richard N., III] Baltimore Vet Affairs Med Ctr, Dept Surg, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Pierson, RN (corresponding author), Univ Maryland, Med Ctr, Div Cardiac Surg, N4W94,22 S Greene St, Baltimore, MD 21201 USA.	rpierson@smail.umaryland.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066719, U01AI066335] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000095, M01 RR016500] Funding Source: Medline; NIAID NIH HHS [U01 AI066719, U01 AI066335] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan JS, 1998, ANN NY ACAD SCI, V862, P87, DOI 10.1111/j.1749-6632.1998.tb09120.x; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Cooper DKC, 2007, TRANSPLANTATION, V84, P1, DOI 10.1097/01.tp.0000260427.75804.f2; *DIABECELL, LIF CHANG CELL THER; Fishman JA, 2004, AM J TRANSPLANT, V4, P1383, DOI 10.1111/j.1600-6143.2004.00542.x; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Naruse K, 2007, WORLD J GASTROENTERO, V13, P1516, DOI 10.3748/wjg.v13.i10.1516; PIERSON RN, 1989, J EXP MED, V170, P991, DOI 10.1084/jem.170.3.991; REES MA, 2003, THESIS U CAMBRIDGE C; Schulte am Esch II J, 2001, ANN TRANSPL, V6, P12; Shimizu A, 2005, J AM SOC NEPHROL, V16, P2732, DOI 10.1681/ASN.2004121148; Wu GS, 2007, XENOTRANSPLANTATION, V14, P34, DOI 10.1111/j.1399-3089.2006.00362.x; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172	14	13	14	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					967	969		10.1001/jama.2009.237	http://dx.doi.org/10.1001/jama.2009.237			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19258587	Green Accepted			2022-12-28	WOS:000263784600029
J	Mo, YF; Turner, KT; Szlufarska, I				Mo, Yifei; Turner, Kevin T.; Szlufarska, Izabela			Friction laws at the nanoscale	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; FORCE MICROSCOPY; BOUNDARY FRICTION; CONTACT MECHANICS; SURFACE FORCES; ADHESION; MODEL; NANOTRIBOLOGY; DEFORMATION; ASPERITY	Macroscopic laws of friction do not generally apply to nanoscale contacts. Although continuum mechanics models have been predicted to break down at the nanoscale(1), they continue to be applied for lack of a better theory. An understanding of how friction force depends on applied load and contact area at these scales is essential for the design of miniaturized devices with optimal mechanical performance(2,3). Here we use large-scale molecular dynamics simulations with realistic force fields to establish friction laws in dry nanoscale contacts. We show that friction force depends linearly on the number of atoms that chemically interact across the contact. By defining the contact area as being proportional to this number of interacting atoms, we show that the macroscopically observed linear relationship between friction force and contact area can be extended to the nanoscale. Our model predicts that as the adhesion between the contacting surfaces is reduced, a transition takes place from nonlinear to linear dependence of friction force on load. This transition is consistent with the results of several nanoscale friction experiments(4-7). We demonstrate that the breakdown of continuum mechanics can be understood as a result of the rough (multi-asperity) nature of the contact, and show that roughness theories(8-10) of friction can be applied at the nanoscale.	[Mo, Yifei; Turner, Kevin T.; Szlufarska, Izabela] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA; [Turner, Kevin T.] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Turner, Kevin T.; Szlufarska, Izabela] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Szlufarska, I (corresponding author), Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.	izabela@engr.wisc.edu	Szlufarska, Izabela/AFY-3304-2022; Mo, Yifei/F-5671-2011	Mo, Yifei/0000-0002-8162-4629	National Science Foundation [DMR-0512228]; American Chemical Society [PRF-47978-G5]	National Science Foundation(National Science Foundation (NSF)); American Chemical Society(American Chemical Society)	We thank D. Morgan for helpful discussions. Financial support from the National Science Foundation grant DMR-0512228 and from the American Chemical Society PRF-47978-G5 grant is gratefully acknowledged.	Amontons G, 1699, MEM ACAD R A, P275; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BOWDEN FP, 1950, FRICTION LUBRICATION, P12110; Brenner DW, 2002, J PHYS-CONDENS MAT, V14, P783, DOI 10.1088/0953-8984/14/4/312; BUSH AW, 1975, WEAR, V35, P87, DOI 10.1016/0043-1648(75)90145-3; Carpick RW, 1999, J COLLOID INTERF SCI, V211, P395, DOI 10.1006/jcis.1998.6027; Chandross M, 2008, LANGMUIR, V24, P1240, DOI 10.1021/la702323y; Colburn TJ, 2007, LANGMUIR, V23, P4959, DOI 10.1021/la062259m; Delrio FW, 2005, NAT MATER, V4, P629, DOI 10.1038/nmat1431; Gao GT, 2007, LANGMUIR, V23, P5394, DOI 10.1021/la062254p; Gao JP, 2004, J PHYS CHEM B, V108, P3410, DOI 10.1021/jp036362l; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; GRIERSON DS, 2008, THESIS U WISCONSIN, P12110; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; HORN RG, 1987, J COLLOID INTERF SCI, V115, P480, DOI 10.1016/0021-9797(87)90065-8; ISRAELACHVILI JN, 1999, HDB MICRO NANOTRIBOL, P371; Johnson KL, 1997, P ROY SOC A-MATH PHY, V453, P163, DOI 10.1098/rspa.1997.0010; Luan BQ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026111; Luan BQ, 2005, NATURE, V435, P929, DOI 10.1038/nature03700; MAUGIS D, 1992, J COLLOID INTERF SCI, V150, P243, DOI 10.1016/0021-9797(92)90285-T; Muser MH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.055504; Perry SS, 2004, MRS BULL, V29, P478, DOI 10.1557/mrs2004.142; Persson BNJ, 2001, J CHEM PHYS, V115, P3840, DOI 10.1063/1.1388626; Pietrement O, 2001, LANGMUIR, V17, P6540, DOI 10.1021/la010458u; PUTMAN CAJ, 1995, APPL PHYS LETT, V66, P3221, DOI 10.1063/1.113729; Riedo E, 2001, SURF SCI, V477, P25, DOI 10.1016/S0039-6028(01)00701-4; Ruths M, 2003, J PHYS CHEM B, V107, P11149, DOI 10.1021/jp0353946; Ruths M, 2003, LANGMUIR, V19, P6788, DOI 10.1021/la034003b; Schwarz UD, 2003, J COLLOID INTERF SCI, V261, P99, DOI 10.1016/S0021-9797(03)00049-3; Socoliuc A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134301; Szlufarska I, 2005, SCIENCE, V309, P911, DOI 10.1126/science.1114411; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001; TABOR D, 1977, J COLLOID INTERF SCI, V58, P2, DOI 10.1016/0021-9797(77)90366-6; Wenning L, 2001, EUROPHYS LETT, V54, P693, DOI 10.1209/epl/i2001-00371-6; Zykova-Timan T, 2007, NAT MATER, V6, P230, DOI 10.1038/nmat1836	35	683	699	17	565	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1116	1119		10.1038/nature07748	http://dx.doi.org/10.1038/nature07748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242472				2022-12-28	WOS:000263680100037
J	Chhetri, SK; Aziz, I				Chhetri, Suresh Kumar; Aziz, Imran			Where is the leak?	LANCET			English	Editorial Material							EMPHYSEMA		[Chhetri, Suresh Kumar; Aziz, Imran] Royal Albert Edward Infirm, Dept Resp Med, Wigan WN1 2NN, Lancs, England		Aziz, I (corresponding author), Royal Albert Edward Infirm, Dept Resp Med, Wigan Lane, Wigan WN1 2NN, Lancs, England.	imran.aziz@wwl.nhs.uk	Chhetri, Suresh/T-8723-2019	chhetri, Suresh Kumar/0000-0002-3325-5582				Hur T, 1995, EUR RESPIR J, V8, P2188, DOI 10.1183/09031936.95.0812188; MEYERS MA, 1974, RADIOLOGY, V111, P17, DOI 10.1148/111.1.17; OETTING HK, 1955, AM J MED, V19, P872, DOI 10.1016/0002-9343(55)90155-8; Schmidt GB, 2008, WORLD J GASTROENTERO, V14, P3922, DOI 10.3748/wjg.14.3922	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					692	692		10.1016/S0140-6736(09)60405-0	http://dx.doi.org/10.1016/S0140-6736(09)60405-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410FS	19231635				2022-12-28	WOS:000263563500034
J	Houseley, J; Tollervey, D				Houseley, Jonathan; Tollervey, David			The Many Pathways of RNA Degradation	CELL			English	Review							MESSENGER-RNA; RIBOSOMAL-RNA; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; YEAST EXOSOME; BINDING PROTEINS; NUCLEAR-RNA; DUAL ROLE; GENE	From the earliest comparisons of RNA production with steady-state levels, it has been clear that cells transcribe more RNA than they accumulate, implying the existence of active RNA degradation systems. In general, RNA is degraded at the end of its useful life, which is long for a ribosomal RNA but very short for excised introns or spacer fragments, and is closely regulated for most mRNA species. RNA molecules with defects in processing, folding, or assembly with proteins are identified and rapidly degraded by the surveillance machinery. Because RNA degradation is ubiquitous in all cells, it is clear that it must be carefully controlled to accurately recognize target RNAs. How this is achieved is perhaps the most pressing question in the field.	[Houseley, Jonathan; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020; Houseley, Jon/AAF-7409-2021	Tollervey, David/0000-0003-2894-2772; Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust; Leverhulme Trust.	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust.(Leverhulme Trust)	We thank J. Coller for communicating results prior to publication and G. Kudla, H. Tekotte, and E. Thomson for critical reading of the manuscript. This work was supported by the Wellcome Trust and the Leverhulme Trust.	Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beau I, 2008, TRENDS CELL BIOL, V18, P311, DOI 10.1016/j.tcb.2008.05.001; Beckham CJ, 2007, J VIROL, V81, P9759, DOI 10.1128/JVI.00844-07; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRANDHORST BP, 1974, J MOL BIOL, V85, P451, DOI 10.1016/0022-2836(74)90444-6; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chandran V, 2007, J MOL BIOL, V367, P113, DOI 10.1016/j.jmb.2006.12.014; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deshmukh MV, 2008, MOL CELL, V29, P324, DOI 10.1016/j.molcel.2007.11.027; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hong YG, 1998, VIROLOGY, V242, P80, DOI 10.1006/viro.1997.8999; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; KARBSTEIN K, 2009, WILEY ENCY CHEM BIOL; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee HJ, 2008, MOL CELLS, V25, P545; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Peng Y, 2008, MOL BIOL CELL, V19, P546, DOI 10.1091/mbc.E07-08-0774; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rissland OS, 2008, BBA-GENE REGUL MECH, V1779, P286, DOI 10.1016/j.bbagrm.2008.03.003; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rougemaille M, 2008, BIOL CELL, V100, P327, DOI 10.1042/BC20070143; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Skruzny M, 2009, PLOS BIOL, V7, P164, DOI 10.1371/journal.pbio.1000008; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Taghbalout A, 2008, J BIOL CHEM, V283, P13850, DOI 10.1074/jbc.M709118200; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010	117	734	754	4	153	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					763	776		10.1016/j.cell.2009.01.019	http://dx.doi.org/10.1016/j.cell.2009.01.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239894	Bronze			2022-12-28	WOS:000263688200024
J	Saunders, LR; Verdin, E				Saunders, Laura R.; Verdin, Eric			CELL BIOLOGY Stress Response and Aging	SCIENCE			English	Editorial Material							SHOCK TRANSCRIPTION FACTOR-1; CALORIE RESTRICTION; LIFE-SPAN; SIRT1; RESVERATROL; ACTIVATION; EXPRESSION; SURVIVAL; SIRTUINS; ROLES		[Saunders, Laura R.; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Saunders, Laura R.; Verdin, Eric] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Saunders, LR (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183				Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonelli MA, 1999, EXP CELL RES, V252, P20, DOI 10.1006/excr.1999.4614; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heydari AR, 1996, DEV GENET, V18, P114, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;114::AID-DVG4&gt;3.0.CO;2-C; Heydari AR, 2000, EXP CELL RES, V256, P83, DOI 10.1006/excr.2000.4808; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	19	62	66	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1021	1022		10.1126/science.1170007	http://dx.doi.org/10.1126/science.1170007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	409AK	19229027				2022-12-28	WOS:000263478400029
J	Liang, CY; Lin, MS				Liang, Chi-Yen; Lin, Ming-Shian			Achalasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liang, Chi-Yen; Lin, Ming-Shian] Chiayi Christian Hosp, Chiayi 600, Taiwan	Chia-Yi Christian Hospital	Liang, CY (corresponding author), Chiayi Christian Hosp, Chiayi 600, Taiwan.	oswallow@tpts8.seed.net.tw							0	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					801	801		10.1056/NEJMicm075739	http://dx.doi.org/10.1056/NEJMicm075739			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228623				2022-12-28	WOS:000263411300010
J	Ekiert, DC; Bhabha, G; Elsliger, MA; Friesen, RHE; Jongeneelen, M; Throsby, M; Goudsmit, J; Wilson, IA				Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap; Wilson, Ian A.			Antibody Recognition of a Highly Conserved Influenza Virus Epitope	SCIENCE			English	Article							A VIRUSES; MEMBRANE-FUSION; HIV-1 NEUTRALIZATION; STRUCTURAL BASIS; AVIAN INFLUENZA; BINDING SITE; HEMAGGLUTININ; RECEPTOR; COMPLEX; PH	Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.	[Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Johnson & Johnson; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Ekiert, Damian/0000-0002-2570-0404; Elsliger, Marc Andre/0000-0002-1989-7626	NIH [AI-058113]; predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM074898, Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant AI-058113 (I.A.W.) and a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D.C.E.) and the Skaggs Institute. The Joint Center for Structural Genomics (JCSG) is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM074898). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The authors thank H. Tien and D. Marciano of the Robotics Core at the JCSG for automated crystal screening; C. Ogata and the staff of the APS GM/CA CAT 23-ID-B for beamline support; X. Dai and R. Stanfield for excellent assistance with data collection and processing and analyses; R. Pejchal, M. Crispin, M. Wormald, and D. Wolan for valuable comments; and R. Lerner for insightful discussion. This is publication 19980 from the Scripps Research Institute. Coordinates and structure factors are deposited in the Protein Data Bank (PDB) (3GBN and 3GBM for CR6261-SC1918/H1 and CR6261-Viet04/H5, respectively).	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Smirnov YA, 1999, ACTA VIROL, V43, P237; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443; 2008, MMWR MORB MORTAL WKL, V57, P393	39	995	1123	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					246	251		10.1126/science.1171491	http://dx.doi.org/10.1126/science.1171491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19251591	Green Accepted			2022-12-28	WOS:000265024400045
J	Neugebauer, JM; Amack, JD; Peterson, AG; Bisgrove, BW; Yost, HJ				Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph			FGF signalling during embryo development regulates cilia length in diverse epithelia	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; ZEBRAFISH FIN REGENERATION; KUPFFERS VESICLE; LEFTWARD FLOW; CELLS; SPECIFICATION; INHIBITION; XENOPUS; MUTANT	Cilia are cell surface organelles found on most epithelia in vertebrates. Specialized groups of cilia have critical roles in embryonic development, including left-right axis formation. Recently, cilia have been implicated as recipients of cell-cell signalling(1,2). However, little is known about cell-cell signalling pathways that control the length of cilia(3). Here we provide several lines of evidence showing that fibroblast growth factor (FGF) signalling regulates cilia length and function in diverse epithelia during zebrafish and Xenopus development. Morpholino knockdown of FGF receptor 1 (Fgfr1) in zebrafish cell-autonomously reduces cilia length in Kupffer's vesicle and perturbs directional fluid flow required for left-right patterning of the embryo. Expression of a dominant-negative FGF receptor (DN-Fgfr1), treatment with SU5402 ( a pharmacological inhibitor of FGF signalling) or genetic and morpholino reduction of redundant FGF ligands Fgf8 and Fgf24 reproduces this cilia length phenotype. Knockdown of Fgfr1 also results in shorter tethering cilia in the otic vesicle and shorter motile cilia in the pronephric ducts. In Xenopus, expression of a dn-fgfr1 results in shorter monocilia in the gastrocoel roof plate that control left-right patterning(4) and in shorter multicilia in external mucociliary epithelium. Together, these results indicate a fundamental and highly conserved role for FGF signalling in the regulation of cilia length in multiple tissues. Abrogation of Fgfr1 signalling downregulates expression of two ciliogenic transcription factors, foxj1 and rfx2, and of the intraflagellar transport gene ift88 (also known as polaris), indicating that FGF signalling mediates cilia length through an Fgf8/Fgf24-Fgfr1-intraflagellar transport pathway. We propose that a subset of developmental defects and diseases ascribed to FGF signalling are due in part to loss of cilia function.	[Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph] Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Bldg 533,Room 3160,15 North 2030 East, Salt Lake City, UT 84112 USA.	jyost@genetics.utah.edu		Amack, Jeffrey/0000-0002-5465-9754	American Heart Association; NRSA Postdoctoral fellowship; NHLBI; NICHD; Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD048886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066292, R01HL075472] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NRSA Postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Moon and M. Condic for critical discussions on the manuscript; M. Karthikeyan, J. Shen, D. Coombs and E. Martini for technical help; and S. Miyagawa- Tomita, K. Poss and H. Issacs for reagents. This work was supported by American Heart Association predoctoral fellowship to J. M. N., NRSA Postdoctoral fellowship to J. D. A. and grants from NHLBI, NICHD and Primary Children's Medical Foundation to H. J. Y.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fischer A, 2002, CURR BIOL, V12, P1807, DOI 10.1016/S0960-9822(02)01222-8; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; R Development Core Team, 2007, R FDN STAT COMP; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	33	186	188	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					651	U119		10.1038/nature07753	http://dx.doi.org/10.1038/nature07753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242413	Green Accepted			2022-12-28	WOS:000264796200045
J	Cooper, LA				Cooper, Lisa A.			A 41-Year-Old African American Man With Poorly Controlled Hypertension Review of Patient and Physician Factors Related to Hypertension Treatment Adherence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE CONTROL; PRIMARY-CARE; ALTERNATIVE MEDICINE; DECISION-MAKING; NATIONAL-HEALTH; UNITED-STATES; EDUCATIONAL INTERVENTION; GUIDELINE ADHERENCE; RACIAL CONCORDANCE	Mr R is an African American man with a long history of poorly controlled hypertension and difficulties with adherence to recommended treatments. Despite serious complications such as hypertensive emergency requiring hospitalization and awareness of the seriousness of his illness, Mr R says at times he has ignored his high blood pressure and his physicians' recommendations. African Americans are disproportionately affected by hypertension and its complications. Although most pharmacological and dietary therapies for hypertension are similarly efficacious for African Americans and whites, disparities in hypertension treatment persist. Like many patients, Mr R faces several barriers to effective blood pressure control: societal, health system, individual, and interactions with health professionals. Moreover, evidence indicates that patients' cognitive, affective, and attitudinal factors and the patient-physician relationship play critical roles in improving outcomes and reducing racial disparities in hypertension control.	[Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Dept Med, Baltimore, MD 21205 USA; [Cooper, Lisa A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cooper, LA (corresponding author), Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Dept Med, 2024 E Monument St,Ste 2-500, Baltimore, MD 21205 USA.	lisa.cooper@jhmi.edu			National Heart, Lung, and Blood Institute (NHLBI) [K24HL083113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL083113] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant K24HL083113 from the National Heart, Lung, and Blood Institute (NHLBI).	*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ard JD, 2000, J NATL MED ASSOC, V92, P515; Arkowitz H., 2008, MOTIVATIONAL INTERVI; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Beach MC, 2007, J GEN INTERN MED, V22, P1119, DOI 10.1007/s11606-007-0241-1; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Bodenheimer T, 2007, JAMA-J AM MED ASSOC, V298, P2048, DOI 10.1001/jama.298.17.2048; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Bonds DE, 2009, AM HEART J, V157, P278, DOI 10.1016/j.ahj.2008.09.021; Bosworth HB, 2008, PATIENT EDUC COUNS, V70, P338, DOI 10.1016/j.pec.2007.11.014; BOSWORTH HB, 2009, AM J MED, V119; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Boutin-Foster C, 2007, ETHNIC DIS, V17, P29; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Brown CM, 2007, J ALTERN COMPLEM MED, V13, P751, DOI 10.1089/acm.2006.6392; Bultman DC, 2000, PATIENT EDUC COUNS, V40, P173, DOI 10.1016/S0738-3991(99)00083-X; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Cho Alex H, 2007, J Clin Hypertens (Greenwich), V9, P330, DOI 10.1111/j.1524-6175.2007.06489.x; Clever SL, 2006, MED CARE, V44, P398, DOI 10.1097/01.mlr.0000208117.15531.da; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Cooper LA, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00305.x; Cooper LA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-7; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Di Tullio MR, 2003, STROKE, V34, P2380, DOI 10.1161/01.STR.0000089680.77236.60; DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; DUNBARJACOB JM, 1998, HDB HLTH BEHAV CHANG, P491; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Epstein RM, 2004, JAMA-J AM MED ASSOC, V291, P2359, DOI 10.1001/jama.291.19.2359; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Feldman R, 1998, CAN J PUBLIC HEALTH, V89, pI16, DOI 10.1007/BF03404494; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; Flaskerud J H, 1990, Issues Ment Health Nurs, V11, P321, DOI 10.3109/01612849009006520; Fretheim A, 2006, PLOS MED, V3, P783, DOI 10.1371/journal.pmed.0030134; Ghods BK, 2008, J GEN INTERN MED, V23, P600, DOI 10.1007/s11606-008-0539-7; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Goldstein MK, 2005, AM J MANAG CARE, V11, P677; Goodyear-Smith F, 2001, HEALTH CARE ANAL, V9, P449, DOI 10.1023/A:1013812802937; Graham RE, 2005, J NATL MED ASSOC, V97, P535; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Grimm RH, 1997, ARCH INTERN MED, V157, P638, DOI 10.1001/archinte.157.6.638; Grimm RH, 1997, HYPERTENSION, V29, P8, DOI 10.1161/01.HYP.29.1.8; Gu QP, 2008, ANN EPIDEMIOL, V18, P302, DOI 10.1016/j.annepidem.2007.11.013; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heisler M, 2007, J GERONTOL A-BIOL, V62, P1435, DOI 10.1093/gerona/62.12.1435; Hennessy S, 2006, PHARMACOTHERAPY, V26, P1342, DOI 10.1592/phco.26.9.1342; HEURTINROBERTS S, 1992, AM J HYPERTENS, V5, P787, DOI 10.1093/ajh/5.11.787; Hicks LS, 2008, J GEN INTERN MED, V23, P429, DOI 10.1007/s11606-007-0403-1; Hicks LS, 2004, HYPERTENSION, V44, P429, DOI 10.1161/01.HYP.0000141439.34834.84; HOOPER EM, 1982, MED CARE, V20, P630, DOI 10.1097/00005650-198206000-00009; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Jacobs EA, 2006, J GEN INTERN MED, V21, P642, DOI 10.1111/j.1525-1497.2006.00485.x; Jahng KH, 2005, PATIENT EDUC COUNS, V57, P308, DOI 10.1016/j.pec.2004.08.006; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kaplan S, 1989, COMMUNICATING MED PA; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; King WD, 2004, J GEN INTERN MED, V19, P1146, DOI 10.1111/j.1525-1497.2004.30443.x; Kinmonth AL, 1998, BMJ-BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Krupat E, 2000, PATIENT EDUC COUNS, V39, P49, DOI 10.1016/S0738-3991(99)00090-7; Krupat E, 2001, J FAM PRACTICE, V50, P1057; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Kushnir T, 2008, J DEV BEHAV PEDIATR, V29, P18, DOI 10.1097/DBP.0b013e3181469016; LavizzoMourey R, 1996, ANN INTERN MED, V124, P919, DOI 10.7326/0003-4819-124-10-199605150-00010; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; LOW SM, 1984, SOC WORK HEALTH CARE, V9, P13, DOI 10.1300/J010v09n03_02; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; McKinstry B, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004134.PUB2; McLean DL, 2008, ARCH INTERN MED, V168, P2355, DOI 10.1001/archinte.168.21.2355; Mechanic D, 1996, MILBANK Q, V74, P171, DOI 10.2307/3350245; Meland E, 1997, SCAND J PRIM HEALTH, V15, P57, DOI 10.3109/02813439709043432; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Morris AB, 2006, PHARMACOTHERAPY, V26, P483, DOI 10.1592/phco.26.4.483; Ngo-Metzger Q, 2004, J GEN INTERN MED, V19, P111, DOI 10.1111/j.1525-1497.2004.30143.x; Ni HY, 2002, MED CARE, V40, P353, DOI 10.1097/00005650-200204000-00011; O'Malley AS, 2004, PREV MED, V38, P777, DOI 10.1016/j.ypmed.2004.01.018; Oliver MN, 2001, J NATL MED ASSOC, V93, P380; Organization WH, 2003, ADHERENCE LONG TERM; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; ORTH JE, 1987, HEALTH PSYCHOL, V6, P29, DOI 10.1037/0278-6133.6.1.29; Park IU, 2007, ANN FAM MED, V5, P444, DOI 10.1370/afm.708; Piette JD, 2000, J GEN INTERN MED, V15, P797, DOI 10.1046/j.1525-1497.2000.91107.x; Pill R, 1998, FAM PRACT, V15, P229, DOI 10.1093/fampra/15.3.229; Rand CS, 1998, HDB HLTH BEHAV CHANG, P114; Roter D, 2000, PATIENT EDUC COUNS, V39, P5, DOI 10.1016/S0738-3991(99)00086-5; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Roumie CL, 2006, ANN INTERN MED, V145, P165, DOI 10.7326/0003-4819-145-3-200608010-00004; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Safran DG, 1998, J FAM PRACTICE, V47, P213; Safran DG, 2001, J FAM PRACTICE, V50, P130; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Schlomann P, 2007, J AM ACAD NURSE PRAC, V19, P358, DOI 10.1111/j.1745-7599.2007.00238.x; Schneider RH, 2005, AM J HYPERTENS, V18, P88, DOI 10.1016/j.amjhyper.2004.08.027; Schroeder K, 2005, FAM PRACT, V22, P144, DOI 10.1093/fampra/cmh717; Schroeder K., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004804; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Shapiro J, 2004, MENT RETARD, V42, P37, DOI 10.1352/0047-6765(2004)42<37:AAPOLM>2.0.CO;2; SHARKNESS CM, 1992, AM J PREV MED, V8, P141, DOI 10.1016/S0749-3797(18)30821-3; Simon SR, 2005, AM J MED, V118, P521, DOI 10.1016/j.amjmed.2004.12.023; Sohler NL, 2007, AIDS BEHAV, V11, P884, DOI 10.1007/s10461-007-9212-0; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Street RL, 2008, ANN FAM MED, V6, P198, DOI 10.1370/afm.821; Svarstad BL, 1986, APPL SOCIAL SCI CLIN; Takakuwa KM, 2008, AM J EMERG MED, V26, P545, DOI 10.1016/j.ajem.2007.08.020; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; Thom DH, 1997, J FAM PRACTICE, V44, P169; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Tobe SW, 2006, CAN MED ASSOC J, V174, P1267, DOI 10.1503/cmaj.050030; Turnbull F, 2003, LANCET, V362, P1527; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yin C, 2007, NEUROL RES, V29, pS98, DOI 10.1179/016164107X172220; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	128	30	30	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1260	1272		10.1001/jama.2009.358	http://dx.doi.org/10.1001/jama.2009.358			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19258571	Green Accepted			2022-12-28	WOS:000264492800026
J	Bushnell, CD; Jamison, M; James, AH				Bushnell, Cheryl D.; Jamison, Margaret; James, Andra H.			Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; RISK-FACTORS; YOUNG-WOMEN; HEADACHE; ASSOCIATIONS; PREECLAMPSIA; PREVALENCE; COHORT; ONSET	Objective To examine the association between migraine and cardiovascular diseases during pregnancy. Design US population based case-control study. Setting Nationwide inpatient sample, from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality. Population 18 345 538 pregnancy related discharges from 2000 to 2003. Main outcome measures Diagnosis of migraine, as identified by ICD-9 codes 346.0 and 346.1. Stroke and other vascular diseases were identified by using standard ICD-9 codes. Results From the hospital discharges with a pregnancy discharge code, 33 956 migraine codes were identified: 185 per 100 000 deliveries. Diagnoses that were jointly associated with migraine codes during pregnancy (excluding pre-eclampsia) were stroke (odds ratio 15.05, 95% confidence interval 8.26 to 27.4), myocardial infarction/heart disease (2.11, 1.76 to 2.54), pulmonary embolus/venous thromboembolism (3.23, 2.06 to 7.07), and hypertension (8.61, 6.43 to 11.54), as well as preeclampsia/gestational hypertension (2.29, 2.13 to 2.46), smoking (2.85, 2.53 to 3.21), and diabetes (1.96, 1.64 to 2.35). However, migraine was not associated with several non-vascular diagnoses (pneumonia, transfusions, postpartum infection or haemorrhage). Conclusions In this large, population based sample of pregnant women admitted to hospital, a strong relation existed between active peripartum migraine and vascular diagnoses during pregnancy. Because these data do not allow determination of which came first, migraine or the vascular condition, prospective studies of pregnant women are needed to explore this association further.	[Bushnell, Cheryl D.] Wake Forest Univ Hlth Sci, Dept Neurol, Winston Salem, NC 27157 USA; [Jamison, Margaret] Univ N Carolina, Sch Med, Off Educ Dev, Chapel Hill, NC 27599 USA; [James, Andra H.] Duke Univ, Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Durham, NC 27710 USA	Wake Forest University; Wake Forest University School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Bushnell, CD (corresponding author), Wake Forest Univ Hlth Sci, Dept Neurol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cbushnel@wfubmc.edu		James, Andra/0000-0003-4570-6595	National Institutes of Health [5K12-HD043446-03, K02-NS058760]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS058760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: The study was funded in part by the National Institutes of Health (5K12-HD043446-03 and K02-NS058760). The funding agency had no role in the conception or design of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The authors were independent from the funders in all aspects of the study design, analysis of data, and writing of the manuscript.	Adeney KL, 2006, HEADACHE, V46, P794, DOI 10.1111/j.1526-4610.2006.00432.x; Adeney KL, 2005, J MATERN-FETAL NEO M, V18, P167, DOI 10.1080/14767050500260566; *AG HEALTHC RES QU, 2004, INTR NAT INP SAMPL N; *AG HEALTHC RES QU, 2002, OV NAT INP SAMPL NIS; Banhidy F, 2007, EUR J OBSTET GYN R B, V134, P157, DOI 10.1016/j.ejogrb.2006.08.025; BOUSSER MG, 1998, STROKE PATHOPHYSIOLO, P623; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; CHEN TC, 1994, HEADACHE, V34, P107, DOI 10.1111/j.1526-4610.1994.hed3402107.x; CHEN TC, 1987, ARCH NEUROL-CHICAGO, V44, P1024, DOI 10.1001/archneur.1987.00520220030011; Crassard I, 2001, CEPHALALGIA, V21, P630, DOI 10.1046/j.1468-2982.2001.00205.x; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Facchinetti F, 2005, EUR J OBSTET GYN R B, V121, P143, DOI 10.1016/j.ejogrb.2004.12.020; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; GORELICK PB, 1986, NEUROLOGY, V36, P1445, DOI 10.1212/WNL.36.11.1445; HENRY P, 1992, CEPHALALGIA, V12, P229, DOI 10.1046/j.1468-2982.1992.1204229.x; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lockwood CJ, 2002, OBSTET GYNECOL, V99, P333, DOI 10.1016/S0029-7844(01)01760-4; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; Milhaud D, 2001, NEUROLOGY, V57, P1805, DOI 10.1212/WNL.57.10.1805; Mitchell P, 1998, AUST NZ J MED, V28, P627, DOI 10.1111/j.1445-5994.1998.tb00659.x; MOORE MP, 1983, BRIT MED J, V287, P580, DOI 10.1136/bmj.287.6392.580; OLESEN J, 1993, BRAIN, V116, P187, DOI 10.1093/brain/116.1.187; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schwaag S, 2003, HEADACHE, V43, P90, DOI 10.1046/j.1526-4610.2003.03023.x; Schwaiger J, 2008, NEUROLOGY, V71, P937, DOI 10.1212/01.wnl.0000325918.48056.75; SILVESTRINI M, 1994, EUR NEUROL, V34, P316, DOI 10.1159/000117069; SOMERVILLE BW, 1972, NEUROLOGY, V22, P824, DOI 10.1212/WNL.22.8.824; SPEIRS L, 1998, HOSP PAYLOR ICD 9 CM; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; TZOURIO C, 1993, BMJ-BRIT MED J, V307, P289, DOI 10.1136/bmj.307.6899.289; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; VESTERGAARD K, 1993, STROKE, V24, P1621, DOI 10.1161/01.STR.24.11.1621	40	96	98	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b664	10.1136/bmj.b664	http://dx.doi.org/10.1136/bmj.b664			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278973	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264205300002
J	Chalmers, I; Leaning, J; Shannon, HS; Zurayk, H				Chalmers, Iain; Leaning, Jennifer; Shannon, Harry S.; Zurayk, Huda			Lancet Steering Group on the occupied Palestinian territory	LANCET			English	Editorial Material									[Chalmers, Iain] James Lind Lib, James Lind Initiat, Oxford, England; [Leaning, Jennifer] Harvard Humanitarian Initiat, Cambridge, MA USA; [Shannon, Harry S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Zurayk, Huda] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon	Harvard University; McMaster University; American University of Beirut	Chalmers, I (corresponding author), James Lind Lib, James Lind Initiat, Oxford, England.	shannonh@mcmaster.ca						Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; HORTON R, 2009, LANCET; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Jolly R., 2006, HUMAN SECURITY FRAME; MATARIA A, 2009, LANCET; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2	7	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					788	790		10.1016/S0140-6736(09)60102-1	http://dx.doi.org/10.1016/S0140-6736(09)60102-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416BT	19268357				2022-12-28	WOS:000263980900006
J	Padmanabhan, S; Mukhopadhyay, A; Narasimhan, SD; Tesz, G; Czech, MP; Tissenbaum, HA				Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.			A PP2A Regulatory Subunit Regulates C-elegans Insulin/IGF-1 Signaling by Modulating AKT-1 Phosphorylation	CELL			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR GENE; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS RESISTANCE; DAUER FORMATION; CELL-PROLIFERATION; LARVAL DEVELOPMENT	The C. elegans insulin/IGF-1 signaling (IIS) cascade plays a central role in regulating life span, dauer, metabolism, and stress. The major regulatory control of IIS is through phosphorylation of its components by serine/threonine-specific protein kinases. An RNAi screen for serine/threonine protein phosphatases that counterbalance the effect of the kinases in the IIS pathway identified pptr-1, a B56 regulatory subunit of the PP2A holoenzyme. Modulation of pptr-1 affects IIS pathway-associated phenotypes including life span, dauer, stress resistance, and fat storage. We show that PPTR-1 functions by regulating worm AKT-1 phosphorylation at Thr 350. With striking conservation, mammalian B56 beta regulates Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes. In C. elegans, this ultimately leads to changes in subcellular localization and transcriptional activity of the forkhead transcription factor DAF-16. This study reveals a conserved role for the B56 regulatory subunit in regulating insulin signaling through AKT dephosphorylation, thereby having widespread implications in cancer and diabetes research.	[Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849; Padmanabhan, Srivatsan/0000-0003-2958-1390	National Institute of Aging [AG025891]; Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Eun-soo Kwon, Kelvin Yen, Craig Mello, and Marian Walhout for advice and critical comments on the manuscript, Paul Furcinitti of the UMass Medical School Digital Light Microscopy Core Facility for help with the confocal microscopy, Nina Bhabhalia for technical support, and Sandhya Pande for help with the phospho- westerns. We thank Marian Walhout, Gary Ruvkun, Maren Hertweck, and Ralf Baumeister for plasmids and strains. Some of the strains were kindly provided by Theresa Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by the National Institute of Aging (AG025891), the Glenn Foundation, and an endowment from the William Randolph Hearst Foundation.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; DORMAN JB, 1995, GENETICS, V141, P1399; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gems D, 1998, GENETICS, V150, P129; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Hakem R, 2001, ANNU REV GENET, V35, P209, DOI 10.1146/annurev.genet.35.102401.090432; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jensen VL, 2007, GENETICS, V177, P661, DOI 10.1534/genetics.107.076703; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Munoz MJ, 2003, GENETICS, V163, P171; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Savage-Dunn C., 2005, WORMBOOK; Smith U, 1999, ANN NY ACAD SCI, V892, P119, DOI 10.1111/j.1749-6632.1999.tb07790.x; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; VOWELS JJ, 1992, GENETICS, V130, P105; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582	80	122	142	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					939	951		10.1016/j.cell.2009.01.025	http://dx.doi.org/10.1016/j.cell.2009.01.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249087	Green Accepted, Bronze			2022-12-28	WOS:000263930900016
J	Goldston, D				Goldston, David			The climate to get things done	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					21	21		10.1038/458021a	http://dx.doi.org/10.1038/458021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	414AJ	19262646	Bronze			2022-12-28	WOS:000263836000009
J	Rosen, CJ				Rosen, Clifford J.			Serotonin Rising - The Bone, Brain, Bowel Connection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	5	42	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					957	959		10.1056/NEJMp0810058	http://dx.doi.org/10.1056/NEJMp0810058			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264685				2022-12-28	WOS:000263824500003
J	Heinrich, AJ				Heinrich, Andreas J.			Looking Below the Surface	SCIENCE			English	Editorial Material									IBM Corp, Div Res, San Jose, CA 95120 USA	International Business Machines (IBM)	Heinrich, AJ (corresponding author), IBM Corp, Div Res, San Jose, CA 95120 USA.	heinrich@almaden.ibm.com						Ashcroft N.W., 1976, SOLID STATE PHYS; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Moon CR, 2009, NAT NANOTECHNOL, V4, P167, DOI [10.1038/NNANO.2008.415, 10.1038/nnano.2008.415]; SHEN ZX, 1993, PHYS REV LETT, V70, P1553, DOI 10.1103/PhysRevLett.70.1553; Weismann A, 2009, SCIENCE, V323, P1190, DOI 10.1126/science.1168738	6	6	6	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1178	1179		10.1126/science.1170744	http://dx.doi.org/10.1126/science.1170744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251618				2022-12-28	WOS:000263687600026
J	Benazet, JD; Bischofberger, M; Tiecke, E; Goncalves, A; Martin, JF; Zuniga, A; Naef, F; Zeller, R				Benazet, Jean-Denis; Bischofberger, Mirko; Tiecke, Eva; Goncalves, Alexandre; Martin, James F.; Zuniga, Aimee; Naef, Felix; Zeller, Rolf			A Self-Regulatory System of Interlinked Signaling Feedback Loops Controls Mouse Limb Patterning	SCIENCE			English	Article							VERTEBRATE LIMB; BUD; EXPRESSION; ROBUSTNESS; OUTGROWTH; EXPANSION; MESODERM; BMP4; SHH; CRE	Embryogenesis depends on self- regulatory interactions between spatially separated signaling centers, but few of these are well understood. Limb development is regulated by epithelial- mesenchymal (e-m) feedback loops between sonic hedgehog ( SHH) and fibroblast growth factor ( FGF) signaling involving the bone morphogenetic protein ( BMP) antagonist Gremlin1 ( GREM1). By combining mouse molecular genetics with mathematical modeling, we showed that BMP4 first initiates and SHH then propagates e- m feedback signaling through differential transcriptional regulation of Grem1 to control digit specification. This switch occurs by linking a fast BMP4/ GREM1 module to the slower SHH/ GREM1/ FGF e- m feedback loop. This self- regulatory signaling network results in robust regulation of distal limb development that is able to compensate for variations by interconnectivity among the three signaling pathways.	[Benazet, Jean-Denis; Tiecke, Eva; Goncalves, Alexandre; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Expt Canc Res, Computat Syst Biol Grp, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Martin, James F.] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Basel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Zeller, R (corresponding author), Univ Basel, Dept Biomed, Mattenstr 28, CH-4058 Basel, Switzerland.	rolf.zeller@unibas.ch	Naef, Felix/C-9527-2011; Benazet, Jean-Denis/I-8495-2016; Zuniga, Aimée/Q-2692-2018; Zeller, Rolf/C-2610-2013	Zuniga, Aimée/0000-0002-9953-3637; Naef, Felix/0000-0001-9786-3037; Bischofberger, Mirko/0000-0002-0878-8184; Zeller, Rolf/0000-0002-3186-7403	Swiss National Science Foundation [3100A0-100240, 3100A0-113866, 3100A0- 113617, 3100A0- 112607]; Novartis Foundation; NIH [2R01DE12324-12, R01DE16329]; FCT [SFRH/BD/24301/2005]; University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016329] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank B. Hogan, C. Hoffmann, and G. Hollander for making Bmp mutant alleles available to us; F. Lehembre for help with quantitative polymerase chain reaction (QPCR); J. Lopez-Rios for input into the design of the network architecture; and M. Affolter, M. Kmita, and group members for input. This research is supported by the Swiss National Science Foundation (grants 3100A0-100240 and 3100A0-113866 to R.Z., grant 3100A0- 113617 to F.N., and grant 3100A0-112607 to AZ), the Novartis Foundation (to R.Z. and E.T.), the NIH (grants 2R01DE12324-12 and R01DE16329 to J.F.M.), the FCT (SFRH/BD/24301/2005 to A.G.), and the University of Basel. The authors declare no competing financial interests.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Hofmann C, 1996, DEV GENET, V19, P43, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;43::AID-DVG5&gt;3.0.CO;2-0; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	27	150	153	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1050	1053		10.1126/science.1168755	http://dx.doi.org/10.1126/science.1168755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229034				2022-12-28	WOS:000263478400039
J	Jones, R; Sleet, S				Jones, Roger; Sleet, Sarah			Easily Missed? Coeliac disease	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; DIAGNOSIS; POPULATION; PEOPLE; LESSON		[Jones, Roger] Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Sleet, Sarah] Coeliac UK, High Wycombe HP11 2HS, Bucks, England	University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk						Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; DUBE C, 2005, GASTROENTEROLOGY, V128, pS1; Furse RM, 2005, BMJ-BRIT MED J, V330, P773, DOI 10.1136/bmj.330.7494.773; GODLEE F, 2009, BRIT MED J, V338, pB821; Graber ML, 2007, BRIT MED J, V334, P732, DOI 10.1136/bmj.39161.587720.BE; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Jones R, 2007, BRIT MED J, V334, P704, DOI 10.1136/bmj.39170.410347.80; Lewis NR, 2006, ALIMENT PHARM THER, V24, P47, DOI 10.1111/j.1365-2036.2006.02967.x; *NIH CLIN EXC, 2008, CLIN GUID NICE, V61; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sanders DS, 2005, BMJ-BRIT MED J, V330, P775, DOI 10.1136/bmj.330.7494.775; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380; Tikkakoski S, 2007, SCAND J GASTROENTERO, V42, P60, DOI 10.1080/00365520600789974; Watson RGP, 2005, BRIT MED J, V330, P739, DOI 10.1136/bmj.330.7494.739; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	20	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								a3058	10.1136/bmj.a3058	http://dx.doi.org/10.1136/bmj.a3058			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228763				2022-12-28	WOS:000264052200002
J	Liu, K; Victora, GD; Schwickert, TA; Guermonprez, P; Meredith, MM; Yao, KH; Chu, FF; Randolph, GJ; Rudensky, AY; Nussenzweig, M				Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Randolph, Gwendalyn J.; Rudensky, Alexander Y.; Nussenzweig, Michel			In Vivo Analysis of Dendritic Cell Development and Homeostasis	SCIENCE			English	Article							BONE-MARROW; MONOCYTES; SUBSETS; DIFFERENTIATION; PROGENITORS; PRECURSORS; SUBTYPES; DISTINCT; TISSUE; MOUSE	Dendritic cells (DCs) in lymphoid tissue arise from precursors that also produce monocytes and plasmacytoid DCs (pDCs). Where DC and monocyte lineage commitment occurs and the nature of the DC precursor that migrates from the bone marrow to peripheral lymphoid organs are unknown. We show that DC development progresses from the macrophage and DC precursor to common DC precursors that give rise to pDCs and classical spleen DCs (cDCs), but not monocytes, and finally to committed precursors of cDCs (pre-cDCs). Pre-cDCs enter lymph nodes through and migrate along high endothelial venules and later disperse and integrate into the DC network. Further cDC development involves cell division, which is controlled in part by regulatory T cells and fms-like tyrosine kinase receptor-3.	[Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Rudensky, Alexander Y.; Nussenzweig, Michel] Rockefeller Univ, HHMI, New York, NY 10021 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Rockefeller University	Liu, K (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	liuk@rockefeller.edu; nussen@rockefeller.edu	Victora, Gabriel/C-5946-2011; Guermonprez, Pierre/ABE-7718-2020; Nussenzweig, Michel/AAE-7292-2019	Guermonprez, Pierre/0000-0001-5621-2262; Schwickert, Tanja/0000-0002-3371-2376; Victora, Gabriel/0000-0001-8807-348X	Rockefeller University; Schering Foundation; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	Rockefeller University; Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank S. Bhuvanendran for two-photon microscopy, K. Velinzon and T. Shengelia for cell sorting, and R. Steinman and A. Silva for discussions and critical reading of the manuscript. K.L. was supported by a C. H. Li Memorial Scholarship Award from the Rockefeller University. T.A.S. was supported by the Schering Foundation. This work was supported in part by grants from the NIH to M.C.N. M.C.N. is an HHMI investigator.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; DIPUCCHIO D, 2008, SCIENCE, V9, P551; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615	25	962	980	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					392	397		10.1126/science.1170540	http://dx.doi.org/10.1126/science.1170540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286519	Green Accepted			2022-12-28	WOS:000265221600044
J	Tomson, CRV				Tomson, Charles R. V.			Blood pressure and outcome in patients on dialysis	LANCET			English	Editorial Material							REVERSE EPIDEMIOLOGY; ESRD PATIENTS; HEMODIALYSIS; HYPERTENSION; MORTALITY; SURVIVAL; FALL		Southmead Hosp, Dept Renal Med, Bristol BS10 5NB, Avon, England	Southmead Hospital	Tomson, CRV (corresponding author), Southmead Hosp, Dept Renal Med, Bristol BS10 5NB, Avon, England.	charlie.tomson@nbt.nhs.uk		Tomson, Charles/0000-0002-0224-8726				Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; Fishbane S, 1996, AM J KIDNEY DIS, V28, P257, DOI 10.1016/S0272-6386(96)90309-1; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kalantar-Zadeh K, 2005, HYPERTENSION, V45, P811, DOI 10.1161/01.HYP.0000154895.18269.67; LAMBERSHEERSPIN.HJ, 2009, LANCET, V373, P1009, DOI DOI 10.1016/S0140-6736(09)60212-9; Leypoldt JK, 2002, KIDNEY INT, V61, P266, DOI 10.1046/j.1523-1755.2002.00099.x; Luik AJ, 1998, BLOOD PURIFICAT, V16, P197, DOI 10.1159/000014335; Lynn KL, 2002, KIDNEY INT, V62, P2281, DOI 10.1046/j.1523-1755.2002.00685.x; Mazzuchi N, 2000, KIDNEY INT, V58, P2147; Shaldon S, 2008, NEPHROL DIAL TRANSPL, V23, P2118, DOI 10.1093/ndt/gfn175; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46	13	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					981	982		10.1016/S0140-6736(09)60213-0	http://dx.doi.org/10.1016/S0140-6736(09)60213-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19249093				2022-12-28	WOS:000264398200004
J	Han, JH; Kushner, SA; Yiu, AP; Hsiang, HL; Buch, T; Waisman, A; Bontempi, B; Neve, RL; Frankland, PW; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Buch, Thorsten; Waisman, Ari; Bontempi, Bruno; Neve, Rachael L.; Frankland, Paul W.; Josselyn, Sheena A.			Selective Erasure of a Fear Memory	SCIENCE			English	Article							BINDING PROTEIN OVEREXPRESSION; DIPHTHERIA-TOXIN; CONDITIONED FEAR; AMYGDALA; EXPRESSION; RECONSOLIDATION; HIPPOCAMPUS; RETRIEVAL; CIRCUITS; NEURONS	Memories are thought to be encoded by sparsely distributed groups of neurons. However, identifying the precise neurons supporting a given memory (the memory trace) has been a long-standing challenge. We have shown previously that lateral amygdala (LA) neurons with increased cyclic adenosine monophosphate response element-binding protein (CREB) are preferentially activated by fear memory expression, which suggests that they are selectively recruited into the memory trace. We used an inducible diphtheria-toxin strategy to specifically ablate these neurons. Selectively deleting neurons overexpressing CREB (but not a similar portion of random LA neurons) after learning blocked expression of that fear memory. The resulting memory loss was robust and persistent, which suggests that the memory was permanently erased. These results establish a causal link between a specific neuronal subpopulation and memory expression, thereby identifying critical neurons within the memory trace.	[Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Kushner, Steven A.] Erasmus Univ, Med Ctr, Dept Psychiat, NL-3015 CE Rotterdam, Netherlands; [Buch, Thorsten] Univ Zurich, Dept Pathol, CH-8057 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, D-55131 Mainz, Germany; [Bontempi, Bruno] CNRS, UMR 5228, Ctr Neurosci Integrat & Cognit, F-33405 Talence, France; [Bontempi, Bruno] Univ Bordeaux 1, F-33405 Talence, France; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Erasmus University Rotterdam; Erasmus MC; University of Zurich; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Massachusetts Institute of Technology (MIT)	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Buch, Thorsten/P-1659-2019; Han, Jin-Hee/C-2069-2011; Waisman, Ari/C-7383-2015	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Han, Jin-Hee/0000-0002-2139-5596; Kushner, Steven/0000-0002-9777-3338	Canadian Institutes of Health Research [MOP74650, MOP77561]; EJLB Foundation; National Alliance for Research on Schizophrenia and Depression [fellowship]; France-Canada Research Foundation [travel fellowship]; Agence Nationale de la Recherche (France) [06-NEURO-027-03]; Hospital for Sick Children [Restracomp Fellowships]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EJLB Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); France-Canada Research Foundation; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Hospital for Sick Children(University of Toronto)	We thank T. Pekar, J. Park, and J. Guo for technical assistance. Supported by Canadian Institutes of Health Research (MOP74650, MOP77561) and EJLB Foundation grants to S.A.J. and P.W.F., National Alliance for Research on Schizophrenia and Depression fellowship to J.H.H., travel fellowship (France-Canada Research Foundation), Agence Nationale de la Recherche (France) grant (06-NEURO-027-03) to B.B., and Restracomp Fellowships from the Hospital for Sick Children to A.P.Y. and J.H.H.	BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DORLAND RB, 1979, J BIOL CHEM, V254, P1337; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levine ES, 1997, ANN NY ACAD SCI, V835, P12, DOI 10.1111/j.1749-6632.1997.tb48614.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NAGLICH JG, 1990, P NATL ACAD SCI USA, V87, P7250, DOI 10.1073/pnas.87.18.7250; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010	26	370	377	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1492	1496		10.1126/science.1164139	http://dx.doi.org/10.1126/science.1164139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286560				2022-12-28	WOS:000264101700045
J	Shen, GJ; Gao, X; Gao, B; Granger, DE				Shen, Guanjun; Gao, Xing; Gao, Bin; Granger, Darryl E.			Age of Zhoukoudian Homo erectus determined with Al-26/Be-10 burial dating	NATURE			English	Article							MIDDLE PLEISTOCENE; CHINA; SITE; CALIBRATION; LOCALITY-1; CHRONOLOGY; LOESS	The age of Zhoukoudian Homo erectus, commonly known as 'Peking Man', has long been pursued, but has remained problematic owing to the lack of suitable dating methods(1-7). Here we report cosmogenic Al-26/Be-10 burial dating of quartz sediments and artefacts from the lower strata of Locality 1 in the southwestern suburb of Beijing, China, where early representatives of Zhoukoudian Homo erectus were discovered. This study marks the first radioisotopic dating of any early hominin site in China beyond the range of mass spectrometric U-series dating. The weighted mean of six meaningful age measurements, 0.77 +/- 0.08 million years (Myr, mean +/- s.e.m.), provides the best age estimate for lower cultural layers 7-10. Together with previously reported U-series dating of speleothem calcite(3) and palaeomagnetic stratigraphy(4), as well as sedimentological considerations(8,9), these layers may be further correlated to S6-S7 in Chinese loess stratigraphy or marine isotope stages (MIS) 17-19, in the range of similar to 0.68 to 0.78 Myr ago. These ages are substantially older than previously supposed and may imply early hominin's presence at the site in northern China through a relatively mild glacial period corresponding to MIS 18.	[Shen, Guanjun; Gao, Bin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China; [Gao, Xing] Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Granger, Darryl E.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Nanjing Normal University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shen, GJ (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China.	gjshen@njnu.edu.cn; dgranger@purdue.edu			National Natural Science Foundation of China; Wenner-Gren Foundation; NSF	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	This project was jointly supported by the National Natural Science Foundation of China and Wenner-Gren Foundation. Accelerator mass spectrometer 26 Al and 10 Be measurements were supported by an NSF facility grant to PRIME Lab. We thank Zhoukoudian Site Museum for assistance in sample collection, L. Zhou, T.-	Aigner J. S., 1986, ANTHROPOS, V23, P157; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; Dong W., 2000, ACTA ANTHR SINICA, V19, P246; Gaboardi M, 2005, QUATERNARY RES, V63, P329, DOI 10.1016/j.yqres.2005.02.006; Goldberg P, 2001, J HUM EVOL, V41, P483, DOI 10.1006/jhev.2001.0498; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Grun R, 1997, J HUM EVOL, V32, P83; GUO SL, 1991, ACTA ANTHR SINICA, V10, P73; LIU ZC, 1985, QUATERNARY RES, V23, P139; Ludwig KR, 2000, EVOL ANTHROPOL, V9, P101, DOI 10.1002/(SICI)1520-6505(2000)9:2<101::AID-EVAN4>3.3.CO;2-N; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Pike AWG, 2003, REV MINERAL GEOCHEM, V52, P607, DOI 10.2113/0520607; QIAN F, 1985, MULTIDISCIPLINARY ST, P251; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shen GJ, 2004, QUATERNARY RES, V62, P208, DOI 10.1016/j.yqres.2004.06.004; Shen GJ, 2001, J HUM EVOL, V41, P679, DOI 10.1006/jhev.2001.0516; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Wu, 1990, ACTA ANTHR SINICA, V9, P312; Wu R., 1985, MULTIDISCIPLINARY ST; YANG Z, 1985, MULTIDISCIPLINARY ST, P1; Yuan S., 1991, ACTA ANTHROPOL SIN, V10, P189; Zhao JX, 2001, GEOLOGY, V29, P27, DOI 10.1130/0091-7613(2001)029<0027:TIMSUS>2.0.CO;2; Zhao S.S., 1985, MULTIDISCIPLINARY ST, P239; Zhou C, 2000, J ARCHAEOL SCI, V27, P101, DOI 10.1006/jasc.1999.0428; Zhou LP, 1999, EARTH PLANET SC LETT, V168, P117, DOI 10.1016/S0012-821X(99)00052-7	30	148	191	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					198	200		10.1038/nature07741	http://dx.doi.org/10.1038/nature07741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279636				2022-12-28	WOS:000264059700042
J	Outram, AK; Stear, NA; Bendrey, R; Olsen, S; Kasparov, A; Zaibert, V; Thorpe, N; Evershed, RP				Outram, Alan K.; Stear, Natalie A.; Bendrey, Robin; Olsen, Sandra; Kasparov, Alexei; Zaibert, Victor; Thorpe, Nick; Evershed, Richard P.			The Earliest Horse Harnessing and Milking	SCIENCE			English	Article							ORIGINS	Horse domestication revolutionized transport, communications, and warfare in prehistory, yet the identification of early domestication processes has been problematic. Here, we present three independent lines of evidence demonstrating domestication in the Eneolithic Botai Culture of Kazakhstan, dating to about 3500 B.C.E. Metrical analysis of horse metacarpals shows that Botai horses resemble Bronze Age domestic horses rather than Paleolithic wild horses from the same region. Pathological characteristics indicate that some Botai horses were bridled, perhaps ridden. Organic residue analysis, using delta C-13 and delta D values of fatty acids, reveals processing of mare's milk and carcass products in ceramics, indicating a developed domestic economy encompassing secondary products.	[Outram, Alan K.; Kasparov, Alexei] Univ Exeter, Dept Archaeol, Exeter EX4 4QE, Devon, England; [Stear, Natalie A.; Evershed, Richard P.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Bendrey, Robin] CNRS, Museum Natl Hist Nat, UNR 5197, F-75005 Paris, France; [Olsen, Sandra] Carnegie Museum Nat Hist, Pittsburgh, PA 15206 USA; [Kasparov, Alexei] Inst Hist Mat Culture, St Petersburg 191186, Russia; [Zaibert, Victor] Kokshetau Univ, Kokshetau 020000, Akmolinsk Oblas, Kazakhstan; [Bendrey, Robin; Thorpe, Nick] Univ Winchester, Dept Archaeol, Winchester SO22 4NR, Hants, England	University of Exeter; University of Bristol; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Kokshetau State University; University of Winchester	Outram, AK (corresponding author), Univ Exeter, Dept Archaeol, Exeter EX4 4QE, Devon, England.	a.k.outram@ex.ac.uk	Bendrey, Robin/G-1658-2015; Outram, Alan K/A-1139-2010	Bendrey, Robin/0000-0001-5286-1601; Outram, Alan/0000-0003-3360-089X; Kasparov, Aleksei/0000-0001-7761-9301	Natural Environment Research Council [NE/B504506/1]; British Academy [SG-35540]; NSF [BS9816476, BCS0415441]; Natural Environment Research Council [NE/B504514/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Academy; NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Thanks to E. Usmanova, V. Varfolomeev, V. Loman, V. Logvin, S. Kalieva, L. Gayduchenko, D. Chivall, R. Berstan, B. Bradley, S. Babich, and E. Isayev. We are grateful for the following grants: Natural Environment Research Council grant NE/B504506/1, British Academy grant SG-35540, and NSF grants BS9816476 and BCS0415441.	Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bendrey R, 2007, J ARCHAEOL SCI, V34, P1036, DOI 10.1016/j.jas.2006.09.010; Bennett D.G., 2005, EQUINE DENT 2 EDITIO, P9, DOI [10.1016/B978-0-7020-2980-6.00003-9, DOI 10.1016/B978-0-7020-2980-6.00003-9]; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Eisenmann V., 1986, EQUIDS ANCIENT WORLD, V1, P67; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; Foronova Irina V., 2006, P20; Gilbert A.S., 1991, EQUIDS ANCIENT WORLD, V19/2, P75; Grebnev I.E., 1994, STEREGUSHCHIYE ZOLOT, P106; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Kalieva S. S., 1997, SKOTOVODY TURGAYA TR; Kremenetski CV, 1997, QUATERN INT, V41-2, P125, DOI 10.1016/S1040-6182(96)00044-4; Levi M, 2003, PREHISTORIC STEPPE A, P1; Levine M., 1999, LATE PREHISTORIC EXP, P5; MALLORY JP, 1976, SEARCH INDOEUROPEANS; Olsen S, 2006, COLLOQ PONTICA, P89; Olsen SL, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P245; Olsen Sandra L., 2006, BAR International Series, V1560, P81; Piggott, 1992, WAGON CHARIOT CARRIA; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; Tarasov PE, 1997, PALAEOGEOGR PALAEOCL, V136, P281, DOI 10.1016/S0031-0182(97)00072-2; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Yevdokimov V.V., 2002, EHPOXA BRONZY CENTRA; Zaibert V.F., 2007, TAJNY DREVNYEJ STEPI	27	360	384	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1332	1335		10.1126/science.1168594	http://dx.doi.org/10.1126/science.1168594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265018				2022-12-28	WOS:000263876700039
J	Burgos, JAM; Luginbuhl, A				Burgos, Jose A. Melendez; Luginbuhl, Adam			Lymphedema Tarda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Burgos, Jose A. Melendez; Luginbuhl, Adam] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA	University of Connecticut	Burgos, JAM (corresponding author), Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA.								0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					1015	1015		10.1056/NEJMicm053461	http://dx.doi.org/10.1056/NEJMicm053461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264690				2022-12-28	WOS:000263824500009
J	Fuchs, VR				Fuchs, Victor R.			Reforming US Health Care Key Considerations for the New Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Fuchs, Victor R.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuchs, VR (corresponding author), Natl Bur Econ Res, 30 Alta Rd, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Blendon RJ, 2008, NEW ENGL J MED, V359, P2050, DOI 10.1056/NEJMsr0807717; Boswell James, 1934, LIFE SAMUEL JOHNSON, V3, P167; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Emanuel E.J., 2007, 200711 BROOK I; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; FUCHS VR, 1993, JAMA-J AM MED ASSOC, V269, P1678, DOI 10.1001/jama.269.13.1678; JOHNSON H, 1996, SYSTEM AM WAY POLITI; Leavitt M, 2008, HEALTH AFFAIR, V27, pW52, DOI 10.1377/hlthaff.27.1.w52; ORSZAG P, 2008, EVIDENCE BASED MED C; RUSHEFSKY ME, 1998, POLITICS POWER POLIC; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Skocpol T., 1997, BOOMERANG HLTH CARE	12	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					963	964		10.1001/jama.2009.248	http://dx.doi.org/10.1001/jama.2009.248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19258585				2022-12-28	WOS:000263784600027
J	Roehr, B				Roehr, Bob			Should men who have ever had sex with men be allowed to give blood? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSFUSION					bobroehr@aol.com						Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Hurley R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b779; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Moore R J, 1991, Transfus Med, V1, P201, DOI 10.1111/j.1365-3148.1991.tb00034.x; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Schrimshaw EW, 2006, ARCH SEX BEHAV, V35, P225, DOI 10.1007/s10508-005-9006-2; VAMVAKAS EC, 2009, BLOOD           0202; Weber B, 2006, EXPERT REV MOL DIAGN, V6, P399, DOI 10.1586/14737159.6.3.399	10	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b311	10.1136/bmj.b311	http://dx.doi.org/10.1136/bmj.b311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DS	19246548				2022-12-28	WOS:000264056300006
J	Martin, KC; Ephrussi, A				Martin, Kelsey C.; Ephrussi, Anne			mRNA Localization: Gene Expression in the Spatial Dimension	CELL			English	Review							FRAGILE-X-SYNDROME; XENOPUS-OOCYTES; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; RIBONUCLEOPROTEIN-PARTICLES; INTRACELLULAR-LOCALIZATION; CYTOPLASMIC LOCALIZATION; ASYMMETRIC LOCALIZATION; DROSOPHILA OOGENESIS	The localization of mRNAs to subcellular compartments provides a mechanism for regulating gene expression with exquisite temporal and spatial control. Recent studies suggest that a large fraction of mRNAs localize to distinct cytoplasmic domains. In this Review, we focus on cis-acting RNA localization elements, RNA-binding proteins, and the assembly of mRNAs into granules that are transported by molecular motors along cytoskeletal elements to their final destination in the cell.	[Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	University of California System; University of California Los Angeles; European Molecular Biology Laboratory (EMBL)	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu; ephrussi@embl.de	Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620	NIH; DFG; EMBL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); EMBL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Black, D. O. Wang, and L. Zipursky for critical reading of the manuscript and E. Lecuyer and H. Krause for the image in Figure 2. Work on mRNA localization in our laboratories is supported by the NIH ( K. C. M.) and the DFG and the EMBL ( A. E.).	Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bergsten SE, 1999, DEVELOPMENT, V126, P659; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Condeelis J, 2005, BIOL CELL, V97, P97; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Deshler JO, 1997, SCIENCE, V276, P1128, DOI 10.1126/science.276.5315.1128; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doyle Francis, 2008, V419, P39, DOI 10.1007/978-1-59745-033-1_3; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; King ML, 2005, BIOL CELL, V97, P19; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lange S, 2008, TRAFFIC, V9, P1256, DOI 10.1111/j.1600-0854.2008.00763.x; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lewis RA, 2004, MECH DEVELOP, V121, P101, DOI 10.1016/j.mod.2003.09.009; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; LUK SKS, 1994, GENETICS, V137, P521; Macchi P, 2003, J NEUROSCI, V23, P5778; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Macdonald PM, 1997, RNA, V3, P1413; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rehbein M, 2000, MOL BRAIN RES, V79, P192, DOI 10.1016/S0169-328X(00)00114-5; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rusten TE, 2007, NATURE, V445, P497, DOI 10.1038/445497a; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Shan JG, 2003, J NEUROSCI, V23, P8859; Smith R, 2004, NEUROSCIENTIST, V10, P495, DOI 10.1177/1073858404266759; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	102	686	699	2	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					719	730		10.1016/j.cell.2009.01.044	http://dx.doi.org/10.1016/j.cell.2009.01.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239891	Green Accepted, Bronze			2022-12-28	WOS:000263688200021
J	Wood, AJJ				Wood, Alastair J. J.			Progress and Deficiencies in the Registration of Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Wood, Alastair J. J.] Symphony Capital, New York, NY USA; [Wood, Alastair J. J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Wood, AJJ (corresponding author), Symphony Capital, New York, NY USA.							Department of Health Education and Welfare, 1979, BELM REP ETH PRINC G; Ide NC, 2007, J AM MED INFORM ASSN, V14, P253, DOI 10.1197/jamia.M2233; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Lenzer Jeanne, 2005, BMJ, V330, P922, DOI 10.1136/bmj.330.7497.922-c; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Psaty BM, 2007, JAMA-J AM MED ASSOC, V297, P1917, DOI 10.1001/jama.297.17.1917; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; World Medical Association, 1964, DECL HELS ETH PRINC; Zarin DA, 2008, SCIENCE, V322, P45	11	54	54	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					824	830		10.1056/NEJMsr0806582	http://dx.doi.org/10.1056/NEJMsr0806582			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228628				2022-12-28	WOS:000263411300016
J	Schnabel, RB; Sullivan, LM; Levy, D; Pencina, M; Massaro, JM; D'Agostino, RB; Newton-Cheh, C; Yamamoto, JF; Magnani, JW; Tadros, TM; Kannel, WB; Wang, TJ; Ellinor, PT; Wolf, PA; Vasan, RS; Benjamin, EJ				Schnabel, Renate B.; Sullivan, Lisa M.; Levy, Daniel; Pencina, Michael; Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; Newton-Cheh, Christopher; Yamamoto, Jennifer F.; Magnani, Jared W.; Tadros, Thomas M.; Kannel, William B.; Wang, Thomas J.; Ellinor, Patrick T.; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.			Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study	LANCET			English	Article							PHYSICAL-ACTIVITY; PREVENTION; OBESITY; PREDICTION; MORTALITY; FAILURE; EVENTS; ADULTS; ONSET	Background Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the condition, and to provide a framework for researchers to assess new risk markers. Methods We assessed 4764 participants in the Framingham Heart Study from 8044 examinations (55% women, 45-95 years of age) undertaken between June, 1968, and September, 1987. Thereafter, participants were monitored for the first event of atrial fibrillation for a maximum of 10 years. Multivariable Cox regression identified clinical risk factors associated with development of atrial fibrillation in 10 years. Secondary analyses incorporated routine echocardiographic measurements (5152 participants, 7156 examinations) to reclassify the risk of atrial fibrillation and to assess whether these measurements improved risk prediction. Findings 457 (10%) of the 4764 participants developed atrial fibrillation. Age, sex, body-mass index, systolic blood pressure, treatment for hypertension, PR interval, clinically significant cardiac murmur, and heart failure were associated with atrial fibrillation and incorporated in a risk score (p<0.05, except body-mass index p=0.08), clinical model C statistic 0.78 (95% Cl 0.76-0.80). Risk of atrial fibrillation in 10 years varied with age: more than 15% risk was recorded in 53 (1%) participants younger than 65 years, compared with 783 (27%) older than 65 years. Additional incorporation of echocardiographic measurements to enhance the risk prediction model only slightly improved the C statistic from 0.78 (95% CI 0.75-0.80) to 0.79 (0.77-0.82), p=0.005. Echocardiographic measurements did not improve risk reclassification (p=0.18). Interpretation From clinical factors readily accessible in primary care, our risk score could help to identify risk of atrial fibrillation for individuals in the community; assess technologies or markers for improvement of risk prediction, and target high-risk individuals for preventive measures.	[Benjamin, Emelia J.] Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA; [Sullivan, Lisa M.; Pencina, Michael; Massaro, Joseph M.; Yamamoto, Jennifer F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kannel, William B.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Massaro, Joseph M.; Tadros, Thomas M.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Kannel, William B.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany	Boston University; Framingham Heart Study; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johannes Gutenberg University of Mainz	Benjamin, EJ (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.	emelia@bu.edu	Schnabel, Renate B/ABE-6668-2021; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Schnabel, Renate B/F-6527-2014; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Schnabel, Renate B/0000-0001-7170-9509; Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Ellinor, Patrick/0000-0002-2067-0533; Pencina, Michael/0000-0001-5798-8855; Wolf, Philip/0000-0002-3628-301X; Sullivan, Lisa/0000-0003-0726-7149; Benjamin, Emelia/0000-0003-4076-2336; Massaro, Joseph/0000-0002-2682-4812; Wang, Thomas/0000-0003-4063-6508	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute [N01-HC-25195]; NIH [HL076784, AG028321, AG029451, HL092577, HL080124, HL077477, HL71039, HL093328, R01 NS 17950, 2K24 HL04334]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/1-1]; Doris Duke Charitable Foundation Clinical Scientist Development Award [HL080025]; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute contract N01-HC-25195 and NIH grants HL076784, AG028321. and AG029451 (E)B) HL092577 (EJB, PTE); HL080124, HL077477, HL71039, and HL093328 (RSV); R01 NS 17950 (PAW). NIH Research Career Award 2K24 HL04334 (RSV); Deutsche Forschungsgemeinschaft (German Research Foundation) Research Fellowship SCHN 1149/1-1 (RBS); HL080025, Doris Duke Charitable Foundation Clinical Scientist Development Award, and Burroughs Wellcome Fund Career Award for Medical Scientists (CN-C).	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; D'Agostino RB, 2004, HDB STAT, P1; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; KANNEL WB, 1998, AM J CARDIOL, V0082; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Miyasaka Y, 2007, AM J MED, V120, P357, DOI 10.1016/j.amjmed.2006.06.042; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psaty BM, 1997, CIRCULATION, V96, P2455; Quan SF, 1997, SLEEP, V20, P1077; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Soliman EZ, 2008, J NATL MED ASSOC, V100, P447, DOI 10.1016/S0027-9684(15)31282-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281	35	753	773	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					739	745		10.1016/S0140-6736(09)60443-8	http://dx.doi.org/10.1016/S0140-6736(09)60443-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249635	Green Accepted			2022-12-28	WOS:000263725400033
J	Brekke, M; Gjelsvik, B				Brekke, Mette; Gjelsvik, Bjorn			Secondary cardiovascular risk prevention-we can do better	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; EUROPEAN GUIDELINES; CLINICAL-PRACTICE; REHABILITATION		[Brekke, Mette; Gjelsvik, Bjorn] Univ Oslo, Inst Gen Practice & Community Med, NO-0318 Oslo, Norway	University of Oslo	Brekke, M (corresponding author), Univ Oslo, Inst Gen Practice & Community Med, NO-0318 Oslo, Norway.	mette.brekke@medisin.uio.no						Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Balady GJ, 2000, CIRCULATION, V102, P1069, DOI 10.1161/01.CIR.102.9.1069; Getz L, 2004, SCAND J PRIM HEALTH, V22, P202, DOI 10.1080/02813430410006693; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Mildestvedt T, 2007, SCAND J PUBLIC HEALT, V35, P591, DOI 10.1080/14034940701349241; *STAT NORW, STEAD DECL NUMB DAIL; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5	9	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					873	875		10.1016/S0140-6736(09)60524-9	http://dx.doi.org/10.1016/S0140-6736(09)60524-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286069				2022-12-28	WOS:000264158700007
J	Rahim, HFA; Wick, L; Halileh, S; Hassan-Bitar, S; Chekir, H; Watt, G; Khawaja, M				Rahim, Hanan F. Abdul; Wick, Laura; Halileh, Samia; Hassan-Bitar, Sahar; Chekir, Hafedh; Watt, Graham; Khawaja, Marwan			Health in the Occupied Palestinian Territory 2 Maternal and child health in the occupied Palestinian territory	LANCET			English	Article							DEVELOPING-COUNTRIES; ALMA-ATA; CARE; SURVIVAL; FERTILITY; MORTALITY; CONFLICT; NEWBORN; REBIRTH; BIRTH	The Countdown to 2015 intervention coverage indicators in the occupied Palestinian territory are similar to those of other Arab countries, although there are gaps in continuity and quality of services across the continuum of the perinatal period. Since the mid 1990s, however, access to maternity facilities has become increasingly unpredictable. Mortality rates for infants (age <= 1 year) and children younger than 5 years have changed little, and the prevalence of stunting in children has increased. Living conditions have worsened since 2006, when the elected Palestinian administration became politically and economically boycotted, resulting in unprecedented levels of Palestinian unemployment, poverty, and internal conflict, and increased restrictions to health-care access. Although a political solution is imperative for poverty alleviation, sustainable development, and the universal right to health care, women and children should not have to wait. Urgent action from international and local decision makers is needed for sustainable access to high-quality care and basic health entitlements.	[Rahim, Hanan F. Abdul] Qatar Univ, Int Affairs Program, Coll Arts & Sci, Doha, Qatar; [Rahim, Hanan F. Abdul; Wick, Laura; Halileh, Samia; Hassan-Bitar, Sahar] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Chekir, Hafedh] UN, Populat Fund, New York, NY 10017 USA; [Watt, Graham] Univ Glasgow, Div Community Based Sci, Glasgow, Lanark, Scotland; [Khawaja, Marwan] Amer Univ Beirut, Ctr Res Populat & Hlth, Beirut, Lebanon; [Khawaja, Marwan] Yale Univ, New Haven, CT USA	Qatar University; Birzeit University; United Nations Population Fund; University of Glasgow; American University of Beirut; Yale University	Rahim, HFA (corresponding author), Qatar Univ, Int Affairs Program, Coll Arts & Sci, POB 2713, Doha, Qatar.	hanan.arahim@qu.edu.qa	Rahim, Hanan Abdul/S-5987-2019; Hassan, Sahar J./GWV-4893-2022	Rahim, Hanan Abdul/0000-0002-3719-5142; Hassan, Sahar J./0000-0002-6887-9993	Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine; Norwegian Programme for Development, Research and Education	Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine; Norwegian Programme for Development, Research and Education	We thank the Lancet Palestine Steering Group (lain Chalmers, Rita Giacaman, Jennifer Leaning, Harry Shannon, and Huda Zurayk) for critical reading and commenting on several drafts of this report; Fahed Alsayed, Rajaie Batniji, Gerd Holmboe-Ottesen, and Belgin Tekce for reading and commenting on the report; and Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine, and the Norwegian Programme for Development, Research and Education for their financial contributions that made the workshops related to this Series possible.	Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Ahmad-Nia S, 2002, SOC SCI MED, V54, P753, DOI 10.1016/S0277-9536(01)00107-1; Al-Adili N, 2006, INT J GYNECOL OBSTET, V93, P164, DOI 10.1016/j.ijgo.2005.11.009; *AMN INT UK CARE I, 2008, GAZ STRIP HUM IMPL; [Anonymous], MILLENNIUM DEV GOALS; *AR LEAG SOC SECT, 2006, LEB FAM HLTH SURV 20; Assaf S, 2009, J BIOSOC SCI, V41, P107, DOI 10.1017/S0021932008002940; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; *BIS CTR RES DEV W, 2006, ROL PERF PAL NGOS HL; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Cavagnero E, 2008, LANCET, V371, P1284, DOI 10.1016/S0140-6736(08)60563-2; *CENTR BUR STAT, 2008, PAN AR PROJ FAM HLTH; Courbage Y, 2010, RENDEZ VOUS CIVILISA; CURTIS SL, 1995, OCCASIONAL PAPERS OR, V3; Department of Statistics (Jordan) & ORC Macro, 2003, JORD POP FAM HLTH SU; Donnay F, 2000, INT J GYNECOL OBSTET, V70, P89, DOI 10.1016/S0020-7292(00)00236-8; El-Zanaty F, 2009, EGYPT DEMOGRAPHIC HL; Fargues P, 2000, POPUL DEV REV, V26, P441, DOI 10.1111/j.1728-4457.2000.00441.x; Fargues P, 2005, REPROD HEALTH MATTER, V13, P43, DOI 10.1016/S0968-8080(05)25161-3; GEETA N, 2005, ACCELERATING PROGR A; Giacaman R, 2005, HEALTH POLICY, V72, P129, DOI 10.1016/j.healthpol.2004.06.012; Giacaman R, 2003, HEALTH POLICY PLANN, V18, P59, DOI 10.1093/heapol/18.1.59; Giacaman R, 2007, EUR J PUBLIC HEALTH, V17, P86, DOI 10.1093/eurpub/ckl089; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Hamdan M, 2003, INT J HEALTH PLAN M, V18, P63, DOI 10.1002/hpm.691; HASSAN S, 2006, NEEDS ASSESSMENT MAT; Hassan-Bitar S, 2007, REPROD HEALTH MATTER, V15, P103, DOI 10.1016/S0968-8080(07)30321-2; HEIBERG M, 1993, PALESTINIAN SOC GAZA, P60; HILL A, 1983, POPUL DEV REV, V9, P88; *HLTH DEV INF POL, 2005, HLTH SEGR 2 IMP ISR; *I COMM PUBL HLTH, 2006, EV UNFPA REPR HLTH S; Jackson N, 2001, BEST PRACT RES CL OB, V15, P49, DOI 10.1053/beog.2000.0148; Kalter HD, 2008, PAEDIATR PERINAT EP, V22, P321, DOI 10.1111/j.1365-3016.2008.00943.x; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khawaja M, 2000, POP STUD-J DEMOG, V54, P331, DOI 10.1080/713779091; KHAWAJA M, 2003, POPULATION, V58, P273, DOI DOI 10.3917/POPE.303.0273; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Kuttab E., 2007, 1 EESCWAECW; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; LOVEDAY P, 2007, REPROD HEALTH MATTER, V15, P28; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; *MIN HLTH, 2006, ANN REP MIN HLTH; *MIN HLTH PAL NAT, 2008, NAT STRAT HLTH PLAN; *MIN HLTH STAT ISR, 1981, HLTH HLTH SERV JUD S, P39; MOUSA F, 2004, MATERNAL MORTALITY P; MURRAY C, 2005, LANCET, V370, P1040; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; Obermeyer CM, 2006, BMJ-BRIT MED J, V333, P851, DOI 10.1136/bmj.38994.400370.7C; *PAL CENTR BUR STA, 1995, DEM SURV MICR; *PAL CENTR BUR STA, 1999, HLTH SURV W BANK GAZ; *PAL CENTR BUR STA, 2008, ANN REP 2008 PAL CHI; *PAL CENTR BUR STA, 2001, HLTH SURV 2000 FIN R; *PAL CENTR BUR STA, 1998, AN REP SER PAL CENTR, V1; *PAL CENTR BUR STA, 2006, WOM MEN PAL ISS STAT; *PAL CENTR BUR STA, 2003, NUTR SURV 2002 AN RE; *PAL CENTR BUR STA, 2004, DEM HLTH SURV MICR; *PAL CENTR BUR STA, 2006, DEM HLTH SURV 2004 F; *PAL CENTR BUR STA, 1997, DEM SURV W BANK GAZ; *PAL CENTR BUR STA, 2000, HLTH SURV MICR; *PAL CENTR BUR STA, 1999, AN REP SER PAL CENTR, V1; Palestinian Central Bureau of Statistics, 2007, PAL FAM HLTH SURV 20; *PAPFAM, 2001, SYR 2001 FAM HLTH SU; *PAPFAM, 2004, LEB FAM HLTH SURV 20; PEDERSEN J, 2001, GROWING FAST PALESTI, P135; *POP REF BUR, 2008, 2007 WORLD POP DAT S; PUYET JJ, 1979, INFANT MORTALITY STU; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; RUTSTEIN SO, 1984, WORLD FERTIL SURV CO, V43; SARRIOT EG, 2004, ASSESSMENT MARAM PRO, P11; Sayigh Y., 1999, STRENGTHENING PALEST; SCHMELZ UO, 1977, TECHNICAL PUBLICATIO, V44; Schoenbaum M., 2005, STRENGTHENING PALEST; STANFORTH R, 2007, POVERTY PALESTINE HU; *STAT ISR, 1983, HLTH HLTH SERV JUD S, P4; TAMARI S, 1980, SOCIAL IMPACT INTRO; *UN DEV PROGR REG, 2006, AR HUM DEV REP 2005; *UN FAO UN WORLD F, 2007, COMPR FOOD SEC VULN; *UN OFF COORD HUM, 2007, GAZ STRIP HUM FACT S; *UN REL WORKS AG, 2007, UN REL WORKS AG PAL; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; *WFP UNRWA FAO, 2008, JOINT RAP FOOD SEC S; WHO, 2008, ACC HLTH SERV PAL PE; WHO, 2004, MAT MORT 2000 EST DE; *WHO UNFPA, 2006, MARR AD NO PLAC SAF; Wick L, 2005, INT J GYNECOL OBSTET, V89, P174, DOI 10.1016/j.ijgo.2005.01.029; WICK L, 2004, CHILDBIRTH PALESTINE; Wick L, 2008, CULT MED PSYCHIAT, V32, P328, DOI 10.1007/s11013-008-9098-y; World Bank, 2008, PAL EC PROSP AID ACC; *WORLD BANK, 2008, W BANK GAZ EC DEV PR	93	59	59	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					967	977		10.1016/S0140-6736(09)60108-2	http://dx.doi.org/10.1016/S0140-6736(09)60108-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19268353				2022-12-28	WOS:000264158700037
J	Trikalinos, TA; Alsheikh-Ali, AA; Tatsioni, A; Nallamothu, BK; Kent, DM				Trikalinos, Thomas A.; Alsheikh-Ali, Alawi A.; Tatsioni, Athina; Nallamothu, Brahmajee K.; Kent, David M.			Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis	LANCET			English	Article							DRUG-ELUTING STENTS; CHRONIC STABLE ANGINA; BARE-METAL STENTS; MYOCARDIAL-INFARCTION; MEDICAL THERAPY; HEART-DISEASE; ANGIOPLASTY; TRIALS; STRATEGIES; EFFICACY	Background Over the past 20 years, percutaneous transluminal balloon coronary angioplasty (PTCA), bare-metal stents (BMS), and drug-eluting stents (DES) succeeded each other as catheter-based treatments for coronary artery disease. We undertook a systematic overview of randomised trials comparing these interventions with each other and with medical therapy in patients with non-acute coronary artery disease. Methods We searched Medline for trials contrasting at least two of the four interventions (PTCA, BMS, DES, and medical therapy). Eligible outcomes were death, myocardial infarction, coronary artery bypass grafting, target lesion or vessel revascularisation, and any revascularisation. Random effects meta-analyses summarised head-to-head (direct) comparisons, and network meta-analyses integrated direct and indirect evidence. Findings 61 eligible trials (25388 patients) investigated four of six possible comparisons between the four interventions; no trials directly compared DES with medical therapy or PTCA. In all direct or indirect comparisons, succeeding advancements in percutaneous coronary intervention did not produce detectable improvements in deaths or myocardial infarction. The risk ratio (RR) for indirect comparisons between DES and medical therapy was 0.96 (95% CI 0.60-1-52) for death and 1.15 (0.73-1.82) for myocardial infarction. By contrast, we recorded sequential significant reductions in target lesion or vessel revascularisation with BMS compared with PTCA (RR 0.68 [0-60.0.77]) and with DES compared with BMS (0.44 [0.35-0.56]). The RR for the indirect comparison between DES and PTCA for target lesion or vessel revascularisation was 0.30 (0.17-0.51). Interpretation Sequential innovations in the catheter-based treatment of non-acute coronary artery disease showed no evidence of an effect on death or myocardial infarction when compared with medical therapy. These results lend support to present recommendations to optimise medical therapy as an initial management strategy in patients with this disease.	[Trikalinos, Thomas A.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Boston, MA 02111 USA; [Alsheikh-Ali, Alawi A.] Tufts Med Ctr, Div Cardiol, Dept Med, Boston, MA 02111 USA; [Nallamothu, Brahmajee K.] Ann Arbor VA Med Ctr, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	Tufts Medical Center; Tufts Medical Center	Trikalinos, TA (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Box 63,800 Washington St, Boston, MA 02111 USA.	ttrikalin@mac.com	Tatsioni, Athina/AAQ-5413-2020		National Institutes of Health [1UL1 RR025752]; Pfizer/Tufts Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer/Tufts Medical Center(Pfizer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	TAT and DMK are partially supported by a grant of the National Institutes of Health (NIH/NCRR 1UL1 RR025752). AAA is a recipient of a faculty development award from Pfizer/Tufts Medical Center.	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P13, DOI 10.1186/1471-2288-2-13; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ernst E, 2006, J INTERN MED, V260, P488, DOI 10.1111/j.1365-2796.2006.01707.x; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Grines CL, 2008, J AM COLL CARDIOL, V51, P615, DOI 10.1016/j.jacc.2007.10.028; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P34, DOI 10.1016/j.jcin.2007.10.001; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Ioannidis JPA, 2007, AM HEART J, V154, P1065, DOI 10.1016/j.ahj.2007.07.049; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Katritsis DG, 2005, AM J CARDIOL, V95, P640, DOI 10.1016/j.amjcard.2004.10.041; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kent DM, 2008, AM HEART J, V155, P624, DOI 10.1016/j.ahj.2007.11.005; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Prochaska JO, 2007, J HEALTH PSYCHOL, V12, P170, DOI 10.1177/1359105307071751; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; Soares PR, 2006, CIRCULATION, V114, pI420, DOI 10.1161/CIRCULATIONAHA.105.000679; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Tung R, 2006, ANN INTERN MED, V144, P913, DOI 10.7326/0003-4819-144-12-200606200-00009	36	176	187	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					911	918		10.1016/S0140-6736(09)60319-6	http://dx.doi.org/10.1016/S0140-6736(09)60319-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286090	Green Accepted			2022-12-28	WOS:000264158700032
J	Wollert, T; Wunder, C; Lippincott-Schwartz, J; Hurley, JH				Wollert, Thomas; Wunder, Christian; Lippincott-Schwartz, Jennifer; Hurley, James H.			Membrane scission by the ESCRT-III complex	NATURE			English	Article							MULTIVESICULAR ENDOSOMES; STRUCTURAL BASIS; CELL-DIVISION; PROTEINS; VPS4; RECOGNITION; BIOGENESIS; MACHINERY; HIV-1; ALIX	The endosomal sorting complex required for transport (ESCRT) system is essential for multivesicular body biogenesis, in which cargo sorting is coupled to the invagination and scission of intralumenal vesicles. The ESCRTs are also needed for budding of enveloped viruses including human immunodeficiency virus 1, and for membrane abscission in cytokinesis. In Saccharomyces cerevisiae, ESCRT-III consists of Vps20, Snf7, Vps24 and Vps2 (also known as Did4), which assemble in that order and require the ATPase Vps4 for their disassembly. In this study, the ESCRT-III-dependent budding and scission of intralumenal vesicles into giant unilamellar vesicles was reconstituted and visualized by fluorescence microscopy. Here we show that three subunits of ESCRT-III, Vps20, Snf7 and Vps24, are sufficient to detach intralumenal vesicles. Vps2, the ESCRT-III subunit responsible for recruiting Vps4, and the ATPase activity of Vps4 were required for ESCRT-III recycling and supported additional rounds of budding. The minimum set of ESCRT-III and Vps4 proteins capable of multiple cycles of vesicle detachment corresponds to the ancient set of ESCRT proteins conserved from archaea to animals.	[Wollert, Thomas; Hurley, James H.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Wunder, Christian; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Wunder, Christian/K-8542-2017	Wunder, Christian/0000-0001-9091-0080; Wollert, Thomas/0000-0001-9732-4789	Intramural NIH HHS [Z01 DK036123-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609, ZICHD008874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123, Z01DK036123, ZIADK036125] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; EVANS WH, 1985, BIOCHEM J, V232, P33, DOI 10.1042/bj2320033; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	38	433	439	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					172	U2		10.1038/nature07836	http://dx.doi.org/10.1038/nature07836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19234443	Green Accepted			2022-12-28	WOS:000264059700036
J	Newman-Toker, DE; Pronovost, PJ				Newman-Toker, David E.; Pronovost, Peter J.			Diagnostic Errors-The Next Frontier for Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EVENTS		[Newman-Toker, David E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Newman-Toker, DE (corresponding author), Johns Hopkins Univ Hosp, Pathol Bldg 2-210,600 N Wolfe St, Baltimore, MD 21287 USA.	toker@jhu.edu	Newman-Toker, David/C-6083-2008	Newman-Toker, David/0000-0003-2789-4115	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS017755] Funding Source: NIH RePORTER; AHRQ HHS [HS017755-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HEALTHC RES QU, 2007, SPEC EMPH NOT SEN AH; *AM MED INF ASS, 2008, DIAGN ERR MED PROGR; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; *CDCP DIV HEART DI, 2008, STROK FACT SHEET; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Graber M, 2005, JT COMM J QUAL PATIE, V31, P106, DOI 10.1016/S1553-7250(05)31015-4; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P2405, DOI 10.1001/jama.288.19.2405-JLT1120-2-3; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Marine JE, 2007, ANN INTERN MED, V146, P469, DOI 10.7326/0003-4819-146-6-200703200-00021; Newman-Toker DE, 2008, ANN NEUROL, V64, pS17; Schiff GD., 2005, ADV PATIENT SAFETY R; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; WACHTER RM, WHY DIAGNOSTIC ERROR; Weeks WB, 2001, J LAW MED ETHICS, V29, P335, DOI 10.1111/j.1748-720X.2001.tb00352.x	15	291	303	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1060	1062		10.1001/jama.2009.249	http://dx.doi.org/10.1001/jama.2009.249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278949				2022-12-28	WOS:000264015800031
J	Smith, AK; Sudore, RL; Perez-Stable, EJ				Smith, Alexander K.; Sudore, Rebecca L.; Perez-Stable, Eliseo J.			Palliative Care for Latino Patients and Their Families Whenever We Prayed, She Wept	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; LIMITED ENGLISH PROFICIENCY; FUNCTIONAL HEALTH LITERACY; AFRICAN-AMERICAN; MEDICAL INTERPRETATION; TREATMENT PREFERENCES; ETHNIC-DIFFERENCES; DECISION-MAKING; SELF-MANAGEMENT; ADVANCED CANCER	Latinos account for 15% of the US population, a proportion projected to grow to 30% by the year 2050. Although there is tremendous diversity within this community, commonalities of language, beliefs, attitudes, and behaviors unite Latinos, making them more similar than different. Differences by national origin, although important, are attenuated when immigrants come to the United States, dominated by an English-language, Anglo-centric culture. Fornon-Latino and non-Spanish-speaking clinicians, communication barriers and cultural misunderstandings can impede the care of dying Latino patients and their families. We present the case of a young, pregnant, Spanish-speaking woman from Central America diagnosed with a fatal leukemia. As illustrated by this case, Latino immigrants face a number of external challenges to optimal end-of-life care: (1) geographic distance as well as political and economic realities of ten separate patients from their valued families; ( 2) undocumented immigrants are frequently uninsured and fear of deportation may create a barrier to accessing health services; (3) language and literacy barriers; and (4) concerns about discrimination. Other Latino issues that may be more pronounced in end-of-life settings include cultural themes and religious and spiritual influences. We recommend that professional interpreters must be used for discussions about goals of care with Spanish-speaking patients and families or when negotiating conflict between the patient, family, and the health care team. Concrete suggestions are provided for clinicians in working with interpreters, eliciting culturally based attitudes and beliefs, and implementing universal strategies for clear health communication.	[Smith, Alexander K.; Sudore, Rebecca L.] Univ Calif San Francisco, Div Geriatr, Dept Med, San Francisco, CA 94121 USA; [Perez-Stable, Eliseo J.] Univ Calif San Francisco, Div Gen Internal Med, Dept Med, Med Effectiveness Res Ctr Diverse Populat, San Francisco, CA 94121 USA; [Smith, Alexander K.; Sudore, Rebecca L.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smith, AK (corresponding author), Univ Calif San Francisco, Div Geriatr, Dept Med, 4150 Clement St,181G, San Francisco, CA 94121 USA.	aksmith@ucsf.edu	Sudore, Rebecca/AAF-1635-2021		NATIONAL INSTITUTE ON AGING [R01AG028481, P30AG015272] Funding Source: NIH RePORTER; NIA NIH HHS [R01AG028481, R01 AG028481, P30-AG15272, R01 AG028481-02S1, P30 AG015272-13, P30 AG015272] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abraido-Lanza AF, 2007, ETHNIC DIS, V17, P153; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 1996, ARCH FAM MED, V5, P329, DOI 10.1001/archfami.5.6.329; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Braun UK, 2008, J GEN INTERN MED, V23, P267, DOI 10.1007/s11606-007-0487-7; BRUERA E, 1993, J PAIN SYMPTOM MANAG, V8, P365, DOI 10.1016/0885-3924(93)90054-Y; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Castro CM, 2007, AM J HEALTH BEHAV, V31, pS85; Cianelli R, 2008, CULT HEALTH SEX, V10, P297, DOI 10.1080/13691050701861439; Cohen LL, 2008, J PALLIAT MED, V11, P763, DOI 10.1089/jpm.2007.0216; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Crawley LM, 2008, CANCER EPIDEM BIOMAR, V17, P1937, DOI 10.1158/1055-9965.EPI-08-0005; Crawley Lavera M, 2002, J Palliat Med, V5, P775, DOI 10.1089/109662102320880697; Crawley LM, 2001, J NATL MED ASSOC, V93, p14S; Crawley LM, 2002, ANN INTERN MED, V136, P673, DOI 10.7326/0003-4819-136-9-200205070-00010; Cristancho S, 2008, QUAL HEALTH RES, V18, P633, DOI 10.1177/1049732308316669; DAIMOND LC, 2009, JAMA-J AM MED ASSOC, V301, P426; DeLima L, 1997, J PAIN SYMPTOM MANAG, V13, P213, DOI 10.1016/S0885-3924(96)00325-9; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Doak CC, 1996, TEACHING PATIENTS LO; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Fischer SM, 2007, J PALLIAT MED, V10, P1023, DOI 10.1089/jpm.2007.0070; Flores G, 2003, PEDIATRICS, V111, P6, DOI 10.1542/peds.111.1.6; Florez KR, 2009, J IMMIGR MINOR HEALT, V11, P291, DOI 10.1007/s10903-008-9118-6; Fortuny K., 2007, CHARACTERISTICS UNAU; Gelfand D E, 2001, Am J Hosp Palliat Care, V18, P391, DOI 10.1177/104990910101800608; Greiner KA, 2003, J AM GERIATR SOC, V51, P970, DOI 10.1046/j.1365-2389.2003.51310.x; Grubbs V, 2006, J GEN INTERN MED, V21, P683, DOI 10.1111/j.1525-1497.2006.00492.x; Hakimzadeh S., 2007, ENGLISH USAGE HISPAN; HASNIANWYNIA R, HOSP LANGUAGE SERVIC; *HISP HER MONTH 20, 2007, FACTS FEAT; HOLLAND JC, 1987, CANCER INVEST, V5, P151, DOI 10.3109/07357908709018468; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Karliner LS, 2004, J GEN INTERN MED, V19, P175, DOI 10.1111/j.1525-1497.2004.30268.x; Kindig DA, 2004, HLTH LITERACY PRESCR; KIRSCH IS, 1993, ADULT LIT AM 1 LOOK; Kleinman A., 1988, ILLNESS NARRATIVES; Krakauer EL, 2002, J AM GERIATR SOC, V50, P182, DOI 10.1046/j.1532-5415.2002.50027.x; Kripalani S, 2006, J GEN INTERN MED, V21, P888, DOI 10.1111/j.1525-1497.2006.00543.x; Kutner M, 2005, 1 LOOK LIT AM ADULTS; Lauderdale DS, 2006, MED CARE, V44, P914, DOI 10.1097/01.mlr.0000220829.87073.f7; Lee KC, 2006, JAMA-J AM MED ASSOC, V296, P1050, DOI 10.1001/jama.296.9.1050; MALONE N, 2000, FOREIGN BORN POPULAT; Mancuso CA, 2006, J ASTHMA, V43, P41, DOI 10.1080/02770900500447052; MARIN G, 1990, HISPANIC J BEHAV SCI, V12, P422, DOI 10.1177/07399863900124006; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; Napoles-Springer AM, 2005, HEALTH EXPECT, V8, P4, DOI 10.1111/j.1369-7625.2004.00298.x; Norris Wendi M, 2005, J Palliat Med, V8, P1016, DOI 10.1089/jpm.2005.8.1016; Ortega AN, 2007, ARCH INTERN MED, V167, P2354, DOI 10.1001/archinte.167.21.2354; OTEROSABOGAL R, 2003, HEALTH EDUC BEHAV, P337; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Paosche-Orlow MK, 2008, J GEN INTERN MED, V23, P100, DOI 10.1007/s11606-007-0447-2; Passell J. S., 2005, ESTIMATES SIZE CHARA; Perez-Stable E. J., 2004, CLIN CORNERSTONE, V6, P62; Perez-Stable Eliseo J, 2004, Clin Cornerstone, V6, P49, DOI 10.1016/S1098-3597(04)80064-4; PEREZSTABLE EJ, 1992, JAMA-J AM MED ASSOC, V268, P3219, DOI 10.1001/jama.268.22.3219; Pham K, 2008, CHEST, V134, P109, DOI 10.1378/chest.07-2852; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Potocky-Tripodi M., 2002, BEST PRACTICES SOCIA; Raffaelli M, 2004, SEX ROLES, V50, P287, DOI 10.1023/B:SERS.0000018886.58945.06; Roll IJ, 2009, J PAIN SYMPTOM MANAG, V37, P325, DOI 10.1016/j.jpainsymman.2008.02.015; SABOGAL F, 1995, HISPANIC J BEHAV SCI, V17, P139, DOI 10.1177/07399863950172001; SABOGAL F, 1987, HISPANIC J BEHAV SCI, V9, P397, DOI 10.1177/07399863870094003; Schenker Y, 2008, ANN INTERN MED, V149, P264, DOI 10.7326/0003-4819-149-4-200808190-00008; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Schillinger D, 2004, PATIENT EDUC COUNS, V52, P315, DOI 10.1016/S0738-3991(03)00107-1; SCHLOSBERG C, 1998, IMPACT INS PUBLIC CH; Smith AK, 2008, J CLIN ONCOL, V26, P4131, DOI 10.1200/JCO.2007.14.8452; Smith AK, 2007, J PALLIAT MED, V10, P938, DOI 10.1089/jpm.2006.0244; Smith AK, 2009, J AM GERIATR SOC, V57, P153, DOI 10.1111/j.1532-5415.2008.02081.x; SONTAG D, 2008, NY TIMES        0803, pA1; Sudore RL, 2006, J AM GERIATR SOC, V54, P770, DOI 10.1111/j.1532-5415.2006.00691.x; Sudore RL, 2006, J GEN INTERN MED, V21, P867, DOI 10.1111/j.1525-1497.2006.00535.x; Sudore Rebecca L, 2009, J Clin Outcomes Manag, V16, P20; Sulmasy DP, 2006, JAMA-J AM MED ASSOC, V296, P1385, DOI 10.1001/jama.296.11.1385; Talamantes M A, 1995, Hosp J, V10, P35; Talamantes MA, 2000, CULTURAL ISSUES END, P83, DOI [10.4135/9781452204819.n7, DOI 10.4135/9781452204819.N7]; Thornton JD, 2009, CRIT CARE MED, V37, P89, DOI 10.1097/CCM.0b013e3181926430; TRIANDIS HC, 1984, J PERS SOC PSYCHOL, V47, P1363, DOI 10.1037/0022-3514.47.6.1363; Walter N, 2002, J GEN INTERN MED, V17, P221, DOI 10.1046/j.1525-1497.2002.10501.x; Weinick RM, 2004, MED CARE, V42, P313, DOI 10.1097/01.mlr.0000118705.27241.7c; Wenk R, 2008, J PALLIAT MED, V11, P717, DOI 10.1089/jpm.2007.0212; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Yoon J, 2004, J AM BOARD FAM PRACT, V17, P165, DOI 10.3122/jabfm.17.3.165; ZIV TA, 1995, NEW ENGL J MED, V332, P1095, DOI 10.1056/NEJM199504203321612; PERCENT PROJECTED PO; CHANGING FAITHS LATI; 1998, FED REG, V63, P41658; GUIDELINES USE MED I	98	96	96	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1047	1057		10.1001/jama.2009.308	http://dx.doi.org/10.1001/jama.2009.308			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416OQ	19278947	Green Accepted			2022-12-28	WOS:000264015800029
J	Richman, DD; Margolis, DM; Delaney, M; Greene, WC; Hazuda, D; Pomerantz, RJ				Richman, Douglas D.; Margolis, David M.; Delaney, Martin; Greene, Warner C.; Hazuda, Daria; Pomerantz, Roger J.			The Challenge of Finding a Cure for HIV Infection	SCIENCE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; REPLICATION-COMPETENT HIV; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; CELLULAR RESERVOIRS; ANTIVIRAL THERAPY; P-TEFB; LATENCY	Although combination therapy for HIV infection represents a triumph for modern medicine, chronic suppressive therapy is required to contain persistent infection in reservoirs such as latently infected CD4(+) lymphocytes and cells of the macrophage-monocyte lineage. Despite its success, chronic suppressive therapy is limited by its cost, the requirement of lifelong adherence, and the unknown effects of long-term treatment. This review discusses our current understanding of suppressive antiretroviral therapy, the latent viral reservoir, and the needs for and challenges of attacking this reservoir to achieve a cure.	[Richman, Douglas D.] San Diego VA Healthcare Syst, La Jolla, CA 92093 USA; [Margolis, David M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Delaney, Martin] Project Inform, San Francisco, CA 94103 USA; [Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Hazuda, Daria] Merck & Co Inc, West Point, PA 19486 USA; [Pomerantz, Roger J.] Johnson & Johnson Corp, Yardley, PA 19067 USA; [Pomerantz, Roger J.] Tibotec Pharmaceut Inc, Yardley, PA 19067 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; The J David Gladstone Institutes; Merck & Company; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Richman, DD (corresponding author), San Diego VA Healthcare Syst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	drichman@ucsd.edu	Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002	Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH; V. Miller and the Forum for Collaborative HIV Research	Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); V. Miller and the Forum for Collaborative HIV Research	We acknowledge the encouragement and support of C. Dieffenbach of the Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, and V. Miller and the Forum for Collaborative HIV Research. We also thank J. C. W. Carroll from the J. David Gladstone Institutes for graphic artwork. This article is dedicated to the memory of our friend and colleague, Martin Delaney.	Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bedimo Roger, 2008, Curr HIV/AIDS Rep, V5, P140, DOI 10.1007/s11904-008-0022-4; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Florescu D, 2007, ANTIVIR THER, V12, P149; Gunthard HF, 1999, J VIROL, V73, P9404; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Lambotte O, 2005, AIDS, V19, P217, DOI 10.1097/00002030-200501280-00018; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Maldarelli F, 2008, ANTIVIR THER, V13, pA79; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mallon PWG, 2007, AIDS REV, V9, P3; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mondy K, 2007, ANNU REV MED, V58, P141, DOI 10.1146/annurev.med.58.072905.180040; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; World Health Organization, 2008, UN ACC SCAL PRIOR HI; YOUNG CW, 1988, CANCER RES, V48, P7304; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	48	658	691	1	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1304	1307		10.1126/science.1165706	http://dx.doi.org/10.1126/science.1165706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265012				2022-12-28	WOS:000263876700031
J	Andreotti, B; Fourriere, A; Ould-Kaddour, F; Murray, B; Claudin, P				Andreotti, Bruno; Fourriere, Antoine; Ould-Kaddour, Fouzia; Murray, Brad; Claudin, Philippe			Giant aeolian dune size determined by the average depth of the atmospheric boundary layer	NATURE			English	Article							SAND DUNES; AIR-FLOW; DYNAMICS; FIELD; SIMULATIONS; VELOCITIES; SELECTION; BEDFORMS; RIPPLES; SHAPES	Depending on the wind regime(1,2), sand dunes exhibit linear(3,4), crescent-shaped or star-like forms(5) resulting from the interaction between dune morphology and sand transport(6-8). Small-scale dunes form by destabilization of the sand bed(9-11) with a wavelength (a few tens of metres) determined by the sand transport saturation length(11-13). The mechanisms controlling the formation of giant dunes, and in particular accounting for their typical time and length scales, have remained unknown. Using a combination of field measurements and aerodynamic calculations, we show here that the growth of aeolian giant dunes, ascribed to the non-linear interaction between small-scale superimposed dunes(4,10,14,15), is limited by the confinement of the flow within the atmospheric boundary layer(16,17). Aeolian giant dunes and river dunes form by similar processes, with the thermal inversion layer that caps the convective boundary layer in the atmosphere(18) acting analogously to the water surface in rivers. In both cases, the bed topography excites surface waves on the interface that in turn modify the near-bed flow velocity. This mechanism is a stabilizing process that prevents the scale of the pattern from coarsening beyond the resonant condition. Our results can explain the mean spacing of aeolian giant dunes ranging from 300m in coastal terrestrial deserts to 3.5 km. We propose that our findings could serve as a starting point for the modelling of long-term evolution of desert landscapes under specific wind regimes.	[Andreotti, Bruno; Fourriere, Antoine; Claudin, Philippe] ESPCI, PMMH, CNRS,UMR 7636, Lab Phys & Mecan Milieux Heterogenes,P6,P7, F-75005 Paris, France; [Ould-Kaddour, Fouzia] Univ Abou Bekr Belkaid, Phys Theor Lab, Tilimsen, Algeria; [Murray, Brad] Duke Univ, Ctr Nonlinear & Complex Syst, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Universite Abou Bekr Belkaid; Duke University	Claudin, P (corresponding author), ESPCI, PMMH, CNRS,UMR 7636, Lab Phys & Mecan Milieux Heterogenes,P6,P7, 10 Rue Vanquelin, F-75005 Paris, France.	claudin@pmmh.espci.fr		Andreotti, Bruno/0000-0001-8328-6232; Murray, A. Brad/0000-0002-2484-9151	ANR	ANR(French National Research Agency (ANR))	We thank R. Littlewood for discussions and assistance with the field work. This study was supported by an ANR grant.	Andersen KH, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066308; Andreotti B, 2002, EUR PHYS J B, V28, P341, DOI 10.1140/epjb/e2002-00237-3; Andreotti B, 2002, EUR PHYS J B, V28, P321, DOI 10.1140/epjb/e2002-00236-4; Baddock MC, 2007, GEOMORPHOLOGY, V87, P322, DOI 10.1016/j.geomorph.2006.10.006; BEST J, 2005, J GEOPHYS RES, V100, P12110; Bristow CS, 2007, GEOLOGY, V35, P555, DOI 10.1130/G23369A.1; Bristow CS, 2000, NATURE, V406, P56, DOI 10.1038/35017536; Claudin P, 2006, EARTH PLANET SC LETT, V252, P30, DOI 10.1016/j.epsl.2006.09.004; Elbelrhiti H, 2005, NATURE, V437, P720, DOI 10.1038/nature04058; Ewing RC, 2006, EARTH SURF PROC LAND, V31, P1176, DOI 10.1002/esp.1312; Fryberger S.G., 1979, GEOLOGICAL SURVEY PR, V1052, P137; Hanna S.R., 1969, J APPL MET LANCASTER, V8, P874, DOI [10.1175/1520-0450(1969)008%3C0874:tfolsd%3E2.0.co;2, DOI 10.1175/1520-0450(1969)008<0874:TFOLSD>2.0.CO;2]; Hersen P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.264301; KOCUREK G, 1991, SEDIMENTOLOGY, V38, P751, DOI 10.1111/j.1365-3091.1991.tb01018.x; Kroy K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.054301; LANCASTER N, 1989, SEDIMENTOLOGY, V36, P273, DOI 10.1111/j.1365-3091.1989.tb00607.x; Lancaster N, 1996, GEOMORPHOLOGY, V17, P55, DOI 10.1016/0169-555X(95)00095-M; LANCASTER N, 1988, SEDIMENT GEOL, V55, P69, DOI 10.1016/0037-0738(88)90090-5; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Parteli EJR, 2006, GEOMORPHOLOGY, V81, P29, DOI 10.1016/j.geomorph.2006.02.015; Politi P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090601; Raudkivi AJ, 2006, J HYDRAUL ENG-ASCE, V132, P1316, DOI 10.1061/(ASCE)0733-9429(2006)132:12(1316); Savijarvi H, 2004, Q J ROY METEOR SOC, V130, P669, DOI 10.1256/qj.03.59; Stull R. B., 1988, INTRO BOUNDARY LAYER; Tokano T, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002704; TSOAR H, 1983, SEDIMENTOLOGY, V30, P567, DOI 10.1111/j.1365-3091.1983.tb00694.x; WERNER BT, 1995, GEOLOGY, V23, P1107, DOI 10.1130/0091-7613(1995)023<1107:EDCSAA>2.3.CO;2; Wiggs GFS, 1996, GEOMORPHOLOGY, V17, P29, DOI 10.1016/0169-555X(95)00093-K; WILSON IG, 1972, SEDIMENTOLOGY, V19, P173, DOI 10.1111/j.1365-3091.1972.tb00020.x; Wurtele MG, 1996, ANNU REV FLUID MECH, V28, P429, DOI 10.1146/annurev.fl.28.010196.002241	30	105	107	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1120	1123		10.1038/nature07787	http://dx.doi.org/10.1038/nature07787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242473				2022-12-28	WOS:000263680100038
J	Epstein, SS				Epstein, Slava S.			Microbial awakenings	NATURE			English	Editorial Material									Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Epstein, SS (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu							0	121	123	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1083	1083		10.1038/4571083a	http://dx.doi.org/10.1038/4571083a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242455				2022-12-28	WOS:000263680100020
J	Srivastava, R				Srivastava, Ranjana			Dying to Talk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					807	808		10.1001/jama.2009.207	http://dx.doi.org/10.1001/jama.2009.207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244180				2022-12-28	WOS:000263609900001
J	Rosenson, RS; Hislop, C; McConnell, D; Elliott, M; Stasiv, Y; Wang, N; Waters, DD				Rosenson, Robert S.; Hislop, Colin; McConnell, Daniel; Elliott, Michael; Stasiv, Yuri; Wang, Nan; Waters, David D.		PLASMA Investigators	Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A(2) (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial	LANCET			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; FOAM CELL-FORMATION; GROUP-V; PROGNOSTIC VALUE; ATHEROSCLEROSIS; PROTEOGLYCANS; EXPRESSION; SPLA(2); ATHEROGENESIS	Background Secretory phospholipase A(2) (sPLA,) enzymes, produced and secreted in human blood vessels and hepatocytes, contribute to the development of atherosclerosis through mechanisms that are both dependent and independent of lipoprotein. We examined the effects of an sPLA, inhibitor on enzyme concentration and on plasma lipoproteins and inflammatory biomarkers in patients with coronary heart disease. Methods Patients aged 18 years and older with stable coronary heart disease from the USA and Ukraine were eligible for enrolment in this phase II, randomised, double-blind, placebo-controlled, parallel-arm, dose-response study. 393 patients were randomly assigned by computer-generated sequence to receive either placebo (n=79) or one of four doses of an sPLA, inhibitor, A-002 (1-H-indole-3-glyoxamide; 50 mg [n=79], 100 mg [n=80], 250 mg [n=78], or 500 mg [n=77] twice daily), for 8 weeks. The primary endpoint was the change in sPLA(2) group IIA (sPLA(2)-IIA) concentration or activity from baseline to week 8. Analysis was by modified intention to treat (ITT). The ITT population consisted of all patients who received one dose of study treatment; data for patients who dropped out before the end of the study were carried forward from last observation. This trial is registered with ClinicalTrials. gov, number NCT00455546. Findings All randomised patients received at least one dose and were included in the ITT population. Data for 45 patients were carried forward from last observation (36 in the A-002 group and nine in the placebo group); the main reason for dropout before completion was because of adverse events. 348 patients reached the primary endpoint (A-002 n=278, placebo n=70). Mean sPLA,-IIA concentration fell by 86.7%, from 15 . 7 pmol/L to 2 . 1 pmol/L, in the overall active treatment group, and by 4.8%, from 15.7 pmol/L to 14.3 pmol/L, in the placebo group (p<0.0001 treatment vs placebo). The reductions in sPLA(2)-IIA concentration in the A-002 groups were dose dependent (ranging from 69.2% in the 50 mg group to 95.8% in the 500 mg group) and differed significantly from placebo (p<0 . 0001 for all doses). In the 500 mg A-002 treatment group, there was one serious adverse event (exacerbation of underlying chronic obstructive pulmonary disease), but the proportion of patients reporting treatment-emergent adverse events did not differ from placebo. The main side-effects of the drug included headache (n=20), nausea (n=17), and diarrhoea (n=12). Interpretation The reductions in sPLA(2)-IIA concentration suggest that A-002 might be an effective anti-atherosclerotic agent. Funding Anthera Pharmaceuticals.	[Rosenson, Robert S.] Univ Michigan, Div Cardiovasc Med, Cardiovasc Ctr 2722D, Ann Arbor, MI 48109 USA; [McConnell, Daniel] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Hislop, Colin; Elliott, Michael; Stasiv, Yuri] Anthera Pharmaceut, San Mateo, CA USA; [Wang, Nan] Pharmolam Int, Houston, TX USA; [Waters, David D.] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; San Francisco General Hospital Medical Center	Rosenson, RS (corresponding author), Univ Michigan, Div Cardiovasc Med, Cardiovasc Ctr 2722D, 1500 E Med Ctr Dr,SPC 5853, Ann Arbor, MI 48109 USA.	rrosenso@umich.edu		Yena, Larisa/0000-0001-9633-1848				Abraham E, 2003, CRIT CARE MED, V31, P718, DOI 10.1097/01.CCM.0000053648.42884.89; Beck S, 2003, J BIOL CHEM, V278, P29799, DOI 10.1074/jbc.M211763200; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Flood C, 2004, ARTERIOSCL THROM VAS, V24, P564, DOI 10.1161/01.ATV.0000117174.19078.85; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; GRUNDY SM, 2004, CIRCULATION, V44, P720; Hakala JK, 2001, ARTERIOSCL THROM VAS, V21, P1053, DOI 10.1161/01.ATV.21.6.1053; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P300, DOI 10.1161/01.ATV.17.2.300; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Jonsson-Rylander AC, 2008, CURR ATHEROSCLER REP, V10, P252, DOI 10.1007/s11883-008-0039-6; KLEINMAN Y, 1988, J LIPID RES, V29, P729; Kugiyama K, 2000, AM J CARDIOL, V86, P718, DOI 10.1016/S0002-9149(00)01069-9; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Liu PY, 2003, EUR HEART J, V24, P1824, DOI 10.1016/j.ehj.2003.07.003; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Menschikowski M, 1995, ATHEROSCLEROSIS, V118, P173, DOI 10.1016/0021-9150(95)05604-1; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Nyyssonen K, 1996, SCAND J CLIN LAB INV, V56, P681, DOI 10.3109/00365519609088815; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Porela P, 2000, BASIC RES CARDIOL, V95, P413, DOI 10.1007/s003950070041; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Sartipy P, 1999, J BIOL CHEM, V274, P25913, DOI 10.1074/jbc.274.36.25913; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shaposhnik Z, 2009, J LIPID RES, V50, P623, DOI 10.1194/jlr.M800361-JLR200; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1	33	98	101	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					649	658		10.1016/S0140-6736(09)60403-7	http://dx.doi.org/10.1016/S0140-6736(09)60403-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231633				2022-12-28	WOS:000263563500030
J	Cam, HP; Chen, ES; Grewal, SIS				Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.			Transcriptional Scaffolds for Heterochromatin Assembly	CELL			English	Article							RNA; CHROMATIN; COMPLEX; GENES; ROLES	Heterochromatin is dynamically regulated during the cell cycle and in response to developmental signals. Recent findings from diverse systems suggest an extensive role for transcription in the assembly of heterochromatin, highlighting the emerging theme that transcription and noncoding RNAs can provide the initial scaffold for the formation of heterochromatin, which serves as a versatile recruiting platform for diverse factors involved in many cellular processes.	[Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011208-04, Z01 BC010523-05, Z01 BC010523-04, ZIA BC011208-05, Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	20	58	60	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					610	614		10.1016/j.cell.2009.02.004	http://dx.doi.org/10.1016/j.cell.2009.02.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239883	Bronze, Green Accepted			2022-12-28	WOS:000263688200013
J	Taylor, RJ				Taylor, Robin J.			Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; RAMIPRIL; EVENTS		Queen Elizabeth Hosp, Newcastle Upon Tyne, Tyne & Wear, England		Taylor, RJ (corresponding author), Queen Elizabeth Hosp, Newcastle Upon Tyne, Tyne & Wear, England.			Taylor, Robin/0000-0002-3408-2716				Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Maggioni AP, 2002, J AM COLL CARDIOL, V40, P1414, DOI 10.1016/S0735-1097(02)02304-5; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4							JC2-6	10.7326/0003-4819-150-4-200902170-02006	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19238604				2022-12-28	WOS:000263562500027
J	Silverman, D; Gendreau, M				Silverman, Danielle; Gendreau, Mark			Medical issues associated with commercial flights	LANCET			English	Review							VENOUS THROMBOEMBOLIC DISEASE; ACUTE RESPIRATORY SYNDROME; HUMAN CIRCADIAN-RHYTHMS; BREAST-CANCER RISK; AIR-TRAVEL; LONG-HAUL; JET-LAG; PREFLIGHT EVALUATION; PANDEMIC INFLUENZA; PULMONARY-EMBOLISM	Almost 2 billion people travel aboard commercial airlines every year. Health-care providers and travellers need to be aware of the potential health risks associated with air travel. Environmental and physiological changes that occur during routine commercial flights lead to mild hypoxia and gas expansion, which can exacerbate chronic medical conditions or incite acute in-flight medical events. The association between venous thromboembolism and long-haul flights, cosmic-radiation exposure, jet lag, and cabin-air quality are growing health-care issues associated with air travel. In-flight medical events are increasingly frequent because a growing number of individuals with pre-existing medical conditions travel by air. Resources including basic and advanced medical kits, automated external defibrillators, and telemedical ground support are available onboard to assist flight crew and volunteering physicians in the management of in-flight medical emergencies.	[Gendreau, Mark] Lahey Clin Med Ctr, Dept Emergency Med, Burlington, MA 01805 USA; [Gendreau, Mark] Tufts Med Sch, Boston, MA USA; [Silverman, Danielle] Georgetown Univ Hosp, Dept Emergency Med, Washington, DC 20007 USA; [Silverman, Danielle] Washington Hosp Ctr, Washington, DC 20010 USA	Lahey Hospital & Medical Center; Tufts Medical Center; Tufts University; Georgetown University; MedStar Washington Hospital Center	Gendreau, M (corresponding author), Lahey Clin Med Ctr, Dept Emergency Med, 41 Mall Rd, Burlington, MA 01805 USA.	mark.a.gendreau@lahey.org						Aerospace Med Assoc, 2003, AVIAT SPACE ENVIR MD, V74, pA1; Agostoni P, 2000, AM J MED, V109, P450, DOI 10.1016/S0002-9343(00)00532-5; Akero A, 2005, EUR RESPIR J, V25, P725, DOI 10.1183/09031936.05.00093104; Akero A, 2008, AVIAT SPACE ENVIR MD, V79, P518, DOI 10.3357/ASEM.2120.2008; Amornkul PN, 2004, J INFECT DIS, V189, pS81, DOI 10.1086/377698; [Anonymous], 1995, MMWR-MORBID MORTAL W, V44, P137; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Arya R, 2002, BRIT J HAEMATOL, V116, P653, DOI 10.1046/j.0007-1048.2001.03330.x; Aryal KR, 2006, EUR J VASC ENDOVASC, V31, P187, DOI 10.1016/j.ejvs.2005.08.025; *AV CONS PROT DIV, 2001, FACT SHEET STEPS TAK; Aw JJ, 2003, J TRAVEL MED, V10, P19, DOI 10.2310/7060.2003.30669; BARISH RJ, 1990, HEALTH PHYS, V59, P199, DOI 10.1097/00004032-199008000-00006; Barish RJ, 2004, OBSTET GYNECOL, V103, P1326, DOI 10.1097/01.AOG.0000126947.90065.90; Becker NG, 2006, AUST NZ J PUBL HEAL, V30, P5, DOI 10.1111/j.1467-842X.2006.tb00077.x; Belcaro G, 2002, ANGIOLOGY, V53, P635, DOI 10.1177/000331970205300603; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bettes TN, 1999, AM FAM PHYSICIAN, V60, P801; Blettner M, 1998, RADIAT ENVIRON BIOPH, V37, P75, DOI 10.1007/s004110050097; Boulos Z, 2002, AVIAT SPACE ENVIR MD, V73, P953; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Burgess HJ, 2003, J BIOL RHYTHM, V18, P318, DOI 10.1177/0748730403253585; Burnett JCD, 2006, J TRAVEL MED, V13, P255, DOI 10.1111/j.1708-8305.2006.00057.x; Cannegieter SC, 2006, PLOS MED, V3, P1258, DOI 10.1371/journal.pmed.0030307; *CDCP, 1963, MMWR-MORBID MORTAL W, V12, P56; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; Chee YL, 2005, BRIT J HAEMATOL, V130, P671, DOI 10.1111/j.1365-2141.2005.05617.x; Chen J, 2005, RADIAT PROT DOSIM, V114, P475, DOI 10.1093/rpd/nch493; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; Cocks R, 2007, EMERG MED AUSTRALAS, V19, P1, DOI 10.1111/j.1742-6723.2006.00928.x; Coker RK, 2007, EUR RESPIR J, V30, P1057, DOI 10.1183/09031936.00024707; Coker RK, 2002, THORAX, V57, P289; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; COPELAND K, 2005, SOLAR RAD ALERT SYST; Luna LKD, 2007, J INFECT DIS, V195, P675, DOI 10.1086/511432; Deacon S, 1996, PHYSIOL BEHAV, V59, P665, DOI 10.1016/0031-9384(95)02147-7; DeJohn CA, 2002, AVIAT SPACE ENVIR MD, V73, P580; DILLARD TA, 1989, ANN INTERN MED, V111, P362, DOI 10.7326/0003-4819-111-5-362; DILLARD TA, 1995, CHEST, V107, P352, DOI 10.1378/chest.107.2.352; Dine CJ, 2008, CHEST, V133, P1002, DOI 10.1378/chest.07-1354; DONALDSON E, 1991, AVIAT SPACE ENVIR MD, V62, P654; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Erdmann J, 1998, AM J CARDIOL, V81, P266, DOI 10.1016/S0002-9149(97)00901-6; Evans A, 2006, AVIAT SPACE ENVIR MD, V77, P974; *FED AV ADM, 2005, FAA200418596; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; FRIEDBERG W, 1989, AVIAT SPACE ENVIR MD, V60, P1104; Gallus AS, 2005, SEMIN THROMB HEMOST, V31, P90, DOI 10.1055/s-2005-863810; GANDER PH, 1985, AM J PHYSIOL, V249, pR704, DOI 10.1152/ajpregu.1985.249.6.R704; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Herxheimer A, 2001, COCHRANE DB SYST REV; Hsieh HF, 2005, J ADV NURS, V51, P83, DOI 10.1111/j.1365-2648.2005.03463.x; Hughes R, 2006, RESPIROLOGY, V11, P75, DOI 10.1111/j.1440-1843.2006.00787.x; Hughes RJ, 2003, LANCET, V362, P2039, DOI 10.1016/S0140-6736(03)15097-0; Humphreys S, 2005, ANAESTHESIA, V60, P458, DOI 10.1111/j.1365-2044.2005.04124.x; *ICAO, 2007, GUID STAT MAN COMM D; *INT AIR TRANSP AS, 2004, MED MAN; Jacobson BF, 2003, SAMJ S AFR MED J, V93, P522; Jorge A, 2005, J TRAVEL MED, V12, P306, DOI 10.2310/7060.2005.12602; Kenfack R, 2007, Rev Med Liege, V62, P144; Kojo K, 2005, OCCUP ENVIRON MED, V62, P488, DOI 10.1136/oem.2004.014738; Kuipers S, 2007, J INTERN MED, V262, P615, DOI 10.1111/j.1365-2796.2007.01867.x; Kuipers S, 2006, J THROMB HAEMOST, V4, P2373, DOI 10.1111/j.1538-7836.2006.02204.x; Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290; Lagarde D, 2001, MED SCI SPORT EXER, V33, P628; Lahti T, 2007, INT J CIRCUMPOL HEAL, V66, P365, DOI 10.3402/ijch.v66i4.18280; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lindgren T, 2005, INDOOR AIR, V15, P65, DOI 10.1111/j.1600-0668.2005.00353.x; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x; Martin SE, 2007, QJM-INT J MED, V100, P361, DOI 10.1093/qjmed/hcm033; Martinelli I, 2003, ARCH INTERN MED, V163, P2771, DOI 10.1001/archinte.163.22.2771; MCFARLAND JW, 1993, LANCET, V342, P112, DOI 10.1016/0140-6736(93)91311-9; McMullan R, 2007, Travel Med Infect Dis, V5, P276, DOI 10.1016/j.tmaid.2007.06.002; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Muhm JM, 2007, NEW ENGL J MED, V357, P18, DOI 10.1056/NEJMoa062770; NICHOLAS JSC, 2000, GALLACTIC COSMIC RAD, V2; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Philbrick JT, 2007, J GEN INTERN MED, V22, P107, DOI 10.1007/s11606-006-0016-0; Pierson K, 2007, AVIAT SPACE ENVIR MD, V78, P361; Possick SE, 2004, ANN INTERN MED, V141, P148, DOI 10.7326/0003-4819-141-2-200407200-00014; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Rafnsson V, 2003, OCCUP ENVIRON MED, V60, P807, DOI 10.1136/oem.60.11.807; Reilly T, 2001, INT J SPORTS MED, V22, P166, DOI 10.1055/s-2001-16379; Revell VL, 2006, J CLIN ENDOCR METAB, V91, P54, DOI 10.1210/jc.2005-1009; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Reynolds P, 2002, CANCER CAUSE CONTROL, V13, P317, DOI 10.1023/A:1015284014563; Robson AG, 2008, RESP MED, V102, P1592, DOI 10.1016/j.rmed.2008.05.005; Roby H, 2002, AVIAT SPACE ENVIR MD, V73, P91; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; SADUN AA, 1984, BRAIN RES, V302, P371, DOI 10.1016/0006-8993(84)90252-X; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schobersberger W, 2002, THROMB RES, V108, P19, DOI 10.1016/S0049-3848(02)00347-X; Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Seccombe LM, 2006, CURR OPIN PULM MED, V12, P140, DOI 10.1097/01.mcp.0000208454.03597.bb; Simons R, 1996, LANCET, V348, P416, DOI 10.1016/S0140-6736(05)65046-5; SKJENNA OW, 1989, CAN MED ASSOC J, V140, P1126; Srinivasan Venkataramanujan, 2008, Travel Med Infect Dis, V6, P17, DOI 10.1016/j.tmaid.2007.12.002; Tasker Andrew, 2004, Travel Med Infect Dis, V2, P75, DOI 10.1016/j.tmaid.2004.04.006; TAUXE RV, 1987, AM J EPIDEMIOL, V125, P150, DOI 10.1093/oxfordjournals.aje.a114498; Teichman PG, 2007, NEW ENGL J MED, V356, P262, DOI 10.1056/NEJMra063651; Thibeault C, 2007, AVIAT SPACE ENVIR MD, V78, P1170, DOI 10.3357/ASEM.2188.2007; TIBERGE M, 2003, SLEEP PHYSL INVESTIG; Toff WD, 2006, JAMA-J AM MED ASSOC, V295, P2251, DOI 10.1001/jama.295.19.2251; Tonks A, 2008, BRIT MED J, V336, P584, DOI 10.1136/bmj.39511.444618.AD; Trujillo-Santos AJ, 2008, ANN HEMATOL, V87, P79, DOI 10.1007/s00277-007-0373-8; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; Watson HG, 2008, BLOOD REV, V22, P107, DOI 10.1016/j.blre.2007.11.001; *WHO, 2005, INT TRAV HLTH SIT 1; *WHO, 2006, WHOHTMTB2006363; *WHO, 2003, WHOCDSCSR200311; Widdowson MA, 2005, JAMA-J AM MED ASSOC, V293, P1859, DOI 10.1001/jama.293.15.1859; Wilder-Smith A, 2004, J TRAVEL MED, V11, P130; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; WYATT J, 2005, OXFORD HDB ACCIDENT; Zahger D, 2000, AM HEART J, V140, P241, DOI 10.1067/mhj.2000.107998; Zitter JN, 2002, JAMA-J AM MED ASSOC, V288, P483, DOI 10.1001/jama.288.4.483; 2008, AVIAT SPACE ENV MED, V79, P433; 2008, FED REG, V73, P27613	128	148	153	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2067	2077		10.1016/S0140-6736(09)60209-9	http://dx.doi.org/10.1016/S0140-6736(09)60209-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19232708	Green Published, Bronze			2022-12-28	WOS:000267080100034
J	Metrangolo, P; Carcenac, Y; Lahtinen, M; Pilati, T; Rissanen, K; Vij, A; Resnati, G				Metrangolo, Pierangelo; Carcenac, Yvan; Lahtinen, Manu; Pilati, Tullio; Rissanen, Kari; Vij, Ashwani; Resnati, Giuseppe			Nonporous Organic Solids Capable of Dynamically Resolving Mixtures of Diiodoperfluoroalkanes	SCIENCE			English	Article							PERFLUOROALKYL IODIDES; COORDINATION POLYMERS; HALOGEN; VAN; COMPLEXES; MOLECULES; HYDROGEN; TRANSFORMATIONS; RECOGNITION; CHEMISTRY	Halogen bonding has increasingly facilitated the assembly of diverse host-guest solids. Here, we show that a well-known class of organic salts, bis(trimethylammonium) alkane diiodides, can reversibly encapsulate alpha,omega-diiodoperfluoroalkanes (DIPFAs) through intermolecular interactions between the host's I(-) anions and the guest's terminal iodine substituents. The process is highly selective for the fluorocarbon that forms an I(-)center dot center dot center dot I(CF(2))(m)I center dot center dot center dot I(-) superanion that is matched in length to the chosen dication. DIPFAs that are 2 to 12 carbons in length (common industrial intermediates) can thereby be isolated from mixtures by means of crystallization from solution upon addition of the dissolved size-matched ionic salt. The solid-state salts can also selectively capture the DIPFAs from the vapor phase, yielding the same product formed from solution despite a lack of porosity of the starting lattice structure. Heating liberates the DIPFAs and regenerates the original salt lattice, highlighting the practical potential for the system in separation applications.	[Metrangolo, Pierangelo; Carcenac, Yvan; Resnati, Giuseppe] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Nanostruct Fluorinated Mat, I-20131 Milan, Italy; [Lahtinen, Manu] Univ Jyvaskyla, Dept Chem, FI-40014 Jyvaskyla, Finland; [Pilati, Tullio; Resnati, Giuseppe] Univ Milan, CNR, Ist Sci & Tecnol Mol, I-20133 Milan, Italy; [Rissanen, Kari] Univ Jyvaskyla, Dept Chem, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Vij, Ashwani] AF Res Lab RZSP, Edwards AFB, CA 93524 USA	Polytechnic University of Milan; University of Jyvaskyla; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Milan; University of Jyvaskyla	Metrangolo, P (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Nanostruct Fluorinated Mat, I-20131 Milan, Italy.	pierangelo.metrangolo@polimi.it	Vij, Ashwani/A-2836-2012; Lahtinen, Manu/A-6088-2013; Resnati, Giuseppe/C-8650-2011; Metrangolo, Pierangelo/D-4106-2011; Lahtinen, Manu/AAG-3302-2019; Rissanen, Kari T/B-5688-2008	Vij, Ashwani/0000-0003-1144-4080; Lahtinen, Manu/0000-0001-5561-3259; Resnati, Giuseppe/0000-0002-0797-9296; Lahtinen, Manu/0000-0001-5561-3259; Rissanen, Kari T/0000-0002-7282-8419; METRANGOLO, PIERANGELO/0000-0002-7945-099X	Fondazione Cariplo; Academy of Finland [project 212588]; U.S. Air Force Research Laboratory/Air Force Office of Scientific Research [Window on Europe]	Fondazione Cariplo(Fondazione Cariplo); Academy of Finland(Academy of Finland); U.S. Air Force Research Laboratory/Air Force Office of Scientific Research(United States Department of DefenseUS Air Force Research LaboratoryAir Force Office of Scientific Research (AFOSR))	P.M., T.P., and G.R. thank Fondazione Cariplo (Project "Self-Assembled Nanostructured Materials: A Strategy for the Control of Electrooptic Properties") for generous support. K.R. thanks the Academy of Finland (project 212588) for generous support. A.V. thanks the U.S. Air Force Research Laboratory/Air Force Office of Scientific Research for a generous Window on Europe grant, A. Garscadden for his endorsement, and R. Channell, R. Corley, and M. Huggins for their support. The authors declare no conflict of interest. A part of the present work is the object of the patent application PCT/EP2008/058588 (2008), priority date 7 November 2007, by Y.C., P.M., and G.R. to Politecnico di Milano. The authors' contributions were as follows: A.V., Y.C., M.L., T.P., and P.M. performed experiments; P.M., G.R., K.R., M.L., T.P., and Y.C. performed data analysis; and P.M., G.R., K.R., M.L., and T.P. wrote the paper. Crystallographic data for compounds 1a.2a, 1a.2b, 1b.2b, 1b.2d, 1b, and 1c.2c can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif under reference numbers CCDC 709470 to 709475, respectively.	Ameduri B., 2004, ELSEV SCI; Atwood JL, 2002, SCIENCE, V298, P1000, DOI 10.1126/science.1077591; Atwood JL, 2002, SCIENCE, V296, P2367, DOI 10.1126/science.1072252; BAUM K, 1994, J ORG CHEM, V59, P6804, DOI 10.1021/jo00101a048; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BONEVA S, 1988, CHROMATOGRAPHIA, V25, P735, DOI 10.1007/BF02290482; Brace NO, 2001, J FLUORINE CHEM, V108, P147, DOI 10.1016/S0022-1139(01)00348-7; Braga D, 2006, ANGEW CHEM INT EDIT, V45, P142, DOI 10.1002/anie.200502597; Cao HP, 2007, J FLUORINE CHEM, V128, P1187, DOI 10.1016/j.jfluchem.2007.04.018; Chandler BD, 2008, NAT MATER, V7, P229, DOI 10.1038/nmat2101; Dalgarno SJ, 2007, CHEM SOC REV, V36, P236, DOI 10.1039/b606047c; Dindi H., 2004, Process for manufacturing diiodoperfluoroalkanes, Patent No. [US006825389, 006825389]; HOSSEINI MW, 1982, J AM CHEM SOC, V104, P3525, DOI 10.1021/ja00376a056; Kitagawa S, 2005, CHEM SOC REV, V34, P109, DOI 10.1039/b313997m; Liantonio R, 2003, CRYST GROWTH DES, V3, P355, DOI 10.1021/cg0340244; Libri S, 2008, ANGEW CHEM INT EDIT, V47, P1693, DOI 10.1002/anie.200703194; LOGOTHETIS AL, 1994, ORGANOFLUORINE CHEM, P373; LOHR HG, 1984, J ORG CHEM, V49, P1621; Menozzi E, 2005, CHEM COMMUN, P5530, DOI 10.1039/b509189f; Metrangolo P, 2008, SCIENCE, V321, P918, DOI 10.1126/science.1162215; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Nelen MI, 1997, J CHEM SOC PERK T 2, P1359, DOI 10.1039/a607737d; Rissanen K, 2008, CRYSTENGCOMM, V10, P1107, DOI 10.1039/b803329n; Sun PC, 2003, J POROUS MAT, V10, P145, DOI 10.1023/A:1026039931096; Vittal JJ, 2007, COORDIN CHEM REV, V251, P1781, DOI 10.1016/j.ccr.2007.02.002	26	245	245	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1461	1464		10.1126/science.1168679	http://dx.doi.org/10.1126/science.1168679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286551				2022-12-28	WOS:000264101700036
J	Ma, YM; Eremets, M; Oganov, AR; Xie, Y; Trojan, I; Medvedev, S; Lyakhov, AO; Valle, M; Prakapenka, V				Ma, Yanming; Eremets, Mikhail; Oganov, Artem R.; Xie, Yu; Trojan, Ivan; Medvedev, Sergey; Lyakhov, Andriy O.; Valle, Mario; Prakapenka, Vitali			Transparent dense sodium	NATURE			English	Article							HIGH-PRESSURE PHASES; CRYSTAL-STRUCTURE PREDICTION; AUGMENTED-WAVE METHOD; LITHIUM; SUPERCONDUCTIVITY; METALS	Under pressure, metals exhibit increasingly shorter interatomic distances. Intuitively, this response is expected to be accompanied by an increase in the widths of the valence and conduction bands and hence a more pronounced free-electron-like behaviour. But at the densities that can now be achieved experimentally, compression can be so substantial that core electrons overlap. This effect dramatically alters electronic properties from those typically associated with simple free-electron metals such as lithium (Li; refs 1-3) and sodium (Na; refs 4, 5), leading in turn to structurally complex phases(6-8) and superconductivity with a high critical temperature(9-11). But the most intriguing prediction-that the seemingly simple metals Li (ref. 1) and Na (ref. 4) will transform under pressure into insulating states, owing to pairing of alkali atoms-has yet to be experimentally confirmed. Here we report experimental observations of a pressure-induced transformation of Na into an optically transparent phase at similar to 200 GPa (corresponding to 5.0-fold compression). Experimental and computational data identify the new phase as a wide bandgap dielectric with a six-coordinated, highly distorted double-hexagonal close-packed structure. We attribute the emergence of this dense insulating state not to atom pairing, but to p-d hybridizations of valence electrons and their repulsion by core electrons into the lattice interstices. We expect that such insulating states may also form in other elements and compounds when compression is sufficiently strong that atomic cores start to overlap strongly.	[Ma, Yanming; Xie, Yu] Jilin Univ, Natl Lab Superhard Mat, Changchun 130012, Peoples R China; [Ma, Yanming; Oganov, Artem R.; Lyakhov, Andriy O.] ETH, Dept Mat, Crystallog Lab, CH-8093 Zurich, Switzerland; [Eremets, Mikhail; Trojan, Ivan; Medvedev, Sergey] Max Planck Inst Chem, D-55020 Mainz, Germany; [Oganov, Artem R.] Moscow MV Lomonosov State Univ, Dept Geol, Moscow 119992, Russia; [Valle, Mario] Swiss Natl Supercomp Ctr CSCS, Data Anal & Visualizat Serv, CH-6928 Manno, Switzerland; [Prakapenka, Vitali] Univ Chicago, Consortium Adv Radiat Sources, Chicago, IL 60637 USA	Jilin University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Lomonosov Moscow State University; University of Chicago	Ma, YM (corresponding author), Jilin Univ, Natl Lab Superhard Mat, Changchun 130012, Peoples R China.	mym@jlu.edu.cn	Oganov, Artem R./AAA-1478-2021; Valle, Mario/C-3691-2013; Ma, Yanming/A-7297-2008; Oganov, Artem R/A-1213-2008; Medvedev, Sergey A/A-9495-2015; Oganov, Artem R./O-8234-2019; Troyan, Ivan/AAQ-9617-2021; Xie, Yu/E-5875-2011; Ma, Yanming/ABE-8450-2020	Valle, Mario/0000-0002-6644-1533; Ma, Yanming/0000-0003-3711-0011; Oganov, Artem R/0000-0001-7082-9728; Medvedev, Sergey A/0000-0002-2871-0886; Oganov, Artem R./0000-0001-7082-9728; Troyan, Ivan/0000-0001-8065-1687; Xie, Yu/0000-0002-7782-5428; 				BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Christensen NE, 2001, SOLID STATE COMMUN, V119, P477, DOI 10.1016/S0038-1098(01)00277-0; Deemyad S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167001; Dye JL, 1997, INORG CHEM, V36, P3816, DOI 10.1021/ic970551z; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; Glass CW, 2006, COMPUT PHYS COMMUN, V175, P713, DOI 10.1016/j.cpc.2006.07.020; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Gregoryanz E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.185502; Gregoryanz E, 2008, SCIENCE, V320, P1054, DOI 10.1126/science.1155715; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Hanfland M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184109; Hanfland M., 2002, 2002 HIGH PRESS GORD; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Leger JM, 1997, EUR J SOL STATE INOR, V34, P785; Ma YM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064101; Ma YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014102; McMahon MI, 2007, P NATL ACAD SCI USA, V104, P17297, DOI 10.1073/pnas.0709309104; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; Neaton JB, 2001, PHYS REV LETT, V86, P2830, DOI 10.1103/PhysRevLett.86.2830; Oganov AR, 2006, EARTH PLANET SC LETT, V241, P95, DOI 10.1016/j.epsl.2005.10.014; Oganov AR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210932; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Raty JY, 2007, NATURE, V449, P448, DOI 10.1038/nature06123; Shimizu K, 2002, NATURE, V419, P597, DOI 10.1038/nature01098; Shishkin M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235102; Struzhkin VV, 2002, SCIENCE, V298, P1213, DOI 10.1126/science.1078535; Tamblyn I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.075703	28	619	643	18	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					182	U3		10.1038/nature07786	http://dx.doi.org/10.1038/nature07786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279632	Green Submitted			2022-12-28	WOS:000264059700038
J	Mintz, ED; Guerrant, RL				Mintz, Eric D.; Guerrant, Richard L.			Global Health: A Lion in Our Village - The Unconscionable Tragedy of Cholera in Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mintz, Eric D.] Ctr Dis Control & Prevent, Enter Dis Epidemiol Branch, Diarrheal Dis Epidemiol Team, Atlanta, GA USA; [Guerrant, Richard L.] Univ Virginia, Sch Med, Ctr Global Hlth, Charlottesville, VA 22908 USA	Centers for Disease Control & Prevention - USA; University of Virginia	Mintz, ED (corresponding author), Ctr Dis Control & Prevent, Enter Dis Epidemiol Branch, Diarrheal Dis Epidemiol Team, Atlanta, GA USA.				NIDDK NIH HHS [P30 DK067629] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Ram PK, 2008, B WHO, V86; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE	5	42	42	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1060	1063		10.1056/NEJMp0810559	http://dx.doi.org/10.1056/NEJMp0810559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417BW	19279337				2022-12-28	WOS:000264051000002
J	Trounson, A				Trounson, Alan			Xiangzhong (Jerry) Yang (1959-2009) OBITUARY	NATURE			English	Biographical-Item									Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				YANG KT, PUBLICATION LIST	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					161	161		10.1038/458161a	http://dx.doi.org/10.1038/458161a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279628	Bronze			2022-12-28	WOS:000264059700033
J	Hammell, CM; Lubin, I; Boag, PR; Blackwell, TK; Ambros, V				Hammell, Christopher M.; Lubin, Isabella; Boag, Peter R.; Blackwell, T. Keith; Ambros, Victor			nhl-2 Modulates MicroRNA Activity in Caenorhabditis elegans	CELL			English	Article							MEDIATED TRANSLATIONAL REPRESSION; PHYSIOLOGICAL GERMLINE APOPTOSIS; C-ELEGANS; RING FINGER; P-BODIES; RNA; GW182; PROTEIN; COMPLEX; DEADENYLASE	TRIM-NHL proteins represent a large class of metazoan proteins implicated in development and disease. We demonstrate that a C. elegans TRIM-NHL protein, NHL-2, functions as a cofactor for the microRNA-induced silencing complex (miRISC) and thereby enhances the posttranscriptional repression of several genetically verified microRNA targets, including hbl-1 and let-60/Ras (by the let-7 family of microRNAs) and cog-1 (by the lsy-6 microRNA). NHL-2 is localized to cytoplasmic P-bodies and physically associates with the P-body protein CGH-1 and the core miRISC components ALG-1/2 and AIN-1. nhl-2 and cgh-1 mutations compromise the repression of microRNA targets in vivo but do not affect microRNA biogenesis, indicating a role for an NHL-2: CGH-1 complex in the effector phase of miRISC activity. We propose that the NHL-2: CGH-1 complex functions in association with mature miRISC to modulate the efficacy of microRNA: target interactions in response to physiological and developmental signals, thereby ensuring the robustness of genetic regulatory pathways regulated by microRNAs.	[Hammell, Christopher M.; Lubin, Isabella; Ambros, Victor] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Boag, Peter R.; Blackwell, T. Keith] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dept Pathol,Joslin Diabet Ctr, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Ambros, V (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	victor.ambros@umassmed.edu		Boag, Peter/0000-0002-0889-0859; Hammell, Christopher/0000-0002-5961-0976	NIH [F32 GM69186]; National Institutes of Health [GM30428, GM63826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030428, R01GM034028, F32GM069186, R01GM063826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to members of the Ambros laboratory and M. Hammell for thoughtful critiques of the data and the manuscript. We thank C. Mello and M. Han for antisera and worm strains and the Caenorhabditis Genetics Center for worm strains. C. M. H. was supported by an NIH postdoctoral fellowship (F32 GM69186). P. R. B. was supported by a fellowship from the M. R. Reinhard Family Foundation. V. A. and T. K. B. were supported by grants from the National Institutes of Health (GM30428 and GM63826, respectively).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; BRENNER S, 1974, GENETICS, V77, P71; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Glasscock E, 2005, GENETICS, V170, P1677, DOI 10.1534/genetics.105.043174; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; HAN M, 1990, GENETICS, V126, P899; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	40	128	142	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					926	938		10.1016/j.cell.2009.01.053	http://dx.doi.org/10.1016/j.cell.2009.01.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269369	Green Accepted, Bronze			2022-12-28	WOS:000263930900015
J	Chapman, HA; Kim, DA; Susskind, JM; Anderson, AK				Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.			In Bad Taste: Evidence for the Oral Origins of Moral Disgust	SCIENCE			English	Article							ANGER	In common parlance, moral transgressions "leave a bad taste in the mouth." This metaphor implies a link between moral disgust and more primitive forms of disgust related to toxicity and disease, yet convincing evidence for this relationship is still lacking. We tested directly the primitive oral origins of moral disgust by searching for similarity in the facial motor activity evoked by gustatory distaste (elicited by unpleasant tastes), basic disgust (elicited by photographs of contaminants), and moral disgust (elicited by unfair treatment in an economic game). We found that all three states evoked activation of the levator labii muscle region of the face, characteristic of an oral-nasal rejection response. These results suggest that immorality elicits the same disgust as disease vectors and bad tastes.	[Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Anderson, A. K.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Chapman, HA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.	hanah@aclab.ca; anderson@psych.utoronto.ca		Kim, David/0000-0003-0151-5121	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	Supported by the Natural Sciences and Engineering Research Council of Canada and by the Canada Research Chairs Program (A.K.A.). We thank G. Cosgrove, S. Couto, R. Landy, A. Meyers, J. Robinson, and M. Sutrisno for assistance in collecting and processing the data, and W. Grabski for technical assistance.	Bloom Paul, 2004, DESCARTES BABY SCI C; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Ekman P., 2002, MANUAL INVESTIGATORS; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harmon-Jones E, 2003, PERS INDIV DIFFER, V35, P995, DOI 10.1016/S0191-8869(02)00313-6; HENRICH SR, 2004, FDN HUMAN SOCIALITY; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Nabi RL, 2002, COGNITION EMOTION, V16, P695, DOI 10.1080/02699930143000437; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Rozin P., 2000, HDB EMOTIONS, P637; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tassinary L. G., 2000, HDB PSYCHOPHYSIOLOGY, P163; Turiel E., 1987, EMERGENCE MORALITY Y, P155; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x	30	422	437	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1222	1226		10.1126/science.1165565	http://dx.doi.org/10.1126/science.1165565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251631				2022-12-28	WOS:000263687600041
J	Orgill, DP				Orgill, Dennis P.			Excision and Skin Grafting of Thermal Burns.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FULL-THICKNESS BURNS; BLOOD-LOSS; FIBRIN SEALANT; MANAGEMENT; SURGERY; WOUNDS; INJURY; INFLAMMATION; AUTOGRAFT; EFFICACY	A 45-year-old man was rescued from his burning house. Firefighters removed his smoldering clothes and initiated intravenous access, pulse oximetry, and electrocardiographic monitoring. An endotracheal tube was inserted, and ventilation with 100% oxygen was initiated for presumed airway instability and inhalation injury. He was taken to a local emergency department with both superficial and deep dermal burns involving his torso and arms; the burns covered 42% of his total body-surface area. Intravenous fluid resuscitation was initiated. He was then transferred to a burn center for definitive treatment. Tube feeding was initiated through a nasogastric tube. The burns were cleansed and a slow-release silver dressing was applied. On day 3 after the injury, he is clinically stable. The clinicians are now deciding whether to excise the burns and how to cover the open wounds.	Brigham & Womens Hosp, Div Plast & Reconstruct Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Orgill, DP (corresponding author), Brigham & Womens Hosp, Div Plast & Reconstruct Surg, 75 Francis St, Boston, MA 02115 USA.	dorgill@partners.org	Orgill, Dennis P./H-7596-2019	Orgill, Dennis P./0000-0002-8279-7310				*AM BURN ASS, NAT BURN REP 2007 RE; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Baskaran H, 2001, J SURG RES, V101, P56, DOI 10.1006/jsre.2001.6262; Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc; Cartotto R, 2000, J TRAUMA, V49, P1034, DOI 10.1097/00005373-200012000-00010; COPE O, 1947, ANN SURG, V125, P1, DOI 10.1097/00000658-194701000-00001; Despa F, 2005, BURNS, V31, P568, DOI 10.1016/j.burns.2005.01.015; Devgan Lara, 2006, J Burns Wounds, V5, pe2; Faucher L, 2006, J BURN CARE RES, V27, P659, DOI 10.1097/01.BCR.0000238117.41490.00; Foster K, 2008, J BURN CARE RES, V29, P293, DOI 10.1097/BCR.0b013e31816673f8; Fritz D A., 2008, CURRENT DIAGNOSIS TR, P836; Garner W. L., 1993, Journal of Burn Care and Rehabilitation, V14, P458, DOI 10.1097/00004630-199307000-00011; Gibran NS, 2007, J BURN CARE RES, V28, P577, DOI 10.1097/BCR.0B013E318093E44C; Gomez M, 2001, J BURN CARE REHABIL, V22, P111, DOI 10.1097/00004630-200103000-00005; Greenhalgh DG, 1999, J TRAUMA, V46, P433, DOI 10.1097/00005373-199903000-00014; HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; Janzekovic Z, 1970, J Trauma, V10, P1103; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2007, ANN SURG, V246, P351, DOI 10.1097/SLA.0b013e318146980e; Jeschke MG, 2007, CRIT CARE MED, V35, P579, DOI 10.1097/01.CCM.0000253812.09236.98; Johansson PI, 2007, BURNS, V33, P435, DOI 10.1016/j.burns.2006.08.010; Lund CC., SURG GYNECOL OBSTET, V79, P352; Lupi O, 2002, J AM ACAD DERMATOL, V46, P790, DOI 10.1067/mjd.2002.120624; MORITZ AR, 1947, AM J PATHOL, V23, P695; Ong YS, 2006, BURNS, V32, P145, DOI 10.1016/j.burns.2005.09.005; Orgill DP, 2002, J BURN CARE REHABIL, V23, P216, DOI 10.1097/00004630-200205000-00012; Robertson RD, 2001, BURNS, V27, P835, DOI 10.1016/S0305-4179(01)00057-2; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Shankar R, 2007, J BURN CARE RES, V28, P566, DOI 10.1097/BCR.0B013E318093DF16; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; Silver GM, 2007, J BURN CARE RES, V28, P222, DOI 10.1097/BCR.0B013E318031AA44; Van Loey NEE, 2001, BURNS, V27, P103, DOI 10.1016/S0305-4179(00)00099-1; WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I; WALLACE AB, 1951, LANCET, V260, P501, DOI 10.1016/S0140-6736(51)91975-7; Wood FM, 2006, BURNS, V32, P538, DOI 10.1016/j.burns.2006.02.025; Wu XW, 2002, ARCH SURG-CHICAGO, V137, P1049, DOI 10.1001/archsurg.137.9.1049	38	102	119	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					893	901		10.1056/NEJMct0804451	http://dx.doi.org/10.1056/NEJMct0804451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246361				2022-12-28	WOS:000263624700008
J	Rishi, P; Bhende, PS				Rishi, Pukhraj; Bhende, Pramod S.			Proliferative Diabetic Retinopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rishi, Pukhraj; Bhende, Pramod S.] Sankara Nethralaya, Madras 600006, Tamil Nadu, India		Rishi, P (corresponding author), Sankara Nethralaya, Madras 600006, Tamil Nadu, India.		Rishi, Pukhraj/AAZ-5296-2020						0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					912	912		10.1056/NEJMicm0708063	http://dx.doi.org/10.1056/NEJMicm0708063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246363				2022-12-28	WOS:000263624700010
J	Cooper, TA; Wan, LL; Dreyfuss, G				Cooper, Thomas A.; Wan, Lili; Dreyfuss, Gideon			RNA and Disease	CELL			English	Review							SPINAL MUSCULAR-ATROPHY; ALTERNATIVE SPLICING REGULATORS; MESSENGER-RNA; BINDING-PROTEINS; ANTISENSE OLIGONUCLEOTIDES; MYOTONIC-DYSTROPHY; DROSOPHILA MODEL; GENE-EXPRESSION; OCULAR NEOVASCULARIZATION; NONSENSE MUTATIONS	Cellular functions depend on numerous protein-coding and noncoding RNAs and the RNA-binding proteins associated with them, which form ribonucleoprotein complexes (RNPs). Mutations that disrupt either the RNA or protein components of RNPs or the factors required for their assembly can be deleterious. Alternative splicing provides cells with an exquisite capacity to fine-tune their transcriptome and proteome in response to cues. Splicing depends on a complex code, numerous RNA-binding proteins, and an enormously intricate network of interactions among them, increasing the opportunity for exposure to mutations and misregulation that cause disease. The discovery of disease-causing mutations in RNAs is yielding a wealth of new therapeutic targets, and the growing understanding of RNA biology and chemistry is providing new RNA-based tools for developing therapeutics.	[Cooper, Thomas A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	tcooper@bcm.tmc.edu; gdreyfuss@hhmi.upenn.edu	wan, li/GRY-7634-2022; Dreyfuss, Gideon/D-1218-2013	Dreyfuss, Gideon/0000-0001-8129-8774	National Institutes of Health; Muscular Dystrophy Association; Association Francaise Contre les Myopathies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060733, R01AR045653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. A. C is supported by the National Institutes of Health and the Muscular Dystrophy Association. G. D. is supported by the Association Francaise Contre les Myopathies ( AFM). G. D. is an Investigator of the Howard Hughes Medical Institute.	Aigner A, 2007, APPL MICROBIOL BIOT, V76, P9, DOI 10.1007/s00253-007-0984-y; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Asparuhova MB, 2007, J GENE MED, V9, P323, DOI 10.1002/jgm.1027; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Danos O, 2008, GENE THER, V15, P864, DOI 10.1038/gt.2008.69; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Holmlund JT, 2003, ANN NY ACAD SCI, V1002, P244, DOI 10.1196/annals.1281.027; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lauriat TL, 2008, J NEUROSCI RES, V86, P785, DOI 10.1002/jnr.21534; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Mordes D, 2007, NEUROBIOL DIS, V26, P291, DOI 10.1016/j.nbd.2006.08.026; Mordes D, 2006, MOL VIS, V12, P1259; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Nezu Y, 2007, NEUROMUSCULAR DISORD, V17, P306, DOI 10.1016/j.nmd.2007.01.002; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pappas TC, 2008, EXPERT OPIN THER TAR, V12, P115, DOI 10.1517/14728222.12.1.115; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Reich S, 2003, MOL VIS, V9, P210; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Rossi JJ, 2008, HUM GENE THER, V19, P313, DOI 10.1089/hum.2008.026; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641; Singh RN, 2007, RNA BIOL, V4, P7, DOI 10.4161/rna.4.1.4535; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2008, CURR OPIN NEUROBIOL, V18, P516, DOI 10.1016/j.conb.2008.09.018; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Whelan JW, 2005, DRUG DISCOV TODAY, V10, P1014, DOI 10.1016/S1359-6446(05)03547-6; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zingman LV, 2007, CLIN PHARMACOL THER, V81, P99, DOI 10.1038/sj.clpt.6100012	149	830	862	1	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					777	793		10.1016/j.cell.2009.02.011	http://dx.doi.org/10.1016/j.cell.2009.02.011			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239895	Green Accepted, Bronze			2022-12-28	WOS:000263688200025
J	Chapman, S				Chapman, Simon			The inverse impact law of smoking cessation	LANCET			English	Editorial Material							MASS-MEDIA; PREVALENCE; SERVICES		Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	sc@med.usyd.edu.au	Chapman, Simon/D-4114-2009					Australian Institute of Health and Welfare, 2008, 2007 NAT DRUG STRAT; Bauld L, 2007, TOB CONTROL, V16, P400, DOI 10.1136/tc.2007.021626; Biener L, 2006, AM J PREV MED, V30, P217, DOI 10.1016/j.amepre.2005.10.026; CHAPMAN S, 1985, LANCET, V1, P918; Doran CM, 2006, ADDICT BEHAV, V31, P758, DOI 10.1016/j.addbeh.2005.05.054; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hill D, 1998, TOB CONTROL, V7, P5, DOI 10.1136/tc.7.1.5; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Illich I., 1977, DISABLING PROFESSION; Miller CL, 2003, TOB CONTROL, V12, P53, DOI 10.1136/tc.12.suppl_2.ii53; Milne E, 2005, BMJ-BRIT MED J, V330, P760, DOI 10.1136/bmj.38407.755521.F7; SILAGY C, 2006, COCHRANE DB SYST REV, V1; Tocque K, 2005, TOB CONTROL RES  MAR, pl; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Walsh RA, 2008, DRUG ALCOHOL REV, V27, P529, DOI 10.1080/09595230802245527; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0	17	34	34	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					701	703		10.1016/S0140-6736(09)60416-5	http://dx.doi.org/10.1016/S0140-6736(09)60416-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249616	Green Submitted			2022-12-28	WOS:000263725400008
J	Byberg, L; Melhus, H; Gedeborg, R; Sundstrom, J; Ahlbom, A; Zethelius, B; Berglund, LG; Wolk, A; Michaelsson, K				Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Sundstrom, Johan; Ahlbom, Anders; Zethelius, Bjorn; Berglund, Lars G.; Wolk, Alicja; Michaelsson, Karl			Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort (Reprinted from BMJ, vol 338, b688, 2009)	BRITISH JOURNAL OF SPORTS MEDICINE			English	Reprint							LIFE EXPECTANCY; RISK; HEALTH; ASSOCIATION; PREVENTION; SMOKING; WOMEN; CHOLESTEROL; FRACTURE; DISEASE	Objective To examine how change in level of physical activity after middle age influences mortality and to compare it with the effect of smoking cessation. Design Population based cohort study with follow-up over 35 years. Setting Municipality of Uppsala, Sweden. Participants 2205 men aged 50 in 1970-3 who were reexamined at ages 60, 70, 77, and 82 years. Main outcome measure Total (all cause) mortality. Results The absolute mortality rate was 27.1, 23.6, and 18.4 per 1000 person years in the groups with low, medium, and high physical activity, respectively. The relative rate reduction attributable to high physical activity was 32% for low and 22% for medium physical activity. Men who increased their physical activity level between the ages of 50 and 60 continued to have a higher mortality rate during the first five years of follow-up (adjusted hazard ratio 2.64, 95% confidence interval 1.32 to 5.27, compared with unchanged high physical activity). After 10 years of follow-up their increased physical activity was associated with reduced mortality to the level of men with unchanged high physical activity (1.10, 0.87 to 1.38). The reduction in mortality associated with increased physical activity (0.51, 0.26 to 0.97, compared with unchanged low physical activity) was similar to that associated with smoking cessation (0.64, 0.53 to 0.78, compared with continued smoking). Conclusions Increased physical activity in middle age is eventually followed by a reduction in mortality to the same level as seen among men with constantly high physical activity. This reduction is comparable with that associated with smoking cessation.	[Byberg, Liisa; Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, SE-75185 Uppsala, Sweden; [Byberg, Liisa; Gedeborg, Rolf; Berglund, Lars G.; Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Clin Pharmacol Sect, SE-75185 Uppsala, Sweden; [Gedeborg, Rolf] Uppsala Univ, Dept Surg Sci, Sect Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Sundstrom, Johan] Uppsala Univ, Dept Med Sci, Sect Acute & Internal Med, SE-75185 Uppsala, Sweden; [Ahlbom, Anders] Karolinska Inst, Inst Environm Med, Dept Epidemiol, SE-17177 Stockholm, Sweden; [Zethelius, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, SE-75185 Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Dept Nutrit Epidemiol, SE-17177 Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University; Karolinska Institutet	Byberg, L (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, SE-75185 Uppsala, Sweden.	liisa.byberg@surgsci.uu.se	Berglund, Lars/AAD-3856-2019; Michaelsson, Karl/AAM-9094-2021; Berglund, Lars/AAA-3188-2019; Gedeborg, Rolf/AAV-6702-2020; Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019	Berglund, Lars/0000-0002-7437-9047; Gedeborg, Rolf/0000-0002-8850-7863; Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454; Michaelsson, Karl/0000-0003-2815-1217				Aires N, 2003, EUR J EPIDEMIOL, V18, P479, DOI 10.1023/A:1024682523710; Andersen LB, 2004, AM J EPIDEMIOL, V160, P189, DOI 10.1093/aje/kwh195; Andersen R. M., 1970, MED CARE USE SWEDEN; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bostrom G, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034950600677287; BULL FC, 2004, COMP QUANTIFICATION, P729; Byberg L, 2001, DIABETOLOGIA, V44, P2134, DOI 10.1007/s001250100022; Byberg L, 2009, BRIT J SPORT MED, V43, P482, DOI 10.1136/bmj.b688; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; Carlsson S, 2007, AM J EPIDEMIOL, V166, P255, DOI 10.1093/aje/kwm132; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; COLLEN MF, 1969, ARCH INTERN MED, V123, P664, DOI 10.1001/archinte.123.6.664; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Farahmand BY, 2000, INT J EPIDEMIOL, V29, P308, DOI 10.1093/ije/29.2.308; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hedman A, 2002, ACTA PHYSIOL SCAND, V175, P325, DOI 10.1046/j.1365-201X.2002.01000.x; Jonker JT, 2006, DIABETES CARE, V29, P38; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; LOCHEN ML, 1992, J EPIDEMIOL COMMUN H, V46, P103, DOI 10.1136/jech.46.2.103; Michaelsson K, 2007, PLOS MED, V4, P1094, DOI 10.1371/journal.pmed.0040199; Munro JF, 2004, J EPIDEMIOL COMMUN H, V58, P1004, DOI 10.1136/jech.2003.014225; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Portegijs E, 2007, SCAND J MED SCI SPOR, V17, P473, DOI 10.1111/j.1600-0838.2006.00606.x; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rankinen T, 2007, AM J EPIDEMIOL, V166, P260, DOI 10.1093/aje/kwm130; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Schnohr P, 2003, AM J EPIDEMIOL, V158, P639, DOI 10.1093/aje/kwg207; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SEQUEIRA MM, 1995, AM J EPIDEMIOL, V142, P989, DOI 10.1093/oxfordjournals.aje.a117748; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8	53	184	187	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUL	2009	43	7					482	U25						8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	467FS	19264819	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000267724100003
J	Fischer, J; Koch, L; Emmerling, C; Vierkotten, J; Peters, T; Bruning, JC; Ruther, U				Fischer, Julia; Koch, Linda; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Bruening, Jens C.; Ruether, Ulrich			Inactivation of the Fto gene protects from obesity	NATURE			English	Article							FUSED TOES FT; GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; HORMONAL-CONTROL; ADULT OBESITY; FAT MASS; ADIPONECTIN; WEIGHT; HUMANS; MICE	Several independent, genome-wide association studies have identified a strong correlation between body mass index and polymorphisms in the human FTO gene(1-4). Common variants in the first intron define a risk allele predisposing to obesity, with homozygotes for the risk allele weighing approximately 3 kilograms more than homozygotes for the low risk allele(1). Nevertheless, the functional role of FTO in energy homeostasis remains elusive. Here we show that the loss of Fto in mice leads to postnatal growth retardation and a significant reduction in adipose tissue and lean body mass. The leanness of Fto-deficient mice develops as a consequence of increased energy expenditure and systemic sympathetic activation, despite decreased spontaneous locomotor activity and relative hyperphagia. Taken together, these experiments provide, to our knowledge, the first direct demonstration that Fto is functionally involved in energy homeostasis by the control of energy expenditure.	[Fischer, Julia; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Internal Med 2, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, CMMC, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Max Planck Inst Biol Ageing, D-50674 Cologne, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Univ Str 1, D-40225 Dusseldorf, Germany.	jens.bruening@uni-koeln.de; ruether@uni-duesseldorf.de	Peters, Thomas/GQB-3622-2022	Koch, Linda/0000-0002-2943-1993	Deutsche Forschungsgemeinschaft; NGFNplus	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NGFNplus	The authors thank S. Kuschel and B. Hampel for technical assistance, S. Fischer for critical reading of this manuscript, as well as W. Stoffel, B. Jehnke and H. Bronneke for support during assessment of energy expenditure. This work was supported by the Deutsche Forschungsgemeinschaft (to U.R. and J.C.B.) and in part by NGFNplus (to U.R.).	Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Jeon JY, 2006, DIABETES, V55, P428, DOI 10.2337/diabetes.55.02.06.db05-0203; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; MIYOSHI H, 1988, J CLIN INVEST, V81, P1545, DOI 10.1172/JCI113487; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	690	732	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					894	U10		10.1038/nature07848	http://dx.doi.org/10.1038/nature07848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19234441				2022-12-28	WOS:000265182500044
J	Yudkin, JS				Yudkin, John S.			The responsibilities of the World Medical Association President	LANCET			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Yudkin, JS (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.yudkin@blueyonder.co.uk	Yudkin, John S/C-1988-2008					BLACHAR Y, 2009, COMMUNICATION   0108; *BRIT RED CROSS, 2009, GAZ IS FULL BLOWN HU; *DEF CHILDR INT PA, 2008, ISR MIL CONT TORT PA; DYER O, 2007, BRIT MED J, V334, P871; *ISR MED ASS, 2007, PROH PHYS PART INT T; *ISR MED ASS, IMA POS PAP ASS MED; *PHYS HUM RIGHTS I, 2008, HOLD HLTH RANS GSS I; Public Committee Against Torture in Israel, 2007, TICK BOMBS TEST TORT; *WORLD MED ASS, 2008, HLTH CAR SYST MUST B; Worth D, 2009, LANCET, V373, P295, DOI 10.1016/S0140-6736(09)60013-1; YUDKIN JS, 2008, COMMUNICATION   1231; 2009, LANCET, V373, P95	12	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1155	1157		10.1016/S0140-6736(09)60373-1	http://dx.doi.org/10.1016/S0140-6736(09)60373-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19268348				2022-12-28	WOS:000264940600008
J	Singhal, AB; Kimberly, W T; Schaefer, PW; Hedley-Whyte, ET				Singhal, Aneesh B.; Kimberly, W. Taylor; Schaefer, Pamela W.; Hedley-Whyte, E. Tessa			Case 8-2009: A 36-Year-Old Woman with Headache, Hypertension, and Seizure 2 Weeks Post Partum.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACENTAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; CEREBRAL VASOCONSTRICTION; POSTPARTUM ANGIOPATHY; TYROSINE KINASE-1; RISK-FACTORS; VASCULITIS; STROKE; PREGNANCY; DIAGNOSIS		[Singhal, Aneesh B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kimberly, W. Taylor] Massachusetts Gen Hosp, Partners Neurol Residency Program, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Singhal, Aneesh B.; Kimberly, W. Taylor] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Singhal, AB (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021; Schaefer, Pamela/AAA-1323-2019	Hedley-Whyte, E Tessa/0000-0002-1687-8905; 				Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Bartynski WS, 2008, AM J NEURORADIOL, V29, P447, DOI 10.3174/ajnr.A0839; BUCKLE RM, 1964, J NEUROL NEUROSUR PS, V27, P440, DOI 10.1136/jnnp.27.5.440; Calabrese LH, 2007, ANN NEUROL, V62, P430, DOI 10.1002/ana.21283; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-4; CALL GK, 1988, STROKE, V19, P1159, DOI 10.1161/01.STR.19.9.1159; Chen SP, 2008, ANN NEUROL, V63, P751, DOI 10.1002/ana.21384; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; DUNA GF, 1995, J RHEUMATOL, V22, P662; Goldszmidt E, 2005, CAN J ANAESTH, V52, P971, DOI 10.1007/BF03022061; Hajj-Ali RA, 2002, ARTHRIT RHEUM-ARTHR, V47, P662, DOI 10.1002/art.10797; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Hirshfeld-Cytron J, 2006, OBSTET GYNECOL SURV, V61, P471, DOI 10.1097/01.ogx.0000219564.65999.0d; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Lanska DJ, 2000, STROKE, V31, P1274, DOI 10.1161/01.STR.31.6.1274; Lee VH, 2008, ARCH NEUROL-CHICAGO, V65, P205, DOI 10.1001/archneurol.2007.46; Levine RJ, 2006, NEW ENGL J MED, V355, P1840; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MITSIAS P, 1992, CEPHALALGIA, V12, P269, DOI 10.1046/j.1468-2982.1992.1205269.x; Okamoto T, 2003, AM J OBSTET GYNECOL, V188, P135, DOI 10.1067/mob.2003.71; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.21226; Schievink WI, 2001, NEUROSURGERY, V48, P513, DOI 10.1097/00006123-200103000-00009; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Singhal AB, 2005, NEUROCRIT CARE, V3, P91, DOI 10.1385/NCC:3:1:091; Singhal AB, 2004, ARCH NEUROL-CHICAGO, V61, P411, DOI 10.1001/archneur.61.3.411; Singhal AB, 2002, NEUROLOGY, V58, P130, DOI 10.1212/WNL.58.1.130; SINGHAL AB, 2004, TOP STROKE REHABIL, V11, P1, DOI DOI 10.1310/ATK7-QTP7-7NE2-5G8X; Stella CL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.034; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Venkatesha S, 2006, NAT MED, V12, P862, DOI 10.1038/nm0706-862c; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Williams Timothy L., 2007, Archives of Gynecology and Obstetrics, V275, P67, DOI 10.1007/s00404-006-0194-3; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; 2006, N ENGL J MED, V354, P980	44	63	64	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1126	1137		10.1056/NEJMcpc0809063	http://dx.doi.org/10.1056/NEJMcpc0809063			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279345				2022-12-28	WOS:000264051000012
J	de Borst, MH; Lacor, MEM				de Borst, Martin H.; Lacor, Marjolein E. M.			Picture quiz Something's in the air	BRITISH MEDICAL JOURNAL			English	Editorial Material							GALLSTONE ILEUS		[de Borst, Martin H.; Lacor, Marjolein E. M.] Leeuwarden Med Ctr, Dept Med, NL-8901 BR Leeuwarden, Netherlands	Medical Center Leeuwarden	de Borst, MH (corresponding author), Leeuwarden Med Ctr, Dept Med, POB 888, NL-8901 BR Leeuwarden, Netherlands.	martin.de.borst@znb.nl						FRANKLIN ME, 1994, J LAPAROENDOSC SURG, V4, P265, DOI 10.1089/lps.1994.4.265; Kaiser AM, 1997, NEW ENGL J MED, V336, P879; REISNER RM, 1994, AM SURGEON, V60, P441; Swift SE, 1998, CLIN RADIOL, V53, P451, DOI 10.1016/S0009-9260(98)80276-6	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 11	2009	338								b425	10.1136/bmj.b425	http://dx.doi.org/10.1136/bmj.b425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419GA	19282277				2022-12-28	WOS:000264206100008
J	Tzimas, T; Baxevanos, G; Akritidis, N				Tzimas, Thomas; Baxevanos, Gerasimos; Akritidis, Nikoloos			Chilaiditi's sign	LANCET			English	Editorial Material									[Tzimas, Thomas; Baxevanos, Gerasimos; Akritidis, Nikoloos] Gen Hosp Ioannina Hatzikosta, Dept Internal Med, Ioannina 45445, Greece		Tzimas, T (corresponding author), Gen Hosp Ioannina Hatzikosta, Dept Internal Med, Ioannina 45445, Greece.	thomastzimas@hotmail.com		Tzimas, Thomas/0000-0002-7875-7842					0	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					836	836		10.1016/S0140-6736(09)60486-4	http://dx.doi.org/10.1016/S0140-6736(09)60486-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269521	Bronze			2022-12-28	WOS:000263980900034
J	Perros, P; Neoh, C; Dickinson, J				Perros, Petros; Neoh, Christopher; Dickinson, Jane			Thyroid eye disease	BRITISH MEDICAL JOURNAL			English	Review							GRAVES OPHTHALMOPATHY; EUROPEAN GROUP; ORBITOPATHY; MANAGEMENT; GLUCOCORTICOIDS; HYPERTHYROIDISM; PATHOGENESIS; THERAPY		[Perros, Petros] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Neoh, Christopher; Dickinson, Jane] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Perros, P (corresponding author), Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	petros.perros@ncl.ac.uk		Perros, Petros/0000-0001-7320-5574				BALDESCHI L, 2008, GRAVES ORBITOPATHY M, P160; Bartalena L, 2005, EUR J ENDOCRINOL, V153, P13, DOI 10.1530/eje.1.01938; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; BARTLEY GB, 1995, AM J OPHTHALMOL, V120, P511, DOI 10.1016/S0002-9394(14)72666-2; Boboridis K, 2008, GRAVES ORBITOPATHY M, P88; Coulter I, 2007, EUR J ENDOCRINOL, V157, P127, DOI 10.1530/EJE-07-0205; Dickinson AJ, 2001, CLIN ENDOCRINOL, V55, P283, DOI 10.1046/j.1365-2265.2001.01349.x; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Hart R H, 2003, Minerva Endocrinol, V28, P223; Hart RH, 2005, J OCUL PHARMACOL TH, V21, P328, DOI 10.1089/jop.2005.21.328; KENDALLTAYLOR P, 2008, GRAVES ORBITOPATHY M, P78; Khoo TK, 2007, THYROID, V17, P1013, DOI 10.1089/thy.2007.0185; Krassas Gerasimos E, 2007, Pediatr Endocrinol Rev, V4, P218; Mourits MP, 2002, BRIT J OPHTHALMOL, V86, P104; NEOH C, 2008, GRAVES ORBITOPATHY M, P188; ORGIAZZI J, 2008, GRAVES ORBITOPATHY M, P41; Perros P, 2006, EUR J ENDOCRINOL, V155, P207, DOI 10.1530/eje.1.02201; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; SALVI M, 1990, J CLIN ENDOCR METAB, V70, P89, DOI 10.1210/jcem-70-1-89; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wiersinga WM, 2007, NAT CLIN PRACT ENDOC, V3, P396, DOI 10.1038/ncpendmet0497	22	45	47	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 6	2009	338								b560	10.1136/bmj.b560	http://dx.doi.org/10.1136/bmj.b560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EE	19270020				2022-12-28	WOS:000264058500001
J	de Heus, R; Mol, BW; Erwich, JJHM; van Geijn, HP; Gyselaers, WJ; Hanssens, M; Harmark, L; van Holsbeke, CD; Duvekot, JJ; Schobben, FFAM; Wolf, H; Visser, GHA				de Heus, Roel; Mol, Ben Willem; Erwich, Jan-Jaap H. M.; van Geijn, Herman P.; Gyselaers, Wilfried J.; Hanssens, Myriam; Haermark, Linda; van Holsbeke, Caroline D.; Duvekot, Johannes J.; Schobben, Fred F. A. M.; Wolf, Hans; Visser, Gerard H. A.			Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL HEMODYNAMICS; MYOCARDIAL-INFARCTION; NIFEDIPINE; THERAPY; FETAL; COMPLICATIONS; INDOMETHACIN; MANAGEMENT; BIRTH	Objective To evaluate the incidence of serious maternal complications after the use of various tocolytic drugs for the treatment of preterm labour in routine clinical situations. Design Prospective cohort study. Setting 28 hospitals in the Netherlands and Belgium. Participants 1920 consecutive women treated with tocolytics for threatened preterm labour. Main outcome measures Maternal adverse events (those suspected of being causally related to treatment were considered adverse drug reactions) leading to cessation of treatment. Results An independent panel evaluated the recorded adverse events, without knowledge of the type of tocolytic used. Of the 1920 women treated with tocolytics, 1327 received a single course of treatment (69.1%), 282 sequential courses (14.7%), and 311 combined courses (16.2%). Adverse drug reactions were categorised as serious or mild in 14 cases each. The overall incidence of serious adverse drug reaction was 0.7%. Compared with atosiban, the relative risk of an adverse drug reaction for single treatment with a beta adrenoceptor agonist was 22.0 (95% confidence interval 3.6 to 138.0) and for single treatment with a calcium antagonist was 12 (1.9 to 69). Multiple drug tocolysis led to five serious adverse drug reactions (1.6%). Multiple gestation, preterm rupture of membranes, and comorbidity were not independent risk factors for adverse drug reactions. Conclusions The use of beta adrenoceptor agonists or multiple tocolytics for preventing preterm birth is associated with a high incidence of serious adverse drug reactions. Indometacin and atosiban were the only drugs not associated with serious adverse drug reactions. A direct comparison of the effectiveness of nifedipine and atosiban in postponing preterm delivery is needed.	[de Heus, Roel; Visser, Gerard H. A.] Univ Med Ctr Utrecht, Dept Perinatol & Gynaecol, Utrecht, Netherlands; [Mol, Ben Willem] Maxima Med Ctr, Dept Perinatol & Gynaecol, Veldhoven, Netherlands; [Mol, Ben Willem; Wolf, Hans] Univ Amsterdam, Acad Med Ctr, Dept Perinatol & Gynaecol, NL-1012 WX Amsterdam, Netherlands; [Erwich, Jan-Jaap H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Perinatol & Gynaecol, Groningen, Netherlands; [van Geijn, Herman P.] Univ Amsterdam, Free Univ, Med Ctr, Dept Obstet & Gynaecol, NL-1012 WX Amsterdam, Netherlands; [Duvekot, Johannes J.] Erasmus Univ, Med Ctr, Dept Perinatol & Gynaecol, Rotterdam, Netherlands; [Haermark, Linda] Pharmacovigilance Ctr Lareb, sHertogenbosch, Netherlands; [Schobben, Fred F. A. M.] Univ Med Ctr, Dept Clin Pharm, Utrecht, Netherlands; [Gyselaers, Wilfried J.; van Holsbeke, Caroline D.] Hosp Oost Limburg, Dept Perinatol & Gynaecol, Genk, Belgium; [Hanssens, Myriam] Katholieke Univ Leuven Hosp, Dept Perinatol & Gynaecol, Louvain, Belgium	Utrecht University; Utrecht University Medical Center; Maxima Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; East Limburg Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	de Heus, R (corresponding author), Univ Med Ctr Utrecht, Dept Perinatol & Gynaecol, KJ-02-507-0,POB 85090, Utrecht, Netherlands.	R.deHeus-2@umcutrecht.nl	Mol, Ben/I-4526-2012	Wolf, Hans/0000-0003-3924-2149	Ferring Pharmaceuticals BV, Hoofddorp, The Netherlands	Ferring Pharmaceuticals BV, Hoofddorp, The Netherlands(Netherlands Government)	This research was funded by an unconditional grant from Ferring Pharmaceuticals BV, Hoofddorp, The Netherlands.	Abbas Ossama M, 2006, Am J Obstet Gynecol, V195, pe3, DOI 10.1016/j.ajog.2006.06.032; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; [Anonymous], 2003, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD002255; Anotayanonth S, 2004, Cochrane Database Syst Rev, pCD004352, DOI 10.1002/14651858.CD004352.pub2; Blea CW, 1997, AM J OBSTET GYNECOL, V176, P922, DOI 10.1016/S0002-9378(97)70622-7; Cabrol D, 2001, EUR J OBSTET GYN R B, V98, P177; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P1045, DOI 10.1016/S1470-0328(03)03971-5; Coomarasamy Aravinthan, 2002, Med Sci Monit, V8, pRA268; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; HARAKE B, 1987, AM J OBSTET GYNECOL, V157, P1003, DOI 10.1016/S0002-9378(87)80104-7; Hodges R, 2004, BJOG-INT J OBSTET GY, V111, P380, DOI 10.1111/j.1471-0528.2004.00092.x; Hoyert DL, 2006, PEDIATRICS, V117, P168, DOI 10.1542/peds.2005-2587; King J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub2; MAJOR CA, 1994, AM J OBSTET GYNECOL, V170, P102; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Nassar AH, 2007, INT J GYNECOL OBSTET, V97, P148, DOI 10.1016/j.ijgo.2007.01.011; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Oei SG, 2006, EUR J OBSTET GYN R B, V126, P137, DOI 10.1016/j.ejogrb.2006.03.001; Oei SG, 1999, NEW ENGL J MED, V340, P154, DOI 10.1056/NEJM199901143400219; Papatsonis Dimitri N M, 2007, Am J Ther, V14, P346, DOI 10.1097/01.mjt.0000209679.76335.df; Papatsonis DNM, 1997, OBSTET GYNECOL, V90, P230, DOI 10.1016/S0029-7844(97)00182-8; Rosen LJ, 2001, AM J OBSTET GYNECOL, V184, P1, DOI 10.1067/mob.2001.109595; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Vaast P, 2004, EUR J OBSTET GYN R B, V113, P98, DOI 10.1016/j.ejogrb.2003.05.004; van Geijn HP, 2005, BJOG-INT J OBSTET GY, V112, P79; van Veen AJ, 2005, BJOG-INT J OBSTET GY, V112, P509, DOI 10.1111/j.1471-0528.2004.00480.x; Venulet J, 1998, DRUG SAFETY, V19, P165, DOI 10.2165/00002018-199819030-00001; Verhaert D, 2004, ACTA CARDIOL, V59, P331, DOI 10.2143/AC.59.3.2005191; Worldwide Atosiban versus Beta-agonists Study Group, 2001, BJOG, V108, P133	29	84	88	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2009	338								b744	10.1136/bmj.b744	http://dx.doi.org/10.1136/bmj.b744			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417ED	19264820	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000264058400003
J	Hurley, R				Hurley, Richard			Public Health Bad blood: gay men and blood donation	BRITISH MEDICAL JOURNAL			English	Editorial Material							EVER HAD SEX		BMJ, London WC1H 9JR, England		Hurley, R (corresponding author), BMJ, London WC1H 9JR, England.	rhurley@bmj.com						[Anonymous], 2008, BBC NEWS        1104; Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; *CAN BLOOD SERV, IND DEF; *CARE2PETITIONSITE, ALL GAY PEOPL BLOOD; *DEP HLTH HUM SERV, 2006, BLOOD SAF AV ADV COM; *FOOD DRUG ADM, FDA POL BLOOD DON ME; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; IRVINE C, 2008, DAILY TELEGRAPH 1112; *NAT BLOOD SERV EN, WHO CAN GIV BLOOD; *NHS BLOOD TRANSP, 2008, EXCL MEN WHO HAV SEX; *PRIM MIN OFF, 2007, BLOODB EP RESP; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; *SCOTT PARL INF CT, 2008, BRIEF PUBL PET COMM; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; *STON, STON CALLS END BLOOD; *TERR HIGG TRUST, BLOOD DON PEOPL HIGH; *UK BLOOD TRANSF S, 2007, BLOOD DON SEL MIN RI; 2008, BEHAV DONOR DEFERRAL; 2007, MCGILL TRIBUNE  0306; 2008, US NEWS         0204	20	12	12	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b779	10.1136/bmj.b779	http://dx.doi.org/10.1136/bmj.b779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DS	19246551				2022-12-28	WOS:000264056300003
J	Lauren, J; Gimbel, DA; Nygaard, HB; Gilbert, JW; Strittmatter, SM				Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.			Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers	NATURE			English	Article							ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; TRANSGENIC MICE; BINDING-SITES; PRP; RECEPTORS; MEMORY; IDENTIFICATION; TRANSMISSION; A-BETA(1-42)	A pathological hallmark of Alzheimer's disease is an accumulation of insoluble plaque containing the amyloid-beta peptide of 40-42 amino acid residues(1). Prefibrillar, soluble oligomers of amyloid-beta have been recognized to be early and key intermediates in Alzheimer's-disease-related synaptic dysfunction(2-9). At nanomolar concentrations, soluble amyloid-beta oligomers block hippocampal long-term potentiation(7), cause dendritic spine retraction from pyramidal cells(5,8) and impair rodent spatial memory(2). Soluble amyloid-beta oligomers have been prepared from chemical syntheses, transfected cell culture supernatants, transgenic mouse brain and human Alzheimer's disease brain(2,4,7,9). Together, these data imply a high-affinity cell-surface receptor for soluble amyloid-beta oligomers on neurons-one that is central to the pathophysiological process in Alzheimer's disease. Here we identify the cellular prion protein (PrPC) as an amyloid-beta-oligomer receptor by expression cloning. Amyloid-beta oligomers bind with nanomolar affinity to PrPC, but the interaction does not require the infectious PrPSc conformation. Synaptic responsiveness in hippocampal slices from young adult PrP null mice is normal, but the amyloid-beta oligomer blockade of long-term potentiation is absent. Anti-PrP antibodies prevent amyloid-beta-oligomer binding to PrPC and rescue synaptic plasticity in hippocampal slices from oligomeric amyloid-beta. Thus, PrPC is a mediator of amyloid-beta-oligomer-induced synaptic dysfunction, and PrPC-specific pharmaceuticals may have therapeutic potential for Alzheimer's disease.	[Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	Brown-Coxe Postdoctoral Fellow; NIH [5T32GN07205]; Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042304, R01NS039962, R37NS033020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	Brown-Coxe Postdoctoral Fellow; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Tomita for cRNAs encoding GluR1-4 and stargazin (also known as CACNG2), B. Chesebro for providing us the Prnp null mice, M. Schachner for providing the PrP-Fc expression vector, E. Flechsig, C. Weismann and D. Harris for providing the PrP C deletion expression plasmids, D. Westaway for the Sprn expression plasmid and P. Seeburg for N-methyl-D-aspartate receptor subunit cDNAs. We thank S. Sodi for assistance with mouse husbandry. We thank E. Folta-Stogniew for SEC, and C. Rahner and M. Graham for electron microscopy. J.L. is a Brown-Coxe Postdoctoral Fellow, J.W.G. is supported by NIH Medical Scientist training Program grant 5T32GN07205, and S. M. S. is a member of the Kavli Institute for Neuroscience at Yale University. This work was supported by research grants from the Falk Medical Research Trust and the NIH to S. M. S. The SEC was supported by a NIDA-funded Neuroproteomic Center.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Folta-Stogniew Ewa, 2006, V328, P97; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130	37	1213	1269	3	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1128	U84		10.1038/nature07761	http://dx.doi.org/10.1038/nature07761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242475	Green Accepted			2022-12-28	WOS:000263680100040
J	Mammoto, A; Connor, KM; Mammoto, T; Yung, CW; Huh, D; Aderman, CM; Mostoslavsky, G; Smith, LEH; Ingber, DE				Mammoto, Akiko; Connor, Kip M.; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Aderman, Christopher M.; Mostoslavsky, Gustavo; Smith, Lois E. H.; Ingber, Donald E.			A mechanosensitive transcriptional mechanism that controls angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-SHAPE; EXTRACELLULAR-MATRIX; RETINAL NEOVASCULARIZATION; LINEAGE SPECIFICATION; CYTOSKELETAL TENSION; REGULATORY NETWORKS; GEOMETRIC CONTROL; TFII-I; VEGF	Angiogenesis is controlled by physical interactions between cells and extracellular matrix as well as soluble angiogenic factors, such as VEGF. However, the mechanism by which mechanical signals integrate with other microenvironmental cues to regulate neovascularization remains unknown. Here we show that the Rho inhibitor, p190RhoGAP (also known as GRLF1), controls capillary network formation in vitro in human microvascular endothelial cells and retinal angiogenesis in vivo by modulating the balance of activities between two antagonistic transcription factors, TFII-I (also known as GTF2I) and GATA2, that govern gene expression of the VEGF receptor VEGFR2 (also known as KDR). Moreover, this new angiogenesis signalling pathway is sensitive to extracellular matrix elasticity as well as soluble VEGF. This is, to our knowledge, the first known functional cross-antagonism between transcription factors that controls tissue morphogenesis, and that responds to both mechanical and chemical cues.	[Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Dept Surg, Boston, MA 02115 USA; [Connor, Kip M.; Aderman, Christopher M.; Smith, Lois E. H.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Mostoslavsky, Gustavo] Harvard Univ, Sch Med, Harvard Inst Med, Dept Genet, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Ingber, DE (corresponding author), Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA.	donald.ingber@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019; Huh, Dong Eun/J-5715-2012; Huh, Dongeun/I-4152-2013	Connor, Kip/0000-0002-2048-9080; Mostoslavsky, Gustavo/0000-0002-0784-2169	NIH; V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award; American Heart Association; Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award(Research to Prevent Blindness (RPB)); American Heart Association(American Heart Association); Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Polte, E. Pravda, M. de Bruijn and K. Johnson for their technical suggestions and assistance, T. Nakano and H. Sabe for providing plasmids, the National Institutes of Health (NIH) for providing VEGF, and D. Weitz for providing assistance with rheometry measurements. This work was supported by funds from the NIH (to D. E. I., L. E. H. S. and K. M. C.), V. Kann Rasmussen Foundation (to L. E. H. S.), Children's Hospital Mental Retardation and Developmental Disabilities Research Center (to L. E. H. S.), a Research to Prevent Blindness Lew Wasserman Merit Award (to L. E. H. S.), American Heart Association (to A. M.), and a Children's Hospital House Officer Development Award (to A. M.); D. E. I. is a recipient of a DoD Breast Cancer Innovator Award.	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Robinson CJ, 2001, J CELL SCI, V114, P853; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Sheibani N, 1998, MOL BIOL CELL, V9, P701, DOI 10.1091/mbc.9.4.701; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wong CG, 2001, CURR EYE RES, V22, P140, DOI 10.1076/ceyr.22.2.140.5528; Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431	47	389	408	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1103	U57		10.1038/nature07765	http://dx.doi.org/10.1038/nature07765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242469	Green Accepted			2022-12-28	WOS:000263680100034
J	Tricoci, P; Allen, JM; Kramer, JM; Califf, RM; Smith, SC				Tricoci, Pierluigi; Allen, Joseph M.; Kramer, Judith M.; Califf, Robert M.; Smith, Sidney C., Jr.			Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; ACUTE MYOCARDIAL-INFARCTION; PERIOPERATIVE CARDIOVASCULAR EVALUATION; ACUTE CORONARY SYNDROMES; CHRONIC HEART-FAILURE; CHRONIC STABLE ANGINA; ACC AHA GUIDELINES; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; CARDIAC-CATHETERIZATION	Context The joint cardiovascular practice guidelines of the American College of Cardiology ( ACC) and the American Heart Association ( AHA) have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. Objective To describe the evolution of recommendations in ACC/ AHA cardiovascular guidelines and the distribution of recommendations across classes of recommendations and levels of evidence. Data Sources and Study Selection Data from all ACC/ AHA practice guidelines issued from 1984 to September 2008 were abstracted by personnel in the ACC Science and Quality Division. Fifty- three guidelines on 22 topics, including a total of 7196 recommendations, were abstracted. Data Extraction The number of recommendations and the distribution of classes of recommendation ( I, II, and III) and levels of evidence ( A, B, and C) were determined. The subset of guidelines that were current as of September 2008 was evaluated to describe changes in recommendations between the first and current versions as well as patterns in levels of evidence used in the current versions. Results Among guidelines with at least 1 revision or update by September 2008, the number of recommendations increased from 1330 to 1973 ( + 48%) from the first to the current version, with the largest increase observed in use of class II recommendations. Considering the 16 current guidelines reporting levels of evidence, only 314 recommendations of 2711 total are classified as level of evidence A ( median, 11%), whereas 1246 ( median, 48%) are level of evidence C. Level of evidence significantly varies across categories of guidelines ( disease, intervention, or diagnostic) and across individual guidelines. Recommendations with level of evidence A are mostly concentrated in class I, but only 245 of 1305 class I recommendations have level of evidence A ( median, 19%). Conclusions Recommendations issued in current ACC/ AHA clinical practice guidelines are largely developed from lower levels of evidence or expert opinion. The proportion of recommendations for which there is no conclusive evidence is also growing. These findings highlight the need to improve the process of writing guidelines and to expand the evidence base from which clinical practice guidelines are derived.	[Tricoci, Pierluigi] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Tricoci, Pierluigi; Califf, Robert M.] Duke Univ, Div Cardiol, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Div Gen Internal Med, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Duke Ctr Educ & Res Therapeut, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27705 USA; [Allen, Joseph M.] Amer Coll Cardiol Sci, Washington, DC USA; [Allen, Joseph M.] Qual Div, Washington, DC USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; American College of Cardiology; University of North Carolina; University of North Carolina Chapel Hill	Tricoci, P (corresponding author), Duke Univ, Duke Clin Res Inst, 2400 Pratt St,Room 0311,Terrace Level, Durham, NC 27705 USA.	trico001@dcri.duke.edu			Agency for Healthcare Research and Quality [U18HS010548]; Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010548] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant U18HS010548 from the Agency for Healthcare Research and Quality. Dr Smith's efforts in this work were supported by a Distinguished Scholarship from the Rose Azus Cardiac Research Education Fund, Sharp Hospital Foundation, San Diego, California.	*ACC AHA SUBC NUCL, 1986, J AM COLL CARDIOL, V8, P1471; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 2001, CIRCULATION, V104, P2118; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Armstrong PW, 2003, HEART, V89, P349, DOI 10.1136/heart.89.3.349; Bassand JP, 2008, EUR HEART J SUPPL, V10, pC22, DOI 10.1093/eurheartj/sun001; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Califf RM, 2007, EUR HEART J SUPPL, V9, pB8, DOI 10.1093/eurheartj/sum002; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Dubois Robert W, 2006, Dis Manag, V9, P210, DOI 10.1089/dis.2006.9.210; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Eagle KA, 1996, J AM COLL CARDIOL, V27, P910; Eagle Kim A, 2004, Circulation, V110, pe340; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; Field MJ., 1992, GUIDELINES CLIN PRAC; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; FORCINITO M, 1991, J AM COLL CARDIOL, V18, P1, DOI 10.1016/S0735-1097(10)80209-8; FORCINITO M, 1989, J AM COLL CARDIOL, V14, P1827; FORCINITO M, 1990, J AM COLL CARDIOL, V16, P1505; Frye R L, 1984, Circulation, V70, p331A; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; Gunnar R M, 1990, Circulation, V82, P664; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KIRKLIN JW, 1991, CIRCULATION, V83, P1125; Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/j.jacc.2003.08.011; KNOEBEL SB, 1989, J AM COLL CARDIOL, V13, P249, DOI 10.1016/0735-1097(89)90578-0; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Manchanda Puneet, 2005, Yale J Health Policy Law Ethics, V5, P785; McMurray J, 2006, EUR HEART J, V27, P1773, DOI 10.1093/eurheartj/ehl123; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; PEPINE CJ, 1991, CIRCULATION, V84, P2213, DOI 10.1161/01.CIR.84.5.2213; RITCHIE JL, 1995, J AM COLL CARDIOL, V25, P521, DOI 10.1016/0735-1097(95)90027-6; RYAN TJ, 1993, CIRCULATION, V88, P2987, DOI 10.1161/01.CIR.88.6.2987; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SCHLANT RC, 1992, J AM COLL CARDIOL, V19, P473; SCHLANT RC, 1986, CIRCULATION, V74, pA653; Shea AM, 2007, AM J MED QUAL, V22, P170, DOI 10.1177/1062860607300291; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Sood R, 2007, NETH J MED, V65, P167; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; Tunis SR, 2007, HEALTH AFFAIR, V26, pW500, DOI 10.1377/hlthaff.26.4.w500; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *US FOOD DRUG ADM, FDA DUK LAUNCH PUBL; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; ZIPES DP, 1995, J AM COLL CARDIOL, V26, P555, DOI 10.1016/0735-1097(95)80037-H; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	80	644	659	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					831	841		10.1001/jama.2009.205	http://dx.doi.org/10.1001/jama.2009.205			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244190	Bronze, Green Published			2022-12-28	WOS:000263609900024
J	Freedland, J				Freedland, Jonathan			Commentary: Toughen up	BRITISH MEDICAL JOURNAL			English	Editorial Material									Guardian, London N1 9GU, England		Freedland, J (corresponding author), Guardian, London N1 9GU, England.	freedland@guardian.co.uk						*BTSEL, STAT FAT; BUTT R, 2009, GUARDIAN        0127; Clarfield AM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b722; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b500; *IND LOND, 2009, ACT DISR ISR PR OP; INGRAMS R, 2003, GUARDIAN; O'Donnell M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2094; Sabbagh K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a2066; Summerfield D, 2004, BRIT MED J, V329, P924, DOI 10.1136/bmj.329.7471.924	9	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2009	338								b524	10.1136/bmj.b524	http://dx.doi.org/10.1136/bmj.b524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19244223				2022-12-28	WOS:000264056100008
J	Cruz, JA; Westhof, E				Cruz, Jose Almeida; Westhof, Eric			The Dynamic Landscapes of RNA Architecture	CELL			English	Article							GROUP-II INTRON; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; INDUCED FIT; TRANSCRIPTION; RIBOSWITCH; KINETICS; RIBOZYME; INTERMEDIATE; CATALYSIS	A wealth of information on RNA folding and ribonucleoprotein assembly has emerged from analyses of structures and from the use of innovative biophysical tools. Although integrating data obtained from static structures with dynamic measurements presents major challenges, such efforts are opening new vistas on the RNA folding landscape.	[Cruz, Jose Almeida; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.	e.westhof@ibmc.u-strasbg.fr		Almeida Cruz, Jose/0000-0003-1425-1444				Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Breaker RR, 2008, SCIENCE, V319, P1795, DOI 10.1126/science.1152621; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Geis M, 2008, J MOL BIOL, V379, P160, DOI 10.1016/j.jmb.2008.02.064; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Jackson SA, 2006, RNA, V12, P2149, DOI 10.1261/rna.184206; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Pereira MJB, 2008, J MOL BIOL, V382, P496, DOI 10.1016/j.jmb.2008.07.020; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; STEINER M, 2008, NATL ACAD SCI US, V105, P13853; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Waldsich C, 2008, J MOL BIOL, V375, P572, DOI 10.1016/j.jmb.2007.10.052; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601	31	226	232	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					604	609		10.1016/j.cell.2009.02.003	http://dx.doi.org/10.1016/j.cell.2009.02.003			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239882	Bronze			2022-12-28	WOS:000263688200012
J	Michael, PJ; Cheadle, MJ				Michael, Peter J.; Cheadle, Michael J.			GEOCHEMISTRY Making a Crust	SCIENCE			English	Editorial Material							LOWER OCEANIC-CRUST; SW INDIAN RIDGE; TI-IN-ZIRCON; ATLANTIS BANK		[Michael, Peter J.] Univ Tulsa, Dept Geosci, Tulsa, OK 74104 USA; [Cheadle, Michael J.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA	University of Tulsa; University of Wyoming	Michael, PJ (corresponding author), Univ Tulsa, Dept Geosci, Tulsa, OK 74104 USA.	pjm@utulsa.edu; cheadle@uwyo.edu		Michael, Peter/0000-0003-2829-9502				Baines AG, 2008, EARTH PLANET SC LETT, V273, P105, DOI 10.1016/j.epsl.2008.06.013; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Coogan LA, 2007, J PETROL, V48, P2211, DOI 10.1093/petrology/egm057; Coogan LA, 2006, GEOLOGY, V34, P633, DOI 10.1130/G22737.1; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Fu B, 2008, CONTRIB MINERAL PETR, V156, P197, DOI 10.1007/s00410-008-0281-5; Grimes CB, 2007, GEOLOGY, V35, P643, DOI 10.1130/G23603A.1; Hooft EEE, 1996, EARTH PLANET SC LETT, V142, P289, DOI 10.1016/0012-821X(96)00101-X; John BE, 2004, EARTH PLANET SC LETT, V222, P145, DOI 10.1016/j.epsl.2004.02.014; Lissenberg CJ, 2009, SCIENCE, V323, P1048, DOI 10.1126/science.1167330; Schwartz JJ, 2005, SCIENCE, V310, P654, DOI 10.1126/science.1116349	11	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1017	1018		10.1126/science.1169556	http://dx.doi.org/10.1126/science.1169556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229024				2022-12-28	WOS:000263478400026
J	Moore, MJ; Proudfoot, NJ				Moore, Melissa J.; Proudfoot, Nick J.			Pre-mRNA Processing Reaches Back to Transcription and Ahead to Translation	CELL			English	Review							EXON-JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; POLYMERASE-II TRANSCRIPTS; C-TERMINAL DOMAIN; GENE-EXPRESSION; SR PROTEINS; IN-VIVO; CYTOPLASMIC LOCALIZATION; CAENORHABDITIS-ELEGANS; UPF1 PHOSPHORYLATION	The pathway from gene activation in the nucleus to mRNA translation and decay at specific locations in the cytoplasm is both streamlined and highly interconnected. This review discusses how pre-mRNA processing, including 50 cap addition, splicing, and polyadenylation, contributes to both the efficiency and fidelity of gene expression. The connections of pre-mRNA processing to upstream events in transcription and downstream events, including translation and mRNA decay, are elaborate, extensive, and remarkably interwoven.	[Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, 364 Plantat St, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu; nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222	Wellcome Trust; Howard Hughes Medical Institute	Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Thanks to N. Gromak and H. Mischo for help with preparing this review. The N. J. P. lab is supported by a Program grant from the Wellcome Trust. The M. J. M. lab is supported by the Howard Hughes Medical Institute.	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Casolari JM, 2004, TRENDS CELL BIOL, V14, P222, DOI 10.1016/j.tcb.2004.03.007; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Custodio N, 2004, RNA, V10, P622, DOI 10.1261/rna.5258504; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Manley JL, 2002, NAT STRUCT BIOL, V9, P790, DOI 10.1038/nsb1102-790; Marcello A, 2004, GENE, V326, P1, DOI 10.1016/j.gene.2003.10.018; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morlando M, 2004, EMBO J, V23, P2392, DOI 10.1038/sj.emboj.7600254; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Palacios IM, 2002, CURR BIOL, V12, pR50, DOI 10.1016/S0960-9822(01)00671-6; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rosner A, 2007, CURR MED CHEM, V14, P2517, DOI 10.2174/092986707782023677; Rosonina E, 2005, MOL CELL, V20, P167, DOI 10.1016/j.molcel.2005.10.004; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Wu WH, 1999, GENETICS, V153, P643; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	131	637	652	2	135	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					688	700		10.1016/j.cell.2009.02.001	http://dx.doi.org/10.1016/j.cell.2009.02.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239889	Bronze			2022-12-28	WOS:000263688200019
J	Park, S; Lee, DH; Xu, J; Kim, B; Hong, SW; Jeong, U; Xu, T; Russell, TP				Park, Soojin; Lee, Dong Hyun; Xu, Ji; Kim, Bokyung; Hong, Sung Woo; Jeong, Unyong; Xu, Ting; Russell, Thomas P.			Macroscopic 10-Terabit-per-Square- Inch Arrays from Block Copolymers with Lateral Order	SCIENCE			English	Article							THIN-FILMS; BOTTOM-UP; LITHOGRAPHY; GRAPHOEPITAXY; TEMPLATES; SURFACES; ROUTE	Generating laterally ordered, ultradense, macroscopic arrays of nanoscopic elements will revolutionize the microelectronic and storage industries. We used faceted surfaces of commercially available sapphire wafers to guide the self- assembly of block copolymer microdomains into oriented arrays with quasi- long- range crystalline order over arbitrarily large wafer surfaces. Ordered arrays of cylindrical microdomains 3 nanometers in diameter, with areal densities in excess of 10 terabits per square inch, were produced. The sawtoothed substrate topography provides directional guidance to the self- assembly of the block copolymer, which is tolerant of surface defects, such as dislocations. The lateral ordering and lattice orientation of the single- grain arrays of microdomains are maintained over the entire surface. The approach described is parallel, applicable to different substrates and block copolymers, and opens a versatile route toward ultrahigh- density systems.	[Xu, Ting] Univ Calif Berkeley, Dept Mat Sci & Engn, Dept Chem, Berkeley, CA 94720 USA; [Xu, Ting] Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA; [Park, Soojin; Lee, Dong Hyun; Xu, Ji; Kim, Bokyung; Hong, Sung Woo; Russell, Thomas P.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Jeong, Unyong] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Massachusetts System; University of Massachusetts Amherst; Yonsei University	Xu, T (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Dept Chem, Berkeley, CA 94720 USA.	tingxu@berkeley.edu; russell@mail.pse.umass.edu	Park, Soojin/E-5899-2010; Jeong, Unyong/R-7436-2019; Russell, Thomas Paul/ADL-3689-2022	Park, Soojin/0000-0003-3878-6515; Russell, Thomas Paul/0000-0001-6384-5826	U.S. Department of Energy (DOE) [DE-FG-0296ER45612, DE-FG-0296ER42126, DE-AC02-05CH11231]; NSF-supported Materials Research Science and Engineering Center [DMR-0820506]; Nanoscale Science and Engineering Center [DMI-0531171]; University of Massachusetts, Amherst; DOE; Office of Science; Office of Basic Energy Sciences [DE-AC02-05CH11231]; Korea Science and Engineering Foundation [R11-2007-05002004-0]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF-supported Materials Research Science and Engineering Center(National Science Foundation (NSF)); Nanoscale Science and Engineering Center; University of Massachusetts, Amherst; DOE(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the U.S. Department of Energy (DOE) under contracts DE-FG-0296ER45612 (to T.P.R., S.P., and S.H.), DE-FG-0296ER42126 (T.P.R.), and DE-AC02-05CH11231 (T.X.); by the NSF-supported Materials Research Science and Engineering Center [DMR-0820506 (J.X. and B.K.); and by the Nanoscale Science and Engineering Center (DMI-0531171 (D.L.)] at the University of Massachusetts, Amherst. Use of the Advanced Light Source, Berkeley National Laboratory, was supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-05CH11231. U.J. acknowledges the support of the Korea Science and Engineering Foundation through grant R11-2007-05002004-0. The authors are also most indebted to the insightful comments of one referee whose persistence substantially enhanced our arguments.	Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bita I, 2008, SCIENCE, V321, P939, DOI 10.1126/science.1159352; Cheng JY, 2004, NAT MATER, V3, P823, DOI 10.1038/nmat1211; Fasolka MJ, 1997, PHYS REV LETT, V79, P3018, DOI 10.1103/PhysRevLett.79.3018; Fredrickson GH, 1996, ANNU REV MATER SCI, V26, P501, DOI 10.1146/annurev.ms.26.080196.002441; Gabai R, 2007, ADV MATER, V19, P1325, DOI 10.1002/adma.200601625; Hawker CJ, 2005, MRS BULL, V30, P952, DOI 10.1557/mrs2005.249; Hexemer A, 2005, MACROMOLECULES, V38, P7083, DOI 10.1021/ma050286y; Huth M, 2002, ADV FUNCT MATER, V12, P333, DOI 10.1002/1616-3028(20020517)12:5<333::AID-ADFM333>3.0.CO;2-C; Kim SH, 2004, ADV MATER, V16, P226, DOI 10.1002/adma.200304906; LAMBOOY P, 1994, PHYS REV LETT, V72, P2899, DOI 10.1103/PhysRevLett.72.2899; LAZZARI M, 2006, BLOCK COPOLYMERS NAN, pCH9; Lee B, 2005, MACROMOLECULES, V38, P4311, DOI 10.1021/ma047562d; Li HW, 2004, NANO LETT, V4, P1633, DOI 10.1021/nl049209r; Park S, 2008, NANO LETT, V8, P1667, DOI 10.1021/nl0805110; Park S, 2008, ACS NANO, V2, P766, DOI 10.1021/nn7004415; Park S, 2008, ADV MATER, V20, P681, DOI 10.1002/adma.200701997; Rockford L, 1999, PHYS REV LETT, V82, P2602, DOI 10.1103/PhysRevLett.82.2602; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; Segalman RA, 2003, MACROMOLECULES, V36, P3272, DOI 10.1021/ma021367m; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Soles CL, 2008, SCIENCE, V322, P689, DOI 10.1126/science.1165174; Stein GE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.086101; Tang CB, 2008, SCIENCE, V322, P429, DOI 10.1126/science.1162950; WALTON DG, 1994, MACROMOLECULES, V27, P6225, DOI 10.1021/ma00099a045; Xu T, 2003, ADV FUNCT MATER, V13, P698, DOI 10.1002/adfm.200304374	26	663	679	1	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1030	1033		10.1126/science.1168108	http://dx.doi.org/10.1126/science.1168108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229031				2022-12-28	WOS:000263478400033
J	Sharp, PA				Sharp, Phillip A.			The Centrality of RNA	CELL			English	Article							GENE; TRANSCRIPTION; INTERFERENCE; ARGONAUTE; DNA	New roles for RNAs in biology continue to emerge, and a glance at the history of RNAs may prepare molecular biologists for future discoveries about these powerful molecules. A striking new role for RNAs is their widespread involvement in the regulation of numerous genes, suggesting that there is much yet to discover about these amazing cellular components.	[Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu						Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	25	298	307	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					577	580		10.1016/j.cell.2009.02.007	http://dx.doi.org/10.1016/j.cell.2009.02.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239877	Bronze, Green Published			2022-12-28	WOS:000263688200007
J	Montalescot, G; Wiviott, SD; Brounwald, E; Murphy, SA; Gibson, CM; McCabe, CH; Antman, EM				Montalescot, Gilles; Wiviott, Stephen D.; Brounwald, Eugene; Murphy, Sabina A.; Gibson, C. Michael; McCabe, Carolyn H.; Antman, Elliott M.		TRITON-TIMI 38 Investigators	Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial	LANCET			English	Article							ORAL ANTIPLATELET THERAPY; PLATELET INHIBITION; STENT THROMBOSIS; UNCOATED STENTS; ASPIRIN; TICLOPIDINE; ABCIXIMAB; SAFETY; ANTICOAGULATION; THROMBOLYSIS	Background Mechanical reperfusion with stenting for ST-elevation myocardial infarction (STEMI) is supported by dual antiplatelet treatment with aspirin and clopidogrel. Prasugrel, a potent and rapid-acting thienopyridine, is a potential alternative to clopidogrel. We aimed to assess prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention (PCI) for STEMI. Methods We under-took a double-blind, randomised controlled trial in 707 sites in 30 countries. 3534 participants presenting with STEMI were randomly assigned by interactive voice response system either prasugrel (60 mg loading, 10 mg maintenance [n=1769]) or clopidogrel (300 mg loading, 75 mg maintenance [n=1765]) and were unaware of the allocation. The primary endpoint was cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke. Efficacy analyses were by intention to treat. Follow-up was to 15 months, with secondary analyses at 30 days. This trial is registered with ClinicalTrials.gov, number NCT00097591. Findings At 30 days, 115 (6.5%) individuals assigned prasugrel had met the primary endpoint compared with 166 (9.5%) allocated clopidogrel (hazard ratio 0.68 [95% Cl 0.54-0.87]; p=0.0017). This effect continued to 15 months (174 [10.0%] vs 216 [12.4%]; 0.79 [0.65-0.97]; p=0.0221). The key secondary endpoint of cardiovascular death, myocardial infarction, or urgent target vessel revascularisation was also significantly reduced with prasugrel at 30 days (0.75 [0.59-0.96]; p=0.0205) and 15 months (0.79 [0.65-0.97]; p=0.0250), as was stent thrombosis. Treatments did not differ with respect to thrombolysis in myocardial infarction (TIMI) major bleeding unrelated to coronary-artery bypass graft (CABG) surgery at 30 days (p=0.3359) and 15 months (p=0.6451). TIMI life-threatening bleeding and TIMI major or minor bleeding were also similar with the two treatments, and only TIMI major bleeding after CABG surgery was significantly increased with prasugrel (p=0.0033). Interpretation In patients with STEMI undergoing PCI, prasugrel is more effective than clopidogrel for prevention of ischaemic events, without an apparent excess in bleeding.	[Montalescot, Gilles] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, INSERM,Inst Cardiol,U856, F-75013 Paris, France; [Wiviott, Stephen D.; Brounwald, Eugene; Murphy, Sabina A.; Gibson, C. Michael; McCabe, Carolyn H.; Antman, Elliott M.] Brigham & Womens Hosp, Dept Med, Div Cardiol, TIMI Study Grp, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital	Montalescot, G (corresponding author), Univ Paris 06, Pitie Salpetriere Hosp, AP HP, INSERM,Inst Cardiol,U856, Bur 236,437 Boul Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Wiviott, Stephen/HIK-2534-2022; Gibson, C. Michael/AAE-8212-2019		Daiichi Sankyo; Eli Lilly	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly)	The TRITON-TIMI 38 trial is supported by Daiichi Sankyo and Eli Lilly.	Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antoniucci D, 2003, J AM COLL CARDIOL, V42, P1879, DOI 10.1016/j.jacc.2003.07.017; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Maree AO, 2007, CIRCULATION, V115, P2196, DOI 10.1161/CIRCULATIONAHA.106.675991; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Neumann FJ, 2000, J AM COLL CARDIOL, V35, P915, DOI 10.1016/S0735-1097(99)00635-X; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sabatine MS, 2007, J AM COLL CARDIOL, V49, P2256, DOI 10.1016/j.jacc.2007.01.092; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Urban P, 1998, CIRCULATION, V98, P2126, DOI 10.1161/01.CIR.98.20.2126; Van de Werf F, 2006, NEW ENGL J MED, V355, P1169, DOI 10.1056/NEJMe068165; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Wolfram RM, 2006, AM J CARDIOL, V97, P984, DOI 10.1016/j.amjcard.2005.10.064; Zeymer U, 2007, CARDIOLOGY, V108, P265, DOI 10.1159/000096988	32	826	863	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					723	731		10.1016/S0140-6736(09)60441-4	http://dx.doi.org/10.1016/S0140-6736(09)60441-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249633				2022-12-28	WOS:000263725400031
J	Cook, PJ; Ju, BG; Telese, F; Wang, XT; Glass, CK; Rosenfeld, MG				Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Glass, Christopher K.; Rosenfeld, Michael G.			Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HISTONE H2AX; EYES ABSENT; GENOMIC INSTABILITY; SIGNALING PATHWAYS; CELLULAR-RESPONSE; DROSOPHILA EYE; IN-VIVO; PROTEIN	Life and death fate decisions allow cells to avoid massive apoptotic death in response to genotoxic stress. Although the regulatory mechanisms and signalling pathways controlling DNA repair and apoptosis are well characterized, the precise molecular strategies that determine the ultimate choice of DNA repair and survival or apoptotic cell death remain incompletely understood. Here we report that a protein tyrosine phosphatase, EYA, is involved in promoting efficient DNA repair rather than apoptosis in response to genotoxic stress in mammalian embryonic kidney cells by executing a damage-signal-dependent dephosphorylation of an H2AX carboxy-terminal tyrosine phosphate (Y142). This post-translational modification determines the relative recruitment of either DNA repair or pro-apoptotic factors to the tail of serine phosphorylated histone H2AX (gamma-H2AX) and allows it to function as an active determinant of repair/survival versus apoptotic responses to DNA damage, revealing an additional phosphorylation-dependent mechanism that modulates survival/apoptotic decisions during mammalian organogenesis.	[Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Cook, Peter J.] Univ Calif San Diego, Sch Med, Dept Biol Grad Program, La Jolla, CA 92093 USA; [Ju, Bong Gun] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Sogang University; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; xiangting, wang/P-1010-2014	Glass, Christopher/0000-0003-4344-3592; xiangting, wang/0000-0003-2106-3425; Telese, Francesca/0000-0003-3877-0628	NIH; NCI; Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Kastan for providing reagents/technical assistance for the I-PpoI system. We thank V. Lunyak, J. Dixon and R. Koladner for review and discussions. We thank the laboratory of R. S. Johnson for use of equipment and advice on hypoxia incubations, as well as H. Taylor for animal care assistance and C. Nelson for cell culture assistance. We thank A. Nussenzweig, Y. Xu and H. Song for H2ax 2/2 MEFs. We thank J. Hightower and M. Fisher for assistance with figure and manuscript preparation. We additionally thank X. Li and W. Liu. M. G. R. is an HHMI Investigator. This work was supported by grants from NIH and NCI to M. G. R. and C. K. G. This work also was supported by the Sogang University Research Grant of 2008 to B. G. J and PCF and USAMRAA grants to M. G. R.	Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Karagiannis TC, 2007, LEUKEMIA, V21, P195, DOI 10.1038/sj.leu.2404478; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sambrook J., 2001, MOL CLONING LAB MANU; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	35	388	414	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					591	U53		10.1038/nature07849	http://dx.doi.org/10.1038/nature07849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19234442	Green Accepted, Green Submitted			2022-12-28	WOS:000264796200032
J	Truscott, R				Truscott, Ryan			Feature International Health Zimbabwe's health challenges	BRITISH MEDICAL JOURNAL			English	Editorial Material												truscottryan@hotmail.com						ROELF W, 2009, REUTERS         0220; SHAW A, 2008, ZIMBABWE DOCTORS ADV; SHOKO B, 2009, ZIMBABWE STANDA 0228; Zimbabwe Association of Doctors for Human Rights, 2009, CHOL TIM HLTH SYST C	4	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2009	338								b930	10.1136/bmj.b930	http://dx.doi.org/10.1136/bmj.b930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NT	19289414				2022-12-28	WOS:000264435700007
J	Carabello, BA; Paulus, WJ				Carabello, Blase A.; Paulus, Walter J.			Aortic stenosis	LANCET			English	Review							PRESSURE-OVERLOAD HYPERTROPHY; DIASTOLIC HEART-FAILURE; VALVE-REPLACEMENT; NATRIURETIC PEPTIDE; VENTRICULAR HYPERTROPHY; CARDIAC-HYPERTROPHY; NATURAL-HISTORY; RISK-FACTORS; PROGRESSION; GRADIENT	In developed countries, aortic stenosis is the most prevalent of all valvular heart diseases. A manifestation of ageing, the disorder is becoming more frequent as the average age of the population increases. Symptomatic severe disease is universally fatal if left untreated yet is consistent with a typical lifespan when mechanical relief of the stenosis is provided in a timely fashion. Management of mild disease, severe asymptomatic disease, and far advanced disease, and the effect of new percutaneous treatments, provide both controversy and exciting promise to care of patients with aortic stenosis. We discuss these issues in this Review.	[Carabello, Blase A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Carabello, Blase A.] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Paulus, Walter J.] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vrije Universiteit Amsterdam	Carabello, BA (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	blasec@bcm.tmc.edu						Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089; Ando T, 1996, CHEST, V110, P462, DOI 10.1378/chest.110.2.462; Aronow WS, 2001, AM J CARDIOL, V88, P693, DOI 10.1016/S0002-9149(01)01821-5; ASSEY ME, 1993, CATHETER CARDIO DIAG, V30, P287, DOI 10.1002/ccd.1810300405; Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; BREISCH EA, 1984, LAB INVEST, V51, P333; Briand M, 2006, J AM COLL CARDIOL, V47, P2229, DOI 10.1016/j.jacc.2005.12.073; BROGAN WC, 1993, J AM COLL CARDIOL, V21, P1657, DOI 10.1016/0735-1097(93)90383-C; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; Buermans HPJ, 2005, EUR HEART J, V26, P1697, DOI 10.1093/eurheartj/ehi344; Burwash IG, 2007, CURR OPIN CARDIOL, V22, P84, DOI 10.1097/HCO.0b013e32801466f5; CARABELLO BA, 1980, CIRCULATION, V62, P42, DOI 10.1161/01.CIR.62.1.42; Carabello BA, 1994, CARDIOLOGY PEARLS; CARABELLO BA, 2003, CURRENT DIAGNOSIS TR, P108; Choo SJ, 1999, J HEART VALVE DIS, V8, P407; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Connolly HM, 2000, CIRCULATION, V101, P1940, DOI 10.1161/01.CIR.101.16.1940; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Das P, 2005, EUR HEART J, V26, P1309, DOI 10.1093/eurheartj/ehi250; DAVIES SW, 1991, EUR HEART J, V12, P10, DOI 10.1093/oxfordjournals.eurheartj.a059815; DONNER R, 1983, AM J CARDIOL, V51, P946, DOI 10.1016/S0002-9149(83)80171-4; FOLLAND ED, 1984, J AM COLL CARDIOL, V4, P1207, DOI 10.1016/S0735-1097(84)80139-4; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; GAASCH WH, 1990, CIRCULATION, V81, P1644, DOI 10.1161/01.CIR.81.5.1644; Garcia D, 2006, J HEART VALVE DIS, V15, P601; Gehlot A, 1996, J THORAC CARDIOV SUR, V111, P1026, DOI 10.1016/S0022-5223(96)70379-3; GORLIN R, 1951, AM HEART J, V41, P1, DOI 10.1016/0002-8703(51)90002-6; Gould KL, 2003, CIRCULATION, V107, P3121, DOI 10.1161/01.CIR.0000074243.02378.80; Grossman W, 1975, J CLIN INVEST, V53, P332; GUNTHER S, 1979, CIRCULATION, V59, P679, DOI 10.1161/01.CIR.59.4.679; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; HESS OM, 1984, CIRCULATION, V69, P855, DOI 10.1161/01.CIR.69.5.855; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Horwich TB, 2006, J AM COLL CARDIOL, V47, P85, DOI 10.1016/j.jacc.2005.08.050; HUBER D, 1981, CIRCULATION, V64, P126, DOI 10.1161/01.CIR.64.1.126; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; KEANE JF, 1993, CIRCULATION, V87, P16; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; KHOT UN, 2005, NEW ENGL J MED, V348, P1756; Koide M, 1997, CIRCULATION, V95, P1601; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lichtenstein SV, 2006, CIRCULATION, V114, P591, DOI 10.1161/CIRCULATIONAHA.106.632927; Lim P, 2004, EUR HEART J, V25, P2048, DOI 10.1016/j.ehj.2004.09.033; LINDBLOM D, 1990, J AM COLL CARDIOL, V15, P566, DOI 10.1016/0735-1097(90)90627-2; MARCUS ML, 1982, NEW ENGL J MED, V307, P1362, DOI 10.1056/NEJM198211253072202; MartinezRubio A, 1997, CIRCULATION, V96, P500; Mistiaen WP, 2001, J HEART VALVE DIS, V10, P354; Monin JL, 2003, CIRCULATION, V108, P319, DOI 10.1161/01.CIR.0000079171.43055.46; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; NAKANO K, 1989, CIRC RES, V65, P1555, DOI 10.1161/01.RES.65.6.1555; Nessmith MG, 2005, AM J CARDIOL, V96, P1445, DOI 10.1016/j.amjcard.2005.06.092; Ngo M V, 2001, Am J Geriatr Cardiol, V10, P86, DOI 10.1111/j.1076-7460.2001.00839.x; Nishimura RA, 2002, CIRCULATION, V106, P809, DOI 10.1161/01.CIR.0000025611.21140.34; Novaro GM, 2001, CIRCULATION, V104, P2205, DOI 10.1161/hc4301.098249; Ohara T, 2005, CIRC J, V69, P1535, DOI 10.1253/circj.69.1535; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; OTTO CM, 1994, CIRCULATION, V89, P642, DOI 10.1161/01.CIR.89.2.642; Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497; PAULUS WJ, 1991, J AM COLL CARDIOL, V17, P1263, DOI 10.1016/S0735-1097(10)80133-0; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G; Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072; Pibarot P, 2007, CAN J CARDIOL, V23, p40B, DOI 10.1016/S0828-282X(07)71009-7; Popovic ZB, 2005, AM J PHYSIOL-HEART C, V288, pH416, DOI 10.1152/ajpheart.00615.2004; Quere JP, 2006, CIRCULATION, V113, P1738, DOI 10.1161/CIRCULATIONAHA.105.568824; RAHIMTOOLA SH, 1994, J AM COLL CARDIOL, V23, P1076, DOI 10.1016/0735-1097(94)90593-2; Rajamannan NM, 2004, CIRCULATION, V110, P1180, DOI 10.1161/01.CIR.0000140722.85490.EA; Rajappan K, 2003, CIRCULATION, V107, P3170, DOI 10.1161/01.CIR.0000074211.28917.31; RICHARDS AM, 1984, LANCET, V2, P1113; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J MED, V49, P151, DOI 10.1016/S0002-9343(70)80070-5; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Ross J Jr, 1968, Circulation, V38, P61; SCHWARTZ LS, 1969, AM J CARDIOL, V23, P647, DOI 10.1016/0002-9149(69)90025-3; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; SELZER A, 1987, NEW ENGL J MED, V317, P91, DOI 10.1056/NEJM198707093170206; Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031; Supino Phyllis G, 2006, Heart Fail Clin, V2, P379, DOI 10.1016/j.hfc.2006.09.010; Taylor HA, 2005, AM J CARDIOL, V95, P401, DOI 10.1016/j.amjcard.2004.09.043; Tseng EE, 1997, ANN SURG, V225, P793, DOI 10.1097/00000658-199706000-00017; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Weber M, 2006, HEART, V92, P1639, DOI 10.1136/hrt.2005.085506; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	94	496	517	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					956	966		10.1016/S0140-6736(09)60211-7	http://dx.doi.org/10.1016/S0140-6736(09)60211-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19232707				2022-12-28	WOS:000264158700036
J	Thukral, A; Khan, I; Tripathi, K				Thukral, Anubhav; Khan, Imran; Tripathi, Kamlakar			Slurred speech and spirochaetes	LANCET			English	Editorial Material							NEUROLEPTOSPIROSIS		[Thukral, Anubhav; Tripathi, Kamlakar] Banaras Hindu Univ, Inst Med Sci, Sir Sunderlal Hosp, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Khan, Imran] Banaras Hindu Univ, Inst Med Sci, Dept Anaesthesiol, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Thukral, A (corresponding author), Banaras Hindu Univ, Inst Med Sci, Sir Sunderlal Hosp, Dept Med, Varanasi 221005, Uttar Pradesh, India.	anubhavthukral@rediffmail.com						de Souza AL, 2006, INDIAN J MED RES, V124, P125; Mathew T, 2006, INDIAN J MED RES, V124, P155; Panicker JN, 2001, POSTGRAD MED J, V77, P589, DOI 10.1136/pmj.77.911.589; ROSS CAC, 1960, LANCET, V2, P1278; Speelman P, 2008, HARRISONS PRINCIPLES, P1048	5	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					978	978		10.1016/S0140-6736(09)60288-9	http://dx.doi.org/10.1016/S0140-6736(09)60288-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286094				2022-12-28	WOS:000264158700038
J	Wilson, TJ; Lilley, DMJ				Wilson, Timothy J.; Lilley, David M. J.			The Evolution of Ribozyme Chemistry	SCIENCE			English	Editorial Material							DELTA VIRUS RIBOZYME; ACTIVE-SITE; CRYSTAL-STRUCTURE; TRANSITION-STATE; CATALYTIC RNA; SPLICEOSOME; MECHANISM; GUANINE; INTRON; DOMAIN		[Wilson, Timothy J.; Lilley, David M. J.] Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, Dundee DD1 5EH, Scotland	University of Dundee	Wilson, TJ (corresponding author), Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.m.j.lilley@dundee.ac.uk			Biotechnology and Biological Sciences Research Council [B17092] Funding Source: Medline; Cancer Research UK [11722] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)		Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; Forconi M, 2008, BIOCHEMISTRY-US, V47, P6883, DOI 10.1021/bi800519a; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Klein DJ, 2007, J AM CHEM SOC, V129, P14858, DOI 10.1021/ja0768441; Lee TS, 2008, J AM CHEM SOC, V130, P3053, DOI 10.1021/ja076529e; LILLEY DMJ, 2008, RIBOYZMES RNA CATALY; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pena V, 2008, EMBO J, V27, P2929, DOI 10.1038/emboj.2008.209; Ritchie DB, 2008, NAT STRUCT MOL BIOL, V15, P1199, DOI 10.1038/nsmb.1505; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698	20	29	29	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1436	1438		10.1126/science.1169231	http://dx.doi.org/10.1126/science.1169231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286542				2022-12-28	WOS:000264101700026
J	Kamikouchi, A; Inagaki, HK; Effertz, T; Hendrich, O; Fiala, A; Gopfert, MC; Ito, K				Kamikouchi, Azusa; Inagaki, Hidehiko K.; Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.; Ito, Kei			The neural basis of Drosophila gravity-sensing and hearing	NATURE			English	Article							TRANSDUCTION CHANNEL; TRP CHANNELS; MELANOGASTER; EXPRESSION; MUTATIONS; PATHWAYS; CEREBELLUM; AUDITION; NEURONS; NUCLEI	The neural substrates that the fruitfly Drosophila uses to sense smell, taste and light share marked structural and functional similarities with ours, providing attractive models to dissect sensory stimulus processing. Here we focus on two of the remaining and less understood prime sensory modalities: graviception and hearing. We show that the fly has implemented both sensory modalities into a single system, Johnston's organ, which houses specialized clusters of mechanosensory neurons, each of which monitors specific movements of the antenna. Gravity- and sound-sensitive neurons differ in their response characteristics, and only the latter express the candidate mechanotransducer channel NompC. The two neural subsets also differ in their central projections, feeding into neural pathways that are reminiscent of the vestibular and auditory pathways in our brain. By establishing the Drosophila counterparts of these sensory systems, our findings provide the basis for a systematic functional and molecular dissection of how different mechanosensory stimuli are detected and processed.	[Kamikouchi, Azusa; Inagaki, Hidehiko K.; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa; Effertz, Thomas; Hendrich, Oliver; Goepfert, Martin C.] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany; [Kamikouchi, Azusa] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan; [Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.] Univ Gottingen, Johann Friedrich Blumenbach Inst, D-37073 Gottingen, Germany; [Fiala, Andre] Univ Wurzburg, Dept Genet & Neurobiol, Theodor Boveri Inst, D-97074 Wurzburg, Germany	University of Tokyo; University of Cologne; Tokyo University of Pharmacy & Life Sciences; University of Gottingen; University of Wurzburg	Ito, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	mgoepfe@gwdg.de; itokei@iam.u-tokyo.ac.jp	Effertz, Thomas/E-2930-2010; Fiala, André/AAA-3852-2019	Fiala, André/0000-0002-9745-5145; Hendrich, Oliver/0000-0003-1185-520X; Gopfert, Martin/0000-0001-8201-5334; Inagaki, Hidehiko/0000-0003-4580-2763; Kamikouchi, Azusa/0000-0003-1552-6892	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation; Japan Society for the Promotion of Science; DFG Collaborative Research Centre 554; Volkswagen Foundation; BMBF Bernstein Network for Computational Neuroscience; DFG Research Centre Molecular Physiology of the Brain; Human Frontier Science Program Organisation; BIRD/Japan Science and Technology Agency	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DFG Collaborative Research Centre 554(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); BMBF Bernstein Network for Computational Neuroscience(Federal Ministry of Education & Research (BMBF)); DFG Research Centre Molecular Physiology of the Brain(German Research Foundation (DFG)); Human Frontier Science Program Organisation(Human Frontier Science Program); BIRD/Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Japanese Cell Science Research Foundation, the Alexander von Humboldt Foundation, and the Japan Society for the Promotion of Science ( to A. K.), the DFG Collaborative Research Centre 554 ( to A. F.), the Volkswagen Foundation, the BMBF Bernstein Network for Computational Neuroscience, and the DFG Research Centre Molecular Physiology of the Brain ( to M. C. G.), and the Human Frontier Science Program Organisation, BIRD/Japan Science and Technology Agency, and the Japan Society for the Promotion of Science ( to K. I.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; ALBERT JT, 2006, NATURE PROTOCOLS, DOI DOI 10.1038/NPROT.2006.364; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Beckingham KM, 2005, ADV GENET, V55, P105, DOI 10.1016/S0065-2660(05)55004-1; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; FIALA A, 2003, SCI STKE, pP16; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; GOLDBERG ME, 2000, PRINCIPLES NEURAL SC, P801; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; HORN E, 1978, J COMP PHYSIOL, V126, P137, DOI 10.1007/BF00666366; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Keppel G., 2004, DESIGN ANAL RES HDB; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Newsome TP, 2000, DEVELOPMENT, V127, P851; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Phelan P, 1996, J NEUROSCI, V16, P1101; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Smith HK, 1996, DEV GENES EVOL, V206, P14, DOI 10.1007/s004270050026; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	43	251	257	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					165	U1		10.1038/nature07810	http://dx.doi.org/10.1038/nature07810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279630				2022-12-28	WOS:000264059700035
J	Delamothe, T				Delamothe, Tony			On the Contrary Cry freedom	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 11	2009	338								b982	10.1136/bmj.b982	http://dx.doi.org/10.1136/bmj.b982			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GA	19279065				2022-12-28	WOS:000264206100014
J	Streiff, MB; Haut, ER				Streiff, Michael B.; Haut, Elliott R.			The CMS Ruling on Venous Thromboembolism After Total Knee or Hip Arthroplasty Weighing Risks and Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECT THROMBIN INHIBITOR; DOUBLE-BLIND; DABIGATRAN ETEXILATE; PREVENTION; ENOXAPARIN; REPLACEMENT; XIMELAGATRAN; PROPHYLAXIS; TRIAL; THROMBOPROPHYLAXIS		[Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Streiff, MB (corresponding author), Johns Hopkins Med Inst, Dept Med, 1830 E Monument St,Ste 7300, Baltimore, MD 21205 USA.	mstreif@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X				Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Deep vein thrombosis (DVT)/pulmonary embolism (PE), 2008, FED REG, V73, P48480; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Michota FA, 2007, J GEN INTERN MED, V22, P1762, DOI 10.1007/s11606-007-0369-z; Turpie AGG, 2002, LANCET, V359, P1721, DOI 10.1016/S0140-6736(02)08648-8	15	62	66	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1063	1065		10.1001/jama.301.10.1063	http://dx.doi.org/10.1001/jama.301.10.1063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278950				2022-12-28	WOS:000264015800032
J	Horton, R				Horton, Richard			The occupied Palestinian territory: peace, justice, and health	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Abu-Mourad T, 2008, J EPIDEMIOL COMMUN H, V62, P701, DOI 10.1136/jech.2007.065243; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; BATNIJI R, 2009, LANCET, DOI DOI 10.1016/S0140-6736(O9)60110-0; Chalmers I, 2009, LANCET, V373, P788, DOI 10.1016/S0140-6736(09)60102-1; Commission on Human Security, 2003, HUM SEC NOW; Dugard J., 2008, HUMAN RIGHTS SITUATI; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; HORTON R, 2007, NEW YORK REV BO 0315, P22; *HOUS COMM INT DEV, 2007, DEV ASS OCC PAL TERR, V2; *HOUS COMM INT DEV, 2007, DEV ASS OCC PAL TERR, V1; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; KHOURI RG, 2009, INT HEARLD TRIB 0102, P7; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Mikolajczyk R. T., 2008, BMC PREGNANCY CHILDB, V8, P26, DOI [10.1186/1471-2393-8-26, DOI 10.1186/1471-2393-8-26]; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Santa Barbara J, 2004, LANCET, V364, P384; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; The World Bank, 2007, W BANK GAZ INV CLIM; *WHO, 2008, WHO STAT DIR GEN HLT; *WHO, 2008, WHO WARNS RIS DEATHS	21	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					784	788		10.1016/S0140-6736(09)60100-8	http://dx.doi.org/10.1016/S0140-6736(09)60100-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416BT	19268358				2022-12-28	WOS:000263980900005
J	Fiedler, D; Braberg, H; Mehta, M; Chechik, G; Cagney, G; Mukherjee, P; Silva, AC; Shales, M; Collins, SR; van Wageningen, S; Kemmeren, P; Holstege, FCP; Weissman, JS; Keogh, MC; Koller, D; Shokat, KM; Krogan, NJ				Fiedler, Dorothea; Braberg, Hannes; Mehta, Monika; Chechik, Gal; Cagney, Gerard; Mukherjee, Paromita; Silva, Andrea C.; Shales, Michael; Collins, Sean R.; van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.; Weissman, Jonathan S.; Keogh, Michael-Christopher; Koller, Daphne; Shokat, Kevan M.; Krogan, Nevan J.			Functional Organization of the S-cerevisiae Phosphorylation Network	CELL			English	Article							H2A VARIANT HTZ1; PROTEIN-KINASES; TRANSCRIPTION ELONGATION; SIGNALING PATHWAYS; GENETIC-ANALYSIS; IN-VIVO; YEAST; PHOSPHATASE; COMPLEX; ROLES	Reversible protein phosphorylation is a signaling mechanism involved in all cellular processes. To create a systems view of the signaling apparatus in budding yeast, we generated an epistatic miniarray profile (E-MAP) comprised of 100,000 pairwise, quantitative genetic interactions, including virtually all protein and small-molecule kinases and phosphatases as well as key cellular regulators. Quantitative genetic interaction mapping reveals factors working in compensatory pathways (negative genetic interactions) or those operating in linear pathways (positive genetic interactions). We found an enrichment of positive genetic interactions between kinases, phosphatases, and their substrates. In addition, we assembled a higher-order map from sets of three genes that display strong interactions with one another: triplets enriched for functional connectivity. The resulting network view provides insights into signaling pathway regulation and reveals a link between the cell-cycle kinase, Cak1, the Fus3 MAP kinase, and a pathway that regulates chromatin integrity during transcription by RNA polymerase II.	[Fiedler, Dorothea; Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Mehta, Monika; Mukherjee, Paromita; Silva, Andrea C.; Keogh, Michael-Christopher] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Chechik, Gal; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.] Univ Med Ctr Utrect, Dept Physiol Chem, Utrecht, Netherlands	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University College Dublin; Utrecht University; Utrecht University Medical Center	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	shokat@cmp.ucsf.edu; krogan@cmp.ucsf.edu	Silva, Andrea Cristina/K-8837-2014; Holstege, Frank/AAM-9944-2021; Silva, Andrea/O-8852-2019	Silva, Andrea Cristina/0000-0001-5248-5511; Chechik, Gal/0000-0001-9164-5303; Mehta, Monika/0000-0003-3928-3733; Kemmeren, Patrick/0000-0003-2237-7354; Collins, Sean/0000-0002-4276-5840; Cagney, Gerard/0000-0001-7189-9496; Weissman, Jonathan/0000-0003-2445-670X	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation; New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute; NIH; Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation(National Science Foundation (NSF)); New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Roguev, C. Kaplan, C. J. Ingles, P. Aguilar, T. Walther, J. H. Morris, and members of the Krogan, Shokat, and Keogh labs for advice and comments. We also thank W. A. Lim for discussion on MAP kinase cascades. We are grateful to A. Chan, E. Cheng, Y. Nijati, and Li Jieying for technical assistance. We thank F. Winston and S. Buratowski for providing yeast strains and B. Strahl, S. Hahn, and D. Morgan for sharing unpublished data. The work was supported by an Ernst Schering Postdoctoral Fellowship (D.F.), the Biophysics Graduate Group at UCSF (H.B.), the National Science Foundation (G.C. and D. K.), the New York Speakers Fund for Biomedical Research (M.-C.K.), the Howard Hughes Medical Institute (K.M.S.), the NIH (N.J.K. and K. M. S.), and Sandler Family Funding (N.J.K.).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cullen PJ, 2002, EUKARYOT CELL, V1, P884, DOI 10.1128/EC.1.6.884-894.2002; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Espinoza FH, 1998, MOL CELL BIOL, V18, P6365, DOI 10.1128/MCB.18.11.6365; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Green KD, 2007, J AM CHEM SOC, V129, P10, DOI 10.1021/ja066828o; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostapenko D, 2005, MOL CELL BIOL, V25, P3906, DOI 10.1128/MCB.25.10.3906-3913.2005; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Schaber M, 2002, MOL CELL BIOL, V22, P57, DOI 10.1128/MCB.22.1.57-68.2002; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zanzoni A, 2007, NUCLEIC ACIDS RES, V35, pD229, DOI 10.1093/nar/gkl922	68	198	202	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					952	963		10.1016/j.cell.2008.12.039	http://dx.doi.org/10.1016/j.cell.2008.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269370	Green Accepted, Bronze			2022-12-28	WOS:000263930900017
J	Gago, S; Elena, SF; Flores, R; Sanjuan, R				Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael			Extremely High Mutation Rate of a Hammerhead Viroid	SCIENCE			English	Article							EVOLUTION		[Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain; [Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Valencia	Sanjuan, R (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain.	rafael.sanjuan@uv.es	Elena, Santiago F./A-4191-2011; Flores, Ricardo/K-2788-2014; Gago Zachert, Selma/N-2902-2017	Elena, Santiago F./0000-0001-8249-5593; Flores, Ricardo/0000-0002-3033-5077; Gago Zachert, Selma/0000-0002-1084-2119; Sanjuan, Rafael/0000-0002-1844-545X	Spanish Ministerio de Ciencia e Innovacion [BFU2006-14819-C02-01/BMC, BFU2008-03154/BMC, BFU2008-03978/BMC]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion: BFU2006-14819-C02-01/BMC to S.F.E., BFU2008-03154/BMC to R.F., and BFU2008-03978/BMC to R.S. GenBank sequence accession numbers are FJ647228 to FJ647553.	DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Drake JW, 1998, GENETICS, V148, P1667; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duran-Vila N, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374153-0.00002-3; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W	8	154	162	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1308	1308		10.1126/science.1169202	http://dx.doi.org/10.1126/science.1169202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265013				2022-12-28	WOS:000263876700032
J	Conley, DJ; Paerl, HW; Howarth, RW; Boesch, DF; Seitzinger, SP; Havens, KE; Lancelot, C; Likens, GE				Conley, Daniel J.; Paerl, Hans W.; Howarth, Robert W.; Boesch, Donald F.; Seitzinger, Sybil P.; Havens, Karl E.; Lancelot, Christiane; Likens, Gene E.			ECOLOGY Controlling Eutrophication: Nitrogen and Phosphorus	SCIENCE			English	Editorial Material							LIMITING NUTRIENT; MANAGEMENT; LAKES; ECOSYSTEM; HYPOXIA; SEA		[Conley, Daniel J.] Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, SE-22362 Lund, Sweden; [Paerl, Hans W.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Howarth, Robert W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14873 USA; [Boesch, Donald F.] Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; [Havens, Karl E.] Royal Swedish Acad Sci, Int Geosphere Biosphere Programme, SE-10405 Stockholm, Sweden; [Havens, Karl E.] Univ Florida, Florida Sea Grant, Gainesville, FL 32611 USA; [Lancelot, Christiane] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Likens, Gene E.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA	Lund University; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University System of Maryland; University of Maryland Center for Environmental Science; Royal Swedish Academy of Sciences; State University System of Florida; University of Florida; Universite Libre de Bruxelles; Cary Institute of Ecosystem Studies	Conley, DJ (corresponding author), Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, Solvegatan 12, SE-22362 Lund, Sweden.	daniel.conley@geol.lu.se; hpaerl@email.unc.edu; rwh2@cornell.edu; boesch@umces.edu; sybil.seitzinger@igpb.kva.se; khavens@ufl.edu; lancelot@ulb.ac.be; likensg@ecostudies.org		Howarth, Robert/0000-0001-9531-4288; Boesch, Donald/0000-0002-8154-133X; Conley, Daniel Joseph/0000-0001-9668-9284				Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Havens KE, 2001, ENVIRON POLLUT, V111, P263, DOI 10.1016/S0269-7491(00)00074-9; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Howarth RW, 2005, MILLENNIUM ECOSYSTEM, P295; LIKENS GE, 1972, LIMNOLOGY OCEANOGRAP, V1, P328; Malone TC, 1996, ESTUARIES, V19, P371, DOI 10.2307/1352457; Marino R, 2006, MAR ECOL PROG SER, V309, P25, DOI 10.3354/meps309025; National Research Council, 2000, CLEAN COAST WAT UND; National Research Council, 1992, REST AQ EC; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Scavia D, 2007, ENVIRON SCI TECHNOL, V41, P8111, DOI 10.1021/es0714235; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Skogen MD, 2004, J MARINE SYST, V46, P23, DOI 10.1016/j.jmarsys.2003.11.013; Sylvan JB, 2007, LIMNOL OCEANOGR, V52, P2679, DOI 10.4319/lo.2007.52.6.2679; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; van Beusekom JEE, 2005, HELGOLAND MAR RES, V59, P45, DOI 10.1007/s10152-004-0206-2; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wulff F, 2007, AMBIO, V36, P243, DOI 10.1579/0044-7447(2007)36[243:MOAEOA]2.0.CO;2	27	2363	2639	126	2448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1014	1015		10.1126/science.1167755	http://dx.doi.org/10.1126/science.1167755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229022				2022-12-28	WOS:000263478400024
J	Lewis, SL; Lopez-Gonzalez, G; Sonke, B; Affum-Baffoe, K; Baker, TR; Ojo, LO; Phillips, OL; Reitsma, JM; White, L; Comiskey, JA; Djuikouo, MN; Ewango, CEN; Feldpausch, TR; Hamilton, AC; Gloor, M; Hart, T; Hladik, A; Lloyd, J; Lovett, JC; Makana, JR; Malhi, Y; Mbago, FM; Ndangalasi, HJ; Peacock, J; Peh, KSH; Sheil, D; Sunderland, T; Swaine, MD; Taplin, J; Taylor, D; Thomas, SC; Votere, R; Woll, H				Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Sonke, Bonaventure; Affum-Baffoe, Kofi; Baker, Timothy R.; Ojo, Lucas O.; Phillips, Oliver L.; Reitsma, Jan M.; White, Lee; Comiskey, James A.; Djuikouo K., Marie-Noel; Ewango, Corneille E. N.; Feldpausch, Ted R.; Hamilton, Alan C.; Gloor, Manuel; Hart, Terese; Hladik, Annette; Lloyd, Jon; Lovett, Jon C.; Makana, Jean-Remy; Malhi, Yadvinder; Mbago, Frank M.; Ndangalasi, Henry J.; Peacock, Julie; Peh, Kelvin S. -H.; Sheil, Douglas; Sunderland, Terry; Swaine, Michael D.; Taplin, James; Taylor, David; Thomas, Sean C.; Votere, Raymond; Woell, Hannsjoerg			Increasing carbon storage in intact African tropical forests	NATURE			English	Article							CLIMATE; BIOMASS; IMPACTS; BALANCE; CYCLE	The response of terrestrial vegetation to a globally changing environment is central to predictions of future levels of atmospheric carbon dioxide(1,2). The role of tropical forests is critical because they are carbon- dense and highly productive(3,4). Inventory plots across Amazonia show that old- growth forests have increased in carbon storage over recent decades(5-7), but the response of one- third of the world's tropical forests in Africa(8) is largely unknown owing to an absence of spatially extensive observation networks(9,10). Here we report data from a ten- country network of long- term monitoring plots in African tropical forests. We find that across 79 plots ( 163 ha) above- ground carbon storage in live trees increased by 0.63 Mg C ha(-1) yr(-1) between 1968 and 2007 ( 95% confidence interval ( CI), 0.22 - 0.94; mean interval, 1987 - 96). Extrapolation to unmeasured forest components ( live roots, small trees, necromass) and scaling to the continent implies a total increase in carbon storage in African tropical forest trees of 0.34 Pg C yr(-1) ( CI, 0.15 - 0.43). These reported changes in carbon storage are similar to those reported for Amazonian forests per unit area(6,7), providing evidence that increasing carbon storage in old- growth forests is a pan- tropical phenomenon. Indeed, combining all standardized inventory data from this study and from tropical America and Asia(5,6,11) together yields a comparable figure of 0.49 Mg C ha(-1) yr(-1) (n = 156; 562 ha; CI, 0.29 - 0.66; mean interval, 1987 - 97). This indicates a carbon sink of 1.3 Pg C yr(-1) ( CI, 0.8 - 1.6) across all tropical forests during recent decades. Taxon- specific analyses of African inventory and other data(12) suggest that widespread changes in resource availability, such as increasing atmospheric carbon dioxide concentrations, may be the cause of the increase in carbon stocks(13), as some theory(14) and models(2,10,15) predict.	[Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Baker, Timothy R.; Phillips, Oliver L.; Feldpausch, Ted R.; Gloor, Manuel; Lloyd, Jon; Peacock, Julie; Peh, Kelvin S. -H.] Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Sonke, Bonaventure; Djuikouo K., Marie-Noel] Univ Yaounde I, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Affum-Baffoe, Kofi; Votere, Raymond] Forestry Commiss Ghana, Resource Management Support Ctr, Kumasi, Ghana; [Ojo, Lucas O.] Univ Agr, Dept Environm Management & Toxicol, Abeokuta, Ogun, Nigeria; [Reitsma, Jan M.] Bur Waardenburg BV, NL-4100 AJ Culemborg, Netherlands; [White, Lee] IRET, Libreville, Gabon; [Comiskey, James A.; Sunderland, Terry] Smithsonian Inst, SI MAB Biodivers Program, Washington, DC 20560 USA; [Ewango, Corneille E. N.] Univ Wageningen & Res Ctr, Dept Environm Sci, Forest Ecol & Management Grp, NL-6700 Wageningen, Netherlands; [Hamilton, Alan C.] Plantlife Int, Salisbury SP1 1DX, Wilts, England; [Hart, Terese; Makana, Jean-Remy] Wildlife Conservat Soc DRC, Kinshasa, DEM REP CONGO; [Hladik, Annette] MNHN, Dept Hommes Nat Soc, F-91800 Brunoy, France; [Lovett, Jon C.; Taplin, James] Univ York, Dept Environm, Ctr Ecol Law & Policy, York YO10 5DD, N Yorkshire, England; [Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Mbago, Frank M.; Ndangalasi, Henry J.] Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; [Sheil, Douglas] Ctr Int Forestry Res, Bogor 16000, Indonesia; [Swaine, Michael D.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; [Taylor, David] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Geog, Dublin 2, Ireland; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada	University of Leeds; University of Yaounde I; University of Agriculture, Abeokuta; Smithsonian Institution; Wageningen University & Research; Museum National d'Histoire Naturelle (MNHN); University of York - UK; University of Oxford; University of Dar es Salaam; CGIAR; Center for International Forestry Research (CIFOR); University of Aberdeen; Trinity College Dublin; University of Toronto	Lewis, SL (corresponding author), Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	Phillips, Oliver/A-1523-2011; Sheil, Douglas/N-3291-2019; Sunderland, Terence/AAE-7851-2019; Lloyd, Jonathan J/F-8893-2010; Mitchard, Edward T A/C-6346-2009; Ndangalasi, Henry Joseph/ABD-8651-2020; Sheil, Douglas/A-3867-2015; THOMAS, Sean C./B-6089-2008; Sheil, Douglas/H-1466-2012; Peh, Kelvin/C-3408-2013; Feldpausch, Ted/D-3436-2009; Feldpausch, Ted/ABH-3123-2020	Phillips, Oliver/0000-0002-8993-6168; Sunderland, Terence/0000-0002-1985-9849; Lloyd, Jonathan J/0000-0002-5458-9960; Mitchard, Edward T A/0000-0002-5690-4055; Ndangalasi, Henry Joseph/0000-0003-3738-6405; Sheil, Douglas/0000-0002-1166-6591; THOMAS, Sean C./0000-0002-0686-2483; Peh, Kelvin/0000-0002-2921-1341; Feldpausch, Ted/0000-0002-6631-7962; Feldpausch, Ted/0000-0002-6631-7962; Taylor, David/0000-0002-6098-5636; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Makana, Jean-Remy/0000-0002-6006-2938; Lewis, Simon/0000-0002-8066-6851; Comiskey, James/0000-0001-6710-1269	Royal Society and the Natural Environment Research Council (UK); NERC [NE/D005590/1] Funding Source: UKRI; Natural Environment Research Council [NE/D005590/1, NE/D000300/1, NE/B503384/1, NE/B504630/1] Funding Source: researchfish	Royal Society and the Natural Environment Research Council (UK); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the villagers from Oban (Nigeria), Prince Town, Baneekurom and Dadieso (Ghana), Somolomo, Mekas, Lomie and Alat Makay (Cameroon) and Ekobakoba (Gabon) for hosting our fieldwork, and A. Moungazi, S. Mbadinga, H. Bourobou, L. N. Banak, T. Nzebi, K. Jeffery, SEGC/CIRMF/WCS Research Station Lope, K. Ntim, K. Opoku, Forestry Commission of Ghana, T. Tafoek, Federal University of Agriculture, Abeokuta, Nigeria, ECOFAC- Cameroon, Cameroon Ministry Scientific Research and Innovation, Cameroon Ministry of Forests and Fauna (MINFOF), Forest Development Authority (Liberia), S. Grahame, R. Lowe, L. Banin and K. C. Nguembou for field assistance and logistical support. We thank R. Condit for helping access the Edoro and Lenda data sets, C. Chatelain for providing data from the African Flowering Plants database to standardize our species identifications, J. Chave for providing allometric data, L. Poorter for providing gap size- frequency data, B. Nelson for providing large- scale blow- down data, D. Appleyard for assistance with the plot map, and the Network for Vegetation Function (Nation Evolutionary Synthesis Center and ARC-NZ) for providing some wood mass density data. This work was supported by the Royal Society and the Natural Environment Research Council ( UK).	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Ciais P, 2008, BIOGEOSCIENCES, V5, P1259, DOI 10.5194/bg-5-1259-2008; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Deans JD, 1996, FOREST ECOL MANAG, V88, P215, DOI 10.1016/S0378-1127(96)03843-1; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Houghton RA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000076; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Ngomanda A, 2007, QUATERNARY RES, V67, P411, DOI 10.1016/j.yqres.2007.01.006; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Urquiza-Haas T, 2007, FOREST ECOL MANAG, V247, P80, DOI 10.1016/j.foreco.2007.04.015; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3	30	651	687	12	352	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1003	U3		10.1038/nature07771	http://dx.doi.org/10.1038/nature07771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225523				2022-12-28	WOS:000263425400040
J	Post, R				Post, Robert			Prescribing Records and the First Amendment-New Hampshire's Data-Mining Statute	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Post, Robert] Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Post, R (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Post R, 2000, UCLA LAW REV, V48, P1; Post R, 2007, U ILLINOIS LAW REV, P939	2	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					745	747		10.1056/NEJMp0810339	http://dx.doi.org/10.1056/NEJMp0810339			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228615				2022-12-28	WOS:000263411300001
J	Yan, H; Parsons, DW; Jin, GL; McLendon, R; Rasheed, BA; Yuan, WS; Kos, I; Batinic-Haberle, I; Jones, S; Riggins, GJ; Friedman, H; Friedman, A; Reardon, D; Herndon, J; Kinzler, KW; Velculescu, VE; Vogelstein, B; Bigner, DD				Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.			IDH1 and IDH2 Mutations in Gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; COMPARATIVE GENOMIC HYBRIDIZATION; FACTOR RECEPTOR GENE; MALIGNANT GLIOMAS; GLIOBLASTOMA; PATHWAYS; AMPLIFICATION; EXPRESSION; MECHANISM; MAJORITY	Background A recent genomewide mutational analysis of glioblastomas ( World Health Organization [ WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene ( IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower- grade gliomas ( secondary glioblastomas). Methods We determined the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system ( CNS) tumors and 494 non- CNS tumors. The enzymatic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was determined in cultured glioma cells that were transfected with these genes. Results We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower- grade lesions. Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid ( R172) of the IDH2 gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild- type IDH genes. Each of four tested IDH1 and IDH2 mutations reduced the enzymatic activity of the encoded protein. Conclusions Mutations of NADP(+)-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.	[Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Kos, Ivan; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Henry] Duke Univ, Med Ctr, Dept Neurooncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Allan; Reardon, David] Duke Univ, Med Ctr, Dept Surg, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Kos, Ivan; Batinic-Haberle, Ines; Friedman, Henry; Friedman, Allan; Reardon, David; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Herndon, James] Duke Univ, Med Ctr, Canc Stat Ctr, Durham, NC 27710 USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Riggins, Gregory J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yuan, Weishi] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; US Food & Drug Administration (FDA)	Yan, H (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	yan00002@mc.duke.edu; dwparson@txccc.org	Jin, Genglin/F-6868-2011; Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins [R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, 2P30-CA-14236]; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University; NATIONAL CANCER INSTITUTE [R01CA140316, P50CA062924, R01CA121113, R37CA057345, P50CA108786, R01CA118822, R37CA011898, R37CA043460, P30CA014236, R01CA043460, R01CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Pediatric Brain Tumor Foundation Institute, a Damon Runyon Foundation Scholar Award, a grant from the Southeastern Brain Tumor Foundation, Alex's Lemonade Stand Foundation, a grant from the V Foundation for Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Pew Charitable Trusts, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, grants (R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, and 2P30-CA-14236) from Beckman Coulter, and grants from the Accelerate Brain Cancer Cure Foundation.; Drs. Yan, Parsons, Jones, Kinzler, Velculescu, Vogelstein, and Bigner report being eligible for royalties received by Johns Hopkins University on sales of products related to research described in this article, under licensing agreements between the university and Beckman Coulter. No other potential conflict of interest relevant to this article was reported.; The views expressed in this article are those of the authors and do not necessarily represent the official views of the Food and Drug Administration.; We thank Melissa J. Ehinger, Diane L. Satterfield, Eric Lipp, Michael Leonard, Jennifer D. Funkhouser, and Patrick Killela for their assistance with the clinical information; P. Buckhaults, S. Powell, S. Kern, J. Eshleman, C. Civin, I.- M. Shih, and A. Gazdar for providing DNA from non-central nervous system cancers; and Dr. A. T. Campagnoni at the University of California, Los Angeles, for donating the human oligodendroglioma cell line.	Batinic-Haberle I, 2008, FREE RADICAL RES, V42, P618, DOI 10.1080/10715760802209639; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Burger PC, 2000, PATHOLOGY GENETICS T, P45; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Jennings GT, 1997, BIOCHEMISTRY-US, V36, P13743, DOI 10.1021/bi970916r; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RIEFENBERGER J, 1994, AM J PATHOL, V145, P1175; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; The WHO, 2020, CLASSIFICATION TUMOU; Ueki K, 1996, CANCER RES, V56, P150; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Weber RG, 1996, ONCOGENE, V13, P983; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200	24	3919	4094	12	299	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					765	773		10.1056/NEJMoa0808710	http://dx.doi.org/10.1056/NEJMoa0808710			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228619	Green Accepted			2022-12-28	WOS:000263411300006
